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Introduction Ventilator-associated pneumonia (VAP) is the most com-
mon ICU-acquired infection in intubated critically ill patients. Micro-
aspiration of gastric and oropharyngeal contaminated secretions 
represents the primary mechanism involved in the pathogenesis of 
VAP. Tracheal cuff plays an important role in stopping the progression 
of contaminated secretions into the lower respiratory tract. In vitro and 
animal studies suggested that leakage was significantly reduced with 
polyvinyl chloride (PVC) conical-cuffed tubes compared with barrel 
(standard) or cylindrical cuffs. Clinical studies found conflicting results. 
Therefore, the aim of this study is to determine the superiority of PVC 
conical- versus barrel (standard)-cuffed tracheal tube on abundant 
microaspiration of gastric contents in intubated critically ill patients.
Materials and methods BEST CUFF is a prospective multicenter (ten 
French ICUs) cluster randomized controlled crossover and open-label 
trial performed in patients with predicted duration of mechanical 
ventilation ≥48  h. Patients were allocated to be intubated using a 
PVC standard (barrel)-shaped or a PVC conical-shaped tracheal tube. 
Prevention measures of VAP were standardized in all ICUs. The main 
objective was to demonstrate the superiority of conical versus stand-
ard cuff shape in reducing abundant microaspiration of gastric con-
tents (pepsin level >200 ng/ml in at least 30 % of tracheal aspirates). 
After inclusion, tracheal aspirates were collected for 48 h to measure 
pepsin and salivary amylase, and diagnose gastric and oropharyngeal 
microaspiration. To diagnose tracheobronchial colonization, quanti-
tative aspirate was performed after intubation and two times a week 
until extubation. In patients with suspected VAP, quantitative tracheal 
aspirate or bronchoalveolar lavage was performed to confirm the 
diagnosis. We hypothesized that the use of conical-cuffed tracheal 
tubes would reduce the incidence of abundant microaspiration of gas-
tric contents from 50 to 30 % of study patients. With a two-sided alpha 
risk of 5 %, a power of 80 %, and to account for an anticipated rate of 
10 % of patients without any tracheal secretions, 312 patients had to 
be recruited.
Results A total of 326 patients were included during the study period 
(June 2014–September 2015). Pepsin and salivary amylase measure-
ment is actually performed, and all results should be available in Novem-
ber 2015. Statistical analyses will be performed in mid-December, and 
study results will be presented at the 2016 Réanimation Congress.
Discussion Our study is sufficiently powered to detect a significant 
difference in microaspiration of gastric contents between patients 
intubated with conical-cuffed tracheal tubes and standard-cuffed tra-
cheal tubes. One of the strengths of this study is the use of quantita-
tive measurement of pepsin as a marker of microaspiration.
Conclusion BEST CUFF is the first randomized controlled study evalu-
ating the impact of PVC tracheal cuff shape on microaspiration of gas-




Bicarbonate versus saline for contrast‑induced acute kidney 
injury prevention in critically ill patients
Xavier Valette1, Isabelle Desmeulles2, Benoit Savary3, Romain Masson2, 
Amélie Seguin1, Cédric Daubin1, Bertrand Sauneuf1, Jennifer Brunet2, 
Pierre Verrier1, Véronique Pottier2, Marie Orabona2, Désiré Samba2, Gérald 
Viquesnel2, Mathilde Lermuzeaux2, Pascal Hazera3, Jean‑Luc Hanouz2, 
Jean‑Jacques Parienti4, Damien Du Cheyron1
1Réanimation médicale, C.H.U de Caen, Caen, France; 2Réanimation 
chirurgicale, C.H.U de Caen, Caen, France; 3Réanimation polyvalente, 
C.H. Mémorial France ‑ Etats‑Unis (Saint‑Lô), Saint‑Lô, France; 4Unité de 
biostatistique et de recherche clinique, C.H.U de Caen, Caen, France 
Correspondence: Xavier Valette ‑ valette3l2ax@sfr.fr 
Annals of Intensive Care 2016, 6(Suppl 1):O2
Introduction The administration of contrast media for imaging and 
interventional procedures is frequent in intensive care unit (ICU). 
Whether volume expansion with bicarbonate is better than isotonic 
saline to reduce the risk of contrast-induced acute kidney injury (CI-
AKI) in critically ill patients is unknown.
Materials and methods The HYDRAREA study was a randomized, 
double-blind, multicenter trial including adults admitted in three ICUs 
in France who received intravascular contrast media. Patients with 
unstable renal function (increase in serum creatinine level of at least 
0.3 mg/dL during the previous 48 h, anuria during the previous 12 h, 
renal replacement therapy) or contraindication to volume expansion 
Open Access
Page 2 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
or bicarbonate load (uncontrolled cardiogenic pulmonary edema, 
metabolic alkalosis with pH >7.50, hypokalemia <3  mmol/L, chronic 
hypercapnia) were not included. Patients were randomized in a 1:1 
ratio to receive 0.9  % sodium chloride or 1.4  % sodium bicarbonate 
administered with the same infusion protocol: 3 mL/kg for 1 h started 
before contrast media administration followed by 1  mL/kg/h for 6  h. 
The primary outcome was the incidence of CI-AKI defined by the Acute 
Kidney Injury Network criteria within 72  h after contrast medium 
administration. Secondary outcomes included CI-AKI using alterna-
tive definitions (AKIN without urine output criteria, RIFLE classification, 
creatinine increase ≥0.5 mg/dL or 25 %), need for renal replacement 
therapy, ICU length of stay and mortality.
Results Among the 307 patients randomized, the mean (SD) age 
was 56 ± 15 years and 208 (68 %) patients were male. Patients were 
admitted in ICU for medical reason in 132 (43  %) patients, for emer-
gency surgery in 118 (38  %) patients, following trauma in 45 (15  %) 
patients and after a scheduled surgery in 12 (4 %) patients. The mean 
(SD) SAPS II and SOFA scores at ICU admission were 42 ± 17 and 7 ± 4, 
respectively. Contrast media were used for computed tomography 
in 193 (63  %) patients and for arteriography in 114 (37  %) patients. 
Low-osmolar contrast media were used in 276 (90  %) patients. At 
randomization, 243 (79  %) patients were under mechanical ventila-
tion, 100 (33 %) patients needed vasopressor, 104 (34 %) patients had 
sepsis, and 40 (13 %) patients had a RIFLE stage equal or higher than 
the “Risk of Kidney Injury” class. Patient characteristics were well bal-
anced between groups excepted for the use of nephrotoxic medica-
tions which was more common in saline group (40 (26 %) patients vs 
59 (38 %) patients; p < 0.05).
As expected, patients receiving bicarbonate (n  =  151) had higher 
urinary pH at the end of the infusion than patients receiving saline 
(n = 156) (6.7 ± 2.1 vs 6.2 ± 1.8, respectively; p < 0.001). The incidence 
of CI-AKI was similar in both groups: 52 (33.3  %) patients in saline 
group and 53 (35 %) patients in bicarbonate group (RR 0.96; 95 % CI 
[0.70–1.30]; p = 0.81). There was no difference between groups what-
ever the definition used to define CI-AKI. The need for renal replace-
ment therapy (five (3.2 %) patients in saline group vs six (4 %) patients 
in bicarbonate group; RR 0.81; 95  % CI [0.25–2.59]; p  =  0.77), ICU 
length of stay (24.7 ± 22.9 days in saline group vs 23 ± 23.8 days in 
bicarbonate group, p = 0.52) and mortality (25 (16 %) patients in saline 
group vs 24 (15.9 %) patients in bicarbonate group; RR 1.00; 95 % CI 
[0.60–1.68]; p = 0.97) were also similar between groups.
Conclusion Hydration with sodium bicarbonate for CI-AKI preven-
tion in critically ill patients does not provide supplementary beneficial 
effect in comparison with hydration by isotonic sodium chloride.
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Introduction Neurally adjusted ventilatory assist (NAVA) is a ventila-
tory mode that tailors the level of assistance delivered by the ventila-
tor to the electromyographic activity of the diaphragm. The objective 
of the present study was to compare the impact of mechanical ven-
tilation with NAVA or pressure support ventilation (PSV) on the early 
phase of weaning from mechanical ventilation.
Patients and methods A multicenter randomized controlled trial of 
128 intubated adults recovering from an acute respiratory failure was 
conducted in 11 intensive care units (ICUs) from April 2010 to June 
2012. Patients were randomly assigned to NAVA or PSV. The primary 
endpoint was the probability to remain in an assisted mode during 
the entire first 48 h. Secondary endpoints included asynchrony index, 
duration of mechanical ventilation and hospital mortality at 28 days.
Results The proportion of patients remaining in an assisted mode dur-
ing the entire first 48 h was 67.7 % in the NAVA group versus 69.4 % in 
the PSV group (p = 0.47). The time spend in an assisted mode similar 
in the two groups (47 [43–48] vs. 47 [40–48], p = 0.55). The asynchrony 
index was lower in the NAVA group (19.7 vs. 32.6  %). Duration of 
mechanical ventilation was similar in the two groups (12.0 [7.0–17.0] 
in the NAVA group vs. 13.5 [10.0–21.0] in the PSV group, p = 0.121) as 
was the ICU mortality rate (12.9 vs. 21.2  %, p =  0.21). More patients 
required post-extubation noninvasive mechanical ventilation in the 
PSV group (66.6 vs. 43.5 %, p = 0.008).
Conclusion NAVA can be applied efficiently in a clinical setting and 
improves patient ventilator interaction. However, NAVA does not increase 
the probability to remain in an assisted mode during the first 48 h.
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Introduction We compared hemodynamic and biological effects 
of the Cascade system, which uses very high volume hemofiltration 
(HVHF) (120 ml/kg/h), with those of usual care in patients with septic 
shock.
Patients and methods Multicenter, prospective, randomized, open-
label trial was conducted in three intensive care units (ICU). Adults 
with septic shock with administration of epinephrine/norepinephrine 
were eligible. Patients were randomized to usual care plus HVHF (Cas-
cade group) or usual care alone (Control group). Primary endpoint was 
the number of catecholamine-free days up to 28 days after randomi-
zation. Secondary endpoints were number of days free of mechanical 
ventilation, renal replacement therapy (RRT) or ICU up to 90 days, and 
7-, 28- and 90-day mortality.
Results We included 60 patients (29 Cascade and 31 usual care). Base-
line characteristics were comparable. Median number of catechola-
mine-free days was 22 [IQR 11–23] versus 20 [0–25] for Cascade versus 
Control; there was no significant difference even after adjustment. 
There was no significant difference in number of mechanical ventila-
tion-free days or ICU requirement. Median number of RRT-free days 
was 85 [46–90] versus 74 [0–90] for Cascade versus Control groups, 
p  =  0.42. By multivariate analysis, the number of RRT-free days was 
significantly higher in the Cascade group (up to 25 days higher after 
adjustment). There was no difference in mortality at 7, 28 or 90 days.
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Conclusion Very HVHF using the Cascade system can safely be used in 
patients presenting septic shock, but was not associated with a reduc-
tion in the need for catecholamines during the first 28 days.
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Introduction Although rapid response systems (RRSs) are known to 
reduce in hospital cardiac arrest rate, their effect on mortality remains 
in question. The present study aimed at evaluating the effect of a med-
ical emergency team (MET) implementation on mortality in hospital-
ized patients.
Patients and methods A prospective study was conducted in the four 
hospitals of the regional healthcare center of Montpellier, France. An 
intensivist-led MET was implemented on a 24/7 basis in only one of 
the four hospitals from January 2012 to June 2012. Patients >18 years 
admitted for more than 24 h in the medical-surgical wards from July 
2010 to December 2011 (pre-MET period) and from July 2012 to 
December 2013 (MET period) were included. The main outcome was 
unexpected mortality in hospitalized patients. An updated systematic 
review and meta-analysis were also performed.
Results A total of 137,251 patients were admitted for 24 h or more in 
the medical-surgical wards during the pre-MET and MET periods. MET 
implementation was associated with a decrease in unexpected mor-
tality rate in the hospital that implemented MET (from 21.9 to 17.4 per 
1000 admissions; P = 0.002). Reduction in unexpected mortality asso-
ciated with MET implementation could be estimated at 1.5 lives saved 
per week in the MET hospital. In the three other hospitals, mortality 
rate was not significantly modified (from 19.5 to 19.9 per 1000 admis-
sions; P  =  0.69). Patients in the MET hospital were more frequently 
admitted to the intensive care unit (ICU) during the MET period (45.8 
vs 52.9 per 1000; P = 0.002), and their sequential organ failure assess-
ment (SOFA) score upon ICU admission significantly decreased from 
7 [4–10] to 5 [2–9]; P  <  0.001. The updated meta-analysis including 
the present results showed that RRS was associated with a significant 
decrease in both unexpected (OR 0.51; 95 % CI 0.35–0.76) and overall 
mortality (OR 0.89; 95 % CI 0.85–0.93).
Conclusion In the present prospective study, implementation of a 
MET was associated with a decrease in unexpected and overall mortal-
ity. Updated meta-analysis confirms the benefit of RRS on unexpected 
and overall mortality (Fig. 1).
Competing interests None.
O6  
Beta‑lactams serum concentrations in critically ill cirrhotic 
patients: a matched control study
Olivier Lheureux1, Eric Trepo2, Maya Hites3, Frederic Cotton4, Fleur Wolff4, 
Rudy Surin3, Jacques Créteur1, Jean‑Louis Vincent1, Thierry Gustot2, 
Frederique Jacobs3, Fabio Silvio Taccone1
1Service de soins intensifs, Hospital Erasme, Brussel, Belgium; 2Service de 
gastroentérologie, Hospital Erasme, Brussel, Belgium; 3Service de mala‑
dies infectieuses, Hospital Erasme, Brussel, Belgium; 4Service de biochimie 
médicale, Hospital Erasme, Brussel, Belgium 
Correspondence: Olivier Lheureux ‑ olheureu@ulb.ac.be 
Annals of Intensive Care 2016, 6(Suppl 1):O6
Introduction Few data are available on the pharmacokinetics of 
β-lactams in critically ill cirrhotic patients. The objective of this study 
was to evaluate whether β-lactam concentrations were altered in 
patients with cirrhosis compared with other critically ill patients and to 
identify the principal risk factors for any differences.
Materials and methods We reviewed data from critically ill cirrhotic 
patients and matched controls in which routine therapeutic drug 
monitoring of broad-spectrum β-lactam antibiotics (piperacillin/
tazobactam; meropenem) was performed. Serum drug concentra-
tions were measured twice during the elimination phase by high-per-
formance liquid chromatography. Antibiotic pharmacokinetics was 
calculated using a one-compartment model. We considered therapy 
was adequate when serum drug concentrations were between 4 and 
8 times the minimal inhibitory concentration of Pseudomonas aerugi-
nosa during optimal periods of time for each drug ≥50 % for piperacil-
lin/tazobactam; ≥40 % for meropenem).
Results We studied 38 cirrhotic patients (16 for piperacillin/tazobac-
tam and 22 for meropenem) and 38 matched controls. Drug dosing 
was similar in the two groups. The pharmacokinetic analysis showed 
a lower volume of distribution of meropenem (p = 0.05) and a lower 
antibiotic clearance of piperacillin/tazobactam (p = 0.009) in patients 
with cirrhosis when compared to non-cirrhotic patients. Patients with 
cirrhosis more often had excessive (23/38) than insufficient (5/38) or 
adequate (10/38) serum β-lactam concentrations; they also had exces-
sive drug concentrations more frequently than did control patients 
(23/38 vs. 13/38—p  =  0.02), particularly for piperacillin/tazobactam 
(9/16 vs. 2/16—p  =  0.01). The only variable significantly associated 
with insufficient drug concentrations was the creatinine clearance on 
the day of the therapeutic drug monitoring. No specific variable was 
associated with excessive drug concentrations.
Conclusion This case–control study shows that standard doses of 
β-lactams result in excessive serum concentrations in two-thirds of 
critically ill patients with cirrhosis, especially in those treated with 
piperacillin/tazobactam. Our results support routine β-lactam thera-
peutic drug monitoring in this patient population.
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Fig. 1 Evolution of unexpected death rate per 1000 admissions by 
month in the MET pavilion (left side) and in the three other pavilions 
(right side). Dotted lines represent the mean rate per month. Grey 
rectangles represent the standard deviations
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Introduction Oxacillin and cloxacillin are the most frequently used 
penicillins for the treatment of severe methicillin-susceptible Staphylo-
coccus aureus (MSSA) infections in intensive care units (ICU), especially 
endocarditis. No adaptation of the dosage is required in case of renal 
failure. We wanted to assess the risk factors for overdosing in ICU, and 
the related observed side effects.
Patients and methods All patients with a therapeutic drug moni-
toring (TDM) of oxa- or cloxa-cillin between 2008 and 2014 were 
included. The optimal trough concentration was considered to be 
20 mg/L, i.e., 10 times the minimum inhibitory concentration of cloxax-
illin for MSSA. Data concerning the medical history, the characteristics 
of the infection, the given treatment, the renal function and the attrib-
uted side effects of overdosing were collected. A negative binomial 
model was used to compute the measured trough concentrations.
Results Sixty-two patients were included in this study. We found 
a median trough plasma concentration of 134.3  mg/L [IQR 65.3–
201  mg/L]. Only one patient reached the target concentration; all 
other patients were overdosed. Eleven patients (17.7 %) experienced 
neurological side effects attributed to a high antibiotic concentration, 
i.e., persistent coma and delirium. When adjusted on the dosage used, 
the first trough concentration was significantly increased by a creati-
nine clearance below 10 ml/min (with or without hemodialysis) and by 
endocarditis as the source of infection (Fig. 2).
Conclusion With the recommended dose of 12  g/day for cloxacillin 
treatment in case of endocarditis and severe infections occurring in 
ICU, almost all patients are largely overdosed. Considering the high 
frequency of observed side effects, doses should be accurately moni-
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Introduction More than half of adult patients receiving extracorpor-
eal membrane oxygenation (ECMO) require an antibiotic therapy dur-
ing their stay in ICU. Amikacin is the most used aminoglycoside for 
the treatment of septic shock given its good bactericidal activity on 
Pseudomonas aeruginosa and the low resistance rate observed with 
the other Gram-negative bacilli. However, data on pharmacokinetics 
of amikacin in patients receiving ECMO support have scantly been 
studied in these conditions. We aimed to report on the distribution of 
peak serum concentration (Cmax) of amikacin and on factors associated 
with insufficient Cmax in a population of critically ill patients receiving 
ECMO.
Materials and methods We conducted an observational single-center 
study of patients admitted to a general ICU. Inclusion criteria were: (1) 
age ≥18 years and (2) a suspected Gram-negative infection requiring a 
loading dose of intravenous amikacin. Amikacin was routinely admin-
istered intravenously at a dose of 25 mg/kg of total body weight over a 
30-min infusion time. Cmax was measured 30 min after the end of infu-
sion and trough serum concentration 24  h after the end of infusion 
(Cmin). ECMO patients were matched with critically ill patients without 
ECMO support (controls) for characteristics that had been previously 
identified as independent predictors for insufficient Cmax, namely 
body mass index (BMI), cirrhosis and 24-h fluid balance. An amikacin 
Cmax >60 mg/L and <80 mg/l was considered the target concentration 
(adequate drug concentrations). An amikacin Cmax <60 mg/L was con-
sidered as an insufficient drug concentration, and a Cmax >80 mg/l was 
considered as an excessive one. The primary outcome was the distri-
bution of Cmax (mg/L) between ECMO patients and controls.
Results A total of 50 episodes in 46 ECMO patients were matched with 
50 controls. Baseline characteristics did not differ between groups, 
except for age (61 vs. 63.5 years), reason for ICU admission and SOFA 
score (12 [10–14] vs. 9 [6–11]). At the day of Cmax, in ECMO patients the 
SOFA score was 9 [5.3–9.8], and 100  % episodes required mechani-
cal ventilation, 96  % vasopressors and 44  % renal replacement ther-
apy. There were no significant differences in serum concentrations 
between ECMO and non-ECMO patients: The amikacin Cmax was 71.7 
[58.9–79.7] mg/l for ECMO patients versus 68.4 [53–81] mg/l for non-
ECMO patients (p = 0.36). The proportion of insufficient [13/50 (26 %) 
episodes vs. 17/50 (34 %) episodes), adequate (25/50 (50 %) episodes 
vs. 18/50 (36  %) episodes] and excessive [12/50 (24  %) episodes vs. 
15/50 (30 %) episodes] drug concentrations was similar in ECMO and 
non-ECMO patients (Table  1). Cmin was measured in 43 (86  %) epi-
sodes, and 28/43 (65 %) measurements were above the toxic threshold 
of 5 mg/L in ECMO patients versus 30/50 (60 %) in non-ECMO patients.
Conclusion ECMO therapy did not significantly impact on peak and 
trough serum concentrations of amikacin.
Competing interests None.
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Introduction Infections caused by multi-drug-resistant (MDR) Gram-
negative (GN) organisms in critically ill patients are a therapeutic chal-
lenge. The administration of high-dose aminoglycoside (HDA) therapy 
coupled with high-flow continuous venovenous hemodiafiltration 
(CVVHDF) could allow required high drug peaks to be achieved with 
acceptable drug elimination.
Patients and methods All adult patients present on the intensive care 
unit (ICU) between October 2009 and July 2014 who had MDR-GN 
sepsis were considered for HDA and high-flow (>45 mL/kg/h) CVVHDF 
when an isolated pathogen was susceptible or intermediate suscepti-
ble to aminoglycosides, and the patient’s condition was not improving 
with conventional therapy. Optimal antibacterial activity was defined 
as a peak concentration of at least eight times the minimal inhibitory 
concentration.
Results Fifteen patients infected with MDR-GN pathogens (11 with 
Pseudomonas aeruginosa; ten with abdominal and five with res-
piratory infections) were treated with amikacin (n =  11), gentamicin 
(n = 3) or tobramycin (n = 1) and high-flow CVVHDF. A favorable clini-
cal response was observed in eight (53  %) patients, including three 
in whom microbial eradication was obtained. Six patients were dis-
charged alive from the ICU and five from the hospital. No renal toxicity 
was observed among survivors.
Conclusion In this cohort of septic patients with MDR-GN infections, 
HDA combined with high-flow CVVHDF represented a valuable thera-
peutic option. The effectiveness of this approach should be further 
evaluated in larger studies.
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Introduction Continuous intravenous administration of vancomycin 
(CIV) in intensive care unit (ICU) patients requires dose adjustment 
according to weight and renal function, but its assessment remains 
difficult. The aim of this study was to validate a new dose regimen of 
CIV correlated with renal function assessed by creatinine clearance 
(Creat Cl).
Materials and methods In this prospective randomized study, we 
evaluated septic critically ill patients in whom CIV was given for more 
than 48 h in the absence of renal replacement therapy. The CIV proto-
col was developed based on recommendations of IDSA for the load-
ing dose (30  mg/kg), but a new protocol for the maintenance dose 
was tested (depending on weight and daily Creat Cl). The serum target 
vancomycin (vanco) concentration was 25–30  μg/ml. Patients were 
randomized in three groups by daily assessment of renal function by 
a Creat Cl of 4 h (from 4 to 8 a.m.) or 12 h of Creat Cl (from 8 p.m. to 
4 a.m.) or by the MDRD. Acute kidney injury (AKI) was defined as a daily 
urine output <0.5 ml/kg/h and/or an increase in the serum creatinine 
of ≥0.3  mg/dL from baseline levels. Multivariable logistic regression 
analysis was performed to identify predictors of CIV under-/over-dose 
and predictors of AKI.
Results During 23  months, in a medico-surgical 36 beds ICU (CHU 
Charleroi, Belgium), 67 patients were randomized: 21 (31  %) in the 
MDRD group, 21 (31 %) in the 4 h Creat Cl and 25 (38 %) in the 12 h 
Creat Cl. The three groups were comparable in demographic terms, 
severity score, kidney function before CIV and bacteriology. For 7/67 
(10  %) patients, CIV was targeted on bacteriological findings (one 
MRSA and six Enterococcus faecium). In the other patients, vanco 
was introduced empirically for clinically evolving sepsis. Vanco con-
centration <25 μg/ml on day 1 was found in 15 patients (22 %) in the 
MDRD group, 11 (16 %) in 4 h Creat Cl and 15 (22 %) in 12 h Creat Cl 
(p = 0.5), and in 12 (17 %), 12 (17 %) and 13 (19 %), respectively, on 
day 2 (p = 0.8). In logistic regression analysis, BMI <30 and an elevated 
Creat Cl >90 were found independent predictors of under-dosing 
vanco (<25 μg/ml) at day 1 with an OR of 1.098 [1.01–1.19] and 0.935 
[0.8–1], respectively. The day 1–day 2 CIV overdose was found to be an 
independent risk factor for AKI with an OR of 7.5 [2.2–23.7].
Discussion Our protocol cannot optimally achieve target levels on 
days 1–2. However, the chosen therapeutic target (25–30  μg/ml) 
seems a posteriori not justified given the local epidemiology. With the 
Table 1 Episodes characteristics at  ICU admission 
and time of Cmax
Variables ECMO (n = 50) Non-ECMO 
(n = 50)
P value
Characteristics at ICU admission
 Age (years) 61 (43–68) 63.5 (54–72) 0.03
 Cirrhosis 2 (4) 4 (8) 0.68
 Acute respiratory 
failure
7 (14) 13 (26) <0.001
 Severe sepsis/septic 
shock
5 (10) 12 (24)
 Cardiogenic shock 21 (42) 4 (8)
 Cardiac surgery 10 (20) 11 (22)
 Post‑cardiac arrest 5 (10) 3 (6)
 Others 2 (4) 7 (14)
 BMI (kg/m2) 26.5 (24.2–29.4) 26.3 (24.5–30.9) 0.50
 SAPS II 51 (42.5–73.3) 53.5 (41–73.3) 0.98
Characteristics at time of therapeutic monitoring
 SOFA score 12 (10–14) 9 (6–11) <0.001
 24‑h fluid balance 
(mL)
100 (−925 to 
1860)
100 (−1550 to 
1019)
0.52
 Weight (kg) 88.5 (73–100) 82 (70–93) 0.37
 Amikacin dose (mg) 2250 (1825–2500) 2000 (1713–
2300)
0.17
 Amikacin regimen 
(mg/kg)
25 (25–25.6) 24.9 (24.5–25.5) 0.10
 Amikacin Cmax (mg/L) 71.7 (58.9–79.7) 68.4 (53–81) 0.36
 Patients with Cmax 
<60 mg/L
13 (26) 17 (34) 0.51
 Patients with Cmax 
>80mgL
12 (24) 15 (30) 0.65
 Amikacin Cmin (mg/L) 8.5 (3–15.4) 9.6 (2.5–16.9) 0.45
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target proposed in the literature (20–30 μg/ml), vanco concentration 
at day 1 was <20 μg/ml in nine patients (43 %) in MDRD group, four 
(19 %) in 4 h CCU and nine (36 %) in 12 h CCU, and in 3 (14 %), 3 (14 %) 
and 5 (20 %), respectively, at day 2. It would therefore be preferable to 
target therapeutic levels between 25 and 30  μg/ml only for patients 
in the presence of multi-resistant germs demonstrated. For empirical 
antibiotic choice, therapeutic target [20–30 μg/ml] is probably enough 
and more careful. The assessment of renal function using three differ-
ent methods failed to highlight difference in Creat Cl. The evaluation 
of Creat Cl by the MDRD formula may be sufficient.
Conclusion Insufficient vancomycin concentration is a frequent find-
ing at days 1–2. Predictors were BMI and high Creat Cl. Vanco level 
>30 μg/ml at days 1–2 is an independent predictive factor for AKI with 
an OR of 7.5.
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Introduction Elevated intra-abdominal pressure (IAP) has been sug-
gested to decrease the accuracy of dynamic parameters of fluid 
responsiveness, especially for the distensibility index of the inferior 
vena cava (∆IVC). The goal of our study was to confirm this limitation in 
a large series of unselected patients.
Materials and methods This is a sub-study of an observational, prospec-
tive and multicenter study (Hemopred) that we conducted between 
November 2012 and November 2014. All sedated patients under 
mechanical ventilation who required an echocardiographic assessment 
for an acute circulatory failure, with an inserted central venous catheter 
and arterial catheter, were eligible. Acute circulatory failure was defined 
as a sustained hypotension (systolic blood pressure <90 mmHg or mean 
blood pressure <65  mmHg) and/or the presence of clinical signs of 
hypoperfusion (e.g., mottled skin, oliguria), metabolic acidosis (pH <7.35 
and base excess less than −5 mmol/L), elevated lactate (>2 mmol/L) or 
decreased central venous oxygen saturation (ScvO2 <70  %). Dynamic 
parameters used to predict fluid responsiveness assessed in this study 
were pulse pressure variations (∆PP) and the following echocardio-
graphic indices: respiratory variations of aortic Doppler maximal velocity 
(∆Vmax), collapsibility index of superior vena cava (∆SVC) and ∆IVC.
At the time of echocardiography, a systematic measurement of the 
bladder pressure was performed as recommended and elevated IAP 
was defined as a pressure ≥12 mmHg.
Response to fluids was defined by an increase in cardiac output 
of more than 10  % during a passive leg raising (PLR), as previously 
validated. Area under the ROC curve (AUC) was built for each recorded 
dynamic parameter.
Results Among the 540 patients included in the study, 174 (32  %) 
had an elevated IAP (group 1). No difference was observed compared 
with the remaining patients without elevated IAP (group 2), except 
for patients with an abdominal surgery (32 vs 23 %, p = 0.03). Among 
group 1, 81 patients had an IAP between 12 and 15  mmHg and 93 
patients had an IAP >15  mmHg. Central venous pressure (CVP) was 
increased in group 1 compared with group 2 (11 ± 5 vs 9 ± 5 mmHg, 
p < 0.001), as well as plateau pressure (Pplat) (20 ± 5 vs 18 ± 5 cmH2O, 
p < 0.001). In group 1, 81 (46 %) patients were classified as responders 
by the PLR, compared with 124 (40 %) in group 2 (p = 0.18). No dif-
ference between the AUC for ∆IVC (0.64 vs 0.59, p = 0.46), ∆PP (0.71 
vs 0.66, p  =  0.47) and ∆Vmax (0.83 vs 0.71, p  =  0.06) was observed 
between groups 1 and 2, respectively, although AUC was increased in 
group 1 for ∆SVC (0.72 vs 0.82, p = 0.02). No difference was observed 
regarding the feasibility between the two groups for any parameters, 
although feasibility for ∆IVC was 74 % in group 1 compared with 80 % 
in group 2 (p = 0.1).
Conclusion Thirty-two percent of patients in our series of unselected 
ventilated patient with shock had an elevated IAP. They demon-
strated higher CVP and Pplat and more benefited from abdominal 
surgery. Elevated IAP did not have significant effect on accuracy of 
dynamic parameters of fluid responsiveness, even though ∆IVC was 
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Introduction We performed a systematic review and meta-analysis 
of studies that investigated the passive leg raising (PLR)-induced 
changes in cardiac output (CO) or surrogates and the PLR-induced 
changes in arterial pulse pressure (PP) as predictors of fluid respon-
siveness in adults.
Patients and methods MEDLINE, EMBASE and Cochrane Database 
of Systematic Reviews were screened for relevant original and review 
articles.
Results Twenty-one studies (995 patients) were included. CO was 
measured by echocardiography in six studies, calibrated pulse con-
tour analysis in six studies, bioreactance in four studies, oesophageal 
Doppler in three studies, either transpulmonary thermodilution or 
pulmonary artery catheter in one study and suprasternal Doppler in 
one study. The pooled correlation between the PLR-induced and the 
volume expansion-induced changes in CO was 0.76 (0.73–0.80). The 
best threshold was a PLR-induced increase in CO ≥10  ±  2  %. The 
pooled sensitivity was 0.85 (0.81–0.88), and the pooled specificity was 
0.91 (0.88–0.93). The area under the ROC curve was 0.95 ± 0.01. Eight 
studies (432 patients) met the selection criteria for the PLR-induced 
changes in PP. For the PLR-induced changes in PP, the pooled sensi-
tivity was 0.56 (0.49–0.53), the pooled specificity was 0.83 (0.77–0.88), 
and the pooled area under the ROC curve was 0.77 ± 0.05.
Conclusion The changes in CO induced by a PLR test are highly reli-
able in predicting the response of CO to volume expansion in adult 
patients with acute circulatory failure. When its effects are assessed by 
changes in PP, the specificity of the PLR test remains acceptable, but its 
sensitivity is poor.
Competing interests XM and J-LT are members of the Medical Advi-
sory Board of Maquet.
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Introduction The changes in intrathoracic pressure induced by 
end-expiratory (1) and end-inspiratory occlusions induce significant 
changes in cardiac preload that may be used to test preload depend-
ence. We tested whether the effects of respiratory occlusions on the 
velocity–time integral of the subaortic flow (VTI) could serve as a func-
tional test for predicting volume responsiveness in patients with circu-
latory failure.
Patients and methods In ten mechanically ventilated patients with 
circulatory failure in whom volume expansion was planned, we con-
tinuously measured VTI (transthoracic echocardiography) during the 
5 last seconds of 15-s end-inspiratory and end-expiratory occlusions, 
separated by 1  min, and after the subsequent infusion of 500-mL 
saline. Patients in whom volume expansion induced an increase in 
cardiac index (transpulmonary thermodilution, PICCO2) >15  % were 
defined as “volume-responders”.
Results Volume expansion increased cardiac index by more than 15 % 
(2.75 ± 0.66–3.36 ± 0.71 L/min/m2, p < 0.05) in four patients. In these 
volume-responders before volume expansion, the end-expiratory 
occlusion increased VTI to a significantly larger extent than in non-
volume-responders (9 ± 5 vs. 3 ± 1 % p = 0.02, respectively). Similarly, 
before volume expansion, the end-inspiratory occlusion decreased VTI 
to a significantly larger extent in volume-responders than in non-vol-
ume-responders (−11 ± 3 vs. −5 ± 2 % p = 0.01, respectively). Volume 
responsiveness was predicted by an increase in VTI >4  % during the 
end-expiratory occlusion with a sensitivity of 75 % (95 % CI 19–99 %) 
and a specificity of 100 % (95 % CI 54–100 %). If the absolute values of 
the VTI changes recorded during end-expiratory and end-inspiratory 
occlusions were added, the predictive accuracy of volume responsive-
ness tended to be better than for the VTI changes recorded during the 
only end-expiratory occlusion [area under the ROC curve: 0.917 (95 % 
CI 0.575–0.999) vs. 0.771 (95 % CI 0.415–0.964), p = 0.24, respectively].
Conclusion The sum of the absolute values of changes in VTI recorded 
during consecutive end-expiratory and end-inspiratory occlusions 
could reliably predict volume responsiveness. This prediction tends 
to be better than the changes in VTI during the only end-expiratory 
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Introduction Based on previously published case reports demon-
strating dynamic left intraventricular obstruction triggered by hypo-
volemia or catecholamines, this study aimed to establish: (1) IVO 
occurrence in septic shock patients; (2) correlation between the intra-
ventricular gradient and volume status and fluid responsiveness; and 
(3) mortality rate.
Patients and methods We prospectively analyzed patients with 
septic shock admitted to a general ICU over a 28-month period who 
presented Doppler signs of left intraventricular obstruction. Clinical 
characteristics and hemodynamic parameters as well as echocardio-
graphic data regarding left ventricular function, size, and calculated 
mass, and left ventricular outflow Doppler pattern and velocity before 
and after fluid infusions were recorded.
Results During the study period, 218 patients with septic shock were 
admitted to our ICU. Hemodynamic and echocardiographic charac-
teristics of patients with intraventricular obstruction before and after 
fluid infusion are given in Table 2. Left intraventricular obstruction was 
observed in 47 (22 %) patients. Mortality rate at 28 days was found to 
be higher in patients with than in patients without left intraventricular 
obstruction (55 vs 33 %, p < 0.01). Small, hypercontractile left ventri-
cles (end-diastolic left ventricular surface 4.7 ± 2.1 cm2/m2 and ejec-
tion fraction 82 ± 12 %), and frequent pseudohypertrophy were found 
in these patients. A rise ≥12 % in stroke index was found in 87 % of 
patients with left intraventricular obstruction, with a drop of 47 % in 
left intraventricular obstruction after fluid infusion.
A late velocity of diastolic mitral flow, A′ late velocity of diastolic mitral 
annulus motion, E early diastolic velocity of mitral flow, E′ early veloc-
ity of diastolic mitral annulus motion, ns not significant.
Discussion The presence of left intraventricular obstruction is asso-
ciated with high mortality rate. The data showed an association 
between the presence of this obstructive flow pattern on left ventricu-
lar Doppler flow and the presence of hypovolemia and cardiac hyper-
contractility and also demonstrated that these patients frequently 
present small and pseudo-hypertrophic left ventricular. Furthermore, 
this study also demonstrates the high rate of fluid responsiveness 
in these patients with left intraventricular obstruction despite the 
absence of significant pulse pressure variations.
Conclusion In our study, left intraventricular obstruction is a frequent 
event in septic shock patients bearing an important correlation with 
fluid responsiveness. Mortality rate was found to be higher in these 
patients in comparison with patients without obstruction.
Competing interests None.
Table 2 Hemodynamic and  echocardiographic charac‑
teristics of  patients with  intraventricular obstruction 
before and after fluid infusion
Before After p value
Heart rate (beats/min) 109 ± 25 102 ± 22 ns
Systolic arterial pressure (mmHg) 110 ± 28 141 ± 32 <0.01
Diastolic arterial pressure (mmHg) 54 ± 11 65 ± 14 <0.01
Mean arterial pressure (mmHg) 71 ± 16 89 ± 1 <0.01
Cardiac output (l/min) 4.6 ± 1.9 5.8 ± 2.1 <0.01
Cardiac index (l/min/m2) 2.4 ± 0.9 3 ± 1 <0.01
Stroke volume (ml) 43 ± 18 58 ± 22 <0.01
Indexed stroke volume (ml/m2) 23 ± 10 31 ± 11 <0.01
Intraventricular obstruction (m/s) 1.9 ± 0.9 1 ± 1 <0.01
Intraventricular obstruction (mmHg) 18 ± 18 8 ± 13 <0.01
Inferior vena cava diameter (mm) 16 ± 6.4 18 ± 6.6 ns
E/A 0.8 ± 0.46 0.9 ± 0.3 ns
E′ (cm/s) 14 ± 5 16 ± 5 ns
E′/A′ 0.77 ± 0.26 0.87 ± 0.37 ns
E/E′ 5.8 ± 2.1 6.8 ± 1.8 ns
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Introduction In the intensive care unit (ICU), the presence of edema 
after the initial phase of fluid resuscitation is an independent poor 
prognostic factor. The fluid removal (using diuretics or during renal 
replacement therapy) is an important component of care. However, 
the depletion can decrease cardiac output and provoke hypotension. 
Therefore, it can be harmful. Our objective was to determine factors 
for poor hemodynamic tolerance to fluid removal.
Patients and methods We conducted a single-center prospective 
observational study in the medical ICU of the University Hospital of 
Amiens in France from March to September 2015. Inclusion criteria 
were critical patients initially requiring fluid therapy and then hemo-
dynamically stabilized, in whom fluid removal was decided. Exclu-
sion criterion was failure to perform a thoracic (or lung) or a cardiac 
ultrasonography. We collected the main clinical and biological char-
acteristics. Hemodynamic status before the initiation of depletion was 
assessed by transthoracic echocardiography. Thoracic ultrasound was 
performed to estimate extravascular lung water. Our primary outcome 
was poor hemodynamic tolerance in the 24 h following the initiation 
of fluid, corresponding to at least one episode of hypotension (mean 
arterial pressure <65 mmHg) or initiation/increase of catecholamines.
Results Sixteen patients were included in the study. The median age 
was 69  years (IQR 16.3), SAPS II was 52 (IQR 25.8), and the propor-
tion of men was 56.3  %. Median time to initiation of fluid removal 
was 4  days (IQR 4.5). Fluid removal was performed in nine cases by 
loop diuretics and in eight cases with renal replacement therapy. 
The median depletion was 1617.5 ml (IQR 2025.8). Fifty percent were 
intubated and ventilated. Seven out of eight patients had spontane-
ous ventilatory cycles. Pulse pressure variation could be calculated in 
only one patient. Nine patients (56.2 %) did not tolerate fluid removal. 
The median SOFA at inclusion was significantly higher in patients 
who had poor hemodynamic tolerance to depletion compared with 
patients who well tolerated the depletion (9 ± 3 vs 5 ± 5.5, p = 0.036). 
All patients with catecholamine therapy (n  =  4; median posology 
0.087 µg/kg/min) did not hemodynamically tolerate fluid removal. Ini-
tial median cardiac index in patients who developed arterial hypoten-
sion was 2.7 ± 1.6  l/min/m2 and 3.6 ± 3  l/min/m2 among those who 
did not develop hypotension (p = 0.088). All patients having cardiac 
index lower than 2.7 l/min/m2 developed hypotension. Diastolic blood 
pressure of patients with hemodynamic instability was significantly 
lower (56 ± 10.5 vs 72 ± 18 mmHg, p = 0.042). Four out of five (80 %) 
of the patients with positive passive leg raising test showed hemody-
namic intolerance to fluid removal, while only one patient (16.7 %) had 
a positive passive leg raising test in the well-tolerated depletion group 
(p = 0.58). Patients with well hemodynamic tolerance to fluid removal 
had approximately twice as many B lines than patients having poorly 
tolerated fluid removal (14 ± 17 vs 7 ± 13.3, p = 0.152).
Discussion Our results suggest that a preload dependence (shown 
by a positive passive leg raising test) and a lower accumulation of 
extravascular lung water (shown by fewer B lines) are associated with 
a poor hemodynamic tolerance to fluid removal. A precarious hemo-
dynamic state (cardiac index lower than 2.7 l/min/m2, catecholamines 
therapy and lower diastolic arterial pressure) also appears predictive 
of a poor fluid removal hemodynamic tolerance. Patients with poorly 
tolerated fluid depletion had a higher SOFA score, indicating a greater 
severity of these patients. These results must be confirmed in a larger 
cohort.
Conclusion Our results suggest that poor hemodynamic tolerance to 
fluid removal is associated with a lower diastolic pressure, the pres-
ence of catecholamine and a preload dependency as suggested by a 
low cardiac index and a positive passive leg raising test. The presence 
of many B lines assessed by thoracic ultrasound seems to be protec-
tive of poor hemodynamic tolerance.
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Introduction Viral bronchiolitis is an acute infection disease of the 
lower respiratory tract. In the most severe cases, acute respiratory fail-
ure occurs. High-flow nasal cannula (HFNC) therapy is a relatively new 
noninvasive ventilator support that can improve respiratory distress 
for infants with bronchiolitis. The objectives of this study were (1) to 
evaluate a study design suggesting the use of HFNC as the first-line 
treatment for infants with bronchiolitis in a pediatric intensive and 
intermediate care unit (PI&ICU) and (2) to identify risk factors for HFNC 
failure.
Patients and methods This study was prospective during two consec-
utive seasons (2013–2014 and 2014–2015) in a PI&ICU (18 beds). Inclu-
sion criteria were patients <2 years with bronchiolitis needing invasive 
or noninvasive ventilation. During the 2013–2014 season, no recom-
mendation between HFNC and continuous positive airway pressure 
(CPAP) was proposed. During the 2014–2015 season, a study design 
suggested the use of the HFNC as noninvasive ventilation as first-line 
tratment (before C PAP) for bronchiolitis. Primary outcome was the 
percentage of HFNC (comparison between the two periods). For the 
secondary outcome, failure of HFNC was defined by the need of CPAP 
or invasive ventilation. Clinical and biological variables were collected 
during the PI&ICU stay at different times (before ventilation, H1–H2, 
H4–H6, H10–H12 and H24). Comparisons of percentage and logistic 
regression were made with SAS software (SAS Institute, Cary, NC, USA).
Results During the 2013–2014 season, 34  % (14/41 infants) were 
treated by HFNC at admission compared with 90  % (55/61 infants) 
during the 2014–2015 season (p  <  10−4) (Fig.  3). The intubation rate 
at admission and during the hospitalization was not different between 
the two seasons.
During the 2014–2015 season, HFNC therapy failed in 21 infants (38 %; 
21/55). In the responders group, the use of HFNC therapy decreased 
the respiratory rate, the heart rate (HR) and the CO2 (p < 0.001). With 
multivariate analysis, non-responders patients to HFNC therapy have a 
Fig. 3 Characteristics of ventilation modalities during the 2 periods
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hypercapnia higher (OR 1.136; 95 % CI 1.04–1.24; p < 0.01) and a tachy-
cardia lesser (OR 0.95; 95  % CI 0.91–0.99; p  =  0.02) compared with 
responders patients.
Discussion The use of HNCF as first-line treatment for patients with 
bronchiolitis has been frequently possible and accepted by all the 
team in our PI&ICU. No differences for complications are observed dur-
ing these two periods.
Conclusion HFNC can be used as a first-line treatment for moderate or 
severe bronchiolitis hospitalized in our PI&ICU. HFNC requires a moni-
toring to determine the failure criteria. A multicenter study will be nec-
essary to confirm these results.
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Introduction Bronchiolitis is the first pathology encountered in pedi-
atric intensive care unit during winter. In the management of respira-
tory failure, noninvasive ventilation may improve work of breathing 
and has been suggested to be effective in preventing intubation. 
High-flow nasal cannula had increasingly been used and tends to 
replace nasal continuous positive airway pressure in this indication 
despite the lack of evidence. Nowadays, no randomized control trial 
had compared nasal continuous positive airway pressure and high-
flow nasal cannula in this indication. Only observational studies exist. 
Most authors have described a superiority of high-flow nasal cannula 
against nasal continuous positive airway pressure but with some con-
troversies. In this study, we compared retrospectively nasal continuous 
positive airway pressure and high-flow nasal cannula in patients with 
bronchiolitis admitted to pediatric intensive care unit during two sea-
sons in our tertiary hospital.
Patients and methods We included 77 patients, in which 13 treated 
with nasal continuous positive airway pressure and 24 treated with 
high-flow nasal cannula. We compared vital signs at H0, H1, H2, H3, 
H6, H9 and H12 after device positioning, length of stay and rescue 
intubation.
Results There was a significantly lower respiratory rate at H6; fraction of 
inspired oxygen was significantly lower at H2 and H6, with comparable 
pulse oximeter oxygen saturation; length of stay tended to be shorter 
and intubation rate lower in the high-flow nasal cannula group.
Conclusion Our results tend to show a small advantage to use high-
flow nasal cannula over nasal continuous positive airway pressure in 
respiratory failure in bronchiolitis. Larger prospective randomized clin-
ical trials are needed to compare these two techniques.
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Introduction Pneumonia remains the world’s leading cause of death 
among children under 5 years old. Treatment of hypoxemic pneumo-
nia is based on oxygen therapy. High-flow nasal cannula (HFNC) is a 
technique whereby heated and humidified oxygen can be delivered to 
the nose at high flow rates. It generates a low level of positive pressure 
in the upper airways and decreases the work of breathing. This tech-
nique might be useful to hypoxemic pneumonia treatment and could 
reduce the need of invasive or noninvasive ventilation in pediatric 
patients.
Patients and methods This retrospective monocentric study included 
all the children from 1 to 18 years old, admitted in pediatric intensive 
care unit between January 1, 2010, and June 1, 2014, and affected by 
hypoxemic pneumonia. Children affected by bronchiolitis or asthma 
were excluded. The goals of our study were to determine predictive 
factors for success or failure of HFNC. The failure group was defined as 
the group of patients which required the switch of HFNC to another 
oxygen delivery system (oxygen mask, noninvasive ventilation (NIV) 
or invasive ventilation). We studied clinical, biological and radiological 
criteria at different times for the first 48 h. Then, we compared these 
criteria between the failure group and the success group.
Results Ninety-two children were included. HFNC was a success for 
62 patients (67  %). No side effects were reported and the tolerance 
was good for all the patients. There was no demographic difference 
between the two groups of patients. The risk of failure was an initial 
higher FiO2 [mean of 0.69 in failure group vs 0.46 in the other group 
(p = 0.001)], an initial lower ratio SpO2/FiO2 [164.6 vs 260.2 (p = 0.001)] 
and a higher PELOD score at admission [5.27 vs 3.35 (p = 0.042)]. This 
risk of failure of HFNC persisted for the first 48 h. This risk was signifi-
cantly higher for patients who had three or more affected quadrants 
in pulmonary chest X-ray (p = 0.006). Immunocompromised patients 
(n  =  26) were at higher risk of failure of HFNC in our population 
(p = 0.047). In the failure group (n = 30), 15 patients needed NIV, 15 
patients were intubated, and four died. There was no hypercapnia in 
either group and no modification of the capnia at any time. We finally 
defined criteria and threshold for patients at higher risk of failure of 
HFNC: immunodepression, FiO2 ≥0.6, ratio SpO2/FiO2 ≤194, PELOD ≥6, three or more affected quadrants in pulmonary chest X-ray.
Conclusion Our study is one of the first on hypoxemic pneumonia in 
children. HFNC could be secure, useful and effective in this indication. 
The successful rate is 67  %. Identification of criteria associated with 
failure could help the physician to optimize the timing of secondary 
support, mainly intubation. Those criteria should be validated in mul-
ticenter and prospective studies. HFNC seems to be a promising tech-
nique of ventilation for patients with hypoxemic pneumonia. The rate 
of failure may be higher in immunocompromised children, patients 
with a severe hypoxemia or with an other organ failure (Fig. 4).
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Introduction Concerning the management of severe bronchiolitis, 
nCPAP is the gold standard. HFNC is increasingly used in this indica-
tion even if there are no randomized studies evaluating its efficacy and 
safety in this population. Our objective was to evaluate the failure rate 
of HFNC compared with the nCPAP during the initial management of 
severe bronchiolitis.
Patients and methods Prospective, controlled, randomized, multi-
center study was conducted in five French pediatric intensive care 
units (PICU). Infants from 0 to 6  months old, admitted in PICU for 
severe bronchiolitis (modified Wood score >3), were randomized into 
two groups: “HFNC” (2 l/kg/min) and “nCPAP” (6 cm H2O) during 24 h. 
The primary endpoint was the percentage of failure in both arms dur-
ing the first 24 h. Failure was define as an increase in (1) clinical score 
for respiratory distress (modified Wood score) or (2) respiratory rate 
(RR) or (3) discomfort (EDIN score) or (4) apnea.
Results {median (SD) and %(IC)} A total of 142 infants were included 
from November 2014 to March 2015. Their weight was 4100 (1200) 
g, and they were 40 (35)  days old, the RR: 53 (13)  breath/min, FiO2: 
30 (12), modified Wood score: 4.3 (1), PCO2: 59 (14) mmHg, pH: 7.28 
(0.1). Seventy one were included in HFNC group and 71 in the nCPAP 
group. There was no difference between the two groups (weight, age, 
HR, BP, RR, FIO2, modified Wood score, EDIN, PCO2). The failure rate 
was higher in the HFNC group 49 (39–62) vs 31 (20–42)  % [OR 0.49 
(0.2–0.9), p  =  0.018]. We did not find any predictive failure criteria. 
The main cause of failure in the HFNC group was a raise of the respira-
tory distress (58 %) and discomfort in the nCPAP group (59 %). Failure 
occurred rapidly during the first 18  h in the two groups. We did not 
find any difference between the two groups concerning the length 
of stay [6.2 (6) vs 7.5 (13) days; p = 0.46] or the number of intubation 
(3/71 vs 5/71; p = 0.51).
Conclusion During severe bronchiolitis management, the failure rate 
is higher with the high flow compared with nasal CPAP (Fig. 5).
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Introduction Severity of cerebral venous thrombosis (CVT) may 
require the transfer to intensive care unit (ICU). This report described 
the context for CVT transfer to ICU, the strategy of care, and the out-
come after 1 year.
Patients and methods We studied a monocentric cohort of 41 con-
secutive CVT in a French tertiary hospital. Data collected were as fol-
lows: demographic data, clinical course, incidence of craniectomy and/
or endovascular procedures, outcome in ICU, after 3, and 12 months.
Results
1—Characteristics 73.2 % were female, 47 years old (IQ 26–53), having 
a SAPS II 41 (32–45), GCS 7 (5–8), and at least one episode of mydriasis 
in 48.8 %. 48.8 % had seizures before ICU admission and 43.9 % during 
ICU stay.
2—Lesions Thrombosis location was 80.5 % in lateral sinus and 53.7 % 
in superior sagittal sinus; intracranial hematoma was present in 78.0 %, 
signs of intracranial hypertension in 60.9 %, cerebral edema in 58.5 %, 
and venous ischemia in 43.9 %.
3—Monitoring All patients had an imaging technique (TDM, angio-
TDM, and MRI). All patients were closely monitored for CO2 (PCO2 and 
end-tidal CO2). When feasible, transcranial Doppler was performed 
in 78 % of patients. Despite the risk of bleeding, eight patients had a 
monitoring of intracranial pressure.
4—Therapies All patients received heparin therapy, and nine cases had 
endovascular treatment (21.9 %), osmotherapy (53.7 %), and decom-
pressive craniectomy (16 cases, 39 %) were necessary to control intrac-
ranial hypertension. 63.4 % received norepinephrine to improve brain 
perfusion, and 90.2 % of patients were under mechanical ventilation. 
Thirty-one patients received antiepileptic drugs.
5—Outcome Ten out of 41 patients (24.4  %) died in ICU, and 18/31 
(58.1  %) discharged from ICU had a good outcome (mRS 0–3). After 
12 months, 92 % of survivors (23/25) had a mRS between 0 and 3. The 
proportion of death was 31.7 % at 1 year.
Compared with ICU deaths, survivors were: predominance of female 
(p = 0.039), a worse initial GCS [4 (3–6); p = 0.0004], a more frequent 
mydriasis (100 vs. 32.3  %, p  =  0.0001) with more frequent signs of 
intracranial hypertension on imaging techniques (p =  0.003), with a 
trend for more frequent use of norepinephrine (90 and 54.8 %, respec-
tively) and an anticoagulation more difficult to be adequate (50 vs. 
80.6  %, respectively). Comparing good outcome with poor outcome 
after 1-year evolution, patients mRS 0–3 appeared with a higher plate-
lets count at day 1 (p = 0.03) and day 5 (p = 0.06) during ICU stay, as a 
lower D-dimer level after initiation of anticoagulation (p = 0.03).
Conclusion The large proportion of acceptable outcome in survivors, 
which continue to functionally improve after 1  year, motivates the 
hospitalization in ICU for severe CVT. Persistence of fibrinolysis and 
activation of coagulation and difficulty to reach efficient anticoagula-
tion during the initial phase might lead to a poor outcome.
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Introduction Infective endocarditis (IE) is a severe disease, associated 
with a high mortality. Neurological events are the most frequent com-
plications of left-sided endocarditis, occurring in 20–40 % of patients. 
Embolic events from vegetations are commonly accepted as the main 
mechanism responsible for brain lesions, but other hypotheses were 
highlighted, including a potential subacute cerebral vasculitis. The 
main objective of the present study was to define the cerebral lesion 
spectrum in an IE rat model.
Materials and methods Wistar rats underwent an experimental aor-
tic Staphylococcus aureus or Enterococcus faecalis IE. During a surgical 
procedure, a catheter was inserted into the left ventricle via the right 
carotid artery. Twenty-four hours later, animals were inoculated with 
bacterial strain. A systematic brain magnetic resonance imaging (MRI) 
was performed 2  days after bacterial inoculation. After killing, brains 
and vegetations were removed. Brains were stained with Masson’s tri-
chrome, hematoxylin and eosin, diaminobenzidine-enhanced Perls, 
and Gram stainings. Immunohistochemistry was performed on brains, 
including 4′,6′-diamidino-2-phenylindole, myeloperoxidase, glial fibril-
lary acidic protein, and ionized calcium-binding adapter molecule 1 
immunostaining. Finally, DNA extraction and polymerase chain reac-
tion (PCR) were performed on the brains and vegetations for specific 
bacterial DNA amplification. Three other animals groups underwent 
the same analyses and served as controls: rats of the sham A group 
were only inoculated with S. aureus or E. faecalis without any surgical 
procedure; rats of the sham B group underwent the surgical procedure 
without bacterial inoculation; and rats of the control group were free 
of any procedure.
Results Cerebrovascular lesions were detectable on MRI in 12/23 
(52 %) animals with IE. Lesions included mostly cerebral micro-bleeds 
(n = 8, 35 %) and brain infarcts (n = 9, 39 %). We observed no differ-
ence related to the involved microorganism. None of the sham A and 
control rats revealed MRI lesions. In contrast, the radiological lesion 
type was similar in the sham B and IE rats. Neuropathological find-
ings showed a cerebral lesion load larger than the one observed on 
brain MRI. In IE rats, a scattered brain injury pattern was documented 
made of brain infarcts (n  =  12, 52  %), micro-hemorrhages (n  =  10, 
44  %), and micro-abscesses (n =  11, 48  %), associated with a patchy 
inflammatory perivascular and small vessel wall infiltrate. Reactional 
gliosis was present around the lesion areas. The IE rats had signifi-
cantly higher pathological lesions compared with the sham A rats. In 
contrast, no significant difference was observed between the IE and 
sham B groups, except for microglial activation, higher in the IE group 
(p = 0.02). Of note, bacterial studies including Gram staining and PCR 
for bacterial DNA in brains were inconclusive.
Discussion We report here the first rat model of brain injury in the set-
ting of IE. Brain lesion spectrum was relevant to clinical findings in IE. 
We did not find strong arguments in favor of septic embolism. Moreo-
ver, lesion spectrum found is similar to those observed in cerebral vas-
culitis in human. Therefore, embolism from vegetations may not be 
the unique mechanism involved in IE-related brain injury. We found 
similar lesion type in IE and sham B groups, but higher microglial acti-
vation in the IE group. Taken together, these results suggest that sepsis 
and valvular lesion are synergistic conditions involved in brain injury. 
In this hypothesis, sepsis appears to amplify observed brain injury 
and reactional gliosis. Finally, this model appears to be adapted for 
cerebral micro-bleeds detection and analysis, whose physiopathology 
needs to be further investigated.
Conclusion In this rat model of IE, we characterized brain injury as 
scattered infarcts, micro-abscesses, micro-bleeds, and small vessel wall 
inflammation. This lesion spectrum probably results from a combina-
tion of thromboembolism and cerebral vasculitis, promoted by addi-
tional sepsis and systemic inflammation.
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Introduction Parkinson’s disease is associated with an increased risk 
of severe septic complications that can lead to intensive care unit (ICU) 
admissions. Despite this, no prognosis data for Parkinson’s disease (PD) 
patients in ICU are available.
Patients and methods The objective was to describe PD patients 
characteristics admitted to ICU and assess mortality and prognosis at 
the end of hospitalisation and up to 18 months after discharge. To this 
purpose, data on 62 PD patients admitted between 1999 and 2014 in 
two university hospital ICUs have been analysed.
Results The admitted patients were of variable age profiles, duration 
of evolution and severity of Parkinson’s disease. The admission reason 
was sepsis for 59 % of patients (n = 61), and 85 % had at least one sep-
sis during their hospitalisation (n = 60). Mortality was 12.5 % (n = 55) 
after the ICU stay and tended to increase over the 18 months of follow-
up. A Hoehn and Yahr score >3 was associated with an extra mortality 
at M1 (OR 13.22; 95 % CI [1.4–124.9]). The HY average score increased 
at an early stage from M1 (2.95–3.9; p =  0.031) (n =  21) and lasting 
until M18 (2.7–3.6; p = 0.049) (n = 11). The proportion of subjects with 
cognitive disorders increased to reach over 30 % at M18. Thirty-eight 
percentage of patients had returned home at M18.
Conclusion The ICU hospitalisation, mostly for a sepsis, marks a turn-
ing point in the development of Parkinson’s disease. Broader prospec-
tive studies are required to assess more accurately the impact of sepsis 
on Parkinson’s disease evolution.
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Introduction In patients with subarachnoid hemorrhage (SAH), the 
monitoring of brain metabolism through microdialysis catheters 
showed a decrease in brain glucose concentrations and an increase in 
lactate levels as a marker of cellular distress. However, the use of such 
catheters is not routinely applied. No data are available on glucose 
and lactate concentrations into the cerebrospinal fluid (CSF) of such 
patients.
Patients and methods We performed a retrospective analysis of 
patients admitted after a non-traumatic SAH from January 2011 to 
December 2014. Inclusion criteria were: (a) age >18  years; (b) the 
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presence of an external ventricular drain (EVD) for intracranial pres-
sure monitoring; (c) daily analysis of CSF including glucose and lactate 
concentrations for at least four consecutive days; and (d) concomitant 
analysis of glucose and lactate concentrations on the arterial blood 
gas analysis. Demographics and clinical characteristics were recorded 
on admission as the development of complications and 3-month neu-
rological outcome (favorable outcome was defined as a Glasgow out-
come scale of 4–5).
Results A total of 223 patients with SAH were admitted over the study 
period; among them, 131 needed a DVE placement and 54 met the 
inclusion criteria for the final analysis (median age: 57 [49–64]  years; 
male gender: 28/54). A DVE was placed in most of the patients (41/54) 
on the day of hospital admission and was maintained for a period of 
12 [9–16] days. Of the 48 identified aneurysms, 44 were treated with 
endovascular therapy. Median Glasgow coma scale on admission was 
12 [8–14], and CT scan Fisher’s scale was 4 [3–4]. A total of 16 patients 
developed a delayed neurological ischemic deficit (DNID); ICU mortal-
ity was 30  % (16/54), and 20 (37  %) patients had a favorable neuro-
logical outcome. Despite a similar CSF red blood cells count, CSF and 
blood glucose levels than survivors, non-survivors patients had higher 
blood (1.9 [1.6–2.3] vs. 1.2 [1.0–1.9] mEq/L; p < 0.009) and CSF lactate 
levels (4.6 [3.6–5.8] vs. 3.2 [2.3–4.1] mEq/L; p = 0.002) and a lower CSF 
glucose/lactate ratio (21.5 [15.1–25.1] vs. 28.1 [20.9–35.1]; p = 0.01) on 
the first CSF analysis. Similar results were also found when patients 
with poor neurological outcome were compared with others.
Conclusion Patients with poor outcome after SAH demonstrated 
higher CSF lactate levels and a lower CSF glucose/lactate ratio than 
patients with favorable outcome on the first day of DVE placement. 
These CSF findings may suggest a more pronounced metabolic brain 
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Introduction Non-aneurysmal angionegative subarachnoid hemor-
rhage (NA-SAH), which concerns about 15 % of patients, is known to 
be associated with a good prognosis [1, 2]. Thus, systematic prolonged 
clinical observation in neuro-ICU might not be necessary, and to date, 
no recommendation exists about this point. The aim of our study was 
to describe the incidence of neurological complications in NA-SAH 
and try to identify associated risk factors.
Patients and methods We performed a retrospective analysis of NA-
SAH patients in two university-affiliated hospital from 2008 January to 
2015 September. NA-SAH was confirmed in all patients with a negative 
catheter cerebral angiography.
Usual clinical and demographic data and pattern of bleeding on CT 
scan (perimesencephalic, non-perimesencephalic, Fischer’s score) on 
admission were recorded. During ICU stay, occurrence of neurological 
and medical complications was analyzed: rebleeding, hydrocephalus, 
requirement of external ventricular drain (EVD), symptomatic or not 
cerebral vasospasm, delayed ischemic deficit (DID), dysnatremia (>145 
or <135  mmol/L), cardiac and respiratory complications. Follow-up 
lasted until hospital discharge, and clinical status was described with 
Glasgow outcome scale (GOS). Results were presented as mean ± SD 
or median (first interquartile–third interquartile), and we compared 
patients with and without complications. Statistical analysis was per-
formed with SPSS®.
Results Sixty-eight patients were included. Mean age was 51  ±  9, 
SAPS 2 was 17 (15–20), 96 % were WFNS grades 1–2, and one patient 
was grade 4. Bleeding was strictly limited to perimesencephalic spaces 
in 32 (47  %) patients, and 36 (53  %) had a non-perimesencephalic 
pattern.
22 (33 %) patients developed at least one complication. Nine patients 
had hydrocephalus, and five of them required EVD. Seven had non-
symptomatic vasospasm, and no patient developed DID. GOS at dis-
charge was good in all cases.
Factors associated with occurrence of complication were non-per-
imesencephalic pattern compared with perimesencephalic (48 vs 
18 %, p = 0.01), intraventricular hemorrhage (54 vs 23 %, p = 0.01). In 
perimesencephalic pattern, no patient experienced serious complica-
tion: one patient developed hydrocephalus that did not require EVD, 
one patient had an asymptomatic vasospasm on CT scan, and four 
patients had mild dysnatremia. Besides neurological complication, 
patients often needed multimodal analgesia including opioids to con-
trol headaches and nausea/vomiting symptoms.
Conclusion Our retrospective analysis confirms previously published 
results [1, 2] that patients presented a very low rate of complication. 
Serious complication occurred in <10  % of patients and consisted in 
requirement of EVD. Perimesencephalic was never associated with 
early or late serious complication.
Besides, it is admitted that repetition of brain imaging in non-peri-
menscephalic SAH gets an average 10 % yield for detection of unrec-
ognized vascular abnormality [1, 2], but we do not confirm this in our 
population.
Further study on larger cohort might lead to a precision of manage-
ment in patients with a perimesencephalic pattern including a propo-
sition of a short observation in ICU before discharge to the opposite of 
non-perimesencephalic patients that require a close observation due 
to the risk of early and late neurological complication.
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Introduction Cardiopulmonary resuscitation and immediate activa-
tion of emergency medical services are crucial determinants of sur-
vival after out-of-hospital cardiac arrest. All citizens should then be 
taught how to call for help and to perform cardiopulmonary resusci-
tation. Teaching basic life support to secondary school students has 
been proved feasible, but not much evaluated. We conducted a study 
to evaluate the efficacy of a 1-h basic life support training course for 
secondary school students.
Materials and methods From September 2014 to June 2015, six sec-
ondary schools (in two neighboring towns) were included in the study. 
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Two of them received a 1-h basic life support session conducted by an 
intensivist assisted by three medical students. Our work focused on 
youngest students (first and second year of secondary school). Ses-
sions contained: a theoretical lecture and a practical simulation-based 
training (chest compression, use of automated external defibrillators) 
using low-fidelity manikins (MiniAnnePlus®, Laerdal). Between 2 and 
3  months later, both trained and untrained students were assessed 
using a serious game reproducing real-life cardiac arrest situation (3D 
real-time simulation software, Stayingalive®, ILUMENS-Dassault sys-
tem). Primary outcome was the time spent to complete the serious 
game (from onset of cardiac arrest to shock delivery and recovery). 
Secondary outcomes included knowledge of emergency call (15, 112 
or 18), hand placement during chest compressions and electrodes 
placement of automated external defibrillator.
Results Among 199 students (none of them have ever played on Stay-
ingalive® Web site) assessed on the serious game, 72 had received the 
1-h basic life support session. Children’s ages did not differ between 
the two groups (12 [11–12] vs 12 [11–12] years old, p = 0.7).
The total game completion time was 169 (±28) s in the trained group 
versus 185 (±32) s in the non-trained group (p = 0.0006; see Fig. 6).
Knowledge of emergency call did not differ between the two groups 
(92 % in trained group vs 86 % in non-trained group, p = 0.2). Hands 
were more often properly placed during chest compression in the 
trained group (92 vs 73 %, p = 0.002). Electrodes of automated exter-
nal defibrillator were more often properly placed in the trained group 
(44 vs 10 %, p = 0.0001).
Conclusion A 1-h basic life support training session with low-fidelity 
manikin improved significantly young students’ performance during 
a 3D real-life simulation session. This study forms the basis of a large 
educational health program in Hauts-de-Seine department in France.
Competing interests Manikins were provided by Laerdal Medical 
without any compensation.
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Introduction There is a growing interest in emergency extracorpor-
eal life support for the management of out-of-hospital refractory car-
diac arrest (OHRCA). However, preliminary results are discrepancy and 
many questions remain unresolved. We describe here the preliminary 
results of our CARECMO program in Nancy, France.
Patients and methods We evaluated retrospectively our monocenter 
experience between September 2012 and September 2015. Patients 
were eligible to receive a vaECMO if they presented an out-of-hospital 
cardiac arrest respecting the CARECMO criteria: (1) witnessed cardiac 
arrest; (2) no flow <2 min; (3) patient located at <15 min to the ECMO 
center; (3) no ROSC despite advanced cardiac life support (ACLS) pro-
vided by the medical mobile team unit; (4) first call to the ECMO center 
within the 15 min after the beginning of ACLS; and (5) transfer to the 
ECMO center under mechanical chest compressor.
Results Thirty-two patients presented a OHRCA respecting CARECMO 
criteria. Thirteen out of 32 patients had prior cardiovascular history, 
while 8/32 had no prior medical history. Median age was 43 [IQR 
34–48] and sex ratio F/M 1:4. Surgical ECMO implantation was success-
ful in 32 patients (100 %). Immediate coronarography was performed 
in 28/32 (88 %) patients, and at least one coronary artery was revascu-
larized in 20/28 (71 %) patients. Eight out of 28 (28 %) patients had no 
coronary artery disease, among which none survived. A total of 11/32 
(34 %) patients were weaned from vaECMO, and 8/32 (25 %) were dis-
charged from intensive care unit. In survivors, median length of stay in 
ICU was 30 days [10–43]. All of these patients were alive at 6 months, 
and seven of them had a Glasgow outcome score at 5. Initial cardiac 
rhythm, prothrombin time within the 4 h following admission (survi-
vors 48  % [IQR 39–76] vs. non-survivors 41  % [IQR 37–55], p =  0.29) 
and duration of low flow (survivors 68 [IQR 56–76] vs. non-survivors 
76  min [IQR 67–93], p =  0.16) was not associated with the outcome. 
No difference was found between survivors and non-survivors for pH 
(7.27 [7.12–7.32] vs. 7.18 [7.12–7.30], p = 0.5) and lactate (7.2 [3.4–13] 
vs. 8.4 [4.5–14], p = 0.6) at admission in ICU.
Conclusion Following rigorous inclusion criteria, ECMO should be 
considered in out-of-hospital refractory cardiac arrest.
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Introduction Post-cardiac arrest syndrome leads to a systemic inflam-
matory response that shares many similarities with the one observed 
in sepsis. As a decrease in monocyte HLA-DR expression (mHLA-DR) 
has been repeatedly described in septic patients with an increase 
risk of death, we tested whether this immune alteration could also be 
observed after out-of-hospital cardiac arrest (OHCA).
Patients and methods Fifty-five OHCA patients sampled at day 0 (D0: 
within 4 h after OHCA), D1 (the next day), and D3 (after two additional 
days) were included. CD4  +  lymphocyte count and mHLA-DR were 
evaluated by flow cytometry.
Results We observed a marked decrease in mHLA-DR as early as D0 in 
patients compared with normal values. This decrease persisted till D3 
and was associated with a moderate decrease in the number of CD4+ 
lymphocytes. No correlations were identified between mHLA-DR and 
both usual prognostic markers after OHCA and sequential organ fail-
ure assessment (SOFA) score. However, overtime evolution in mHLA-
DR values appeared different between survivors and non-survivors 
Fig. 6 See text for description
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with a quasi-systematic decrease between D1 and D3 in non-survivors 
versus an increase in survivors.
Conclusion This preliminary pilot study describes the occurrence of 
OHCA-induced immune alterations as illustrated by a decreased mHLA-
DR and CD4+ lymphopenia. CD4+ count and mHLA-DR could be sim-
ple tools to assess the systemic inflammatory response after OHCA.
Competing interests None.
O28  
Is emergent PCI associated with a clinical benefit in post‑cardiac 
arrest patients without ST‑segment elevation pattern? Insights 
from the PROCAT II registry
Florence Dumas1, Wulfran Bougouin2, Guillaume Geri2, Lionel Lamhaut3, 
Julien Rosencher4, Frédéric Pène2, Jean‑Daniel Chiche2, Olivier Varenne5, 
Pierre Carli6, Xavier Jouven7, Jean‑Paul Mira2, Christian Spaulding8, Alain 
Cariou2
1Emergency department, Cochin hospital‑APHP, Paris, France; 2Réanima‑
tion Médicale, Hôpital Cochin, Paris, France; 3Réanimation adulte, Hôpital 
Necker ‑ Enfants Malades, Paris, France; 4Cardiologie, Hôpital Cochin‑Port 
Royal, Paris, France; 5Cardiologie, Hôpital Cochin, Paris, France; 6Réanima‑
tion adulte ‑ samu, Hôpital Necker ‑ Enfants Malades, Paris, France; 7Cardi‑
ologie, Hôpital Européen Georges‑Pompidou, Paris, France; 8Cardiologie, 
Hopital Europeen Georges‑Pompidou, Paris, France 
Correspondence: Florence Dumas ‑ florence.dumas@aphp.fr 
Annals of Intensive Care 2016, 6(Suppl 1):O28
Introduction Emergent coronary angiogram and reperfusion are cur-
rently a standard of care in patients resuscitated from an out-of-hos-
pital cardiac arrest (OHCA) with ST-segment elevation (STE). However, 
using a similar invasive strategy is still debated in patients without 
ST-segment elevation (non-STE). In a large cohort of OHCA patients 
without STE, we assessed the relationship between the use of an early 
invasive strategy and patient outcome.
Materials and methods In the absence of an obvious extra-cardiac 
cause, since many years our practice is to perform an emergent cor-
onary angiogram (CAG) in all OHCA patients (STE and non-STE) at 
admission, followed by percutaneous coronary intervention (PCI) 
when required. All patients’ characteristics are prospectively collected 
in a database (PROCAT). Focusing on non-STE patients and using logis-
tical regression, we investigated the association between early PCI and 
favorable outcome (CPC1–2 at discharge), and we searched predictive 
factors for PCI requirement.
Results During the study period (2004–2013), we investigated 958 
OHCA patients with an emergent CAG. Among them, 695/958 (73 %), 
mostly male (76 %) and average age of 60 years, had no evidence of 
STE on the post-resuscitation ECG. A PCI was deemed necessary in 
199/695 (29 %). A favorable outcome was observed in 87/200 (43 %) 
in patients with PCI compared with 164/495 (33  %) in patients with-
out PCI (p = 0.02). After adjustment, PCI was associated with a better 
outcome (ORadj = 1.80 [1.09–2.97], p = 0.02). The other predictive fac-
tors were a shorter resuscitation length (<20 min), an initial shockable 
rhythm and a lower dose of epinephrine (p < 0.001). An initial shock-
able rhythm (ORadj = 2.83 [1.84–4.36], p < 0.001) was an independent 
indicator for PCI requirement.
Conclusion A culprit coronary lesion requiring PCI was found in nearly 
one-third of OHCA patients without STE. In these patients, emergent PCI 
was associated with a nearly twofold increase in the rate of favorable 
outcome. These findings support the use of an invasive strategy in these 
patients, particularly in those resuscitated from a shockable rhythm.
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Introduction Determinants of health-related quality of life (HRQOL) 
are poorly known in patients resuscitated from out-of-hospital cardiac 
arrest (OHCA).We aimed at comparing long-term HRQOL between 
OHCA survivors and controls from the general population and to 
assess factors associated with HRQOL.
Patients and methods HRQOL was evaluated by telephone interview 
using SF-36 questionnaire in a large cohort of OHCA survivors. As a 
comparison group, each OHCA case was age- and gender-matched 
with four controls from the French general population. Association 
between pre- and in-hospital Utstein variables and early interventions 
with the different dimensions of the SF-36 questionnaire was investi-
gated using MANCOVA.
Results During the study period (2000–2013), 1829 OHCA patients 
were admitted in our unit and 602 discharged alive. SF-36 interview 
took place 50  months [min, max: 22–93] after cardiac arrest in 255 
patients (137 patients died and 210 were lost of follow-up) with a 
median age of 55 years [45, 64] and including 73.7 % of males. Global 
physical and mental components did not differ between OHCA survi-
vors and controls (47.0 vs. 47.1, p = 0.88 and 46.4 vs. 46.9, p = 0.45). 
Physical functioning (74.1 vs. 78.4, p = 0.02) and vitality (50.7 vs. 56.2, 
p  <  0.01) were significantly altered in OHCA survivors. Younger age, 
male gender and initial shockable rhythm were associated with almost 
all SF-36 dimensions. Early coronary reperfusion was associated with 
better physical functioning (+7.0, p  =  0.06), general health (+7.3, 
p = 0.02) and vitality (+4.4, p = 0.08).
Conclusion HRQOL of OHCA survivors appeared similar to that of 
the general population, but some physical components of SF36 scale 
were significantly altered. Younger age, male gender, initial shockable 
rhythm and early coronary reperfusion were independently associated 
with a better HRQOL.
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Introduction Severe sepsis and septic shock are common compli-
cations for patients with hematological malignancies. Anemia is a 
frequent underlying condition in such patients who are then likely 
to receive red blood cell transfusion as part of early hemodynamic 
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resuscitation. However, the optimal threshold and the eventual benefit 
of red blood cell transfusion in septic acute circulatory failure remain 
debated. In this study, we investigated the indications of red blood cell 
transfusion and its impact on outcome in a large cohort of patients 
with hematological malignancies who were admitted to the ICU for 
the main diagnosis of severe sepsis and septic shock.
Patients and methods TRIAL-OH is a prospective, multicenter obser-
vational study that included 1011 patients with hematological malig-
nancies who required ICU admission in 2010–2011 in 17 French and 
Belgian centers (1). We focused on patients admitted in ICU with a def-
inite diagnosis of severe sepsis or septic shock according to the Surviv-
ing Sepsis Campaign definitions. We addressed the requirements for 
red blood cell transfusion during the first 48 h as part of initial resusci-
tation. Continuous variables were expressed as median [interquartile 
range]. Endpoints were vital status at 7  days, ICU and hospital dis-
charge. Multivariate logistic regression was used to assess the impact 
of transfusion on mortality.
Results Among the 1011 patients of the whole TRIAL-OH cohort, 631 
(62.4  %) were admitted to the ICU for severe sepsis (55  %) or septic 
shock (45  %). Patients were mostly males (64.3  %) with an age of 60 
[49–70] years. The admission SOFA score was 7 [4–10]. The hemoglobin 
level at the time of ICU admission was 9.1 [7.9–10.4] g/dL. One hundred 
and forty-eight (23.5 %) and 89 (14.5 %) patients received red blood cell 
transfusion at days 1 and 2, respectively. Overall, 210 (33.3 %) patients 
received 2 [1–3] packed red cells during the first 48  h. Hemoglobin 
levels were lower in transfused patients at day 1 (7.8 [7.1–8.8] vs. 9.7 
[8.7–11] g/dL, p < 0.001) and day 2 (8.9 [7.9–9.9] vs. 9.3 [8.4–10.2] g/dL, 
p = 0.001) and became similar to those of non-transfused patients at 
day 3 (8.9 [8.2–9.8] vs. 8.9 [8–10]). Early red blood cell transfusion was 
more likely in patients with myeloid neoplasms and neutropenia. Trans-
fused patients appeared with more severe presentations as assessed 
by higher admission SOFA scores (8 [5–11] vs. 6 [4–9], p  <  0.001) and 
blood lactate levels (2.4 [1.6–5.6] vs. 1.9 [1.1–3.6] mmol/L, p  <  0.001) 
and the requirements for organ failure supports including vasopressive 
drugs (78.9 vs. 49.7 %, p < 0.001), invasive mechanical ventilation (75.5 
vs. 33.5 %, p < 0.001) and renal replacement therapy (38.7 vs. 15.4 %, 
p < 0.001). In univariate analysis, red blood cell transfusion within the 
first 48  h was associated with increased mortality at day 7 (20.5 vs. 
13.3 %, p = 0.02), in the ICU (39 vs. 25.2 %, p < 0.001) and in the hospital 
(51 vs. 36.6 %, p < 0.001). After adjustment with other significant vari-
ables, red blood cell transfusion was no longer associated with day 7 
mortality (OR 1.18 [0.78–1.98], p = 0.52), but tended to be associated 
with in-ICU and in-hospital mortality (OR 1.48 [0.96–2.26], p = 0.07 and 
OR 1.54 [1.04–2.29], p = 0.03, respectively).
Discussion Although early red blood transfusion was provided to the 
most severe septic patients, it remained associated with a poor prog-
nosis in the multivariate analysis. Whether transfusion may represent a 
potent marker of severity in this setting or may favor subsequent side 
effects in septic patients deserves further investigations.
Conclusion Red blood cell transfusion is commonly used in early 
resuscitation of hematological patients with severe sepsis, and par-
ticularly in those with septic shock. The poor prognostic value was 
associated with transfusion calls for prospective studies in this high-
risk subgroup of patients.
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Introduction Septic patients tend to be anemic with limited tolerance 
in intensive care unit. Red blood cell transfusion (RBCT) is the main treat-
ment but can be deleterious. In that context, one RCT(1) concluded that 
7 g/dl is a good target but excluded patients with overt bleeding or low 
hemoglobin level during the day of admission and showed significant 
increase in ischemic events. Moreover, many cohort studies estimated 
the impact of RBCT, but reached opposite results. One of their main lim-
its was they did not handle time-dependent covariates and past history 
of treatment. In that context, the aim of our study was to estimate the 
causal effect on outcomes and adverse events of RBCT in septic shock 
patients thanks to a marginal structural model.
Patients and methods We used the prospective French multicen-
tric Outcomerea database. Four outcomes were assessed: death, the 
occurrence of nosocomial infection, ischemic event and acute res-
piratory distress syndrome. In each analysis, we included patients with 
sepsis severe and septic shock since 04/01/1998 and excluded patients 
with hemorrhagic shock on admission. Only patients staying for more 
than 48 h were analyzed to estimate the risk of nosocomial infection. 
Similarly, patients having ischemic events during the first 48  h were 
not included in the estimation of the risk of ischemic event. A marginal 
structural cox model with ponderation on the inverse probability of 
treatment weight (IPTW) and inverse probability of censoring weight 
(IPCW) was then used to estimate the impact of transfusion with a cen-
soring at day 30. Subgroups with similar hematocrit evolution pattern 
were determined thanks to a trajectory modeling. Impact of transfu-
sion on death was assessed among those subgroups.
Results Finally, 6016 patients were included, and 1940 (32.2  %) of 
them were transfused during their ICU stay and received 3 [2–5] 
(median [IQR]) red cell pack per patient transfused per ICU stay. RBCT 
was not associated with death [HR 0.8, 95  % confidence interval (CI) 
0.544–1.176, p  =  0.255], with the occurrence of ischemic event (HR 
0.774, 95 % CI, 0.343–1.749, p = 0.538) or with the occurrence of ARDS 
(HR 0.948, 95 % CI, 0.811–1.107, p = 0.498). However, RBCT was associ-
ated with the occurrence of nosocomial infections (HR 2.149, 95 % CI, 
1.662–2.779, p < 0.001). Four subgroups were identified thanks to our 
trajectory modeling. In the subgroup with the lowest hematocrit level 
(hematocrit 26 [24–28]), transfusion had a beneficial effect (HR 0.375, 
95 % CI 0.225–0.625, p < 0.001), whereas in the subgroup with a hema-
tocrit at 30 [28–31.2], transfusion had no more impact on outcome (HR 
0.942, 95 % CI 0.601–1.477, p = 0.795).
Conclusion Transfusion was not associated with death in the entire 
cohort. Modification of transfusion practice such as systematic deleu-
kocytation and lower transfusion thresholds might have improve the 
tolerance of transfusion. The protective effect in the subgroup with 
the lower hematocrit level might reflect the limits of a drastic lower-
ing of the transfusion thresholds. RBCT still remained associated with 
nosocomial infections. Others immunomodulating factors than leuko-
cytes might explain this association.
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Introduction Autoimmune hemolytic anemia (AIHA) is a rare, het-
erogeneous and potentially life-threatening disease. Data on AIHA 
patients requiring admission to the intensive care unit (ICU) are scarce. 
The aim of our study was to describe the characteristics and outcome 
of patients with AIHA in the ICU.
Patients and methods Patients with AIHA admitted to the ICU of 
Saint Louis University Hospital between years 2002 and 2015 were 
retrospectively identified using a computerized database. Clinical and 
biological data including past medical history, etiologic diagnosis, 
type of direct antiglobulin test (DAT), organ failures, treatments and 
follow-up were abstracted from the patients’ charts. Primary outcome 
was ICU mortality. Data are presented as numbers (%) or medians 
(interquartile range). Survivors (S) and decedents (D) were compared 
using Chi squared test for binary variables and Mann–Whitney test for 
continuous variables.
Results During the study period, 270 patients with hemolytic ane-
mia required ICU admission, including 44 (16.3 %) patients with AIHA. 
Twenty patients presented with a DAT positive for immunoglobulin G 
(IgG) only (45.5  %), eight with a DAT positive for both IgG and com-
plement (36.3  %) and 16 with a DAT positive for complement only 
(18.1 %). There were 24 men (54.5 %) with an age of 57 years (44.5–69). 
Twenty-five patients (56.8 %) had a past history of malignant hemopa-
thy, five (11.4 %) had solid cancer, and five (11.4 %) had HIV infection. 
Median delay from first symptoms of AIHA to hospitalization was 
14  days (2–38). Patients were mostly hospitalized for hematological 
(23 [52.3 %]) or respiratory (11 [25 %]) failure. Median sequential organ 
failure assessment score (SOFA) at day 1 was 6 (3.8–8). Hemoglobin 
rate at admission was 6.8  g/dl (4.6–9.1). Corticosteroids were admin-
istered to 39 patients (88.6  %) and anti-CD20 monoclonal antibody 
rituximab to 11 patients (25.6 %). ICU stay was 2.5 days (2–6), and hos-
pital stay was 15 days (9–42). Follow-up was 74 days (11.5–695.2).
Thirteen patients (29.5 %) died in the ICU, and none of the survivors 
died during post-ICU hospitalization. There was no difference between 
S and D regarding associated comorbidities like hemopathy (18 
[58.1 %] vs 7 [53.8 %], p = 0.80), solid cancer (3 [9.7 %] vs 2 [15.4 %], 
p = 0.59) or HIV (4 [12.9 %] vs 1 [7.7 %], p = 0.62). In D, age was higher 
(72 years old [57.8–76.3] vs 50 years old [34.3–64], p < 0.01) and organ 
dysfunctions were more severe at day 1 (SOFA 8 [7–11] vs 5.5 [3–7], 
p < 0.01). Patients with a DAT positive for IgG only (DAT-IgG) displayed 
poorer outcome in comparison with patients with a Coombs test posi-
tive for IgG+ complement or complement only (DAT-IgG + C/C) (ICU 
mortality 69.2 vs 35.5 %, p = 0.04). In comparison with patients with 
DAT-IgG  +  C/C, DAT-IgG patients were older (65  years old [52–73.5] 
vs 49  years old [34.5–59.5], p =  0.01), presented with higher rates of 
hemoglobin at admission (8.3 [6.7–9.8] vs 5.5 [3.7–7.5], p < 0.01) and 
were less likely to receive rituximab in the ICU (2 [10 %] vs 9 [39.1 %], 
p = 0.03).
Discussion Mortality rate of AIHA patients requiring ICU admis-
sion is higher than previously reported and appears to be impacted 
by age, organ failures and DAT-IgG. Those results are tempered by 
evident recruitment biases (over-representation of hemopathies, 
paucity of cold hemagglutinin disease), confounding factors (age, 
rituximab) and the small sample size. Further larger studies are needed 
to confirm DAT-IgG as an independent prognostic factor and explain 
its pathophysiology.
Conclusion The mortality rate of AIHA patients in ICU is consequential. 




Pre‑ICU location, lead time bias and outcomes in patients 
with thrombotic microangiopathies
Damien Vimpere1, Sandrine Valade1, Marion Venot1, Claire Pichereau1, 
Akli Chermak2, Virginie Lemiale1, Emmanuel Canet1, Lionel Galicier3, Elie 
Azoulay1, Eric Mariotte1
1Réanimation médicale, Hôpital Saint Louis, Paris, France; 2Réanimation 
polyvalente, CH sud Essonne, Paris, France; 3Immuno‑hématologie, Assis‑
tance Publique Hôpitaux de Paris, Paris, France 
Correspondence: Damien Vimpere ‑ vimpere.damien@gmail.com 
Annals of Intensive Care 2016, 6(Suppl 1):O33
Introduction The thrombotic microangiopathy (TMA) syndrome 
encompasses a wide spectrum pathologies including thrombotic 
thrombocytopenic purpura (TTP) and complement-mediated TMA 
[formerly known as atypical hemolytic uremic syndrome (HUS)]. The 
aim of the present study was to describe the first clinical symptoms in 
critically ill TMA patients and to evaluate the impact of pre-intensive 
care unit (ICU) location on the patients’ outcomes.
Patients and methods Patients with TMA admitted to a 12-bed medi-
cal university hospital ICU between 2009 and 2015 were identified 
using a computerized database. Data concerning the pre-ICU period 
and clinico-biological parameters were abstracted from medical 
charts. Data are expressed as numbers (%) and medians (interquar-
tile range). Comparisons were made using the Chi square test or the 
Mann–Whitney U test as appropriate.
Results Among the 74 TMA patients admitted in our ICU (43 [58  %] 
females, aged 42 [32–55]  years), 51 patients (68.9  %) had TTP, 13 
(17.6  %) HUS and 10 (13.5  %) other TMA. At ICU admission, hemo-
globin rate was 8.2 g/dl (6.8–9.7), platelet rate 17 G/l (9–31), LDH level 
1743 U/l (1064–2581) and creatininemia 113.5 µmol/l (75–184), and 43 
patients (64.2 %) displayed elevated troponin levels. Day 1 SAPS2 score 
was 21.5 (12–32) and SOFA score was 6 (4–8). ICU length of stay was 
7  days (4–11), and hospital length of stay was 16.5  days (12.5–28.5). 
Five patients (9.4 %) died during hospital stay. Earlier TMA manifesta-
tion was neurologic in 25 cases (33.8 %), digestive in 20 cases (27 %), 
uro-nephrologic in 14 cases (18.9 %), dermatologic in 12 cases (16.2 %), 
cardiologic in ten cases (13.5 %) and respiratory in nine cases (12.2 %). 
Sixteen patients (21.6  %) reported simultaneous occurrence of more 
tha one first symptom. The occurrence of diarrhea or abdominal pains 
as first symptoms of TMA was more frequent in HUS patients in com-
parison with TTP and other TMA patients (respectively, 8 [61.5 %] vs 11 
[21.6 %] vs 1 [10 %], p < 0.001). Time from first clinical symptom to first 
medical contact was 4 days (0–8.5). This time was longer when the first 
alleged symptom was dyspnea (14 days [10.5–18.5] vs 3.5 days [0–7], 
p = 0.03). First medical contact consisted in hospital consultation in 58 
cases (78.4 %) including 45 emergency department (ED) consultations, 
six direct admissions to specialized ICUs (three neurologic and three 
cardiologic) and three direct admissions to medico-surgical wards. In 
16 (21.6 %) cases, the first medical contact was community based (15 
general practice and one cardiology practice). Patients were admitted 
in one hospital ward (range 0–5) before medical ICU referral. Only 14 
patients (18.9 %) were directly admitted to a medical ICU performing 
PEX, after first medical contact with an ED (11 cases) or hospital-based 
consultations (three cases). None of these patients died. Prior to ICU 
admission, 21 patients were managed in the ED (27 cases [34.5  %]), 
another medical ICU in nine cases (15  %) or a medico-surgical ward 
(24 cases [40  %]). Secondary referral to ICU where PEX was available 
was similar in patients first admitted to ED or medico-surgical wards 
(63 vs 70.8 %), but time to ICU transfer was shorter for patients admit-
ted first to ED than for patients directly admitted to wards (1  days 
[0–1] vs 3 days [1.5–7], p < 0.01). Patients admitted first to another ICU 
were secondarily referred to our ICU for refractory TMA within 6 days 
(0.5–10.5).
Discussion Our data suggest that family physicians and ED specialists 
must maintain a high level of suspicion for the diagnosis to appro-
priately refer these patients to specialized ICUs. Indeed, no patient 
directly admitted to ICU died, suggesting that early recognition of 
TMA syndrome and quick transfer to specialized centers may improve 
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TMA outcomes. However, we found no association of pre-ICU charac-
teristics and mortality, likely because of the low case fatality rate.
Conclusion TMA patients still display relatively long pre-ICU trajec-
tories before referral to specialized ICUs, with inappropriate referral 
resulting in longer delays for ICU admission in centers where PEX and 
specific management is available. These data need to be repeated at 
large scale and with outcomes such as morbidity, length of stay, unre-
sponsive TMAs and long-term outcomes.
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Introduction The lack of a patent source of infection and microbio-
logical documentation is not uncommon during the first 24 h manage-
ment of a septic shock, raising the possibility of non-infectious causes.
Patients and methods Among patients admitted in the intensive 
care unit (ICU) with a “clinical phenotype” of septic shock, we aimed to 
determine the prevalence of shock with no early etiological diagnosis, 
to identify their main causes and to compare their outcome to those of 
patients with an “early-diagnosed” septic shock. We conducted a pro-
spective, multicenter, observational cohort study in ten ICUs of public 
hospitals in France.
Results From November 2014 to June 2015, 508 patients were admit-
ted for a suspicion of septic shock. Among them, 374 (74  %) had a 
proven diagnosis of septic shock made during the first 24  h (“early” 
septic shock, ESS), while the 134 (26 %) others had no source of infec-
tion nor microbiological documentation identified within the first 
24 h. These patients had either septic shock confirmed during the first 
24 h (“late” septic shock, LSS; n = 37/134, 28 %) or a severe systemic 
inflammatory response syndrome (SIRS) (n  =  97/134, 72  %) encom-
passing patients having a non-septic severe SIRS (NS-SIRS) (i.e., a non-
infectious cause was identified; n = 59/134, 44 %) or a severe SIRS of 
unknown origin (SIRS-UO) (n =  38/134, 28  %). The leading causes of 
non-septic severe SIRS were adverse drug reactions, acute mesen-
teric ischemia, malignancies and inflammatory diseases. There were 
no differences regarding the in-ICU mortality (n =  139/374, 37  % vs. 
49/134, 37  %; p  =  0.90) and the median duration of ICU stay (7 vs. 
7  days, p =  0.69), of tracheal intubation (4 vs. 4  days, p =  0.19) and 
of vasopressor support (3 vs. 3 days, p = 0.55) between patients with 
“early” septic shock (ESS) and others. A multivariable Cox model with 
adjustment on variables significantly associated with day-60 mortal-
ity showed that patients with a severe SIRS of unknown origin had a 
higher risk of mortality than others (Fig. 7).
Conclusion One-quarter of the patients admitted in the ICU for a sus-
picion of septic shock had no infection identified 24 h after vasopres-
sors introduction, and almost three-quarters of these had a severe 
SIRS that mimicked sepsis. Patient with a severe SIRS of unknown ori-
gin had a poorer outcome (Fig. 8).
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Introduction The role of intensive care-acquired weakness (ICU-AW) 
and diaphragm weakness (DW) is questioned in case of prolonged or 
failed weaning from mechanical ventilation. The relative contribution 
of DW and ICU-AW on this outcome is unclear. We aimed at assessing 
Fig. 7 See text for description
Fig. 8 See text for description
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the respective prevalence and impact of DW and ICU-AW on the suc-
cess (WS) or failure (WF) of the weaning process. We combined the use 
of twitch airway occlusion pressure and ultrasound to evaluate dia-
phragm stength.
Patients and methods In ICU patients undergoing a first spontaneous 
breathing trial, diaphragm function was evaluated by twitch tracheal 
pressure in response to bilateral anterior magnetic phrenic nerve stim-
ulation (Ptr,stim) and by diaphragm ultrasonography [end-expiratory 
thickness (TdiEXPI), thickening fraction (TFdi), excursion (EXdi). MRC 
score below 48 defined ICU-AW and Ptr, stim below 11 cmH2O defined 
DD.
Results Seventy-six patients were included: age: 60 years (47–69) and 
duration of mechanical ventilation: 5 days (3–9). DW and ICU-AW were, 
respectively, present in 48 (63  %) and 26 (34  %) patients. The preva-
lence of DW was similar among patients with or without ICU-AW (62 
vs. 64 %, p = 0.83) as well was the median MRC score in patients with 
or without DW [51 (43–56) vs. 51 (44–59), p =  0.30]. The proportion 
of patients with DW but without ICU-AW was 42 %, whereas the pro-
portion of patients with both DW and ICU-AW was 21  % (p  <  0.05). 
By contrast, the proportion of patients with ICU-AW but without DW 
was 13  %. The proportion of patients without ICU-AW neither DW 
was 24  %. DW was associated with WF (OR 23.7, 95  % CI 5.0–112.2, 
p < 0.001) but not ICU-AW (OR 1.9, 95 % CI 0.73–5.0, p = 0.23). Patients 
with both DW and ICU-AW had a significantly higher ICU mortality as 
compared to patients with ICU-AW without DW (38 vs. 0 %, p < 0.001). 
The areas under the receiver operating characteristic curves of Ptr, 
stim, TFdi and MRC score to predict weaning outcome were 0.92, 0.90 
and 0.67, respectively.
Conclusion Diaphragm weakness had higher prevalence and worst 
impact on weaning outcome than ICU-AW. Diaphragm ultrasound 
predicted weaning outcome with good performance. Determination 
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Introduction In difficult-to-wean ICU patients under mechanical ven-
tilation, the influence of sleep quality on weaning duration has never 
been studied. We aimed to compare sleep quality between patients 
with a short weaning duration and those with a prolonged weaning 
duration.
Patients and methods Prospective physiological study performed 
in a French teaching hospital. All patients intubated at least 24 h and 
difficult-to-wean, i.e., those who experienced at least one weaning trial 
failure, could be included. Patients with continuous sedation, central 
nervous system or psychiatric disease, or peripheral neuromuscular 
disease were excluded. A complete polysomnography was performed 
as soon as possible the night following the first weaning trial failure. 
Peripheral muscle strength, maximal inspiratory pressure and delirium 
were measured at time of polysomnography. Weaning duration was 
defined as the time from polysomnography to extubation. Prolonged 
weaning was defined as a weaning duration more than or equal to 
3 days (failure of at least three weaning trials) according to the interna-
tional conference consensus of weaning [1].
Results Over the first 6  months of the study, 25 patients intubated 
for at least 24  h were considered as difficult-to-wean. Among the 15 
patients included in the study, six patients (40 %) had short weaning 
period and nine patients (60  %) had prolonged weaning (≥3  days). 
Patients with prolonged weaning group had less rapid eye movement 
(REM) sleep episodes and shorter REM sleep duration than patients 
with short weaning (0.0 episodes [0.0–2.0] vs 6.0 [4.5–6.8] and 0 min 
[0–6] vs 43 [33–77], p =  0.02 for both). Atypical sleep and/or patho-
logical wake [2] was more likely to be found in the prolonged weaning 
group: 56 % of the patients (5/9) versus 17 % (1/6) although this dif-
ference was not significant (p = 0.29). Patients with absent or altered 
electroencephalographic reactivity (n  =  10/15) were more likely to 
have prolonged weaning than the others (80  % of the patients with 
absent/altered reactivity had prolonged weaning vs 20  % of the 
patients with normal reactivity, p = 0.03). Maximal inspiratory pressure 
was similar in the two groups as well proportion of delirium. The only 
difference was a lower peripheral muscular strength in the prolonged 
weaning group as indicated by a lower MRC score (32 [28–55] vs 59 
[55–60], p = 0.02).
Conclusion Our preliminary results show that decreased REM sleep 
time and altered electroencephalographic reactivity measured by pol-
ysomnography seem to be associated with prolonged weaning dura-
tion in ICU patients.
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Introduction Establishing the correct time of weaning from mechanical 
ventilation (MV) is a crucial issue in the critical care practice. We hypoth-
esize that the use of an integrative thoracic ultrasound assessment, 
encompassing bedside respiratory, cardiac and diaphragm sonographic 
data, could significantly improve weaning decision process. The aim of 
the present study was to prospectively compare the predictive value of 
an integrated thoracic ultrasound (TUS) applied in this setting, against 
a standard approach (CB) elaborated from clinical and biological data.
Patients and methods We prospectively recruited consecutive 
patients from three ICU of an university teaching hospital. TUS assess-
ments were determined before (H0) at the end of a 60-min (H1) spon-
taneous breathing trial. Clinical and biological (arterial blood gas, 
plasma BNP) data were recorded concomitantly to create a standard 
predictive mode. We applied machine-learning methods to improve 
the accuracy of the related predictive assessments and explore the 
specific predictive load of each clinical, biological and ultrasono-
graphic parameters.
Results One hundred and thirty-four patients who succeeded a SBT 
test were extubated and included in the study. Among these patients, 
103 were definitely weaned and 31 suffered from postextubation dis-
tress. The most relevant clinical/biological parameters (CB model) were 
the spontaneous respiratory rate and the PaCO2. Regarding the whole 
ultrasound dataset (TUS model), only lung parameters (A, B1 and B2 
profiles) and the echocardiographic estimation of left ventricular fill-
ing pressures (E/e) emerged as reliable predictors. Crucially, the predic-
tive value of TUS was significantly greater than CB during both H0 and 
H1 assessments (Fig. 9).
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Conclusion An integrative thoracic ultrasound assessment during a 
successful breathing trial appears to be a most accurate predictor of 
weaning from MV than a standard clinical and biological approach.
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Introduction Weaning from mechanical ventilation (MV) is a crucial 
step in the management of intensive care patients. Weaning failure 
is associated with prolonged duration of MV leading to morbidities, 
increased mortality as well as increased hospital expenses. However, 
the prediction of weaning outcome remains challenging. We aimed to 
investigate the end-tidal CO2 (ETCO2) and hypothesized that the prod-
uct “ETCO2  ×  Respiratory Rate,” called ETCO2  ×  RR, reflects alveolar 
ventilation and could predict MV weaning outcome.
Patients and methods We conducted aprospective observational 
study. All patients under MV that met the criteria for weaning as 
defined by the International Consensus Conference for Weaning from 
Mechanical Ventilation were enrolled. Patients underwent a T-piece 
spontaneous breath trial (SBT) for 30  min, and the usual respiratory 
and hemodynamic clinical parameters were recorded every 5  min. 
ETCO2 was recorded blindly by an independent physician using cap-
nography. Patients ventilated through tracheostomy were excluded. 
SBT failure was defined as one or more of the clinical and biological 
criteria from International Consensus Conference. PaO2, PaCO2 and pH 
were determined at the beginning (i) and at the end of the SBT (f ).
Results During a 10-month period, 310 SBTs were analyzed, 196 
patients underwent 1 SBT, 57 did two trials and 48 did three or more. 
For the first SBT, we analyzed 196 first SBT with three groups: success 
(n  =  139), hypoxemia-related failure (n  =  11) and non-hypoxemia-
related failure (n = 46). Mean age was 57 ± 17 years, 63 % were men, 
and SAPS II was 47  ±  16. Duration of mechanical ventilation was 
2.0 (1.0–3.4) days before starting SBT, FiO2 was 38 ± 18 %, and PEEP 
level was 4 ±  1  cm H2O. After 30  min of SBT, ETCO2, respiratory rate 
and ETCO2  ×  RR were predictive of MV weaning outcome as AUC 
was, respectively, 71  % [75–94], 80 [74–89] and 88  % [80–93] (all, 
P < 0.0001). A threshold of ETCO2 × RR of 860 predicted weaning fail-
ure with a sensitivity of 78 % (CI95 % [61–88]) and a specificity of 81 % 
(CI95  % [72–87]). We found a significant correlation between delta 
PaCO2 (f–i) and delta ETCO2 ×  RR (f–i) (r =  0.35, P  <  0.0001). During 
the second SBT, we analyzed 57 patients according to weaning out-
come: success (n  =  31), hypoxemia-related failure (n  =  5) and non-
hypoxemia-related failure (n = 21). After 30 min of SBT, the predictive 
performance of ETCO2*RR was better (AUC 84 % [73–96]), P = 0.0001) 
than ETCO2 alone (AUC 75 % [59–90]), P = 0.0002) or RR (68 % [52–84], 
P = 0.03).
Conclusion In unselected mechanically ventilated patients undergo-
ing SBT, ETCO2*RR predicts weaning outcome.
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Introduction Weaning-induced pulmonary oedema (WIPO) has 
not been investigated in large series of patients. Although diuret-
ics are widely used to treat it, the dose that must be administered is 
unknown. Our aim was to describe the incidence of weaning-induced 
pulmonary oedema (WIPO) in a population of critically ill patients, to 
compare the characteristics of patients with and without WIPO and to 
detail the effects of diuretics on WIPO.
Patients and methods We systematically monitored all consecu-
tive spontaneous breathing trials (SBT, 1-h trial, T-tube trial) that were 
performed in our unit. In the patients for whom cardiac index (CI) was 
monitored (PiCCO device), a passive leg raising (PLR) test was system-
atically performed before SBT in order to assess preload dependence. 
The diagnosis of WIPO was established a posteriori by four experts 
who based their diagnosis on clinical, echocardiographic and bio-
logical (haemoconcentration) data and on the evolution after SBTs. 
Experts were unaware of the effects of PLR test in the patients in 
whom it had been performed.
Results From April to September 2015, 150 SBTs were performed in 
36 patients. SBT failed in 67 cases (35 % of all SBTs). According to the 
experts, the diagnosis of WIPO was positive in 44 cases (66  % of fail-
ing cases), negative in 98 cases and inconclusive in five cases. The inci-
dence of previous COPD was 33 % in patients who experienced at least 
one WIPO and 0 % in patients who experienced no WIPO (p = 0.03). The 
incidence of previous cardiopathy, hypertension or supraventricular 
arrhythmia was 78  % in patients who experienced at least one WIPO 
and 50  % in patients who experienced no WIPO (p  =  0.16). Patients 
with and without WIPO were similar in terms of left ventricular ejection 
fraction or of mitral E/E′ ratio at baseline and in terms of fluid balance 
of the previous day. Compared with patients without WIPO, patients 
with WIPO had a larger gain in weight from admission. Myocardial 
ischaemia was not detected during any cases WIPO. Among the 34 
patients with cardiac output monitoring, the effects of PLR on CI were 
significantly larger in patients without than with WIPO (changes in CI 
13 ± 15 vs. 5 ± 14 %, respectively, p = 0.04). This confirmed our previ-
ous finding that the presence of preload dependence is associated with 
a better cardiac tolerance to the SBT. All patients with WIPO received 
diuretics. Among the six cases with WIPO in which cardiac output was 
monitored, the PLR was negative. The PLR test performed after diuret-
ics administration on the following day was positive in two of these six 
cases. These two cases succeeded to the next SBT. The PLR performed 
after diuretics administration was negative in the remaining four cases. 
Three of these cases experienced WIPO during the next SBT.
Conclusion In this population of critically ill patients, WIPO was 
responsible for two-third of weaning failures. WIPO was associated 
with preload independence, indicating the incapacity of the heart to 
adapt to the changes in loading conditions during SBT. After a failing 
SBT, when diuretics had changed the PLR test from negative to posi-
tive, the following SBT was very likely to succeed.
Competing interests XM and J-LT are members of the Medical Advi-
sory Board of Maquet.
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Introduction Systemic antifungal therapy of invasive candidiasis 
needs to be initiated immediately upon clinical suspicion. Unfortu-
nately, no diagnostic tests are available to firmly confirm or discard the 
diagnosis of IC in the absence of positive blood cultures or non-con-
taminated positive sample from a sterile site. Controversies exist about 
adequate time and potential harms of antifungal de-escalation in doc-
umented and suspected candidiasis in intensive care unit patients. Our 
objective was to investigate whether de-escalation within 5  days of 
antifungal initiation is associated with an increase of the 28-day death 
in systemic antifungal therapy treated non-neutropenic adult inten-
sive care unit patients.
Patients and methods From the 835 non-neutropenic adults 
recruited in a multicenter prospective observational study, we 
selected the patients receiving systemic antifungal therapy for a docu-
mented or suspected invasive candidiasis in the intensive care units 
and who were still alive 5 days after systemic antifungal therapy initia-
tion. They were included into two groups according to the occurrence 
of observed systemic antifungal therapy de-escalation before day 6. 
The average causal systemic antifungal therapy de-escalation effect 
on 28-day death was evaluated by using a double-robust inverse 
probability of treatment weight estimator which is a causal inference 
method based on observational data. The objective of this estimator 
is to balance the distribution of baseline confounders across de-esca-
lation groups, in order to reach the condition of a randomized con-
trolled trial.
Results Among the 647 included patients, early de-escalation at day 
5 after antifungal initiation occurred in 142 patients (22 %), including 
48 (34  %) patients whose systemic antifungal therapy was stopped 
before day 6. Patients in the de-escalation group were younger and 
had a shorter previous intensive care unit stay, but their SAPSII or SOFA 
score at intensive care unit admission was similar. The rate of proven 
invasive candidiasis was not different between de-escalation and no 
de-escalation groups. After adjustment on the baseline confounders, 
early systemic antifungal therapy de-escalation was not associated 
with increased 28-day mortality (RR 1.12, 95  % CI [0.76–1.66]). Sub-
group analyses did not show any effect of early de-escalation on mor-
tality, and there was no effect of early stopping on morality either (RR 
0.98 [0.71–1.35]) (Fig. 10). Finally, the number of days alive without SAT 
at day 28 was higher in the de-escalation group (14 days [5; 23]) than 
in the no de-escalation group (10  days [2; 17] p  <  0.01) leading to a 
median cost difference of 1100 euros in favor of de-escalation group.
Conclusion Our causal analysis based on a large prospective obser-
vational multicenter study showed that systemic antifungal de-esca-
lation in case of suspected or documented IC in non-neutropenic 
ICU patients occurred in only 22  % of the cases. In non-neutropenic 
critically ill adult patients with documented or suspected inva-
sive candidiasis, SAT de-escalation within 5  days was not related to 
increased day-28 mortality, but it was associated with a subsequent 
and significant decrease in the antifungal consumption. These results 
remained valid on different subgroups and were confirmed by sensi-
tivity analysis. Early stop in the absence of proven invasive candidiasis 
or de-escalation to fluconazole at day 5 could be done safely. The lat-
ter has to be confirmed in randomized controlled trials.
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Introduction Pneumonia is the most frequent ICU-acquired infection. 
The increasing prevalence of ESBL-PE carriage on ICU admission raises 
important questions on empiric therapy policies in patients present-
ing with ICU-acquired pneumonia, which may include the use of a 
carbapenem as first-line therapy. The incidence of and risk factors for 
ICU-acquired pneumonia (ICUAP) among patients with ESBL-PE car-
riage are unknown.
Patients and methods This 6-year prospective study (May 2009–
January 2015) was conducted in the medical intensive care unit of 
an university-affiliated hospital. All patients with ESBL colonization 
or infection were prospectively recorded. A detailed clinical profile of 
each patient was established, and variables associated with ESBL-PE 
pneumonia after colonization was analyzed.
Results A total of 6168 patients were admitted to our medical ICU dur-
ing the study period. Nine patients were excluded because they devel-
oped ESBL-PE ICUAP before ESBL-PE colonization. Of these patients, 
826 (13.4 %) were detected as ESBL-PE carriers on admission screening 
samples or acquired ESBL carriage while in the ICU. One hundred and 
six (12.8 % of carriers) patients developed ICUAP after colonization, 47 
(44  %) with ESBL-PE, mostly Enterobacter spp. and K. pneumoniae. By 
multivariable analysis, SAPS II ≥43 (OR 2.6 [1.02–6.8]), more than one 
episode of ICUAP before the index pneumonia (OR 5.4 [1.2–24.6]), and 
colonization with E.cloacae or K. pneumoniae rather than with E. coli (OR 
7.2 [1.8–28.9]) were independent predictive factors for ESBL-PE ICUAP 
with prior colonization. More than 2 days of fluoroquinolone within the 
past 3 months fell short of statistical significance (P = 0.058) Amoxicillin/
clavulanic acid during ICU was a protective factor for ESBL-PE ICUAP (OR 
0.29 [0.10–0.82]), thus predictive for another microorganism than ESBL-
PE, mostly Pseudomonas. All patients but one (98 %) with ICU-acquired 
infection caused by ESBL-PE had rectal carriage of ESBL-PE with the 
same species. Appropriate antibiotherapy was given to most patients 
without difference between ESBL-PE infections and others, even if ami-
noglycosides were not considered. ESBL-PE ICUAP had higher SOFA 
score, a trend to more frequent septic shock at ICU-AP onset and worse 
outcome [57 % died in ICU vs 41 % (p = 0.09)]. Twenty-four patients had 
Fig. 10 See text for description
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ICUAP caused by a carbapenem-resistant microorganism after coloniza-
tion, most of which (87  %) were nonfermenting gram-negative bacilli. 
Carbapenem exposure before or after ICU admission was associated 
with carbapenem-resistant microorganism.
Conclusion This study highlights the high rate (44 %) of ESBL-PE pneu-
monia acquired in ICU in patients with prior colonization. We identi-
fied new risk factors for ESBL-PE ICUAP after colonization. These data 
may be useful for identifying which patients may warrant empiric 
ESBL-targeted antimicrobial drug therapy, as improving carbapenem 
use is currently a major challenge for intensivists.
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Introduction International guidelines support the need to remove 
totally implantable venous-access ports in septic patients admitted to 
intensive care unit. Nevertheless, the clinical relevance of this attitude 
is debated. Therefore, we undertook the present study to determine 
the proportion of confirmed totally implantable venous-access ports-
related infection in case of removal. We also assessed the epidemio-
logical, clinical and microbiological characteristics of these patients.
Patients and methods We conducted a multicenter, retrospective, 
observational study from 2012 to 2014. All patients with life-threat-
ening sepsis in whom a decision of totally implantable venous-access 
ports removal was taken by the clinician in charge were included. 
Catheter-related infection was defined by the association of general or 
local signs of infection and bacteremia and/or positive culture of the 
catheter or differential time to positivity of simultaneous blood cul-
tures or good evolution 48 h after device removal and after antibiotics 
initiation.
Results One hundred and fifty one patients were included 
(57 ± 14 years old, 61.5 % of male). Totally implantable venous-access 
ports-related infection was confirmed in 75 patients (45 %). IGS2 was 
47 ±  15 and 56 ±  17 (p  <  0.05) in patients with and without cathe-
ter-related infection, respectively. On admission, temperature was 
38.6 ± 1.5 and 38.2 ± 1.5 °C (p > 0.05) and mean arterial pressure was 
69 ± 23 and 70 ± 18 mmHg (p > 0.05) in patients with and without 
catheter-related infection, respectively. Local signs of sepsis were 
present in 27 (18 %) and 6 (4 %) patients with and without catheter-
related infection, respectively (p  <  0.05). There was no difference 
between patients with and without catheter-related infection regard-
ing aplasia on admission (30 and 37  %, respectively, p  >  0.05). The 
microbiological findings identified enterobacteria as the most com-
mon pathogen (37.5 %). Coagulase-negative staphylococci and Staphy-
lococcus aureus were the others frequent pathogens (30.3 and 16  %, 
respectively).
Intensive care unit, day 28, day 90 and 6  months mortality were, 
respectively, for patients with and without catheter-related infection 9 
and 40 % (p < 0.01), 22 and 48 % (p < 0.01), 32 and 53 % (p < 0.05) and 
40 and 57 % (p > 0.05).
Discussion Almost half of our population had a confirmed totally 
implantable venous-access ports infection. It is noteworthy that 
patients with or without catheter-related infection had similar charac-
teristics on admission but a clear difference regarding the short- and 
long-term survival. These findings support the removal of the catheter 
in case of life threatening.
Conclusion Almost half of the totally implantable venous-access ports 
removed in patients admitted for life threatening were really infected. 
The clinical course of these patients was better than patients with sep-
sis from other origin.
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Introduction Genetic association studies and genome-wide associa-
tion studies have demonstrated the role of human genetic variations 
in the epidemiology of infectious diseases in ICU. However, no study 
has used the power of genome or exome sequencing in this clinical 
condition. Hence, we design an exome study to search for genetic fac-
tors involved in the risk of ventilator-associated pneumonia (VAP) due 
to Pseudomonas aeruginosa (Pa).
Patients and methods Patients had been previously participated in 
Pneumagene study that included 3200 ICU patients, which should 
be on invasive mechanical ventilation for more than 2 days and had 
no immunodepression, and no risk factor for Pseudomonas aerugi-
nosa VAP (COPD, Pa colonization). For PaVAP group, inclusion crite-
ria included the presence of two or more VAP due to Pa during the 
same ICU stay. Control group (C) included patients that had no VAP 
and have not been colonized by Pa during mechanical ventilation 
(MV) and that can be matched with one PaVAP patient on values 
of age, SAPS2, duration of MV, reason for ICU admission, potential 
risk factors for VAP (coma, ARDS, head trauma) and outcome. The 
Knome Company performed exome sequencing and analysis with 
the SKAT Common Rare algorithm. Multiple testing was corrected 
by bootstrap resampling technique with 1000 resamples and a 
FWER = 0.05.
Results Fifty patients were included in each group. Median age, SAPS2, 
gender and Pa risk factors were not different between the groups. 
The control group had higher duration of MV that PaVAP group (59 vs 
52.6, respectively, p < 0.05). One thousand genetic variants were finally 
detected and analyzed. After multiple corrections, 178 loci remain sta-
tistically associated with PaVAP risk. Interestingly, two areas appear to 
be of high interest on the same part of the genome chr 16 p11.2 (26 
SNPs and 20 SNPs, respectively, for area 1 and area 2). These two areas 
are gene deserts but have already been reported in GWAs and seem to 
be involved in gene regulation.
Conclusion This is the first exome study in ICU patients that did not 
reveal clear significant genetic variant that can be associated with risk 
of PaVAP, despite the presence of two promising areas on the chro-
mosome 16. This powerful approach may offer new opportunities for 
understanding infectious disease susceptibility, severity, treatment, 
control and prevention.
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Introduction Cytomegalovirus (CMV) reactivation is common in 
immunocompetent mechanically ventilated patients. Lungs are a fre-
quent site of reactivation. CMV reactivation may be responsible for 
higher mortality, length of stay and mechanical ventilation. A higher 
incidence of bacteremia and nosocomial pneumonia following CMV 
reactivation may in part explain the worse prognosis of these patients. 
The aim of this study was to assess the virulence of a staphylococcal 
pneumonia developed during CMV reactivation in a mouse model.
Materials and methods The study was approved by our local ethic com-
mittee. Female BALB/c mice were used in all experiments. CMV primo-
infection was obtained by intraperitoneal inoculation of 2 × 104 PFU of 
murine CMV (MCMV) Smith strain. Seropositivity was confirmed by immu-
nofluorescence in serum. MCMV was considered to be latent 4  months 
later. Reactivation was triggered by cecal ligature and puncture (CLP). 
Mice were considered to have a CMV reactivation 2 weeks after CLP. After 
this, 32 MCMV-positive mice underwent an intranasal inoculation with 
5  ×  108 CFU of methicillin-susceptible Staphylococcus aureus (MSSA) 
to induce pneumonia. Twenty-nine MCMV-negative BALB/c mice were 
treated according to the same protocol, including CLP (control group). 
Daily weight, signs of sepsis and spontaneous mortality were noted. After 
15 days, surviving mice were euthanized. Blood and lung were collected 
for bacterial culture. Interferon alpha and gamma were assessed in the 
serum of both groups. MCMV reactivation was assessed by PCR in the 
lungs. A second cohort of 26 mice was treated according to the same pro-
tocol (13 MCMV positive and 13 control) but were killed at day 2 and day 5 
after pneumonia. The same samples were performed after killing.
Results No mortality from staphylococcal pneumonia was observed 
in the control group, whereas the mortality rate was of 9  % in the 
MCMV group (p = 0.09). The weight loss at day 3 after pneumonia was 
higher in MCMV mice than in the control group (2.2 vs 0.7 g, respec-
tively; p = 0.005). Macroscopic observation and bacteriological analy-
sis of lungs showed staphylococcal abscesses in 5/32 mice in MCMV 
group as compared to 0/29 in control group at day 15. At day 5, 3/8 
mice had lung abscesses in MCMV group as compared to 0/6 in control 
group. Overall, 8/40 (20 %) mice had lung staphylococcal abscesses in 
MCMV group as compared to 0 % in control group (p = 0.011). Lung 
bacterial count (median (interquartile range) was significantly higher 
in MCMV-positive mice as compared to control mice at day 2 [5 × 103 
(103–3 × 105) CFU/lung vs 102 (0–4 × 102) CFU/lung; p = 0.007] and 
day 5 [2.5 × 104 (1.6 × 103–6.5 × 105) vs 15 (10–40); p = 0.005]. Two 
days after staphylococcal pneumonia, MCMV-positive mice had higher 
interferon alpha serum levels (p = 0.023). No difference between the 
two groups was observed concerning interferon gamma levels.
Conclusion In a mouse model, CMV reactivation leads to the switch 
from a non-lethal to a lethal staphylococcal pneumonia, increases 
bacterial lung count and favors the occurrence of staphylococcal lung 
abscesses. The role of the immune response and especially the way of 
interferon alpha seems to be determining.
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Introduction In the context of brain death, a survey led by the French 
Institution, the Agence de Biomédecine, in 2007, showed that for 
34  % of caregivers, organ donation could increase the pain of the 
family. The family is at the heart of the organ donation process: if the 
patient is not registered as a non-donor, then discussions are led with 
his/her relatives. In a recent study focused on relatives’ experience 
and grieving process after request for organ donation, relatives were 
followed up for 9 months to complete instruments measuring the risk 
of presenting anxiety, depression and post-traumatic stress symp-
toms as well as complicated grief. After this follow-up, in-depth inter-
views were led with voluntary relatives in order to permit a better 
understanding of their experience: understand how they construct 
and frame their experience 1  year after the patient’s death; analyse 
the meaning they give to their decision; draw parallels, regarding 
experiences and feelings, between the experience of donor versus 
non-donor relatives; and qualify the impact of the decision on the 
grieving process.
Patients and methods In the main study, 202 relatives were followed 
up three times over 9  months. After this period, 24 relatives (satura-
tion obtained at 24) participated in an in-depth interview (16 rela-
tives whose loved-one was a donor, eight whose loved-one was not 
a donor). Interviews were recorded and fully transcribed. Medium 
length of interview was 1  h 10  min. We privileged an inductive 
approach (grounded theory) and obtained four themes through the-
matic analysis: relationship to the patient in the context of brain death; 
meaning-making regarding organ donation and the decision; search 
for continuity (follow-up of transplantation process); and impacts on 
the grieving process (for oneself and for others).
Results
Relationship to the patient in the context of brain death is complex and 
ambiguous. Relatives question the patient’s condition and wonder 
whether he/she can hear. Whatever their subjective answer to this 
question, they need to talk to the patient. Talking to the patient is a 
ritual that permits closure. Relatives need the clinicians’ support to 
be able to express their feelings and say good-bye to the patient who 
remains a person until he/she is taken to the operating theatre.
 Meaning-making regarding organ donation and the decision relatives 
express a strong responsibility about organ donation decision-making. 
Three justifications of the decision can be put forward: respect of the 
patient’s choices; altruism; and the hope of life in spite of death.
 Search for continuity Relatives stress the importance of being able to 
follow-up the transplantation process. If some relatives want news, 
they must get it; if others do not, they need to know they can. Ambi-
guity is central, as relatives are incapable of considering a possible 
failure of the organ donation process. With failure comes the risk of 
dehumanising the organ donation process.
Impact on the grieving process Organ donation decision impacts on 
relatives’ experience at two levels. First, on a personal level, accept-
ing organ donation can help give meaning to the patient’s death 
(“He did not die for nothing”) but can also be experienced as a moral 
duty (“I respected my son, there was no choice”). Second, on a social 
level, relatives who accepted become organ donation “ambassadors” 
by encouraging discussions about organ donation and by expressing 
their positive perspective on the subject.
Conclusion Relatives invest strong meaning into organ donation deci-
sion-making. The decision requires reflection prior to the experience 
and is made with respect to the patient and to the relative him/her-
self. Relatives cannot afford ambiguity as the decision impacts on their 
grieving process and on the meaning they give to the patient’s death.
Competing interests None.
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Introduction After the death of a loved-one in the ICU, relatives are 
particularly vulnerable and at high risk of presenting symptoms of 
anxiety, depression, posttraumatic stress and complicated grief. More-
over, these relatives may experience persistent incomprehension and 
a feeling of abandonment regarding the ICU team. Many relatives 
also express the need to contact the ICU team after the death of the 
patient. In their official report in 2009, the French institution IGAS rec-
ommended to prevent complicated grief, emphasizing on the fact that 
“care of the family must not end with the death of the patient.” In this 
perspective, a condolence letter (CL) could help recognize both the 
relative’s pain and his/her strong link to the ICU team. The CL could 
also help decrease the risk of presenting post-ICU syndrome. In a 
recent study by the Famiréa group aimed at measuring the impacts 
of the CL on relatives’ grieving process—a randomized multicentre 
trial—242 relatives were followed up over 6 months, half of whom had 
received a CL. The objective of this presentation is to analyse sponta-
neous feedback by relatives having received a CL. This feedback was 
gathered orally during telephone follow-up and also using the letters 
written by relatives to the ICU teams.
Patients and methods Relatives in the intervention group received 
a CL 15 days after the patient’s death. They were contacted over the 
phone twice, 1 and 6 months after the loss. During telephone calls, the 
interviewers noted all spontaneous feedback regarding the CL. Addi-
tionally, all letters spontaneously written to the clinician after receiv-
ing the CL were retrieved and analyzed. All feedback was transcribed 
verbatim. This corpus was analyzed using thematic analysis. Three 
themes will be put forward: humanization of medical care; reflection 
on care received by the patient; and closure.
Results
Humanization of medical care Relatives are touched by the time spent 
by physicians in writing the CL. They say that the letters are personal-
ized and feel that they are not “just a number,” but are recognized for 
the role they played in caring for the patient and in their pain after the 
loss. The CL helps to give a positive image of the institution: “With this 
letter you give me the hope that medical care can be humanized and 
that means a lot to me.”
Reflection on care received by the patient After receiving a CL, relatives 
want to thank the ICU team for the patient’s care and want to renew 
their feeling of trust, more specifically regarding pain management. 
Many relatives also validate decisions made by the ICU team and show 
their understanding of the situation. Last, the CL helps to think the 
patient as a whole, with a specific trajectory and personality, thus reaf-
firming, from the relative’s perspective, the quality of care. “Thank you 
for your kind letter. I am convinced that my husband received the best 
care during his stay. I know that he passed away without any pain and 
this is a great comfort to me.”
Closure The CL is a way of remembering the person who died with the 
team that cared for him/her. It also confirms the relationship between 
the clinicians and the relatives. Remembering, sharing and express-
ing emotions permit closure that, in turn, helps bereaved relatives to 
accept the loss and to start healing. “Your letter has been a tremen-
dous help, it really did help to ease our pain.”
Conclusion The CL helps relatives give meaning to the patient’s tra-
jectory. Emphasis is put of personalization, showing that these letters 
cannot be systematic. Writing a CL must also have meaning for the cli-
nician. More importantly, offering the possibility of a last contact with 
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Introduction According to the 2009 SFAR/SRLF guidelines for improv-
ing hospital conditions in ICU, the admission of children who wish to 
visit a critically ill relative “should be facilitated and supervised” by ICU 
staff members. Yet, the difficulties faced by caregivers in this challeng-
ing setting potentially induce restrictions in children visits. The objec-
tive of this work was to evaluate the impact on ICU staff practices of a 
specifically designed children information booklet.
Materials and methods The booklet was designed by a multidis-
ciplinary team (nurses, intensivists, psychiatrists, cartoonist) and 
included both child-centred explanations (5–12  years old) and 
advices for accompanying adults. During the study period, booklets 
were provided freely to patients’ relatives and ICU staff members as 
a practical tool to help accompanying children who were likely to 
visit a patient. We used a prospective before–after study design with 
a questionnaire at baseline and 1  year post-intervention to assess 
the impact of the booklet on practices in ICU staff members (nurses, 
auxiliary nurses and physicians). The participants were split into an 
intervention centre (booklet available) and a control centre (book-
let not available). Both centres were general ICUs and were part of a 
same university hospital. These ICUs were comparable regarding the 
nurse-to-patient ratio, the number of visiting hours and the admis-
sion policy for family visits. Primary endpoints were the proportion 
of participants who supported visiting children over the 3  months 
prior to the questionnaire, and the Moral Distress Scale Revised 
(MDS-R) to evaluate the emotional experience of staff members in 
this setting.
Results Fifty-seven booklets were distributed in the intervention 
ICU (8  % of admitted patients). During the study period (07/2014–
07/2015), 93 children were likely to visit their relative. A total of 195 
staff members participated in the study (75 % of ICU staff). They were 
nurses, auxiliary nurses and physicians in 56, 27 and 14  % of cases, 
respectively. Participants were equally recruited at the intervention 
ICU (87 participants, 74 % of ICU staff) and the control ICU (108 par-
ticipants, 76  % of ICU staff). In the intervention ICU, the proportion 
of staff members who supported at least one visiting child over the 
3  months prior to the questionnaire increased from 41  % before the 
intervention to 69 % after the intervention (p < 0.001), whereas it was 
not significantly different in the control ICU (38 vs 39 %, p = 0.97). A 
multivariate analysis confirmed that the use of the booklet was an 
independent factor for increasing the rate of caregivers who sup-
ported visiting children [OR 4.0, 95 % CI [2.0; 7.9], p < 0.001]. No sig-
nificant effect of occupation (OR 0.9, p = 0.89), age (OR 1.7, p = 0.15) 
and years of experience in critical care (OR 0.7, p = 0.34) emerged from 
this analysis. In the intervention ICU, the proportion of participants 
who disagreed with child visits decreased from 35 to 14 % (p = 0.002), 
whereas it remained stable in the control ICU (30 vs 34 %, p = 0.51). 
In the intervention ICU, the proportion of participants who claimed 
that the admission policy for child visits had to be improved decreased 
from 94 to 76  % (p =  0.001), whereas it remained stable in the con-
trol ICU (91 vs 91 %, p = 0.94). There were no significant differences in 
MDS-R before and after the intervention in both the intervention ICU 
(21 [12; 30] vs 20 [9; 30], p = 0.44) and the control ICU (18 [10; 29] vs 21 
[8; 33], p = 0.13).
Conclusion We reported a substantial increase in visiting children 
admission in ICU when a specifically designed children information 
booklet was available. Despite the fact that no emotional effect was 
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identified, the implementation of booklets seemed useful to stand-
ardize practices regarding child visits policy among staff members. 
Further work would be necessary to assess the utility of the booklet 
regarding children experience during their visit in the ICU.
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Introduction Intensivists’ decision to withdraw or withhold life-sus-
taining therapies may have considerable impact on patient outcome 
since data suggest that one death out of two in the intensive care 
unit ensures such a decision. The vast majority of decisions (including 
withdrawal/withholding life-sustaining therapies) in the intensive care 
are evidence-based, stemming from ICU trials. We therefore sought to 
investigate how decisions of withholding/withdrawing life-sustaining 
therapies are addressed in randomized controlled trials in critically ill 
patients.
Materials and methods This is an ancillary analysis of a systematic 
review of randomized clinical trials in critically ill patients. These rand-
omized controlled trials were identified through an exhaustive search 
conducted in Medline (PubMed®) over a 1-year period (2013). Data 
extraction was performed by two independent authors (senior inten-
sivists). Whether or not withdrawing/withholding of life-sustaining 
therapies was reported in these trials was systematically reported. 
Data are expressed in median [IQR], or n (%) as appropriate.
Results Among the 150 randomized control trials performed on criti-
cally ill patients retrieved from the search, only 7 (4.6 %) reported the 
number of patients for whom decisions of withdrawal/withholding of 
life-sustaining therapies had been taken. In the subset of studies that 
had mortality as primary outcome (n  =  25), only four reported the 
number of patients concerned by these end-of-life decisions.
The seven trials involved a total of 2,620 subjects (300 [80–548] 
patients per trial), totalizing 1055 death (150 [8–225] per trial) for 
which 413 (5 [4–118]–39  %) were preceded by a limitation of thera-
peutic effort. The median survival rate was 52 %.
The interventions assessed were drugs for four trials (balanced vs 
chloride-rich solution in brain injury patients; enoxaparin for throm-
boprophylaxis; vasopressin, steroids and epinephrine in cardiac arrest; 
and recombinant human activated protein C in septic shock) and 
therapeutic strategies for three (high-frequency oscillation ventilation; 
blood glucose control algorithm; and targeted temperature manage-
ment after cardiac arrest). All studies reported figures regarding these 
patients in the results section, including one in a table, but none of 
them mentioned this information in the abstract. Only one trial indi-
cated in Methods section the way these data were obtained. In the 
trial assessing target temperature management in cardiac arrest, 
pre-specified criteria for withdrawal of life-sustaining therapy were 
established.
Discussion Withdrawal/withholding of life support therapies is very 
rarely reported in randomized controlled studies in critically ill patients 
since <5 % numbered this information.
This is prejudicial when mortality is the primary outcome, given the 
huge impact on mortality when such decisions are taken in patients. 
We suggest that guidelines for reporting of randomized controlled tri-
als in critically ill patients include reporting on withdrawal/withhold-
ing of life-sustaining therapies, at least in studies with mortality as 
primary outcome, in Methods and Results sections.
Conclusion Although accounting for a number of deaths of intensive 
care patients, the number of patients with withdrawal/withholding of 
life-sustaining therapies decisions are scarcely reported in critical care 
trials. Whether reporting these figures could alter conclusions of the 
some of these studies remains to be investigated.
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Introduction Gasp onset is frequent during children end-of-life and 
may provoke distress in the witnessing parents. The knowledge and 
the feelings of healthcare providers confronted to the gasps have 
never been studied.
Materials and methods We conducted a prospective study in two 
neonatal and two pediatric intensive care units in Paris, France. We 
developed a 12-item survey, about the feelings of the healthcare pro-
viders witnessing gasps during end-of-life, their knowledge about 
these events and the information that should be given to the families. 
The survey was distributed to all healthcare providers in contact with 
patients.
Results Fifty-one percent of the 488 healthcare providers of the four 
wards responded to the survey. Among them, 77 % mentioned a dis-
comfort when confronted to gasps, when 43 and 91 % of the respond-
ents think that gasps are uncomfortable for the dying child and for 
the parents, respectively. Consequently, 83  % of the respondents 
declare that gasps should be ceased, primarily for the parents or the 
child discomfort, but also for the healthcare providers. According to 
the respondents, the efficient treatments against gasps are sedation, 
analgesia, and neuromuscular blockers. About one-third and two-
thirds of the respondents reported that gasps are interfering with their 
accompaniment of the dying child and of their parents, respectively. 
Finally, one-third of the respondents declare that they are personally 
emotionally affected by the occurrence of gasps. Most of the respond-
ents (78 %) state that parents should be informed before the onset of 
gasps. Avoiding words with negative meanings, they suggest explain-
ing that gasps are not associated with a willingness to survive and are 
not respiratory movements and further that their occurrence and their 
length are unpredictable and above all that they are not uncomfort-
able or painful. Thirty-eight percent of the respondents declare not 
knowing the mechanism leading to gasps when 60 % think that gasps 
are secondary to severe brainstem hypoxia or decerebration.
Discussion The prevalence of gasps is not found in the literature but 
seems to be high according to pediatricians and neonatologists. Gasp 
is a reflex of auto-resuscitation that follows a functional decerebra-
tion induced by a severe brainstem hypoxia. It is believed that gasps 
are not painful or uncomfortable for the dying patient although this 
is debated. Nonetheless, in our study, 43 % of the healthcare provid-
ers declare that gasps are uncomfortable for the patient, which is 
indicating a treatment to stop them. Moreover, 91  % think that they 
provoke discomfort for the parents and 77 % for the healthcare pro-
viders. There exist some case reports about the negative feelings of 
the parents witnessing gasps, but no studies addressing how health-
care providers confronted to sign of end-of-life in dying child react. 
Even if gasps are not uncomfortable for the dying child, a treatment 
would seem to be required to avoid distress of the witnessing parents. 
However, neuromuscular blockers, the only active compounds against 
gasps, are related to active euthanasia in ventilator-free children. No 
official instructions exist on the timing and the content of information 
to be given to the parents. Some recommendations about the sign of 
end-of-life suggest informing the family before their onset. Only one-
third of the respondents, although working in intensive care units, 
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followed a specific formation for palliative cares or end-of-life. This 
could explain that more than one-third does not know the mecha-
nisms leading to gasps, resuscitating in part their discomfort.
Conclusion Gasps seem to be frequent at the time of end-of-life, and 
they can be very impressive for the parents. In our study, we show 
that gasps provoke discomfort to the healthcare providers too and 
complicate their accompaniment of the parents and the dying child. 
Almost half of the healthcare providers think that gasps should be 
prevented, mainly for the well-being of the parents. A lack of specific 
formation is likely a source of the difficulties of the healthcare provid-
ers. A dedicated formation would allow the healthcare providers to 
better assist the parents and diminish their distress. Finally, studies on 
the prevalence of gasps in pediatric population and on how the par-
ents are dealing with them, depending upon the information given by 
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Introduction In the two past decades, the admission of cancer 
patients to the intensive care unit (ICU) has increased steadily and 
accounts for 10–20 % of all ICU admissions nowadays. Malignant pri-
mary brain tumors (MPBT) are rare tumors representing <2  % of all 
new cancer cases in Europe in 2012. Interestingly, if the prognosis 
improvement of hematological malignancies or solid tumors has been 
well documented over the past 20  years, few data exist concerning 
the prognosis of MPBT in ICU. Data on survival of these patients when 
admitted to the ICU could help accurate triage and management deci-
sion. The aim of our study was to describe the profile of MPBT patient 
admitted to the ICU, to assess ICU and 90-day survival and to identify 
factors associated with ICU and 90-day mortality in a large cohort of 
critical MPBT patients.
Patients and methods We performed a bi-center retrospective study 
of a consecutive cohort of patients with MPBT admitted to ICU over 
a 19-year period (March 1995–May 2014). Only non-metastatic malig-
nant primary brain tumors were included. Were excluded brain metas-
tases of solid cancers, diffuse lymphomas with cerebral localization 
and benign brain tumors. The median and the interquartile range 
were calculated for continuous variables and the absolute and rela-
tive frequencies for categorical variables. Statistical analysis consisted 
of univariate and multivariate logistic regression analysis on ICU and 
90-day mortality.
Results A total of 197 patients were included. Acute respiratory fail-
ure (ARF) was the main reason for ICU admission (45  %) followed by 
seizures (25 %) non-epileptic comas (14 %) and shock (12 %). Pneumo-
cystis pneumonia and pulmonary embolism accounted, respectively, 
for 18 and 9  % of ARF. Admission for epilepsy was more common in 
patients with glial lesions (84.0 vs. 66.7 %, p = 0.019), and patients with 
primary brain lymphoma were more frequently admitted for shock 
(41.6 vs. 18.4 %, p = 0.015). Leukopenia was more commonly found in 
patients with primary brain lymphoma (50.0 vs. 18.9 %, p = 0.005). ICU 
and 90-day mortality were, respectively, 23 and 51 %. Date of admis-
sion did not impact on mortality. The introduction of invasive mechan-
ical ventilation (MV) in epileptic patients did not affect ICU mortality. 
In multivariate analysis, factors associated with ICU mortality were the 
reason for admission for seizure, cancer progression, respiratory rate 
and Glasgow coma scale (GCS). Factors associated with 90-day mor-
tality were the admission for seizure, cancer progression, the need for 
mechanical ventilation, systolic blood pressure, respiratory rate, GCS 
and the Charlson comorbidity index (Table 3). A long-term (1 year) sur-
vival was not rare and was observed in around 30 % of cases.
Conclusion ICU mortality of MPBT approaches that of the other 
solid tumors. Among MPBT patients admitted to ICU, half are alive 
at 90 days. Epilepsy is associated with a particularly good short-term 
prognosis. Today, the existence of a MPBT does not appear to be suf-
ficient for ICU recusal admission.
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Table 3 See text for description
The median and the interquartile range were calculated for continuous variables 
and the absolute and relative frequencies for categorical variables
OR odds ratio, CI confidence interval, MV mechanical ventilation
Variables OR 95 % CI p value
Multivariate analysis on 90‑day mortality
 Epilepsy 0.15 [0.06–0.42] 0.0002
 Need for MV 4.67 [1.94–11.25] 0.0005
 Cancer progression 6.81 [2.83–16.37] 0.00002
 Charlson comorbidity index 1.45 [1.11–1.91] 0.007
 Systolic blood pressure 1.02 [1.00–1.03] 0.019
 Respiratory rate 1.06 [1.01–1.10] 0.016
 Glasgow coma scale 0.91 [0.83–0.99] 0.039
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Introduction Encephalitis due to anti-N-methyl-d-aspartate recep-
tor (NMDAR) antibodies is a rare neurological syndrome, representing 
4 % of all encephalitis. Despite the fact that intensive care need is both 
prognostic of a bad neurological outcome and frequent in the course 
of the disease (75  % of patients), there are presently no data on this 
specific population. We aimed to describe patients admitted to an 
intensive care unit (ICU) with anti-NMDAR encephalitis and to identify 
prognostic factors for good neurological outcome.
Patients and methods In this multicentre study, we included con-
secutive patients meeting all the following criteria: (1) age >15 years, 
(2) admission to an ICU with a diagnostic of encephalitis, and (3) posi-
tive testing for anti-NMDAR antibodies by immunochemistry and cell-
based assay in the cerebrospinal fluid (CSF) at the French National 
Reference Centre. The primary outcome was a good neurological 
status at 6  months, defined by a modified Rankin score ≤2. Data on 
ICU management were retrospectively collected, and neurological 
outcome was prospectively assessed up to 24 months after ICU admis-
sion. Early treatment was defined as administration of the treatment 
<9  days after intensive care unit admission. Data are presented as 
numbers (percentages) and medians [inter-quartiles]. Clinically rele-
vant variables with a p value ≤0.1 in univariate analysis were included 
in the multivariate analysis.
Results We identified 77 patients between 1 January 2007 and 31 
December 2014 from 52 hospitals and three countries (France n = 73, 
Belgium n  =  2, Switzerland n  =  2). One patient was excluded from 
analysis because of missing data on the primary outcome.
Patients (aged 24 [20–31] years, female gender 68 (88 %)) were admit-
ted to the ICU mainly for coma (n =  31, 40  %) and seizures (n =  31, 
40  %), with a Simplified Acute Physiology Score (SAPS) II of 27 [16–
38.5]. The delay between first neurological symptoms and ICU admis-
sion was 10 [5–26] days. A tumour was diagnosed in 31 patients (41 %) 
and consisted in mature teratoma (n = 23, 30 %), immature teratoma 
(n = 6, 8 %) and small cell lung carcinoma (n = 2, 3 %).
During ICU stay, 70 patients (92  %) experienced seizures and 35 
(46  %) presented a status epilepticus. ICU length of stay was 55 
[24–88]  days. First-line immunomodulating treatment consisted in 
steroids (n = 61/74, 82 %), intravenous immunoglobulins (n = 71/74, 
96 %) and plasmapheresis (n = 17/74, 23 %). Second-line therapy was 
necessary for 46/74 patients (62  %) and included cyclophosphamide 
(n = 6/45, 13 %), rituximab (n = 24/45, 53 %) or both (n = 15/45, 33 %). 
At 6, 12 and 24 months, good neurological outcome was achieved in, 
respectively, 43/76 (57 %), 59/74 (80 %) and 49/56 (87 %) patients. At 
6 months, 3 (4 %) patients were dead.
Variables tested in the multivariate model were: age at admission, 
delay from ICU admission to tumour imaging, delay from ICU admis-
sion to first immunomodulating treatment, type of first treatment 
and white blood cell (WBC) count in the first CSF examination. By 
contrast, SAPS II, extra-neurological organ failures, status epilepticus, 
the presence of a tumour and type of second-line treatment were not 
associated with outcome. Low WBC count on first CSF examination 
and early combined first-line treatment were independent factors for 
good neurological outcome at 6 months (Table 4).
Conclusion We report in this study the largest cohort to date of inten-
sive care patients with anti-NMDAR encephalitis. We show that a low 
CSF inflammation and early combined immunomodulating treatment 
by steroids and intravenous immunoglobulins are independent prog-
nostic factors for good neurological outcome, advocating for prompt 
diagnosis and aggressive treatment of this rare disease. We also show 
that severe neurological dysfunction and non-neurological organ fail-
ures at admission are not prognostic and that despite prolonged ICU 
stays, the long-term neurological outcome is good, with improvement 
up to 24 months after ICU admission.
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Introduction Neurological failure in patients with hematological 
malignancy admitted to the intensive care unit has received little 
attention. We sought to report determinants of outcome in these 
patients.
Patients and methods We performed a post hoc analysis of the TRIAL 
OH database. The TRIAL OH study was prospectively carried out in 17 
university or university-affiliated centers in France and Belgium (2010–
2012). Central neurological failure was defined by any neurological 
disorder of central origin among impairment of consciousness, seizure 
with or without status epilepticus, focal neurological signs, encepha-
lopathy, and meningeal symptoms.
Results Of the 1011 patients initially enrolled, 226 (22.4  %) demon-
strated central neurological failure. There were 132 males and 94 
women, aged 62 years (IQR 53–72). Median SAPS II score was 53 (42–
66). Median Charlson comorbidity index was 3 (2–4) at ICU admission, 
and poor performance status was encountered in 54 (24 %) patients.
Median time diagnosis of malignancy and median time from onset of 
neurological manifestations at ICU admission were 120  days (8–847) 
and 0 days (0–1), respectively.
42 (42 %) patients were managed at the diagnosis phase of hemato-
logical malignancy, and 47 (21 %) patients were in complete or partial 
remission. Underlying malignancies were as follows: non-Hodgkin’s 
lymphoma in 85 (38 %), acute myeloid leukemia in 48 (21 %), myeloma 
in 22 (10  %), acute lymphocytic leukemia in 17 (8  %), chronic lym-
phocytic leukemia in 17 (8 %), myelodysplastic syndrome in 11 (5 %), 
Hodgkin’s disease in 5 (2 %), chronic myeloid leukemia in 5 (2 %) and 
others in 16 (7  %). Bone marrow or hematopoietic stem cell trans-
plantation were performed in 39 (17 %) patients associating 21 (9 %) 
autologous and 18 (8  %) allogenic stem cell recipients. A history of 
cancer chemotherapy within 30 days before ICU admission was noted 
Table 4 Multivariate analysis of  factors for  good neuro‑
logic outcome at 6 months
OR 95 % CI p
First‑line immunomodulating treatment
 Early intravenous immunoglobulins 2.26 0.54−9.35
 Early steroids 3.26 0.62–17.19
 Early combined treatment 8.42 2.11–33.57
 Late treatment 1 – 0.026
White blood cell count in first CSF (cells/mm3)
 <10 6.88 1.58–29.92
 10–50 3.60 1.03–12.65
 >50 1 – 0.026
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in 95 (42 %), and neutropenia was found at ICU admission in 52 (23 %) 
patients.
Presenting manifestations were drowsiness (65 %), coma (32 %), tired-
ness (26 %), seizures (19 %), nausea/vomiting (15 %), headache (11 %), 
focal neurological signs (10  %), meningism (6  %) and visual distur-
bances (5 %).
Median SOFA score at day-1 after ICU admission was 8 (5–12) resulting 
to a total number of organ failures of 3 (2–3). Median GCS score was 12 
(7–15). Mechanical ventilation was required in 124 (55 %) patients, cat-
echolamine support in 93 (41 %) and dialysis in 25 (34 %). Eleven (5 %) 
received chemotherapy during their ICU stay.
Neuroimaging, lumbar puncture and EEG were performed in 113 
(50  %), 73(32  %) and 63 (28  %) patients and were deemed contribu-
tive to final diagnosis in 51 (45  %), 18 (25  %) and 24 (38  %) cases, 
respectively. Finally, a neurosurgical biopsy was performed in only one 
patient providing the cause of neurological impairment.
Topographic localizations of the cause of neurological failure were 
as follows: encephalic in 200 (88 %), meningeal in 5 (2 %), brainstem 
in 2, cerebellar and/or medullary in 1, and undetermined in 17 (8 %). 
According to the direct/indirect classification, malignancy involve-
ment was sought being direct in 11 (5 %) (central nervous system infil-
tration), neurological indirect in 114 (50  %) (metabolic in 73, central 
nervous system infection in 12, vascular damage in 14, iatrogenic in 
15), extraneurologic in 77 (34 %) (shock in 52, sepsis in 10 and cardiac 
arrest in 15) and remained unknown in 24 (11 %).
Among 226 patients with neurological failure, hospital mortality 
was 50  %. By multivariate analysis, independent positive predictors 
of hospital mortality were poor performance status [odds ratio (OR) 
3.99, 95  % CI 1.82–9.39, p  =  0.0009], non-Hodgkin’s lymphoma [OR 
2.60, 95 % CI 1.35–5.15, p = 0.005], shock [OR 1.95, 95 % CI 1.04–3.72, 
p = 0.04] and respiratory failure [OR 2.18, 95 % CI 1.14–4.25, p = 0.02], 
whereas GCS score at day 1 [OR 0.88/point, 95  % CI 0.81–0.95, 
p = 0.0009] and autologous stem cell transplantation [OR 0.25, 95 % CI 
0.07–0.75, p = 0.02] were negative predictors of hospital mortality. The 
2-year probability of survival was markedly lower in patients requiring 
ICU management with neurological failure than in the absence thereof 
(HR 1.45, 95 % CI 1.18–1.78, p = 0.0003).
Conclusion In hematological patients requiring ICU management, 
neurological failure is frequent and associated with poor outcome. 
Type of underlying hematological malignancy, poor performance sta-
tus, hemodynamic and respiratory failures and intensity of conscious-
ness impairment are independently associated with poor outcome. 
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Background Hepatic encephalopathy (HE), a complication of cirrho-
sis, presents clinically from mild neuropsychiatric symptoms to coma. 
It is a major public health problem, it is associated with a poor prog-
nosis, one-half of the patients presenting HE will die in the follow-
ing year. The physiopathology of HE is complex and multifactorial. 
Since decades, a relationship between ammonia and the occurrence 
HE has been proposed, but remains still controversial. The correla-
tion between the severity of HE and the ammonia levels is thus still 
debated. Often in clinical practice, the serum ammonia is not meas-
ured in cirrhotic patients with altered neurological examination.
Aim The aim of this study was to determine whether ammonia was 
correlated with the severity of HE episode and with the outcome, in a 
large series of patients with cirrhosis admitted in Liver Intensive Care 
Unit.
Methods We included prospectively all cirrhotic patients hospital-
ised in Liver ICU for severe cirrhosis decompensations. Serum ammo-
nia was measured at admission, during the hospitalisation and at the 
discharge from ICU. Neurological status was assessed by West-Haven 
(WH) and Glasgow scores. Overt HE was diagnosed as a West-Haven 
score ranging between 2 and 4.
Results Ninety-eight cirrhotic patients hospitalised in ICU between May 
2014 and September 2015 were included. The main clinical characteris-
tics were as follows: mean age was 58 ± 13 years, 74 patients were male, 
and the aetiology of the liver cirrhosis was: alcoholic (48 %), virus (12 %), 
mixed (alcool + virus/metabolic) (22 %) and other (15 %). 91 % of the 
patients had a decompensated cirrhosis (Child–Pugh B and C). 85 % of 
patients had an abnormal neurological examination at admission, 27 % 
were hospitalised for HE, and 17 % had already a treatment for HE. The 
mean ammonia was 99.1 ± 57.3 µmol/L, and 80 % of patients displayed 
abnormally elevated ammonia (>50  µmol/L). Ammonia was higher in 
patients with HE than in those without [108 (95 % CI 86–123) vs 57 (95 % 
CI 50–81), p = 0.0004]. In patients with HE, ammonia was significantly 
correlated with severity of HE assessed by GCS (p = 0.001). Overall, 34 
HE patients experienced worsening of their neurological status during 
hospitalisation. Ammonia at admission was significantly higher in those 
patients [128 (95 % CI 108–147) vs 87 (95 % CI 64–110), p = 0.007]. In 
multivariate analysis, parameters independently associated with wors-
ening of neurological status were MELD score and ammonia levels at 
admission (p = 0.01 and 0.02, respectively).
Conclusion Hyperammonia reflects the severity of HE and is corre-
lated with the poor prognosis in cirrhotic patients with HE.
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Introduction Varicella zoster virus (VZV) is responsible for human 
infections with various clinical presentations, followed by long-lasting 
viral latency in the spinal and cranial ganglia. VZV reactivation can be 
responsible for encephalitis. The purpose of this study is to describe 
the clinical features and the prognosis of VZV encephalitis in adults 
patients admitted to the intensive care unit (ICU).
Patients and methods A retrospective multicenter cohort study 
was performed, including consecutive adult patients admitted to 18 
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French ICUs between 01/01/1999 and 01/09/2015 with a diagnosis of 
VZV encephalitis. Data and follow-up were abstracted from the medi-
cal charts. Patients were evaluated for vital status at ICU discharge. A 
univariate analysis was performed to identify factors associated with 
ICU survival.
Results Forty-seven patients were included in the study. Median age 
was 54 (inter-quartile range 35–67)  years and 22 (47  %) were male. 
Thirty-nine patients (83  %) reported an underlying cause of immune 
deficiency. The three main causes of immune deficiency were malig-
nancy (12, 31 %) solid organ transplantation (10, 26 %) and HIV infec-
tion (8, 21  %). Long-term exposure to steroids was reported in 19 
(49  %) patients. Patients were admitted to the ICU 2 (1–6)  days after 
the onset of the first neurological symptoms. Altered mental status 
at ICU admission was constant. The other symptoms were focal neu-
rological signs (17, 36 %), seizure (13, 34 %) and status epilepticus (9, 
19 %). Thirty-three (70 %) patients had a rash. The median coma Glas-
gow score (CGS) at ICU admission was 12 (8–15); 12 (27  %) patients 
had a CGS ≤ 8. Two-third of the patients had fever. The median white 
blood cell count in the cerebrospinal fluid (CSF) was 59 (16–116)/mm3 
with 73 (67–84)  % of lymphocytes and 21 (8–67)  % of neutrophils. 
Median CSF protein level was 1.4 (0.7–3.8)  g/L, and median CSF glu-
cose level was 3.7 (2.5–5.0) mmol/L. CSF PCR for VZV was tested in 37 
(79 %) patients and positive in 89 % of the cases.
Thirty-two (68  %) patients had a central nervous system imaging, 27 
(57  %) a computed tomography (CT) and 21 a magnetic resonance 
imaging (MRI). Twenty (74  %) CTs were reported as normal. Main 
abnormal findings reported with CT were cerebral edema (2, 7.4  %) 
and petechial hemorrhages (2, 7.4  %). When performed, most MRI 
reported abnormal findings (16, 76 %), including brainstem lesions (5, 
29  %), arteritis and ischemic infarctions (4, 20  %) and demyelinating 
lesions (4, 20 %).
The median SOFA score at day 1 was 7 (4–9). Patients were treated 
intravenously with 10 (10–15) mg/kg/8 h of acyclovir during a median 
of 14 (9–20)  days. In addition, three (6  %) patients received intrave-
nous globulins. During ICU stay, 41 (87  %) patients required invasive 
mechanical ventilation, 20 (43 %) received vasopressors, and RRT was 
implemented in 14 (30 %) patients. The median ICU length of stay was 
16 (6–39) days. Thirty-six (77 %) patients were alive at ICU discharge.
By univariate analysis, two factors were associated with an increased 
likelihood of ICU mortality: a SOFA score ≥7 at day 1, odds ratio (OR) 
28.8, 95 % confidence interval (1.54–538.4), p < 0.01, and the presence 
of disseminated intravascular coagulation, OR 7.0, 95  % CI (1.23–39.8), 
p = 0.03.
Discussion We report the clinical features of 47 patients admitted to 
the ICU for the management of VZV encephalitis. This diagnosis may 
be challenging as clinical signs and symptoms may be diminished by 
an underlying cause of immunosuppression. Indeed, one-third of the 
patients had no fever and up 30 % had no skin rash. Patients should be 
investigated for VZV-related cerebral arteritis despite the fact that its 
treatment remains a matter of debate.
Conclusion Severe VZV encephalitis occurs mainly in patients with 
a history of immune deficiency. In the ICU setting, about 20 % of the 
patients experienced status epilepticus. MRI is useful to evaluate 
patients with VZV encephalitis. ICU mortality is 23  % and correlates 
with the number of organ dysfunction at ICU admission.
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Introduction In immunocompromised patients with acute respiratory 
failure (ARF), invasive mechanical ventilation remains associated with 
high mortality. Choosing the adequate device for oxygenation is of 
the utmost importance in that setting. High-flow nasal cannula (HFNC) 
has been associated with decreased mortality in ARF. In this study, we 
assess outcomes of immunocompromised patients treated with HFNC.
Patients and methods We performed a post hoc analysis of iVNIctus 
study, a multicentre trial of NIV in critically ill immunocompromised 
patients admitted for ARF in 29 intensive care units in France and 
Belgium. Only those alive at day 2 were analyzed in this study. A pro-
pensity score-based approach was used to assess the impact of HFNC 
compared with oxygen only on hospital mortality. Propensity score 
was based on randomization group, severity at admission and etiol-
ogy of acute respiratory failure. Primary endpoint was mortality at day 
28. Secondary endpoints were intubation rate, duration of mechanical 
ventilation, ICU-acquired infection, ICU and hospital stay lengths.
Results Among 374 patients included in the study, 353 met inclusion 
criteria. Underlying disease included malignancy (n = 296, 84 %), solid 
organ transplantation (n = 24, 6.8 %) and other cause of immunosup-
pression (n = 33, 9.3 %). ARF etiologies were mostly bacterial pulmo-
nary infections (n = 157, 44.4 %) and opportunistic infection (n = 76, 
21.5 %). 180 (50 %) patients received NIV. D-28 mortality was 22.6 % 
(80 deaths). Mechanical ventilation was ultimately needed in 142 
(40.2 %) patients.
At ICU admission, 127 patients received HFNC, whereas 226 patients 
never received HFNC. D-28 mortality was, respectively, 33 (25.9 %) and 
47 (20.7 %) (p = 0.26). Ninety patients in each group (HFNC or oxygen 
only) were matched according the propensity score. Among them, 92 
patients received NIV (44/90 in HFNC group vs 48/90 in oxygen group). 
HFNC was not associated with a decreased D-28 mortality (23.3 vs 
25.5  %, p  =  0.76). Intubation rate and ICU-acquired infections were, 
respectively (43.3 vs 50 %, p = 0.47, and 23.3 vs 26.7 %, P = 0.73). ICU 
lengths of stay and mechanical ventilation duration were not different 
(respectively, 8 [7–11] vs 7 [6–16  days, p =  0.89, and 13 [4–46] vs 14 
[8–33 days, p = 0.72).
Conclusion In this study, HFNC during acute respiratory failure in 
immunocompromised patients did not improve survival compared 
with oxygen only. HFNC was associated with neither a decrease intu-
bation rate nor a lower ICU-acquired infection rate.
Competing interests None.
O56  
High‑flow oxygen therapy through a nasal cannula 
in immunocompromised patients with acute hypoxemic 
respiratory failure
Jean‑Pierre Frat1, Stéphanie Ragot2, Christophe Girault3, Remi Coudroy1, 
René Robert1, Jean‑Michel Constantin4, Gwenael Prat5, Thierry Boulain6, 
Angéline Jamet,1, Alain Mercat7, Laurent Brochard8, Arnaud, W. Thille1
1Réanimation Médicale, CHU de Poitiers, Poitiers, France; 2Département 
de Biostatistiques et d’Epidémiologie, CHU de Poitiers, Poitiers, France; 
3Réanimation Médicale, Centre Hospitalier Universitaire Rouen, Rouen, 
France; 4Réanimation adulte, C.H.U. Estaing, Clermont‑Ferrand, France; 
5Réanimation médicale, CHRU de Brest, Brest, France; 6Réanimation 
Page 29 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
médicale polyvalente, Hôpital de La Source, CHR Orléans, Orléans, France; 
7Service de réanimation médicale et médecine hyperbare, Centre Hospi‑
talier Universitaire d’Angers, Angers, France; 8Interdepartmental division 
of critical care‑ university of toronto, Hospital St. Michael and Keenan 
research center, Toronto, Canada 
Correspondence: Remi Coudroy ‑ remi.coudroy@chu‑poitiers.fr 
Annals of Intensive Care 2016, 6(Suppl 1):O56
Introduction In the early 2000s, two randomized controlled trials 
showed that as compared to standard oxygen therapy, noninvasive 
ventilation could decrease mortality of immunocompromised patients 
admitted to ICU for acute respiratory failure. However, the benefits of 
noninvasive ventilation in immunocompetent patients with acute res-
piratory failure are debated. High-flow oxygen therapy through a nasal 
cannula may offer an alternative in hypoxemic patients. We recently 
found in a randomized controlled trial including 310 patients with 
acute respiratory failure (FLORALI study) that as compared to noninva-
sive ventilation, high-flow oxygen therapy decreased mortality. Immu-
nocompromised patients could also be included in this study, except 
for those with profound neutropenia. Therefore, we assessed the ben-
efits of high-flow oxygen therapy or noninvasive ventilation in this 
subgroup of patients. Our objective was to compare intubation and 
mortality rates in the subset of immunocompromised patients admit-
ted to ICU for acute respiratory failure.
Patients and methods We performed a subgroup analysis in the 
framework of the FLORALI study. This study included all patients with 
non-hypercapnic (PaCO2 ≤45  mmHg) acute respiratory failure while 
excluding patients with cardiogenic pulmonary edema and those with 
underlying chronic lung disease. Patients were assigned to three groups 
according to treatment: high-flow oxygen therapy, standard oxygen 
therapy or noninvasive ventilation. The primary outcome was the intuba-
tion rate, and secondary outcome included 90-day mortality. We focused 
on the subset of immunocompromised patients included in this study, 
while patients with profound neutropenia were deliberately excluded.
Results Among the 310 patients with acute respiratory failure, 82 
(26 %) were immunocompromised including 26 patients in the high-
flow oxygen therapy group, 30 in the standard oxygen group and 26 
in the noninvasive ventilation group. Intubation rates were 31, 43 and 
55 % in the high-flow oxygen therapy, standard oxygen therapy and 
noninvasive ventilation groups, respectively (p  =  0.04). The 90-day 
mortality rates were 15, 27 and 46 % in the high-flow oxygen therapy, 
standard oxygen therapy and noninvasive ventilation groups, respec-
tively (p = 0.046). Ventilator-free days at day 28 were 26 ± 6, 23 ± 10 
and 14 ± 13 days in the high-flow oxygen therapy, standard oxygen 
therapy and noninvasive ventilation groups, respectively (p < 0.0001).
Conclusion In immunocompromised patients admitted to ICU for 
acute hypoxemic respiratory failure, as compared to standard oxygen 
therapy or noninvasive ventilation, high-flow oxygen therapy was 
associated with lower intubation and mortality rates and reduced 
duration of invasive mechanical ventilation.
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Introduction Pneumocystis jiroveci pneumonia (PjP) occurs increas-
ingly in non-AIDS immunocompromised patients, chiefly those with 
HMs. Delayed implementation of trimethoprim–sulfamethoxazole is 
associated with increased mortality. A clinical score to early assess at 
the bedside the clinical pretest probability of PjP before proceeding 
with diagnostic testing would allow avoiding missed diagnosis and 
delayed treatment.
Patients and methods Last year, we presented at REANIMATION 
2015 the PASTEIL score (see Table 5) that was developed in 1092 HM 
patients with ARF (134 [12.3  %] with proven PjP) admitted to eight 
ICUs between 2006 and 2012 (“learning set”). First, variables were 
identified through a multivariable logistic regression model after mul-
tiple imputation of missing confounders, and then, the score described 
below was derived from mean of beta regression coefficients and 
validated by bootstrap (resampling). Discrimination (i.e., ability of the 
score can separate PjP from non-PjP patients) was measured by the 
area under the receiver operating characteristic (ROC) curve (AUC, c 
statistic). Calibration (i.e., how well predicted probabilities agree with 
actual observed risk) was measured by the Hosmer–Lemeshow sta-
tistic (goodness-of-fit test and calibration curves) that compares the 
average predicted risk within subgroups to the proportion that actu-
ally develops disease. The score was performing very well in the learn-
ing set, with a very good discrimination (AUC was 0.87 saying that 
predicted values for cases are all higher than for non-cases) and a very 
good calibration (mean goodness of fit of −0.75 and calibration curves 
suggesting applicability of the models to individual cases in this learn-
ing set). Here, we sought to further validate this score in a prospective 
and independent reliability cohort. We first imputed the missing data 
using mice (multiple imputation algorithm), based on 30 multiple 
imputed datasets. On each complete imputed dataset, the score was 
computed for each patient and averaged; lastly, for each patient, the 
predicted probability of PjP was derived from the average score and its 
performance assessed.
Results To validate the diagnostic score, we collected data from an 
independent dataset of 238 patients with HMS admitted to 26 ICUs 
for ARF (iVNIctus trial), including 15 (6.3  %) patients with PjP. When 
compared to patients with other ARF etiologies, PjP patients were 
younger (33 aged <50 vs. 20 %, P = 0.02), had more frequently a lym-
phoproliferative disorder (93.3 vs. 45.7 %, P = 0.0003), never received 
prophylaxis (vs. 36 % in other ARF etiologies, P < 0.0001) and had more 
frequently an interstitial pattern on chest imaging (67 vs. 32  %). The 
three other components of the score, namely time since respiratory 
symptoms onset, shock at admission and pleural involvement, were 
not significantly different between PjP patients and those with other 
ARF etiologies. In this reliability cohort, the score has a very good 
discrimination [AUC was 0.83 (95 % CI 0.73–0.93, DeLong estimates)]. 
However, the calibration was suboptimal with predicted probabilities 
of PjP above the observed proportions of actual PjP in the low deciles 
of the score.
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Conclusion Within hours from ICU admission, bedside clinicians are 
able to establish the clinical pretest probability of PjP in patients with 
HMs and ARF. The PASTEIL score has a very good discrimination that 
provides promising ways to avoid missing the diagnosis and delaying 




Bedside contribution of electrical impedance tomography (EIT) 
to set mechanical ventilation for severe acute respiratory distress 
syndrome (ARDS) on extracorporeal membrane oxygenation 
(ECMO)
Guillaume Franchineau1, Nicolas Brechot2, Guillaume Lebreton3, 
Guillaume Hekimian2, Ania Nieszkowska4, Charles‑Edouard Luyt5, Pascal 
Leprince6, Jean Louis Trouillet5, Alain Combes7, Matthieu Schmidt8
1Paris, Pitié‑Salpêtrière Hospital, Paris, France; 2Medical intensive care 
unit, ican, institute of cardiometabolism and nutrition, Pitié‑Salpêtrière 
Hospital, Paris, France; 3Cardiac and thoracic surgery, ican, institute of car‑
diometabolism and nutrition, Groupe Hospitalier Pitié Salpêtrière, Paris, 
France; 4Medical intensive care unit, ican, institute of cardiometabolism 
and nutrition, Hopital Pitie Salpetrière, Paris, France; 5Medical intensive 
care unit, ican, institute of cardiometabolism and nutrition, Groupe Hos‑
pitalier Pitié Salpêtrière, Paris, France; 6Cardiac and thoracic surgery, ican, 
institute of cardiometabolism and nutrition, Hopital Pitie Salpetrière, Paris, 
France; 7Medical intensive care unit, ican, institute of cardiometabolism 
and nutrition, hôpital de la pi, Groupe Hospitalier Pitié Salpêtrière, Paris, 
France; 8Medical intensive care unit, ican, institute of cardiometabolism 
and nutrition, Groupe Hospitalier Pitié‑Salpêtrière, Paris, France 
Correspondence: Guillaume Franchineau ‑ gfranchineau@gmail.com 
Annals of Intensive Care 2016, 6(Suppl 1):O58
Introduction Extracorporeal membrane oxygenation (ECMO) has been 
proposed as a possible therapeutic option for patients with severe 
acute respiratory distress syndrome (ARDS) who have refractory hypox-
emia or excessively high inspiratory airway pressures as well as being 
unable to tolerate volume and pressure limited strategy. This device 
also permits “ultraprotective” mechanical ventilation with further 
reduction in volume and pressure that might ultimately enhance lung 
protection and improve clinical outcomes of acute respiratory distress 
syndrome (ARDS) patients. In addition, high level of positive end-expir-
atory pressure (PEEP) during the first day on ECMO may be associated 
with better outcome. On the other hand, inappropriate high PEEP level 
may also lead to overdistension, hyperinflation and definitive lung 
damage. Because of these considerations, continuous monitoring of 
harmful effects of PEEP appears relevant. Considering the high severity 
of these patients, electrical impedance tomography (EIT) could allow 
an individual, noninvasive, real-time, bedside, radiation-free imaging of 
the lungs, with global and regional dynamic analysis.
The aims of this study were: (1) to evaluate the ability of EIT to monitor 
a PEEP trial in patients with severe ARDS on ECMO and ventilated with 
very low tidal volume and (2) to evaluate the benefits of EIT to provide 
tools to individualize and match PEEP with the regional distribution of 
ARDS lesions.
Patients and methods We conducted a monocentric observational 
prospective study. Inclusions criteria were: (1) sedated patients 
mechanically ventilated in pressure-controlled mode for severe ARDS 
that required veno-venous ECMO; (2) delay between ECMO initiation 
and inclusion <7 days. Exclusion criteria were manufacturer contrain-
dications to use of a thoracic belt, cardiac pacing, pneumothorax or 
past history of barotrauma and hemodynamic instability. A decre-
mental PEEP trial, using 5  cmH2O 20-min steps, was performed from 
20 to 0 cmH2O. Driving pressure and respiratory frequency were main-
tained constant at 14 cmH2O and 24/min, respectively. At the end of 
each PEEP level, hemodynamic, pulmonary compliance, blood gases 
and EIT were recorded. Lung images were divided into four symmet-
rical frontal to dorsal region of interest (ROI). For each PEEP level, we 
recorded impedance variation (Δz) in each ROI, end-expiratory lung 
impedance (EELI) and estimation of the alveolar collapse (CL) and 
overdistension (OD) area.
Results We included 15 patients [age 57 (range 40–72), six males, 
SOFA score 15 (12–17)]. Origin of ARDS was viral pneumonia (46  %) 
and bacterial pneumonia for 20 % of patients. Analysis was conducted 
after a median time of mechanical ventilation of 8 (6–12) days and 4 
(2–6)  days of ECMO. Compared with PEEP 20, decremental PEEP trial 
led to a decrease in EELI of 14, 37, 60 and 96 % at PEEP 15, 10, 5 and 0, 
respectively. Regional analyses of EELI and Δz illustrated that “ultrapro-
tective” ventilation of the most dorsal region of the lungs did not 
participate in ventilation regardless the level of PEEP. However, mid-
ventral and mid-dorsal regional ventilations were more dependent 
on PEEP. Meanwhile, pulmonary compliance was 13.4, 18.7, 18.6, 18.7 
and 12.1  mL/cmH2O at the five decreasing PEEP levels, respectively, 
resulting to median tidal volumes ranging from 2.8 to 4 ml/kg. Median 
overdistension decreased from 37 to 0  % and collapsed area of the 
lung increased from 0 to 50 % while decreasing PEEP level. Based on 
the best compromise between low overdistension and low collapse, 
EIT provided “best PEEP level” for each patient on ECMO. These results 
were variable, and depending on patients, optimal PEEP was between 
5 and 15 cmH2O (see Fig. 12).
Conclusion Our study is the first using EIT on severe ARDS with ECMO. 
Our results indicate that EIT is a simple and feasible technique that 
could provide good assessment of regional changes during PEEP 
maneuvers, despite a low spatial resolution and very low tidal vol-
umes. In our population, best PEEP level, which protects from both 
overdistension and collapse, did not exist. However, EIT may provide 
a tool to select PEEP level with the best compromise between over-
distension and collapse. This level was very variable from patient to 
patient, illustrating the need to individualize mechanical ventilation 
settings based on monitoring the effects of PEEP.
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Introduction There is no clear recommendation on which level of oxy-
genation is better in intensive care patients. Oxygen (O2) is known as a 
double-edged sword because of the risk of oxygen toxicity, especially 
in the lungs in balance with the risk of hypoxemia. In a previous mul-
ticenter international randomized study, we tested the safety and the 
feasibility of management of two levels of oxygenation in ICU patients 
with one group having oxygen saturation kept between 88 and 92 % 
(conservative  =  CO) and the other having oxygen saturation kept 
higher or equal to 96 % (liberal = LO) (Am J Respir Crit Care Med 2015; 
150903080351007). Results of the pilot study confirm the feasibility and 
the safety of conducting a such study. Here, we report results of the 
French cohort with measurement of proinflammatory cytokines, solu-
ble receptor for advanced glycation end products (sRAGE) a marker of 
pulmonary epithelial injury and markers of organ dysfunction.
Patients and methods This is an ancillary study of a multicenter, inter-
national, prospective, randomized study. Inclusion criteria were age 
higher or equal to 18  years, mechanical invasive ventilation begun 
not more than 24 h, previsible length of ventilation higher than 48 h. 
Exclusion criteria were pregnancy, legally incapacitated patient, lack of 
written consent of trusted person or next-of-kind, high risk of death 
during the next 72 h and clinician in charge of the patient refusal. The 
FiO2 was set to achieve targets of 88–92 % SpO2 for the CO group or ≥96  % SpO2 for LO group during mechanical ventilation. IL-1, IL-6, 
TNF-α, IL-12, IL-8 and sRAGE were dosed at days 0, 3 and 6. Troponin, 
catecholamines, lactates, creatininemia, platelets, fibrinogen, hemo-
globin and CRP were measured at days 0, 1, 2, 3, 4, 5, 7 and 10. Hemo-
dynamic instability, new onset of ARDS and PaO2/FiO2 at day 7 was 
noticed in ICU and in the hospital, at day 90 and in ICU for mortality.
Results A total of 240 patients were screened. Twenty-two patients 
were recruited from June 2013 to October 2014. There were 11 
patients per group. Patients characteristics were similar between the 
two groups except a greater number of patients with ARDS at the 
inclusion in CO group. The two groups had different mean PaO2 over 
time with 68 mmHg [64–79] in CO group versus 89 mmHg [84–106] in 
LO group. Variations of IL-1, IL-12 and TNF-α were not detectable.
IL-6 (pg/ml) was 129 [50–333] versus 50 [18–142] at day 0, 40 [14–109] 
versus 25 [8–78] at day 3, 20 [6–61] versus 21 [7–64] at day 6 in, respec-
tively, liberal and conservative groups.
IL-8 (pg/ml) was 43 [20–92] versus 36 [16–84] at day 0, 18 [8–39] versus 
25 18 [8–44] at day 3, 14 [6–33] versus 19 [8–45] at day 6 in, respec-
tively, liberal and conservative groups.
IL-10 (pg/ml) was 3.68 [1.08–4.46] versus 4.54 [0.81–5.86] at day 0, 2.38 
[0.68–3.19] versus 0.64 [0.17–0.97] at day 3, 1.79 [0.35–4.04] versus 0.28 
[0.14–0.77] at day 6 in, respectively, liberal and conservative group.
SRAGE (pg/ml) was 2336 ± 305 versus 2172 ± 334 at day 0, 1756 ± 316 
versus 2038 ± 364 at day 3, 2020 ± 376 versus 1297 ± 364 at day 6 in, 
respectively, liberal and conservative groups.
All show significant variation over time. No significant variation over-
time between the two groups was detected despite a tendency to a 
higher sRAGE elevation in liberal oxygenation group at day 6. There 
was no difference in mortality (in ICU, in hospital or at day 90). There 
was no difference in PaO2/FiO2 at day 7, hemodynamic instability. 
More episodes of hypoxia were detected in the restrictive group as 
expected. There was no difference between the two groups over time 
of troponin level, catecholamine doses, creatininemia, platelet, fibrino-
gen, lactates and CRP. SOFA has nonsignificant tendency to be lower 
in the CO than in the LO group. There was a nonsignificant tendency 
for new onset of ARDS in LO group. Hemoglobin was lower in the CO 
group due to lower basal level.
Conclusion A liberal oxygenation strategy does not induce higher sys-
temic inflammation neither other complication in comparison with a 
conservative oxygenation strategy in ICU patients. However, despite 
nonsignificant, sRAGE, a marker of epithelial pulmonary injury, has 
tendency to stay at high level at day 6, there is tendency to have more 
ARDS, and SOFA score at day 6 has tendency to be higher in patients 
exposed to liberal oxygenation strategy in comparison with conserva-
tive oxygenation strategy. Further research has to be conducted to 
find the more safe level of oxygenation in ICU patients, especially for 
the protection of the lungs.
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Introduction Sepsis remains a major cause of death for intensive 
care unit (ICU) patients. The numerous experimental data published 
contrast with the few biological data (mainly neutrophil and platelet 
count) used by physicians at patients’ bedside in such circumstances. 
Since there are no specific predictive clinical signs in sepsis, it would be 
helpful to have a biological tool to predict the progression of the dis-
ease but also to understand the pathophysiology and especially the 
immune status of the patients. Given the great worsening potential, 
using a prognostic marker to early identify patients at risk of clinical 
deterioration could enable a more specific management. In that way, 
“Septiflux 1,” a single-center trial (Guerin et al., Crit Care Med, 2014) on 
“selected septic patients,” demonstrated that immature granulocyte 
CD10dim/CD16dim level at acute phase of sepsis can predict early 
clinical deterioration. We wanted to confirm these promising results in 
a large multicenter trial. The main objective was to evaluate the ability 
to predict early clinical worsening of immature granulocytes CD10dim/
CD16dim assessed by flow cytometry at the acute phase of sepsis. Sec-
ondary objectives were to appraise the capacity of other leukocyte sub-
sets to predict clinical deterioration at D-2 and D-28 death.
Patients and methods We designed a multicenter prospective 
observational study. Patients hospitalized in the emergency depart-
ment (ED) or in the ICU with SIRS and a clinically or microbiologically 
documented bacterial infection developing for <24  h were eligible. 
Exclusion criteria were pregnancy, progressive neoplastic disease, HIV, 
history of hematological or inflammatory disease, immunosuppressive 
treatment and hospitalization in ICU for more than 48  h. Within 8  h 
after admission, flow cytometry analysis was performed to evaluate 
immature granulocytes CD10dim/CD16dim but also T-lymphocytes 
CD3pos, expression of CD24, CD64 and CD11b on granulocytes, and 
pro-inflammatory monocytes CD16pos. As regards their organ failure, 
all patients were classified as sepsis, severe sepsis and septic shock 
using the international sepsis classification. Sepsis deterioration was 
evaluated 48  h after inclusion and was defined as followed: sepsis 
developing to severe sepsis or septic shock; severe sepsis developing 
to septic shock. Death occurring before 48  h was also considered as 
clinical deterioration. Patients were followed until D-28. SOFA score 
was also calculated at inclusion and after 48 h.
Results From November 2013 to June 2015, at 11 university sites, 1062 
patients were included in this trial. Recruitment has now ended and 
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780 patients have been kept for final analysis, the remaining being 
secondary excluded mainly because sepsis was not confirmed by the 
adjudication committee. At inclusion, 523 (67 %) were hospitalized in 
the ICU and 257 were from the ED. All the sites have performed the 
related flow cytometry according to a standardized protocol. The 
database cleaning process and locking should be done in the coming 
weeks followed by the statistical analysis. Results will be available in 
the coming 2 months.
Conclusion Septiflux 2 is the larger multicenter trial that has evalu-
ated the prognostic value of immature granulocytes and the overall 
interest of flow cytometry at the acute phase of sepsis.
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Introduction Early and appropriate antibiotic therapy is a prognostic 
factor in patients presenting with severe sepsis and septic shock. Inci-
dence of multidrug-resistant bacteria (MRB), especially Gram-negative 
bacilli (GNB), continuously increases. Next-generation sequencing 
(NGS) is a powerful technique that enables sequencing the complete 
genome of bacteria, thus giving access to their precise identification 
and potential antibiotic resistance genes. However, this technique 
is currently too cumbersome and expensive to be implemented in 
routine practice. Accordingly, the feasibility of NGS has been scarcely 
assessed on biological samples obtained from patients with sep-
sis. This study aimed at evaluating the feasibility and the diagnos-
tic capacity of NGS in patients with urosepsis using the detection of 
bacterial microbiome and resistome from urine samples. Results were 
compared with those of conventional microbiology.
Patients and methods In this pilot study, we analyzed the urine sam-
ples of 40 patients with urinary sepsis (n = 17), severe sepsis (n = 8) 
or septic choc (n = 15) secondary to upper tract urinary infection (17 
men; mean age: 71 years). Conventional urine culture was either posi-
tive with a single isolated GNB (n = 27) or two GNB (n = 6), being MRB 
or not, positive with three or more bacteria (n = 3), or negative (n = 4). 
After total DNA extraction and partial depletion of human DNA, 
prokaryotic DNA from urine samples was sequenced using IonPro-
ton™ technology. The bioinformatic analysis was conducted with the 
Geneious® software (microbiome) and the Web site of the Center for 
Genomic Epidemiology (microbiome and resistome). All NGS analyses 
and their final interpretation were performed by a medical fellow who 
had received personalized training prior to the study. NGS results were 
compared to those of conventional culture. Initially, microbiological 
results from conventional culture were known for comparison with 
NGS data (Group 1; n  =  21). Subsequently, the medical fellow who 
performed NGS analysis was blinded from the results of conventional 
cultures (Group 2; n = 19).
Results For the microbiome (Table  6), NGS showed a total concord-
ance for the detection of bacterial species (mainly Escherichia coli), in 
samples with single isolated bacteria. NGS enabled the identification 
of bacteria potentially responsible for urosepsis in three out of four 
urine samples with negative conventional culture. For the resistome, 
NGS enabled the identification of all genes explaining the acquired 
resistance phenotypes (n =  18) and especially all ctx-m genes which 
give MRB phenotype to bacteria (ESBL, n = 11). No relevant difference 
in NGS diagnostic capacity was observed between groups. However, 
the study showed that a time-consuming in-depth analysis was still 
required.
Conclusion NGS performed on urinary samples from patients with 
urosepsis appears feasible and provides concordant information with 
that obtained from conventional culture regarding both the identifi-
cation of bacteria and associated profiles of antibiotic resistance. Even 
if the technical requirements, duration of computerized analysis and 
costs currently preclude its clinical implementation, NGS promises in 
the near future to provide accurate results faster than conventional 
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Introduction In stress situation, inflammation causes several meta-
bolic modifications. To give energetic substrate to vital tissues, an 
activation of proteolysis, lipolysis and hepatic gluconeogenesis occurs 
and, at cell level, the main energy source comes from anaerobic reac-
tions. The metabolomic analysis is an approach that enables to study 
many products from metabolic pathways [1]. We aimed to study meta-
bolic profile of patients admitted in intensive care unit (ICU) to identify 
potential biomarkers of patients’ outcome.
Patients and methods This is a prospective study in a medico-surgical 
ICU. We included adult patients admitted in ICU for <24 h and healthy 
volunteers. At admission, the sera of the patients were analysed by 
1H nuclear magnetic resonance. We first compared patients and vol-
unteers by multivariate analysis. The patients were divided into four 
groups based on their diseases: sepsis, septic shock, shocks from other 
origins than sepsis and other pathologies. We realized a Kruskal–Wallis 
test followed by Dunn correction to analyse the metabolites between 




Urine culture with one 
GNB
27 27 (including four with one 
supplementary bacterial 
species)
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GNB
6 2 (and four with only one 
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GNB and one Gram 
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or more bacteria
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one with anaerobes)
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the different groups. After identification of relevant metabolites, we 
search correlations between these and the mortality and the length of 
stay.
Results A total of 117 consecutive patients were screened, of whom 
111 were included in the study after informed consent signature. 
Mean age was 67 ± 14, mean SOFA score was 5 ± 3, and mean APACHE 
II score was 20 ± 9. The 90-day mortality was 30 %. We first identified 
a significant difference in metabolic profile between volunteers and 
ICU patients (CV-ANOVA, p < 0.001). When septic shock patients were 
compared with non-septic patients, some significant differences in 
the metabolome were observed (p < 0.05): pyruvate, lactate, carnitine, 
creatine, myo-inositol, creatinine, urea, phenylalanine and mannitol. 
Despite all these changes, there was no correlation between metabo-
lomic profile and patients prognosis.
Discussion These metabolic differences indicate a profound change in 
energetic metabolism in septic shock patients. The high ratio lactate/
pyruvate indicates a trend towards anaerobic glycolysis. The lactate 
increasing comes from hypoxic area and can serve for hepatic gluco-
neogenesis via Cori cycle. The increase of carnitine reflects the free 
fatty acids oxidation to be used as energy source. A reflect of proteoly-
sis is observed by the rise of phenylalanine. The amino acids are used 
in the Krebs cycle or are degraded in urea, which is also increased in 
our study. We also observed a rise of creatine—energetic substrate of 
muscles—and its degradation product, creatinine. The myo-inositol 
increase reflects an activation of intra-cellular messages. Finally, the 
mannitol, which does not come from human metabolism, could per-
haps reflect bacterial translocation.
Conclusion Metabolomic approach is a new interesting way to char-
acterize metabolic changes in ICU patients at their admission. In the 
group of septic shock, we observed an increase in anaerobic glycolysis, 
proteolysis, lipolysis and gluconeogenesis. Nevertheless, the differ-
ences are not correlated with prognosis.
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Introduction Two major immuno-inflammatory phases are well 
documented during sepsis: an early active inflammatory phase and a 
deactivated inflammatory phase leading to immunosuppression. Early 
death (<7 days) and late death (>7 days) must be then distinguished. 
The immune deficiency concerned both innate and adaptive system 
and represents a potential indication for immunostimulation therapy 
(IFN-γ, IL-7, PD-1 antagonists, etc.). Finding immune parameters to be 
used as a monitoring of inflammatory status becomes a major goal for 
research. Lymphocyte as a source of mediators for innate immunity 
has a phenotype in severe septic patients that is not well character-
ized. The objective was to describe and compare lymphocyte pheno-
types to healthy volunteers, measured early (<7 days) in the course of 
severe sepsis with or without shock, and to study the relationship of 
this phenotype with prognosis.
Patients and methods We conducted a monocenter prospec-
tive observational study. Patients and groups: Severe Sepsis 
Group =  severe sepsis ±  septic shock; Control group =  healthy vol-
unteers. Measurements at D2 (D1–D3): demographic, clinical severity, 
mortality, blood cell count, monocytic HLA-DR expression, lympho-
cyte phenotype (flow cytometry, CD3+, CD3+CD4+, CD3+CD8+, 
CD19+, CD16+CD56+).
Results Forty-eight healthy volunteers were in control group: 24M/24F 
and aged 42 (31–54) years. Sixty-seven patients were in severe sepsis 
group: 39M/28F and aged 69 (52–85) years. Charlson, SOFA and IGS2 
scores were 5 (2–7), 8 (5–13) and 52 (38–67), respectively; sites of 
sepsis origin are abdominal (33 %), lung (27 %) and others (40 %); early 
death was at J7 (28 %) and late death was at J7–J28 (20 %) (Table 7).
Lymphocyte phenotype was not related to the severity scores (IGS2 
SOFA). Lymphocyte phenotype was not related to early (<day 7) and 
late death (day 28).
Conclusion T lymphopenia (whatever the sepsis severity) is associated 
with a decreased monocytic HLA-DR expression suggesting a syner-
gistic change in both innate and adaptive immunity. This phenome-
non can be physiologic, but could be a marker of immunosuppression 
associated to secondary infections. Monitoring mHLA-DR expression 
and lymphocyte phenotype over the course of sepsis may argue in 
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Introduction Patients who survive the early hours of sepsis 
develop an acquired immune dysfunction responsible for nosoco-
mial infections and late mortality. Myeloid-derived suppressor cells 
(MDSCs), a heterogeneous population characterized by their abil-
ity to suppress T-cell responses, may play a major role. They have 
been described in numerous tumors as well as in inflammatory and 
infectious diseases. However, their phenotype and mechanism of 
action remain unclear. The objective of this study was to broadly 
assess the presence and mechanisms of suppression of MDSC sub-
sets during septic shock.
Table 7 Lymphocyte phenotype and mHLA‑DR expression 
[values are expressed as median (first quartile–third quar‑






Lymphocyte phenotype and mHLA‑DR expression
Lymphocytes  
(/mm3)
1000 (600–1400) 1586 (1372–1991) 0.85
CD3+ (/mm3) 535 (251–832) 1182 (949–1523) <0.0001
CD3+CD4+  
(/mm3)
324 (155–566) 685 (595–1034) <0.0001
CD3+CD8+  
(/mm3)
170 (93–290) 432 (300–508) 0.0003
CD19 (/mm3) 149 (78–263) 141 (94–192) 0.36
NK (/mm3) 102 (54–214) 161 (114–268) 0.39
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Patients and methods In a prospective cohort of patients with septic 
shock (n = 35) and healthy controls (n = 26), peripheral blood myeloid 
cell subsets were quantified and phenotypically analyzed by multi-
color flow cytometry.
The expression of 45 myeloid genes was studied by qRT-PCT on whole-
blood RNA from septic patients (n = 29) and healthy controls (n = 15). 
Plasma levels of MDSC mediators were quantified by ELISA and high-
performance liquid chromatography (HPLC) in 73 septic patients and 
19 healthy controls. In vitro, CFSE-labeled peripheral blood mono-
nuclear cells were depleted or not of CD14pos or CD15pos cells and 
stimulated with anti-CD3/CD28 antibodies; T-cell proliferation was 
assessed by CFSE dilution. Arginase and indoleamine 2,3-dioxygenase 
(IDO) activities were determined by HPLC.
Results We identified a suppressive phenotype in circulating myeloid 
cells from septic patients, characterized by an increase in circulat-
ing monocytic M-MDSC (CD14posHLA-DRlo/neg monocytes) count 
(p  <  0.001) and in CD14negCD15pos low-density granulocytes iden-
tified as granulocytic G-MDSCs (p  <  0.0001). Further phenotypic 
analyses showed that G-MDSCs include subsets of both immature 
granulocytes and mature granulocytes expressing high levels of 
degranulation markers. G-MDSCs were more specifically associated 
with occurrence of nosocomial infections.
A panel of genes involved in MDSC biology, including S100A8, S100A9, 
MMP8 and ARG1, was significantly upregulated in the blood of septic 
patients compared with healthy controls. Plasma levels of MDSC medi-
ators S100A8/A9, S100A12, arginase 1 as well as IDO activity were sig-
nificantly increased in septic patients compared with healthy controls 
(p < 0.001).
In vitro, restoration of T-cell proliferation after CD14pos and CD15pos 
depletion confirmed the suppressive properties of M- and G-MDSCs, 
respectively. Quantitative analysis of amino acids concentrations in 
culture supernatants revealed an arginase activity specifically burden 
by G-MDSCs and an IDO activity burden by both M- and G-MDSCs.
Conclusion In patients with septic shock, M-MDSC and G-MDSC 
counts are increased and promote the occurrence of nosocomial infec-
tions. Those subsets bear IDO and arginase activities and exert a sup-
pressive activity on T-cell proliferation. These new insights highlight 
the complex mechanisms underlying immune dysfunction in septic 
patients and could promote future therapeutic approaches.
This work was supported by the 2012 experimental research grant 
from French Intensive Care Society.
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Introduction Data regarding patients with the most severe manifesta-
tions of ANCA-associated vasculitis admitted to intensive care unit are 
scarce. The objective of the present study was to analyze the main fea-
tures of ANCA-associated vasculitis patients admitted to intensive care 
unit for vasculitis activity and to study long-term outcome.
Patients and methods We analyzed retrospectively consecutive 
adult ANCA-associated vasculitis patients from 17 intensive care units 
admitted for active disease over a 10-year period (2002–2012). This 
intensive care group was compared to a group of ANCA-associated 
vasculitis patients admitted to a nephrology department within the 
same period. ANCA-associated vasculitis patients admitted to inten-
sive care unit or nephrology department for other reasons than dis-
ease activity (i.e., complication of treatments such as sepsis) were 
excluded.
Results A total of 88 patients were included in the intensive care 
group and 55 patients in the non-intensive care group. The mean age 
of patients of the intensive care group was 59 ± 16.1 years, 54 patients 
had granulomatosis with polyangiitis (61  %), 32 had micropolyangii-
tis (36.4 %), and two had eosinophilic granulomatosis with polyangii-
tis (2 %). Proteinase-3 ANCAs were predominant (60 %). Seventy-four 
patients had newly diagnosed ANCA-associated vasculitis, and 14 
were cared for a relapse. When compared to the non-intensive care 
group, the intensive care group had a higher Birmingham Vasculi-
tis Activity Score (23 ± 8 vs 16 ± 4, p < 0.01) and a higher frequency 
of lung (diffuse alveolar hemorrhage in 64 vs 11 %, p < 0.001), heart, 
ear–nose–throat and central nervous system involvement. Respira-
tory assistance, renal replacement therapy and vasopressor amines 
were used in 72, 54 and 27 % of intensive care patients, respectively. 
Renal replacement therapy was required in 44 % of the non-intensive 
group patients (p = 0.254 for comparison with intensive care patients). 
In the intensive care group, all patients were treated with steroids, 
86  % received cyclophosphamide, and 51  % had plasma exchanges 
as remission induction regimen. Rituximab was used in 3  % in the 
intensive care group. Fourteen patients (15.9 %) died during intensive 
care stay. The need for mechanical ventilation, the use of vasopressors 
and the occurrence of at least one infectious event were significantly 
associated with intensive care mortality in univariate analysis. The use 
of plasma exchange was not significantly associated with mortality 
change (OR 0.69 [0.24–1.98]). After adjustment, only the occurrence 
of an infectious event was associated with intensive care mortality in 
the multivariate analysis (OR 11 [1.8–64.2] p < 0.01). Despite a higher 
in-hospital mortality rate (19.3 vs 3.6 %, p = 0.007), the long-term mor-
tality of the intensive care group was not different from that of the 
non-intensive care group (respectively, 1-year mortality, 20.4 vs 17.0 %, 
p = 0.372, and see Fig. 13).
Fig. 13 See text for description
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Conclusion This study represents the largest cohort of ANCA-associ-
ated vasculitis patients with active disease requiring intensive care. 
Even if respiratory failure appears as the main cause of intensive care 
admission, we identified sepsis as the main risk factor for intensive 
care mortality. Our results suggest that surviving patients have a long-
term prognosis that is not significantly different from patients whose 
disease does not require intensive care admission.
Competing interests None.
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Introduction The optimal initial modality of renal replacement ther-
apy remains controversial. Available literature is limited by several 
biases such as lack of statistical power, the absence of standardization 
of renal replacement therapy initiation criterion, lack of information 
concerning dialysis dose and a high rate of crossover between modali-
ties. Moreover, some area of uncertainties remains including optimal 
modality of renal replacement therapy during shock and their impact 
on long-term renal outcome. Additional studies including a sufficient 
number of patients were necessary.
The purpose of our study was to compare the prognostic impact on 
both techniques, adjusting for the probability of being treated by con-
tinuous renal replacement therapy or intermittent hemodialysis a par-
ticular day.
Patients and methods Patients of a French prospective high-quality 
observational multicenter cohort were included if they underwent at 
least one renal replacement therapy session between 2004 and 2014. 
The day of renal replacement therapy initiation for a patient was his 
study inclusion day.
Baseline and daily patients’ characteristics differences between treat-
ment groups were taken into account by using a marginal structural 
Cox model, allowing drawing a causal conclusion in observational lon-
gitudinal data analysis. The composite primary endpoint was 30-day 
mortality and dialysis dependency. Following subgroup analyses were 
planned in the experimental design: chronic renal or heart disease; 
liver cirrhosis; diabetes; hypertension; hemodynamic status at renal 
replacement therapy initiation defined according to SOFA hemody-
namic component (strictly inferior to 3, and equal or above 3); invasive 
mechanical ventilation at inclusion; and extent of daily weight gain 
between intensive care unit admission and inclusion, defined as the 
upper quartile of the study population.
Secondary objective was to assess 6-month prognosis in term of mor-
tality and persistent renal dysfunction by a logistic model with inverse 
probability of treatment weighting, considering the treatment most 
received in the first 7 days.
Results Among 18,834 patients of the cohort 1360 were included, 
with, respectively, 544 (40.0  %) and 816 (60.0  %) patients initially 
treated by continuous therapies and intermittent hemodialysis. 
Median age was 65 [interquartile range: 54; 76], and 204 (15.0  %) 
patients suffered from chronic kidney disease, 235 (17.3  %) from 
chronic heart failure and 327 (24.0 %) from diabetes. A medical condi-
tion was present among 77.3 % of patients. Median initial SOFA score 
was 10 [interquartile range: 7; 13]. Invasive mechanical ventilation 
was required at renal replacement therapy initiation in 930 (68.4  %) 
patients. Both therapies were administered in 265 (19.5 %) patients.
At day 30, 539 (39.6 %) patients died. Among survivors, 150 (23.8 %) 
still required renal replacement therapy. There was no difference 
between initial modalities for the primary endpoint (HR 1.00; 95 % CI 
0.77–1.29; p = 0.97).
In patients with higher weight gain at renal replacement therapy ini-
tiation, mortality and dialysis dependency were significantly lower 
with continuous therapies (HR 0.54; 95  % CI 0.29–0.99; p  =  0.05). 
Conversely, this technique was deleterious in patients without hemo-
dynamic instability (HR 2.24; 95 % CI 1.24–4.04; p = 0.01). In patients 
with shock at inclusion, no improvement in prognosis was noted with 
continuous therapies.
Six-month mortality and persistent renal dysfunction were not influ-
enced by initial renal replacement therapy modality (OR 0.81; 95 % CI 
0.45–1.46; p = 0.48).
Discussion The marginal structural model allowed inclusion of a large 
number of patients while minimizing biases resulting from our obser-
vational design. Hence, variables associated with choice of treatment 
and outcome was taken into account by this model. Switch between 
treatment modalities was considered by an as-treated analysis. Lastly, 
the model was adjusted for timing of renal replacement therapy initia-
tion and dialysis dose.
Main limitation of the study is that even if all known confounding 
factors were introduced in the model, unknown confounding factors 
might not have been considered.
Conclusion Continuous renal replacement therapy did not improve 
30-day and 6-month patients’ prognosis. It seems beneficial for 
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Introduction The classical dichotomy between functional acute kid-
ney injury (AKI) and intrinsic AKI has recently been challenged. Thus, 
authors suggested that transient and persistent AKI in critically ill 
patients might share similar pathophysiological mechanisms. A recent 
study confirmed these findings [1]. However, this previous study suf-
fers a lack of statistical power, and time dependency for renal recovery 
was unaccounted for.
The primary objective of our study was to assess prognostic impact of 
AKI duration. Secondary objective was to assess relationship between 
renal recovery at specific time frame and need for renal replacement 
therapy.
Patients and methods We performed a retrospective analysis of a 
large prospective multicenter cohort database involving 20 French 
ICUs. Every adult patient with AKI at ICU admission according to the 
KDIGO definition was included.
Renal recovery was defined by a decrease in one stage or more accord-
ing to the KDIGO classification.
Results are reported as medians (interquartile range, IQR) or num-
bers (%). Variable of interest was day-28 mortality, and influence of 
renal recovery was assessed after adjustment in a cause-specific haz-
ard model taking time dependency of this variable into account. Dis-
charge alive from the ICU was used as a competing event.
Results Overall, of 18,684 patients of our database, 5229 had an AKI at 
ICU admission and were included in this study. 3167 patients were of 
male gender (60.6 %), median age was of 70.5 [57.7–78.8], and initial 
severity assessed by SAPS 2 was of 51 [39–70]. Main reasons for ICU 
admission were shock (41.0 %) and acute respiratory failure (21.2 %).
AKI severity at admission according to KDIGO classification was stage 1 
in 2453 patients (46.9 %), stage 2 in 1178 (22.5 %) and stage 3 in 1598 
(30.6 %). According to our definition, renal recovery occurred in 65.7, 
62.6 and 45.7 % of patients with AKI stages 1, 2 and 3, respectively.
Day-28 mortality was, respectively, of 22.8, 27.8 and 26.3 % for patients 
with AKI stages 1, 2 and 3. After adjustment for confounders, renal 
recovery was associated with a favorable outcome (cause-specific 
HR 0.53; 95 % CI 0.45–0.62). Results were unchanged when assessing 
influence of a renal recovery defined by renal recovery at day 3.
In patients alive at day 8, rate of renal replacement therapy in patients 
with persistent and transient AKI defined at various time frames is 
reported in Fig. 14.
Conclusion These data confirm short renal dysfunction reversibility to 
be potent prognostic marker in AKI patients and therefore to be clini-
cally relevant in defining severity of AKI. Additionally, our results con-
firm a definition of persistent AKI based upon renal recovery between 
day 3 and day 7 to be potent predictor for need of RRT. Distinction 
between transient and persistent AKI might therefore be clinically rel-
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Introduction Acute kidney injury (AKI) is a common complication in 
critically ill patients. Its incidence in septic shock is around 50  % (1). 
Among patients with severe AKI, 50–70 % receives renal replacement 
therapy (RRT). However, the optimal timing of RRT initiation in patients 
with severe AKI remains controversial (2). This study compared the 
effect of early versus delayed RRT in patients with septic AKI.
Patients and methods This retrospective study included all patients 
hospitalized in our intensive care unit (ICU) between January 2008 
and December 2013 for severe sepsis or septic shock complicated by 
AKI requiring RRT. Exclusion criteria were age <18  years, end-stage 
renal disease and RRT initiation before ICU admission. Reference cre-
atinine was retrieved from blood samples at steady state during the 
year preceding admission. AKI was defined and classified according 
to the KDIGO criteria (both diuresis and serum creatinine). Early group 
was defined as an initiation of RRT within 12H after admission or AKI 
stages 0–1 at initiation. Delayed group was defined as an initiation of 
RRT >12H after admission and AKI stages 2–3 at initiation. The primary 
outcome was in-hospital mortality.
Results A total of 312 patients were treated by RRT during the study 
period. Two hundred and four patients suffered from severe sepsis or 
septic shock, and 169 patients were included in the study. In the early 
group (n = 79), SOFA score (12 vs 10, P = 0.01) and serum creatinine 
level (174 µmol/L [123–283] vs 154 µmol/L [102–229], P = 0.003) were 
higher at ICU admission. One hundred and fifty-eight (93 %) patients 
were receiving norepinephrine and mechanical ventilation when 
EER was initiated. The KDIGO score at RRT initiation was higher in the 
delayed group (3 vs 2; P < 0.0001) on both creatinine and diuresis cri-
teria. The crude hospital mortality was 58 % in the early group versus 
54 % in the delayed group (P = 0.6). A Cox regression model showed a 
better probability of survival adjusted to the SOFA score at ICU admis-
sion in the early group (P =  0.003, Fig.  15). Risk factors for mortality 
Fig. 14 See text for description Fig. 15 See text for description
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analyzed by logistic regression were the PaO2/FiO2 ratio and lactate 
level at initiation of RRT. Survivors had a similar renal recovery in both 
groups, but the hospital length of stay was longer in the delayed 
group (51 vs 34 days, P = 0.05).
Conclusion Our study reflecting our clinical practice reveals a better 
outcome when RRT is early initiated in ICU according to its timing after 
admission and AKI severity. The deleterious effects of fluid overload 
and hypoximia in case of AKI should be precise in further studies.
Competing interests None.
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Introduction Despite substantial improvements in the management 
of multiple myeloma, renal failure remains an important burden which 
tremendously impairs prognosis. The purpose of this study was to 
describe the characteristics and prognostic factors for renal recovery 
in myeloma patients admitted to the intensive care unit (ICU) for acute 
kidney injury (AKI) stage 3 treated with renal replacement therapy 
(RRT).
Patients and methods A retrospective single-center cohort study was 
performed, including consecutive myeloma patients admitted to our 
ICU between 01/01/2007 and 01/09/2015 and treated with RRT. Data 
and follow-up were abstracted from the medical charts. Patients were 
evaluated 60 days after ICU discharge and divided into three groups: 
alive without dialysis, alive and dialysis-dependent or deceased. A 
univariate analysis was performed to identify factors associated with 
being alive without dialysis 60 days after ICU discharge.
Results Fifty-five patients were included in the study. Median age 
was 63 (inter-quartile range 58–70)  years, and 33 (60  %) were male. 
Patients were admitted to the ICU 3 (0–5) years after the diagnosis of 
myeloma, after 1 (1–3) line of chemotherapy. Twenty-two had already 
been treated with autologous stem cell transplantation, at least once. 
The baseline renal function before ICU admission, estimated by the 
glomerular filtration rate (GFR), was 58 (41–78)  ml/min. The median 
SOFA score at day 1 was 6 (4–8). The three main reasons for ICU 
admission were AKI (33, 60 %), sepsis (21, 38 %) and acute pulmonary 
edema (13, 55  %). During ICU stay, 17 (31  %) patients required inva-
sive mechanical ventilation, 13 (27 %) received vasopressors, and RRT 
was implemented in all patients (55, 100 %) during 13 (5–42) days. The 
median ICU and hospital length of stay were 13 (5–43)  days and 24 
(14–35) days, respectively. Forty (73 %) patients were alive at hospital 
discharge.
At day 60 after ICU discharge, 22 (41  %) patients were alive without 
dialysis, 19 (36 %) had died, and 12 (23 %) were still undergoing dialy-
sis. Among the 22 patients who recovered, the median time of dialysis 
was 6 (2–18) days. These patients recovered their previous renal func-
tion with a median GFR of 65 (25–74) ml/min at day 60 (p = 0.70).
By univariate analysis, two factors were associated with a decreased 
likelihood of renal recovery at day 60: a history of autologous stem 
cell transplantation, odds ratio (OR) 0.27, 95  % confidence interval 
(0.08–0.93), p  =  0.04, and a proteinuria at ICU admission >380  mg/
mmol creatininuria, OR 0.22, 95 % CI (0.06–0.71), p = 0.01.
None of the other variables related to the hematological malignancy 
or to the ICU stay were associated with renal recovery at day 60.
Discussion This study is the first to assess renal recovery in critically ill 
myeloma patients with severe AKI, in the era of bortezomib therapy. 
First of all, survival and renal recovery in our study are much higher 
than previously reported. About two-third of the patients were alive at 
day 60, and 41 % had recovered their baseline renal function. We iden-
tified two prognostic factors which can be considered as surrogates of 
more aggressive malignancies.
Conclusion AKI stage 3 in critically ill myeloma patients was associ-
ated with a hospital mortality <30 %. The main cause of AKI is likely to 
influence the likelihood of renal recovery. Patients with more aggres-
sive malignancies (history of autologous transplantation, higher pro-
teinuria) had a poorer renal prognosis.
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Introduction Poor communication is associated with anxiety, dis-
tress and posttraumatic stress-related symptoms in families of both 
survivors and nonsurvivors. Few studies have assessed the impact on 
everyday medical decisions of better communication, most notably 
delivered by a multidisciplinary team. Our objectives are to investigate 
family perceptions of having a nurse participate in family conferences 
and to assess the psychological well-being of the same families after 
ICU discharge.
Patients and methods We designed a parallel-group randomized 
trial comparing family conferences with versus without the proactive 
participation of a nurse in family conferences. The study has a mixed-
method design with a qualitative study embedded in a single-center 
randomized study. We included one family member for each consecu-
tive patient who received more than 48  h of mechanical ventilation 
in the ICU. We scheduled planned proactive participation of a nurse 
in family conferences led by a physician. In the control group, confer-
ences were led by a physician without a nurse. We evaluated family 
conferences on days 1 and 3, weekly, during bad news or end-of-life. 
Audits by checklists were conducted for all conferences. All ICU phy-
sicians and nurses received training of communication by role play-
ers. Physicians and nurses used conferences guides created before 
the study. We used the NURSE acronym, the Ask-Tell-Ask concept and 
the VALUE strategy depending on the type of conferences. The pri-
mary outcome was the score on the Impact of Events Scale-revised 
(IES-R) (for posttraumatic stress-related symptoms) completed by the 
family member 3 months after the death or discharge of the patient. 
Secondary outcomes were symptoms of anxiety and depression in 
family members 3  months after patient death or ICU discharge. We 
conducted a qualitative evaluation of perceptions by family members 
of nurse participation in the family conferences at ICU discharge using 
interview guides. Each interview was transcribed verbatim and evalu-
ated using interpretative phenomenological analysis.
Results Of the 172 eligible family members, 100 (60.2  %) were ran-
domized; among them, 88 underwent semi-structured interviews 
at ICU discharge and 86 completed the Peritraumatic Dissociative 
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Experiences Questionnaire at ICU discharge and the Impact of Event 
Scale and Anxiety Depression Questionnaire 3 months later. The num-
ber of conferences was 188: 90 on day 1; 57 on day 3; 24 on day 7 and 
then weekly; and 17 for patients at the end-of-life. There were 96 con-
ferences in the intervention group and 92 in the control group. The 
audits by checklists showed no significant between-group differences 
in conference contents on days 1, 3, 7 and then weekly or at the end-
of-life. Conference duration was about 30 min at all time points.
Primary and secondary outcomes
The median [IQR] IES-R score was not significantly different between 
the control and intervention groups (24 [12.5–45] and 21 [9–23], 
respectively; P  =  0.24). IES-R scores indicated posttraumatic stress-
related symptoms in 52.2 % and 50 % of family members in the con-
trol and intervention groups, respectively (P  =  0.83). Although the 
intervention group had significant lower anxiety (4 [1–9] vs 8 [4.5–12], 
p =  0.01) and depression (2 [0–6] vs 5.5 [1–11.5], p =  0.04) subscale 
scores, the prevalence of severe anxiety [14 (33.3  %) vs 23 (52.3  %), 
p  =  0.08] and depression symptoms [10 (23.8  %) vs 17 (38.6  %), 
p  =  0.14] (HADS subscale scores >8) did not differ significantly 
between the two groups.
Qualitative findings
The qualitative data indicated that the families valued the principle 
of the conference itself. Perceptions of nurse participation clustered 
into four main themes: trust that ICU teamwork was effective (50/88, 
56.8  %), trust that care was centered on the patient (33/88, 37.5  %), 
trust in effective dissemination of information (15/88, 17  %) and 
trust that every effort was made to relieve anxiety in family mem-
bers (12/88, 13.6  %). In conferences without nurse participation, two 
themes were identified: satisfaction with the information given by the 
physician alone (15/45, 33.3 %) and satisfaction with the information 
given by the nurse in the patient’s room (7/45, 15.5 %).
Conclusion In conclusion, our study adds new insights about the role 
for repeated, routine, structured family conferences in the ICU. The 
families greatly appreciated the conferences themselves. Although the 
participation of a nurse in the conferences did not change significantly 
the post-ICU burden, it was considered positive by the family mem-
bers. Our study offers some guidance on how to conduct family con-
ferences in each specific clinical situation.
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Introduction Platelets (PLTs) can been stored up to 5–7 days depend-
ing on the country’s transfusion policies. Changes in platelets struc-
ture and functional variables during the storage have been described 
in vitro. Although increase in duration of PLTs storage could improve 
PLTs availability in remote area and decrease waste of PLTs, informa-
tion on the impact of platelets storage duration is limited and con-
troversial. This study aims to determine whether the storage duration 
of PLTs transfused to critically ill patients is associated with patient 
outcomes.
Patients and methods We performed a retrospective analysis of 
patients admitted to two intensive care units (ICUs) in tertiary hospi-
tals from 2008 to 2014. Comparison of outcomes of patients receiving 
only PLT with a maximum age higher than 5 days PLT versus patients 
receiving only PLT with a maximum age <5 days has been made. Out-
come variables were hospital mortality and ICU-acquired infection 
(bacteraemia and/or bacteriuria). Associations between PLT age and 
outcomes were modelled using multiple logistic regression and linear 
regression.
Results Among 2250 ICU patients who received one or more PLTs, 
storage duration of all transfused PLTs was available for 1430 (64 %). 
These patients had a mean age of 57.5 ±  18.1  years, mean APACHE 
3 score at admission was 65.8 ±  29.0, and 964 (67.4  %) were male. 
The median PLT age was 4  days (IQR 2, range 2–5). In-hospital mor-
tality was 22.1 %, median ICU LOS in survivors 5.0 days (IQR 8.7) and 
infection rate 13.2  %. When comparing patients who received PLTs 
with a maximum age of 5 days with a maximum age <5 days, there 
were no significant differences in demographics, pre-ICU illness sever-
ity or number of transfused products. There were also no differences 
in mortality (21.6 vs. 22.8  %, p  =  0.59), bacteraemia (7.5 vs. 6.4  %, 
p = 0.44) or LOS (median 4.9 vs. 5.1 days, p = 0.57). After adjusting for 
confounders, age of PLTs was not independently associated with mor-
tality (odds ratio [OR] 1.04, 95  % confidence interval [CI] 0.78–1.40) 
or infection (OR 1.31, 95  % CI 0.88–1.97). Similar results were found 
when considering separately bacteraemia and bacteriuria or when 
analysing the 639 patients who were transfused with only one PLT 
unit.
Conclusion In this large retrospective study, storage duration of PLTs 
is not associated with an increased risk of mortality or infection in 
critically ill patients. Our results support further research investigating 
safety and benefit to extend PLTs storage duration.
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Introduction Improving the safety of care is a challenge for the health 
systems. Development of a safety culture (SC) is one of the objectives.
Morbidity–mortality conferences (MMC) are one tool that could help 
in improving SC.
The main objective of the national multicenter REA-C-SUR project is to 
measure the SC in ICUs in France. The secondary objective is to estab-
lish a link between SC and the characteristics of MMR.
This project was initiated by the national group ‘RMM, Qualité et Sécu-
rité des Soins en Réanimation.’ It is funded by a national grant AO 
PREPS 2012.
Materials and methods SC was measured among professionals (doc-
tors, managers, nurses, etc.) through the questionnaire (Hospital Sur-
vey on Patient Safety Culture, HSOPS) developed by AHRQ in the USA 
and validated in French. This questionnaire, through 40 items, explores 
ten dimensions of SC. A dimension is developed if the score is above 
75 % and “to be improved” if the score is <50 %.
For each unit, MMCs’ organizational characteristics were collected.
Results From September 2013 to September 2014, 64 units (adults or 
pediatric) were included from French hospitals as follows: 40 teaching, 
23 non-teaching and one private sector. A total of 36,149 patients, in 
2012, were admitted.
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Participation rate was excellent: 3692 questionnaires filled out of 
4811 (77  %). SC overall is really undeveloped. The scores for percep-
tion by professionals in the management support for security (dim 9) 
or teamwork between departments (dim 10) are extremely bad: <50 % 
for almost all units. The dimension “non-punitive response” is also very 
undeveloped (Fig. 16).
There is a statistical link between MMR and SC. The more the MMR are 
structured, the better the scores for the overall perception of safety 
and support of management. There is also a link between nurses’ 
involvement and reporting of adverse events, learning organization 
and human resources. Finally, the presence at MMCs, of an external 
participant, seems to improve communication openness.
Conclusion This prospective, multicenter study is the first in ICUs, in 
Europe. It might help in improving SC that is to date really low.
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Introduction We previously reported factors associated with day-120 
outcome in ICU survivors among 1053 patients with solid cancers 
hospitalized in intensive care unit (ICU) [1]. We performed additional 
analysis to assess hospital mortality and factors associated with day-
120 mortality in the overall population of patients.
Patients and methods We conducted an international, multicenter, 
retrospective study. All solid cancer patients, except those admitted 
after scheduled surgery, admitted between 2006 and 2011 in the five 
participating ICUs were included. Variables of interest were in-hospi-
tal and day-120 post-ICU mortality. We performed logistic regression 
analyses to identify variables statistically significantly associated with 
hospital mortality and day-120 post-ICU discharge mortality. A predic-
tion score (Oncoscore) was then built and evaluated.
Results A total of 1053 patients were included. The median age was 
of 63 years (54–71), and 66.8 % of the patients were of male gender. 
The principal underlying cancers were lung in 202 (19.2 %), colonic in 
178 (16.9 %), breast in 129 (12.5 %), and head and neck in 125 (11.9 %).
In-ICU, in-hospital, and day-120 post-ICU discharge mortalities were of, 
respectively, 41.3, 60.7, and 65.8 %. Factors independently associated 
with day-120 mortality were systemic extension of the cancer (OR 2.54; 
95 % CI 1.87–3.45) and organ support including need for mechanical 
ventilation (OR 2.54; 95 % CI 1.80–3.45), renal replacement therapy (OR 
1.54; 95 % CI 0.99–2.38), or vasopressors (OR 2.35; 95 % CI 1.66–3.29). 
Conversely, when compared to lung cancer, other types of tumours 
were found to be protective from poor outcome with odds ratio rang-
ing from 0.25 to 0.52 (P < 0.05 for each).
A prediction model (Oncoscore) was then built ranging from 0 to 11. 
In the studied population, Oncoscore was 6 (3–7). The overall model 
area under ROC curve in predicting day-120 outcome was fair (0.74; 
95 % CI 0.71–0.77). A score of 4 was found to be sensitive of poor out-
come (sensitivity 0.84), while a score of 8 was specific (specificity 0.92). 
According to these cut-offs, day-120 mortality was of 40 % (n = 111), 
70 % (n = 363) and 87 % (n = 216) with Oncoscore <4, of 4–7 and >7, 
respectively. Cumulative survival is reported in Fig. 17.
Conclusion Critically ill patients with solid cancer have a meaningful 
day-120 survival. Conversely to critically ill patients with haematologi-
cal malignancy underlying malignancy and extension of the disease 
seems to be independently associated with day-120 mortality. The 
Oncoscore developed in this study, although performing fairly in the 
studied population remains to be validated in an external population 
of solid cancer patients requiring ICU admission.
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Introduction Organs from donors following circulatory death (DCD) 
have undoubtedly contributed to the expansion of donor organ pool. 
Recently, the French regulation agency, Agence de BioMédecine (ABM) 
and the Intensive Care Societies (SRLF/SFAR) made recommendations 
and authorized “controlled” donation after circulatory death (cDCD) 
Maastricht category III. Here, we describe the experience of one of the 
first authorized pilot centers in France.
Patients and methods From December 2014 to September 2015, all 
cDCD data were prospectively collected, in conformity with the ABM 
protocol [1].
The different steps of our local procedure were: (1) Withdrawal of life-
sustaining therapy (WLST) decision was discussed by intensive care 
staff including external second opinion. This decision was independ-
ent of any discussion to donate organs for transplantation. (2) The rela-
tives were involved in the decision of WLST. The healthcare provider 
ensured the understanding and acceptance of the decision. (3) Only 
after WLST decision, the local organ procurement coordination was 
contacted to indicate that the patient might be eligible for cDCD. (4) 
Then, a representative assessed the patient for potential donation 
(health security). (5) If the patient was suitable for donation, a second 
interview with relatives was done to research the non-opposition for 
donation. (6) Evaluation of kidney and liver function. (7) WLST deter-
mined by the ICU staff and relatives. (8) Declaration of death after 
circulatory arrest. (9) Percutaneous introduction of in  situ regional 
normothermic recirculation (RNR) in intensive care. (10) Transfer in the 
operating room for organ procurement.
This prospective, single-center, descriptive study reports the first data 
from our cohort of cDCD.
Results From 01/12/2014 to 31/08/2015, among 742 intensive care 
admissions, four potentials donors were identified (three anoxic 
encephalopathy and one severe traumatic brain injury). All four had no 
opposition for donation and were eligible for the procedure. Titrated 
sedation and extubation were always used for WLST. Death occurred 
in each case in <3 h. There was one cannulation failure of the RNR. For 
the three other procedures, six kidneys were explanted and grafted. 
There was no delayed graft function. One liver was explanted and 
grafted with success. During the same period, our team accomplished 
17 donation after brain death and six uncontrolled DCD (Maastricht II).
Conclusion The understanding of the cDCD protocol by relatives was 
good. The discussion of donation options was frequently initiated by 
family request for information. There was no procedure failure due 
to delayed cardiac arrest or prolonged hypoperfusion period. These 
results could be explicated by our procedures for WLST with titrated 
sedation, analgesia and comfort care. Our policies and procedures for 
WLST are the same for both donation and non-donation cases. Our 
team met technical difficulties for percutaneous RNR. This percutane-
ous approach needs to be evaluated in the future. cDCD represents 
18 % of our recovery activity for transplantation. After an intense prep-
aration phase, essential to the proper understanding of the protocol, 
the establishment of a cDCD activity in our center led to six kidney and 
one liver transplants. On this short cohort, we had no grafts dysfunc-
tion. These data showed promising results concerning cDCD program 
but need further evaluation (Fig. 18).
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Introduction Elevated plasma levels of cardiac troponin I (cTn-I) have 
been described in about 10  % of cases in the early phase of severe 
multiple trauma patients. However, apparently specific for myocar-
dial cell membrane disruption, the mechanisms of its increase are still 
poorly understood. Moreover, if cTn-I elevation appears as an inde-
pendent prognostic marker in various critical situations, its impact on 
severe trauma outcome in the intensive care unit (ICU) remains con-
troversial. The main objectives of our study were first to determine 
the incidence and factors influencing cTn-I release in severe multiple 
trauma and secondly to assess its prognosis on outcomes in intensive 
care unit.
Patients and methods We performed a retrospective analysis from 
a prospective, multicenter, regional scientific database (Trauma-
base®), of all patients admitted to the Beaujon University Hospital ICU 
between January 2011 and December 2013. Only patients for whom 
a troponin assay was performed on arrival were included for analysis 
(immunological methods of chemiluminescence-ARCHITECT STAT Tro-
ponin-I®, positivity threshold 0.05 ng/ml). If more than one value were 
available, the highest troponin value over the first 24 h was retained 
for analysis. The primary endpoint was the cTn-I elevation and the 
ICU mortality. Continuous variable is expressed as median and inter-
quartile range and categorical variables as absolute value and relative 
frequencies. Univariable and multivariable logistic regression analysis 
was performed for cTn-I elevation and ICU mortality.
Results A total of 1029 patients were included (age 38 ±  18; Injury 
Severity Score 19  ±  14). Pre-hospital variables associated with cTn-I 
elevation in multivariable analysis are reported in Table 8. In a multi-
variable model including the Injury Severity Score and the Simplified 
Acute Physiology Score and the presence of shock and cardiac arrest 
before admission, initial cTn-I elevation is not associated with ICU 
mortality.
Conclusion In this series of more than 1000 patients, the initial serum 
concentration of cTn-I does not appear as an independent predic-
tor of mortality in the ICU. Its initial elevation seems rather to reflect 
the severity of the trauma. However, its association with various 
Fig. 18 See text for description
Table 8 See text for description 
Multivariate analysis on cTn-I elevation at admission
Variables OR 95 % CI P value
Minimum oxygen saturation 0.9568 0.9204–0.9906 0.0180
Severe cranial trauma 0.8366 0.3753–1.8141 0.6554
Hemorragic shock 2.7104 1.392–5.1504 0.0027
Intubation in the field 2.0988 1.0724–4.0273 0.0275
Thoracic trauma 2.3028 1.2988–4.1921 0.0050
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Introduction We previously found predictive factors for hospital 
admission and death during hospitalization in lung cancer patients 
consulting at the emergency department. Systemic inflammation is 
a prognostic factor in cancer patients and can be studied by inflam-
mation-based prognostic scores [1], such as the modified Glasgow 
prognostic score (Table  9), a combination of C-reactive protein and 
albumin, biological parameters easily obtained and measured in rou-
tine. This score was initially described in 2003 in patients with inop-
erable lung cancer and proved to be a prognostic factor for survival 
[2]. Then, it was studied for its prognostic value in patients with oper-
able cancer and receiving chemo-/radio-therapy. A predictive role for 
response to antineoplastic treatment was also suggested [3]. The goal 
of our study was to determine whether systemic inflammation meas-
ured using the modified Glasgow prognostic score could improve the 
predictive value of our previous models, a model for hospitalization 
and a model for death during hospitalization.
Patients and methods We conducted a retrospective study including 
all patients with lung cancer consulting at the emergency department 
of a cancer hospital between January 1, 2008, and December 31, 2010. 
In order to assess whether the Glasgow score improves the prediction 
of the two published models (predicting hospitalization and death 
during hospitalization), we have refitted the two models in the cases 
with the Glasgow score available, dropped the variables one per one 
with a nonsignificant p value, and then added the Glasgow score to 
both models.
Results Of the 548 emergency department visits, CRP and albumin 
needed for calculating the modified Glasgow prognostic score were 
available in 291 cases. Of these, 94 (32 %) involved patients with clini-
cally documented infection. The 291 visits resulted in 222 hospitali-
zations. The majority of patients had a modified Glasgow prognostic 
score of one and a stage IV cancer. In multivariate analysis based on 
the model originally developed, the modified Glasgow prognos-
tic score is an independent predictor of hospital admissions (odds 
ratio 2.72 per one-unit increase; p value <0.0001) as well as arrival by 
ambulance (odds ratio 25.93; p value <0.0001) and the presence of 
physical signs associated with the chief complaint (odds ratio 2.83; p 
value = 0.001). One hundred and eighty-one consultations (first visit 
only) were considered for determining prognostic factors for death 
during hospitalization. The modified Glasgow prognostic score is an 
independent predictor of death during hospitalization (odds ratio 2.95 
per one-unit increase; p value <0.001) as well as arrival by ambulance 
(odds ratio 19.03; p value = 0.0002). After stratifying patients into two 
groups according to the presence of an infection or not, this score 
added significant information in the two strata (p value 0.003 and 
0.001, respectively).
Discussion This is an original study. To our knowledge, this score has 
never been evaluated in emergency departments in cancer patients or 
even in a general population.
Conclusion The modified Glasgow prognostic score is an independent 
predictive factor for hospitalization and death during hospitalization 
in patients with lung cancer consulting at the emergency department.
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Introduction The early detection of patients at risk of massive transfu-
sion (MT) is challenging in bleeding trauma patients [1]. Mortality has 
been shown to be higher in severely injured obese patients compared 
with non-obese patients. However, to our knowledge, the risk of MT 
has never been assessed in obese population. Moreover, although the 
Trauma-Associated Severe Haemorrhage (TASH) score is a robust scor-
ing system for predicting MT requirements [2], its predictive perfor-
mance has never been validated in obese patients. The main objective 
of the study was to compare the MT rate in trauma patients according 
to obesity status. The secondary objectives were to assess and revali-
date the TASH score in predicting MT in population of obese and non-
obese trauma patients and to use a grey zone approach to providing 
relevant thresholds to optimize the ability to predict MT in clinical 
practice.
Patients and methods All trauma obese and non-obese patients 
admitted in a Level I Regional Trauma Center were included. Were 
excluded patients who died immediately after admission or not 
directly admitted or with important clinical data missing in the data-
base. MT rate and TASH score were assessed in obese [body mass 
index (BMI) ≥30  kg/m2] and non-obese (BMI <30  kg/m2) patients. 
Logistic regression was performed to assess the relationship between 
obesity and MT, before and after adjusting for ISS score. The odds ratio 
(OR) was provided for obesity status and for an increase of 5 units of 
BMI with the 95  % confidence interval (CI). Received operating char-
acteristic (ROC) curve analysis was performed for the TASH score in 
predicting MT in the obese and non-obese groups. Thereafter, thresh-
olds analysis was carried out from the ROC curves using the grey zone 
method.
Results Between January 2008 and December 2012, 119 obese 
trauma patients and 791 non-obese trauma patients were included. 
The MT rate was 10 % (94/910) in the whole population. The MT rate 
trended to be higher in obese patients versus non-obese patients: 
15  % (18/119) versus 10  % (76/791), OR 1.68 [95  % CI 0.97‒2.92], 
p = 0.07. After adjusting for ISS score, obesity was significantly associ-
ated with MT rate (OR 1.79 [95 % 1.00‒3.21], p = 0.049). BMI as a con-
tinuous variable was also significantly associated with MT before (OR 
1.24 [95  % CI 1.00‒1.54], p =  0.047) and after adjusting for ISS score 
Table 9 The modified Glasgow prognostic score
The modified Glasgow prognostic score Points allocated
C‑reactive protein ≤10 mg/l 0
C‑reactive protein >10 mg/l and albumin ≥35 g/l 1
C‑reactive protein >10 mg/l and albumin <35 g/l 2
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(OR 1.28 [95  % CI 1.03‒1.60], p =  0.028). The TASH score was higher 
in the obese group than in the non-obese group: 8 ± 5 versus 6 ± 5. 
The area under the ROC curves of the TASH score in predicting MT 
(≥10 U of packed red blood cells in the first 24 h) was very high and 
comparable between the obese and non-obese groups: 0.93 (95 % CI 
0.89‒0.98) and 0.94 (95  % CI 0.92‒0.96), respectively (p =  0.80). The 
grey zone ranged, respectively, from 10 to 13 and 9 to 12 in obese and 
non-obese patients and allowed to separate patients into three sub-
groups using the TASH score: low, intermediate and high risk, signifi-
cantly associated with ICU and hospital stay (Fig. 19).
Conclusion Obesity was associated with a higher rate of MT and a 
higher TASH score, which was a strong and accurate predictor of MT 
in both obese and non-obese populations. For the first time, the TASH 
score was validated in obese patients and a grey zone was established 
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Introduction When anesthesia quality is controlled, tracheal intuba-
tion (TI) difficulty may be related to: patient’s conditions and charac-
teristics, the environment where the maneuver is performed and the 
skill of the physician. In case of difficult laryngoscopy, the Eschmann 
stylet (ES) is proposed as a second-step intubation tool to access the 
trachea. We have hypothesized that when difficult emergency intuba-
tion is encountered, first-step ES (ES-1) may reduce TI delay.
Materials and methods We conducted two prospective succes-
sive evaluations. The first one was a simulation trial performed over 
3  months. In our airway management laboratory, 24 physicians (12 
novices and 12 skilled physicians) were involved. Each of them had 
to intubate a manikin allowing to simulate simple or difficult TI (Cor-
mack grade = 1 or 3: C1 or C3) placed in three different positions and 
environment: standard operating table (OT), lying on the ground (LG) 
and with very restricted access to the head (RA). All the sequences of 
TI were randomized for C1, C3, OT, LG, RA and to either conventional 
tracheal intubation technique using the tracheal tube as first tracheal 
assess tool (TT-1) or ES-1. With the results of this simulation trial and 
obtention of ethical approval, the 12 skilled physicians conducted the 
clinical study over 1  year in prehospital conditions. Anesthesia and 
difficult airway management procedures were standardized, and the 
patients were randomly allocated to either TT-1 or ES-1 group. Pre-
hospital TI characteristics were recorded. The study was preemptively 
dimensioned and powered to demonstrate 30 % reduction in TI delay 
for the patients with difficult laryngoscopy as attested by the low per-
centage of glottis inlet visible (POGO score) of below 30  % (Ref ). In 
both studies, TI difficulties (anticipated and post-maneuver) and com-
fort were assessed.
Results A total of 276 tracheal intubations were timed and analyzed 
for the simulation trial. We demonstrated that ES-1 as compared to 
TT-1 was a powerful mean to significantly reduce TI delay of: novices 
when C3 was imposed in OT, LG and RA; and skilled physicians when 
C3 was imposed for LG and RA. For the clinical trial, 250 patients were 
included. Details of both groups were similar. We demonstrated in the 
subgroup of patients with POGO score of <30 % (n = 73) that ES-1 as 
compared to TT-1 significantly reduced TI delay.
Conclusion We have observed in a difficult TI simulation trial that ES-1, 
as compared to conventional TI, was a powerful strategy to shorten TI 
delay when direct laryngoscopy was difficult for novices and skilled 
physicians. We demonstrated that simulation results translated to clini-
cal conditions. Our clinical data suggest that ES-1 may be useful strat-
egy when emergency difficult TI is anticipated because of the patient’s 
characteristics or environment. Moreover, we believe that the recom-
mended 2d TI attempt using TT is not necessary and the switch to ES 
could be proposed at the first difficult laryngoscopy.
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Introduction Eclampsia remains an important cause of maternal and 
perinatal mortality and morbidity worldwide [1]. The aim of this study 
was to determine the eclamptic patient’s characteristics and to iden-
tify risk factors associated with maternal mortality in patients with 
eclampsia.
Patients and methods We conducted a retrospective study between 
January 2002 and December 2013, including all patients diagnosed as 
eclampsia in the obstetrical intensive care unit of our hospital.
Results During this period, a total of 1130 cases of eclampsia were 
collected, yielding an overall incidence rate of 1.05 %. Mean age was 
27 ± 6.64 (15–48) years. The major proportion of patients was nullipa-
rous (63.4 %), 819 (72.4 %) cases were diagnosed during the antenatal 
period, whereas 311 (27.6 %) had a postnatal onset. Mean gestational 
age at onset was 34.5 ±  4.3 (21–43)  weeks of gestation. HELLP syn-
drome was identified as the most frequent complication in our study, 
associated with 34.3 % of patients, while acute kidney injury, placental 
abruption and neurological disorders were, respectively, associated in 
18.5, 17.7 and 16.5 % of cases. In our study 55 patients died, yielding a 
case fatality rate of 4.9 %, cerebral hemorrhage was identified as the 
first cause of death associated with 25.5 % of deceased patients. In uni-
variate analysis, risk factors for maternal mortality in eclampsia were: 
advanced maternal age (≥ 30 years), diagnosis of eclampsia during the 
antenatal period, low GCS (≤ 8), the presence of a neurological deficit, 
Fig. 19 Rates of massive transfusion, death, length of ICU and hos‑
pital stays according to the TASH score in the obese and non‑obese 
groups
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oligo-anuria or jaundice, the presence of these biological disorders: 
low platelets count (<100,000) – ASAT >70 UI/l – ALAT >70 UI/l – LDH 
>600  UI/l, the occurrence of HELLP syndrome, acute kidney injury, 
cerebral hemorrhage, acute pulmonary edema, abruption placentae, 
postpartum hemorrhage, disseminated intravascular coagulation, the 
use of an anticonvulsant treatment other than the magnesium sulfate, 
subcapsular liver hematoma and long assisted ventilation (>72  h). 
According to logistic regression model, we have identified as risk 
factors for maternal mortality in eclampsia: advanced maternal age 
(≥30 years), low GCS (≤8), ALAT >70 UI/l, cerebral hemorrhage, acute 
pulmonary edema, disseminated intravascular coagulation, subcapsu-
lar liver hematoma and long assisted ventilation (>72 h).
Conclusion Eclampsia is still a major cause of maternal morbidity and 
mortality worldwide. It incidence remains high, especially for devel-
oping countries in need of health care. Several studies are needed to 
determine all the risk factors and improve maternal prognosis.
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Introduction Severe sepsis and septic shock are a frequent life-
threatening cause of ICU admission of cirrhotic patients. Among the 
antibiotics frequently used in intensive care, the prescription of ami-
noglycosides to cirrhotic patients is controversial because of their 
nephrotoxicity. The aim of this study was to evaluate the use of amino-
glycosides administration among cirrhotic patients admitted in inten-
sive care unit for severe sepsis and septic shock and study their impact 
on mortality and renal function.
Patients and methods Cirrhotic patients with severe sepsis and septic 
shock were selected over a 18-year period (1997–2014) from a longi-
tudinal prospective French multicenter database. We investigated the 
factors associated with the prescription of aminoglycosides started 
between day 1 and day 3 of admission, and we studied the modalities 
of administration of aminoglycosides. Using a competing risk analysis, 
we evaluated the impact of aminoglycosides administration on the risk 
of renal replacement therapy or death at day 28. Among survivors who 
required dialysis or with a renal failure when leaving ICU, we retrospec-
tively collected renal status at day 90 after leaving intensive care.
Results Among the 332 cirrhotic patients admitted for severe sepsis or 
septic shock in ICU, 119 (35.8 %) received antibiotic therapy with amino-
glycosides. In multivariate analysis, factors associated with aminoglyco-
sides prescription were immunosuppression, SAPS II, and surgical cause 
for ICU admission. Administration of aminoglycosides was also sig-
nificantly different between centers. All patients received a once-daily 
administration of aminoglycosides for a 2-day median time (IQR 1–5). 
Using a cause-specific model for competing risk adjusted on risk factors 
for death and renal replacement therapy, administration of aminoglyco-
sides between days 1 and 3 was not associated with renal replacement 
therapy or death at day 28 (death: cause-specific hazard ratio CSHR 1.41, 
95 % CI 0.98–2.02, p = .06; renal replacement therapy: CSHR 1.44, 95 % 
CI 0.67–3.1, p = .35). Among 195 patients discharged alive from the ICU, 
49 patients had persistent kidney failure or needed renal replacement 
therapy during their ICU stay. Among these patients, 16 patients (33 %) 
died at day 90 and no patient required dialysis at day 90.
Conclusion The use of aminoglycosides in cirrhotic patients with 
severe sepsis and septic shock is frequent in intensive care units. Their 
administration with a daily dose is not associated with renal replace-
ment therapy or death in this study.
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Introduction The specific diagnostic and therapeutic yield of liver 
biopsy in patients hospitalized in intensive care unit (ICU) is unknown. 
The main goal of this study was to evaluate the contribution of liver 
biopsy to diagnosis and treatment in this population.
Patients and methods An 8-year (2006–2014) retrospective study was 
conducted in medical and surgical ICU of Caen University Hospital on 
patients without transplanted liver who underwent liver biopsy during 
their management. Medical files were retrieved for data analysis.
Results Forty-six patients underwent a liver biopsy mostly by tran-
sjugular route (94 %). The liver biopsies were performed for a suspicion 
of cirrhosis in 20  % of cases, for acute liver failure in 26  %, for a sus-
picion of severe acute alcoholic hepatitis in 22 % and for a suspicion 
of blood disease in 28  %. Biopsy-related intraperitoneal hemorrhage 
occurred in two (4 %) patients requiring an embolization in one case. 
Liver biopsy established a specific diagnosis in 38 (83  %) patients. 
Therapeutic modifications followed the results of the biopsy in 18 
(39 %) patients. ICU mortality was of 57 % and was not different in the 
group of patients with a specific diagnosis established by the biopsy 
and in the group of patients for which the biopsy was non-contribu-
tory (21 deaths/38 patients vs 5/7; p = 0.68).
Conclusion In this cohort highly selected by the treating physicians, 
liver biopsy helped to establish a specific diagnosis in the majority of 
the patients with a limited complications rate.
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Introduction Fulminant hepatitis or acute on chronic liver failure can 
result in multiple organ failure. In these settings, liver transplantation 
is the treatment required for recovery. However, such patients have a 
pejorative post-transplant prognosis when compared to patients who 
Page 44 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
undergo transplantation with stable chronic liver disease. This results 
in an unresolved ethical dilemma given the context of graft shortage. 
Moreover, published data or guidelines to cope with this dilemma are 
scarce. Our objective was to assess long-term post-transplant progno-
sis in patients admitted to intensive care unit (ICU) in relation to mul-
tiple organ failure and acute liver failure, and to search for possible 
pre-transplant predictive factors for post-transplant mortality.
Patients and methods We performed a retrospective monocentric 
study in 84 critically ill patients requiring liver transplantation accord-
ing to standard worldwide accepted criteria. These patients were 
admitted in our ICU from 2007 to 2014. We used χ2 or t test for uni-
variate analysis and Cox proportional hazards model for multivariate 
analysis to identify factors associated with mortality.
Results Pre-transplant median model for end-stage liver disease 
(MELD) score was 42 and mean SOFA (Sequential Organ Failure Assess-
ment) score 15/24, reflecting, respectively, liver dysfunction and 
overall severity. In addition, 20  % out of the patients demonstrated 
septicemia before transplantation (i.e., during ICU stay). Overall post-
transplant mortality rate was 33 % with a mean follow-up of 2.3 years. 
After 1  year, de novo acute liver failure patients had better survival 
rates than those from the French National Survey average, while the 
mortality rate of acute on chronic liver failure was 40  %. In addition, 
97 % of survivors were autonomous, yet 2 % required chronic dialysis.
Ten pre-transplant factors were significantly predictive of 90-day 
post-transplant mortality in univariate analysis, among which arte-
rial lactate, low platelet count, SOFA score, SAPS (Simplified Acute 
Physiology) II score and respiratory failure (PaO2/FiO2 ≤300  mmHg) 
for the overall cohort (p < 0.05). Severe pre-transplant respiratory fail-
ure (PaO2/FiO2 ≤200  mmHg) and a late initiation of invasive ventila-
tion (>24 h after admission to ICU) were strongly predictive of 90 days 
post-transplant mortality in multivariate analysis (hazard ratio 7.1, 
p < 0.04, and 7.2, p < 0.05, respectively). In contrast, the need for nor-
epinephrine infusion, renal replacement therapy or the occurrence of 
septicemia did not influence post-transplant mortality.
Discussion When excluding the seven deaths influenced by pre-trans-
plant acute respiratory failure, the overall remote mortality is decay-
ing to 25 %, which is close to post-transplant survival rates observed 
nationwide in liver transplantation for stable chronic liver disease. 
Moreover, in our cohort, long-term morbidity for survivors was low if 
compared to data from the literature.
Conclusion Our data suggest that liver transplantation can be safe 
and successful despite critical care criteria and poor underlying con-
ditions (i.e., a context of circulatory failure requiring infusion of high 
doses of norepinephrine, septicemia or renal replacement therapy). 
They also suggest that liver transplantation should cautiously be 
advised in the presence of preoperative acute lung injury criteria. In 
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Introduction There is no current recommendation for the use of albu-
min dialysis with the molecular adsorbent recirculating system (MARS) 
in patients with acute or chronic liver failure. We performed a retro-
spective survey in France in patients who were treated with MARS, 
2004–2008. The aim of the study was to assess the indications of MARS 
treatments, hospital survival, with or without liver transplantation 
(LTx), and also long-term follow-up, especially in patients with preex-
isting liver disease.
Patients and methods All the hospitals in which MARS technique was 
regularly performed were requested to participate to the study. All 
patients who had received MARS therapy in adult care setting over the 
5-year study period were eligible. A questionnaire was sent to inves-
tigators and should be completed for each treated patient. The study 
was approved by the National Research Consultative Committee and 
the Institutional Ethics Committee. Variables associated with outcome 
were identified by multivariate analysis using logistic regression.
Results Among 25 centers, 16 participated to the study. A total of 383 
patients received 393 MARS treatments (1091 sessions). Based on the 
examination of Mars treatment kits consumption records at all French 
hospitals during the study period, it could be estimated that the study 
accounted for 78  % of total MARS sessions in adult care setting in 
France.
The recorded indications for MARS (% of treatments) The indications 
were: major hyperbilirubinemia (37.1 %); hepatic encephalopathy (HE, 
23.6 %); any kidney dysfunction (22.9 %; either hepatorenal syndrome 
[HRS, 15.3  %] or other renal dysfunction [7.6  %]); refractory pruritus 
(9.9  %); acute liver failure (ALF, 32.6  %); early nonfunction after LTx 
(6.1 %); liver failure after liver resection (3.8 %); ≥2 indications (37.1 %).
Hospital survival rate according to the indication (%, 95 % CI) One hun-
dred and thirty-one patients were listed and 86 underwent LTx. Sur-
vival was assessed according to whether or not the patients were on 
the transplant list. (1) Not listed (66.3 %): ALF, 46 % (35‒57); hyperbili-
rubinemia, 22 % (15‒31); HE, 14 % (7‒24); HRS, 20 % (10‒34); refractory 
pruritus, 85 % (69‒95); nonfunction after LTx, 0 % (0‒21); liver failure 
after liver resection. 29 % (10‒53); ≥2 indications, 17 % (15‒25).
(2) Listed (33.7 %): ALF, 75 % (63–85); hyperbilirubinemia, 63 % (48–76); 
HE, 41  % (25–59); HRS, 44  % (23‒67); refractory pruritus, 100  % (79–
100); nonfunction after LTx, 82 % (55–96); ≥2 indications, 59 % (45‒73).
Hospital survival rate in patients with nonbiliary cirrhosis (n = 137) The 
overall rate was 38 % (30‒46) (listed for LTx: 56 % [40‒71]; not listed: 
32  % [23–41]). Variables associated with hospital death were HE (OR 
3.00 [1.25‒7.19], p  =  0.01), hyperbilirubinemia (OR 2.40 [1.08‒5.38], 
p  =  0.03) and the absence of listing for LTx (OR 3.18 [1.30‒7.76, 
p = 0.01).
Outcome in ALF patients Thirty-eight ALF patients (29.5  %) under-
went LTx during their hospital stay. Listing with the “Superurgence” 
priority was the single variable associated with hospital survival (OR 
3.79 [1.69‒8.48], p  =  0.001). Hospital survival without transplanta-
tion was associated with paracetamol etiology (OR 2.41 [1.04‒5.58], 
p = 0.04) and the number of sessions performed (OR 1.49 [1.11‒2.00], 
p = 0.009).
One-year Kaplan–Meier survival estimate according to preexisting liver 
disease (%, 95  % CI) The patients with preexisting liver disease were 
classified into five main diagnostic categories and were evaluated sep-
arately whether or not they underwent LTx. Fifteen patients were lost 
to follow-up.
(1) Without LTx: nonfunction after LTx, 9 % (−8 to 26); liver failure after 
liver resection. 0 %; late graft dysfunction, 5 % (−5 to 15); nonbiliary 
cirrhosis, 15 % (8‒22); biliary cirrhosis/sclerosing cholangitis, 67 % (29‒
greater than 100).
(2) With LTx: nonfunction after LTx, 88  % (65‒greater than 100); late 
graft dysfunction, 80 % (60‒100); nonbiliary cirrhosis, 91 % (80‒greater 
than 100); biliary cirrhosis/sclerosing cholangitis, 90  % (71‒greater 
than 100).
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Discussion ALF was the recorded indication of one-third of all MARS 
treatments and was associated with acceptable outcome even for 
nontransplanted patients. In patients with preexisting liver disease 
who were not candidates to LTx, the prognosis of nonbiliary cirrho-
sis was very poor, especially when HE or hyperbilirubinemia was the 
indication for MARS. Nonfunction after LTx was fatal in all cases with-
out reLTx. Regarding late graft dysfunction and liver failure after liver 
resection, MARS provided no survival benefit in the absence of LTx 
perspective.
Conclusion MARS therapy could be used in patients with ALF even in 
those for whom LTx is not considered. In patients with preexisting liver 
disease, MARS should be best restricted to those who are suitable for 
LTx. Prospective studies are required to reassess the benefit of MARS in 
listed patients awaiting a liver graft.
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Introduction Severe brain injuries are most often due to road traffic 
accidents and usually occur in young persons. Despite the progress 
made, their management remains dependent on the availability of 
resources. In this study, we tried to establish the profile of severe trau-
matic brain injury (TBI) in the teaching department of intensive care 
unit of the regional hospital of Zaghouan and compare it to the litera-
ture. Then, we tried to determine outcome factors.
Materials and methods We performed a retrospective study over 
04  years from 2011 to 2014. We enrolled all adult patients admitted 
to intensive care via emergency following a cranial trauma with GCS 
≤8 after normalization of hemodynamic status. We excluded from the 
results analysis patient records with insufficient clinical or para-clinical 
data.
Results During the study period, 132 patients admitted for TBI were 
collected representing 3  % of all admissions and 12  % of all head 
trauma hospitalized in the unit. The most common mechanism was 
the road traffic accident (78 % of cases). All transport was non-medi-
calized. So there was no intubation–ventilation at the site of trauma. 
The takeover delay was 78  min. The average age of patients was 
43 ± 16 years with extremes ranging from 19 to 83 years. The sex ratio 
was 4.3. The state of consciousness was evaluated by the GCS with an 
average of 5 ± 2. Sixty-six percent of patients had a pupillary anom-
aly, 19 % had a neurological deficit, and 81 % had associated lesions. 
The most frequent CT lesions were subarachnoid hemorrhage and 
cerebral contusions. All patients required intubation and mechanical 
ventilation with an average duration of hospitalization of 9 ± 2 days. 
The prognosis, assessed by the Glasgow Outcome Scale (GOS), was 
correlated with several factors. The takeover delay (p < 0.02), the GCS 
(p < 0.01), the presence of pupillary anomaly (p < 0.01), the presence of 
associated lesions (p = 0.01), the ISS score (p < 0.01) and the CT scan 
score (p  <  0.01) were considered as outcome indicators in univariate 
analysis. A Kaplan–Meier survival curve showed a correlation between 
the age, the takeover delay and the outcome of the patients. Correla-
tion with secondary systemic insults was not established in our study. 
Multivariate analysis showed a correlation between the Glasgow coma 
scale and mortality.
Conclusion The profile of TBI in ICU of Zaghouan is similar to data in 
recent literature. The prognostic factors identified in our study were: 
the mean delay of management, the GCS, the presence of pupillary 
anomalies, the presence of associated injuries, the ISS and the CT 
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Introduction The short-term prognosis of stroke in ICU remains very 
reserved. Therefore, the management of this disease remains con-
troversial. Few Tunisian studies have examined this subject, and no 
withhold and withdrawal treatment decisions were established in 
the severe cases. The purpose of this study is to explore predictors of 
stroke mortality in intensive care.
Patients and methods Sixty patients with stroke confirmed by CT 
scan (either intracerebral hematoma or ischemic stroke) were included 
in this study from patients admitted into the ICU (six beds) of the 
regional hospital of Bizerte between January 2010 and August 2015. 
The socio-demographic, anamnestic, clinical, biological and evaluative 
data were evaluated by univariate and multivariate analysis.
Results The median age was 60  years (interquartile range 54–66). 
Twenty (33.3  %) of the patients were women with a sex ratio equal 
to 2. The diagnosis of recurrent stroke was retained in 20 (33.3  %) 
patients. Sixty percent of patients had an ischemic stroke. IGS2 and 
APACHE 2 mean were, respectively, 41.57 ±  15 and 19.5 ±  6.7. One 
hundred percent of patients with GCS <6 died. The use of mechanical 
ventilation was required in 76.7  % of patients (38/60). The length of 
stay was 13.4 ± of 18 days. Mortality was 71.7 %.
In univariate analysis, factors associated with death were a high IGS2 
(p =  0.009) and APACHE 2 (p =  0.01), a low coma scale (p  <  10−3), a 
low PaO2/FiO2 ratio (p  =  0.003), mechanical ventilation (p  =  0.002) 
and septic shock appeared during evolution (p =  0.04). In multivari-
ate analysis, a low coma scale and the onset of septic shock during 
the evolution were the only factors associated independently with 
increased ICU mortality among patients admitted for stroke.
Discussion Withhold and withdrawal treatment decisions in severe 
stroke are related mainly to neurological status and advanced age 
(1). The absence of reversible complications and a deep coma (GCS 
<9) shall qualify the usefulness of the resuscitation (2). Also, the use 
of mechanical ventilation is associated with high mortality (3). In this 
study, advanced age and mechanical ventilation were not associ-
ated with a significant mortality. For against a Glasgow score of <6 
is associated with 100 % mortality. This could be a major criterion in 
therapeutic decisions limiting serious stroke and help Tunisian health 
authorities to improve the standards established in the management 
of severe stroke.
Conclusion The severity of the stroke at admission is related to the 
depth of the coma which depends on withhold and withdrawal treat-
ment decisions. However, prognosis mainly relies on the improve-
ment in the quality of stroke management and the prevention of its 
complications.
1 O84 Noradrenaline dose levels predict futility of liver transplantation in 
patients with paracetamol-overdose-related acute liver failure (ALF). http://
onlinelibrary.wiley.com/doi/10.1002/hep.28236/full.
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Introduction Encephalic death is one of the traumatic brain injury 
consequences. The goal of our study case-witnesses was to determine 
the predictive factors for them.
Patients and methods All patients hospitalized for traumatic brain 
injury are prospectively included between September 2008 and Sep-
tember 2013, and the only criterion of exclusion was the presence of a 
confusing factor. If they evolved to encephalic death, we paired them 
with deceased ones, but not of neurological cause.
Age, sex, Glasgow score, tomodensitometric classification (Marshall 
classification), medical transport and kidney injury (uremia) were 
collected.
We carried out an univariate then multivariate analysis to identify pre-
dictive factors for encephalic death post-traumatic.
Results A total of 95 cases and 95 witnesses were included in 
our study. All profited from a therapeutic without limitation of 
care. The average score at admission was 5.40  ±  2.29 at the cases 
and 6.96  ±  3.45 at the witnesses (p  =  0.01), middle age being of 
25.88 ± 15.08 years at the cases and of 38.71 ± 21.53 years at the wit-
nesses (p = 0.01).
Male sex (p  =  0.004; OR 3), transport >60 mn (p  =  0.02; OR 2), 
age < 50 years (p = 0.0001; OR 6), a class IV on the scannographic clas-
sification of Marshall (Traumatic Coma Data Bank) (p = 0.01; OR 5.47) 
and high uremia (p = 0.01; OR 0.01) were found as predictors of ence-
phalic death in univariate analysis.
In multivariate analysis, predictors were age lower than 50  years 
(p = 0.000; OR 8.9) and a unilateral mydriasis (p = 0.025; OR 4.026).
Discussion The aim of the study was to provide predictive clinical 
elements of passage to encephalic death. Two risk factors are come 
out from this analysis significantly, age factor (OR 8.9) and unilateral 
mydriasis (OR 4). These elements will make it possible to anticipate 
an unfavourable evolution and to adapt the therapeutic protocol 
consequently.
Conclusion These elements will make it possible to anticipate an 
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Introduction Several complications related to Guillain–Barré syn-
drome (GBS) can lead to admission in ICU. The objective of our study is 
to describe clinical and laboratory characteristics of patients with GBS 
in ICU and identify predictive factors for poor prognosis in this patients 
group.
Patients and methods Retrospective study included all patients 
over a period of 8  years with GBS confirmed by an electromyogram. 
Categorical variables were expressed as frequencies and percentage, 
whereas quantitative variables were expressed as media [quartiles]. 
Two groups were compared in univariate analysis: survivors and 
deceased. Multivariate analysis was performed to identify the inde-
pendent predictors of poor prognosis.
Results During the study period, 30 patients were admitted for GBS. 
The median age was 42.5 [26.3–59]. The sex ratio (M/W) was 0.6. 
The main indication to ICU admission was insufficient acute respira-
tory (86.7 %), shock (10 %) and impaired consciousness (13.3 %). The 
median SAPSII was 33.5 [29.5–39] points. The median SOFA score was 
3 [2–5] points. The median SAPSIII score was 52 [50.3–56.5] points. 
The motor deficit was present in all patients. An associated sensory 
loss was observed in 76.7 % of cases. An anomaly of the ocular mobil-
ity was observed in 6.7  % of cases. Autonomic disorders were found 
in only one patient (3.3  %). A albumin-cytological dissociation was 
observed in 76.7  % of cases. The electromyographic study identified 
axonal damage in 36.7  % of cases. The mechanical ventilation was 
reported in 18 patients (60 %) for a median duration of 19 [8–31] days. 
Noninvasive ventilation has been attempted unsuccessfully in two 
patients. A tracheotomy was performed in nine patients (50  % of 
ventilated patients). Plasmapheresis was performed in 21 patients 
(70 %), while the immunoglobulins were administered in six patients 
(20  %). The ICU stay was complicated by nosocomial pneumonia in 
13 patients (43.3 %) and pulmonary embolism in two patients (6.7 %). 
The duration median ICU stay was 11.5 [4.8–21.8] days. ICU mortality 
was 36.7 %. In multivariate analysis, only the occurrence of nosocomial 
pneumonia was associated with a poor prognosis (OR 44.6; 95  % CI 
[3.5–560]; p = 0.003).
Conclusion GBS is a serious disease involving life threatening. Mortal-
ity of severe forms seems to be conditioned by serious complications 
occurring during the ICU stay, especially pneumonia nosocomial.
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Introduction Eclampsia is a serious paroxysmal gravidic–puerperal 
accident complicates vascular and renal conditions of pregnancy. It is 
characterized by convulsive seizures that can be fatal to both mother 
and fetus [1]. The aim of our work is to study the epidemiological 
and clinical characteristics in obstetric patients admitted in ICU for 
eclampsia
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Patients and methods Our study is retrospective and includes all 
cases of eclampsia collected in the medical ICU of the University Hos-
pital of Sfax over a period of 20 years (1993–2012)
Results During our study period, 725 patients were hospitalized in 
the ICU. Among these patients, 194 presented eclampsia (26.7  %). 
Pregnancy has been followed medically in 79 women (40.6  %). The 
average age of patients was 28  ±  4.3  years. The average parity was 
1.7 ±  1.2 with a primiparity from 49.5  %. The mean gestational age 
was 34.8 ± 2.9 weeks. HELLP syndrome was noted in 30 cases (15.5 %), 
placental retro hematoma in 15 cases (7.87  %), acute renal failure in 
43 cases (22.3 %), disseminated intravascular coagulation in 27 cases 
(14 %), acute pulmonary edema in 17 cases (8.8 %) and state of shock 
in seven cases (3.6 %). The cesarean delivery was urgent in 161 cases 
(83  %). Mechanical ventilation more than 24  h was necessary in 79 
cases (40.7 %), and 43 patients (22.2 %) received a transfusion (packed 
red blood cells and/or fresh frozen plasma and/or platelet button). 
Hemodialysis was carried in two cases (1 %). Antihypertensive therapy 
was initiated in 171 patients, magnesium sulfate in 190 patients and 
anticonvulsant therapy in 187 patients. The average length of ICU stay 
was 2.7 ± 2.2 days. Mortality hit nine patients (4.6 %) and 25 fetuses 
(12.8 %).
Conclusion Eclampsia is a serious accident complicating gestational 
hypertension. It particularly affects the primipara. Obstetric medical 
management including emergency cesarean section and adequate 
reanimation reduces maternal and fetal mortality.
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Introduction Eclampsia is a severe complication of preeclampsia 
liable to an important maternal and fetal mortality, principally in 
developing countries [1]. The aim of our study was to describe neuro-
radiological lesions in preeclampsia/eclampsia in obstetric ICU of our 
hospital and to study clinical and therapeutic characteristics of this 
pathology as well as the outcome of our patients.
Patients and methods We conducted a retrospective descriptive 
study spread over 5  years, from January 1, 2010, to December 31, 
2014, including all patients with posterior reversible encephalopathy 
syndrome (PRES), hemorrhagic stroke and cerebral ischemia occur-
ring eclampsia or preeclampsia and hospitalized in obstetric ICU 
department.
Results Twenty-seven patients were included in the study. The mean 
age was 28.18 years. Only five patients had a well-attended pregnancy. 
The average systolic blood pressure was 158  mmHg, and the mean 
diastolic blood pressure was 96.29 mmHg. The mean Glasgow score at 
ICU admission was 11.18, and the observed neurological deficits were: 
hemiparesis (22 %), blindness (19 %), hemiplegia (7 %) and facial paral-
ysis (7  %). Complications were: HELLP syndrome (29.6  %), placental 
hematoma (25.9 %), acute renal failure (3.7 %) and pulmonary edema 
(3.7  %). All patients had conventional neuroradiological exploration 
showing damage in all cases. CT showed two cases of ischemia (7.4 %), 
seven cases of cerebral edema (six cases of PRES: 22.2 %; one case of 
diffuse edema: 3.7 %) and three cases of hemorrhagic stroke (11.11 %). 
MRI diffusion sequence approved in 15 patients has showed a PRES in 
ten cases (37.03 %), cerebral ischemia in two cases (7.4 %), one case of 
hemorrhagic stroke and two cases of diffuse edema. The main mode of 
delivery was cesarean section under general anesthesia for 22 patients 
(81.48  %). All patients had received antihypertensive treatment and 
anticonvulsant treatment. The outcome was critical in one patient how 
died from a septic shock. Perinatal mortality was about 25.9 %.
Conclusion From this study, improving maternal and fetal prognosis 
requires:
  • Prevention, with early and regular monitoring of pregnant women;
  • An appropriate treatment of pregnancy hypertension;
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Introduction Delayed brain ischemia as a result of cerebral vasospasm 
is the most common cause of death and disability after aneurysmal sub-
arachnoid hemorrhage (SAH). Because clinical signs cannot be detected 
for sedated patients, monitoring tools have been developed. As an 
example, transcranial Doppler is an easily bedside method to detect 
middle cerebral artery vasospasm [1], but fails in the detection of others 
intracranial vessels spasm. Tissue brain oxygen tension measurement 
(PbrO2) has been described as a useful monitoring tool to detect tissue 
hypoxia before irreversible neuronal damage in trauma brain-injured 
patients [2]. The goal of the study was to determinate the accuracy of 
PbrO2 to detect cerebral vasospasm after severe aneurysmal SAH.
Patients and methods We performed a retrospective observational 
study on ten patients admitted in our institution from January 2014 
to September 2015 for SAH and monitored with PbrO2 (Lycox). PbrO2 
data were recorded retrospectively. Cerebral vasospasm was assessed 
with angiography and treated with in  situ vasodilators. PbrO2 before 
and after cerebral spasm angioplasty was defined “with” and “without” 
cerebral spasm values of PbrO2. Continuous variable PbrO2 was pre-
sented mean (SE) and compared with paired t test.
Fig. 20 See text for description
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Results Ten comatose SAH patients (WNFS IV) were included, and 48 
angiographies were performed for cerebral vasospasm. PbrO2 probe 
was inserted in all patients 7 (3–14) days after SAH without any com-
plication. The mean duration of PbrO2 monitoring was 8 (4–16) days. 
Two vasospasm episodes were excluded because PbrO2 probe was 
located in the opposite side of the vasospasm area. In four cases of 
vasospasm, the angioplasty failed and it was impossible to obtain the 
“without spasm” value of PbrO2.
In cerebral vasospasm, mean value of PbrO2 was 19(9)  mmHg 
but with a large spread of values. After angiographic treatment 
of vasospasm, mean value of PbrO2 was significantly higher and 
reached 27(9) mmHg (p  <  0.0001) (Fig.  20). Despite a wide over-
lap between the two groups of PbrO2 values, we could observe 
that a PbrO2 value lower than a threshold value of 22 mmHg pre-
dicted vasospasm with both sensibility and specificity of 75 %, and 
when PbrO2 value was under 11 mmHg, all patients had a cerebral 
vasospasm.
Conclusion Continuous monitoring of PbrO2 could have an interest to 
predict the cerebral vasospasm and to avoid delayed brain ischemia in 
comatose patients after aneurismal subarachnoid hemorrhage.
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Introduction Myasthenic crisis is defined by acquired myasthenic 
gravis severe enough to require intubation. The actual recommenda-
tions are to intubate patients who have a vital capacity <15 mL/kg, or 
30 % (1) while waiting for treatment by intravenous immunoglobulins 
to be effective.
The use of noninvasive ventilation (NIV) to prevent intubation was 
described in only two retrospective studies (2, 3). NIV was success-
ful for 20–25  % of patients showing myasthenic crisis. We wanted to 
describe our experience of NIV in myasthenic crisis.
Patients and methods This is an observational prospective study 
from 01.11.2013 to 01.03.2015. Patients included were assisted with 
NIV when they showed a single myasthenic crisis, an Osserman score 
<70 and a vital capacity (VC) <50 %. Durations of NIV were adapted to 
the patient’s comfort.
The NIV failure was: inhalation, intubation, hypoxemia, major asthenia.
Every day, the demographics and treatment modalities, pulmonary 
complications, intubation outcomes, duration of NIV and duration of 
stay in intensive care were recorded.
Results Eight patients were included. The median age was 53 (16–
81)  years. At the admission in intensive care unit, the median Osser-
man’s score was 50 (23–68) and VC 38 % (22–43 %). Median duration 
of NIV was 4  days (2–10), and median ICU length of stay was 7  days 
(4–13). Nobody was intubated. Five patients with deglutition troubles 
did not show pulmonary complications.
Conclusion In this group, NIV was always successful. Systematic use of 
NIV seems to prevent muscular asthenia caused by gravis myasthenic 
crisis and avoids patient’s respiratory worsening. NIV in intensive care 
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Introduction After a serious traumatic brain injury (TBI), the occur-
rence of intracranial hypertension (intracranial hypertension) is associ-
ated with an increased risk of morbidity and mortality. The appearance 
of intracranial hypertension at an early stage worsens the prognosis, 
and thus, through the clinic, brain CT, monitoring intracranial pressure 
and evaluation of cerebral circulation by transcranial Doppler ultra-
sound treatment can be given quickly. The objective of the study was 
to compare the advantage brought by one or other of the means used 
for the diagnosis and monitoring of intracranial hypertension.
Patients and methods The work was exhibited/performed at the ICU 
of the UMC CHUOran.
This is a prospective study over 2 years (2012 and 2013) of 59 patients 
who received simultaneously a monitoring intracranial pressure (ICP) 
and a transcranial Doppler monitoring by the TCDU. Simultaneous 
recording of intracranial pressure, cerebral perfusion pressure, the pul-
satility index, systolic and diastolic velocity has been achieved.
Results The number of STBI compiled was 59. The study popula-
tion was young, the median age was 29 years, and 80 % were trauma 
patients. No pupillary changes are observed for higher numbers of 
ICP >45  mmHg. There is a linear relationship between the ICP and 
the pulsatility index since the correlation coefficient was 0.43 and 
p = 0.019965 and between the CFC and the pulsatility index since the 
correlation coefficient: r2  =  0.60 and p  =  0.000613. The literature is 
contradictory on this issue.
Discussion A study was conducted in 1994 by Boishardy and collabo-
rators in France, out of a total of ten serious head trauma whose age 
was between 17 and 37 years and that benefited dice admission and 
then twice a day, of a simultaneous measurement SV, DV, PI and ICP by 
means of an intraparenchymal catheter to show a significant correla-
tion between mean ICP and PI r = 0.837 and between the PI and CPP 
(r = 0.563; p < 0.001) [1].
By against the US study conducted by Thomas in California on a group 
of 99 severe TBI patients showed that the correlation between ICP and 
PI was classified as moderate to zero [2].
Conclusion All severe TBI monitoring means have their place, with 
superior non-invasive tests on simple clinical surveillance, and indicate 
the need for the installation of the monitoring of the ICP in due time, 
since many patients can develop at any time during their stay an ICHT.
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Introduction Veno-venous ECMO (VV-ECMO) is a rescue therapy in 
refractory ARDS. Despite technological progress and enhanced bio-
compatibility, anticoagulation with unfractionated heparin remains 
the most often used as recommended. Bleeding complications remain 
a main cause of increasing morbidity and mortality in patient treated 
with VV-ECMO. The aim of our study was to study the effectiveness 
of the dosage of unfractionated heparin (aPTT, anti-Xa activity) in 
patients on VV-ECMO for ARDS
Patients and methods We performed a retrospective observational 
study stretching from 2008 to the first quarter 2015. Patient’s base-
line characteristics, the dose of UFH anticoagulation and biological 
data of anticoagulation (aPTT, anti-Xa activity, Hemochron ACT, ATIII, 
fibrinogen) were collected. We studied the incidence of hemorrhagic 
or thromboembolic events under UFH anticoagulation.
Results Forty-eight patients with ARDS requiring VV-ECMO 
were included, with a majority of men [35 (63.6  %) vs 20 (36.4  %) 
(p  <  0.5)]. The mean age was 47  years (±15  years). In 35.4  % of 
cases, a double cannula Avalon common type used (mean diameter 
of 27 GB), while the others had a femoro-jugular cannulation with 
an average diameter of femoral vein of 25  GB. UFH anticoagulant 
was used in most patients. During installation of VV-ECMO, 33  % 
of patients did not have unfractionated heparin (UFH). The aver-
age value of aPTT was 35 ±  8  s and the anti-Xa was 0.14 ±  0.06. 
The average of the Hemochron was 171 ± 23 s. The values of UFH 
administered averaged 778  ±  601  IU/h IVSE. Bleeding complica-
tions were noted in 56.25  % of cases. None of our patients had 
ECMO thrombosis cannulas or oxygenator. Thirty-nine percent of 
patients had positive anti-PF4, and only 11 patients had a change 
in anticoagulation.
Conclusion Anticoagulation used in our study appears lower than rec-
ommendations without increasing thromboembolic complications, 
with persistence of a high rate of bleeding complications with or with-
out a direct connection with ECMO. These results would reinforce the 
possibility of using ECMO with less or no anticoagulant?
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Introduction The way to organize veno-venous circulatory assistance 
in France is still a matter of debate. Particularly, data on the efficiency 
and safety of mobile ECMO teams are still scarce. The aim of this study 
was to evaluate the safety of the mobile ECMO team in our center.
Patients and methods In this retrospective monocenter study, the 
outcome of patients implanted with a veno-venous ECMO by the 
mobile ECMO team of la Pitié-Salpêtrière hospital from 2009 to 2012 
was compared with patients who were implanted on site. Results are 
expressed as median (25th–75th IQR) or n (%).
Results A total of 118 patients were implanted by the mobile ECMO 
team and 39 on site. Both groups were quite comparable and con-
sisted in very severe patients, reflected by a high SAPS-II score of 71 
(61–81) and a PaO2/FiO2 of 58 (50–73). Major complications at ECMO 
implantations were identical between both groups [3 (2.5  %) in the 
mobile ECMO group vs. 2 (5.1 %) in the onsite group, p = 0.6]. All trans-
portations were performed by the SAMU with ground facilities, in the 
presence of a specialized perfusionist. Median time between call and 
ECMO implantation was 192 min (154–225). Distances ranged from 0.5 
to 241 km (median 15 (6–25)), for a median time of 35 min (25–35). No 
major incident was observed during transportation, except 1 (0.8  %) 
patient who died from hemodynamic deterioration. Eight (6.8  %) 
patients in the mobile group needed a subsequent switch to veno-
arterial ECMO due to hemodynamic deterioration, compared with two 
(5.1  %) in the onsite group (p =  0.7). ICU mortality was comparable, 
46.6 % in the mobile group versus 53.8 % in the onsite group, p = 0.5. 
In multivariable analysis, implantation by the mobile ECMO team was 
not associated with ICU mortality (OR 1.1 [0.4–1.7], p = 0.85). Severe 
ECMO-related complications were frequent but comparable between 
groups [63 (53.4 %) in the mobile group vs. 21 (53.8 %) in the onsite 
group, p  =  1.0]. Particularly, the rate of subsequent recannulation, 
bleedings or infection at the insertion site and bacteremia did not dif-
fer between groups.
Conclusion Implantation of a veno-venous ECMO by a mobile ECMO 
team and subsequent transportation of the patient to an experienced 
ECMO center appears to be feasible and safe.
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Introduction Extracorporeal membrane oxygenation (ECMO) is pro-
posed for patients with severe acute respiratory distress syndrome 
(ARDS), which may be defined as not being effectively and/or safely 
treated by current clinical types of mechanical ventilation. Once on 
ECMO, it is immediately possible to limit stress and strain with a vol-
ume- and pressure-limited protective ventilation strategy. This study 
focuses on the mechanical ventilation during the first 24  h of ARDS 
patients transferred with an ECMO mobile team (UMAC) to the referral 
center of Aquitaine region.
Patients and methods All data were prospectively recorded, 1  h 
before ECMO (H-1), at ECMO start before transportation (Humac), 
at 1  h (H1) and 24  h (H24) in the referral center. Patients were trans-
ported by road with SAMU 33 using a Cardiohelp (Maquet, Sweden) 
and a ventilator Elisé 350 (ResMed, Australia). During the first 24  h 
under ECMO, patients were paralyzed and ventilated with a pressure-
controlled mode targeting a plateau pressure of 24 cmH2O, a respira-
tory frequency of 12 and a PEEP of 10 cmH2O. Results are expressed as 
median (interquartile range 25–75 %)
Results We analyzed 15 ARDS patients, between 2013 and 2014, requir-
ing veno-venous ECMO. Median age was 35 (30–55) years; IGS2 was 50 
(43–59). At H-1, PaO2/FiO2 was 49 (42–54), and thoracopulmonary com-
pliance (Ctp) was 16 (13–25) ml/cmH2O. Between H-1 and Humac, pro-
tective ventilation decreased driving pressure and VT from 25 (16–27) 
to 12 (12–15) cmH2O and 6.4 (5.6–7.1) to 3.8 (2.5–5.8) ml  kg−1 PBW, 
respectively, p < 0.0001, whereas PEEP did not change 8 (8–12) versus 
12 (10–12)  cmH2O, p =  0.12. At Humac, Ctp was unchanged with 15 
(10–27) ml/cmH2O. At H24, VT and Ctp were significantly lower than 
Humac 2.6 (1.5–3.2) ml  kg−1 PBW p =  0.01 and 11 (8–14) ml/cmH2O 
p =  0.03, respectively. At H1, eight patients (53  %) had a decrease of 
VT >15 % during transportation, median reduction was −44(19–73) %, 
and VT was 1.5 (1.3–3.7) ml kg−1 PBW. No patient responds to alveolar 
recruitment procedures at H24. Duration of ECMO was 14 (7–24) days, 
and three patients died in the referral center (20 %) (Fig. 22).
Discussion ECMO allowed immediate reduction in driving pressure 
with a stable Ctp. We found a significant reduction in VT and Ctp during 
the first 24 h and for some patients during transportation. This might be 
explained by the worsening of ARDS, by alveolar derecruitment due to a 
pressure-controlled mode (1), by the use of a transport ventilator under 
extremely low Ctp and curare, by the disconnections of the patient from 
the ventilators at each steps of transportation or by the airway suctions.
Conclusion Limiting driving pressure of severe ARDS under ECMO is 
of high clinical interest. By nature, pressure-controlled ventilation per-
mits to achieve this goal, but it may also promote derecruitment and 
affect compliance, especially during patient’s transportation.
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Introduction Extracorporeal dioxide carbon removal (ECCO2R) is an 
extracorporeal decarboxylation technology described in 1978. Physi-
ological studies showed that 50 % of produced CO2 were eliminated. 
Potential indications are: ultra-protective mechanical ventilation for 
acute respiratory distress syndrome (ARDS) and hypercapnic patients 
at risk of non-invasive ventilation failure. Because of the lack of scien-
tific evidence, ECCO2R is not available in the USA. We sought to assess 
the use of ECCO2R in France.
Materials and methods This retrospective, observational study was 
performed in French intensive care units (ICUs) from January 2010 
to January 2015. A phone interview was conducted with French ICUs 
affiliated to national societies and public and private hospitals regis-
tries. Data recorded were the following: use and indications of ECCO2R, 
type of ECCO2R, number of patients treated during the study period, 
complications associated with the technique, satisfaction rates (in 
terms of efficacy, tolerance and global) based on a scale [0 (total unsat-
isfaction)–10 (total satisfaction)], and concomitant use of extracorpor-
eal membrane oxygenation (ECMO) in the unit.
Results A total of 239 French ICUs were contacted (147 mixed, 55 med-
ical, 25 surgical, four cardio-thoracic, six paediatric and two neurosur-
gical ICU). Only three refused to participate. Thirty-five (15 %) ICUs had 
used ECCO2R at least once in the past 5 years, in 303 patients. The most 
frequently used devices were: iLA® (Novalung) (63 %) and Hemolung® 
(Alung) (37 %). The median number of patients treated per ICU was 3 
[1–8]. The most frequent indication was ultra-protective ventilation for 
ADRS (54 %). Other indications were: failure of non-invasive ventilation 
during chronic obstructive pulmonary disease exacerbation (30  %), 
weaning from invasive mechanical ventilation in chronic obstructive 
pulmonary disease patients (12 %) and miscellaneous (4 %).
Among ICUs using ECCO2R, 22 (63  %) reported at least one compli-
cation. The most frequent complications were bleeding (45  %) and 
membrane failure (18  %). Satisfaction rates were: in terms of decar-
boxylation 7.9  ±  2.4; tolerance 6.9  ±  2.6; and overall satisfaction 
6.8 ±  2.2. Twenty-one (63  %) of the 35 ICUs using ECCO2R also used 
ECMO. The main reasons for not using ECCO2R were the lack of trained 
staff, unavailability of the device and the lack of scientific evidence 
(for, respectively, 53, 39 and 17 % of responders). Among 204 ICUs not 
using ECCO2R, 20 (10 %) had the project to start ECCO2R in the coming 
months.
Conclusion These results show that ECCO2R is not widely used in 
French ICUs. The lack of strong scientific data on outcome is probably 
the main reason behind the limited use of ECCO2R. French studies cur-
rently in progress will help define indications of ECCO2R and impact on 
outcome.
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Introduction Veno-venous extra-corporeal membrane oxygenation 
(vvECMO) allows blood oxygenation and CO2 removal for the most 
severe case of acute respiratory distress syndrome (ARDS). One of 
the major complications associated with this technique is the occur-
rence of microthrombi on the ECMO membrane oxygenator which can 
require the change in circuit. The microparticles (MPs) are proinflam-
matory and procoagulant nanovesicles derived from circulating cells, 
and their circulating levels may be elevated in many pathologies asso-
ciated with inflammatory, thrombotic and infectious disorders. The 
main objective of our study is to quantify the presence and to char-
acterize the cellular origin of MPs in patients treated by vvECMO for 
severe ARDS. Secondary objectives are to analyze the kinetic of MPs 
rates between ECMO application and removal and to establish a link 
between the need for a circuit change and MPs evolution.
Materials and methods This is a monocentric pilot study, conducted 
between January 2012 and June 2014, which included patients with 
severe ARDS treated with vvECMO. We measured total MPs, platelet-, 
erythrocyte-, endothelial- and leukocyte-derived MPs, coagulation 
and hemolysis parameters within 6 h after the ECMO application. The 
same parameters were measured at the time of the circuit removal 
(either during weaning or during a circuit change for biological com-
plication or because of death).
Results Nineteen patients were included in the study analysis. Leuko-
cyte-derived (p < 0.0001) and erythrocyte-derived (p = 0.04) MPs were 
higher at the admission in patients who died under ECMO compared 
with those who have been weaned alive. Leukocyte-derived (p = 0.01) 
and endothelial-derived (p = 0.001) MPs were higher in patients who 
needed a circuit change.
Discussion There are subpopulations of MPs associated with the prog-
nosis of patients with severe ARDS treated with veno-venous ECMO.
Conclusion This pilot study suggests a potential role of these bio-
markers as diagnostic or prognostic factor in the occurrence of compli-
cations related to the technique.
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Introduction The mechanical ventilation of some patients with ARDS 
could be facilitated by ECCO2R allowing the reduction in blood acido-
sis and the reduction in tidal volume for the application of the protec-
tive ventilation. Prone position (PP) could be used for some patients 
with PaO2/FiO2 <150. We do not know whether we could associate PP 
and ECCO2R in ARDS patients
The aim of this study is to describe the feasibility of PP under ECCO2R, 
the stability of the parameters of the device and whether we have side 
effects of the PP under ECCO2R.
Materials and methods In our intensive care unit of 15 beds with a 
large experience of PP, we have retrospectively included all sessions of 
PP (at least 16 h of PP) performed on patients under ECCO2R therapy 
between August 2014 and March 2015. We used ILA ACTIVVE® device 
(NOVALUNG®) with MINILUNG® membrane and a double-line femoral 
catheter (NOVAPORT TWIN® 24F). The gas flow was 10 l/min. For each 
session, we compared PaO2/FiO2 and the PaCO2 before and after 1H 
of PP. The device records the flow and pressure parameters every 10 s, 
and we recovered these parameters after each prone position session. 
For each session, we did the mean of blood flow and drainage pres-
sure (P1) during a length of 1 h: during the last hour before PP, the first 
hour after PP and the last hour before stopping PP. We compared with 
a Freidman’s test, the mean and the coefficient of variation of each 
parameter to evaluate the stability of the device. We noted all the side 
effects of the PP (bleeding, decannulation, etc.).
Results We performed nine PP sessions on five patients, one in three 
patients and three in two patients. The PaO2/FiO2 ratio was higher dur-
ing PP [136 (78–250)] than before PP [126 (58–145)] (p < 0.05). There 
is no difference of PaCO2 before PP [55  mmHg (34–80)] than during 
PP [54 (34–70)]. Between before, the beginning and the end of PP, we 
did not find difference in blood flow, respectively, 1472 ml/min (1201–
1971), 1403 ml/min (1216–1850) and 1447 ml/min (1231–2012), and in 
P1, respectively, −37 mmHg (−46 to −25), −41 mmHg (−50 to −28) 
and −41 mmHg (−47 to −29). The coefficient of variation of the blood 
flow was low, and we did not find variations of it between these three 
moments, respectively 0.9 % (0.7–2.8), 0.7 % (0.4–2.1) and 0.6 % (0.4–
1.6). The coefficient of variation of P1 was low, and it was lower at PP 
than before PP (p < 0.05), respectively: 8.2 % (3.7–9.9), 5.6 % (2.8–6.8) 
and 4.2 % (2.9–5.8). We did not find side effects of the PP maneuver. 
There were no decannulation, bleeding and skin lesion on the tubing 
paths.
Conclusion Prone position under ECCO2R with a femoral catheter is 
possible. We found no side effects of this technique. No differences 
in the blood flow, in the drainage pressure and in the stability of the 
blood flow were found. The stability of the drainage pressure is better 
in PP. The PaO2/FiO2 ratio is better in PP.
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Introduction The utility and feasibility of ECCO2R in an intensive care 
unit (ICU) which does not use ECMO has not been described. In our 
general ICU of 15 beds, we do not use ECMO, and we decided to intro-
duce ECCO2R in COPD and ARDS patients.
The purpose is to describe the feasibility of this technique in our ICU 
and the actual uses of it.
Materials and methods We chose ILA ACTIVVE® device (NOVALUNG®) 
with MINILUNG® membrane and a double-line femoral catheter 
(NOVAPORT TWIN 24F). A training for each member of the team was 
conducted (physicians and nurses), and we wrote a detailed procedure 
between February 2014 and July 2014. We wrote a procedure for: the 
preparation of the device, laying the catheter, monitoring, removal of 
the catheter and the machine, any malfunctions, etc.). Between august 
2014 and February 2015, data were collected for each patient receiv-
ing ECCO2R. Indication, mortality at J28, duration of ECCO2R, compli-
cations and success of the technique were evaluated.
Results During this period, ten of the 348 patients admitted to our ICU 
have received ECCO2R therapy. We included five patients with ARDS 
(we laid the device because tidal volume (Vt) was 6 ml/kg PBW with a 
PaO2/FiO2 ratio between 80 and 150, after at least one prone position 
session, and with a plateau pressure between 25 and 30 cm of water 
and high level of PaCO2). We included three COPD patients in failure 
of non-invasive ventilation (NIV) in a hypercapnic coma, one asthmatic 
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patient in severe respiratory acidosis under invasive ventilation (IV) 
and one severe COPD patient unweaning of the IV. Patients with ARDS 
normalized arterial pH, and we decreased Vt (3–4  ml/kg) and res-
piratory rate. Three of them are alive at J28 and had received 5, 7 and 
14 days of ECCO2R, and two of them died under ECCO2R after 16 and 
9 days of ECCO2R. The reason of the death was nosocomial lung infec-
tion. None of the COPD patients with hypercapnic coma were intu-
bated, and they received 5, 3 and 6 days of ECCO2R and were alive at 
J28. The asthmatic patient received 7 days of ECCO2R, was extubated 
under ECCO2R and was alive at J28. The unweaning COPD patient was 
extubated two times and reintubated two times due to severe neu-
ropathy and tracheal inhalation. He was tracheotomized and weaned 
from the ECCO2R after 19  days, and he was alive at J28, but died at 
J76. There was no bleeding leading by catheter but one hemothorax 
requiring a blood transfusion during an overdose of heparin
Conclusion The ECCO2R in a general ICU could have multiple indica-
tions in COPD and ARDS patients. These indications remain to be vali-
dated, but ECCO2R could improve the management of those patients. 
The implementation of ECCO2R is possible but requires a great invest-
ment, a training of the medical and the paramedical team and a writ-
ten detailed procedure. Nevertheless, the installation of the device for 
each patient must for now be discussed in a team taking into account 
the risk–benefit ratio of each procedure.
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Introduction High-frequency oscillatory ventilation (HFOV) is usually 
considered as an alternative continuous technique to conventional 
mechanical ventilation (CMV) with the aim of improving the oxygen-
ation. Our goal was to use HFOV not as a surrogate to CMV but as a 
recruitment process during only 6  h a day alternating with the CMV 
and to test whether this new sequential HFOV use could increase the 
end-expiratory lung volume (EELV) and the respiratory system compli-
ance (used as recruitment markers) and thus improve the oxygenation.
Patients and methods Interventional prospective study, in single-
center ICU, was performed in patients with moderate-to-severe ARDS 
(PaO2/FiO2 ratio <150 after a 6-h period of optimized CMV for maximal 
alveolar recruitment). Patients were placed under HFO sequentially 
(6 h a day) up to 4 days in a row, as long as PaO2/FiO2 ratio was <200. 
The primary endpoint was the before/after HFO session EELV differ-
ence measured by the nitrogen wash-in/wash-out technique. Second-
ary endpoints were the before/after HFO session PaO2/FiO2 ratio and 
respiratory system compliance differences.
Results Twenty-two patients (mean IGS 55  ±  14) were enrolled 
between November 2012 and May 2015 for a total of 29 sessions. Three 
of these (10  %) were stopped (two for hemodynamic failure and one 
for respiratory failure). After the 6-h HFOV session, the EELV increased 
significantly by more than 30 %, while the PaO2/FiO2 ratio and the res-
piratory system compliance increased significantly by more than 90 % 
and more than 20 %, respectively. By considering as responder to the 
HFOV session a patient with an EELV increase of more than 15 % after 
the HFOV, we obtained 19 responders (66 %) for 10 non-responders. By 
considering as responder to the HFOV session a patient with an EELV 
increase of more than 15 % and a PaO2/FiO2 ratio increase of more than 
30  % after the HFOV, we obtained 16 responders (55  %) for 13 non-
responders. No significant change in hemodynamic parameters was 
found, except the significant 10 ± 6 % cardiac index decrease after 1 h 
of HFOV for the 15 sessions monitored by transpulmonary thermodilu-
tion. No pneumothorax occurred during the protocol.
Conclusion In ARDS patients with a PaO2/FiO2 ratio <150, an early 6-h 
HFOV session provides a significant improvement in oxygenation and 
ventilatory mechanics by alveolar recruitment. HFOV could be used 
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Introduction In the lack of guidelines, prescription of laboratory tests 
in ICU sometimes seems to pertain to individual or team habits. We 
aimed to assess the impact of clinical guidelines to improve the vol-
ume of laboratory tests performed.
Materials and methods It was a monocentric, comparative study, 
before and after guidelines implementation at patient bedside, in a 
surgical ICU of a French university hospital. All consecutive patients 
present between May 1 and October 31, 2013, and between May 1, 
and October 31, 2014, were enrolled. The prescription help-guide was 
displayed in each patient room from May 2, 2014. Physicians were 
encouraged to rely on this help-guide for laboratory tests prescription, 
once patients stabilized. The primary outcome measure was the varia-
tion of routine laboratory tests per patient ICU day, before compared 
with after guidelines. Secondary outcomes were the number of ICU 
days, the mortality, the variation of blood transfusion, the variation of 
nosocomial infections potentially related to blood samplings and the 
economic impact after guidelines implementation. We also assessed 
the variation of laboratory tests per patient ICU day, during the same 
periods, in the medical ICU of the university hospital, without any 
guidelines.
Results A total of 274 patients were admitted, staying for 3167 ICU 
days during Period-1, and 342 patients were admitted, for 2799 ICU 
days during Period-2. The patients’ general characteristics were simi-
lar, except for the ICU days significantly shorter for Period-2. A 27.21 % 
relative reduction in routine laboratory tests per patient ICU day was 
observed after guidelines implementation. A 27.45  % relative reduc-
tion in blood transfusion was also observed, without difference nei-
ther on mortality in ICU, nor on nosocomial infections potentially 
related to blood samplings. The mean decrease per laboratory test 
was significantly more important in the surgical ICU than in the medi-
cal ICU (27.21 vs. 15.13 %, p = 0.00837). There were a 124,000 € overall 
cost reduction on 6 months related to the guidelines implementation, 
and a transfusion economy of 53,000 €.
Conclusion This help-guide induced an important decrease in the 
volume of routine laboratory tests performed. We also demonstrated 
a major reduction in blood transfusion, without difference either on 
mortality, or on nosocomial infections potentially related to blood 
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Introduction The aim of this study was to evaluate the long-term 
effects of the implementation of “good laboratory test practices” pro-
cedure on blood test prescription, cost cutting laboratory test and 
patient outcome and red cells transfusion needs. In addition, we 
looked for factors associated with transfusion.
Patients and methods This is a retrospective, single-center study.
Considering that prescription of laboratory tests was excessive in 
our ICU, we developed in 2009 a procedure aiming at limiting assays 
and blood sampling. All adult patients over 18 years admitted in the 
ICU from January 1, 2008, to December 31, 2012, were consecutively 
included. For each patient, the following data were retrospectively 
obtained from medical records and institutional databases: demo-
graphic and severity of illness parameters, the amount and costs of 
laboratory tests, daily blood volume drawn, number of red cells trans-
fusions and ICU and in-hospital outcomes.
Results A total of 3568 patients were included between January 1, 
2008, and December 31, 2012. Patient’s characteristics were similar 
during the study with respect to overall severity and vital organ sup-
port, except the need for vasoactive drugs which increased across 
time. After implementation of guidelines, the total number of labora-
tory tests decreased from 78,406 in 2008 (18.1  tests/patient/day) to 
27,514 in 2012 (6.4  tests/patient/day). 318,000€ were saved in 2012 
on the five more expensive tests as compared to 2008. Average daily 
blood drawn volume decreased from 29.2  ±  13  ml/day in 2008 to 
22.4 ±  10.1  ml/day (p  <  0.001) in 2012 in the whole population. The 
decline was larger for transfused patients (33.8 ± 15.6 ml/day in 2008 
to 23.6 ±  10.7  ml/day in 2012 p  <  0.001). We observed a nonsignifi-
cant reduction in PRBC administered after the institution of guidelines. 
Hemoglobin threshold for blood transfusion remained unchanged 
over time. There was a significant relationship between daily blood 
volume loss and blood transfusion [OR 1.012 per ml volume drawn CI 
(1.009–1.014), p  <  0.001], but mechanical ventilation, renal replace-
ment, invasive monitoring and use of vasoactive drugs were more 
potent independent factors for transfusion. ICU and in-hospital mor-
tality did not change across time (p = 0.367 and p = 0.361)
Conclusion Guidelines of laboratory tests prescription led to a sus-
tained reduction in the number of laboratory tests and related costs, 
the average daily blood volume drawn, without changing the ICU and 
in-hospital mortality. Although there was a correlation between the 
amount of blood sampled and the transfusion of PRBC, the number of 
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Introduction ICU caregivers can achieve useless precautions to limit 
stress and feeling of uncertainty about their patients.
We tried to identify and eradicate some behaviors of useless precau-
tion inducing supplementary use of medical devices of drugs in our 
ICU. We made the hypothesis that suppressing these practices could 
reduce the variable costs of our 12-bed unit.
Patients and methods In a first step, two senior intensivists analyzed 
the expenditures of drugs and medical devices during 1 year to iden-
tify excessive consumptions related to useless precautions. Strategies 
were set on to reduce these behaviors. In a second step, the impact of 
these measures was analyzed 1 year after their implementation.
Results Three behaviors of useless precaution were identified: (1) the 
daily systematic preparation of two sets of intubation drugs (succi-
nylcholine, ketamine, atropine, and epinephrine), (2) routine bed-side 
hematocrit measurement in non-bleeding patients and (3) use of car-
bapenem for community-acquired infections.
Corrective measures included: (1) intubation drugs were routinely 
gathered but were prepared only if an intubation was decided by the 
attending physician, (2) bed-side hematocrit was performed only after 
medical prescription and physicians were encouraged to limit its use 
to bleeding patients, and (3) recommendations encouraging use of 
ceftriaxone instead of ertapenem for community-acquired pneumonia 
and intra-abdominal infections were implemented in the unit.
One-year consumption of the drugs and devices related to these 
measures decreased dramatically after the intervention: 245 doses of 
succinylcholine versus 860 (1896€ vs 6656€), 448 doses of ketamine 
versus 925 (821€ vs 2081€), 750 doses of atropine versus 3234 (133€ 
vs 728€) and 1660 doses of epinephrine versus 2400 (1444€ vs 2087€). 
Only 4800 bedside measurements of the hematocrit were performed 
during the year after the intervention versus 13,200 before (5052€ vs 
14,841€). The consumption of ertapenem decreased from 330 doses 
(12,359€) to 87 doses (3198€).
No adverse event was related to the new practices.
Conclusion Useless precautions were frequent reassurance behaviors 
in our unit. Identification of such practices and strategies to limit them 
allowed us to decrease the consumption of drugs and medical devices. 
The reduction in annual expenditures was superior to 26,000€.
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Introduction The objective of an ICU is to take care of critically ill 
patients who are presenting at least one potential or effective organ 
failure impairing directly with the vital prognosis and requiring the 
setting in emergency of replacement techniques.
According to the complexity of the care bring to these patients, a spe-
cial attention is focused on the quality of the care in ICU.
Very few studies concerning the quality of the care in ICU are made in 
countries with low incomes.
The objective of this study was to have a global overview of our ICU 
and to evaluate our activities.
Patients and methods We made an evaluation of professional prac-
tices by following-up indicators of structure, of procedures of care and 
of results. All medical records of patients admitted in our ICU between 
1 January and 30 June 2015 were analysed retrospectively. An inves-
tigation of satisfaction a day given was carried out, to collect the 
opinion of families of patients on the quality of the care given to their 
neighbours during their stay in our ICU.
Our service is a multipurpose ICU with a capacity of eight beds. It is 
held by a professor of university assisted by 14 specialists in resuscita-
tion and 34 doctor-assistants (internal) in formation. Only the doctor-
assistants take night duties our ICU.
Our equipment is composed by a life support machine and a multipar-
ametric monitor multiparametric for two beds. We have no equipment 
for measuring gases of blood, neither bronchial fibroscope, nor cardiac 
echography device. No technique of renal replacement is available.
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Results During 6 months, 140 patients (71 % men) were admitted in 
our service. The mean age was of 46 ± 22 years. The main reasons for 
admissions were related to medical pathologies (60  %), followed by 
surgical pathologies (35.6  %) and traumatic pathologies (4.4  %). No 
gravity score was recorded at the admission
During the stay in ICU, 39 % of patients were ventilated, 27 % received 
vasoactives amines, no patient received a parenteral nutrition, and 
only three patients were dialysed. Especially severe septic patients 
who represent the majority of our admissions, the global compli-
ance in the recommendations of the Surviving Sepsis Campaign “SSC” 
passed from 50 % during the second half-year 2014 to 33.3 % in the 
first half-year 2015.
The rate of observance of hand hygiene practice was low (11 %) and 
the rate of nosocomial infections was high (31.1  %). The mean dura-
tion of stay was 8.2 ± 4.2 days, and the mortality rate was 86.6 %.
Surprisingly, the majority of the questioned people declared very sat-
isfied with the care given to their relatives in our ICU.
Discussion
  • Multipurpose ICU of young adults;
  • Numerous specialists in resuscitation (2md/bed vs 1MD/4beds);
  • No specialists on duty;
  • Lack of nurses (1 inf/4 beds);
  • Lack of equipment;
  • Most patients are ventilated and got nosocomial infections (NI 
31.1 %, SAPI 5–40 %, France 5.4 %);
  • Lack of protocols;
  • Not use of gravity score;
 • High mortality.
Conclusion This study shows that the equipment of our intensive care 
unit has to be optimised. During the first half of 2015, the mortality 
rate was high and the compliance to recommendations, of SSC, was 
low. It will be advisable to develop and to promote protocols of care 
and to ensure the presence of a specialist in resuscitation in our ICU 
24 h a day and 7j/7.
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Introduction During their stay in hospital, patients might be con-
fronted to many risks due to health care. In France, health authori-
ties command to identify those risks: either in an a posteriori way 
for intensive care units (ICU) like morbidity–mortality meetings, 
or in an a priori way, that is to say before the occurrence of unde-
sirable events, in such process that operating rooms. A priori risk 
identification is not recommended for ICU, yet ICU patients are very 
exposed to iatrogenic events, which can eventually conduct to per-
manent after effects, or even death. Our aim was to identify risks of 
patients during their stay in ICU, in an “a priori” way, by realising a risk 
cartography.
Materials and methods This study took place in a French ICU of 
a general hospital. The methodology used is the one described in 
French quality reference documents. A volunteer multi-professional 
group was created, including doctors, nurses, auxiliary nurses, head 
nurses, and quality engineer. Risks identification meetings took place 
from April to September 2014. Patient’s general process through ICU 
was firstly described, from the admission to the discharge of the unit. 
Risk quotation was made through scales about frequency, seriousness 
and control of the risks, concerning each risk of the patient’s process. 
From these quotations, gross criticality was calculated by multiplying 
frequency and seriousness, and residual criticality by multiplying gross 
criticality and control. Residual criticalities were classified into three 
groups: criticality bearable without any action (up to 6), criticality 
bearable, but actions will be needed later (up to 27), and unbearable 
criticality, needing immediate action (over 28). Cartography represen-
tation was made, as a Kiviat diagram, using the mean, minimal and 
maximal values of residual criticality for each step of the patient’s 
process.
Results A 188 risks have been identified during the different steps of 
the patient’s process in ICU, as follows: admission/welcoming, circula-
tory care, ventilatory care, blood purification, hygiene/isolation, and 
discharge. Cartographic representation shows that none of the mean 
residual criticalities of those previous steps has reached the thresh-
old of unbearable residual criticality. Hygiene/isolation has the worst 
mean residual criticality (18). Inside every steps but one (blood purifi-
cation) of the process, some individual risks reached the threshold of 
unbearable residual criticality, requiring correcting measures. Many 
actions, including additional lecture of previous procedures, crea-
tion of new procedures, creation of healthcare pathways, and training 
courses for nurses and physicians, were recorded in the 2015 action 
plan. A new assessment of those actions shall take place in 2016–2017 
(Fig. 23).
Conclusion Our study of a priori risks during the whole ICU stay of 
patients is completely unique to our knowledge. It has shown that 
many point of our practice can be improved rapidly, without wait-
ing for the undesirable event to occur, avoiding potential iatrogenic 
complications for patients. Furthermore, it is a complete match with 
the current French trend, commanded by our healthcare authori-
ties, of healthcare management through security culture and risk 
management. However, the results of this cartography cannot be 
applied directly to any ICU: The identified risks are specific only to 
the ICU where has taken place the study. Nevertheless, the method-
ology used in this study, and probably a good part of the patient’s 
process through ICU, can be reused in other ICU. That way our study 
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Introduction Reading medical articles represents one of the main 
sources of information for medical doctors. However, the exponen-
tial availability of medical articles leads to difficulty in the selection of 
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articles and reading the full version of an article is time-consuming. A 
reading of a shorter version of the article could represent an interest-
ing and time-saving alternative to the full version.
Materials and methods We aimed to test the impact of an abbrevi-
ated reading of a medical article on the understanding and acquisi-
tion of medical messages by residents in intensive care medicine. We 
performed a multicenter prospective study in three medical inten-
sive care units of the Paris area over a 6-month period. Residents in 
intensive care medicine read articles selected by senior intensivists. 
For each article, residents were randomly assigned to one of the three 
following versions: (1) full version of the article; (2) incomplete ver-
sion, without discussion; and (3) flash version, restricted to abstract, 
tables and figures. The evaluation of the understanding of the arti-
cle was evaluated by a senior physician according to a standardized 
grid, assessing six main points: (1) objectives, (2) study population, 
(3) design, (4) main outcomes, (5) main bias and (6) external validity. 
Residents were asked to give the main message of the study. All arti-
cles were then discussed with the senior intensivists during a journal 
club session. One month later, residents were asked to recall the main 
message of each article. Data are presented as percentages or median 
(interquartile range).
Results Twenty residents evaluated 25 different articles (randomized 
controlled studies n = 16, cohorts n = 7). A total of 131 articles were 
read in three different versions, as follows: full version (n = 50), incom-
plete version without discussion (n =  35) and flash version (n =  46). 
The characteristics of the three centers, of residents and of the stud-
ied articles were not different between groups. The median time 
spent on reading the article was significantly lower for the flash ver-
sion group [15 (10–16) min] than for the complete version group [40 
(30–50)  min] and for the incomplete version group [30 (21–30)  min] 
(p < 0.0005). Reading only the flash version of the article allowed resi-
dents to accurately identify the objective, the population, the design 
and the primary outcome of the study, with no significant difference 
compared with the other groups. However, accurate identification of 
potential bias and of external validity was significantly less frequently 
observed in the flash version group compared with the two other 
groups. Moreover, an accurate identification of the main message 
of the study was less frequently observed in the flash version group 
(52 %) than in the full version (78 %) and the incomplete version (71 %) 
groups (p = 0.02). At 1 month, the recalling of the main message from 
the initial reading was significantly reduced in the full version group 
(52 vs. 78  %, p =  0.006) and in the incomplete version group (46 vs. 
71 %, p = 0.03), while there was no change in the flash version group 
(61 vs. 52 %, p = 0.4).
Conclusion The reading of a shorter version of a medical article by 
residents in training accurately identifies the objective, the population, 
the design and the main outcome of a study. However, it is associated 
with a decrease in the understanding of important methodological 
issues which may lead to inappropriate translation of the results into 
clinical practice. An accurate recalling of the main message of the arti-
cle at 1 month was observed in approximately 50 % of cases, irrespec-
tive of the reading style.
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Introduction Intensivists communicate daily with family members 
about the main diagnosis (‘cardiac arrest’ and ‘acute respiratory dis-
tress syndrome’) and various medical complications (‘tracheal intu-
bation’, ‘artificial ventilation’ and ‘septic shock’). Frequently family 
members go on home and make internet searches concerning the 
terms they have heard.
Concordance between information obtained on the internet, medical 
publications and social media channels have rarely been studied.
Materials and methods We used the Google Trend application to 
retrieve search volumes about the aforementioned diagnosis and 
complications. We compared search volumes on Google to the num-
ber of publications on PubMed from 2004 to 2015. In addition to that, 
a search through Ritetag (a site for trends in tweets) was conducted.
Results ‘Cardiac arrest’ and ‘septic shock’ searches on Google had a 
constant distribution over the years. Meanwhile, searches conducted 
for ‘artificial ventilation’, ‘acute respiratory distress syndrome’ and ‘tra-
cheal intubation’ had a burst starting in 2008. Occurrences in PubMed 
followed a similar distribution with the exception of ‘cardiac arrest’ that 
showed two downfalls in 2008 and in 2010. The trends over the time 
period were, however, different between Google and PubMed. For 
Tweeter, we have found a median of four tweets per hour for the term 
‘cardiac arrest’, whereas for the other terms it was difficult to retrieve 
any viable information (Fig. 24).
Conclusion This preliminary study suggests that searches for medical 
terms related to intensive care unit show similar results in Google and 
PubMed. This could suggest that intensivists and family members tend 
to have access to similar information. Meanwhile, the social media 
channels have yet to catch up in this domain.
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Introduction Burnout syndrome results from a strong emotional 
interpersonal implication in help professions. It is composed of three 
dimensions: emotional distress, depersonalization and professional 
fulfillment. It is frequent in intensive care units all over the world. The 
aim of our study was to identify the prevalence and to describe the 
epidemiological profile of burnout syndrome in a Tunisian medical 
intensive care unit. We tried also to compare the prevalence of the 
burnout syndrome between caregivers working in the intensive care 
unit and between the departments of the hospital.
Materials and methods We performed a prospective observational 
study in the teaching department of emergency and medical intensive 
care medicine (EMICU) in Zaghouan Hospital in Tunisia. All caregivers 
who gave their approval to participate were enrolled in the study. Each 
Fig. 23 See text for description
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caregiver answered to a questionnaire about socio-demographic char-
acteristics (age, sex, marital status) and the work conditions (intensive 
care unit conditions, number of hours of work per day, the number of 
on-call duty hours at the hospital). The Malasch Burn Inventory score 
was used to assess the burnout syndrome in our sample.
Results One hundred questionnaires were distributed in the depart-
ments of EMICU, surgery and pediatrics. Only 79 were collected, regis-
tered and then analyzed.
The participation rate was about 79 %. We found that 58 % of all car-
egivers working in EMICU had a burnout syndrome and 26 % of them 
were seriously affected. Forty-two percent of the affected caregivers 
had a high level of emotional distress, 43 % had a high level of deper-
sonalization, and 39 % had a low level of professional fulfillment.
The mean average age of our sample was 33  years with a standard 
deviation of 9. We have a female predominance with a sex ratio of 0.46. 
Fifty-six percent of the caregivers enrolled in the study were married.
From all the persons who answered to the questionnaire, 47 % chose 
their department of work. More than half of our population (72  %) 
works in the hospital from < 10 years. The average number of hours of 
work per week was 41 h. Twenty-seven percent of all caregivers had to 
work at least two on-call duties per week.
Analytical study showed that among the socio-demographic charac-
teristics, the female sex was significantly associated with the lowest 
score of professional fulfillment (p = 0.03). Seventy-two percent of car-
egivers affected by burnout were male with 40 % who were seriously 
affected. Sixty-one percent of our affected population was married 
with a severe score in 22.7 % of cases.
General surgery department had the highest level of emotional dis-
tress and depersonalization (73 and 64  %) followed by our EMICU 
department (56 and 60  %), while the level of professional fulfillment 
was the lowest in pediatric department (14.3  %) followed by our 
EMICU department (23.5 %).
Conclusion As expected, the prevalence of burnout syndrome is par-
ticularly high in our Tunisian emergency and intensive care unit. We 
found also that it was correlated with socio-demographic character-
istics. Our department had one of the highest levels of burnout syn-
drome in the hospital. We are trying to identify the causes of this high 
level. Preventive and interventive measures against burnout syndrome 
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Introduction Increase in resistance of endotracheal tube (RETT) dur-
ing mechanical ventilation in ICU should reflect reduction in internal 
diameter due to accumulation of secretions. The aim of this study was 
to measure RETT after extubation in ICU patients. Our hypothesis was 
that RETT increased with the length of use of invasive mechanical 
ventilation.
Patients and methods The study was performed over patients intu-
bated for at least 1  day in our ICU. Once the patient was extubated, 
the tube was immediately stored in a plastic bag at room temperature 
and kept in a safe place until bench assessment. This was performed 
maximal 24 h after extubation as follows. The endotracheal tube was 
attached to a filter (Hygrobac), and both were set to ASL 5000 active 
servo lung (IngMar Medical). The lung model was set in passive con-
dition in order to deliver two consecutive breaths at constant flow 
from 2 to −2 L/s. The filter was tested first, and then, the filter and the 
endotracheal tube were run. The relationship of pressure (P) to flow 
was fitted to the following equation P = K1 flow + K2 flow2, where K1 
and K2 are constants. P pertaining to endotracheal tube was obtained 
by subtracting P from filter to P from filter and endotracheal tube. 
Dividing P by flow led to RETT = K1 + K2 flow. RETT at 1 L/s (cm H2O) 
was equal to K1 + K2. The relationships of K1, K2 or RETT to length of 
intubation was analysed by linear mixed model where tube brand and 
size were factors with random effects.
Results We included 52 patients (34 male) of median (first–third quar-
tiles) age 68 (61–78) years. The median duration of intubation was 5.5 
(2–9) days (min 1–max 19 days). Endotracheal tubes were from Mall-
inckrodt (n = 45), TaperGuard (n = 4) or Rush (n = 3) brands and inter-
nal diameter 7.0 (n = 10), 7.5 (n = 39), 8.0 (n = 3) mm. The relationships 
of K1, K2 or RETT to length of intubation were not significant taking 
into account both brand and size of endotracheal tubes (Fig. 25).
Conclusion Increase in resistance of endotracheal tube used in the 
ICU is not related to the length of tracheal intubation.
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Introduction After intubation, the resistance of the inspiratory line is 
usually increased. This rise in airway resistance is associated with the 
presence of the endotracheal tube, a heat and moisture exchanger 
(HME) and/or any another tubing in the breathing circuit. During 
assisted ventilation or in spontaneously breathing patient, these 
high resistances will increase the work of breathing and negatively 
impact the chance of weaning. To limit this elevation in resistance, the 
endotracheal tube is sometime shortened and a heated humidifier 
used instead of a HME. The aim of this study was to evaluate the actual 
effect of these strategies on the airway resistance.
Materials and methods A two-compartment model of adult lung 
(DTL: TTL 1600 Dual Test Lung, Michigan Instrument) was connected 
to a Dragër Evita 4® Ventilator. The ventilator was set in volume-con-
trolled mode (Vt: 0.5 L; respiratory frequency: 20 bpm; inspiratory flow: 
70 L/min). To simulate normal and obstructive clinical conditions, two 
different resistances were placed at the entry of the airline connected 
to DTL by using Pneuflo® (parabolic resistor, Michigan Instrument; 
mean ± SD: 2.5 ± 0.06 and 17.04 ± 0.03 cmH2O/L s−1). Compliance of 
the artificial lung was set to 70 ml/cmH2O.
The airline was compounded of an endotracheal tube and a humidifi-
cation system. Three different inside diameters (ID) (Portex® endotra-
cheal tube of 7, 8 and 9  mm) and two humidification systems (HME 
(Gibbeck Humid Vent® Adult) or Fisher and Paykel MR850 Heated 
Humidifier®) were evaluated before and after shortening of the tube 
at 10 cm length. The change in pressure was measured by an analog 
Fig. 24 See text for description
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iWorx station/digital IWx/214. Resistance value was calculated from 
the following equation:
Statistical test (Student’s test) was performed. Values are presented as 
mean ± standard deviation.
Results
Conclusion The use of heated humidifier instead of HME and shorten-
ing of endotracheal tube (10 cm of length) allow significant decrease 
in airway resistance. Both strategies may be helpful for the weaning 
of obstructive patients. However, the shortening of the tube (relative 
impact) has a decreasing impact when the tube diameter is growing 
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Introduction Bronchoalveolar lavage (BAL) is a diagnostic tool that 
explores the deep lung; it can provide useful histological and micro-
biological information. However, endobronchial injection of important 
volumes of saline serum may cause hypoxemia. This risk is particularly 
important to consider in ICU patients. The aim of this study was to 
determine the diagnostic value and to identify incidents attributable 
to BAL in intensive care unit.
Patients and methods This was a retrospective study conducted from 
January 2011 to December 2014 at the respiratory ICU of the Abder-
rahmen Mami Hospital in Ariana (Tunisia). Were included all patients 
who underwent BAL in intensive care unit. We recorded demographic, 
Inspiratory Resistance
= (Peak pressure− Plateau pressure/Inspiratory flow)
clinical and paraclinical characteristics of patients, results and inci-
dents of BAL.
Results During the 4 years of the study, 100 BALs were performed in 
100 patients (55 men and 45 women) with a mean of age of 44 years 
[15 years—87 ans].
Respiratory history was present in 22 patients and systemic disease in 
31 patients, and 42 patients were smokers.
The main cause of admission was acute respiratory failure (97 
patients).
On chest X ray, alveolar and/or interstitial damage was found in 93 
patients; 78 were bilateral.
BAL was performed under invasive ventilation in 20 patients, under 
NIV in 20, on oxygen in 54 and for six patients in ambient air.
BAL was contributory to diagnosis in 77 patients: 28 cases of intra-alve-
olar hemorrhage, 26 cases of bacterial pneumonia (ten community-
acquired pneumonia and 16 nosocomial), eight cases of pulmonary 
pneumocystosis, six cases of active pulmonary tuberculosis, six cases 
of malignant pulmonary infiltrate, two cases of eosinophilic pneumo-
nia and one case of histiocytosis X.
The major occurring incident was severe hypoxemia in four patients 
among which three had required endotracheal intubation. In the 96 
remaining patients, BAL was safe and harmless.
Conclusion In ICU, BAL is a good and safe tool; it contributes to diag-
nosis in 77 % of cases. However, the risk of worsening breathing after 
BAL should be evaluated, especially in critically ill patients.
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Introduction Fiberoptic bronchoscopy (FOB) is frequently performed 
in intensive care unit (ICU) for diagnostic and/or therapeutic proce-
dures. The main complication of FOB is hypoxemia, which can lead 
Fig. 25 See text for description
Table 10 See text for description
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to intubation and mechanical ventilation in patients with hypoxemic 
acute respiratory failure (ARF), and heavily strike the prognosis, par-
ticularly in cases of underlying immunosuppression. Noninvasive 
ventilation (NIV) has been proposed to improve oxygenation during 
FOB. The purpose of this study was to evaluate the impact of FOB per-
formed under NIV on the outcome of patients with hypoxemic ARF.
Materials and methods We conducted a retrospective cohort study, 
in the medical ICU of the Rouen University Hospital from January 2003 
to December 2013 and compared two different strategies of FOB, 
under either NIV or spontaneous breathing with standard oxygen 
therapy by mask (O2). The main evaluation criterion was the incidence 
of intubation after FOB within 48 h. Secondary criteria were ICU mor-
tality, predictive factors for intubation and ICU mortality, as well as 
diagnostic and therapeutic yield of FOB.
Results Ninety-two patients were included. In the FOB-NIV, 14 of 39 
patients were intubated (36 %) versus 8 of 53 patients in the FOB-O2 
group (17 %) (HR 2.58; p = 0.03). Mortality in the FOB-NIV group was 
46 versus 12 % in the FOB-O2 group (HR 1.66; p = 0.29). Patients in the 
FOB-NIV group were older (64 vs 60, p = 0.028), more severe (SAPS2, 
SOFA, PaO2/FiO2 ratio) on admission or the day of FOB. In multivariate 
analysis, predictive factors for intubation were higher heart rate (HR 
per heart beat: 1.03, p = 0.02), SpO2 <95 % (HR 5.07; p = 0.001) and 
SAPS2 score the day of FOB (HR per unit: 1.06; p  <  0.0001). The type 
of ventilatory support during FOB was not found as an independent 
predictive factor for intubation (p > 0.05).
Conclusion Performing FOB under NIV in hypoxemic ARF patients 
seems to be associated with an increased risk of intubation as com-
pared to FOB with O2, but without increase in their ICU mortality. As 
the ventilatory support used during the FOB does not appear as a 
predictive factor for intubation within the 48 h after the FOB, this risk 
appears closely related to the underlying severity of patients. Finally, 
the choice to perform FOB under NIV by the clinician appears to be 
guided by this severity.
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Introduction Bronchoscopy can be particularly challenging in 
patients with acute respiratory distress (ARDS) who required lung-
protective ventilation strategies. In a previous study, we showed that 
a bronchoscope with an external diameter of 4  mm (or less) would 
allow safer bronchoscopic interventions. Diameter reduction cannot 
be at the expense of the suction channel which needs to be sufficient 
to easily removed thick secretion. From the single-use bronchoscope 
technology, we proposed an innovation of flexible bronchoscope with 
a variable outer diameter as follows: a proximal 4 mm diameter for the 
part inserted in the endotracheal tube, distal head camera with clas-
sical diameter (5.3 mm), and 2 mm diameter for the suction channel. 
The aim of our study was to demonstrate that our prototype of flexible 
bronchoscope: (1) does not disrupt the protective ventilation, while it 
is in place in the endotracheal tube (ETT); and (2) enables an efficient 
suctioning capacity.
Materials and methods In vitro We simulated ARDS lungs mechani-
cally ventilated according to actual guidelines. We used four models 
of flexible bronchoscope (FB): reusable adult, single-use adult, reus-
able paediatric, and prototype. All combinations between FB and ETTs 
(7.0–8.0  mm of internal diameters) were evaluated in pressure-con-
trolled ventilation mode (inspiratory pressure of 22 cmH2O for a target 
tidal volume of 380 mL, respiratory rate at 27/min, PEEP at 10 cmH2O, 
inspiratory flow at 60 L/min, compliance at 35 mL/cmH2O, inspiratory/
expiratory 1:2). We measured the percentage of minute ventilation 
(MV) delivered compared with baseline and the increase in total posi-
tive end-expiratory pressure (ΔtotalPEEP). To test the capacity of the 
suction channel, we measured the suction flow (water and viscous 
fluid) with two vacuum levels.
In vivo We described and compared the consequences of bronchos-
copy during protective ventilation on two ventilated pigs with a sin-
gle-use FB and our prototype of FB.
Results In vitro Inserting adult FB in ETTs severely altered ventilation: 
19–61 % of the baseline MV was delivered (7.0–8.0 ETTs). On the con-
trary, the modifications on the ventilation were reduced with the pro-
totype FB (72–87 % of the baseline MV). When the inspiratory pressure 
was set to guaranty the targeted tidal volume, the ΔtotalPEEP was +13 
and +11 cmH2O, respectively, for the reusable and for the single-use 
adult FB (ETT 7.0), whereas totalPEEP was unmodified for the proto-
type (as for the paediatric FB). At −150  mmHg vacuum level, proto-
type FB suction flow was identical (247 ml ± 12 mL/min for water and 
176 mL ± 4 mL/min for viscous fluid) to the adult FB and was clearly 
superior to the suction flow provided by paediatric FB (147 ± 10 mL/
min for water and 100 ± 6 mL/min for viscous fluid). Similar observa-
tions were made for the 300 mmHg vacuum level.
In vivo
When the adult FB was inserted in the 7.0 ETT of the ventilated pigs, 
it was not anymore possible to ventilate them with the initial settings 
(inspiratory pressure of 15  cmH2O, respiratory rate at 27/min, PEEP 
at 10  cmH2O). Indeed, the inspiratory pressure was increased up to 
52 cmH2O to deliver the targeted tidal volume, leading to a total PEEP 
of 16 cmH2O. On the contrary, no significant difficulties were observed 
with the prototype of FB.
Conclusion Our prototype of single-use FB did not disrupt the lung-
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Introduction Difficult intubation (DI) remains an issue of concern 
in critically ill patients. Though its incidence and risk factors are well 
described in anesthesiology, few authors studied difficult airway man-
agement in ICU patients (1). The aim of our study was to describe the 
incidence and risks factors for DI in our ICU.
Patients and methods We conducted a monocentric, prospective 
observational study between January 2014 and May 2015. All patients 
admitted to our ICU and requiring intubation were included in the 
study. Exclusion criteria comprised age under 18 and refusal from the 
patients or their relatives to participate.
An intubation procedure was defined as difficult whenever it required 
more than two laryngoscopic attempts by a senior intensivist or the 
use of a different technique (stylet, gum bougies, laryngeal masks, 
fiberoptic intubation, cricothyroidotomy or tracheostomy). Patients’ 
comorbidities, demographic data and classical risk factors for difficult 
intubation in anesthesiology, as well as the MACOCHA score, were col-
lected on admission. For each intubation, modalities of the procedure 
were recorded. A multivariate logistic regression was used to identify 
risk factors for DI. Variables were selected after univariate analysis with 
a significant association (p < 0.20).
Results During the study period, 263 intubation procedures were 
studied. Patients were mostly men (n = 173, 65.3 %), with a mean IGS 
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II of 54 (52–56). The cause of ICU admission was medical for the great 
majority of them (n = 239, 90 %). A total of 33 (12.6 % [8.8–17.2]) pro-
cedures out of 263 turned out to be difficult.
When the MACOCHA score was recorded (n = 153, 58 %), it was signifi-
cantly higher in the DI group (median = 2 [1–7] vs 1 [1–2]). In this sub-
group of 153 patients, the MACOCHA score appeared to be the only 
predictive factor for DI (OR per point = 1.47, 95 % CI [1.23–1.75]).
In the global population (n  =  173), patients with a DI had a signifi-
cantly higher Mallampati score, had a more frequent history of head 
and neck disease (n = 7 [21 %] vs n = 4 [1, 72 %], p < 0.0001) and pre-
sented more often with a low thyro-mental distance (n = 13 [39 %] vs 
n = 34 [15 %]) or a reduced mobility of cervical spine (n = 5 [15 %] vs 
n = 7 [3 %]). After adjustment, a Mallampati score higher than 2 (OR 
37.8 [10.6–135.1]) and a limited mouth opening (OR 5.38, 95 % CI 1.1–
26.4) were both associated with DI.
Discussion In our study, the incidence of DI was comparable to pre-
vious studies. Predictive independent factors for DI (Mallampati score 
higher than 2 and limited mouth opening) differed from those which 
recently led to the validation of the MACOCHA score in a medico-sur-
gical ICU population 1. In our medical ICU population, the MACOCHA 
score often showed to be difficult to record. The Mallampati classifica-
tion, which represents one of its fundamental items, was not hardly 
ever feasible in emergency in medical patients, nor was it predeter-
mined by the anesthesiologist (as in scheduled surgery patients).
Conclusion Two clinical items predictive of difficult intubation were 
identified in our study. The MACOCHA score seemed to be difficult 
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Introduction Endotracheal self-extubation (ESE) is a common adverse 
event in the intensive care unit (ICU). It may carry significant safety 
risks for the patients and exceptionally cause death. We aimed to 
investigate the incidence and consequences of ESE in ICU patients and 
to assess the risk factors for complicated ESE
Materials and methods This is a single-center prospective obser-
vational study conducted in a medical and surgical ICU and affiliated 
intermediate care of 26 beds. From January 2013 to December 2014, 
all ESEs were prospectively recorded including the circumstances of 
the event, the characteristics of the patients and the outcome. Quanti-
tative and qualitative variables are presented as mean (standard devia-
tion), median [interquartile range] or number (%), as appropriate.
Results During the study period, 42 episodes of ESE occurred in 41 
patients, among 690 intubated patients (6 %). The patients (31 males) 
were aged of 56.5 [47–72]  years and had a median Charlson comor-
bidity index of 5 [4–7] points. The main reasons for ICU admission 
were respiratory failure (54 %), postoperative monitoring (14 %), and 
severe sepsis or septic shock (10 %). The SAPSII score was 42 [33–58]. 
ICU length of stay (LOS) was 16 [9–26] days, and ICU mortality rate was 
19.5 % [95 % CI 0.07–0.32].
At the time of ESE, 35 patients (83 %) were on a respiratory weaning 
program (PSV), with a pressure support of 12 [8–13] cmH2O and a 
FiO2 of 35 % [30–40]; 18 patients (43 %) were still sedated, 15 (36 %) 
had agitation, and 15 (36  %) had physical restraints. ESE occurred 
4 [3–9]  days after intubation and 64.5 [20–102]  h after PSV onset. 
Nine patients (21  %) had a spontaneous breathing trial before ESE. 
Altogether, 66 % of ESE occurred around 7:00 a.m. (n = 7), 13:00 p.m. 
(n = 15) and 7:00 p.m. (n = 6) and 31 % (n = 13) occurred during the 
weekend. ESE resulted in a complicated outcome (CO) in 24 patients 
(57  %), including non-invasive ventilation (NIV) (n =  11; 26  %), rein-
tubation (RI) (n =  16; 38  %), bacterial pneumonia (n =  7; 17  %) and 
death (n = 8; 19 %). On univariate analysis, the need for RI was associ-
ated with a prolonged ICU LOS (p = 0.003), an increased ICU mortality 
(p = 0.03) and a trend for an increased pulmonary infection (p = 0.08). 
Analysis of specific circumstances before ESE highlights a shorter time 
from the beginning of weaning (p = 0.03) and a higher pressure sup-
port level (p = 0.05) in case of CO.
Discussion Most of ESE occurred during the weaning period and 
around some critical hours during the day, particularly during the 
work shifts in the morning and the evening, and at noon. Risk factors 
associated with a CO, like a shorter time from the beginning of wean-
ing and a higher pressure support level, might reflect insufficient prep-
aration for extubation.
Conclusion ESE is a common and serious adverse event in the ICU, 
and the need for RI may potentially be associated with higher morbid-
ity and mortality. A prevention policy of ESE is warranted to minimize 
ESE, particularly in patients at risk of CO.
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Introduction Daily evaluation of patients for weaning from mechani-
cal ventilation (MV) by nurses has been shown to decrease duration of 
MV. Evaluation is based on the search of weaning criteria allowing the 
start of a T-piece trial and the assessment of patient tolerance during 
spontaneous breathing. Nonetheless, reintubation occurs in 5–10 % of 
cases [1], increases the duration of MV and ICU stay and is associated 
with significant morbidity and mortality. Failure to wean patients may 
result from respiratory failure (high respiratory workload, poor gas 
exchange) or extubation failure (inability to clear secretions, laryngo-
spasm). Weaning criteria commonly used are poor predictors of extu-
bation failure. We have tested the interest of adding to our weaning 
test-specific criteria to assess muscle strength, cough effectiveness, 
airway patency and patient’s consciousness (Table 11).
Patients and methods We have retrospectively reviewed charts of all 
patients mechanically ventilated in the 24-bed MICU of Cochin Univer-
sity Hospital from 01/2007 to 12/2013. These patients were assessed 
twice a day by nurses who look for the presence of weaning criteria. 
Patients who met those criteria underwent a spontaneous breathing 
trial on T-piece during which tolerance was assessed. All patients data 
were continuously recorded in a clinical information management 
system (Clinisoft®, GE Healthcare), including data related to wean-
ing success/failure. In 08/2008, we progressively introduced a five-
item new component to our weaning protocol to improve our ability 
to test muscle strength, cough effectiveness, airway patency and 
patient’s consciousness. To evaluate the effectiveness of this strategy, 
we assessed the incidence of weaning failure (defined as respiratory or 
extubation failure requiring reintubation within 48 h), the incidence of 
self-extubation, the duration of MV and ICU stay, and survival before 
(T1), during (T2) and after (T3) implementation of the new compo-
nent. Informed consent was waived by our IRB for this study. Data are 
reported as median and interquartile ranges. A P  <  0.05 was consid-
ered significant for all statistical tests performed.
Results A total of 4488 treated with invasive MV have been included in 
the study from 01/2007 to 08/2008 (T1, n = 982), 08/2008 to 08/2009 
(T2, n = 642) and 08/2009 to 12/2009 (T3, n = 2864). Main results are 
summarized below.
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Conclusion Addition of a new component to an existing nurse-driven 
weaning protocol to evaluate readiness for extubation was not asso-
ciated with improved ability to predict successful extubation. These 
results mandate a thorough analysis of causes of reintubation.
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Introduction The accident represents the first cause of death, handi-
cap and hospitalization in children. Most of the accidents arise further 
to a relaxation of the surveillance and the awareness of the parents. 
The risk is everywhere, in the house and in the street. Some situations 
favor the relaxation of awareness as it is the case during the school 
holidays.
Our aim is to describe the epidemiological profile of the accidents dur-
ing the school holidays
Materials and methods It is a descriptive observational cohort study 
during the school holidays from December 2014 to January 2015, at 
the pediatrics hospital in Canastel in Oran. All children under age of 
15 years who are victims of accident were included.
Results One hundred and fifteen children were enrolled. The mean of 
age was 5.2 years (±4.1) with sex ratio of 1.78. The most frequent con-
sultation in the pediatric emergency was the traumatology (62.6  %) 
of the cases followed by the burn (32.2 %) of the cases. The majority 
of the children are from Oran (63.5  %). Eight couples were divorced. 
The child was alone at the time of the accident in 80.3 % of the cases. 
61.3 % of the children live with the big family. The age of the father was 
between 30 and 40 years in 46.2 % and more than 40 years in 41.5 %, 
while the age of the mother was between 20 and 30 years in 49.2 % 
of the cases and between 30 and 40 years in 43.1 %. No attempts of 
suicide or voluntary accident were noted. The children required a hos-
pitalization in 24.3  % and stay in pediatric intensive care in 4.3  % of 
the cases. A 9-month-old child died following an inhaled foreign body.
Conclusion The most of the accidents could be avoided. The imple-
mentation of a preventive strategy to emphasize the information and 
the education of the family and on the necessity of creating a safer 
environment for children seems to be necessary in our city.
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Introduction The mortality of ARDS is related to several factors: eti-
ologies, severity of hypoxemia (PaO2/FiO2 ratio or oxygenation index 
value) and prolonged mechanical ventilation. Sometimes, VV ECMO 
has been used to rescue patients suffering from pulmonary failure 
unresponsive to conventional therapies (2). Due to high risk of throm-
botic and bleeding complications, its duration and effectiveness 
may be limited. Prone position (PrP) and lung-protective and ultra-
protective mechanical ventilation (tidal volume <2  ml/kg with Peep 
>10 cmH2O, ±HFOV) are recognized pulmonary rehabilitation strate-
gies. The increase in oxygenation has been reported, associated with 
VILI reduction and improvement in alveolar recruitment (1). The main 
objective of the study was to reduce the duration of VV ECMO and 
ARDS morbi-mortality, by using these respiratory strategies in pediat-
ric ARDS, requiring VV support.
Patients and methods Following the recommendations of Pediat-
ric Acute Lung Injury Consensus conference, we used double-lumen 
venous cannula VV support, in right internal jugular vein, with echo-
graphic control (3). During ECMO, the respiratory strategies were: 
ultra-protective controlled ventilation (UCV), PrP for 12  h daily, early 
reversal neuromuscular blockade (NMB) and spontaneous neurally 
adjusted ventilatory assist (NAVA) ventilation. Durations of ECMO, UCV 
and NMB were collected, as well as the time of introduction of NAVA 
during ECMO and extubation after the weaning off ECMO.
Results Six patients suffering from ARDS were admitted in our ICU 
and included in this study. The age ranged from 21  days to 4  years. 
The diverse causes of ARDS were VRS bronchiolitis, Enterobacter cloa-
cae pneumonia, systemic inflammatory reaction syndrome (SIRS) and 
stage 4 drowning and macrophage activation syndrome. No increased 
cannulation site bleeding and flow issues, notably during the PrP pro-
cedure, were observed. The reversal NMB was at 3.7 days (±2.3) dur-
ing the ECMO. NAVA ventilation was initiated also during the ECMO at 
7 days (±2.6), and the duration of VV support was 7.3 days (±3). The 
patients were extubated 3.9 days (±2.6) after decannulation. All chil-
dren survived.
Discussion The durations of ECMO and invasive ventilation observed 
in our study were dramatically short regarding the severity of ARDS 
(2). Our study showed the successful of respiratory rehabilitation strat-
egies during VV support that included rapid improvement in oxygena-
tion, early NMB weaning, using NAVA ventilation before decannulation 
and then decrease ECMO duration.
Conclusion VV ECMO, with double-lumen venous cannula, in severe 
ARDS in pediatric patients, can be optimized by respiratory reha-
bilitation strategies such as prolonged PrP, UCV and early respiratory 
weaning with NAVA ventilation. All these strategies seem to improve 
outcomes of these patients. However, further studies still required to 
confirm our encouraging results (Table 12).
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Table 11 See text for description
T1 T2 T3 P
Sex (M/F) 602/380 375/267 1818/1046 0.04
Age 58 [43; 72] 60 [47; 72] 62 [48; 74] 0.001
SAPS2 57 [43; 70] 58 [45; 74] 59 [45; 74] 0.001
Reintubation (%) 4.7 4.4 6.7 0.01
Self‑extubation (%) 3.7 6.7 6.6 0.01
Duration of MV (days) 4 [2; 9] 3 [2; 8] 3 [2; 8] NS
ICU LOS (days) 4.6 [1.7; 10.8] 5 [2.1; 11] 5.5 [2.5; 10.7] 0.05
Death (%) 28.9 31.9 27.6 NS
Page 61 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
Correspondence: Guillaume Mortamet ‑ mortam@hotmail.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P36
Introduction In critically ill patients, noninvasive ventilation is classi-
cally set on a variable association of clinical parameters. However, this 
“clinical” setting provides no accurate data regarding the improve-
ment in the respiratory effort and the synchronization of the patient 
with the ventilator. Esophageal pressure and gastric pressure have 
been shown to be useful in the ventilatory management of adult 
patients with acute respiratory failure. The aim of the present study 
is to describe the value of esophageal pressure and gastric pressure 
measurements for determining the usefulness and optimal setting of 
noninvasive ventilation in children with respiratory failure admitted to 
the pediatric intensive care unit (PICU).
Patients and methods We conducted a one single-center retrospec-
tive descriptive study. After the insertion of the esogastric catheter, 
the study started with a period of spontaneous breathing. After this 
period, a series of different noninvasive ventilation settings were 
performed with the first aim to normalize or to maximally reduce 
the patient’s respiratory effort, reflected by the normalization of the 
esophageal pressure and transdiaphragmatic pressure swings. The 
second aim was to obtain the best synchrony between the patient and 
ventilator.
Results All the six patients had a severe underlying condition with 
an associated lung disease. Four patients were naive to noninvasive 
ventilation. The median age of the patients was 7.7 ± 2.8 months. All 
the patients had severe hypercapnic respiratory failure with a mean 
PvCO2 of 71.1 ± 8.9 mmHg and an increase in respiratory rate (mean 
61.8 ± 20.4 breaths/min). Four patients were assisted by CPAP ventila-
tion and two with BiPAP ventilation.
NPPV indication was proved by Pes measurement in four 
patients, as assessed on a reduction in the PTPes/min and PTPdi/
min from 303.0  ±  112.0 and 329.0  ±  141.0 to 169.0  ±  115.0 and 
194.0 ± 106.0 cmH2O s min−1 during NPPV, respectively (p < 0.05). In 
these four patients, two died and one was still on noninvasive pressure 
ventilation (NPPV) at PICU discharge. This decrease in respiratory effort 
was associated with a decrease in RR and PvCO2.
NPPV non-indication was proved by esophageal pressure measure-
ment in two patients. In these two patients, despite the physiological 
findings, NPPV was continued in one patient after esophageal pres-
sure and gastric pressure measurements because of an important 
clinical improvement. One of these two patients died.
Conclusion This descriptive and retrospective study shows that a 
physiological approach, based on the esophageal and gastric pres-
sures measurement, may be gainful to manage noninvasive ventila-
tion, to indicate or non-indicate NPPV and to optimize its settings, 
especially in a heterogeneous population of critically ill children.
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Introduction An adequate choice of antibiotics and antifungal drugs 
with the help of microbiological studies decides the fate of infants 
with bone and joint sepsis.
Materials and methods Over the past 10 years, microbiological stud-
ies were carried out in accordance with the standards and CLSI and 
EUROCAST. To establish the etiological diagnosis of the disease, we 
investigated punctate synovial fluid (mycological and bacteriologi-
cal analyzes) and venous blood (serological and PCR investigations). 
Simultaneously, we examined the activity of the inflammatory process 
by determining blood levels of CRP and PCT.
Results Isolated from the synovial fluid of 16 cultures of microorgan-
isms: nine staphylococcus (three S. aureus, three S. epidermidis and 
three S. heamolyticus); six Enterococcus (four E. faecalis and two T. fae-
cium); and one Bacillus spp.
CRP was 12–96 mmol/l and PCT was 0.5–2.3 ng/LB depending on the 
timing of onset of the disease.
With active septic process (data CRP and PCT)—staphylococci iso-
lated antibody titer of 1: 1280–2560: and PCR in different staphylococci 
(Figs. 26, 27).
Table sensitivity to the antibiotics and the schedule of the selected 
microorganisms.
Conclusion Studies have demonstrated the practical value of micro-
biological research in the treatment of bone and joint sepsis.
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Introduction Toxic shocks (TS) and septic shocks (SS) share many com-
mon clinical signs of an exacerbated inflammatory response but with 
different pathophysiological mechanisms. The objectives were to com-
pare their characteristics of shock and their cellular immune response.
Patients and methods We did a monocentric retrospective study of 
children <18 years old admitted to PICU for TS or SS between January 
2011 and September 2014. Immunocompromised and precociously 
died patients were excluded (death within the first 24 h).
Comparisons of the time course of leukocytes, organ dysfunction 
(PELOD2 score) and nosocomial infections were made between TS and 
SS groups. We used time course of lymphocytes, precisely persistent 
lymphopenia at day 3, like a marker of immunoparalysis.
Results Seventy-nine patients were included, 42 of SS and 37 of TS. 
Most of them were lymphopenic at day 1 (83.3 vs 97.3 % in SS and TS 
groups, respectively), and, respectively, 45.2 and 35.1 % were still lym-
phopenic at day 3.
Significantly, children with TS were more initially lymphopenic and 
corrected faster than septic patients (p = 2.52 × 10−5).
In both groups, the PELOD2 score was higher at day 1 in patients who 
are more lymphopenic.
Table 12 See text for description
Case 1 2 3 4 5 6 Mean ± SD
ECMO duration (days) 9 9 11 5 3 7 7.3 ± 3
NMB duration (days) 8 4 3 3 3 1 3.7 ± 2.3
Mechanical ventilation 
duration (days)
12 18 17 10 8 14 13.2 ± 4
NAVA on ECMO (days) 9 7 11 5 4 6 7 ± 2.6
Extubation after 
ECMO (days)
1 1.5 6 5 5 5 3.9 ± 2.6
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The rate of nosocomial infection was similar between groups and 
was higher in children with persistent lymphopenia at day 3. In SS, 
26.3 % patients with nosocomial infections were still lymphopenic at 
day 3 and 17.6 % were not, while In TS, 23.0 versus 11.8 %. But the dif-
ferences were not statistically significant: in SS OR 1.64, 95 % CI [0.3–
12.7], and in TS OR 2.2, 95 % CI [0.2–30.7].
TS were less lymphopenic at day 3 and had less secondary nosocomial 
infections than SS.
Discussion Whether children who had at day 3 lymphopenia are more 
prone to develop nosocomial infection, as demonstrated in adults, 
may require a larger cohort.
Conclusion The difference in time course of lymphocytes between TS 
and SS groups may be explained by the superantigenic activation of 
lymphocytes in TS group. Our hypothesis is that superantigenic activa-
tion leads to a deeper and more precocious immunosuppression, but 
the recovery is faster than in patients with septic shock.
Immunomodulation therapy perspectives need better knowledge of 
immunosuppression induced by different severe infectious shocks.
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Introduction Carbon monoxide poisoning remains a threat for chil-
dren. Clinical severity and presentation of carbon monoxide (CO) 
poisoning are dependent of COHb level. Our aim was to describe the 
children hospitalized in our department for CO poisoning and to com-
pare HbCO level to clinically reported symptoms.
Materials and methods We are a secondary care center hospital 
with hyperbaric oxygen therapy facilities and represent the refer-
ence center for Ile-de-France region for CO poisoning. The medical 
records of patients aged between 0 and 16 years with a confirmed 
diagnosis of CO poisoning, defined as the presence of a COHb 
level of more than 5  %, were evaluated. Relevant information 
such as age, sex, source of CO, coaffected family members, month 
of presentation, time of presentation and presenting symptoms, 
duration of oxygen treatment in the emergency department, need 
for admission to an inpatient ward or intensive care unit, and Glas-
gow coma scale scores was recorded for each patient on prepre-
pared forms.
Results The records of 50 patients were included. Of them, 26 
(57.1 %) were female and 24 (42.9 %) were male, with a median age 
of 7.0  years (range 1  month–16  years) and a mean COHb level of 
7 %. Thirty-two patients (64 %) had a COHb between 1.5 and 10 % 
on presentation, whereas the remaining 18 patients (36  %) had a 
presenting COHb of >10  %. Neurologic symptoms such as head-
ache, syncope, seizures, and confusion were encountered more fre-
quently in the COHb >10  % group compared with the group with 
1.5–10 % COHb levels.
Conclusion In this study, we managed to demonstrate the presence 
of more frequent symptoms in patients with a COHb level of 10  % 
or greater. Further analysis revealed that severe symptoms were 
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Introduction Septic shock is a constantly evolving challenge for pedi-
atric intensive care units (PICU) physicians. Despite a decrease in the 
trend of mortality, part of these patients dies in the first hours of care 
from refractory septic shock (RSS). A definition for RSS is needed to 
help its earlier diagnostic, have a better understanding of the disease 
and evaluate specific treatments. We aimed to define RSS with a two-
round Delphi study among the European Society of Pediatric and Neo-
natal Intensive Care (ESPNIC), to create septic shock prognostic scores 
on a development cohort and to validate these tools as diagnostic of 
RSS on a multicentric cohort.
Patients and methods A total of 114 PICU physicians from 27 
countries answered a clinical case-based two-round Delphi study. 
Criteria most associated with diagnosis of RSS in clinical cases 
were selected, then validated in the second round of the study 
Fig. 26 See text for description 
Fig. 27 See text for description 
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and compiled in a draft definition. During a 4-year period (2010–
2013), all patients admitted for septic shock without limitation of 
active treatment were screened. Seventy patients from one PICU 
(21 deaths, 30  %) were included in the development population 
and 324 patients from four PICUs (39 deaths, 12  %) in the valida-
tion population. Two septic shock scores were created after com-
bination of the survey results and the multivariate analysis on the 
development population.
Results The resulting draft definition for pediatrics constitutes myo-
cardial dysfunction with high blood lactate levels despite adequate 
vasopressor treatment. Analyzed in the development population, each 
item of the draft definition was independently associated with need 
for ECMO or death. Two septic shock scores were created. A simplified 
septic shock score (4S) ≥2/5 had a mortality positive predictive value 
of 60.4 and 84.6 % if ≥4/5. The complete septic shock score (cSSS) had 
a discriminative power measured with the area under the responder-
operating curve of 95 % (95 % CI 92–98 %).
Discussion There is no existing score to assess risk of death in children 
with septic shock. Blood lactates, VIS and septic cardiomyopathy are 
known factors associated with mortality in septic shock. The combina-
tion of the three criteria is a powerful and sensitive way to diagnose 
patients in RSS. Cutoff proposed for this diagnosis is a 4S ≥2/5 which is 
associated with a hazard ratio of death of 68.69 (95 % CI 30.47–154.9).
Conclusion Refractory septic shock in pediatrics defined with the 
ESPNIC selects patients with high mortality rate in PICU. Septic shock 
scores are useful tools to assess risk of death or need for ECMO at the 
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Introduction End-of-life is a highly debated subject. In France, the 
Leonetti law was promulgated in 2005 to clarify medical practices 
regarding this topic. It draws attention to the aspect of unreasonable 
obstinacy and authorizes withholding or withdrawal of treatments 
such as mechanical ventilation, vital drugs or artificial nutrition when 
they appear “useless or disproportionate.” It also emphasizes the 
necessity to alleviate pain, even when doing so could result in shorten-
ing life. Ten years after its promulgation, this law still seems not fully 
implemented in French Neonatal Intensive Care Unit (NICU) and Pedi-
atric Intensive Care Unit (PICU).
The aim of this study is to assess the implementation of the Leonetti 
law in our NICU and PICU and to study the evolutions of this imple-
mentation over time.
Materials and methods We performed a retrospective observational 
monocentric study using data collected from medical and nursing 
charts. For each case, four criteria to be respected regarding the Leon-
etti law were sought from the charts: collegiate decision regarding the 
implementation of end-of-life care, parental involvement in the deci-
sion, traceability of the decision within the patient medical file, and 
the way dignity and quality of life that were maintained throughout 
end of life. This classification has been done by a physician outside our 
unit, unaware of the child’s situation, in order to lead to a consensual 
classification. The interpretation of the data was based on univariate 
analysis, descriptive at first. We then compared those data year by year.
Results Over this period, 94 cases out of 119 were included. The four 
criteria were met in 40  % of the cases, and this value significantly 
improved over time [8–52 % between 2011 and 2014] (p < 0.01). Three 
criteria out of four were met in on average 76 % of the cases. The legal 
obligation of collegiate decision was respected in 73  % of the cases 
[58–76 %] (p 0.3), parental involvement in 85 % [58–92 %] (p < 0.01) and 
traceability in 99 %. Dignity and quality of life were maintained suitably 
in 53 % of the cases [21–72 %] (p < 0.01). While three criteria out of four 
tended to improve over time, the traceability rate was stable around 
99 %.
Discussion Despite the biases caused by its retrospective nature, 
our study allowed us to confirm the improvement in our practices in 
children end of life. However, there is still room for improvement, par-
ticularly regarding collegiate decision (e.g., systematic presence of an 
external consultant) and assessment of pain and discomfort in end-of-
life situations.
Conclusion Laws and medical recommendations cannot bring all 
answers to end-of-life situations. However, many elements regarding 
the implementation of the Leonetti law within our units still need to 
be improved. Following this study, a series of reflections on ethical 
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Introduction Vitamin K antagonists (VKA) have served as the cor-
nerstone of long-term anticoagulant therapy. Out of the respect of 
the recommendations of prescription and biological monitoring, this 
treatment can be complicated by life-threatening bleeding events.
Patients and methods We carried out a retrospective study of 58 
patients taking oral anticoagulants and who were hospitalized for 
hemorrhagic events from January 2013 to June 2015.
The aim of this study is to describe the characteristics of patients 
treated with VKA presented a bleeding event, to study the hemor-
rhagic event and its management and to search for prognostic factors.
Results Among the 58 patients (24 men and 34 women, aged 
69  ±  11  years) with anticoagulant-associated bleeding event, 41 
patients survived and 17 patients died. All patients were already tak-
ing acenocoumarol for 65 ±  61  months. VKA were used for the pre-
vention of stroke due to atrial fibrillation in 41 (70 %) cases, prosthetic 
cardiac valve replacement in 13 (22 %) cases and venous thromboem-
bolism in four (7 %) cases.
Conclusion The results of this study showed that IGSII ≥37, intracra-
nial and gastrointestinal bleeding and elevated AST level are useful 
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Introduction The polytrauma is a major public health problem, and 
assessment of severity is an important part of the initial management 
which determines prehospital means necessary.
The host structure must take into account the particularities of these 
patients.
The need for a complete and rapid lesion balance makes desirable the 
management of trauma patients in centers with a complete technical 
platform.
Some studies have shown that up to 30 % of deaths in trauma patients 
could have been avoided by better management.
Goal
The goal of this study was to define the epidemiological profile of pol-
ytrauma at the service of medical and surgical emergencies CHUOran.
Patients and methods Retrospective study of trauma patients admit-
ted to the intensive care unit of the UMC from January 1, 2009, to 
December 31, 2011.
Data collection was carried out through a pre-established record 
where data are noted. The coding data entry and data analysis are per-
formed using the EpiInfo Version 6 software.
The main items of the plug are age, sex, mechanism, collection, time of 
admission hemodynamic, respiratory and neurological constants, ini-
tial lesion balance, surgery, secondary lesion balance, ICU hospitaliza-
tion and evolution of the patient.
Results A total of 217 severe trauma patients were collected during 
the period from January 2009 to December 2011.
We note a clear predominance of the male sex with a sex ratio of 8.77.
Most traumatized patients were young with an average age of 
34.217 years.
The accident in the way was the origin of the trauma in 77.4  % fol-
lowed by the fall with a frequency of 22.6 %.
The collection was medicalized in 39.6 % of cases. 11.5 % were trans-
ferred from other cities.
20.7  % had systolic blood pressure ≤90  mmHg and 23  % had SpO2 ≤90 %.
11.1 % had a Glasgow score ≤3/15. For 4.6 % of them, it was of 4/15, 
6 % had a score of 5/15, 8.3 % had a score of 6/15, 13.8 % had a score 
of 7/15, 11.2 % had a score of 8/15, and 45 % had a score ≥9/15 on the 
Glasgow coma scale. 18 % had anisocoria on admission and 1 % was 
in mydriasis.
The revisited trauma score was ≤5 in 19.4 % of patients.
43.78  % had an orthopedic injury. 62.7  % were intubated dice 
admission.
Chest radiography was performed in 92.6 % of patients, and that of the 
basin and abdominal ultrasound was made in 94 % of them.The com-
puted tomography was performed in 95.4 % of traumatized patients, 
and that of the thorax and abdomen was with a respective proportion 
of 76 and 39.6  %. 85.3  % of our patients were polytraumatized, and 
trauma of the head was the most frequent lesion with a proportion of 
85.3 % followed by the thorax with a frequency of 62.8 % and finally 
the abdomen with a rate of 21 %. The average ICU stay was 19.19 days. 
The outcome was unfavorable in 30.9 % of patients
Discussion In our study, we found that the polytrauma mainly 
touched young males under 40 years old. This constitution is similar to 
that reported by David J. Thurman and collaborators in the published 
report on the brain injury in the USA. In the Annual Report of 2013 of 
the Trauma Data Bank and by the state of 805 health centers in the 
USA, the fall was the leading cause of head injury with a frequency of 
40.66 % followed by accident thoroughfare of 28.1 %.






Sex ratio (M/F) 0.57 1.1 0.25
Age, mean (SD), years 68 ± 12 72 ± 8 0.2
IGS II, mean (SD) 27 ± 10 41 ± 17 0.006
IGS II ≥37 7 (17 %) 9 (53 %) 0.005
SOFA, median (IQR) 2 (2–4) 3 (2–4.5) 0.1
Comorbidities, n (%)
 Hypertension 25 (61 %) 13 (76 %) 0.25
 Diabetes 10 (24 %) 8 (47 %) 0.08
 Congestive heart failure 14 (34 %) 6 (35 %) 0.93
 Atrial fibrillation 31 (75 %) 13 (76 %) 0.94
 Liver cirrhosis 3 (7 %) 0 0.54
Alternate‑day dosing 12 (29 %) 6 (35 %) 0.22
Indication of VKA 0.3
 Atrial fibrillation 27 (65 %) 14 (82 %)
 Prosthetic valve replace‑
ment
10 (24 %) 3 (17 %)
 Thromboembolic events 4 (9 %) 0
Daily dose (mg) 0.5 ± 0.27 0.5 ± 0.22 0.71
Timing of anticoagulant 
therapy (months)
65 ± 57 66 ± 92 0.97
Antiplatelet therapy 7 (17 %) 3 (17 %) 1
HAS‑BLED >3 2 [1.75; 3] 3 [2; 4] 0.19
Bleeding site 0.05






 Intracranial 4 (9 %) 5 (29 %)
 Alveolar 5 (12 %) 0
 Gastrointestinal 9 (22 %) 7 (41 %)
 Gynecologic 1 (2 %) 1 (5 %)
 Hematuria 7 (17 %) 0
 Intraabdominal 3 (7 %) 1 (5 %)
 Pericardial 0 1 (5 %)
Initial prothrombin ratio (%) 10 10 0.47
Initial INR 10 15 0.14
Cephalin kaolin time (s) 76 ± 30 74 ± 38 0.85
Hemoglobin (g/dl) 9.7 ± 3.3 8.9 ± 4.4 0.54
Fall in hemoglobin level 
(g/dl)
1 1 0.76
Platelet count (×103e/mm3) 308 ± 131 261 ± 134 0.25
Aspartate aminotransferase 
(AST) (UI/L)
27 [17–38] 68 [34–244] 0.007
AST ≥34 UI/L 12 (29 %) 11 (64 %) 0.008
Alanine aminotransferase 
(ALT) (UI/L)
22 [12–35] 45 [16–136] 0.08
Bilirubin (µmol/l) 20 [14–39] 35 [22–63] 0.05
Blood urea (mmol/l) 13 ± 8 22 ± 14 0.1
Serum creatinine (µmol/l) 118 153 0.22
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At a time where the prehospital medicalization is the subject of 
numerous publications and a wide debate between two different 
management systems:
  •  In the USA, initial support is provided by paramedics, who 
after treatment of respiratory and hemodynamic distress use 
the shortest time possible to transfer the patient to the nearest 
trauma center, and this concept is called “scoop and run.”
 •  In France and in some European countries, the management is 
performed by physicians who take all the time necessary for the 
treatment of different afflictions before transferring the patient to 
the hospital, and it is called “stay and play.”
Our study has found that the initial management of patients was not 
medicalized in 60 % of patients. First, the multicenter study was able to 
show that prehospital medicalization of patients was associated with a 
significant reduction in risk of death in 30th post-traumatic day.
Conclusion The care of the injured polytrauma is complex and must 
not be improvised in any case.
This management must be rational and constantly evaluated in order 
to improve the quality and results. It concerns civil society, hospital 
practitioners and public authorities.
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Introduction The objective of this work is to achieve a system for 
monitoring parameters of respiratory tract and ensure feedback on 
the quality of chest compressions during cardiopulmonary resuscita-
tion (CPR).
Materials and methods This prototype is designed by flow and pres-
sure sensors that plug at the respiratory tract, as well as efficient data 
acquisition card which processes and monitors signals. Communication 
with the user is done by visual interfaces (graphical and numerical) via 
an efficient development tool LABVIEW 2014 (National Instrument).
The settings for the compression quality, frequency, flow, volume and 
respiratory tract pressure are recorded and displayed during CPR.
Results The figure presents a preliminary test and calibration of the sys-
tem’s sensors on a graphical interface using the measurement system 
(Fig. 28).
Conclusion The realized system will give a feedback on respiratory 
parameters generated by chest compressions. Additional tests are 
expected to validate this prototype in more realistic situations.
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Introduction Burns in combat usually represent 5–20 % of injuries [1]. 
The purpose of the study was to describe epidemiological characteris-
tics and the management of burns during French military operations.
Patients and methods A retrospective observational study was per-
formed of French casualties with burns, transported to Percy Burn 
Center (R4 Medical Treatment Facility) between January 1, 2001, and 
December 31, 2014.
Results Forty-six patients were included. Seventy-six percent of 
burns analyzed were non-battle injuries, mainly due to mishaps 
occurring with the burning of waste and the use of fuel. Combat 
burns (n  =  11/46) were all explosions related (improvised explosive 
devices). The median total body surface area burned was 15 % [9; 27]. 
Major anatomical regions affected were upper limbs (91  %), head/
neck (78 %) and hands (70 %). Battle-related burns resulted in higher 
median Injury Severity Score, more patients under mechanical venti-
lation, more blood transfusions and surgeries, respectively, 16 [6; 23] 
versus 4 [1; 8], 64 versus 17 %, 8 [0; 17] versus 0 and 3 [0; 4] versus 0 
(p < 0.05). The case fatality rate was 2.2 % (n = 1/46).
Discussion Majority of burns are non-battle injuries, small in size 
and accessible to prevention [2]. For battle-related burn injuries, the 
anatomical topography can be explained by the personal protective 
equipment and the higher severity score due to the associated trauma 
and mechanism. This study is only the visible tip of the iceberg.
Conclusion All military care providers should be familiar with the 
assessment and treatment of burns in military settings.
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Fig. 28 See text for description
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Introduction Drowning is a public health problem, with a high inci-
dence of 500,000 people worldwide, and 150,000 deaths each year in 
mainland France and the overseas territories. This is one of the lead-
ing causes of accidental death in children and adolescents. Immersion 
exposes them to multiple complications that are often life threatening. 
Infectious complications are, however, poorly understood and not well 
described. The objective of this study was to define the frequency and 
nature of lung infections in victims of drowning admitted to the emer-
gency and ICU departments at the University Hospital of Martinique.
Patients and methods We conducted a retrospective study from vic-
tims of drowning cases admitted to the ER and ICU CHU Martinique 
over a period of 3  years (2012–2015), supplemented by data from 
SAMU 972 records, including presentation of descriptive data and uni-
variate predictors of death.
Results One hundred and forty-four patients were included [102 
men/42 women, mean age 36.5  years (range 1–83  years)]. Drown-
ings occurred in seawater (N = 120, 83 %); swimming (N = 15, 10 %); 
freshwater (N = 5, 3 %) or polluted water (N = 1, 1 %). Seventy-eight 
patients (54  %) had comorbidities including hypertension (N  =  14, 
10  %); diabetes (N =  10, 7  %); epilepsy (N =  12, 8  %); heart disease 
rhythm and ischemic (N = 10, 7 %); chronic alcoholism (N = 8, 6 %); 
and obesity (N = 6, 4 %). The majority of victims (31 %) were in deep 
coma (score Glasgow: 3) and severe hypoxia; 32 victims (22  %) suf-
fered cardiac arrest. Complications were as follows: multiple organ 
failure (97 %), lactic acidosis (75 %, mean arterial pH 7.20), acute res-
piratory failure (49  %) and ARDS (16  %, 2 refractory ARDS patients 
required veno-venous ECMO). Bacterial pneumonia (N = 22, 15 %) was 
the main cause of infectious complications, early onset (within 24 h). 
Antibiotic therapy was started probabilistically on admission (N = 85, 
59 %), with amoxicillin/clavulanic acid (92 %), cefotaxime (6 %) or cefo-
taxime metronidazole+ (1 %). Only 17 % of victims had blood cultures 
and 52 (36  %) lung sampling. Antibiotic therapy was administered 
before performing lung samples (82 %). The most frequently encoun-
tered germs were Aeromonas hydrophilia, Enterobacter aerogenes, 
Enterobacter cloacae, Morganella and Morgani. The average length 
of ICU stay was 7 days. Eighteen of these patients (13 %) died in the 
ICU. Predictors of mortality endpoints were: the occurrence of a pre-
hospital cardiac arrest (p  <  0.0001), ARDS (p  <  0.001), the immersion 
time (p < 0.05), metabolic acidosis (p < 0.05), the Glasgow coma scale 
score <5 (p < 0.01), the resuscitation period (p < 0.01) and hypother-
mia (p < 0.05).
Conclusion The prognosis remains poor after immersion in the 
absence of a rapid response and appropriate treatment, especially in 
cases of occurrence of out-of-hospital cardiac arrest (OHCA).
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Introduction Despite evidence that conflicts are common and harm-
ful in the Emergency Department (ED), no study has been described 
in the literature. This study aimed to evaluate the prevalence and char-
acteristics of conflict in ED physicians and factors associated with still 
ongoing conflict.
Materials and methods This was an observational cross-sectional 
survey conducted among physicians in 12 Moroccan ED, from June 
2012 to January 2013. Socio-demographics, work characteristics, 
conflict-related variables, burnout level and self-estimation measures 
were included. Conflict-related question was formulated in the fol-
lowing way: In the past years, have you been drawn into any kind of 
conflict in ED? Response alternatives were (yes or no). To those who 
answered in the affirmative, the followed characteristics of conflict 
were collected; numbers of episodes of conflicts (<5 or ≥5). (a) The 
source of the conflict (Control, Prevision, Resources, Organisation, 
Coordination); (b) the form of the conflict; (Conflict of content, Con-
flicts of persons, Conflicts of procedure); (c) the degrees of the con-
flict: (Confrontation of viewpoint, Destructive personal attacks); (d) 
the conflict is important or unimportant; (e) the result of the conflict 
is good or poor; (f ) The conflict is terminated or still ongoing; (g) the 
response to the conflict: (Avoidance, Accommodation, Competition, 
Collaboration). Comparison between “terminated conflict” emer-
gency physicians group and “still ongoing conflict” group was made. 
Multiple logistic regression was used to evaluate factors associated 
with still ongoing conflict.
Results A total of 101 emergency physicians were included with a 
response rate of 81 %. The mean age of ED physicians was 40 ± 8 years, 
and 70.3 % among them are men. Conflicts were reported in 97 % of 
emergency physicians, 49.5  % reported more than five episodes of 
conflicts, and 41 % of conflict is still ongoing. The principal sources of 
conflict were: organisation in 82.2 % of case, resources 87.1 % of case 
and coordination 81.2 % of case. Comparison between the two groups 
showed that ED physicians with still ongoing conflict have a longer 
years of practices (11.6 ± 5 vs 9.1 ± 6.8, p = 0.02). Concerning burn-
out, ED physicians with still ongoing conflict are more emotionally 
exhausted (37.3 ±  9.7 vs 32.6 ±  12.8, p =  0.04) and have lesser per-
sonal accomplishment (27.5 ± 3.6 vs 32.6 ± 9.4, p = 0.01). Concerning 
self-rated scales, ED physicians with still ongoing conflict perceived a 
worst mental health (6.6 ±  1.3 vs 7.3 ±  1.3, p =  0.01) are less joyful 
(6 ± 1.2 vs 6.7 ± 1.5, p = 0.02).
Multiple logistic regression showed that longer years of practice 
(OR1.2, 95  % CI 1.02–1.31; p  =  0.02) and emotional exhaustion (OR 
1.2; 95 % CI 1.004–1.11; p = 0.03) were the factors associated with still 
ongoing conflict.
Conclusion The prevalence of conflict is very high in ED. Longer years 
of practice and emotional exhaustion in physicians was associated 
with still ongoing conflict. This high prevalence of conflict suggests 
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Introduction Peripartum morbidities present a clinical challenge due 
to maternal physiological adaptations related to pregnancy. Pregnant 
women may be afflicted with surgical condition and/or medical requir-
ing admission to intensive care unit. The aim of our study is to iden-
tify serious complications occurred during pregnancy and childbirth 
in our health structure and analyze the epidemiological aspects, the 
management and the development of these complications.
Patients and methods We conducted a retrospective descriptive 
study of 127 patients admitted in obstetric ICU for severe peripartum 
complications, during the period from January 2011 to December 
2013.
Results The average age of patients was 31 ±  5  years, ranging from 
19 to 45 years. Eighty-six women were classified as ASA 1 (67 %), and 
41 had a medical history including cardiomyopathy (29 %). The aver-
age gestity in these patients was 2 ± 1 [1–8], the parity was 1 [0–6], 
and the medium-term pregnancy at the time of hospitalization was 
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34 weeks [28–42]. The main reasons for admission were the manage-
ment of postpartum hemorrhage in 36 % of cases followed by severe 
preeclampsia in 31  % of cases. The admission to gravity scores were 
10 ±  7 for APACHE 2 [0–35], 17 ±  13 for the IGS2 and 3 ±  3 for the 
SOFA score. Artificial ventilation was necessary in 42  % of cases. The 
duration of ventilation was 2 ±  2  days [0–16]. The main therapeutic 
implemented during the ICU stay has been in order of frequency: the 
antibiotic therapy in 43  % of patients, anticonvulsants (magnesium 
sulfate) and antihypertensives (40  %), transfusion of blood products 
(27 %) and use of vasopressors (15 % of cases). Fifty-six patients had at 
least one complication during hospitalization. The most frequent one 
was acute kidney failure, infectious and respiratory complications. The 
average hospital stay was 5 days [1–85]. Five patients died.
Conclusion Our study confirms that direct obstetric complications, 
mainly hypertensive and hemorrhagic, predominate. Severity scores 
are lower than for the general population resuscitation, the observed 
mortality was lower than the predicted mortality, and longer durations 
of hospitalization and ventilation are shorter. A structure of obstetric 
ICU could promise earlier management of maternal conditions at high 
risk of serious complications.
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Introduction This study aimed to illustrate the characteristics of sui-
cide attempters treated in the Emergency Departments of a general 
hospital in Tunisia and to provide relevant data for early psychological 
treatment.
Patients and methods Between January 2009 and December 2014, 
571 suicide attempters were treated in the Emergency Departments. 
Data were collected using a semi-structured questionnaire. Descrip-
tive statistics, Chi square tests, and multivariate analyses were used to 
identify the factors associated with suicidal behaviors
Results Females outnumbered males at a ratio of 3.5–1. The great-
est proportion of cases was in the age group of 15–30 years (62.7 %). 
Patients who finished middle school or high school accounted for 
most of the suicide attempters. The most common method used for 
attempted suicide was drug ingestion (85.5 %). The majority of cases 
attempted suicide at home. Marriage frustration, work and study 
problems, family fanaticism and conflict, somatic disease, and his-
tory of mental disorders were all significantly associated with suicide 
attempts. The ratio of patients to be discharged or to die was similar in 
occupation, marital status, and the place of suicide attempt; however, 
the results were different in gender, age, educational level, methods 
used for suicide, time of day, and reason.
Discussion and conclusion Suicide is an important public health 
problem. A previous suicide attempt is a risk factor for suicide; thus, 
assessing the characteristics of suicide attempts or instrumental sui-
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Introduction Septic shock is a worldwide burden with over 750,000 
cases per year in the US only. This pathology, characterized by a sys-
temic inflammation, is associated with a severe cardiovascular dys-
function. Currently, there is no specific treatment for the septic shock 
beside antibiotherapy, fluid resuscitation and vasopressor amine. 
Finding new therapeutic leads in septic shock is important because 
this disease is a major public health problem. Recently, Not et  al. 
showed, during hemorrhagic shock in rats, a beneficial effect of the 
O-GlcNAcylation stimulation on cardiovascular parameters. O-Glc-
NAcylation, a posttranslational modification, is the end product of the 
hexosamine biosynthetic pathway (HBP). We postulated that increase 
in total protein O-GlcNAcylation at the early phase of septic shock 
could improve cardiovascular function and reduce mortality.
Materials and methods To induce an endotoxemic shock, rats 
(n = 6–8) received iv either lipopolysaccharide (LPS, 5 mg/kg) or saline 
(CTRL). After 1  h, fluid resuscitation (FR, 15  ml/kg of colloid, iv) was 
associated or not with HBP substrate: glucosamine (GlcN, 180 mg/kg) 
or an O-GlcNAcase inhibitor (NButGT, 10 mg/kg). Two hours later, ech-
ography and mean arterial pressure (MAP) evaluation were performed; 
blood samples and heart were then collected to evaluate biological 
parameters (lactate, troponin T, creatinine), inflammation, autophagy 
and total O-GlcNAcylation by western blot. Survival analysis was per-
formed in parallel.
Results In vivo studies showed an hypotension in LPS restored by 
FR and treatments (MAP: CTRL 87 ± 1, LPS 73 ± 5*, LPS-FR 93 ± 6#, 
NButGT 83 ±  5, GlcN 92 ±  4  mmHg, *: p  <  0.01 vs CTRL, #: p  <  0.01 
vs LPS) and a systolic dysfunction in LPS with a trend toward improve-
ment by NButGT and GlcN (ejection fraction: CTRL 81 ± 2, LPS 65 ± 3*, 
LPS-FR 69 ± 2, NButGT 75 ± 2#, GlcN 74 ± 2 %, *: p < 0.01 vs CTRL, #: 
p < 0.05 vs LPS). NButGT and GlcN efficiently increased total O-GlcNAc 
(200 and 300  %, respectively, vs LPS-FR). This effect was associated 
with a reduced cardiomyocyte insult, tissue dysoxia and renal dysfunc-
tion (creatinine: CTRL 25.4 ± 1.2, LPS 51.4 ± 5.8*, LPS-FR 77.5 ± 6.8*, 
NButGT 33.7 ±  4.7£, GlcN 38.7 ±  8.2  µmol/l£, *: p  <  0.01 vs CTRL, £: 
p  <  0.05 vs LPS-FR). Moreover, while all LPS +  R rats did not survive 
after 10  h, 20  % of treated rats survived after 18  h. Interestingly, 
NButGT and GlcN effects were not associated with modification of 
autophagic pathway (Beclin-1, LC3, Bcl-2) or inflammation (TNF-α, 
IL-6).
Conclusion At the early phase of septic shock, NButGT and GlcN 
induce an increase in cardiac O-GlcNAcylation leading to improve 
tissue oxygenation and renal function and to reduce cardiac injury. 
These treatments improved cardiovascular function. The next step is 
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Introduction MicroRNAs (miRs) are noncoding RNAs found in all 
eukaryotic cells that regulate the human genome, primarily through 
translational repression. MiR-21 is expressed by inflammatory and 
endothelial cells in response to bacterial LPS, TNF-α or apoptotic 
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debris. Mir-21 limits the production of cytokines and the expression 
of endothelial adhesion molecules and modulates cell survival. Most 
of the miR-21 targets being involved in the pathophysiology of septic 
shock, we hypothesized that miR-21 could play a role in tissue injury 
following bacteria invasion.
Patients and methods We demonstrated genetic invalidation (miR-
21−/−) or pharmacological inhibition of miR-21 (antagomiR-21). We 
reviewed mouse models of severe infections, endotoxinemia (LPS 
15 mg/kg) and non-resuscitated peritonitis.
Results In vitro, LPS-stimulated miR-21−/− splenocytes produced 
more IL-12p70 than miR-21+/+ splenocytes (p  <  0.05). In addition, 
miR-21  −/−  bone marrow-derived macrophages stimulated by LPS 
produced more IL-12p70, Il-1b, TNF-a and less Il-10 than control miR-
21+/+ macrophages (P < 0.05). In a mouse model of endotoxinemia, 
genetic invalidation (miR-21−/−) of miR-21 significantly increased 
mortality (P  <  0.01). Pharmacological inhibition of miR-21 using 
antagomiR-21 significantly increased mortality in two models of lethal 
infections (P  <  0.01, endotoxinemia and peritonitis). MiR-21+/+ and 
miR-21−/− mice were irradiated and retransplanted with MiR-21+/+ 
and miR-21−/− bone marrow. Four groups of chimeric mice were gen-
erated and challenged intraperitoneally with LPS. Interestingly, both 
miR-21 deficiency in leucocytes and in endothelial cells increased mor-
tality in a non-redundant manner.
Conclusion MiR-21 deficiency induced a deviation of the immune 
response towards a pro-inflammatory profile and increased mortality 
during experimental shock septic.
Competing interests None.
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Introduction In recent studies, β1-adrenergic blocker demonstrated 
cardiovascular protection in sepsis. Experimental research showed 
that these benefits are associated with a down-regulation of inflam-
matory pathways. However, the specific impact of heart rate reduction 
on the inflammatory pathways remains unknown. Ivabradine is a pure 
heart rate-lowering drug that acts specifically on the sinoatrial node 
by selectively inhibiting the If current. The present study was designed 
to assess the effects of heart rate reduction by ivabradine on cardio-
vascular function and on the inflammatory pathways involved in peri-
tonitis-induced septic rats.
Materials and methods Sixteen Wistar male rats were treated with 
cecal ligation and perforation (CLP) to evoke peritonitis. Four hours 
after CLP, rats were randomly allocated to CLP (n = 8) and ivabradine 
(n = 8, administrated per os at H4) groups. Another eight Wistar male 
rats underwent sham operation. All rats received a continuous infu-
sion of saline [10 mL/(kg h)], analgesic [nalbuphin: 0.2 mg/(kg h)] and 
antibiotic (imipenem and cilastatin sodium: 10  mg/kg) 4  h after the 
surgery. Assessment at 18 h included in vivo cardiac function by echo-
cardiography and ex  vivo vasoreactivity by myography. Cardiac and 
vascular protein expressions of NF-κB and eNOS/Akt/iNOS pathways 
were also assessed by western blotting.
Results Compared with Sham animals, CLP induced tachycar-
dia (376  ±  26 vs. 431  ±  22  bpm, p  <  0.05), hypotension (111  ±  7 
vs. 80  ±  7  mmHg, p  <  0.05), decrease in cardiac output (95  ±  13 
vs. 56  ±  15  mL/min, p  <  0.05), hyperlactatemia (1.2  ±  0.3 vs. 
2.5  ±  0.5  mmol/L, p  <  0.05) and vascular hypo-responsiveness to 
vasopressors. Adjunction of ivabradine decreased heart rate (329 ± 38 
vs. 431  ±  22  bpm, p  <  0.05) without any impact on blood pressure 
(73  ±  10 vs. 80  ±  7  mmHg, p  >  0.05), cardiac output (37  ±  18 vs. 
56 ± 15 mL/min, p > 0.05), lactatemia (2.6 ± 0.6 vs. 2.5 ± 0.5 mmol/L, 
p > 0.05) and vascular responsiveness to vasopressors, compared with 
CLP group. Results of western blot will be provided later.
Conclusion Isolated reduction in heart rate by ivabradine in an experi-
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Introduction The receptor of epidermal growth factor (EGF-R) is 
expressed by mesenchymal and immune cells. EGF-R is involved in 
survival, migration and proliferation. Pharmacological EGF-R inhibit-
ing therapy using either neutralizing mAbs or small-molecule tyrosine 
kinase inhibitors (TKI) has been successfully used in cancer treatment. 
Few evidences suggested that EGF-R could modulate directly the 
immune system, but the consequences in response to bacteria injury 
remain unknown. We aimed to investigate the effects of EGF-R block-
ing in an experimental model of septic shock.
Patients and methods We demonstrated the specific invalidation 
of Egf-r in myeloid cells (LysMCre Egf-rlox/lox) or pharmacological 
inhibition of EGF-R using TKI in vitro (AG-1478) and in vivo (Erlotinib, 
Tarceva®). We reviewed the model of endotoxinemia by intraperito-
neal injection of LPS (15 mg/kg). Cell culture of splenocytes, purified 
bone marrow neutrophils (isolation kit Miltenyi) and bone marrow-
derived macrophages (BMDMs) were tested.
Results In vitro, LPS-stimulated LysMCre Egf-rlox/lox splenocytes pro-
duced more IL-6 (+300 %, P < 0.05) and more IL-10 (+70 %, P < 0.05) 
than control LysMCre Egf-r+/+ but no difference regarding TNF-α. 
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LPS-stimulated LysMCre Egf-rlox/lox BMDMs produced significantly 
more IL-6 (+70 %) and more IL-10 (+180 %) than control LysMCre Egf-
r+/+ cells. In addition, LysMCre Egf-rlox/lox neutrophils stimulated by 
LPS produced more TNF-α (+48  %) and have a higher MPO activity 
(+50 %, P < 0.05) than control cells. Genetic invalidation and pharma-
cological inhibition of EGF-R significantly decreased the recruitment 
of immune cells within the peritoneal cavity following LPS injection 
(respectively, −65 and −42 %, P < 0.05). However, genetic invalidation 
or pharmacological inhibition of Egf-r did not impair mouse survival in 
a model of endotoxinemia.
Conclusion EGF-R deficiency/inhibition modulated innate immune 
response but did not impair survival during experimental sepsis.
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Introduction Omega-3 supplementation for several weeks has been 
shown to improve myocardial resistance to ischemia–reperfusion in 
rats. In a rat model of myocardial ischemia–reperfusion, we investi-
gated the effect of an intravenous bolus of omega-3, associated or not 
with iodinated contrast media (used for reperfusion process during 
coronarography), at reperfusion time, so as to mimic emergency clini-
cal management of myocardial infarction and reperfusion-induced 
shock.
Materials and methods A myocardial ischemia–reperfusion model 
was performed by left anterior descending coronary artery ligation in 
rats. After a 30-min ischemia, but before reperfusion, an intravenous 
bolus of EPA and DHA (6:1), associated or not with iodinated contrast 
media, was administered. After a 4-h reperfusion, circulating procoag-
ulant microparticles were quantified phenotyped. Vascular and heart 
inflammation, oxidative and nitrosative stresses were assessed. Ex 
vivo vascular reactivity was performed with a pharmacological selec-
tive inhibitor of iNOS. Infarct size was assessed by triphenyltetrazolium 
chloride staining.
Results Treating rats with an EPA/DHA bolus before reperfusion sig-
nificantly improved the ischemia–reperfusion syndrome, increasing 
mean arterial pressure (151 ± 13 vs 122 ± 17 mmHg, p < 0.05), coro-
nary and carotid blood flow, and decreasing infarct size (39.9 ± 2.3 
versus 26.8 ± 5.7 % of left ventricle, p < 0.05). Moreover, ex vivo mes-
enteric resistance artery sensitivity to phenylephrine was improved. 
Finally, endothelial CD54+ microparticle release was decreased 
(9.1 ±  2.5 vs. 4.8 ±  2.0  nM EqPhtdSer, p  <  0.05), as well as vascular 
inflammation and oxidative stress, reflecting a reduced vascular 
dysfunction.
Discussion In our model, the omega-3 vascular beneficial effects 
may partly result from endothelial protection. Indeed, ischemia–rep-
erfusion-induced endothelial dysfunction results in phenotypic and 
physical changes in the endothelium, with a deregulated release of 
potent vasodilators nitric oxide and prostacyclin, reduced vascular 
reactivity to vasoconstrictors, associated with leukocyte and platelet 
aggregation and deregulation of nitric oxide signaling. Rat hemody-
namic parameters were subsequently improved. Associating omega-3 
to iodinated contrast media in the reperfusion process therefore 
deserves further investigating and might be a promising line of devel-
opment in humans.
Conclusion In this rat model, an intravenous omega-3 bolus before 
reperfusion significantly improved cardiovascular resistance to 
ischemia–reperfusion-induced cardiovascular failure and shock.
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Introduction New therapies to improve prognosis of patients with 
septic shock are a major area of research. Urotensinergic system plays 
a role in both modulation of inflammation and cardiovascular system 
and thus could be a therapeutic target. Unpublished work previously 
done highlighted an improvement in inflammatory parameters by 
administration of the antagonist urantide in an endotoxinic model. 
The aim of our study was to evaluate survival and myocardial function 
after administration of urantide during sepsis.
Materials and methods This animal study was subdivided into three 
experimental process involving different mice (C57Bl/6): a survival 
analysis (n = 10/group), an echocardiographic analysis (n = 5/group) 
and a study of tissular inflammation markers (n  =  5/group). Three 
groups of mice were made, a sham group without sepsis, a control 
group (LPS-NaCl) and an urantide-treated group (LPS-urantide). Intra-
peritoneal injection of 30  mg/kg of lipopolysaccharide (LPS) from 
Escherichia coli was administered for septic groups. Echocardiographic 
analysis was performed every 3 h during 9 h for left ventricular ejec-
tion fraction (LEVF), cardiac output, aortic flow, heart rate and the E/A 
ratio obtained from mitral flow. Injection of either NaCl or urantide 
(10−4  M) at hour 3 and 6 was administered. Analysis of survival was 
performed according to the same experimental process, and tissular 
expression of hepatic, renal and myocardial NF-κB was performed at 
hour 9.
Results Survival was significantly improved from 30  % up to 88.9  % 
by urantide. Administration of LPS induced impairment of LVEF 
9  h after the onset of sepsis. Urantide induced a significant differ-
ence in the LVEF and cardiac output at hour 9 with an increase up to 
46  % (p  <  0.05) and 51  % (p  <  0.01), respectively, versus the control 
group. No difference was reported for heart rate or E/A ratio. Renal 
and hepatic expression of NF-κB was reduced down to 60 and 65 %, 
respectively, by urantide administration. Myocardial expression was 
not performed because of technical issues.
Discussion Our results highlighted a key role of urotensinergic system 
in cardiac performance during septic shock and a potential benefi-
cial effect of its antagonizing. Nevertheless, our study was not able to 
determine the preload status of mice. Thus, it was not possible to dis-
criminate a beneficial effect due to vascular or inotropic modulation.
Conclusion Urantide administration induced an improvement in sur-
vival and systolic myocardial function with increase in LVEF and car-
diac output in an endotoxinic model of sepsis. Improvement in tissular 
inflammation may be involved. Further study is necessary in order to 
explore the effect on myocardial performance independently from 
vascular function.
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Introduction Bacterial meningitis is still a severe infectious disease 
worldwide, with high rates of morbidity and mortality in children and 
adults. Dexamethasone (DXM) is recommended in association with 
antibiotics in some specific cases to decrease the risk of sequelae and 
possibly the mortality rate. The poly-β-(1,6)-N-acetyl-glucosamine 
(PNAG) is a surface polysaccharide expressed by numerous patho-
genic bacteria, including species responsible for meningitis as Strep-
tococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae, 
or Escherichia coli K1. Passive immunotherapy by monoclonal (MAb) to 
PNAG and polyclonal antibodies (PAb) to deacetylated PNAG (dPNAG) 
can prevent and treat various infections. The aim of this study was to 
analyze the association of DXM and antibodies to PNAG in neonatal 
bacterial meningitis prevention and treatment, using an E. coli K1 neo-
natal meningitis murine model.
Materials and methods The presence of PNAG on E. coli K1 surface 
in  vitro and in  vivo was assessed by confocal microscopy using fully 
human immunoglobulin G1 MAb with V-regions encoding specificity 
for either P. aeruginosa alginate, MAb F429 (control), or PNAG, MAb 
F598. In vitro experiments of bacterial adhesion on blood brain bar-
rier (BBB) human cells were conducted using hCMEC/D3 cell line. Con-
fluent cells were infected with 3.5 × 10e8 of the well-described E. coli 
K1 S88, alone or with DXM, goat PAb to dPNAG or normal goat serum 
(NGS). Experiment in the neonatal meningitis model was performed in 
3-day-old CD1 mice by intraperitoneal (IP) administration of E. coli S88 
K1 (10−6/mouse). The IP administration of PBS or goat PAb to dPNAG 
(50  µL/mouse) was performed 24  h before and 2  h after challenge. 
DXM (0.7  mg/kg) was also injected 2  h after infection. The newborn 
mice were killed 24 h after challenge, the brain harvested and the col-
ony-forming unit (CFU) count of E. coli determined.
Results In vitro, bacterial growth of E. coli K1 was not affected by the 
presence of different concentrations of DXM, antibodies to PNAG 
or both. PNAG expression was conserved in  vitro on the bacterial 
surface of E. coli K1 in the presence of different concentrations of 
DXM, meaning that antibodies to PNAG could be associated with 
DXM. PNAG was also found on E. coli K1 surface in positive brains’ 
homogenates of newborn mice, confirming that PNAG could effec-
tively serve as a therapeutic target in vivo. hCMEC/D3 experiments 
showed a 50  % decrease of bacterial adhesion in the presence 
of PAb to dPNAG compared to E. coli K1 alone (p =  0.001) or NGS 
(p  =  0.007). DXM was responsible for a significant increase of E. 
coli adhesion in a dose-dependent manner (DXM 100  µM per well 
2 × 10−7 vs 8.2 × 10−6, p = 0.001). The addition of different concen-
trations of DXM to PAb or to NGS did not change E. coli adhesion on 
hCMEC/D3 compared, respectively, to PAb alone (p =  0.98) or NGS 
alone (p =  0.48). In vivo, E. coli K1 meningitis rate was 100  % after 
IP administration. Compared with PBS, the administration of PAb 
decreased significantly the CFU per brain (4.1 ×  10−5 vs 4 ×  10−2, 
p  <  0.001). DXM administration after bacterial challenge did not 
change the CFU in the brain of neonates compared with bacteria 
alone (1.7 ×  10−5 vs 1.3 ×  10−5, p =  0.43). The association of PAb 
to DXM showed a significant decrease in CFU in the brain compared 
with PBS (4.1 × 10−5 vs 10 × 10−3, p = 0.007) but no difference with 
PAb alone (10−3 vs 4 × 10−2, p = 0.33).
Conclusion PAb to dPNAG decrease E. coli K1 adhesion on the BBB 
in vitro and E. coli CFU per brain in vivo. DXM in association with PAb 
to dPNAG does not change the effect of PAb alone in  vitro neither 
in  vivo. Further experiments using the E. coli K1 neonatal model as 
well as adult animal models of meningitis when testing S. pneu-
moniae or N. meningitidis will better determine the possible use of 
DXM in association with PAb or MAb F 598 in bacterial meningitis 
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Introduction Several studies demonstrated an increased mortality 
rate in critically ill patients with hyperoxemia. Reactive oxygen species 
production, atelectasis, alveolar macrophage dysfunction, and acute 
lung injury are well-known consequences of hyperoxemia. In addition, 
these factors have been reported to increase the risk of pneumonia in 
intubated patients. To our knowledge, no study has previously evalu-
ated the relationship between hyperoxemia and ventilator-associated 
pneumonia (VAP).
Patients and methods This retrospective observational study was 
performed during an 18-month period in a 30-bed medical and sur-
gical ICU. All intubated patients requiring mechanical ventilation for 
more than 48 h were eligible. The primary objective was to determine 
the impact of arterial hyperoxemia (defined as PaO2 >120 mmHg) on 
the risk of VAP occurrence. VAP definition included clinical, radiologi-
cal, and quantitative microbiological criteria. Patient characteristics 
and information on VAP occurrence were prospectively collected. Only 
data on arterial blood gases were collected retrospectively. Each day 
with at least one PaO2 >120 mmHg accounted for 24 h with hyperox-
emia. Risk factors for VAP were determined using univariate analysis 
and logistic regression multivariate analysis.
Results VAP was diagnosed in 141 (28  %) out of the 503 included 
patients. The incidence rate of VAP was 14.7 per 1000 ventilator-days. 
Pseudomonas aeruginosa (34  %) and Staphylococcus aureus (11.3  %) 
were the most frequently isolated bacteria. Hyperoxemia at ICU admis-
sion (67 vs. 53 %, OR [95 % CI] 1.8 [1.2–29], p = 0.004) and number of 
days spent with hyperoxemia (5 vs 3 days, p < 0.001) were significantly 
higher in patients with VAP, compared with those without VAP. Univari-
ate analysis also identified (p < 0.05) age, SAPS II, LOD score, shock at 
ICU admission, proton-pump inhibitor (PPI) use, red blood cell trans-
fusion, sedation, and duration of mechanical ventilation as risk factors 
for VAP.
Multivariate analysis identified the number of days spent with hyper-
oxemia (OR [95  % CI] 1.1 [1.04–1.2] per day, p  <  0.05), SAPS II (1.01 
[1.002–1.024] per point, p < 0.05), red blood cell transfusion (1.8 [1.1–
2.7], p = 0.01) and PPI use (1.9 [1.03–1.2], p < 0.05) as independent risk 
factors for VAP. Two other logistic regression models were performed 
to determine the relationship between the percentage of days spent 
with hyperoxemia, or hyperoxemia at ICU admission and VAP. In these 
secondary analyses, the percentage of days spent with hyperoxemia, 
and hyperoxemia at ICU admission were also independently associ-
ated with VAP occurrence.
Conclusion Hyperoxemia is an independent risk factor for VAP. Fur-
ther prospective large multicentre studies are required to confirm our 
results.
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Introduction Ventilator-associated pneumonia (VAP) is frequent in 
intensive care units (ICU). Extended-spectrum beta-lactamase-produc-
ing Enterobacteriaceae (ESBL-EB) are difficult-to-treat pathogens. We 
sought to assess the interest of screening for ESBL-Eb rectal carriage as 
a way to predict their involvement in VAP.
Patients and methods A retrospective cohort study of patients with 
suspected VAP in a medical ICU was conducted. Every patient admit-
ted between January, 2006, and August, 2013, was eligible if subjected 
to mechanical ventilation for more than 48  h. Each patient with sus-
pected VAP was included in the cohort. Active surveillance culture for 
ESBL-EB detection was routinely performed in all patients on admis-
sion and then weekly throughout the study period. ESBL colonisation 
was defined by the isolation of at least on ESBL-EB from rectal swab 
culture.
Results Among 587 patients with suspected VAP, 40 (6.8 %) were colo-
nised with ESBL-EB prior to the development of pneumonia. Over the 
study period, 20 patients (3.4 %) had VAP caused by ESBL-EB, of whom 
17 were previously detected as being colonised with ESBL-EB. Sensitiv-
ity and specificity of prior ESBL-EB colonisation as a predictor of ESBL-
EB involvement in VAP were 85.0 and 95.7 %, respectively. The positive 
and negative predictive values were 41.5 and 99.4 %, respectively. The 
positive likelihood ratio was 19.8.
Conclusion Screening for ESBL-EB digestive colonisation by weekly 
active surveillance cultures could reliably exclude the risk of the 
involvement of such pathogens in VAP in low prevalence area.
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Introduction Ventilator-associated pneumonia (VAP) complicates the 
course of 8–28 % of patients receiving mechanical ventilation (MV). Its 
mortality rate can reach 76 % when lung infection is caused by high-
risk pathogens as Acinetobacter baumannii. Bacterial colonization 
of the trachea and bronchi preceding VAP is well recognized as part 
of the pathogenic mechanisms. The objectives of this study were to 
determine the incidence, the associated risk factors and the impact on 
prognosis of lower respiratory tract colonization in patients under MV.
Patients and methods It is a monocentric prospective study per-
formed within 3 years. All patients admitted to our intensive care unit 
requiring invasive mechanical ventilation for more than 48  h were 
included. Eligible patients had a bacteriological follow-up that starts 
at the third day of hospitalization by realizing tracheal aspirate (TA) 
which is repeated every 3  days during MV length. Lower respiratory 
tract colonization is defined by a positive TA culture in the absence of 
clinical suspicion of VAP.
Results Two hundred and sixty-six patients on MV for more than 48 h 
were prospectively followed in this study. The airway colonization 
occurrence was 38 % with a maximum between day 3 and day 6 of MV. 
The two most frequently isolated germs are Acinetobacter baumannii 
and Pseudomonas aeruginosa with a significant increase in their occur-
rence in time.
In multivariate analysis, the use of proton pump inhibitors, MV’s dura-
tion and length of stay are identified as associated factors to the onset 
of airway colonization.
The incidence of VAP was significantly higher in colonized versus non-
colonized patients (32 vs 18 %; p = 0.006). The onset of airway coloni-
zation was significantly associated with prolonged duration of MV and 
an increased length of stay [19 ±  17 vs 9 ±  7  days (p  <  0.0001) and 
25 ± 23 vs 12 ± 9 days (p < 0.0001), respectively)] The mortality rate 
was comparable between colonized and non-colonized patients.
Conclusion The lower respiratory tract colonization is frequent in 
patients under MV. The use of proton pump inhibitors, MV’s duration 
and length of stay are identified as associated factors to the onset of 
airway colonization. Colonized patients had a greater risk of develop-
ing VAP. The onset of airway colonization was significantly associated 
with prolonged duration of MV and an increased duration of stay.
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Introduction Initiation of antibiotherapy is of major importance in the 
treatment of nosocomial pneumonia in the ICU. Antibiotherapy must 
be early, appropriated to the presumed bacteria, and must take into 
account epidemiology of the ICU and of the hospital. The aim of this 
study was to describe epidemiology of ventilator-associated pneu-
monia (VAP) in the ICU for patients already in hospital before ICU 
admission (HCAP) and to identify risk factors for multidrug-resistant 
pathogens.
Patients and methods This was a monocentric retrospective study of 
patients admitted to a single ICU in a large regional university hospi-
tal, with a diagnosis of ventilator-associated pneumonia, originating 
from another unit in the same hospital. Patients coming from home 
and from another hospital, and immunocompromised patients were 
excluded. Ventilator-associated pneumonias were divided into early 
onset (<5  days) and late onset (≥5  days). Duration of hospitalization 
before ICU admission, and the main risk factors for multidrug-resistant 
pathogens were collected.
Results Between January 2014 and May 2015, 114 patients devel-
oped ventilator-acquired pneumonia in the ICU. There were 69 (61 %) 
early-onset pneumonia and 45 (39 %) late-onset pneumonia. Bacterial 
diagnoses were made on tracheal aspirations (99.1  %) and broncho 
alveolar lavages (35.9). There were no significant differences in the 
bacteriology of early- and late-onset VAP. Gram negative bacteria were 
predominant (30.4 vs 31.1 %, p = 0.94). There were 18.4 % of multid-
rug-resistant pathogens in the overall population. Multidrug-resistant 
pathogens were mainly gram-negative bacteria (four BLSE, 11 cepha-
losporinase, four multiresistant pseudomonas aeruginosa, one steno-
trophomonas maltophilia, and 1 SARM). There was a trend toward a 
higher prevalence of multidrug-resistant pathogen among patients 
with late-onset VAP (13 vs 27  %, p  =  0.07). In univariate analysis, 
multidrug-resistant pathogens were associated with duration of hos-
pitalization before ICU admission (5.9 ± 8.5 vs 24.8 ± 74.5, p < 0.05), 
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duration stay in the ICU (8.8 ± 6.8 vs 27.2 ± 25.9, p = 0.004), and dura-
tion of mechanical ventilation (7.1 ± 5.9 vs 20.6 ± 25.3, p = 0.04).
Conclusion This work did not find significant differences in the epi-
demiology of early-onset versus late-onset VAP for patients already in 
hospital before ICU admission. However, there was a trend toward a 
higher rate of multidrug-resistant pathogens in late-onset VAP. Multid-
rug-resistant pathogens were mainly gram-negative bacteria, whereas 
prevalence of SARM was anecdotal. Duration of hospital stay before 
ICU admission, duration of ICU-stay, and duration of mechanical venti-
lation were risk factors for multidrug-resistant pathogens.
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Introduction Hospital-acquired pneumonia (HAP) is the second most 
common nosocomial infection in hospitalized adults and is a lead-
ing cause of death among critical infections. To face the dramatically 
increasing prevalence of multidrug-resistant pathogen-related HAP, 
new therapeutic options are currently in development. The evaluation 
of these new treatments will require properly designed studies with 
appropriate inclusion criteria and endpoints. During the past 10 years, 
the regulatory agencies repeatedly updated guidance for the design 
of randomized controlled trials (RCT) aiming to evaluate the efficacy of 
antimicrobials for treatment of hospital-acquired and ventilator-asso-
ciated pneumonia (HAP/VAP). However, our hypothesis is that, to date, 
HAP/VAP RCTs greatly differ in population enrolled, in HAP/VAP defi-
nition criteria used and in primary and secondary outcomes assessed. 
Such differences between studies may be of importance because they 
may impact results of studies. Thus, we performed a systematic review 
of characteristics of enrolled populations, inclusion/exclusion crite-
ria and endpoints in RCT addressing the efficacy of antimicrobials for 
HAP/VAP treatment.
Patients and methods A double data search (PubMed–EMBASE, 
ICAAC, ESCMID) was performed of all RCT of the past 20 years evaluat-
ing antimicrobials for treatment of intensive care unit (ICU)-HAP/VAP.
Results The search retrieved 997 abstracts, of which 93 studies were 
reviewed. After exclusion of duplicates, post hoc analyses, studies 
without precise inclusion/exclusion criteria, studies without VAP and 
studies performed only outside the ICU, 25 studies were analyzed. 
One-third of studies included only VAP, while the other two-third 
included both HAP and VAP. The definition of HAP/VAP used various 
clinical radiological and biological criteria. Variable mandatory dura-
tion of prior hospital stay was used and length of mechanical venti-
lation was included in inclusion criteria in 36  % of VAP studies only. 
Microbiological criteria were required in only 48  % (with a microbio-
logical threshold in 36  % of studies). Severe patients (APACHE score 
>25) were excluded in 24 % of studies. Most studies tested a hypoth-
esis of non-inferiority (36  %) or equivalence (24  %), while 16  % of 
studies aimed to demonstrate superiority. Surprisingly, statistical 
hypothesis was not clearly defined and sample size calculation not 
mentioned in 28 and 64  % of studies, respectively. Clinical cure was 
considered as a primary endpoint in 92 % of studies. However, the pri-
mary endpoint was dual and even triple in, respectively, 40 and 12 % 
of studies because it was studied in different analysis population (28 % 
of studies) or it was associated with microbiological cure (16 %) and/
or safety. Assumed clinical cure rate was anticipated in only one-third 
of manuscripts. Mortality was used as a primary endpoint only in two 
studies and safety in one. Definitions of clinical cure consisted in com-
plete or partial remission of clinical signs and symptoms associated 
with pneumonia in 100 % of studies, but improvement in chest radi-
ography was associated in only two-third of the studies. Interestingly, 
the lack of additional antibiotic requirement during follow-up was 
included in clinical cure definition in 29 % of studies. The test-of-cure 
visit evaluating the clinical cure ranged from the end of treatment to 
28 days later.
Conclusion Our study provides a description of populations and end-
points of RCTs evaluating antimicrobials for treatment of ICU-HAP/VAP. 
We show a significant heterogeneity in enrollment criteria, endpoints 
and statistical design that may influence the ability of studies to dem-
onstrate differences between studied drugs.
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Introduction Ventilator-associated pneumonia (VAP) is a frequent 
infection that complicates the course of many critical care patients. 
Early antimicrobial therapy, initiated before the results of pulmonary 
specimen cultures, seems to improve outcome (1). However, empiric 
treatment strategies expose the risk of inappropriate treatment, or 
unnecessary broad-spectrum antibiotic. Best bacteriological tech-
nique for the diagnosis of VAP is still debated. Blindly inserted tel-
escoping plugged catheter (TPC) sampling seems reliable and is 
recommended methods for the bacteriological diagnosis of VAP. The 
threshold of 103 colony-forming units (cfu)  mL−1 provides a good 
sensitivity and specificity. Because 24- to 48-h delay is needed for 
quantitative cultures, early Gram’s stain identification performed 
upon TCP samples could guide empirical antibiotic therapy. How-
ever, accuracy of such strategy is controversial because true sen-
sitivity and specificity of Gram’s stain for diagnosis of VAP remain 
questionable. In the present study, we evaluate whether the Gram 
stain upon initial TPC samples could predict the results of quantita-
tive culture and identification of pathogens in patients suspected for 
VAP. We analyze associated factors that may influence accuracy of 
Gram’s stain identification and the resulting empiric antibiotic treat-
ment adequacy.
Patients and methods We retrospectively analyzed 122 TPC samples 
from 77 patients between January and December 2012, correspond-
ing to all TPC samples retrieved for VAP diagnosis in a 20-bed surgi-
cal intensive care unit of a University Hospital. Positive Gram’s stains 
and culture for any microorganisms, the presence of Gram-positive 
cocci (GPc) and/or Gram-negative rods (GNr) on Gram’s stain and cul-
ture were collected. Cultures were considered positive if they yielded 
organisms on final culture with a threshold value ≥103 cfu mL−1. The 
presence of leukocytes, moment of the day sampling being perform, 
prior to sampling antibiotic therapies, and duration of mechanical 
ventilation before sampling were analyzed as possible associated fac-
tors that may influence results of Gram’s stain. Fisher’s exact test was 
used for comparison of sensitivity and specificity between groups. 
Data are expressed as number (95 % confidence interval); p < 0.05 was 
considered to be statistically significant.
Results A total of 122 TPC samples were analyzed. Details of diagno-
sis performance (sensitivity, specificity, predictive value and likelihood 
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ratio) of Gram staining for positive quantitative culture of any microor-
ganism, GPc and GNr are summarized in Table 14.
Among associated factors, the presence of leukocytes on Gram’s stain 
was associated with an improvement in sensitivity versus the absence 
of leukocytes for any microorganism (0.87, p  <  0.001), for GPc (0.83, 
p = 0.04) and for GNr (0.63, p = 0.036). Other associated factors failed 
to influence the results of Gram’s stains. False negative Gram’s stain 
for any microorganism was significantly associated with non-adapted 
empirical antibiotic treatment (p = 0.008).
Conclusion Gram’s stain identification upon TPC samples has accept-
able accuracy for predicting positive culture for the diagnosis of VAP. 
Prediction of GPc or GNr bacteria involved in VAP has poor accuracy 
excepted for GNr specificity. The presence of leukocytes on TPC results 
of Gram’s stain improves sensitivity for VAP-positive culture. Taking 
Gram’s stain information into account for establishing empiric antibi-
otic treatment may generate non adapted therapy. Results must be 
confirmed by prospective and multicenter studies.
Competing interests None.
Reference
1.  Irequi M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of 
delays in the initiation of appropriate antibiotic treatment for ventilator‑
associated pneumonia. Chest. 2002 Jul;122(1):262–268.
P64  
Colistin in nosocomial pneumonia in intensive care
Hanane Ezzouine1, Mohamed Toufik Slaoui1, Abdellatif Benslama1
1Anesthesiology and intensive care department, University Teaching 
Hospital Ibn Rushd‑Casablanca, Casablanca, Morocco 
Correspondence: Hanane Ezzouine ‑ ezzouinehanane@yahoo.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P64
Introduction The increase in the incidence of ventilator-acquired 
pneumonia (VAP) Acinetobacter baumannii to multiresistant (ABMR) 
is responsible for a high morbidity and mortality in intensive care 
environment worldwide. The gold standard treatment of these seri-
ous infections remains carbapenems, including imipenem and mero-
penem. Sulbactam is a validated therapeutic alternative. Few studies 
have proved the effectiveness of VAP colimycin onto ABMR.
Patients and methods This is a prospective observational study in the 
medical ICU of CHU IBN Rushd of Casablanca for 24 months (October 
2012–October 2014). Inclusion criteria were patients hospitalized in 
intensive care and who developed nosocomial pneumonia after 48 h 
of mechanical ventilation, with isolation of Acinetobacter Baumanii 
only sensitive to colimycin, using the protected distal sampling. After 
the confirmation of the presence of a susceptibility to ABMR, antibiotic 
therapy was started.
Results In our study, 120 cases of ventilator-acquired pneumonia were 
collected. The average age of the patients was 40 ± 15 years, and the 
sex ratio was 1.5 with a male predominance. The reason for hospitali-
zation in the ICU was dominated by diabetics ketoacidosis and serious 
head injuries. The simple gravity index (SAPS II) of the patients was 
35 ±  12. The mean time to onset of VAP was 6 ±  1  days. Treatment 
with intravenous colimycine was considered effective in 114 patients 
(95  % of cases). The overall mortality rate was 25  % (30 cas) in our 
series, and only six cases (5  %) were attributable to VAP AB compli-
cated multi-resistant refractory septic shock. There were no patients 
with impaired kidney function or clinical neurological impairment.
Conclusion Our study suggests that colimycin could be a first-line 
therapy for VAP in ABMR in our Third World countries due to its effi-
cacy, safety and low cost.
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Introduction Intermittent hemodialysis is a key support therapy in ICU. 
Despite protocol-based optimization, arterial hypotension during inter-
mittent hemodialysis remains a frequent issue ranging from 10 to 60 % 
in critically ill patients. Our objective was to test whether tissue perfusion 
parameters assessed at the bedside (mottling, index capillary refill time 
(CRT), and lactate) predict intradialytic hemodynamic instability (HI).
Patients and methods We conducted a prospective observational 
study in a 18-bed medical ICU in a tertiary university hospital includ-
ing hemodialysis sessions performed for acute kidney injury. Exclusion 
criteria were the following: patients with dark skin and dialysis per-
formed in extreme emergency. Mean arterial pressure (MAP), cardiac 
index, mottling, index CRT and lactate level were recorded just before 
starting hemodialysis. HI requiring fluid resuscitation or vasopressors 
introduction/increase was recorded 60, 120, and 240 min after hemo-
dialysis starting.
Results One hundred and six hemodialysis sessions performed in 45 
patients were recorded. Patients received vasopressors in 43 (41  %) 
sessions. HI occurred in 22 (21 %) of all the sessions and was more fre-
quent among patients receiving vasopressors (42 vs 6 %, P < 0.0001). 
Mottling was more frequent (77 vs 40 %, P < 0.0001), index CRT was 
higher (3.3 [1.6–4.6] vs 1.1 [0.8–1.9] s, P < 0.0001), and lactate level was 
higher (2.8 [1.4–6.9] vs 1.1 [0.8–1.5] mmol/L, P  <  0.0001) before ses-
sions with HI in comparison with sessions without. The incidence of 
HI increases with the number of tissue perfusion alterations (2, 14, 31, 
and 65 % for 0, 1, 2, and 3 alterations, respectively, P < 0.0001), inde-
pendently of MAP (P  <  0.0001). A tissue perfusion score, defined as 
“index CRT(s) +  lactate level (mmol/L) + 0/1 if mottling were absent/
present”, was predictive of HI independently of MAP (OR 1.18 [1.05–
1.32], P < 0.0001). According to ROC curves analysis, a threshold of 4.2 
predicted HI with a sensitivity of 82 [60–95] % and a specificity of 82 
[72–90] %.
Conclusion The incidence of HI increases with the number of tissue 
perfusion alterations independently of MAP. At the bedside, a com-
bined tissue perfusion score including mottling, index CRT, and lactate 
level helps to identify patients at risk.
Competing interests None.




Positive Gram’s strain 74 47 43
Positive culture 85 32 66
Sensitivity 0.81 (0.71, 0.89) 0.78 (0.60, 0.91) 0.58 (0.45, 0.70)
Specificity 0.86 (0.71, 0.95) 0.76 (0.65, 0.84) 0.91 (0.80, 0.97)
Positive predictive 
value
0.93 (0.85, 0.98) 0.53 (0.38, 0.68) 0.88 (0.75, 0.96)
Negative predictive 
value





3.20 (2.13, 4.80) 6.45 (2.72, 15.27)
Negative likelihood 
ratio
0.22 (0.14, 0.34) 0.29 (0.15, 0.56) 0.47 (0.35, 0.62)
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Introduction Specific electrolytes and acid–base disorders may 
occur using citrate-based anticoagulation (CBA) for continuous renal 
replacement therapy (CRRT). The aim of this study is to evaluate and 
to compare the impact of two CBA-CRRT protocols on electrolytes and 
acid–base status: one continuous veno-venous hemodialysis (CVVHD) 
protocol using 4 % citrate (group A) and one continuous veno-venous 
hemofiltration (CVVH) protocol using 18/0 citrate (group B), both of 
which use phosphate-containing solutions.
Patients and methods We conducted a retrospective study from 
January 2013 to March 2014. All patients treated by CBA-CRRT 
admitted in three medico-surgical ICUs have been included. We 
collected demographic, clinical and biological data and per-
formed Wilcoxon’s matched-pairs signed-ranks test to compare 
for quantitative values. Data are expressed as median, first and 
third quartile.
Results Forty-seven patients were included, 30 in group A and 17 in 
group B. No severe metabolic alkalosis occurred. One severe metabolic 
acidosis occurred in group A as a complication of citrate accumula-
tion syndrome (pH 6.99, base excess −19  mmol/L and bicarbonate 
12 mmol/L), diagnosed as a total calcium over ionized calcium ratio of 
2.54. This was also the only case of severe hypocalcemia (ionized cal-
cium 0.89 mmol/L). Seven patients (15 %) presented mild hypophos-
phoremia, but no severe hypophosphoremia occurred. We did not 
notice any hyperphosphoremia in our patients. Median pH was 7.41 
(7.38–7.46) on day 3 and 7.34 (7.28–7.39) on day 1 (p < 0001). Median 
natremia on day 3 was 141 (139–141) and 135 (134–135) mmol/L in 
group A and B, respectively (p  =  0.002). Median chloremia was 108 
(106–109) and 95 (95–96) mmol/L in group A and B, respectively 
(p = 0.0002). In group A, one severe hypernatremia occurred on day 
1, corrected on day 2, and two moderate hypernatremia occurred 
on day 1, corrected on day 2. No hypernatremia occurred in group B 
(p  =  0.29). Hypomagnesemia occurrence constantly increased from 
day 1 to day 3, from 0 to 71 %.
Discussion This study pinpoints three interesting findings. First, it is 
well known that hypernatremic metabolic alkalosis may occur under 
CBA-CRRT in case of using trisodium citrate, which contains a high 
sodium load (408  mmol/L) as compared to 18/0 citrate (140  mmol/L 
of sodium), but the mild risk of alkalosis due to hypochloremia using 
dilute citrate (86 mmol/L in 18/0) is mostly unrecognized. However, no 
patient presented severe metabolic alkalosis, but natremia was sig-
nificantly higher in group A and chloremia lower in group B. Second, 
hypophosphoremia rate, which has been diagnosed in as many as 
65 % of the patients undergoing CRRT when using dialysis or replace-
ment solutions without phosphate, is effectively decreased by using 
phosphate containing solutions. Finally, attention must be drawn on 
the high proportion of hypomagnesaemia, even if dialysis and replace-
ment solutions contain magnesium, as citrate creates complex with 
magnesium as well as calcium.
Conclusion Both protocols are effective for correcting acid–base dis-
orders, but in different ways, one by increasing natremia and the other 
by reducing chloremia. Phosphate-containing solutes are effective 
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Introduction For patients with acute kidney injury (AKI), in our inten-
sive care unit (ICU), continuous venovenous hemofiltration (CVVH) 
with citrate has been implemented since 2013. This has been con-
ducted to change replacement fluids (RF), needing inside addition of 
ionic (phosphore and/or calcium), and had a cost impact.
The aim of the study was to assess the cost impact of citrate CVVH ver-
sus non-citrate CVVH and to estimate the cost impact of different RF use.
Patients and methods We performed a retrospective study about all 
ICU patients in AKI and requiring CVVH in 2014. Data collected were 
about: patients characteristics (age, sex ratio, BMI, IGS2); CVVH (indi-
cations, effective duration, filters, RF, calcium and phosphore con-
sumption). For citrate CVVH, RF used were citrate anticoagulation 
solution and bicarbonate-buffered solution and for heparin or no 
anticoagulation, only bicarbonate-buffered solution. To estimate the 
economic impact of other RF, in citrate group, cost of restitution solu-
tion with integrated phosphore was used. In non-citrate group, cost 
of bicarbonate-buffered solution with calcium integrated was used. 
Results about costs were expressed for 24 h of effective CVVH. Differ-
ences between citrate and non-citrate group were assessed with Stu-
dent’s test with p < 0.05. The cost impact simulation of different RF was 
assessed with appariate Student’s test with p < 0.05.
Results In 2014, 66 patients received CVVH in ICU. We included 64 
patients (two excluded because of missing data). They had a mean age 
of 68.1 ± 16.6 years old, a mean IGS2 of 58.2 ± 20.5, a mean stay in ICU 
9.0 ± 9.6 days and a mortality rate of 28.1 %. There was no difference 
between citrate and non-citrate group. Mean effective duration of 
CVVH was 52.1 h. Citrate anticoagulation was used for 40.0 % of them. 
About hemofiltration, there was no statistical difference between 
mean cost/24 h in citrate and non-citrate group. Cost simulations with 
bicarbonate-buffered solution with integrated ionic were significantly 
less expensive with a mean economy of 48.3€/24 h, so an annual total 
economy of 5726.3€ (Table 15).
Conclusion This study highlighted an interesting assessment of 
CVVH practices. There was no statistically difference between citrate 
and non-citrate group about the mean cost/24  h. But cost simula-
tions with ionic integrated RF seem to be less expensive, especially 
as these results are not taking into account human costs. Most CVVH 
was shorter than 24 h, and reflection about the intermittent hemofil-
tration could be needed. Simulations showed that 5726.3 € could be 
spare. With this methodology, only evaluation of cost impact of fluids 
and materials consumptions in ICU is able to help us to identify where 
some interesting economies could be made.
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Introduction Fungal infections represent an increasing and chal-
lenging issue in intensive care unit patients. Antifungal drugs have 
considerably evolved, with new molecules, whose choice depends on 
spectrum and adverse effects. Amphotericin B is an old drug, with a 
wide spectrum and highly efficient, but associated with renal toxic-
ity. Liposomal amphotericin B is supposed to be less nephrotoxic, but 
other molecules may be preferred in case of renal dysfunction. We 
aimed to assess the impact of liposomal amphotericin B administra-
tion on renal function in critically ill patients.
Patients and methods A retrospective single-center cohort study was 
performed, including consecutive patients admitted to our intensive 
care unit between 31/01/2008 and 12/07/2014, and receiving liposo-
mal amphotericin B for at least 2 days. Acute kidney injury was defined 
using the KDIGO criteria. Patients were divided into four groups: those 
who did not develop any acute kidney injury, those who developed 
acute kidney injury 1  day or more after liposomal amphotericin B 
initiation (de novo), those who had acute kidney injury at initiation 
and worsened their renal function 1  day or more after initiation and 
those who had acute kidney injury at initiation and did not worsen 
their acute kidney injury. Patients with worsening renal function 
after liposomal amphotericin B (de novo or on previous acute kidney 
injury) were compared to patients without worsening renal func-
tion (no acute kidney injury or not worsening previous acute kidney 
injury). The analysis of factors associated with liposomal amphotericin 
B-related acute kidney injury was performed in a competing risks 
framework (death and discharge without acute kidney injury consid-
ered as competing events).
Results One hundred and four patients were included. Median age was 
51 [interquartile ranges 31; 58], 60 (58 %) were male, and median SAPS 
2 was 50 [38; 68]. Main comorbidities were: hematologic malignancy 
in 88 (85  %), cardiovascular diseases in 12 (12  %), diabetes mellitus in 
seven (7 %) and chronic kidney disease in eight (8 %). During the week 
before intensive care unit admission, 36 (35 %) received contrast agents, 
37 (36 %) vancomycin and 35 (34 %) aminoglycosides. At admission, 15 
(14  %) were already treated by liposomal amphotericin B. Reasons for 
intensive care unit admission were hemodynamic failure in 48 (46  %), 
respiratory distress in 40 (38  %), neurologic disorder in seven (7  %) 
and close monitoring in nine (9 %). During intensive care unit stay, 71 
patients (68  %) underwent invasive mechanical ventilation, 65 (62  %) 
needed vasopressors, 29 (28 %) received contrast agents, 68 (65 %) van-
comycin and 77 (74  %) aminoglycosides. Intensive care unit, hospital 
and 3-month survivals were, respectively, 56.5, 52.5 and 35.5 %. Patients 
received liposomal amphotericin B during 14 days (from 2 to 64 days). 
29 (28 %) patients worsened their renal function after liposomal ampho-
tericin B initiation: 19 (18 %) de novo and 10 (10 %) on previous acute 
kidney injury. There was no renal degradation in the other 75 (72  %) 
patients: no acute kidney injury in 40 (38 %) and not worsening acute 
kidney injury in 35 (34 %). The only factor associated with the develop-
ment of liposomal amphotericin B-related acute kidney injury was ini-
tiation of liposomal amphotericin B before intensive care unit admission 
(hazard ratio 3.75, 95 % confidence interval [1.70–8.26], p value = 0.001). 
Among the seven patients who worsened their renal function with 
liposomal amphotericin B and were alive 3  months after intensive 
care unit discharge, six (86 %) recovered their previous renal function. 
Among the 10 patients alive at month 3 who had an acute kidney injury 
at liposomal amphotericin B initiation and did not worsen their renal 
function, nine (90 %) recovered their previous renal function.
Discussion While liposomal amphotericin B has been reported to be 
less nephrotoxic than conventional amphotericin B, intensivists are 
often reluctant to use this drug in critically ill patients because they 
are at high risk of acute kidney injury. In our experience, liposomal 
amphotericin B can be used in critically ill patients with a good safety 
profile. Less than 30 % of the patients experienced acute kidney injury 
related to the drug and most of them recovered. Renal function should 
be carefully monitored in patients admitted to the intensive care unit 
and already treated with liposomal amphotericin B.
Conclusion In this retrospective single-center study, more than 70 % 
of the patients treated with liposomal amphotericin B did not worsen 




Regional citrate‑based anticoagulation for dummies 
in continuous venovenous hemofiltration: does it work?
Dorothée Valance1, Richard Galliot1, Romain Zunarelli1, David Vandroux1, 
Cyril Ferdynus2, Bernard‑Alex Gauzere1, Olivier Martinet1, Julien Jabot1
1Réanimation polyvalente, CHU La Réunion, Saint‑Denis, France; 2Unité 
de soutien méthodologique, CHU La Réunion, Saint‑Denis, France 
Correspondence: Julien Jabot ‑ jabot974@gmail.com 
Annals of Intensive Care 2016, 6(Suppl 1):P69
Introduction Regional citrate-based anticoagulation (RCA) has proven 
effective to increase the filter lifespan during continuous venovenous 
hemofiltration (CVVH) [1] whenever performed by experienced practi-
tioners in highly specialized teams. Moreover, from the perspective of 
beginners, such technique may seem to require more nursing time give 
to the numerous interventions to modify citrate doses and/or calcium 
intake. In our 23-bed ICU (University Teaching Hospital, Saint-Denis, Reun-
ion island, France), at the decision to initiate RCA for CVVH, we had no 
medical expertise in dealing with the protocol, technical issues and train-
ing nurses. Therefore, we looked at reaching the same results as an expe-
rienced team with regard to the filter lifespan and the nursing workload.
Patients and methods A homemade protocol primarily tested on five 
patients was used in all patients meeting the criteria for CVVH with no 
contraindication for RCA. This protocol contained a target-oriented 
algorithm for post-filter ionized calcium concentration (between 
0.15 and 0.4 mmoL  L−1) and arterial ionized calcium concentration 
(between 1.00 and 1.15 mmoL L−1). Primary endpoints were filter lifes-
pan and number of handlings for RCA therapy’s adaptation (changes 
in citrate anticoagulation and calcium compensation). Secondary end-
points were safety, changes in biological parameters and reasons to 
terminate the technique.
Table 15 CVVH characteristics and cost impact simulations





No citrate (n = 43) Mean (SD) p*
CVVH dose (ml/kg/h) 36.4 (8.3) 36.2 (9.2) 36.5 (7.6) 0.89
Hemofiltration rate (%) 14.8 (3.7) 16.5 (1.7) 13.5 (4.3) <0.0001
Mean effective duration (h) 52.1 (60.7) 53.8 (60.8) 50.8 (61.3) 0.16
Total cost (€) 70,385.1 26,024.1 44,361.0 –
Simulated cost (€) 64,658.8 25,052.5 39,606.3 –
Mean cost/24 h (€) 590.9 (433.0) p′ = 0.0005 535.2 (383.6) p′ = 0.001 631.0 (465.6) p′ = 0.001 0.33
Mean simulated cost/24 h (€) 564.5 (396.2) 525.3 (387.3) 561.8 (406.3) 0.69
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Results Thirty patients (20 men and 10 women, age 57  ±  12  years, 
SAPS2 53  ±  11) were included from November 2013 to April 2014. 
The protocol was set to deliver a renal replacement therapy dose of 
30  mL  kg−1  h−1. The median filter lifespan was 51 [37–65]  h, and the 
median number of handlings was 2 [1–4]. Only six patients had to 
receive low dose of heparin in order to prevent thromboembolism. 
The 24 other patients received no anticoagulation. Reasons for termi-
nating the therapy were 13 filter clottings, 12 interruption for CT scan, 
operating room or discharge, two catheters dysfunctions, two technical 
problems and one elective filter change (>72 h). We did not record any 
complication. Electrolytes and acid–base disturbances were uncommon 
and transient in patients treated with RCA: median initial pH was 7.39 
[7.33–7.41], 7.44 [7.42–7.47] 24  h later and 7.40 [7.38–7.45] 48  h later; 
median initial serum magnesium level was 0.85 [0.74–0.94] mmol  L−1, 
0.69 [0.62–0.77] mmol L−1 at 24 h and 0.68 [0.60–0.81] mmol L−1 at 48 h.
Discussion Our “RCA for dummies” protocol fulfilled its objectives far 
beyond our expectations. The median filter lifespan (51 h) was surpris-
ingly as high as that of reported by experts (49 h) [1]. The number of 
RCA therapy’s adaptation was low (one intervention every 20 h) with 
no significant nursing overwork.
These first results are promising ones for a non-expert team, and we 
wonder whether we were not too cautious than needed with this new 
technique. As RCA is a routine technique on our hands, we are con-
ducting a second survey in order to rule out a “starter effect.”
Conclusion We confirm that RCA is both efficient and safe since its 
early use in ICUs by inexperienced practitioners, with fairly accept-
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Introduction Liver transplantation (LT) is the reference treatment for 
hepatocellular terminal chronic diseases. Early postoperative acute 
kidney injury (AKI), which incidence varies between 29 and 60  % 
depending on the definitions and cohorts, is a factor of poor progno-
sis, especially when renal replacement therapy (RRT) is necessary. The 
objective of this study is to assess the incidence of early AKI (in the first 
48 h) of a LT considering AKIN classification with consideration of diu-
resis and to identify associated risk factors.
Patients and methods Patients who received a first non-emergency 
LT orthotopic cadaveric graft between January 2011 and December 
2014 at Grenoble University Hospital were included in this retrospec-
tive study. Eleven patients were excluded because of the need for RRT 
before the LT or related kidney transplant. Demographic and clinical 
and biological parameters pre-, intra- and postoperative, including 
comorbidities, etiology and staging of liver disease, anesthetic man-
agement, graft function, use of renal replacement therapy, diuresis 
by 6  h and evolution, were collected. Serum creatinine at 24  h was 
considered to reflect kidney function between H0 and H24 and 1–48 h 
to reflect that between H24 and H48. Logistic regression was used for 
multivariate analysis (alpha risk 0.05).
Results Of the 155 patients in the study, 129 (83.2  %) were male, 
median MELD and Child–Pugh scores were, respectively, 14.5 (11–23) 
and 9 (7–11). Seventy-three percent of patents had alcoholic cirrhosis, 
and median creatinine clearance (according aMDRD) was 95  ml/min 
with 26 patients (16.8  %) below 60  ml/min. 128 (82.6  %) had an AKI 
according to the AKIN criteria, and 31 (20 %) required at least one RRT 
in ICU. The inclusion of diuresis in the definition of the AKI increases 
the number of patients with AKI in 32 (20  %) with peak incidence 
between H24 and H30. During first 48 h, incidence of IRA varies from 
54.4 to 78.1 % depending on the time slot. The median plasma volume 
was 3 liters of crystalloid intraoperatively and 4 liters during the first 
24 h without significant differences by AKI as albumin dose. Patients 
who develop early AKI were more transfused in labile blood products. 
Incidence of nephrotoxics as iodine injection and aminoglycosides 
during first 48 h were, respectively, 20.6 and 6.5 % without significant 
difference. Only the IGS2 and monitoring by Swan–Ganz are signifi-
cant independent predictive factors for AKI. Diabetics, admission nor-
epinephrine concentration and high first residual tacrolimus dosage 
are significant independent predictive factors for RRT (respective OR of 
3.75 (1.15 to −12.12), 2.04 (1.13 to −3.69) and 1.07 (1.05 to −1.09) per 
point of tacrolimus). No patient without early AKI according to these 
criteria has used an RRT during the ICU stay.
Conclusion The incidence of early post-LT AKI with the AKIN criteria is 
high. The use of AKIN classification shows dynamic nature of AKI in this 
context. These criteria appear prognostic for the use of renal replace-
ment therapy in the ICU. Diabetic patients and high norepineph-
rine dose in immediate postoperative time seem to be related to AKI 
requiring RRT and should have special attention. These results need to 
be validated in prospective studies to clarify the impact of graft quality 
in the complex determinism of post-transplant AKI.
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Introduction Metabolic acidosis is a frequent acid–base distur-
bance observed in septic patients. Normally, the physiological adap-
tive response of the kidney is an increased urinary excretion of 
NH4Cl inducing a negative urinary anion gap (UAG =  [Na+]u +  [K+]
u − [Cl−]u).
We investigated, in septic patients, the evolution of the urinary anion 
gap and the correlation with acute kidney injury according to kidney 
disease improving global outcomes (KIDGO) criteria.
Materials and methods This prospective study included patients with 
severe sepsis or septic shock admitted in a 24-bed medico-surgical 
intensive care unit of the CHU-Charleroi Marie Curie (Belgium). Blood 
and urinary chemistry were performed every 12 h after the admission 
during a maximum of 96th hour of intensive care unit length of stay.
Metabolic acidosis was defined according to Stewart’s method (SIDa 
<39  mmol/L) over a period of 24  h. Acute kidney injury was defined 
according kidney disease improving global outcomes (increased cre-
atinine concentration ≥0.3  mg/dL unless 48  h or decreased diuresis 
<0.5 mL/kg/h on 6–12 h). We also defined renal tubular acidosis by a 
serum anion gap <16 mmol/L and urinary anion gap >0 mmol/L.
Data were presented in median values with [25th–75th] percentiles 
and compared by the Mann–Whitney test. A value of p < 0.05 was con-
sidered as significant.
Results Among the 40 patients included, 23 (58  %) have a meta-
bolic acidosis at admission and 20 (50 %) developed an acute kidney 
injury. At the intensive care unit admission, no significant differences 
Page 77 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
were observed between patients with and without metabolic acido-
sis according to the APACHE 2 score, creatinine (1.12 [0.78–1.85] vs 
1.0 [0.62–2.04] mg/dL) and lactate concentrations (1.6 [1.0–4.2] vs 2.2 
[1.5–3.2] mmol/L), quantity and the type of liquid received within 24 h 
(4800 [3438–6528] vs 4475 [2610–4830] mL).
On the 23 patients with metabolic acidosis, 17 (74  %) presented a 
renal tubular acidosis. All, except one, did not have kidney adapta-
tion to metabolic acidosis. This inadequate response persisted during 
the 96  h of this study despite normalization of the acid–base status. 
Despite inadequate kidney response to metabolic acidosis, there was 
no difference in the onset of acute kidney injury between the two 
groups (10 acute kidney injury—group 1 in majority—in each group).
Conclusion Inadequate kidney response to metabolic acidosis was 
frequent in septic patients and persists despite normalization of the 
acid base status. Nevertheless, this tubular dysfunction does not cor-
relate with the onset of acute kidney injury.
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Introduction During intermittent hemodialysis (HD), intradialytic 
hypotension (IDH) is a frequent complication, associated with worse 
outcomes. Blood volume monitoring (BV) by dialysis generator has 
shown its interest in chronic dialysis to predict IDH due to hypov-
olemia, but its utility is unclear in intensive care units.
Patients and methods We conducted a monocentric, prospective, 
observational study. The primary outcome was to assess whether 
IDH (defined by mean arterial pressure lower than 65  mmHg) was 
associated with a decrease in the ratio between BV and ultrafiltra-
tion (UF). Secondary outcome was to assess the association between 
dialysis parameters and IDH. Every dialysis session in our unit has been 
screened for analysis. When BV assessment was not reliable or when 
no UF was realized, the session was excluded of the analysis. Dialysis 
generators, paramedical monitoring and dialysis consumables were 
not modified compared with usual standard of care in our unit. Dialysis 
settings were left to the choice of the medical team.
Results A total of 204 sessions were screened, and 112 (correspond-
ing to 42 different patients) were included. Median dialysate sodium 
was 140, and median dialysate temperature was 36 °C. Under pressor 
amines, 18.8 % of the sessions were made. IDH occurred in 40 % of the 
sessions.
BV/UF ratio was lower in session with IDH (−7.7 vs −10.5  %/L, 
p = 0.027). ROC curve showed an AUC of 0.624, but a cutoff value of 
−8.9 %/L was associated with a sensibility of 80 % to predict IDH.
Others parameters associated with IDH in univariate analysis were a 
higher natremia, a higher bicarbonate dialysate, a lower systolic, dias-
tolic or mean arterial pressure at the beginning of the session, the use 
of pressor amines and sedation and a low difference between sodium 
dialysate and natremia. In multivariate analysis, the use of pressor 
amines and a low mean arterial pressure were associated with IDH.
Discussion
Our study is the first to show an association with BV/UF and IDH for 
adults admitted in intensive care units. Good sensitivity of this test 
may be useful to detect IDH.
BV is widely used since 20  years in chronic hemodialysis and is now 
recommended by international guidelines. In intensive care unit, two 
studies have shown no interest in adults, and another did not find a 
decrease in IDH using a BV feedback protocol. In children, BV using 
was associated with a higher total UF without increasing IDH.
Other guidelines has been proposed in order to reduce IDH: high 
sodium dialysate concentration (145  mmol/l), or moderately cool 
dialysate temperature (0.5  °C beyond body temperature). Our study 
did not find any association between these settings and IDH.
Conclusion Decrease in BV/UF ratio is associated with IDH in our 
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Introduction Acute kidney injury (AKI) is a common complication of 
non-equilibrated diabetes, and it may occur in patients with ketoaci-
dosis (DKA) either in admission or during hospitalization
Patients and methods It is a retrospective study including all cases 
of diabetic ketoacidosis between January 2014 and August 2015. 
Patients with chronic renal failure were not included.
The diagnosis of diabetic ketoacidosis was defined by the association 
of blood glucose >11 mmol/L, ketonuria and metabolic acidosis with a 
pH <7.30 and/or plasma bicarbonate <15 mmol/L.
On admission, acute kidney injury was defined by a reversible increase 
in serum creatinine >110  µmol/L or in blood urea >9  mmol/l or a 
reversible decrease in the urinary output <0.5 ml/kg/day.
Fig. 29 See text for description 
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Results In this study, 53 patients with a mean age 41 ± 21 years were 
included. They have been diagnosed with type 1 diabetes in 60 % of 
the cases and with type 2 diabetes in 40  % of the cases, on average 
5  years before admission. The majority of the patients were female 
(56  %). Sixteen of the patients have had a previous episode of DKA. 
The origin of DKA was attributed to treatment omission in 21 (39 %) 
patients, infections in 16 (30 %) patients and diet errors in six (11 %) 
patients.
On admission, they have a mean serum glucose 32  ±  12  mmol/L, 
mean pH 7.2 ± 0.08 and a bicarbonate level of 9.2 ± 4.2 mmol/L.
On admission, patients were dichotomized in with AKI and with-
out AKI. Clinical and biological parameters were compared in these 
two groups. Twenty-six patients (49  %) have acute renal failure on 
admission, with a mean serum creatinine of 136 ±  41  µmol/L and a 
mean blood urea of 10  mmol/L compared with 72 ±  32  µmol/L and 
6.6 ± 4 mmol/L at discharge (Table 16).
Conclusion Acute kidney injury complicates frequently diabetic 
ketoacidosis on admission in ICU. Age, blood glucose, high osmolarity 
and occurrence in type 2 diabetes are their risk factors.
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Introduction The video laryngoscope Airtraq (VAQ) is now placed 
in the difficult airway management algorithm as second-step device 
to intubate the tracheal of patients when conventional tracheal 
intubation (TI) technique with Macintosh laryngoscope (ML) has failed 
(1). VAQ was also shown in simulation conditions to promote simple 
face-to-face (F2F) tracheal intubation in the patients placed in sitting 
position (2). With significant clinical experience acquisition, we have 
decided to propose F2F-VAQ-TI as an alternative to awake fiberscope-
assisted nasotracheal intubation (AANI) in the patients after failed ML.
Patients and methods After informed consent of the patient initially 
scheduled for elective AANI was obtained, those with previous failed 
ML, showing inter-incisor distance of >20  mm, with no expansive 
tumoral process in the upper airway and those with easy identification 
of anatomical cricothyroid membrane landmarks were proposed F2F-
VAQ-TI in sitting position. An Eschmann stylet (ES) was systematically 
armed in the tracheal tube inserted in the VAQ channel. Preoxygena-
tion and anesthesia induction techniques were standardized. Filmed TI 
maneuver was started 30 s after succinylcholine IV bolus (1 mg kg−1) 
was injected. Insertion of an LMA Fastrach was considered as a Plan B 
in case of difficulty to maintain SaO2 > 90 %. The fiberscope used with 
VAQ or LMA Fastrach was recommended as impossible tracheal access 
Plan B. In the PACU, the patients were asked to evaluate the level of 
comfort of the proposed airway management strategy using a visual 
analogue scale (VAS 0–100). For those patients that had previously 
been proposed AANI, they were asked to quote their comfort during 
both previous AANI and F2F-VAQ-TI. Moreover, they were asked to 
choose for the next surgery step the airway management technique 
among the two proposed options.
Results Over 3  years, 106 F2F-VAQ-TI were performed. The surgical 
indications requesting TI were as follows: maxillofacial reconstruction 
(41 %), orthopedic (32 %), neurological and visceral. The reported rea-
sons for previous ML failure were as follows: restricted mouth aperture 
of below 25 mm, major abnormality of anterior neck structure, severe 
cervical spine ankylosis, previous causes combined with post-surgery/
radiation sequels or unknown non-tumoral causes. Mean age of the 
patients was 49  years. Among them, 3 patients benefited of 3 F2F-
VAQ-TI and 5 of 2. TI succeeded in all patients. TI duration was <15 s, 
15 to <30  s, 30  s to <1  min, 1–2 and >2  min: 24, 25, 42, 6, and 3  %, 
respectively. ES was used in 61 % of cases. Plan B was used twice. One 
tracheal intubation was performed using the fiberscope inserted in 
the tracheal tube armed in the VAQ. Unrecognized laryngeal cyst pre-
vented both tracheal tube and ES tracheal penetration. The second 
Plan B concerned a 39-year-old woman (1.29 m height; 35 kg weight) 
that was oxygenated and intubated through the LMA Fastrach (size 
3). SaO2 < 90 % episodes occurred in 2 patients (nadir 86 and 78 %). 
All the patients (n = 36) that had received AANI for previous surgery 
would ask F2F-VAQ-TI for the next surgery. The mean (SD) comfort of 
F2F-VAQ-TI was remarkably high: 90 (6).
Conclusion We have shown that with respect to our selection process 
and airway management procedures F2F-VAQ-TI in the sitting patient 
was a safe alternative to AANI. This new airway management option 
seems simple for trained skilled operators and very comfortable for 
the patient. Comparison of the learning process of AANI and F2F-VAQ-
TI is now made in our laboratory and department.
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Table 16 See text for description
With AKI (n = 26) Without AKI 
(n = 27)
p
Sex ratio (M/F) 1.1 1.45 0.69
Age (years) 48 ± 24 34 ± 15 0.02
Age ≥49 16 (61 %) 10 (37 %) 0.000
Type 2 diabetes 15 (57 %) 6 (22 %) 0.008
Time of diagnosis of 
diabetes (years)
5 [3.25–13.75] 5 [5–10] 0.78
Blood glucose 
(mmol/l)
39 ± 13 26 ± 8 0.00
Blood glucose ≥28 21 (80 %) 10 (37 %) 0.001
Initial blood pH 7.18 ± 0.09 7.21 ± 0.08 0.25
HCO3− (mmol/l) 9.08 ± 5 9.4 ± 3.6 0.77
Blood osmolarity 
(mosmol/l)
287 ± 14 278 ± 10 0.01
Osmolarity ≥282 17 (65 %) 8 (29 %) 0.009
Serum sodium 
(mmol/L)
135 ± 4.8 133 ± 5.5 0.2
Etiology of DKA 0.26
 Treatment omission 9 (34 %) 12 (44 %)
 Infections 8 (30 %) 8 (29 %)
 Diet errors 5 (19 %) 1 (3 %)
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Introduction For many years, the use of ultrasound has been recom-
mended to secure central venous catheter placement in the intensive 
care units. Many studies and meta-analysis have demonstrated that 
ultrasound-guided technique increases the success rate and decreases 
the number of complications by novice and experienced operators. 
However, several surveys showed that only 50  % of the CVC proce-
dures are performed using the ultrasound-guided technique. The 
reason why physicians continue to use landmarks was the lack of for-
mation and the absence of ultrasound device. In our area (northwest 
of France), ultrasounds have been taught to our residents and learn-
ing courses were implemented for senior physicians. Therefore, we 
designed a survey to elicit information on physician’s characteristics, 
experience in CVC placement, training on ultrasound technique, the 
use of ultrasound for CVC placement, reasons for nonuse of ultrasound 
and their opinion on the necessity to continue to teach the landmark 
technique to residents.
Patients and methods This survey (14 questions) has been electroni-
cally addressed by email (using the Survey Monkey online software) to 
every physician belonging to the group of research on clinical practice 
in the northwest of France composed of 8 university’s and 20 commu-
nity’s ICU. The survey was sent to the 289 physicians (166 seniors and 
121 residents) working in those ICUs.
Results We received 190 responses (response rate 66 %). Among the 
respondents, 66  % were less than 40  years old, 34  % were residents, 
41 % presented an experience in CVC placement ≤5 years and 53 % 
declared putting more than 1 CVC per week. The preferred site of 
insertion was the jugular for 70 %, subclavian for 21 % and femoral for 
9 %. Seventy-one percentage of the residents declared having learned 
both landmark and ultrasound-guided techniques during their resi-
dency. Only 18  % reported using always the ultrasound to put CVC. 
The main reasons why they do not use ultrasound were as follows: (1) 
they think they do not need it (36 %), (2) the ultrasound was not avail-
able (33 %) while 3 % declare the absence of ultrasound device in their 
setting and (3) 11 % reported the absence of formation on ultrasound 
technique. The ultrasound technique used was ultrasound-guided in 
66 %. Coagulation abnormalities (64 %), obesity (54 %) and anatomi-
cal difficulties (52  %) were the main motivations to use ultrasound 
reported. Fifty-three percentage of the respondents declared having 
confronted at least one time during the last 12 months to an urgent 
situation where the ultrasound was not available quickly enough. 
Finally, 91 % think that the landmark technique should still be taught 
to the residents.
Conclusion Our survey shows that a large majority of the intensivists 
declare still performing landmark procedures while almost every phy-
sician received a formation on the ultrasound technique. Ultrasound 
device is present in the large majority of the institution; however, their 
availability is still scarce. Despite the several guidelines, physicians still 
do not use ultrasound for every procedure and think that landmark 
technique should still be taught to residents.
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Introduction Accumulating evidence suggests that ultrasound-
guided venous catheter insertion decreases insertion failure and 
immediate mechanical complications rates. However, due to mislead-
ing opinion, ignorance or absence of training, this method has not 
been widely adopted. Moreover, the exact utilization of this method 
among French intensivists is unknown. The aim of this prospective sur-
vey was to assess knowledge and utilization of ultrasound guidance 
for venous catheter insertion.
Patients and methods A questionnaire (16 questions) assessing 
knowledge, training, mastery and use of ultrasound guidance for 
central venous catheter (CVC) insertion, constructed by the educa-
tional section of the National Intensivists French College (CNER), was 
electronically sent to French intensivists between May and June 2015 
(CNER and SRLF Web site).
Results Answers to the questionnaire were obtained from 300 inten-
sivists [attending physicians (50  %), residents (16  %), fellows (16  %), 
professor or assistant professor (16  %)] with initial training in anes-
thesiology (56  %), pulmonology (13  %), internal medicine (10  %) or 
cardiology (7 %) and who had for most of them (84 %) inserted more 
than 100 CVCs. Ultrasonography use was significantly higher for inter-
nal jugular vein (75 %) than for femoral vein (45 %) or subclavian vein 
(29  %). Dynamic ultrasonic guidance isolated use was reported by 
38 % of respondents while 45 % used both screening before cannula-
tion and dynamic guidance. Use of short-axis approach, as well as the 
long-axis one according to the site, was reported by 56 % of respond-
ents. The majority of respondents (85 %) reported having never used 
a specific guiding device. Whereas 88  % of respondents considered 
specific training as mandatory or absolutely mandatory, only 44 % of 
them (essentially the youngest ones) reported having received a spe-
cific training (most of the them on an inanimate mankind).
Conclusion Despite insufficient training, most of French intensivists 
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Introduction Connected devices have become increasingly com-
mon, including for healthcare purposes, since some items now allow 
a continuous measure of the heart rate (HR) and percutaneous oxy-
gen saturation (SpO2). These devices are sold for wellness, and to 
date, they are not approved by health authorities as medical devices. 
While their use for chronically or acutely ill patients would be of 
great interest, there are no existing data regarding the reliability of 
their measurements.
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Materials and methods We performed a prospective monocentric 
study in the intensive care unit (ICU) of an university hospital to assess 
the concordance of HR and SpO2 measured using the three connected 
devices available on the market to an ICU monitor as gold standard. 
All consecutive patients hospitalized in ICU during September 2015 
were included except for those under vasopressor or mechanical 
ventilation.
•  Connected devices:
Withings Pulse Ox
Safe Heart Smartphone iOximeter
iHealth Wireless Pulse Oximeter
•  Monitor:
Philips MP60 or MP70.
Measurements were taken during the first 24  h after ICU admission 
during nurses’ usual round or when an intercurrent event occurred. 
A maximum of 12 measures per patient per day were performed, and 
measures could be registered over several days. At each time point, HR 
and SpO2 were measured using the three connected devices and the 
gold standard.
A concordance analysis was performed to assess the reliability of each 
connected device compared to the gold standard. Intraclass correla-
tion coefficients and 95  % confidence intervals (CI) were estimated 
using a single pair of measures per patient. Bland–Altman diagrams 
for repeated measures were used to illustrate concordances.
Results Twenty-four patients, among which 16 (67  %) men, were 
included in the analysis. The median age was 60 years [interquartile 
range (IQR) 54–72], and the main cause admission was a medical 
issue [23 (96 %)]. Overall, 119 different measures were analyzed with 
a mean of 5 per patient ranging from 1 to 12 measures per patient. 
The median SpO2 measured on the monitor was 96 [IQR 94–99]. The 
corresponding measures from devices 1, 2 and 3 were, respectively, 
93 [IQR 90–95], 94 [IQR 91–96] and 98 [IQR 97–99]. The median HR 
measured on the monitor was 98 [90–109]. The corresponding meas-
ures from devices 1, 2 and 3 were, respectively, 95 [IQR 86–105], 95 
[91–102], 98 [90–109]. For SpO2, the intraclass correlation coefficient 
between the monitor and the device 1 was 0.12, between the moni-
tor and device 2 was 0.32 and the monitor and device 3 was 0.17. 
Concerning HR, the intraclass correlation coefficient between the 
monitor and device 1 was 0.68, between the monitor and device 2 
was 0.67 and the monitor and device 3 was 0.08. Moreover, devices 
failed to provide any SpO2 measure in 0, 0.8 and 23  % of cases for 
devices 1, 2 and 3, respectively. Device 3 also failed to measure any 
HR measure in 12 % of the cases, while devices 1 and 2 always suc-
ceeded in measuring HR.
Conclusion We observe a poor correlation between devices and the 
gold-standard measures, especially for SpO2. These results need to be 
confirmed in larger studies. For now, these connected devices should 
not be recommended for SpO2 and HR measurement in critically ill 
patients admitted in ICU.
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Introduction Anemia is frequent in the critical care setting. It is the 
result of several mechanisms such as hemodilution, hemorrhage 
or inflammation consequences. Blood spoliation due to repeated 
blood punctures is also one of the factors leading to anemia. The 
reference method to determine the hemoglobin concentration is 
the cyanohemoglobin method performed with an automatic hema-
tology analyzer (HA). The main pitfalls of this method are to require 
a certain volume of blood, further enhancing the blood spoliation, 
and to be completed in a laboratory, increasing the lag time to 
diagnosis. Alternate methods such as HemoCue© (HC) or spectro-
photometry with the blood gas analysis (BGA) have been developed 
to address these issues. Nevertheless, accuracy of these methods 
remains debatable. Therefore, we conducted a study to compare the 
aforementioned techniques agreement, completion time and costs 
in ICU.
Patients and methods This is a single-center prospective study. All 
patients undergoing both a blood cell count and an arterial blood gas 
analysis were included. A capillary HemoCue© was performed just 
after the blood puncture and the capillary hemoglucotest. The com-
pletion time was registered, as well as the hour of the blood puncture. 
We also registered the hours at the blood sample arrival at the labora-
tory and at the availability of the result on the hospital intranet. The 
HA was considered as the reference method. Costs were estimated 
according to the French health system charts. Agreement between the 
methods has been estimated with Bland and Altman test. Results are 
given in mean ±  SD. Comparisons have been made with Student’s t 
test, ANOVA or Chi square test as appropriate.
Results Fifty-one samples have been compared in 37 patients (age 
70 ± 15 years, SAPS II 48 ± 20). We found a difference when compar-
ing the hemoglobin concentration with HA, BGA and HC (respectively, 
9.9 ±  1.8, 10.2 ±  2.1 and 9.5 ±  2.5  g/dl, p =  0.003). The comparison 
between HA and BGA evidenced a systematic positive deviation 
(+0.25  g/dl). Limits of agreement (±2 SD) were ±1.94  g/dl. Three 
measurements were outside these limits. The comparison between HA 
and HC evidenced a systematic negative deviation (−0.4  g/dl). Lim-
its of agreement were ±2.92 g/dl. Three measurements were outside 
these limits. A transfusion was indicated once according to recom-
mended transfusion thresholds by HA. This transfusion was also indi-
cated by BGA. HC would have indicated nine transfusions, only one 
being confirmed by HA.
HC was performed in 1.2 ± 0.5 min (min). The time between the blood 
sample and the result’s availability was significantly lower for the BGA 
as compared to HA (34 ± 19.9 vs. 54.5 ± 32.6 min; p = 0.01). It was the 
result of a faster laboratory technique (23.7 ± 15.5 vs. 31.6 ± 20.2 min; 
p = 0.03), whereas the transport time of both samples was not different.
The costs of HA, BGA and HC were estimated to be, respectively, 
426.87, 1032.75 and 45.9 euros. Nevertheless, when summing these 
“direct costs” with the price of the transfusions that would have been 
indicated according to the tests, HC became the most expensive tool 
(5022.9 euros) as compared to HA (979.87 euros) or BGA (1585.75 
euros).
Discussion Among the three methods, HC was the fastest to perform, 
but seemed to be the less accurate as well. Its precise position in the 
ICU setting must be discussed, since the reference test appears to be 
mandatory to indicate a transfusion. Its utility may be more substantial 
in the pre-hospital setting where no other hemoglobin measurement 
tool is available. The blood gas analysis, often performed in ICU, offers 
the advantage to be more accurate than HemoCue© and to provide 
other useful information.
Conclusion Alternate methods of hemoglobin monitoring allow a 
faster result, but their accuracy is debatable. Their respective utility 
might depend on the clinical setting.
Competing interests None.
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Introduction Monitoring the anticoagulant effect of unfractionated 
heparin (UFH) is mandatory. This monitoring can be done by the mean 
of the activated partial thromboplastin time (aPTT) or by anti-Xa level 
measurements. Compared with anti-Xa levels testing, aPTT is more 
frequently impacted by preanalytic variables and biologic factors 
(increased levels of acute-phase reactants, consumption coagulopa-
thy) often encountered among critically ill patients. We studied the 
agreement of both test results in unselected critically ill patients.
Patients and methods aPTT and anti-Xa levels were simultaneously 
monitored in patients treated by continuous intravenous infusion of 
UFH. Blood samples were drawn into sodium citrate tubes (Greiner 
Bio-One SAS, France). aPTT was measured with TriniCLOT Automated 
aPTT reagent (Tcoag, Ireland) and anti-Xa levels with Biophen Heparin 
(LRT) (HYPHEN Biomed, France). An aPTT of 2–3 times the control and 
anti-Xa levels between 0.3 and 0.7 IU/ml were defined as therapeutic.
Results Forty-four patients (mean age 71.13 ± 15.7 years; mean SAP-
SII 39.1  ±  14.4) were included. Reasons for admission were medical 
in 31 and surgical in 13. The indications for UFH therapy were atrial 
fibrillation (26), venous thromboembolism/pulmonary embolism (13), 
thrombophilia (2), acute coronary syndrome (1), and arterial thrombo-
sis (2). Paired measurements of aPTT and anti-Xa were taken on 353 
samples. Linear regression analysis was used to evaluate the relation-
ship between aPTT and anti-Xa.
The correlation between aPTT and anti-Xa levels was low (r = 0.495).
The concordance of tests results is shown in Table 17.
Concordant aPTT and anti-Xa values were observed in 213 (60.3  %) 
data pairs. aPTT was discordantly high in 96 (29.9  %) data pairs and 
discordantly low in 44 (12.5 %) ones.
Discussion In an unselected population of critically ill patients, the 
concordance of aPTT and anti-Xa levels was low. Considering anti-Xa 
as gold standard, monitoring anticoagulation treatment by aPTT leads 
to a high risk of misdosing. aPTT is frequently impacted by biologic 
factors. Although less commonly, anti-Xa levels can also be influenced 
by biologic cofounders.
Poor correlation between aPTT and anti-Xa could result from altera-
tions in FII and FVIII activity.
Conclusion Use of aPTT and anti-Xa levels to guide heparin therapy 
may lead to different estimates of UFH concentration in the same 
patient.
Both aPTT and anti-Xa have limitations when used for UFH monitoring 
and may not accurately assess anticoagulant status. Further investiga-
tion (using thromboelastometry or thrombin generation assays) could 
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Introduction Several blood analyses are performed in critically ill 
patients. Rapid detection of abnormal values, by point-of-care test-
ing, allows clinicians to promptly deliver the appropriate therapy. We 
sought to investigate the agreement between the last generation of 
blood gas analyzer and central laboratory measurement of electro-
lytes (sodium, potassium, chloride, bicarbonate), hemoglobin, hema-
tocrit and glucose.
Patients and methods Three hundred and fourteen paired samples 
were collected prospectively in 51 patients. All samples were drawn 
from an arterial line in the morning at the 06:00 am. Biological tubes 
were collected through a Vacutainer® and analyzed in the central labo-
ratory (Lab) using Beckman Coulter® automates (DXH and AU 5800). 
BD Preset® heparinized syringe was filled with 1.6 ml of arterial blood 
and analyzed immediately in the ICU using the Point-of-Care Siemens 
RAPIDPoint® 500 Blood gas system (POC). Measurements obtained by 
the two methods were compared using the Bland–Altman method 
(bias and limit of agreements), Deming regression analysis and Pear-
son correlation. We use the proficiency testing criteria to define 
acceptable analytical performance (CLIA 1992): ±4 mmol/l for sodium, 
±0.5  mmol/l for potassium, ±5  % for chloride, ±0.6  g/l for glucose, 
±6 % for hematocrit and ±7 % for hemoglobin.
Results The main results are presented in the Table 18.
Conclusion The Point-of-Care Siemens RAPIDPoint® 500 Blood gas 
system satisfied CLIA criteria of acceptable analytical performance for 
all tested parameters except for hemoglobin (difference = 7.6 %). We 
identified a systematic overestimation of hemoglobin (mean 0.8 g/dl) 
with the RAPIDPoint® 500 Blood gas system.
Competing interests None.
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Table 17 Cross‑tabulation of  clinically relevant aPTT 
and anti‑Xa levels
aPTT below therapeutic range/anti‑Xa below therapeutic range 105
aPTT below therapeutic range/anti‑Xa in therapeutic range 37
aPTT below therapeutic range/anti‑Xa above therapeutic range 2
aPTT in therapeutic range/anti‑Xa below therapeutic range 41
aPTT in therapeutic range/anti‑Xa in therapeutic range 95
aPTT in therapeutic range/anti‑Xa above therapeutic range 5
aPTT above therapeutic range/anti‑Xa below therapeutic range 11
aPTT above therapeutic range/anti‑Xa in therapeutic range 44
aPTT above therapeutic range/anti‑Xa above therapeutic range 13
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Introduction Deliberate self-poisoning with pesticide continues to 
be a major public health concern in many developing countries. This 
study aimed to evaluate the data on cases of acute pesticide poi-
soning and to compare different variables between survivors and 
non-survivors.
Patients and methods In this cross-sectional study, medical records 
of all pesticide-intoxicated patients were reviewed from 2009 to 2013, 
retrospectively. Demographics, clinical features and laboratory find-
ings were evaluated. The variables compared between survivors and 
non-survivors were the amount of pesticide ingested, occurrence of 
vomiting after ingestion, time and place of hospital admission, length 
of hospital stay, leukocytosis, serum creatinine level and the outcomes.
Results A total of 154 patients were evaluated. The mean ± standard 
deviation of patients’ age was 32 ±  18  years. The length of hospital 
stay was 4.76 ± 4.8 days. Most poisonings occurred in spring and sum-
mer. The in-hospital fatality rate was 36 %. Statistically significant asso-
ciations were found between the outcome of patients and the amount 
ingested (P  =  0.002), vomiting (P  =  0.003), early need to intensive 
cares (P = 0.005), leukocytosis (P = 0.001) and serum creatinine levels 
(P = 0.001).
Discussion and conclusion Prompt vomiting, early need to intensive 
cares, leukocytosis and multi-organ failures are major determinants 
for fatal outcome of pesticide poisoning. It may be useful to educate 
health professionals and the general population about the serious 
consequences of exposure to pesticide.
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Introduction Naphyrone is a new psychoactive substance and a 
cathinone derivate. Naphyrone was reported to be used by approxi-
mately 2 % of recreational drug users and is frequently present in bath 
salts. Scarce data are available regarding its toxicity, pharmacokinet-
ics and effects on brain monoamines. Our objectives were to study 
naphyrone-related effects on behavior and brain monomaine content 
according to two administration modalities (acute and binge) mimick-
ing its use in humans.
Materials and methods We performed an experimental study on the 
effects of naphyrone-induced effects after acute and repeated admin-
istration (binge) on the locomotor activity, anxiety (openfield), resig-
nation (forced swimming), memory (Y-maze), hedonic status (sucrose 
consumption) of Swiss mice. We also investigated the effects of naphy-
rone-induced on monoamines in the prefrontal cortex. Plasma naphy-
rone concentrations were measured using high-performance liquid 
chromatography (HPLC) coupled to mass spectrometry (MS) and brain 
monoamine concentrations using HPLC coupled to fluorometry. For 
each animal and each time, we calculated the difference between the 
parameter value at that time and baseline and the area under the curve 
of its time course. Comparisons were made using two-way ANOVA fol-
lowed by posttests using Bonferroni correction. Pharmacokinetics (PK) 
was modeled and parameters calculated using WinNonlin® software.
Results Naphyrone induced dose-dependent stimulation of loco-
motor activity that appeared more marked and prolonged than 
MDPV- and cocaine-related effects (used as positive controls), addi-
tionally increasing after its binge administration (p < 0.001). Significant 
increase in the distance walked at the periphery of the openfield was 
observed up to 24  h postinjection (p  <  0.001), corresponding to the 
behavior compensation of enhanced frighten. During binge admin-
istration (3 times per day, 3 successive days), increased locomotor 
effects at day 3 (after the 9th injection) in comparison with day 1 (after 
the 1st injection) supported naphyrone-induced hyper-sensitization 
process. Similarly, significant effects were observed on mice depres-
sion (p < 0.0001) and memory (p < 0.005) but not on hedonic status. 
Significant dose-dependent increase in aggressively social relation-
ships was also reported among naphyrone-treated mice (p  <  0.001). 
The neurochemical study revealed significant increase in dopamine 
and norepinephrine concentrations in the prefrontal cortex, without 
significant modifications in serotonin concentrations. This monoamine 
profile was similar after repeated naphyrone administration. Naphy-
rone PK profile was described after acute and binge administration 
and effects correlated with plasma concentrations.
Conclusion Neurobehavioral disorders induced by acute and repeated 
naphyrone administration mainly consist in the stimulation of locomo-
tor activity. The increase in the cortical dopamine concentrations may 
suggest an addictive potential that should be further investigated.
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Introduction Acenocoumarin is the most commonly prescribed oral 
anticoagulant in our country. Because of the paucity of data on acute 
acenocoumarin poisoning, we undertook this study, which aimed to 
determine the epidemiologic, clinical, therapeutic characteristics and 
outcome of this intoxication.
Patients and methods It was a retrospective study performed over a 
9-year period (from June 2006 to June 2015). Demographic character-
istics, acenocoumarin long-term treatment history, clinical signs, treat-
ment and outcomes of this intoxication have been analyzed.
Table 18 See text for description
Min lab Max lab Bias Lower limit  
of agreement
Upper limit  
of agreement
Regression Correlation
Sodium (mmol/l) 119.4 150.2 1.3 −2.1 4.7 Lab = 16.007 + 0.891 POC 0.936
Potassium (mmol/l) 2.76 5.8 0.2 −0.2 0.6 Lab = 0.435 + 0.939 POC 0.944
Chloride (mmol/l) 86 116 −0.9 −3.7 1.9 Lab = −1.329 + 1.004 POC 0.967
Bicarbonate (mmol/l) 13.5 43.1 0.8 −1.9 3.4 Lab = 0.272 + 1.019 POC 0.968
Glucose (g/l) 0.5 3.97 −0.1 −0.3 0.1 Lab = −0.0964 + 0.992 POC 0.972
Hemoglobin (g/dl) 6.1 15.5 −0.8 −1.3 −0.2 Lab = −0.0201 + 0.926 POC 0.985
Hematocrit (%) 18 46 −1.1 −2.9 0.7 Lab = −1.353 + 1.008 POC 0.981
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Results Fifty-eight patients aged 28 ± 11 years were eligible; their sex 
ratio was of 1. All cases were self-inflicted. Among them 11 males were 
detained. Acenocoumarin long-term treatment was noted in 40  % 
(n  =  23) patients, for thromboembolic disease (n  =  17) or valvular 
replacement (n = 6). Coingestion of other drugs was reported in 43 % 
of cases. The mean ingested dose was 56 ±  48  mg (extremes 8 and 
240 mg). The average time of consultation was 9 ± 11 h. In the major-
ity of cases, patients were asymptomatic. Bleeding was reported in 4 
detained patients but not observed by physician. Gastric lavage was 
performed in 17 % of cases within 1 h after ingestion. Vitamin K was 
administrated in 52 % of cases. No patient required PPSB perfusion or 
transfusion. The outcome was favorable in all cases. No deaths were 
reported. Length of stay was 30 ± 24 h.
Discussion Acenocoumarin overdose was well described in the litera-
ture, and the treatment is well codified.
However, few studies were interested in acute poisonings and their 
management. Our study suggested that acute acenocoumarin poison-
ing is often not serious if patients were early managed. The administra-
tion of vitamin K could be necessary and safety, especially for patients 
without long-term anticoagulant treatment.
Conclusion Acenocoumarin poisoning is increasingly frequent in our 
country; its prognoses are generally favorable. Hospitalization must 
be indicated in symptomatic patients who presented active bleeding 
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Introduction Deliberate self‑poisoning is a serious problem in Tunisia. 
However, our understanding of the problem of suicidal intoxication remains 
limited. This study aims to reveal the frequency of suicide by self‑poisoning 
in the region of Sfax, to describe the characteristics of victims and to identify 
the difficulties often encountered in determining the toxic substance.
Patients and Methods This study is a retrospective study conducted 
during a period of 08 years (2007-2014), about all cases of self-poison-
ing collected in the Department of Forensic Medicine of Habib Bour-
guiba University Hospital of Sfax, Tunisia.
Results During the study period, 299 cases of suicide are compiled. In 
42 cases (14 %), suicide is committed by self-poisoning, representing a 
little more than 5 cases per year. The sex ratio is 0,7. The mean age of 
victims is 32.9 ± 7,6 years with extremes ranging from 18 to 63 years. 
In 25 cases (60 %) the victim is single, in 15 cases (35 %) she is mar-
ried and she is divorced in only 2 cases (5  %). She is unemployed in 
18 cases (43 %) and she is a daily-worker in 16 cases (38 %). In half of 
cases the victim doesn’t have any known psychiatric illness history. The 
antecedent of suicide attempts is found in 8 cases (19 %). 
In only 14 cases (33  %) death occurred at home. Most of victims 
were hospitalized in intensive care unit (28 cases, 67 %). The average 
time interval between hospitalization and death is 32.45 hours with 
extremes ranging from 8 to 96 hours.
The forensic autopsy is often performed more than one day after 
the intoxication date. The post-mortem toxicological samples 
systematically made during the autopsy were positive in only 5 cases 
(12  %). Toxic samples are often not made during the hospitalization. 
The nature of the toxic substance is determined based only on history 
and clinical information. In our study the nature of the toxic substance 
is a pesticide in 16 cases (38 %) and a medication in 14 cases (34 %). It 
is still undetermined in 6 cases (14 %).
Conclusion Toxicological samples performed after a prolonged inter-
val of time from the intoxication moment are often negative. Thus it 
is fundamental to realize them systematically at the time of admission 
into intensive care unit in case of intoxication suspicion. The determi-
nation of toxics allows not only to orientate the therapeutic manage-
ment but also to strengthen preventive strategies against suicide.
Competing interests None.
P85  
Adverse drug reactions (ADRs) collected by medical‑staffed 
ambulances: pilot study
A. Lillo‑Le Louët1, F. Baud2, C. Le Beller1, B. Vivien2, L. Soufir3, P. Carli2 and H. 
Le Louët4
1Centre Régional de Pharmacovigilance (CRPV) Hôpital Européen 
Georges Pompidou; 2SAMU de Paris, Hôpital Necker EM; 3Réanimation, 
Groupe hospitalier Saint‑Joseph; 4CRPV Hôpital Henri Mondor, AP‑HP, 
France 
Introduction In Paris area, emergency medical assistance is run by the 
“SAMU de Paris.” Medical‑staffed ambulances go directly to take care of 
any patient with an acute medical problem after an evaluation of the 
clinical situation made by phone.
Aim: Collection, analysis, and evaluation of adverse drug events 
(ADRs), whatever it is, acute intoxication, organ failure, allergy, and 
whatever its clinical presentation.
Methods: Every month, forms from all medical interventions performed 
daily by the SAMU de Paris are analyzed retrospectively by a physician 
trained in pharmacovigilance. The following information is available: 
patient’s main characteristics, description of the medical event, main 
diagnosis, and outcome. If an ADR is present or even suspected, a copy 
of the form is made. The pharmacovigilance centers contact medical 
staff that took care of the patient to retrieve more information about 
the final diagnosis and the drug involvement. If a drug adverse effect is 
retained, the case is anonymously registered in the national database, 
and a specific letter is sent to describe and sum up the case.
Results From January 1, 2015, to July 31, 2015, 274 cases of possible 
ADRs have been collected.
  •  203 cases of ADRs (74  % of the total) have been immediately 
diagnosed and registered.
  •  The drug causality is pending for 29 cases. For the last 37 cases, 
a drug implication has been definitely ruled out, with no drug 
intake, another causative agent, illicit substances and food.
  •  For all ADRs retained (n = 203), a fatal outcome occurred in 14 
cases (7 % of ADRs). The main organ failure was central nervous 
system (n = 107, 53 %), cardiovascular (n = 55, 27 %), digestive 
(n = 21, 10 %), and lung (n = 8).
  •  The type of ADRs was voluntary overdose (n = 60, 30 %), bleed-
ing (n = 48, 24 %), hypoglycemia (n = 40, 20 %), allergy (n = 15, 
7 %), and medication error (n = 11, 6 %).
 •  The following drugs were involved for all ADRs retained 
(n =  203): psychotropic drugs (n =  73, 36  %); drugs acting on 
hemostasis (n = 48, 24 %); antidiabetics (n = 41, 6 %); pain kill-
ers (n = 12, 6 %); antiinfectious (n = 11, 6 %), and various (15): 
NSAID (8)—anesthetic agents (3)—corticosteroid (3)—contrast 
media (2)—potassium (1), vaccine (1), GcSF (1), colchicine (1).
Discussion and conclusion To our knowledge, this is the first time 
that serious adverse drug reactions are collected directly from the 
first step of emergency care, before hospitalization. Excepted inten-
tional drug overdose for suicide attempts, the main ADRs observed 
such as bleeding with anticoagulants or hypoglycemia with insulin, 
are expected and evitable. Further analysis on cardiovascular effects 
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is pending. This study increases awareness of physicians working in 
SAMU. The usefulness of toxicological analysis must be discussed.
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Introduction Beta-blockers could be responsible of severe poisoning 
leading to death. The knowledge of prognostic factors is essential and 
could guide the management of these patients.
The purpose of our study is to determine whether the plasma concen-
trations of acebutolol can predict clinical symptoms and prognosis.
Patients and methods It was a retrospective study conducted over 
2  years in a 16-bed toxicological unit including all admitted patients 
for acebutolol poisoning, presenting with shock or cardiac arrest. A 
systematic serum measure of acebutolol was done at least once hos-
pital stay.
Results Eleven patients were eligible. The mean age was 
23.0 ± 6.6 years with a female predominance (9/11).
The average of the presumed ingested dose was 8050 ± 4812 mg.
On admission, cardiovascular manifestations were predominant; the 
main presenting symptoms were bradycardia (n = 5), shock (n = 10) 
and cardiac arrest with favorable evolution in one case.
Electrocardiogram showed a heart block in 7 cases: first degree (n = 4) 
and third degree (n  =  3), wide QRS complex with sodium channel-
blocking effect in 7 cases (mean QRS duration was 220 ± 77 ms) and a 
prolongation of the QT interval in 8 patients (the mean QT interval was 
521 ± 79 ms). The mean plasma concentration of acebutolol at admis-
sion was 19.3 ± 16.6 mg/l. Six patients had required mechanical venti-
lation due to hemodynamic instability. Inotrope drugs were required 
in eight patients; semi-molar sodium bicarbonate was infused in seven 
patients with an average volume of 500 ± 144 ml.
Three patients died. Two early deaths were related to intoxication, and 
the later was related to nosocomial complication.
The analysis of prognostic factors showed the absence of correlation 
between acebutolol plasma concentration either on admission or any 
time and clinical or electrocardiographic signs in serious poisoning.
Conclusion The severity of acebutolol poisoning must be assessed by 
clinical and electrocardiographic manifestations. The plasma concen-
tration of acebutolol should not be considered as prognostic factor.
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Introduction The quality of baseline treatment of COPD patients 
is important in the prevention of acute exacerbation. The aim of our 
study is to describe trends in baseline pharmacologic treatment (BPT) 
use guidelines in a cohort of patients admitted to a Tunisian ICU for 
AECOPD and to assess its conformity with GOLD, which is intended to 
classify patient’s COPD severity and to guide patient’s management.
Patients and methods In a cohort study of consecutive patients 
admitted between 2000 and 2012 for AECOPD in our ICU, we analysed 
BPT and its conformity with GOLD guidelines issued in 2001 and 2007.
Results During the study period, 440 patients admitted for 552 epi-
sodes of severe AECOPD requiring ventilatory support (NIV in 67.8 %). 
Table 19 shows patients’ characteristics and baseline medications used 
in this cohort:
Aminophylline use decreased significantly from around 50 % (in 2000) 
to 21.4 % (in 2012), short-acting ß2 mimetic use remained unchanged 
(70.1 % in 2000 and 64.3 % in 2012), whereas inhaled anticholinergics 
and corticosteroids increased significantly during the same period 
(respectively, from 0 to 18 % and from 13 to 60 %). In patients in whom 
FEV1 was measured and GOLD classification was possible, BPT was 
compliant with 2001 and 2007 recommendations in 58.9 and 15.6 %, 
respectively.
Conclusion In this cohort of severe COPD admitted to ICU for acute 
exacerbation, compliance with GOLD 2001 and 2007 varied substan-
tially and could be explained by changes regarding long-acting ß2 
mimetic use.
Competing interests None.
Table 19 See text for description
Variables All patients (n = 440)
Age [median (IQR)] 68 (61–74)
Gender (M/F) 372/68
pH at ICU admission [median (IQR)] 7.28 (7.23–7.32)
Time course of COPD (years) [median (IQR)] 7 (4–15)
Baseline treatment
 Aminophylline [n (%)] 107 (24.3)
 Short‑acting β2 mimetics [n (%)] 197 (44.7)
 Long‑acting β2 mimetics [n (%)] 46 (10.4)
 Inhaled anticholinergics [n (%)] 39 (8.9)
 Inhaled corticosteroids [n (%)] 116 (26.4)
 Systemic corticosteroids [n (%)] 37 (8.4)
Table 20 See text for description
Eo > 2 % (n = 22) Eo ≤ 2 % (n = 20) p
Age (years) [median 
(IQR)]
70.5 (61–73.2) 63 (57.2–77.5) 0.207
Gender (M/F) 16/6 19/1 0.096
NIV at ICU admission 
[n (%)]
22 (100) 18 (90) 0.221
pH at ICU admission 
median (IQR)
7.32 (7.26–7.36) 7.29 (7.25–7.33) 0.390
CRP median (IQR) 44 (14–76.5) 17 (7–58) 0.045
Procalcitonin median 
(IQR)
0.16 (0.14–0.31) 0.11 (0.05–0.24) 0.092
NT‑proBNP median 
(IQR)
365 (168–3174) 400 (94–1800) 0.911
WBC count (cells/µl), 
median (IQR)
8010 (6282–10,475) 11,240 (9005–
13,145)
0.016
NIV duration (days) 
[n (%)]
8 (5–14.5) 7 (3.75–11) 0.530
MV duration (days) 
[n (%)]
13 (10.5–17) 5 (3.5–7.5) 0.048
ICU LOS (hours) [n 
(%)]
12 (6.5–13) 8 (6–24) 0.718
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Introduction Increased blood eosinophil count (greater than 2 %) has 
been described by several studies as reflecting eosinophilic airway 
inflammation exacerbation and a useful marker to guide systemic cor-
ticosteroids administration in acute exacerbations of COPD (AECOPD) 
[1, 2]. The aim of this study is to describe the rate and the patterns of 
hyper-eosinophilia in a population of patients admitted to an inten-
sive care unit (ICU) for severe AECOPD requiring ventilatory support.
Patients and methods This is a retrospective cohort study, includ-
ing patients consecutively admitted to our ICU between January 
and August 2015 for severe AECOPD requiring ventilatory support. 
COPD patients with an obvious cause of decompensation (pulmo-
nary embolism, acute pulmonary edema, pneumothorax, pneumonia) 
were excluded. Continuous variables are presented as medians and 
interquartile ranges (IQRs) and compared by the Mann–Whitney test, 
whereas dichotomous variables are presented in percentage and com-
pared by the Chi square test.
Results During the study period, 42 patients were admitted for 
AECOPD [median age was 66.5  years (IQR 60–74) with 83.5  % male]. 
Hyper-eosinophilia (>2  %) was present in 52.4  % of patients with a 
median value of 3.25 % (2.2–4.0). Table 20 compares the characteristics 
of patients with and without hyper-eosinophilia.
Conclusion Hyper-eosinophilia (>2  %) appears to be common in 
patients admitted for AECOPD (52.4  % of patients in our study) and 
seems associated with inflammation markers and a trend toward 
longer ventilation and ICU length of stay durations. A policy of corti-
costeroids prescription guided by blood eosinophilia count seems rea-
sonable in our population.
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Introduction After pulmonary resection, a postoperative pulmonary 
complication is present in 12–40 % of cases. Risk factors such as COPD 
are well identified. The phenotype of frequent exacerbator (FE) has 
been recently described. No existing study has evaluated the rate of 
patients called ‘FE’ among COPD patients requiring pulmonary resec-
tion and the relations between exacerbations history and the inci-
dence of acute respiratory postoperative complications (ARPC).
The main objective was to determine the frequency of ARPC (atelec-
tasis, acute respiratory failure, pneumonia) following lung resection 
in COPD patients. The secondary objectives aimed to determine the 
frequency of extra-pulmonary postoperative complications and the 
prevalence of the ‘FE’ phenotype in this population, as well as its rela-
tion with the risk of ARPC.
Patients and methods It was a prospective, observational, single-
center study of patients with COPD hospitalized for elective thoracic 
surgery in the center of Hôpital Cochin, Paris, France. The inclusion 
criteria were as follows: male or female adults, permanent airflow 
obstruction (VEMS/CV < 70 %), scheduled oncologic pulmonary resec-
tion. Collected data were as follows: COPD symptoms and severity 
scores, preoperative severity scores, comorbidities, per operative data, 
postoperative complications and 30-day mortality.
Results Since July 2014 to September 2015, 98 COPD patients were 
included for analysis. Twenty-one were considered as FE (21.6  %). 
COPD classification was as follows: I—5 (%), II—11 (%), III—2 (%). There 
was no difference in demographic or COPD severity score (CAT score, 
IPAQ, MRC) between FE and the rest of the population. There was no 
difference in the 30-day mortality.
Results are in Table 21.
Conclusion FE history does not seem to affect the ARPC rate following 
oncologic pulmonary resection in COPD patients.
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Not EF  
(n = 77)
EF (n = 21) p
Hospital stay (days) 11.4 11.5 11.2 0.64
IGS 17 17 23 0.9
Postoperative pneu‑
monia [n (%)]
24 (25 %) 17 (22 %) 7 (33 %) 0.18
Postoperative exacer‑
bation [n (%)]
45 (46 %) 33 (43 %) 12 (57 %) 0.11
Atelectasis [n (%)] 47 (48 %) 36 (47 %) 11 (52 %) 0.38
Acute respiratory 
failure [n (%)]
35 (36 %) 25 (32 %) 10 (48 %) 0.1
Acute kidney injury 
[n (%)]
14 (14 %) 12 (16 %) 2 (10 %) 0.63
Cardiovascular com‑
plication [n (%)]
19 (19 %) 18 (23 %) 1 (5 %) 0.09
Sepsis 15 (15 %) 13 (17 %) 2 (10 %) 0.5
Noninvasive ventila‑
tion [n (%)]
22 (22 %) 15 (19 %) 7 (33 %) 0.1
Bronchoscopy 20 (20 %) 14 (18 %) 6 (29 %) 0.2
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Introduction Nasal high-flow therapy (HFT) is increasingly used in 
intensive care for patients suffering from respiratory failure who also 
often require inhaled bronchodilators. Pressurized metered-dose 
inhalers (pMDIs) combined with spacers are convenient and cost-
effective to generate aerosols for both ambulatory and mechanically 
ventilated patients. Therefore, administration of salbutamol within 
a spacer, placed in the HFT circuit, using a pMDI, could be relevant. 
The aim of this bench study was to determine optimal settings in this 
regard.
Materials and methods We assessed the mass of salbutamol deliv-
ered downstream of a tridimensional anatomical model reproducing 
aerosol deposition and leakage at the nose and rhinopharynx level 
after ten pMDI actuations (delivery of 1000 µg = nominal dose) of a 
canister connected with a spacer chamber (CombiHaler®) placed in 
an HFT circuit and synchronized with inspiration. The aerosol was col-
lected on a filter and the mass of salbutamol measured by spectro-
photometry. The spacer was placed either before the humidification 
chamber or immediately before the nasal cannula, and we assessed 
the influence of different HFT flow rates (30, 45 and 60  L/min) and 
breathing patterns (“respiratory failure” with mean patient inspiratory 
flow of 45 L/min vs. “quiet” breathing with a mean patient inspiratory 
flow of 15  L/min) on the delivered mass of salbutamol (respirable 
mass). Six experiments were performed for each condition tested.
Results Connection of the spacer before the humidification chamber 
was always poorly efficient, whatever the HFT flow rate used or res-
piratory pattern simulated, with masses collected ranging from 1.5 to 
2.5 % of the nominal dose. When the spacer was placed immediately 
upstream from the cannula, the masses collected were 11.8, 10.7 and 
6.2 % of the nominal dose for HFT flow rates of 30, 45 and 60 L/min, 
respectively, with the quiet breathing setting. During simulation of 
respiratory distress, the amount of salbutamol collected on the filter 
was higher at the HFT flow rate of 30 L/min (16.8 vs. 11.8 %) while it 
was lower at 45 and 60 L/min, compared to the quiet breathing pat-
tern (respectively 4.4 vs. 10.7 % and 3.3 vs. 6.2 %): Fig. 30.
Conclusion Placing the spacer immediately upstream from the 
cannula was the most efficient configuration for pMDI salbutamol 
administration in an HFT circuit, actuation being synchronize with 
inspiration. The masses observed are likely to produce a therapeutic 
effect in the clinical setting, even in case of respiratory failure and high 
patients inspiratory flows. Indeed, an inspiratory flow matching the 
HFT may minimize aerosol leakage during inspiration. These findings 
may lay the foundations for the clinical evaluation of salbutamol deliv-
ery with a pMDI during HFT.
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Fig. 30 See text for description 
Table 22 See text for description
Nurses (%) Physiotherapists 
(%)
Physicians (%)
Intubation for less 
than 12 h
 Passive (in bed) 0 5 5
 Out of bed 39 37 26
Fraction of inspired 
oxygen (FIO2) 
>0.6 and/or O2 
partial pressure 
over FIO2 ratio 
<150 mmHg
 Passive (in bed) 5 5 5
 Out of bed 59 50 50
Respiratory rate at 
rest >30/min
 Passive (in bed) 0 0 5
 Out of bed 25 10 32
O2 saturation <88 % 
at rest
 Passive (in bed) 5 10 11
 Out of bed 53 21 44
Severe respiratory 
acidosis (pH < 7.2)
 Passive (in bed) 11 20 16




 Passive (in bed) 0 10 5
 Out of bed 76 25 53
Prone position
 Passive (in bed) 42 37 21
 Out of bed 100 100 100
Venous femoral line
 Passive (in bed) 0 0 0
 Out of bed 17 11 11
Dialysis catheter in 
femoral position
 Passive (in bed) 0 5 0
 Out of bed 29 22 17
Arterial femoral line
 Passive (in bed) 0 5 0
 Out of bed 33 16 11
Page 87 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
sitaires Saint‑Luc, Bruxelles, Belgium; 4Département de réanimation médi‑
cale et de médecine hyperbare, C.H.U. d’Angers, Angers, France; 5Service 
de physiothérapie, Hôpital neuchâtelois, Neuchâtel, Switzerland; 6Service 
de soins intensifs, Hôpitaux Universitaires de Genève, Genève, Switzerland; 
7Réanimation médico‑chirurgicale, Hôpital Tenon, Paris, France; 8Service 
de réanimation médicale, Clinique de Réanimation Médicale, Grenoble, 
France; 9Service de médecine intensive adulte et centre des brûlés, CHUV | 
Centre hospitalier universitaire vaudois, Lausanne, Switzerland 
Correspondence: Laurent Poiroux ‑ lapoiroux@chu‑angers.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P91
Introduction In intubated patients, early mobilization reduces the 
incidence of ICU-acquired weakness but also mechanical ventilation 
duration and length of stay both in the ICU and in the hospital. Even 
if a relative consensus about the definition of early mobilization has 
emerged (i.e., rehabilitation interventions that are initiated imme-
diately after stabilization of physiologic derangements), there is no 
definite consensus about the safety criteria required to initiate the 
rehabilitation process in acutely ill patients. This is probably at least 
partly due to very different perceptions, particularly between the 
various healthcare professionals working at the bedside of the risks 
related to the rehabilitation procedures.
Materials and methods The aim of the study was to compare what 
the different members of the ICU multidisciplinary team consider as 
contraindications to perform rehabilitation in mechanically ventilated 
critically ill patients. Practically, as preliminary part of a multicenter 
interventional study on early mobilization, a questionnaire was sent to 
the referent nurse, physiotherapist and physician of each participating 
center. Each healthcare professional was asked to define whether pas-
sive or active mobilization, inside or outside the bed, could safely be 
performed in different clinical situations and with various ICU equip-
ment. Each participant was asked to answer by “No” if the mobiliza-
tion was contraindicated in the described situation and by “Yes” if the 
mobilization was possible.
Results Fifty-one questionnaires were analyzed (17 from nurses, 
17 from physiotherapists and 17 from physicians). The percentages 
of “No” answers meaning that mobilization is contraindicated are 
reported in Table 22.
Conclusion In general, passive mobilization is considered as safe and 
possible by all the healthcare professionals in the majority of the clini-
cal situations described. Oppositely, when active mobilization outside 
the bed is considered, major differences in perception of mobilization 
associated safety emerged within the various healthcare profession-
als. In particular, we noticed that the physiotherapists were less afraid 
by poor respiratory conditions than nurses and doctors. On the other 
hand, the presence of an arterial femoral line or of a dialysis catheter in 
femoral position was mainly considered as a contraindication of mobi-
lization outside the bed by the nurses.
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Introduction Early mobilization of critically ill patients is a major 
issue when it comes to ICU stay shortening for multiple organ failure 
patients. It is well accepted that “bed-in-chair” sitting, first chair sitting 
exercise, passive verticalization and walking are crucial steps to better 
rehabilitation in the ICU and after patients have left the ICU. We aimed 
at assessing the real-life conditions performance of early rehabilitation 
practices in ICUs and to study why there are some limitations to a large 
use of such training for patients.
Materials and methods A prospective telephone inquiry was per-
formed from February to March 2015 in 35 ICU (25 from university 
hospitals), representing 1046 beds; it recorded data on ICUs and on 
the real-life practice of rehabilitation in the setting of 5 clinical cases 
(1 coma patient undergoing mechanical ventilation weaning yet he 
was on low tapering NE infusion, 1 ARDS, 1 COPD under noninvasive 
ventilation, 1 acute/chronic liver failure patient infused tapering doses 
of norepinephrine, 1 postoperative patient). For each case, staff was 
questioned on the practice of transferring from flatbed to chair; bed 
Table 23 See text for description
a: transferring from a flat bed to chair; b: bed in armchair position; c: transferring 
to edge of bed; d: standing position; e: marching; NE: norepinephrine
Cases Rehabilitation % Limits
Resolving coma, 
tapering dose 
of NE, ongoing 
respiratory 
weaning
a. Often 3; rarely 
96.9
Consciousness: 
69.7 % presence 
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in armchair positioning; transferring to edge of bed; standing position; 
and marching. In addition, we collected the reasons for not practicing 
early mobilization.
Results One hundred percentage of responses were made by physi-
otherapists, 64.5 % of which had less than 5-year working experience. 
The median number of patients taken in care by one physiotherapist 
was 14 [range (3.5–52)], whereas simultaneously each nurse had 2.5 
patients in charge, and each nurse auxiliary 4.2. Shift hours were on 
12 h a-day in 58.8 % of the ICUs (Table 23).
The main reasons for not proposing early rehabilitation are low con-
sciousness level, NE infusion, curare infusion and the simultaneous 
presence of many surgical drains in the same patient.
Conclusion Despite low sedation, many critically ill patients are 
readily installed in a bed in armchair position because this position 
does not include danger and allows easy visual control. Postopera-
tive patients with complicated surgical devices are not often pro-
posed for early mobilization from bed: nurses and physiotherapists 
bring up the problem of understaffing. Patients with low doses (or 
tapering low doses) of NE are infrequently proposed for early mobi-
lization; although there are no reliable data concerning the dose–
effect relationship with negative side effects in such a population, 
a specific study is deserved to understand whether such patients 
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Introduction Pheochromocytoma is a rare catecholamine-producing 
tumor that might occasionally provoke a stress-induced takotsubo-like 
cardiomyopathy and severe cardiogenic shock. Since the recourse to 
veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has 
rarely been reported in this setting, we reviewed the presentation and 
outcomes of patients admitted to our ICU for pheochromocytoma-
induced refractory cardiogenic shock that was rescued by VA-ECMO.
Patients and methods All cases of pheochromocytoma-induced 
refractory cardiogenic shock managed with VA-ECMO in our ICU 
between January 2007 and March 2015 were retrospectively reviewed.
Results Nine patients were included, 7 women and two men, aged 
31–51  years (median: 43, IQR [36–49]). None of them were previously 
known to suffer pheochromocytoma. The medical history of these 
patients was unremarkable except for 4 of them: one had isolated 
hypertension, one had chronic headache, one had a type 1 multiple 
endocrine neoplasia syndrome and another reported clinical symptoms 
suggestive of the disease in the last 12 months. At hospital admission, 3 
patients had hypertensive crisis and required antihypertensive therapy, 
3 had chest pain mimicking acute coronary syndrome, five had dyspnea 
related to congestive heart failure. For two patients, a surgical triggering 
factor (hysterectomy and hernia surgery) was identified with hemody-
namic instability and acute pulmonary edema during anesthesia. One 
patient had cardiac arrest (Ventricular Fibrillation) before admission.
All 9 patients rapidly developed refractory cardiogenic shock with very 
severe left ventricular impairment (left ventricular ejection fraction 













Age, mean (SD) (years) 66.4 ± 16.1 65.1 ± 16.5 63.6 ± 16.9 63.7 ± 16.6 −2.7 (−2.0 to −3.4)*
Men 1977 (61) 2877 (62.5) 3315 (64) 4152 (65) −4.0 (−6.0 to −1.9)*
SAPS II 58.7 ± 25.3 59.3 ± 24.7 63.8 ± 23.7 64.5 ± 23.3 5.8 (4.8 to 6.8)*
Acute respiratory failure 1149 (35) 2175 (53) 2984 (58) 3410 (53) 18.0 (16.0 to 20.1)*
Coma 506 (16) 1181 (26) 1631 (31.5) 1673 (26) 10.6 (8.9 to 12.2)*
Acute renal failure 1039 (32) 1936 (42) 2807 (54) 3468 (54) 22.3 (20.3 to 24.3)*
Sepsis 649 (20) 1135 (25) 1552 (30) 1815 (28) 8.4 (6.7 to 10.2)*
Cardiac arrest 870 (27) 1400 (30) 1721 (33) 2142 (33.5) 6.8 (4.8 to 8.7)*
Acute myocardial infarction 771 (24) 1018 (22) 1052 (20) 1167 (18) −5.5 (−7.2 to −3.7)*
Drug intoxications 160 (5) 230 (5) 265 (5) 269 (4) −0.7 (−1.6 to 0.2)*
Pulmonary embolism 220 (7) 240 (5) 244 (5) 304 (5) −2.0 (−3.1 to −1.0)*
In‑hospital management
Invasive ventilation 2377 (73) 3446 (75) 3987 (77) 4765 (75) 1.4 (−0.4 to 3.3)*
 Circulatory support 2895 (89) 4052 (88) 4172 (81) 5096 (80) −9.3 (−10.8 to −7.9)*
 Renal support 466 (14) 924 (20) 1342 (26) 1709 (27) 12.4 (10.8 to 14.0)*
In‑CCU Death 1635 (50) 2294 (50) 2416 (46.5) 2860 (45) −5.6 (−7.7 to −3.5)*
Outcomes in survival patients n = 1613 n = 2308 n = 2763 n = 3527
Discharge at home 63 (4) 107 (5) 103 (4) 78 (2) −0.7 (−1.3 to −0.2)*
To another hospital 431 (27) 567 (24) 628 (23) 733 (21) −1.8 (−3.2 to −0.4)*
Intrahospital transfer 1114 (69) 1633 (71) 2009 (73) 2716 (77) 8.3 (6.2 to 10.3)*
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ranged from 5 to 20 %, left ventricular outflow tract velocity time inte-
gral ranged from 3 to 8 cm). Pheochromocytoma was highly suspected 
on abdominal CT scan showing adrenal gland tumor in 7 cases (the two 
others did not have CT scan during ICU stay). Three patients died from 
refractory cardiogenic shock despite ECMO implantation. For the 6 oth-
ers, myocardial function improved and ECMO was removed 3–7  days 
after initiation. Alpha and beta blockers were progressively introduced 
after ECMO removal. Five survivors had adrenalectomy 6  weeks after 
ICU discharge and had satisfactory outcome. In one patient, pheochro-
mocytoma was diagnosed 1  year after the index event and surgical 
adrenalectomy was performed without complication.
Conclusion Pheochromocytoma is a rare but reversible cause of cardio-
genic shock that might be rescued by VA-ECMO. Radiographic imaging 
with echography and CT scan of the adrenal gland should be obtained 
in all patients with unexplained cardiogenic shock. Lastly, adrenalec-
tomy might be safely performed in the weeks following the initial cata-
strophic presentation, after complete recovery of LV systolic function.
Competing interests None.
P94  
Mortality related to cardiogenic shock in critically ill patients 
in France, 1997–2012
Etienne Puymirat1, Jean‑Yves Fagon2, Philippe Aegerter3, Florence 
Boissier4, Jean‑Luc Diehl2, Caroline Hauw‑Berlemont2, Bertrand Guidet5, 
Gilles Chatellier6, Nicolas Danchin7, Nadia Aissaoui2
1Cardiology, Hôpital Européen Georges‑Pompidou, Paris, France; 2Réani‑
mation médicale, Hopital Europeen Georges‑Pompidou, Paris, France; 
3Urc, Hospital Ambroise Paré, Boulogne‑Billancourt, France; 4Réanimation 
Médicale, Hôpital Henri Mondor, Créteil, France; 5Réanimation Médicale, 
Hôpital Saint‑Antoine, Paris, France; 6Unité de recherche clinique, Hopital 
Europeen Georges‑Pompidou, Paris, France; 7Cardiologie, Hopital Europ‑
een Georges‑Pompidou, Paris, France 
Correspondence: Nadia Aissaoui ‑ nadia.aissaoui@egp.aphp.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P94
Introduction There is a lack of data concerning the characteristics, the 
outcome and temporal trends in mortality of cardiogenic shock (CS) 
patients admitted in critical care unit (CCU). Accordingly, we provide an 
extended 15 years long perspective into changing trends in key features 
of patients, use of life-supporting therapies and in-CCU death rates.
Patients and methods We conducted a retrospective study using 
prospectively collected data from the 1997–2012 database of Paris-
ian area critical care units—the CubRea (Intensive Care Database User 
Group). We assessed temporal trends in the use of life-supporting 
therapies and patient outcomes (Crude and SAPS II-Standardized Mor-
tality, discharge location).
Results Among 316,905 patients admitted in CCUs, 19, 416 (6.1  %) 
exhibited CS, with an increasing incidence between 1997 and 2012 
from 4.1 to 7.7 %, P < 0.001. Baseline characteristics of patients accord-
ing to the study period are reported in Table 24. Over time, the age of 
CS patients decreased 66.4 ±  16.1–63.7 ±  16.6, P  <  0.001 and mean 
SAPS II increased from 58.7 ± 25.3–64.5 ± 23.3, P < 0.001. Use of life-
supporting therapies increased with increase in renal replacement 
therapy by 12.4 percentage points (95 % CI 10.8–14.0) and of invasive 
ventilation by 1.4 percentage points (95  % CI −0.4 to 3.3). However, 
crude in-CCU mortality declined from 50 to 45 %, P < 0.001. SAPS II-
Standardized in-CCU mortality rates also declined from 56.5 to 44.2 %, 
P  <  0.001. Among survivors, the numbers of patients discharged at 
home was low and decreased from 4 to 2 %, P < 0.001.
Conclusion In France, the profile of CS patients admitting in CCUs 
changed over a 15-year study period. From 1997 to 2012, CS patients are 
younger but with a higher severity and need for respiratory and renal 
support. Yet, both crude and SAPS II-Standardized Mortality decreased, 
suggesting an improvement in the management and prognosis.
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Introduction Because of the sanitary and social progress, proportion 
of elderly patients undergoing cardiac surgery constantly increases. 
Nevertheless, in case of postcardiotomy refractory cardiogenic 
shock, the need for extracorporeal life support (ECLS) is questionable 
because of the lack of survey data in this population. The aim of this 
study was to investigate the 28-day mortality after cardiac surgery in 
patient ≥80 years old with or without ECLS.
Materials and methods In a monocentric retrospective study, we 
included all patients ≥80 years old undergoing on pump cardiac sur-
gery between January 2013 and December 2014. Primary endpoint 
was the 28-day mortality. Data are expressed in median (25th–75th 
quartile) or percentage. Fisher’s test for qualitative variable or Wilcox-
on’s test for quantitative analysis was used.
Results We included 225 consecutive patients. The median age was 
82 (81–85) with 62.5 % of men. The Euroscore2 was 9.1 % (7.1–10.8). 
ECLS was needed in 8.7 % of cases (n = 20). In control group, without 
ECLS, median age was 82 (81–85), the Euroscore2 was 4 % (3–9), the 
CPB duration was 84 (86–106) min, the initial SAPS2 was 37 (27–49), 
initial SOFA score was 5 (3–6), and postoperative mechanical ventila-
tion duration was 0 (0–1) days. In ECLS group, the median age was 83 
(82–84) (p = 0.74). The Euroscore2 was higher, 13 % (4–25) (p = 0.007). 
Both SAPS2 64 (52–73) (p  <  0.0001) and initial SOFA score increased 
[8 (6–9), p  =  0.0001]. Postoperative mechanical ventilation duration 
increased (5.5 (2.0–11.0) days, p < 0.0001). In ECMO group, in-hospital 
mortality (80 vs 7 %), 28-day mortality (85 vs 11 %) and 6-month mor-
tality (85 vs 15  %) increased significantly in comparison with control 
group (p < 0.0001 for all).
Conclusion In elderly patients undergoing on pump cardiac surgery, 
refractory cardiogenic shock is associated with high morbidity and 
mortality. Nevertheless, in this particular severe cohort, ECLS seems to 
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Introduction Since 2004, patients needing heart transplantation 
in emergency benefit from national prioritization “super urgency 
1” (SU1) for graft attribution. The efficiency of this new modality of 
access to transplantation in emergency is uncertain. Several trans-
plantation teams report increased transplantation survey in patients 
assisted previously with ventricular device (VAD). The aim of this 
work was to compare the survey of patients in SU1 who were trans-
planted during this period in comparison with patients who failed 
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to be transplanted and who benefited of VAD treatment in bridge to 
transplantation.
Patients and methods This monocentric retrospective study 
included all the patients in SU1 between January 1, 2008, and June 
30, 2013. Primary endpoint was the hospital mortality after either 
transplantation or VAD treatment. The second endpoint was the 
1-year mortality. Data are expressed to median (25th–75th quartile) 
and percentage. Groups were compared using Mann–Whitney and 
Fischer tests.
Results During the period study, 227 patients were included in SU1 
program. In total, 162 patients received a cardiac graft and 65 failed 
to be transplanted during the SU1 period. In failed attempt group, 
33 were treated with VAD therapy [22 biventricular assist device 
(BiVAD) and 11 left ventricular assist device (LVAD)], 15 patients 
died without transplantation or any other device and 15 patients 
were excluded of the study because they were transplanted after 
the “SU1” period. One patient survived without any transplantation 
or device at 1  year. Between transplanted and VAD groups, there 
was no difference in terms of age [51 (40–59) vs 49 (40–59) years, 
p  =  0.82], preoperative extracorporeal life support (38 vs 36  %, 
p = 1.0) or SOFA score at the time of heart transplantation or VAD 
implantation [5 (4–6) vs 5 (4–6), p  =  0.19]. There was more male 
gender in the VAD group than in the transplant group (97 vs 82 %, 
p = 0.03). Both hospital mortality and 1-year mortality were lower 
in the transplant group than the VAD group, 23  % versus 55  % 
(p  <  0.001, OR 0.25 [0.11–0.58]) and 25  % versus 61  % (p  <  0.001, 
OR 0.22 [0.09–0.50]) respectively. Mortality of patients assisted by 
BiVAD tended to be more important than patients assisted by LVAD 
[72 vs 36  %, p  =  0.06]. After 1  year, all survivors pretreated with 
LVAD (n = 11) were hundred percent successful transplanted after 
transplantation.
Conclusion Heart transplantation is the best treatment in SU1 condi-
tions for patients with refractory cardiogenic shock. In case of failed 
attempt in SU1, VAD implantation needs meticulous revaluation in 
particular of BiVAD because of high mortality.
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Introduction Veno-arterial extracorporeal membrane oxygenation 
(VA-ECMO) is used as a salvage therapy for refractory cardiogenic 
shock. Since major improvement in the prognosis of immunocom-
promised patients admitted to the intensive care unit (ICU) has been 
reported in recent years, our objective was to analyze short- and long-
term outcomes of immunocompromised refractory cardiogenic shock 
patients supported by VA-ECMO.
Patients and methods We retrospectively collected demographic, 
admission severity scores, pre- and post-ECMO data, ECMO-related 
complications, and 6-month survival of immunocompromised patients 
who received VA-ECMO for refractory cardiogenic shock in our 26-bed 
intensive care unit (ICU) from June 2006 to June 2015. Immunocom-
promised status was defined as hematological malignancy, solid 
cancer <5  years, solid organ transplant, human immunodeficiency 
virus (HIV) infection, long-term corticosteroid or immunosuppressive 
therapies. Patients who received ECMO within 1  year after cardiac 
transplantation or after left ventricular assist device were excluded 
from this cohort. Patients who survived were contacted in September 
2015 and assessed for health-related quality of life, psychological and 
post-traumatic stress disorder status.
Results Eighty-two immunocompromised patients were included 
(median age 43 years, [interquartile range 30–60]; 54 % male, Simpli-
fied Acute Physiology Score II (SAPS II) 72 [55–89]). Reasons for immu-
nodeficiency were hematological malignancies (n = 17), solid cancers 
(n = 14), HIV (n = 8), solid organ transplantation (n = 17) and auto-
immune connective tissue disorders or vasculitis or long-term cor-
ticosteroid therapy (n = 26). Main causes of cardiogenic shock were 
myocarditis (n = 24), dilated cardiomyopathy (n = 12), acute myocar-
dial infarction (n =  10), septic shock (n =  8), cardiac graft rejection 
(n = 8) or post-cardiotomy (n = 5). Twenty-nine patients (35 %) had 
pre-ECMO cardiac arrest, 11 of them (13 %) were cannulated during 
cardiopulmonary resuscitation. Median IGS II score at admission and 
mean SOFA score at cannulation were, respectively, 72 [IQR 55–89] 
and 12 ± 5. Pre-ECMO left ventricle ejection fraction (LVEF), pH, blood 
lactate were, respectively, 10 % [5–18], 7.27 [6.99–7.43] and 10 [7–15] 
mmol/L. Severe hemorrhage and at least one episode of nosocomial 
infection were reported in, respectively, 34 and 50 % patients with no 
impact on survival. Six-month survival was 32  % after, respectively, 
7  days [5–14] on ECMO and a length of stay of 26  days [15–33] in 
ICU and 57 days [33–74] in hospital. Independent factors associated 
with 6-month mortality according to logistic regression analysis were 
SAPS II score  >  65 (OR 4.26 [95  % CI 1.03–17.62]) and LVEF  <  10  % 
at the time of cannulation (OR 8.14 [95  % CI 2.15–62.33]). On the 
other hand, autoimmune connective tissue disorders or vasculitis or 
long-term corticosteroid therapy seemed to be protective (OR 0.11 
[95  % CI 0.02–0.61]). Lastly, 34  months [23–55] after ICU discharge, 
no dependency for the performance of daily living activities was 
reported. However, compared with age- and sex-matched controls, 
our ten responding immunocompromised survivors had significantly 
lower SF-36 physical domain scores and role emotional component 
(p < 0.001).
Conclusion Despite extreme disease severity and major underly-
ing comorbidities, we observed that 32  % of immunocompromised 
patients rescued with VA-ECMO for refractory cardiogenic shock were 
alive at 6  months with acceptable long-term quality of life. Higher 
severity score and profound cardiac impairment at ECMO initiation 
were independently associated with poor outcomes. Although sur-
vival was less in this group of patients than in non-immunocompro-
mised patients, recourse to this salvage therapy should not be denied 
based only on this pre-morbid condition. Lastly, the type of immuno-
suppression might also impact on the outcomes of these patients.
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Introduction Maternal mortality constitutes an indicator impossible 
to circumvent the development in any country and its monitoring 
remains fully of news. So evaluating the risk of mortality and reduc-
ing it to a certain number of scores of gravity were developed in the 
intensive care units, but their application in obstetric medium remains 
discussed.
We aimed in this study to check and to compare the capacity of fore-
cast of four scores of gravity SAPS II, APACHE II, OSF and SAPSO among 
allowed parturient in the gynecologist–obstetric intensive care unit in 
order to be able to determine the most relevant score of gravity to use 
for the obstetric population of our context.
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Materials and methods Four hundred and forty-eight patients 
were studied prospectively the beginning of January until the end 
of December 2013. The four scores were calculated during the first 
24  h. The comparison of the variables called on Student’s t test and 
Chi square (p  <  0.05) and with a multivariate analysis. We compared 
discrimination and the calibration, respectively, by the sectors under 
curve ROC (AUC ROC) and standardized mortality ratios (SMR) calcu-
lated for each score.
Results Four predictive factors independent of mortality were found: 
score of Glasgow, creatininemy, diastolic blood pressure and rate of 
plates.
Discrimination was excellent for the four scores AUR ROC > 0.75.
The SAPS II had an overall good calibration (SMR = 1171). APACHE II 
and the OSF over-estimate mortality, APACHE II and the OSF over-esti-
mate mortality, with a better calibration of the OSF (SMR, respectively, 
0.454 and 0.771), and the SAPSO underestimates mortality in our con-
text (SMR = 2173).
Conclusion Severity scores are applicable in our context. They provide 
important information on the severity of patients and allow people to 
categorize in order to predict their evolution.
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Introduction Maternal mortality (MM) remains a real problem of pub-
lic health worldwide and stills recognized as an indicator of care’s qual-
ity in obstetrics; it reflects risks incurred by mothers during pregnancy 
and delivery. According to the WHO, the maternal mortality is defined 
as the death of a pregnant woman or within 42 days of ending preg-
nancy, from any cause related to pregnancy or aggravated by it or its 
management but not from accidental or incidental causes (1). The aim 
of this study was to specify the incidence of the MM in our hospital 
and to analyze its epidemiological factors and causes for suggesting 
ways of its prevention.
Patients and methods Retrospective study spread of 5  years, from 
January 2010 to December 2014, including all maternal deaths in 
obstetric department of our hospital, with epidemiological analysis of 
risk factors and mortality causes.
Results In this period, 130 cases of maternal deaths have been col-
lected among 43,735 living births let a rate of MM about 297/100,000 
living births. The main causes of those maternal deaths are direct 
obstetric ones in 80  %, including obstetrical hemorrhage (35.38  %) 
and hypertensive diseases (28. 46 %). The average age of our patients 
was 31.34 years, with a peak frequency recorded in the age range of 
35 years and more (34 %). The primipars (36.15 %) and the paucipare 
(36.92 %) were the most affected. Most deaths (53.05 %) carried their 
pregnancies to term; only 19  % were followed in prenatal consulta-
tion. The rate of parturient admitted directly from home to the UH was 
40 %, while 60 % of women passed by another before UH, especially 
peripheral hospitals (37 %). The rate of patients given birth by caesar-
ian is superior to those given birth by low way, with 60.77 and 31.54 %, 
respectively. Most patients were admitted in severe status, 37.69 % of 
the deaths occurred less than 24 h after admission, while 19. 23 % of 
patients died after 7 days of resuscitation’s care.
Conclusion MM rate obtained in our study (297/100000LB) is over-
estimated comparing to actual rate of MM in our country, because 
UH is a referral center and tends to receive serious and complicated 
cases with higher risk of death. To reach the objective of the WHO tell-
ing that all women over the world have the right of not to die while 
procreating, it seemed urgent to mobilize communities for education 
and information of the women to get better outcome of pregnancy, as 
well as an engagement from government and healthcare profession-
als, associated with an adequate equipment of the maternities and 
optimize transportation covering the whole population.
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Introduction Many studies have shown a good correlation between 
the value of the International Society of Thrombosis and Hemostasis 
(ISTH) score, diagnosis of severe coagulopathy and mortality, espe-
cially during severe sepsis and polytrauma. However, physiological 
changes in hemostasis during pregnancy probably alter the significant 
thresholds of the ISTH score compromising the application and inter-
pretation of it for the diagnosis of disseminated intravascular coagu-
lopathy (DIC). The morbidity and mortality associated with severe 
hemorrhage and consumption coagulopathy leading to DIC during 
pregnancy emphasize the need for the adjustment of this ISTH DIC 
score to these patients On this basis, an Israeli team recently created 
from a large retrospective database study (n  =  24,693 deliveries), a 
score of DIC. The components and the coagulation parameter thresh-
olds were determined according to the physiological changes of the 
coagulation of pregnant women.
Primary objective of the study was to test a new scoring system for 
diagnosing disseminated intravascular coagulopathy (DIC), which is 
adapted to hemostasis changes in pregnant women and to compare 
this new score to the International Society of Thrombosis and Hemo-
stasis (ISTH) score. Secondary objectives were to explain differences 
in diagnostic predictive value between the two scores and to assess 
DIC and its evolution of DIC according to the main obstetrics diseases 
causing ICU admission.
Materials and methods This is a population-based retrospective 
study of 154 patients admitted for severe postpartum complications 
from 2008 to 2014 at intensive care center in Lille University Hospital. 
The new score (based on 3 components: platelet count, prothrombin 
time difference and fibrinogen) and the ISTH score (based on 4 compo-
nents: platelet count, fibrinogen, prothrombin time, and fibrin-related 
marker) were calculated from biological data on the day of delivery 
and repeated at ICU admission (day 0) until second day included (day 
2) with reference to the consensus diagnostic analysis by two experts. 
The sensitivity, specificity, and area under the curve (AUC) for each 
score were calculated for each time and overall by generalized linear 
mixed model. The agreement between the two scores was evaluated 
with the Kappa coefficient.
Results The new score allowed us to make the diagnosis of DIC with a 
sensitivity of 0.78, a specificity of 0.97 (p < 0.01), and total AUC of 96 %, 
while the ISTH score had a sensitivity of 0.31, a specificity of 0.99 and 
an AUC of 94 % (p < 0.01). Their Kappa correlation coefficient was 0.35. 
The discriminating thresholds of the components of the new score 
had a good correlation with the expert analysis regarding the differ-
ence in prothrombin time and fibrinogen while the platelet count 
threshold was less adapted. Analysis of ISTH score thresholds showed 
a high prevalence of DIC for high-weighted thresholds and also a 
Page 92 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
significant prevalence for the thresholds considered as not markers of 
DIC. DIC complicated mostly acute fatty liver of pregnancy (AFLP) and 
postpartum hemorrhage and especially if it was associated with HELLP 
syndrome. The correction of the DIC was faster in the postpartum 
hemorrhage compared with preeclampsia, HELLP syndrome or AFLP.
Conclusion The ISTH score should not be used in pregnant women 
because of its poor sensitivity. The new score established from the 
physiological changes of pregnancy seems highly discriminating and 
it assesses the evolution of DIC and the effects of its treatment.
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Introduction The severity scores have been developed in order 
to assess the severity of patients in the ICU and predict their subse-
quent evolution and prognosis [1]. Obstetric patients are a particular 
subgroup for which the interest of these scores is understudied. The 
objective of our study was to evaluate the interest of severity scores 
SAPS II, APACHE II, MPMII 0, MPMII 24 and ODIN in obstetric patients 
admitted to ICU.
Patients and methods A retrospective study includes all patients 
admitted in ICU for 20  years (1993–2012). The discriminatory power 
was investigated by ROC curve method. The calibration was based on 
comparing the observed mortality (OM) and the predicted mortality 
(MPR) (SMR  =  OM/PMR) and verified by the Hosmer–Lemeshow (H) 
goodness-of-fit test.
Results Seven hundred and twenty-five patients were included. The 
average age was 31.2 ± 6.4 years. On admission, 124 patients (17.1 %) 
were in shock. Ninety-four patients (13  %) had the acute pulmonary 
edema. The acute renal failure was observed in 367 patients (50.6 %). 
Two hundred and one patients (27.7 %) had intravenous disseminate 
coagulation. Eighty-five patients (11.7 %) had disorders of conscious-
ness. All these systemic complications were significantly associated 
with high mortality. The childbirth was by cesarean section in 462 
patients (63.7 %). Mechanical ventilation for more than 24 h was per-
formed in 233 women (32.1 %). The average stay of our patients was 
2.8 ± 4.2 days. Mortality has affected 44 patients (6 %).
The areas under the ROC curve for SAPS II, APACHE II, MPM II 0, MPM II 
24 and ODIN were, respectively, 0.88 95 % CI [0.82; 0.93], 0.84 95 % CI 
[0.77; 0.89], 0.86 95 % CI [0.81; 0.91], 0.94 95 % CI [0.90; 0.91] and 0.93 
95 % CI [0.90; 0.95] (Fig. 31). SMR was close to 1 for SAPS II and MPM II 
24 scores (respectively, 0.90 and 0.97), whereas it was 0.53, 0.54 and 
0.6, respectively, for APACHE II, MPM II 0 and ODIN scores. The value of 
H was 13.65 (P > 0.05) and 2.14 (P > 0.05), respectively, for scores SAPS 
II and MPM II 24, while it was 32.48 (P < 0.001), 32.47 (P < 0.001) and 
37.56 (P < 0.001), respectively, for scores APACHE II, MPM II 0 and ODIN.
Conclusion For each of the 5 studied scores, we found an excellent 
discriminatory power in terms of mortality. SAPS II and MPM II 24 had 
a perfect calibration to predict satisfactorily the probability of death. 
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Introduction Despite few studies, a monitoring of a neuromuscular 
blockade with a train of four (TOF) is recommended in intensive care 
unit (ICU) (1). The role of neuromuscular blocking agents (NMBAs), 
without TOF monitoring, was recently enhanced in acute respiratory 
distress syndrome (2). Our objective was to compare the results of a 
TOF with a clinical assessment of a neuromuscular blockade in ICU 
patients treated with recommended doses of benzylisoquinoliniums.
Patients and methods Design: An observational prospective study.
Setting: Two polyvalent ICUs.
Patients: A total of 119 critically ill patients who required a neuromus-
cular blockade for more than 24 h.
Interventions: None.
Measurements: Based on recommendations (1), three levels of neu-
romuscular blockade were defined: “over-paralyzed” (TOF = 0), “well-
paralyzed” (TOF = 1–2), and “under-paralyzed” (TOF = 3–4). Similarly, 
physicians were asked to classify patients as “over-,” “well-,” or “under-” 
paralyzed. Two measurements per day of the TOF on the facial nerve 
were taken and compared to the clinical assessment made by physi-
cians who were blinded to the TOF results.
Results During the study period, 996 measurements of the facial TOF 
were taken, and only 8.8 % of them were in the category “well-para-
lyzed.” The agreement between the facial TOF and clinical assessment 
was very poor (kappa: 0.06; weighted kappa: 0.09). The proportion of 
“under-paralyzed” TOF measurements increased with the duration 
of the neuromuscular blockade (p  <  0.05), suggesting tachyphylaxis. 
No significant difference was found when the plateau pressure and 
PaO2/FiO2 ratio were compared between the three levels of muscle 
relaxation defined by the TOF in the subgroup of patients with acute 
respiratory distress syndrome. The risk of ICU-acquired weakness was 
Fig. 31 ROC curves showing the correlation between SAPS II, 
APACHE II, MPM II 0, MPM II 24 and ODIN and mortality (area under 
the respective curves: 0.88, 0.84, 0.86, 0.94 and 0.93)
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associated with a median infusion rate of NMBAs. It was also associ-
ated with a higher number of “over-paralyzed” TOF measurements 
(p < 0.05).
Conclusion Our results suggest that, according to the facial TOF, less 
than 10 % of patients are “well-paralyzed” with recommended doses of 
benzylisoquinoliniums and that the clinical evaluation of neuromuscu-
lar blockades is inaccurate. However, the clinical impact of adjusting 
doses of NMBAs according to the TOF is still a matter of debate.
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Introduction Many patients are fed enterally 48  h after their admis-
sion to the ICU, and the administration of enteral nutrition is usually 
subjected to the use of a protocol. In contrast, enteral administration 
of drugs, and the shift from parenteral to enteral route of drugs, is out 
of protocol. We aim to evaluate the use of enteral route in the ICU for 
nine drugs of interest (linezolid, amoxicillin–clavulanic acid, metroni-
dazole, spiramycin, fluconazole, levetiracetam, furosemide, amiodar-
one and esomeprazole). These drugs have a suitable form for enteral 
administration, an excellent oral bioavailability, and are often used in 
ICU.
Patients and methods This was a retrospective analysis of all the 
patients staying more than 72  h in our ICU and receiving one of the 
nine drugs of interest, either parenterally or enterally. At 72 h of admis-
sion, we considered eligible for enteral route patients receiving enteral 
nutrition, presenting without shock, small bowel disease, hematologi-
cal disease, or severe sepsis requiring specifically the parenteral route.
Results Seventy-two hours after ICU admission, 45  % of patients 
were eligible for the use of enteral route. Ineligibility to the enteral 
route was most often due to either hemodynamic instability (patients 
with vasopressors) or a non-fed enterally patient. 18.6  % of patients 
(n = 40) received no drug of interest enterally. Linezolid was the only 
drug that was never switched from parenteral to enteral route. Among 
patients eligible for enteral route, 14 % of patients were using enteral 
route from the beginning of treatment and 25  % with a switch from 
parenteral to enteral route. For patients ineligible for enteral route, 
only 22.6 % have received their medication by strict parenteral route 
throughout the duration of treatment.
Discussion To our knowledge, this is the first description of the use of 
enteral route for drug administration in ICU. It included 215 patients 
representing 13,660 drug administrations. It was neither eligibility to 
enteral route (14 % of eligible patients had no drug of interest enter-
ally, whereas 77.4  % of non-eligible patients received at least one 
drug of interest enterally) nor the bioavailability of the drug of inter-
est (drugs selected for this study had excellent bioavailability) or the 
severity of the patient (patients receiving amiodarone had higher 
SAPS II score than the general population of the study, whereas the 
drug was one of the most enterally given) that dictated the primary or 
secondary use of the enteral route in critically ill patients. This suggests 
that there are barriers against the use of enteral route in ICU: igno-
rance of practices, human factors, and ethical considerations.
Conclusion This first inventory of the use of enteral route of drugs in 
the ICU suggests that the choice of enteral administration is poorly 
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Introduction The management of septic shock includes after optimiza-
tion of patient’s preload, administration of alpha-adrenergic drug such 
as norepinephrine, to maintain adequate mean arterial pressure. How-
ever, alterations of tissue perfusion, source of cellular hypoxia, can coex-
ist with optimal macrocirculatory parameters. The aim of our study was 
to analyze the effects of norepinephrine on metabolic parameters of 
microcirculation in septic patients studied by muscle microdialysis.
Patients and methods It was a prospective, randomized, double-
blind study, including all patients aged over 16  years with septic 
shock defined by the bone criteria of the consensus conference of the 
American College of Chest Physicians/Society of Critical Care Medicine 
(ACCP/SCCM) 1991. Patients were randomized to receive either contin-
uous infusion of levosimendan at 0.2 μg/kg per minute over 24 h (lev-
osimendan group) or a continuous infusion of dobutamine at 5 μg/kg 
per minute during all the study period (dobutamine group) or a con-
tinuous infusion of a normal saline solution (placebo group). Before 
inclusion, norepinephrine should be at stable flow for more than an 
hour. Hemodynamic monitoring of macrocirculation was performed 
by echocardiography. Analysis of microcirculation parameters (lactate, 
pyruvate and lactate/pyruvate ratio) was made every 6  h during the 
first 3  days by muscle microdialysis (CMA600, CMA microdialysis AB, 
Table 25 Drugs’ modes of administration
Respect of  
guidelines
Stop feeding before drugs Yes: 100 % Yes
Rinsing with water No: 42 %; yes: 58 % No: 42 %;  
yes: 58 %
Wait 30 min/stop feeding No: 100 % No
Direct refeeding after drug Yes: 100 % No
Drugs by shape
 Liquids/orodispersible Dilution/dispersion in 
water
Yes




 One by one Yes: 42 % Yes: 42 %
 At the same time Yes: 58 % No: 58 %
Equipment used Mortar/pestle/60‑ml 
syringe
Yes
Solution for blocked tube Injection of water to 
flush it
Yes
Changing the tube No
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Stockholm, Sweden). Correlations between microcirculation param-
eters and norepinephrine doses were studied.
Results Thirty patients were included in the study (ten patients in each 
group). Demographic characteristics including age, sex, weight, medi-
cal history as well as the sepsis site, SAPS II score and mortality were 
comparable across the three groups. In total, 390 samples of muscle 
interstitial fluid were analyzed.
No correlation was found between norepinephrine doses and rate 
of muscle lactate and muscle lactate/pyruvate ratio (p  >  0.05) for all 
groups: levosimendan, dobutamine and placebo. We found a weak 
inverse correlation between norepinephrine dose and muscle pyru-
vate levels (p < 0.05) for the control group and dobutamine group but 
not for levosimendan group.
Conclusion The use of vasopressors in the treatment of septic shock 
involves non-selective molecules with an action on macrocirculation 
easily clinically observable but with effects on microcirculation (modi-
fied heterogeneously between organs) remains not entirety assess-
able by current surveillance devises. Norepinephrine is currently the 
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Introduction Drugs administration by stomach tube often needs the 
grinding of the tablets or the opening of the pills, which may seem 
consequent less, but can cause some transformations that can dam-
age patient’s health or cancel the product’s effect [1]. The purpose of 
this work is to evaluate our practice concerning the drug’s adminis-
tration per os, in surgical ICU department comparing to international 
guidelines.
Materials and methods This is a prospective descriptive study for a 
3-month period (From May to August 2015), including all the patients 
of surgical ICU department and collecting all the daily pharmaceutical 
analysis’s data from all the medical prescriptions.
Results During the period of the study, 62 patients have been studied, 
and all had a stomach tube for enteral feeding (Tables 25, 26).
Conclusion This study emphasizes the lack of respect of the recom-
mendations and the urgent need of changing attitudes, by adapting 
the pharmaceutical form, the consequent risk of transformation and 
the means of grinding respecting the rules of good practice. Doc-
tors have few clinical data, and studies at a bigger scale are required 
in order to highlight the drugs’ mode of administration, more signifi-
cantly on ICU’s patients.
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Introduction The consequences of an ICU stay are marked by 
increased long-term mortality and morbidity. The post-intensive care 
syndrome (PICS) is increasingly well described and is characterized by 
psychiatric, cognitive and functional impairments, and the possible 
persistence of organ failures. Management strategies to date are still in 
their infancy, but are a major public health challenge. Since April 2015, 
we initiated an ICU follow-up day clinic (IFUDC) program to assess 
patients’ health and provide care in coordination with the treating 
physician.
Patients and methods We describe here the implementation of the 
IFUDC program with a day care clinic at 1 and 6 months after ICU dis-
charge and a first assessment after 10 sessions. The aim of this first 
step was to assess patients need and program feasibility.
Results From April 2015, patients expected to be discharged alive 
from the ICU were screened on a daily basis according to the follow-
ing criteria: age between 18 and 80  years; living in the department; 
endotracheal intubation for more than 5  days; absence of follow-up 
program already initiated (i.e., chronic dialysis); absence of severely 
debilitating neurological or psychiatric disorders; good long-term 
prognosis. Eight patients were selected between April and July 2015. 
On the day of ICU discharge, they received information about IFUDC 
program and were offered to participate (no patient refused). Two 
weeks after, patients were convoked for the 1 month day clinic, with 
the accompanying person of their choice. Questionnaires such as 
HADS (anxiety and depression), the IES-R (post-traumatic stress dis-
order) and the SF-36 (quality of life) were sent to be completed and 
returned on the day of the clinic. On the day of the IFUDC, patients had 
a measurement of vital parameters, fasting blood and urine collection 
(dipstick test, blood and urine electrolytes and creatinine, proteinuria, 
blood count, hemostasis, lipid status, iron status, liver function test), 
electrocardiogram, pulmonary function test (spirometry) and a chest 
X-ray. Breakfast was then served. They were then received in consulta-
tion by an intensivist to detail the history of their ICU stay, a therapist 
doctor and a psychiatrist. All data and observations were gathered in a 
computer form specifically designed for IFUDC program. After lunch, 
Table 26 Drug’s list administrated by stomach tube in ICU 
and their management
Drugs R (DCI) Presentation Cut into 2 Crushing
Additiva (vit A, B, C, E) Dispersible
Amep (amlodipine) Pills Yes Yes
Aspirine (acide acetyl‑salicylique) Bags
Atarax (hydroxyzine) Pills Yes Yes
Cardioaspirine Pills No Yes
Plavix (Clopidogrel) Pills Yes Yes
Cordarone (amiodarone) Pills Yes Yes
Depakine chrono (valproate de 
sodium)
Pills Yes Yes
Deroxat (paroxétine) Pills Yes Yes
Digoxin (digoxin) Pills Yes Yes
Haldol (haloperidol) Pills Yes Yes
Mag 2+ (magnesium) Liquid







Sintrom (acenocoumarol) Pills Yes Yes
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patients and accompanying persons were invited (all patients agreed) 
to return to visit the ICU in which they were admitted. They were able 
to meet the team that cared for them. This visit was each time seen 
as very positive and full of emotions as by caregivers as by patients 
and their families. If abnormal cardiac, renal and pulmonary exami-
nations were observed, a call to a specialist was made to define the 
necessary actions. By afternoon, patients received an oral summary 
of diagnoses and actions implemented. A computerized report was 
generated and sent to the treating physician, the therapist doctor, the 
psychiatrist and other specialists as needed. The patients (2 patients at 
the moment) were reconvened at 5–6 months of discharge from ICU 
for a second IFUDC day clinic session. For the eight patients seen at 
1 month, 19 diagnoses were made, notably: persisting renal failure (4 
patients), iron deficiency anemia (3 patients), persistent physical weak-
ness (3 patients), shoulder impingement syndrome (2 patients), post-
traumatic stress disorder (2 patients), anxiety of the accompanying 
person (1) and 28 therapeutic actions were implemented (8 treatment 
modifications, 6 physiotherapy prescriptions, 6 referral to specialist, 
2 specialist advices during IFUDC session, etc.). The valuation of each 
session according to French T2A (pay upon activity) system was 502 
euros.
Conclusion ICU follow-up day clinic sessions were well appreciated 
both by patients and caregivers. Frequent diagnoses and therapeutic 
actions were made, but health impact of these measures cannot be 
measured. The sustainability of the IFUDC program will involve signifi-
cant human and financial resources.
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Introduction A part of patients transferred from intensive care unit 
(ICU) to continuing care services is due to the persistence of impor-
tant functional failures. The role of early rehabilitation in the manage-
ment of these patients has shown interest. The creation of unit, with 
both expertise of intensivists and physics Doctor, would improve the 
healthcare network. But physical and rehabilitation medicine requires 
specialized human resources and equipment. This retrospective epide-
miological pilot study was to determine the needs of Amiens Univer-
sity Hospital in post-intensive care rehabilitation department (PICRD).
Patients and methods We determined the number of patients eligi-
ble to PICRD, during 2013. The «Programme Médicalisé des Systèmes 
d’Information» allowed to count all patients admitted to medical–sur-
gical ICUs in Amiens University Hospital. Patients who had brain injury, 
spinal cord injury, or severe peripheral neurological damage regard-
less of origin were included in the study among the ICU patients. Even 
if they did not suffer from those pathologies, patients with duration 
of hospitalization (DH) over 7 days in the ICU were also included. The 
need for PICRD has been evaluated by computing the number of 
eligible patients in PICRD. They were eligible to PICRD: patients with 
persistent neurological impairment in their day 10 of hospitalization, 
without hemodynamic disability in absence of catecholamine, with 
a tracheotomy when a ventilator weaning was impossible. It was 
applied to the group “eligible” a new release date, which corresponded 
to day 2 after the realization of tracheotomy and/or stopping of cat-
echolamine, and/or stopping continuous invasive treatments. This 
allowed calculating a new DH and therefore a new average length of 
stay. Over 70 and under 18 years old and those with undergoing neo-
plasia were excluded from the study.
Results A total of 2690 hospitalizations in ICU were counted at the 
Amiens University Hospital in 2013. Seven hundred and seventeen 
patients were included in the study; after application of the exclusion 
criteria, a total of 388 were analyzed. This group of patients consisted 
of 72  % men, and the median age was 54  years old (IQR  =  20.25). 
The median SAPS II was 42 (IQR =  28) with a median length of stay 
of 12  days (IQR =  14) and a mortality rate of 19.6  %. As regards the 
reasons for hospitalization: over half, 56 %, fell to neurological impair-
ment, with stroke (25 %), severe traumatic brain injury (STBI = 22 %) 
and spinal cord injury (SCI  =  6  %). The other half consisted mostly 
shocks (19 %), acute respiratory failure (8 %), acute respiratory distress 
syndrome (ARDS = 4.5 %), severe sepsis (5 %), cardiopulmonary arrest 
(2.5 %). Nearly 22 % of patients (n = 84) were eligible for PICRD. They 
were young: median of age 55 years old (IQR = 20), mostly men (81 %). 
The median SAPS II was 38 (IQR = 23.25). The main diseases were also 
neurological for 46  % with: stroke, STBI and SCI. Other causes were: 
shock for 14 %, acute respiratory distress and ARDS for a total of 28 %, 
severe sepsis for 11 %. Seventy-seven of them came out alive from the 
ICU, 20 % in intensive care in “Berck”, 10 % in physical and rehabilita-
tion medicine unit, 50 % in medicine or surgery services. After applica-
tion of the new date of stay, a significant difference in hospital stay of 
40 days (p < 0.0001) was demonstrated.
Conclusion There is a need of adults PICRD at Amiens University Hos-
pital. It would allow an early medical and rehabilitative treatment, 
improving the fluidity of the post-intensive care discharge, and lead to 
a reduction in socioeconomic costs of care of these patients who need 
no more ICU care.
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Introduction Although survival of patient remains the priority 
in intensive care unit (ICU), quality of life and level of depend-
ence when returning home have become important issues. This 
study aims to assess these two parameters after a stay in inten-
sive care unit (ICU) and to identify the factors involve in their 
impairment.
Patients and methods This prospective and observational study 
focuses on all the patients admitted into intensive care unit. Patients 
who presented immediately deteriorating of mental status such as 
low or moderate memory disorders and psychiatric disorders were 
excluded. Patients or their relatives were interviewed during their 
stay. Then, patients were clinically reevaluated at third month (M3) 
and interviewed by phone at sixth month (M6) after admission date. 
The independence degree had been measured using IADL (Instru-
mental Activities of Daily living) test score and their quality of life 
using WHOQOL-BREF test score (World Health Organization Quality 
of Life). Data from stay in intensive care, onset of delirium, autonomy 
before hospitalization, physical capacities at home, presence of post-
traumatic stress disorder assessed by the Post traumatic Scale Score 10 
(PTSS10) and anxio-depressive symptoms evaluated by Hospital Anxi-
ety Depression Score (HADS).
Results In total, thirty-five patients were included at the begin-
ning. Four patients died at M3. Three patients cannot be evalu-
ated for the level of dependence at M3. Seven patients left 
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the follow-up at M6. All patients showed decreased quality 
of life at M3. At 3  months, 28 patients were evaluated for the 
independence. Thus, 20/28 patients who were more depend-
ent at 3  months had also a significantly use of nurses at home 
(p  <  0.02), a use of bequille (p  <  0.02), a decrease in psychic 
health (p  <  0.044) and an increase in score of post-traumatic 
stress disorder (p  <  0.05) and in anxiety score (p  <  0.019). 
Between M3 and M6, 15/24 (65 %) patients showed an improve-
ment of their quality of life. Patients with impaired quality of life 
9/24 (25 %) showed significant health degradation (p < 0.05) and 
a decrease in social relationships (p  =  0.084). These alterations 
were associated with increase medical support at home (p < 0.02) 
and required more institutionalization (p  <  0.02). At 6  months, 
12/24 showed decrease independence score. These patients 
experienced more delirium during stay (p  <  0.05), needed more 
medical support at home (p  <  0.05) and were delayed to come 
back home (p < 0.05).
Conclusion Impaired quality of life and increase of dependence 
after stay in ICU were observed for all patients of our study. The early 
screening and adapted therapy for psychiatric disorders, such as delir-
ium, post-traumatic stress disorder and anxio-depressive symptoms, 
may decrease the onset of this impairment.
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Introduction Admitting very elderly patients in ICU has always been 
questionable as the benefit for these patients in terms of survival 
remains unclear. Furthermore, their potential of recovery from loss of 
autonomy induced by the ICU stay is still not well known. The main 
objective was to compare 3 and 6 months mortality between patients 
over and under 80 years old and to identify risk factors associated with 
3 months mortality for those over 80 years old. We also compared evo-
lution of autonomy between the two groups.
Materials and methods Prospective observational study conduced 
from November 2012 to January 2014 in the Hospital of Roubaix 
(France) comparing patients more than 80 years old to younger ones. 
Each very elderly patient hospitalized in the ICU was matched by 
drawing lots to a younger one hospitalized at the same time. Patients 
with an expected length of stay shorter than 48 h were excluded. Data 
were collected at admission, during the whole ICU stay and at 3 and 
6 months from discharge. Patients were followed by a post-ICU clinical 
consultation and/or by phone interviews. ADL and IADL scores were 
chosen to evaluate autonomy. Loss of self-dependence was defined by 
loss of ≥1 point and for ADL score and for IADL score by a raise of ≥3 
points. Severe limitation was defined by ADL score ≤3/6 or IADL score 
≥15/31.
Results Two hundred and forty-eight consecutive patients were 
included, 124 in each group. Median age was, respectively, 83 [81–
86.5] and 62 [55–69.5] years for each group. Admission was mainly 
medical in the 2 groups. The gravity score SAPS II minus the points for 
age was 32.5 [23–48.5] for ≥80 years and 41 [28.5–54] for <80 years. 
Mortality rates were, respectively, 47 versus 37  % (p  =  0.12) and 
51 versus 39  % (p =  0.055) at 3 and 6  months. Analysis adjusted on 
chronic organ failure, gravity score and withholding and withdrawing 
life-sustaining treatment did not show any difference of mortality at 
3 and 6 months. In multivariate analysis, age was not an independent 
risk factor for mortality. Three months risk factors for mortality for very 
elderly patients were withholding and/or withdrawing life-sustaining 
treatments (HR [95 % CI] 6.19 [3.10–12.35]; p < 0.001) and SAPS II score 
minus points for age (1.02 [1.01–1.03]; p = 0.02). Loss of self-depend-
ence on ADL score was more frequent in very elderly compared to 
younger ones at 3 (43 vs 19 %, p = 0.005) and 6 months (54 vs 13 %, 
p < 0.0001). At 6 months, 19 % of the elderly and 5 % of the <80 years 
had severe functional limitations (p = 0.02).
Conclusion No statistically significative difference of mortality was 
found between the 2 groups. Withholding and/or withdrawing life-
sustaining treatments were the main factor for death at 3 months for 
more than 80-year-old patients. More than half of very elderly patients 
were dead at 6  months. Older survivors suffered from major auton-
omy deterioration and became more frequently self-dependent than 
younger patients after an ICU stay.
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Introduction Burns in the elderly are still common cause of morbi-
mortality due to impaired immunological function and preexisting 
cardiopulmonary diseases. They cause devastating complications 
and long-term socioeconomic impact. The purpose of this study was 
to review the characteristics of burn injuries in elderly patients and to 
assess their prognosis.
Patients and methods A retrospective study was conducted in a 
20-bed adult burn ICU in Tunis between January 2009 and Decem-
ber 2012. Elderly burned patients aged over 60  years were enrolled. 
Characteristics of elderly patients, burn injuries and prognostic factors 
were collected. Statistical analysis was performed using the SPPS 20.
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Results During the period of study, 1417 patients were admitted 
with 144 of elderly patients (10  % of total admissions). The mean 
age was 74 ± 8 years old. There were 63 males and 81 females. The 
average TBSA was 25  ±  22  % with an UBS of 56  ±  74. The major 
mechanism of injury for the patients was scalding or flame burns 
(97 %). Elderly burn patients suffer from premorbid conditions: dia-
betes (n =  38), hypertension (n =  30) and cardiovascular diseases 
(n  =  16). In our series, burns affected limbs (75  %) and the head/
neck (57  %). Inhalation injuries were noted in 17  % of cases, and 
mechanical ventilation was required in fifty-three patients (36  %) 
for a duration of 5  days (1–30  day). Our patients developed hypo-
volemic shock at admission in 22 % of cases. Clinical complications 
were sepsis (46  %), acute renal failure (40  %) and thromboembolic 
complications (11 %). The mortality rate was 43 % and occurred at 
12 days after burn injury. In our study, factors associated with death 
in elderly burned patients were: secondary transfer, inhalation 
injury, ARDS, sepsis, mechanical ventilation, acute renal failure and 
septic shock.
Conclusion Burns in elderly patients are frequent (10 %) and serious. 
Burn prevention education and implementation of safety measures at 
home would help reduce such incidences.
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Introduction To determine whether the criteria for admission in inten-
sive care unit (ICU) were different for patients aged 85 or older com-
pared to patients aged 70–84.
Patients and methods This analysis is part of a multicenter, prospec-
tive, observational study (six centers) on the outcome of patients aged 
85 or older (very old group) after an hospitalization in ICU.
The control group consists of patients, from the same centers, aged 
70–84 (mild–old group) randomly selected.
The autonomy-related variables collected were: ALD score six items, 
living conditions (at home, alone in couple or with family, or in retire-
ment homes), comorbidities (cardiac failure NYHA 3 or 4, respiratory 
failure Gold 4, chronic renal disease, dialysis), the pathway before 
resuscitation and ICU stay. Results are given as mean ± standard devi-
ation or percentage.
Results The very old group included 34 patients (age 86 years ± 1.6, 
IGSII 50.7  ±  27); the medium–old group included 57 patients (age 
77.6 years ± 4.7, IGS II 54.2 ± 24.1). The admission mode in ICU was 
the same (Emergencies Department: medium–old  =  32  %, very 
old = 22 %, home by SMUR: medium–old = 2.8 %, very old = 6.5 %, 
already hospitalized: medium–old = 39 %, very old = 34 %, p = 0.34). 
There was no difference about their living conditions nor about crip-
pling heavy histories.
The ALD autonomy score did not exhibit differences, whether 
item by item or on total score (medium–old  =  5.35  ±  1.5, very 
old =  5.11 ±  1.81, p =  0.49). There was no difference for the Knaus 
score noted on the admission. The surgical pathologies were more 
frequent for older patients (medium-old 8.7  %; very old 13.5  %, p 
0.001) as well as admissions for cardiac pathologies, particularly for 
cardiogenic pulmonary edema (medium-old = 8 %, very old = 58 %, 
p = 0.01).
The duration of invasive ventilation was shorter for older patients: 
medium-old: 4.82 ± 7.55; very old: 1.16 ± 1.62, p = 0.005. There was 
no difference on the need for noninvasive ventilation, renal replace-
ment therapy or surgery. The length of stay in ICU was also shorter for 
the oldest (Mb 8.84 ± 8.61; vo 5.41 ± 8.0, p = 0.05). Duration of inva-
sive ventilation was Mb 4.82 ± 7.55; vo 1.16 ± 1.62, p = 0.005.
Discussion In this study, older patients admitted in ICU are not in a 
more serious state, do not have more extensive histories and do not 
usually live more in retirement homes than the younger age group, 
which does not match the expected evolution of the overall popula-
tion. The ICU stay data (length of stay, invasive techniques require-
ment, mortality) seem very similar to data observed for younger 
patients. The admission patterns, known to be rapidly favorable, pre-
vail, raising the question of more stringent admission criteria applied 
by physicians.
Conclusion Despite the absence of any literature or recommendations 
besides precise situations, the oldest patients are admitted in ICU only 
after a serious sorting process. Data collected on the outcome after 
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Introduction It is customary to say that the Algerian population 
is characterized by its youth, but keep in mind that the proportion 
of elderly is increasing. Currently, half of the doctors of activities is 
devoted to the elderly; this patient population is predominant in hos-
pitals and represents almost half of the recruitment of intensive care 
units.
Materials and methods This is a single-center study, observational 
and descriptive, conducted in medical intensive care unit (Algiers, 
Algeria).
Inclusion criteria: Age ≥65 years and a hospital stay ≥48 h.
Results During the period of our study, 852 patients were admitted to 
our service. The average age of these patients was 66.11 ± 18.26 years 
[range 15–98 years] and sex ratio was 1.50. Patients aged 65 and over 
represent 65 % of all admissions to intensive care during this period. 
For our study, 400 elderly patients are retained. The average age of 
these patients was 77.19 ±  7.05  years [range 65–98  years]; there is a 
male predominance (61  %) with a sex ratio of 1.56. Elderly patients 
mainly come from the emergency department (59.50  %), and the 
main reason for admission is the altered state of consciousness 
(56.25 %). The average number of comorbidities by elderly patient is 
3.17 ± 1.40 medical conditions with an average of 4.16 ± 2.16 medica-
tions per patient. The average scores at admission in ICU, respectively: 
24.62 ± 6.41 points for the Acute Physiology and Chronic Health Evalu-
ation II (APACHE II); 47.80 ± 15.12 points for the Simplified Acute Physi-
ology Score II (SAPS II); 13.60 ±  4.68 points for the Short Emergency 
Geriatric Assessment (SEGA) and 6.74 ±  2.22 points for the Charlson 
score (comorbidities). The average length of stay in intensive care for 
older patients was 10.66 ± 11.25 days [range 2–160 days]. The mortal-
ity rate is high, of the order of 57 %. Univariate analysis has allowed us 
to retain 11 predictors of mortality, which are: APACHE II ≥ 22 points 
(OR 8.65 with 95 % CI [5.13–14.71]; p < 0.000001), SAPS II ≥ 40 (OR 5.18 
with 95 % CI [3, 22–8.36]; p < 0.000001), SEGA score ≥8 points (OR 5.18 
with 95 % CI [3.22–8.36]; p < 0.000001), antecedent of hypertension (OR 
1.73 with 95 % CI [1.09–2.75]; p = 0.01), antecedent of heart disease (OR 
1.70 with 95  % CI [1.14–2.48]; p =  0.02), antecedent of stroke (OR 2.23 
with 95  % CI [1.31–3.82]; p  =  0.001), acute renal failure (OR 1.81 with 
95 % CI [1.13–2.91]; p = 0.008), nosocomial infection (OR 3.22 with 95 % 
CI [1.93–5.38]; p <  0. 0001), extra-renal purification (OR 2.16 with 95  % 
CI [1.22–3.83]; p =  0.004), mechanical ventilation (OR 42.95 with 95  % 
CI [22.68–82.24]; p < 0.000001), and finally the use of vasoactive drugs 
(OR 17.46 with 95 % CI [10.23–29.96]; p < 0.000001). Multivariate analy-
sis by logistic regression allows us to retain the final as 4 parameters 
as independent predictors of mortality among our elderly patients: an 
APACHE II score ≥22 points (OR 2.40 with 95 IC % [1.65–3.51]; p = 0.036), 
SAPS II score ≥40 (OR 2.02 with 95 % CI [1.54–3.26]; p = 0.047), use of 
mechanical ventilation (OR 14.53 with 95  % CI [8.15 28.9]; p  <  0.0001), 
and the use of vasoactive drugs (OR 10.17 with 95  % CI [4.67–22.2]; 
p < 0.0001).
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Conclusion The admission of elderly ICU patients raises medical, ethi-
cal, sociological, and economic factors. Although the aging trend of 
the population admitted to intensive care continues, no statistical 
relationship was found between chronological age and mortality. The 
physiological age conditioned by concomitant, illness, and associated 
organ failure is of benefit to consider the actual age of the patients.
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Introduction Following the encouraging results of other countries, 
the uncontrolled donation after circulatory determination of death 
(uDCD) procedure has been introduced in France in 2006 and started 
at the Annecy General Hospital in July 2011. This work presents the 
first 42 months of our experience.
Patients and methods Our hospital is a reference center for the medi-
cal care of cardiorespiratory arrest (CRA) for the department of Haute 
Savoie, and a part of Savoie and Ain (a population of about 1 million 
inhabitants). Distinct indications of uDCD and therapeutic extracor-
poreal life support have been beforehand clearly defined by a team of 
cardiologists, emergency doctors and intensivists.
For each CRA, the opportunity of a uDCD is systematically evaluated 
according to the national criteria edicted by the Agence de la Biomé-
decine. If appropriate, after hospital admission of the potential donor, 
verification of the inclusion criteria and a 5-min period of no-touch, 
death was declared and a Regional Normothermic Recirculation (RNR) 
was surgically implemented. The donor relatives were then informed 
and interviewed. If there was no opposition to the organ donation, the 
donor could be transferred to the operative room for explantation.
We reviewed the charts of uncontrolled donors from July 2011 to 
December 2014. We analyzed the times, conversion rates, and out-
comes of procured organs. Results are given as median [1st–3rd 
quartile].
Results The total number of cardiac arrests over the period was 2170; 
45 potential uDCDs were referred to our hospital. The median no flow 
was 10 min [5–20]. Time from CRA to arrival at the hospital was 95 min 
[72–107]. We faced 4 technical failures, 6 family refusals, 1 family could 
not be contacted, and there were 3 medical contraindications. Thirty-
one patients became donors, for whom the mean time from CRA to 
effective RNR was 137  min [125–143], and time from RNR to organs 
explantation was 232 min [216–240].
Sixty-one kidneys could be explanted, among which 6 had anatomical 
problems and 1 was of bad quality. The mean resistance index at H4 
was 0.15. Finally, 54 kidneys were transplanted (organ conversion rate 
60 %) with a cold ischemia time of 11.1 h [9.1–13.2]. There was 50 % 
of delayed graft function with 2 [0–5] dialysis sessions. The recipients 
mean creatininemia at 6 months was 121 µmol/l [100–149].
A comparison of our results with the national data is exposed in 
Table 27.
After authorization in January 2014, 2 livers were retrieved and trans-
planted. The first recipient died of sepsis at 3 months with a functional 
graft, the other is still living without complication.
Discussion Organization matters appear to be the main strength of 
the procedure: strong involvement of the prehospital teams, unique 
place to admit all CRA, organ preservation by RNR.
Ethical concerns were raised before and during the program, but 
regular discussions between teams and successes of the program 
maintained a stable recruitment with a good attendance of involved 
professionals.
Conclusion uDCD can be implemented in a general hospital and 




Epidemiology of long stays in ICU
Bertrand Hermann1, Caroline Hauw Berlemont1, Alexandra Monnier1, 
Florence Boissier1, Nadia Aissaoui1, Jean‑Yves Fagon1, Jean‑Luc Diehl1, 
Emmanuel Guérot1
1Réanimation médicale, Hopital Europeen Georges‑Pompidou, Paris, 
France 
Correspondence: Caroline Hauw Berlemont ‑ alexis.berlemont@gmail.
com 
Annals of Intensive Care 2016, 6(Suppl 1):P114
Introduction Little is known about the epidemiologic description 
and prognosis of patients undergoing a prolonged stay in ICU. Our 
descriptive study focused on patients who were hospitalized 30 days 
or more, representing the 95th percentile of the duration of all stays in 
our medical ICU; it aimed at describing the characteristics of patients, 
searching for risk factors for mortality and comparing them with 
patients who stayed less than 30 days.
Patients and methods We conducted a retrospective observational 
study, in a medical ICU of a Parisian university hospital between July 
2000 and December 2013, including all patients who stayed 30  days 
or more (long stay patients = LSP). Collected data carried on McCabe 
comorbidity score, autonomy score, diagnosis on admission in ICU, 
SAPSII, using of organ support (mechanical ventilation and/or renal 
replacement therapy—RRT), complications during ICU stay (either 
evolutive, infectious or intercurrent), and in-ICU/in-hospital mortality. 
We compared them with patients who stayed less than 30 days (short 
stay patients = SSP), for some data available in our database (age, sex, 
SAPSII and mortality).
Results Out of 8906 patients hospitalized in the period of the study, 
416 (4.67  %) were hospitalized 30  days or more. The median length 
of stay was 39 days (ranging from 462 to 30). LSP had a mean age of 
65.7 ± 14.7 years versus 62.7 ± 18.6 years for the SSP (p < 0.0001). The 
majority of the LSP, 72 %, came from in-hospital transfer, rather than 
from direct admission 28  %. This was significantly different from the 
SSP, where in-hospital transfer and direct admission were more well 
balanced (respectively, 52 and 48  %, p  <  0.0001). Sixty-one percent-
age had a preserved autonomy (autonomy score A and B) and only 
38  % had a life-threatening comorbidity (defined as a McCabe score 
of 2 or 3). The reasons for admission in the ICU were: acute respiratory 
failure (43 %), sepsis (29 %), weaning from ventilation (10 %), neuro-
logical failure (7.5 %), cardiac arrest (4.5 %), circulatory failure (3.5 %), 
Table 27 Global overview of  the uDCD activity in  Annecy 
and France
Annecy
n (% of national activity)
France
n
Identified potential donors 45 (11 %) 401
Effective donors 31 (18 %) 170
Explanted kidneys 61 (18 %) 336
Transplanted kidneys 54 (22 %) 242
Conversion rates
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metabolic abnormality (1 %), and others (1.5 %). There was no signifi-
cant difference between the severity of illness at admission assessed 
by the SAPSII score between LSP and SSP (53.0 ± 18.5 vs. 52.0 ± 25.6). 
Ninety-nine percentage of LSP underwent mechanical ventilation 
versus 68  % of SSP (p  <  0.0001), with a mean of 36.6 ±  28.0  days of 
mechanical ventilation. There was the same significant difference for 
the use of RRT between long stay group versus short stay group (33 
vs. 19 %, p < 0.0001). The rate of complications was 37 % for the LSP. 
Overall observed in-ICU mortality was 39  %, which was significantly 
higher than mortality of SSP, 30 % (p < 0.001). The in-hospital mortality 
of the LSP rose up to 48 %. Among the LSP the in-hospital mortality 
increased with the McCabe score: 34 % for a score of 0, 42 % for a score 
of 1, 60 % for a score of 2, and 75 % for a score of 3 (p < 0.0004). The 
SAPSII was higher among the deceased, 57.0 ±  18.1 vs. 48.9 ±  18.1 
(p  <  0.0001). There was a higher rate of death among patients who 
had a complication than among those who had not (55 vs. 35  %, 
p < 0.0004). Interestingly, there was no difference between the length 
of stay of the deceased and the survivors (47.2 ± 22.6 vs. 48.7 ± 36.9).
Conclusion Prolonged ICU stays are associated with a slight increase of 
mortality rate and a more frequent use of organ support, but more than 
half of the concerned patients were finally discharged alive from the 
hospital. Mortality is associated with comorbidities, severity at admis-
sion and occurrence of complications but does not increase the length 
of stay. Identification of LSP at the time of admission seems difficult.
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Introduction Despite evidence that daily sedation stops (DSS) by 
nurses reduce duration of mechanical ventilation (MV), DSS are 
not part of routine practice in most ICUs. Reasons for slow adoption 
include scepticism over efficacy, logistical burden in initiating changes, 
and fear of adverse events during sedation stops. Whether sedation 
stops are associated with significant adverse events is unknown.
This study aims to evaluate adverse events occurring during 2-h DSS 
in a medical ICU.
Patients and methods We have retrospectively reviewed charts of 
all patients mechanically ventilated in the 24-bed MICU of Cochin 
University Hospital. In the absence of contraindication, all patients 
underwent a 2-h DSS as part of our combined sedation and weaning 
protocols. During and at the end of DSS, adverse events need for bolus 
or infusion of sedative agents, and RASS scores were prospectively 
recorded in a clinical information management system (Clinisoft®, GE 
Healthcare). Data are reported as median and interquartile ranges. A 
P < 0.05 was considered significant for all statistical tests performed.
Results Between 03/08 and 04/15, 9799 patients (5760 M/4039 F, 62 
[46–76] y.o., SAPS2 43 [29–60], SOFA 5 [2–8]) underwent 12,474 DSS. 
No significant adverse event occurred in 12,217 (97.9  %) of the DSS. 
Adverse events included patient–ventilator asynchrony (n = 159 DSS), 
O2 desaturation (n = 119 DSS), accidental catheter removal (n = 22), 
fall (n  =  9). However, mild to moderate agitation occurred during 
2483 DSS (19.9  %) and led to prematurely resume continuous seda-
tion (n  =  1707, 13.7  %) or to administer boluses of sedative agents 
(n = 776, 6.2 %).
BZD Opiates Propofol Others
Infusion 984 (57.6 %) 575 (33.7 %) 127 (7.5 %) 21 (1.2 %)
Bolus 182 (23.4 %) 240 (30.9 %) 26 (3.3 %) 241 (31 %)
Sedatives administered during DSS
Conclusion Overall, daily sedation stops are safe and associated with 
few adverse events in a setting with nurse-driven monitoring of neu-
rological status. Administration of sedative agents may occasionally be 
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Introduction In critically ill patients, the use of continuous sedation 
increases the morbidity by lengthening the duration of mechani-
cal ventilation. Numerous studies have shown that maintaining light 
levels of sedation improves clinical outcome. However, delay in awak-
ening seems ever frequent after stopping sedation. We therefore per-
formed a study to assess the incidence, associated factors and impact 
on duration of mechanical ventilation of a delay in awakening.
Patients and methods It was a retrospective study, including all consec-
utive adult patients under mechanical ventilation and continuous seda-
tion for at least 48  h, admitted between January 2012 and September 
2013 in two medico-surgical ICUs. Each of these two units used a proto-
col to titrate the depth of sedation. The primary endpoint was the time to 
awakening, defined as the time (in hours) between stopping continuous 
sedation and the appearance of a response to a simple order.
Results Two hundred and thirty-one patients were included in the 
study, with a mean age of 63 ± 15 years, SAPS II at admission 44 ± 15, 
total duration of sedation 147 ± 161 h. The mean time to awakening 
was 26 ± 36 h. Forty-four out of two hundred and thirty-one patients 
(19  %) experienced a delay in awakening ≥48  h. The patients with a 
delay in awakening ≥48 h were older (70 ± 11 vs 62 ± 15, p = 0.003), 
had a higher SAPS II (54 ± 15 vs 42 ± 14, p < 0.0001), lower level of cre-
atinine clearance using MDRD (54 ± 41 vs 84 ± 53, p = 0.0006), lower 
level of prothrombin ratio (60 ± 19 vs 71 ± 16, p = 0.0003), and lower 
left ventricular ejection fraction at admission (43  ±  15 vs 53  ±  12, 
p < 0.0001), they received more frequently renal replacement therapy 
during the first 2 days (45 vs 19 %, p = 0.0004) than patients with time 
to awakening <48  h. Concerning the sedation by itself, the patients 
with a delay in awakening ≥48 h had received more frequently mida-
zolam (93 vs 74  %, p =  0.01); conversely, duration of sedation, aver-
age dose of sedative and incidence of use of a score to titrate sedation 
were similar between the two groups. Multivariate analysis identi-
fied three factors independently associated with delay in awakening 
≥48 h: age ≥70 years (OR 5.84; 95 % CI 2.52–13.5), SAPS II at admis-
sion >50 (OR 5.22; 95 % CI 2.31–11.8) and use of midazolam (OR 8.78; 
95 % CI 2.32–33.2). Patients with a delay in awakening experienced a 
longer duration of mechanical ventilation (404 ± 257 vs 206 ± 191 h, 
p  =  0.0001), notably the duration without sedation (240  ±  150 vs 
61 ± 72, p < 0.0001) than patients with time to awakening <48 h.
Conclusion Despite the use of protocols to titrate sedation, delay in 
awakening after stopping continuous sedation remains common, 
increasing the duration of mechanical ventilation. This study shows 
that age, severity at admission and use of midazolam expose the 
patients to a delay in awakening. These data suggest to use non-ben-
zodiazepine sedation in these patients.
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Introduction Patient–ventilator asynchrony is defined as a mismatch 
between patient and ventilator inspiratory and expiratory times and 
is associated with negative outcomes such as longer duration of 
mechanical ventilation and higher mortality and tracheotomy rates. To 
date, 5 major patterns of asynchrony are described. However, there is 
no universal agreement on the definition of these patterns, resulting 
in heterogeneity of the prevalence of asynchrony and of the associa-
tion between asynchrony and outcome. The aim of our study was to 
prospectively and noninvasively compare the prevalence of patient–
ventilator asynchrony according to two distinct methods. In addition, 
we determined the factors associated with asynchrony and the prog-
nostic impact of asynchrony.
Patients and methods This is a ancillary study of a multicentre, ran-
domized controlled trial comparing neurally adjusted ventilator assist 
to pressure support ventilation during the early phase of weaning. Air-
way flow and pressure and (EAdi) were recorded during 4 sequences 
of 20 min. Main asynchronies were further quantified according to two 
methods: (1) using electrical activity of the diaphragm (EAdi) as a refer-
ence and (2) based on the only visual inspection of the flow and air-
way pressure signal traces. The 5 main asynchronies were quantified, 
and the asynchrony index defined as the proportion of asynchronous 
cycles was calculated.
Results One hundred and six patients mechanically ventilated for 
5  days (1–35) were included, 72 men (68  %), aged 66 (37–86) years, 
SAPS II 44 (14–96), 60  % had a history of hypoxemic respiratory fail-
ure. The distribution of asynchrony and the asynchrony index varied 
according to the method used to quantify asynchronies (Table 28).
Older age [77 (54–86) vs 66 (37–83) years, p  =  0.02] and a higher 
Charlson score [7.5 (5–11) vs 5 (2–9), p = 0.004] were associated with 
a higher rate of patient ventilator asynchrony. Asynchrony was not 
associated with a higher intensive care unit mortality, length of stay 
or duration of mechanical ventilation. Subgroup analysis showed that 
of hospital length of stay was significantly lower in patients with a low 
prevalence of double triggering [28 (10–71) vs 35 (6–96), p = 0.04].
Conclusion The prevalence of patient–ventilator asynchrony varies 
according to the methods and definitions used to quantify asynchrony, 
which suggests the need for a consensus statement in asynchrony’s 
definition. In one decade, the prevalence of patient–ventilator asyn-
chrony has decreased, suggesting an improvement in mechanical ven-
tilation practices. Patient–ventilator asynchrony was not associated 
with a poorer outcome.
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Introduction Acute respiratory failure is the leading cause of ICU 
admission of immunocompromised patients. In the early 2000s, two 
randomized controlled trials suggested that as compared to standard 
oxygen therapy, noninvasive ventilation could decrease mortality of 
immunocompromised patients admitted to ICU for acute respiratory 
failure. However, the benefits of noninvasive ventilation in immuno-
competent patients with acute respiratory failure are still debated. 
High-flow oxygen therapy through a nasal cannula may offer an 
alternative in hypoxemic patients, and we recently found, in a rand-
omized controlled trial including 310 patients with acute respiratory 
failure, that as compared to noninvasive ventilation, high-flow oxy-
gen therapy decreased mortality. In our unit, high-flow oxygen ther-
apy is increasingly used, gradually replacing noninvasive ventilation. 
Our objective was to compare outcomes of immunocompromised 
patients admitted to ICU for acute respiratory failure and treated with 
either high-flow oxygen therapy or noninvasive ventilation as first-line 
therapy.
Patients and methods All patients admitted for acute respiratory fail-
ure to our 15-bed medical ICU of a teaching hospital from January 1, 
2007, to December 31, 2014, were retrospectively screened. Among 
them we included patients with immunosuppression caused by hema-
tological or solid cancer, neutropenia, immunosuppressive therapy 
such as corticosteroids or oral chemotherapy, and who received high-
flow oxygen therapy or noninvasive ventilation as first-line therapy. 
Patients with acute-on-chronic respiratory failure, those treated with 
standard oxygen alone or needing immediate intubation, and those 
with a do-not-intubate order were excluded.
Results Over this 8-year period, 1299 patients were admitted for 
acute respiratory failure including 267 (21 %) immunocompromised 
patients. After excluding 142 patients, 125 patients were analyzed 
including 52 patients (42 %) treated with high-flow oxygen therapy 
and 73 patients (58  %) with noninvasive ventilation. Baseline char-
acteristics between the 2 groups were not different. Patients were 
more likely to be treated with noninvasive ventilation in the first 
period of study (2007–2010): 77 versus 47  % in the second period 
(2011–2014), p  =  0.0015. Intubation rate was lower in patients 
treated with high-flow oxygen therapy (33 %) than in those treated 
with noninvasive ventilation (53  %, p =  0.03). In-ICU mortality and 
day 28 mortality were significantly lower in patients treated with 
high-flow oxygen therapy than in those treated with noninvasive 
ventilation (15 vs. 33  %, p  =  0.04; and 17 vs. 38  %, respectively, 
p = 0.02). After adjustment on Simplified Acute Physiology Score II, 
the use of noninvasive ventilation remained independently associ-
ated with day 28 mortality with an adjusted odds ratio of 3.04 [1.36–
6.78], p = 0.005.
Conclusion In immunocompromised patients admitted to ICU for 
acute respiratory failure, intubation and mortality rates were lower in 
patients treated with high-flow oxygen therapy than in those treated 
with noninvasive ventilation as first-line therapy. The use of noninva-
sive ventilation was independently associated with day 28 mortality.
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Table 28 Prevalence of  asynchrony between  measure‑
ment of neural inspiratory time and visual inspection
With EAdi Visual inspection p
Asynchrony index (%) 24.5 (15.0–38.1) 1.5 (1–4) <0.0001
Ineffective triggering (%) 0 (0–0.2) 0.1 (0–0.6) 0.0410
Double triggering (%) 3.1 (0.8–8.9) 0.6 (0.2–1.5) <0.0001
Auto‑triggering (%) 1.7 (0.8–3.8) 0 (0–0) <0.0001
Short cycle (%) 4.2 (2.3–9.5) 0.15 (0.1–0.5) <0.0001
Prolonged cycle (%) 5.1 (1.4–14.0) 0.1 (0–0.3) <0.0001
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Introduction Noninvasive ventilation (NIV) is indicated in the treat-
ment of acute respiratory failure associated with acute cardiogenic 
pulmonary edema (CPE) and exacerbation of chronic obstructive pul-
monary disease (COPD). Dexmedetomidine is an alpha 2 adrenocep-
tor agonist with a unique mechanism of action providing sedation and 
anxiolysis via receptors within the locus ceruleus. The aim of the study 
was to show the feasibility and the effectiveness of dexmedetomidine 
for patients with NIV.
Patients and methods It was a prospective clinical investigation 
performed in the medical teaching department of emergency and 
intensive care medicine in Zaghouan in Tunisia from January to June 
2015. All patients had acute respiratory failure due to CPE or COPD 
and required NIV but could not continue NIV sessions because of dis-
comfort and agitation. They had 1 on the Ramsay score and +1 on the 
Richmond Agitation-Sedation Scale (RASS). We excluded patients with 
contraindications to NIV. The experimental protocol was approved by 
our local review board.
Results Twelve patients were enrolled in the investigation, which rep-
resents 12/85 (14 %) of all patients who needed NIV in this period.
There were seven men and five women. The mean age was 65. The 
indications of NIV were CPE in five cases and hypercapnic exacerbation 
of COPD in seven cases. All patients received an initial loading dosage 
of 3 yg/kg/h followed by a continuous infusion of 0.5 yg/kg/h.
At baseline, all patients showed response levels of Ramsay score 1 
and RASS score 1.5. Maintenance of Ramsay score at 2.9 ± 1 and RASS 
score at 1.2 ± 1 and obtainment of effective sedation were reached in 
all cases during dexmedetomidine infusion. All settings of NIV were in 
bilevel-PAP. Baseline measures were made at an average of 6  h from 
the time NIV was started. The total infusion time of dexmedetomidine 
was about 12 h. Heart rate, mean arterial pressure and respiratory rate 
decreased significantly (p < 0.05) after the infusion of dexmedetomi-
dine. Blood gas exchange (PaO2 and PaCO2) improved significantly 3 h 
after the start of infusion (p < 0.05).
All patients were weaned successfully from NIV, and we did not 
need endotracheal intubation for all our patients. All patients were 
discharged from intensive care and from hospital alive. They could 
cough and expectorate without assistance. No patients had respiratory 
infections or presented adverse effects like vomiting and no patients 
from those who developed bradycardia needed an intervention.
Conclusion It is at our knowledge the first Tunisian study of dex-
medetomidine in patients requiring NIV in a medical intensive care 
department. This study shows that we can use this drug for patients 
presenting difficulties to perform NIV because of agitation. This drug 
appears to provide several advantages and safe control for NIV seda-
tion in patients with CPE and COPD. Comparative studies are needed 
to assess these findings.
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Introduction The use of noninvasive ventilation (NIV) to prevent acute 
respiratory failure following abdominal surgery has been associated 
with a better outcome, when done immediately after extubation (1). 
However, NIV still fails in one-third of patients. Even if the causes of NIV 
failure are not totally cleared, patient and interface selection seem to 
be the major determinant (2). The aim of this study was to compare 
the tolerance of 4 interfaces used during preventive NIV in intensive 
care units (ICUs), assessed both by patients and by caregivers.
Patients and methods Patients admitted to the ICU after abdominal 
surgery for preventive NIV were included in a prospective, monocenter, 
randomized, crossover study. Four interfaces (Helmet®, Bacou®, Intersur-
gical®, and Respironics®) were studied. The general patient characteristics 
and physiological parameters (saturation, respiratory rate) were collected. 
Patients and caregivers estimated with a visual numeric scale (VNS) tol-
erance parameters: comfort (0  =  maximum discomfort, 10  =  perfect 
comfort), leaks (0  =  maximum leaks, 10  =  no leak), and communica-
tion (0 = no communication, 10 = optimal communication). Positioning 
(0 = very difficult, 10 = very easy) was estimated by caregivers.
Results Twenty-six patients were included. The mean Simple Acute 
Physiologic Score II was 37  ±  10, the PCO2 of 39  ±  7, the PO2 of 
88 ±  22. The level of comfort, self-assessed by patients, did not sig-
nificantly differ between interfaces (p = 0.07, Fig. 32). However, each 
interface was not equivalent for a single patient: The correlations 
between interfaces were either weak, nulls or negatives. The abili-
ties of communication and of positioning, evaluated by patients and 
caregivers, were significantly increased for the Helmet® interface 
(p  <  0.001). Caregivers overestimated the comfort for each interface 
and the abilities of communication compared to patients (p < 0.008). 
The main physiological parameters did not differ between groups.
Conclusion The main result of this study is that comfort of NIV after 
abdominal surgery did not differ across interfaces. However, comfort 
differed between interfaces for a given patient: The correlation of 
comfort between interfaces was weak or null, showing that there is 
no universal interface, but rather an optimal interface for each patient. 
Moreover, comfort and communication assessment strongly differed 
between patients and caregivers, caregivers underestimating the 
inconvenient of interfaces compared with patients. Helmet® mask was 
the best assessed interface in both patients and caregivers for commu-
nication and positioning of the interface.
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Introduction Sedation and analgesia are essential in the care of venti-
lated patients in intensive care. It focuses on patient comfort, calmness, 
pain relief and facilitates mechanical ventilation. Dexmedetomidine is an 
α-2 agonist sedative, selective of the α-2 central presynaptic receptors. It 
is indicated in ventilated patients requiring mild to moderate sedation 
and is an alternative to conventional treatments such as midazolam and 
propofol. Light sedation, increasingly sought in sedation analgesia, is 
part of a practice change and is involved in an “arousable” sedation.
Patients and methods The objective of this study was to describe 
the use of dexmedetomidine in mechanically ventilated patients in 
medical, surgical, cardiac and neurosurgical intensive care units of a 
university hospital during the first year of use. All patients receiving 
dexmedetomidine were included, and data sheets notably includ-
ing assessment of sedation, indication, dosage, duration and adverse 
effects were completed in a prospective way.
Results A total of 87 patients were enrolled and 83 were analyzed. The 
assessment of sedation through RASS (Richmond Agitation-Sedation 
Scale) score was performed at initiation of dexmedetomidine therapy 
in 49 patients (59 %). The definition by the clinician of the RASS target 
objective appeared in 50 % of the prescriptions. There was a significant 
relationship between define a RASS target and assess it (p  =  0.006). 
Treatment indications were gradual awakening in 44 % (with and with-
out agitation history, 22 % each), respiratory weaning in 39 % and main-
taining light sedation to better tolerate orotracheal intubation in case of 
laryngeal edema in 13 %. Initial and mean dosages varied significantly 
between services (p  <  0.001). Mean treatment duration was 3.0  days, 
and mean daily treatment cost was 166 €. Dexmedetomidine was pre-
scribed as second line in 80 % of patients. Over the first 5 days of treat-
ment, 72 % of RASS scores were within the therapeutic range (RASS 0 to 
−3). Extubation was possible under dexmedetomidine (21 extubations 
on 25 attempts), and no withdrawal symptoms have been reported. 
Self-extubation rate was 11 %. Agitation rate under dexmedetomidine 
was 22  %, and it could necessitate discontinuation of treatment but 
was associated with surgical profile (p  =  0.03). It was also related to 
gradual awakening with agitation history (p = 0.049). The incidence of 
adverse cardiovascular effects (bradycardia and hypotension) was 23 %. 
There was a significant association between incidence of cardiovascular 
adverse effects and hypertension (p = 0.016). Medical satisfaction was 
good for the patient’s ability to communicate his pain (7.1/10), to coop-
erate to care (6.9/10) and quality of waking (6.9/10).
Discussion The incidence of cardiovascular adverse events was high, 
according to literature descriptions. However, these effects, due to the 
molecule pharmacology, are predictable, dose-dependent, and no clini-
cal consequences were reported. Sedation assessment through RASS 
score was not always carried out, representing the opportunity to remind 
good sedation practices and use of validated scale to adjust dosage.
Conclusion This descriptive study reflects the complexity and het-
erogeneity of mechanically ventilated patients. It evaluated dexme-
detomidine effectiveness in maintaining a target level of sedation and 
prescribers adaptation to this new α-2 agonist treatment. This work is 
an opportunity to formalize dexmedetomidine sedation by protocol.
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Introduction Noninvasive ventilation (NIV) is widely used in ICUs, but 
could be associated with pain, discomfort, and claustrophobia leading 
in some patients to NIV failure. The aim of the present study is to meas-
ure the frequency and magnitude of pain, confusion, and agitation in a 
population of ICU patients receiving NIV for COPD exacerbation.
Patients and methods In a prospective cohort study conducted in 
ICU between May 1, 2015, and August 31, 2015, we systematically 
recorded a pain visual analogic scale (VAS), CAM-ICU and RASS scales, 
in consecutively admitted patients requiring NIV for COPD exacerba-
tion. Measures were repeated at H0, H1, H24, H72, Day 5, Day 7 follow-
ing ICU admission, and at ICU discharge.
Results During the study period, 32 patients were admitted for COPD 
exacerbation and received NIV [median age 72 years (64–76.5), median 
pH 7.30 (7.26–7.34), and sex ratio of 2.5]. The following table summa-
rizes variation of the recorded scores during ICU stay.













































2 (1–2) 1.5 
(1–2)
1 (0–1) 0.5 
(0–1)
0 (0–1) 0 (0–0) <0.001
At ICU admission, patients suffered from pain (median VAS: 8/10), 
confused (median CAM-ICU: 2) and agitated (median RASS: 2). 
These complaints have gradually improved in an inverse way than pH
Conclusion Our study shows that pain, confusion, and agitation were 
common in patients receiving NIV. These complaints improve in paral-
lel with clinical recovery.
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Introduction The impact of preadmission metformin treatment 
remains controversial regarding lactate levels, intensity of supportive 
therapies and outcome in all ICU patients and particularly in patients 
with septic shock [1, 2].
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Patients and methods We performed a retrospective study of 
patients with diabetes admitted to our ICU over a period of 3 years. We 
focused on lactate levels, supportive therapies and outcome whether 
or not they had preadmission metformin. Then, we analyzed the sub-
group of septic shock patients who is most at risk of tissue hypoperfu-
sion and use of heavy supportive treatments.
Results Six hundred and thirty-five diabetics were included from 3871 
admissions: age 71 [61–79], SAPS 2 39 [31–52], septic shock 131 (20.6) 





Population (n, %) 395 (62.2) 240 (37.8) –
 Age 73 [63–80] 68 [60–78] 0.03
 SAPS 2 40 [32–52] 38 [29–51] 0.41
 Renal failure (n, %) 268 (67.8) 124 (51.7) <0.001
 RRT (n, %) 72 (18.2) 41 (17.1) 0.71
 INR 1.85 ± 1.74 
[1.67–2.03]
1.74 ± 1.43 
[1.68–1.8]
0.42
 Invasive ventilation (n, %) 139 (35.2) 91 (37.9) 0.48
 Vasopressors (n, %) 136 (34.4) 93 (38.8) 0.27
 HCO3 (mmol/L) 21.9 ± 8 
[21.1–22.7]
19.9 ± 7.7 
[19–20.9]
<0.005
 Lactate (mmol/L) 1.78 ± 2.02 
[1.58–1.98]
3.07 ± 3.3 
[2.65–3.49]
<0.001
 Lactate without renal 
failure (mmol/L)
1.39 ± 0.81 
[1.25–1.53]
2.18 ± 1.82 
[1.85–2.52]
<0.001
 ICU LOS (days) 6 [4–10] 6 [3–9] 0.95
 ICU death (n, %) 74 (19.7) 41 (17.1) 0.60
Septic shock (n, %) 79 (60.3) 52 (39.7) –
 Age 62 [64–78] 66 [61–78] 0.13
 SAPS 2 59 [40–68] 57 [46–68] 0.11
 Renal failure (n, %) 62 (78.5) 42 (80.8) 0.75
 RRT (n, %) 24 (30.4) 27 (51.9) 0.02
 INR 2.62 ± 2.40 
[2.09–3.15]
1.89 ± 1.40 
[1.49–2.28]
0.11
 Invasive ventilation (n, %) 56 (70.9) 40 (76.9) 0.44
 Maximum dose of nor‑
epinephrine (mg/h)
3.23 ± 4.28 
[2.21–4.24]





48 [19–71.25] 36 [15–59.25] 0.25
 HCO3 (mmol/L) 19.8 ± 7.7 
[18.1–21.5]
15.3 ± 8.3 
[13.1–17.6]
<0.002
 Lactate (mmol/L) 2.78 ± 3.61 
[1.99–3.58]
5.78 ± 5.0 
[4.42–7.14]
<0.001
 ICU LOS (days) 9 [6–19] 7 [4–13] 0.16
 ICU death (n, %) 31 (39.2) 20 (38.5) 0.93
 Hospital death (n, %) 33 (41.8) 20 (38.5) 0.63
Values are mean ± SD [95 % CI], median [IQR], n (%)
ICU intensive care unit, LOS length of stay, INR international nor-
malized ratio, RRT renal replacement therapy
Conclusion Metformin is associated with higher lactate level what-
ever the kidney function. In septic shock, metformin is associated 




1.  Christiansen, C. F. et al. Preadmission metformin use and mortality among 
intensive care patients with diabetes: a cohort study. Crit. Care Lond. Engl. 
17, R192 (2013).
2.  Salpeter, S. R., Greyber, E., Pasternak, G. A. & Salpeter, E. E. Risk of fatal and 
nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. 
Cochrane Database Syst. Rev. CD002967 (2010). doi:10.1002/14651858.
CD002967.pub4.
P124  
Serum cholinesterase activity in the diagnosis of septic shock due 
to bacterial infections: a new specific biomarker of sepsis
Mabrouk Bahloul1, Turki Olfa1, Najeh Baccouche2, Kais Regaieg2, Chtara 
Kamilia1, Benhamida Chokri1, Hedi Chelly2, Mounir Bouaziz2
1Réanimation polyvalente, Faculté de médecine de Sfax, Sfax, Tunisia; 2Icu, 
CHU Habib Bourguiba, Sfax, Tunisia 
Correspondence: Mabrouk Bahloul ‑ bahloulmab@yahoo.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P124
Introduction We aimed to investigate whether serum cholinesterase 
(SchE) activity could be helpful for the diagnosis of septic shock and to 
evaluate its utility in comparison with procalcitonin (PCT) and C-reac-
tive protein (CRP).
Patients and methods A prospective single-blinded study conducted 
in intensive care unit of university hospital. Patients were classified as 
having cardiogenic shock, septic shock or haemorrhagic shock. More-
over, we have included a control group without hemodynamic insta-
bility and without sepsis. For all included patients, blood samples were 
obtained (Serum ChE, procalcitonin and CRP) at the same time.
Results The comparison of sepsis markers between all groups showed 
that the mean value of PCT and CRP was significantly higher in 
patients with septic shock group. However, serum chE activity was sig-
nificantly lower in this last group. Serum chE activity was found to be 
the finest marker for the diagnosis of septic shock in comparison with 
PCT and CRP. In fact, a SchE activity ≤4000 UI/l was associated with the 
diagnosis of septic shock with sensitivity at 78 %, specificity at 89 %, 
a negative predictive value at 97  % and positive predictive value at 
65 %. However, despite the fact that the low value of ChE activities was 
found to be well correlated with the diagnosis of septic shock, it was 
not associated with a poor outcome (death) in multivariate analysis.
Discussion The SchE activity level was significantly decreased in 
patients with septic shock and was not correlated with morality.
Conclusion The SchE activity level was significantly decreased in patients 
with septic shock and was not correlated with morality. Our results sug-
gest that SchE activity might play an important role in the positive diag-
nosis of septic shock. Others studies are needed on this subject.
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Introduction There is increasing evidence of hyperoxaemia-associ-
ated harmful effect in different conditions, such as stroke, myocardial 
infarction and cardiac arrest. All these pathological situations induce 
ischaemia–reperfusion injuries. A major cause of ICU admission and 
ischaemia–reperfusion injury is septic shock. We wanted to investigate 
whether or not hyperoxemia was common in mechanically ventilated 
patients with septic shock in our ICU.
Patients and methods We performed a single-centre retrospective study.
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Inclusion criteria: We screened all patients with the diagnosis code of 
septic shock admitted in our ICU from January 1, 2010, to December 
31, 2013.
Exclusion criteria: Patients were excluded if they were younger than 
18, if they did not actually have septic shock, if they were not mechani-
cally ventilated, if they received less than 0.25  mg/kg/min of norepi-
nephrine, if they deceased before the 24th hour, if they were already 
included in this study or if less than 3 blood gases analysis was avail-
able during the first 72 h of their ICU care.
For each included patient, we estimated, in the first 72 h of ICU care, 
a hourly arterial partial pressure of oxygen (PaO2) based on the one 
hand on PaO2/FiO2 ratio (assuming a linear variation of this ratio 
between two blood gas analysis) and on the other hand on the auto-
matic report of FiO2 in our electronic chart. According to the Brit-
ish Thoracic Society guidelines (1), the hyperoxaemia threshold was 
120  mmHg. We differentiated mild hyperoxaemia (120–200  mmHg), 
moderate hyperoxaemia (200–300  mmHg) and severe hyperoxaemia 
(>300 mmHg). We also investigated whether patients were exposed to 
hypoxaemia (<60 mmHg).
Results During the study period, 3866 patients were admitted in our 
ICU. A diagnosis code of septic shock was associated with 646 admis-
sions. Two hundred and ten patients did not meet the exclusion cri-
teria and were included in this study. There was a majority of medical 
patients (67.1  %), with a median SAPS2 of 65.5 (IQ1 57; IQ3 74) and 
with a median age of 68.5 years (IQ1 59.25; IQ3 75). The ICU mortality 
was 36.7 %. We were able to estimate 13,836 PaO2 in the first 72 h of 
ICU care for septic shock. The proportion of hyperoxaemia was 19.9 % 
(17.3 % of mild hyperoxaemia, 2.1 % of moderate hyperoxaemia and 
0.5 % of severe hyperoxaemia). By contrast, hypoxemia occurred only 
for 4.5 % of all the PaO2 estimates.
Hyperoxaemia was more frequent during the first hours of manage-
ment (26.2  % in the first 24  h and 34.5  % in the first 6  h). Moreover, 
82.9  % of the included patients experienced at least one episode of 
hyperoxaemia.
Discussion In this single-centre retrospective study, hyperoxaemia 
is four times more frequent than hypoxaemia. Even if in most of the 
cases, the level of hyperoxaemia remains mild, a wide majority of 
patients are exposed. Whether or not hyperoxaemia may influence the 
outcome remains to be determined.
Conclusion In this single-centre retrospective study, hyperoxaemia 
exposure is not a rare event during the management of septic shock 
patients, especially in the first hours of ICU care. Since it has been 
established that hyperoxaemia is associated with a poor outcome in 
cardiac arrest, stroke and myocardial infarction, a possible association 
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Introduction The mechanisms of myocardial depression during sepsis 
are not fully understood, but the hypothesis of a myocardial depres-
sant factor (MDF) has been suggested. Our aim was to scrutinize the 
role of a large panel of cytokines/chemokines using methodological 
approaches derived from functional genomics.
Patients and methods Echocardiographies were performed during 
the first 3 days of septic shock to assess left ventricle ejection fraction 
(LVEF). Patients with immunosuppression and those with chronic heart 
failure were excluded. Blood samples were collected on the first day of 
septic shock, and plasma concentration of 23 cytokines/chemokines 
was assessed using a multi-analyte Milliplex human cytokine kit (Milli-
pore Corporation, Billerica, MA, USA). Analyses were corrected for false 
discovery rate.
Results Seventy-four patients were prospectively included. The main 
source of infection was the lung (49  %). Median SOFA score was 10 
[7–12]. Thirty patients (40 %) died in ICU. Twenty-four (32 %) patients 
had left ventricular hypokinesia (LVEF  <  45  %), 32 (43  %) were nor-
mokinetic (LVEF between 45 and 60  %) and 18 (24  %) were hyperki-
netic (LVEF > 60 %). Plasma concentration (as assessed by fluorescence 
intensity) of the majority of cytokines/chemokines was above normal 
values and closely correlated with each other. Hierarchical cluster-
ing identified three main clusters of cytokines/chemokines involving 
the following pathways: inflammatory response (Th1–Th17), innate 
immunity, and cell death, respectively. Matrix correlation and principal 
component analysis revealed that septic myocardial dysfunction was 
closely related to the cluster of innate immunity.
Conclusion Our comprehensive analysis did not identify a single MDF 
during septic shock. Cytokines/chemokines involved in innate immu-
nity were associated with septic myocardial dysfunction.
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Introduction Peripheral blood mononuclear cells (PBMCs) might play 
a role during compensatory anti-inflammatory response syndrome 
(CARS) following septic shock. This study investigated the time course 
of septic shock-induced mitochondrial respiration alterations of 
human PBMC.
Patients and methods Septic shock patients admitted in intensive 
care unit (ICU) of a university hospital were included following the 
2012 Surviving Sepsis Campaign diagnosis criteria and compared 
to healthy volunteers. After isolating PBMC using Ficoll separation 
medium, we evaluated PBMC mitochondrial capacities by measuring 
oxygen consumption in several plasma media, following two steps: 
firstly a “cellular” step and secondly a “plasmatic” step. The cellular 
step of our work measured septic PBMC mitochondrial respiration at 
days 1, 2 and 7, compared with healthy PBMC. Two plasma treating 
methods were used at this cellular step: fresh homologous plasma—
plasma from same donor used immediately—and frozen heterologous 
plasma—frozen plasma from another donor from same group and 
time. The plasmatic step compared effect of day 1 septic plasma ver-
sus non-septic plasma on oxygen consumption of three types of cells: 
septic PBMC at day 1, U937 and CEM cell lines. All oxygen consump-
tion measures, expressed in pmol/s/million cells, were done using 
high-resolution oxygraphy (oxygraph-2k, Oroboros Instruments, Aus-
tria). We assessed also PBMC apoptosis by annexin V, quantified with 
flow cytometry, plasma pH, and superoxide (O2
−·) production in whole 
peripheral blood using electron spin resonance.
Results We investigated 22 septic shock patients and 12 healthy vol-
unteers. Our cellular step showed an increased mitochondrial respira-
tion of septic PBMC compared to healthy volunteers: at days 1, 2 and 7 
PBMC from septic shock patients consumed, respectively, 8.18 ± 2.77, 
9.50  ±  1.60 and 10.72  ±  2.34  pmol O2/s/millions cells, significantly 
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higher than healthy volunteers at 4.56 ± 1.29 pmol O2/s/millions cells 
(p < 0.01), in fresh homologous plasma. Similar results were observed 
in frozen heterologous plasma, showing septic PBMC oxygen con-
sumption of 9.65 ± 6.34, 11.32 ± 5.27 and 11.65 ± 5.28 pmol, respec-
tively, at days 1, 2 and 7, significantly higher (p  <  0.05) than healthy 
PBMC at 5.45  ±  0.98  pmol O2/s/millions cells. The plasmatic step 
showed an inhibitory effect of day 1 septic plasma compared with 
non-septic plasma: On day 1 septic PBMC, we observed a nonsig-
nificant higher oxygen consumption in healthy plasma versus sep-
tic shock plasma from day 1 (14.02 ± 10.12 vs 9.65 ± 6.34; p = 0.13). 
On both cell lines, oxygraphy showed a significant increase of oxy-
gen consumption in healthy versus septic shock plasma from day 
1: 13.11  ±  0.59 versus 9.67  ±  1.77 (p  =  0.002) in U937 cells, and 
7.54 ± 1.39 versus 6.87 ± 1.11 (p = 0.03) in CEM cells. No significant 
differences in terms of plasma pH, superoxide (O2
−·) production or lym-
pho-monocytes apoptosis were observed in healthy or septic shock 
patients.
Conclusion Our study showed a significant increase of lympho-mono-
cytes mitochondrial respiration of septic patients, from day 1 to day 7, 
compared with healthy volunteers, whereas the septic plasma has an 
inhibitory effect on mitochondrial respiration, suggesting a mitochon-
drial compensatory process, probably by mitochondrial biogenesis, in 
response to sepsis process. The inhibitory role of septic plasma points 
out that this initial sepsis insult on mitochondrial respiration seems to 
be mediated by circulating plasma factors, which are not determined 
yet. Further investigations will allow us to better understand the 
involved mechanisms in both initial mitochondrial injury and second-
ary mitochondrial compensation during CARS.
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Introduction Mottling extension and capillary refill time have been 
identified as strong predictive factors during septic shock. Based on 
experimental and sublingual capillaroscopy-based studies, we specu-
lated that both skin disorders are due to skin hypoperfusion and 
local endothelial dysfunction. The goal of this study was to confirm 
this hypothesis and to investigate skin endothelial functions in ICU 
patients admitted for severe infections and to compare forearm and 
knee skin area.
Patients and methods In a prospective monocentric observational 
study including patients with severe sepsis and septic shock in an 
18-bed ICU in a teaching hospital 6 h after resuscitation, we recorded 
global hemodynamic and organ perfusion parameters, demographic 
data and severity of illness evaluated by the sequential organ failure 
assessment (SOFA) score. Skin endothelial functions were evaluated by 
local administration of acetylcholine by iontophoresis. Iontophoresis 
is a technique that uses an electric current to transport drugs in ionic 
form across the skin. In combination with laser Doppler, the vascular 
reaction was studied by measuring changes in microcirculatory blood 
flow. Global skin microcirculatory blood flow was measured at the 
baseline and monitored after acetylcholine challenge during 10 min. 
The peak of skin blood flow and the area under the curve on both fore-
arm and knee sites were computed.
Results Thirty-one patients were included, 8 with severe sepsis and 
23 patients with septic shock. Six patients died of multi-organ failure 
(MOF). Knee endothelial functions decreased significantly with sep-
sis severity: peak value 56 (43–61) in severe sepsis versus 17 (11–45) 
in septic shock survivors and 8 (5–17) in MOF dead patients (Kruskal–
Wallis test, P = 0.01), area under the curve 20,494 (16,853–29,586) in 
severe sepsis versus 7791 (5762–15,892) in septic shock survivors 
and 3847 (2664–7807) in MOF dead patients (Kruskal–Wallis test, 
P = 0.009). After exclusion of 3 patients with dark skin, we compared 
skin microcirculatory parameters in septic shock patients according 
to the absence (n = 8) or the presence of mottling (n = 12). Endothe-
lial dysfunction was much more pronounced in mottling skin in com-
parison with non-mottling skin: basal value 7 (6–8) versus 5 (4–6) 
(Mann–Whitney test, P =  0.01), peak value 17 (8–52) versus 7 (5–15) 
(Mann–Whitney test, P  =  0.05), area under the curve 7981 (4243–
19,612) versus 3302 (2643–6531) (Mann–Whitney test, P  =  0.03). 
Noteworthy, endothelial function assessed on the forearm area was 
not different between mottling and non-mottling group. Finally, ionto-
phoresis-derived endothelial parameters were highly correlated with 
SOFA score: Knee basal value P =  0.005, r = −0.53, knee peak value 
knee P < 0.001, r = −0.62, area under the curve P = 0.001, r = −0.61.
Conclusion Skin endothelial functions are markedly impaired dur-
ing severe infections. These heterogenous alterations are more pro-
nounced in area with mottling.
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Introduction Microcirculatory disorders leading to tissue hypop-
erfusion play a central role in the physiopathology of organ failure 
during septic shock and have been identified as strong outcome pre-
dictive factors. It is therefore important to develop accurate param-
eters at the bedside to evaluate tissue perfusion. The objectives were 
to evaluate whether Central-to-Toe, Central-to-Knee, Toe-to-Room 
and Knee-to-Room temperature gradients are related to sepsis 
severity and could predict ICU outcome in critically ill patients with 
severe infection.
Patients and methods This is a prospective monocentric obser-
vational study including patients with severe infections. During a 
10-month period, all patients, older than 18  years, admitted for a 
severe infection were included. There were no exclusion criteria. 
Patients were classified as sepsis, severe sepsis and septic shock 
according to 2001 International Sepsis Definitions conference. Patients 
were included at admission for patients with sepsis and severe sep-
sis, and when vasopressors were started (within 24  h of admission) 
for patients with septic shock. General characteristics of the patients 
were recorded: demographic data, diagnoses, severity of illness evalu-
ated by the sequential organ failure assessment (SOFA) score (within 
the 6  h of inclusion) and Simplified Acute Physiologic Score II (SAPS 
II). We collected data that reflected macrocirculation and organ perfu-
sion at inclusion, corresponding to admission or vasopressors infusion 
for septic shock, and at 6, 12 and 24  h after inclusion. Global hemo-
dynamic status was assessed using mean arterial blood pressure, 
heart rate and cardiac index. Microcirculatory dysfunction and organ 
perfusion were assessed through arterial lactate level, urinary output, 
mottling score and knee capillary refill time. Toe and knee skin temper-
ature were measured using skin temperature sensor applied at patient 
inclusion and let in place during the first 24 h. Central body tempera-
ture was measured with an electronic rectal thermometer, and room 
temperature was also recorded.
Results One hundred and twenty-five patients were enrolled, 22 
sepsis, 40 with severe sepsis and 63 with septic shock. Temperature 
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gradients were significantly different according to infection severity; 
Central-to-Toe and Central-to-Knee temperature gradients increased 
with disease severity, but Toe-to-Room and Knee-to-Room tem-
perature gradients decreased. During septic shock, mortality due to 
multi-organ failure (MOF) occurred in 31  % of the cases. After initial 
resuscitation, Toe-to-Room temperature gradient was significantly 
lower in the MOF death group than in the survivors (−0.3 [−1.0; +1.1] 
vs +2.4 [+0.3; +5.8] °C, P < 0.01) and differences increased during the 
first 24 h. There was no correlation between Toe-to-Room temperature 
gradient and cardiac index or vasopressor doses. However, Toe-to-
Room temperature gradient was related to tissue perfusion param-
eters like arterial lactate level (r = −0.42, P =  0.001), urinary output 
(r = 0.29, P = 0.02), capillary refill time (r = −0.39, P = 0.004) and mot-
tling score (P = 0.004).
Conclusion Toe-to-Room temperature gradient reflects tissue perfu-
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Introduction In intensive care unit, patients display immune failure 
associated with an inflammatory response usually after surgery or 
sepsis, and a low expression of HLA-DR on monocytes (mHLA-DR) is 
a predictive factor of nosocomial infections. After heart transplanta-
tion (HTx), recipients’ immunosuppressive therapy increases this sepsis 
risk. The primary endpoint of the study was to observe a correlation 
between mHLA-DR value and clinical outcome.
Patients and methods Eight recipients were prospectively included 
in ICU, 5 with septic risk: 3 with left ventricular assist device (LVAD), 1 
with biventricular assist device and 1 with extracorporeal life support. 
Infection was controlled in LVAD patients. Expression of mHLA-DR was 
measured by flow cytometry on whole blood. A single measure was 
performed between day 12 and day 30 post-HTx. Immune failure was 
classified according to mHLA-DR expression: severe if antibody bound 
per cell (AB/C) <5000, marked if 5000–10,000, moderate if 10,000–
15,000. Immune response was considered normal up to 20,000 with 
a grey zone between 15,000 and 20,000. Immunosuppressive therapy 
was standard. Follow-up was 2 months.
Results Five HTx recipients had marked immune failure, and they pre-
sent neither sepsis nor rejection, patients with LVAD belonged to this 
group. Two patients had severe immune failure (2700 and 4400 AB/C) 
and presented nosocomial infections. One patient without immune 
failure (17,755 AB/C) presented acute antibody-mediated rejection. All 
patients were discharged from hospital.
Conclusion The grading of immune failure according to a single meas-
ure of monocytes HLA-DR expression between day 12 and day 30 after 
HTx is clearly correlated with clinical outcome, infection or rejection. It 
allows to adapt the immunosuppressive therapy to individual patient 
immune status. Immune monitoring with several measures mHLA-DR is 
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Introduction Neonatal ECMO is used as last resort in refractory hypox-
emia or refractory shock. These techniques can lead to complications 
such as hemorrhaging, nosocomial infections, renal and neurologic 
injury. Incidence and impact of nosocomial infection occurring during 
neonatal ECMO have rarely been described.
Patients and methods We retrospectively reviewed all neonatal 
ECMO between January 2010 and June 2015, in our neonatal intensive 
care unit. We review incidence, risk factors, infectious organism and 
outcomes for bloodstream infection, ventilation-acquired pneumonia 
and urinary infection.
Results Ninety patients underwent ECMO support for more than 
48  h. Forty patients developed nosocomial infections (44  % with an 
incidence of 13.8 infections for 1000  days of hospitalization). Initial 
C-reactive protein was lower in infected patients. Bloodstream infec-
tions, ventilation-acquired pneumonia and urinary infections occurred 
in 65, 27.5 and 7.5 %, respectively. Staphylococcus was the most fre-
quent organism in bloodstream infection, and enterobacter was the 
most frequent organism for ventilation-acquired pneumonia. Mean 
time for the first nosocomial infection was 15.3 days. Infected patients 
had longer duration of ECMO support, mechanical ventilation, central 
venous catheter and hospital stays. Furthermore, infected patients 
needed more blood transfusion (p < 0.0001) and platelets (p < 0.0001). 
No significant difference between survival rates was noticed.
Conclusion Neonatal ECMO is at high risk of developing nosocomial 
infections. Strategies aimed at prevent these infections, as early ECMO 
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Introduction The Echoday study has evaluated the prevalence of 
POCUS use in ICU patients and assessed the diagnostic performance 
and therapeutic impact of POCUS in a large cohort of ICU patients 
including pediatric and neonatal ICU (1). We present here detailed 
results of the Echoday study in PICU and NICU.
Patients and methods The prospective multicentric observational 
transversal study Echoday has included 142 ICUs. Among them, 22 
were pediatric and/or neonatal ICUs, all tertiary centers (5 neonatal 
ICUs, 7 mixed ICUs and 10 pediatric ICUs). All the POCUS procedures 
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performed during a 24-h period were prospectively analyzed. 
Data regarding patient condition and the POCUS procedures were 
collected.
Results Among 284 pediatric patients hospitalized during the study 
period, 154 (54.2  %) POCUS/day were performed in 87 (30.6  %) 
patients. POCUS served for diagnostic assessment in 141 (91.6  %) 
cases and procedural guidance in 13 (8.4 %) cases. Among the diagno-
sis POCUS: transthoracic echocardiography accounted for 72 (51.1 %) 
of procedures, brain, transcranial vessel and optic nerve ultrasound for 
43 (30.5 %), lung ultrasound for 9 (6.4 %), renal artery and other ves-
sel ultrasound for 5 (3.6 %), vesical ultrasound for 4 (2.8 %), abdominal 
ultrasound for 3 (2.1 %) and FAST.
ultrasound for 2 (1.4  %). POCUS confirmed 42 diagnosis (29.8  %), 
changed 17 diagnosis (12.1  %), spared imagery or monitoring 
prescription in 5 cases (3.5  %), induced imagery or monitoring 
prescription in 29 cases (20.6  %), induced modification or discon-
tinuation of treatment in 30 cases (21.3  %), induced the continua-
tion of treatment in 30 cases (21.3 %), induced the continuation of 
hospitalization in ICUs in 25 cases (17.7  %), induced the change of 
department of hospitalization in 9 cases (6.4  %). The operator was 
formed to diagnosis ultrasound in 105 cases (74.5 %). In 95 (67.4 %) 
cases of diagnosis ultrasound, patients were admitted for medi-
cal indications, in 41 (29.1  %) cases for surgical indications and in 
4 (2.8  %) cases for traumatism. Fifteen (11.6  %) diagnosis POCUS 
were realized at the entrance of the patient. Nine (7.8  %) cases 
were life-threatening emergencies, 51 (36.2  %) cases were relative 
emergencies and 75 (53.2  %) cases were not emergencies. Diag-
nosis POCUS were performed on newborn in 93 (66.0  %) cases. 
Procedural guidance ultrasound was used in 12 (92.3  %) cases for 
insertion of central venous line and in 1 (7.7 %) case for insertion of 
pleural drain. Twelve (92.3 %) were successful, 8 (61.5 %) on the first 
time and 4 (30.8  %) on the second time. There were complications 
in 4 (30.8 %) cases. The operator was formed to echo guidance in 5 
(38.5 %) cases. Eight (61.5 %) procedural guidance ultrasounds were 
realized on newborn.
Conclusion POCUS use in pediatric and neonatal ICUs for diagnosis is 
high and impacts the management of patients, but POCUS use for pro-
cedural guidance remains low. Impact of US in PICUs and NICUs seems 
to be quite similar than in adult population but some more investiga-
tions are necessary.
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Introduction The provision of adequate sedation and analgesia is 
required in critically ill children to reduce anxiety, pain, and enable 
synchronization during mechanical ventilation. This is commonly 
achieved through a combination of opioids and benzodiazepines. 
Prolonged use of these agents is associated with tolerance and with-
drawal. Recent literature suggests that sedation regimens incorpo-
rating α2-adrenergic agonists may offer several benefits. In 2013, we 
introduced a new sedation protocol including clonidine as an adjunc-
tive sedative agent. We aim to report our experience with clonidine 
used as a sedative in combination with morphine and midazolam and 
to prevent withdrawal syndrome.
Patients and methods We retrospectively reviewed medical records 
of patients admitted in our 20-bed tertiary paediatric intensive care 
unit between November 2013 and April 2015, who received clonidine. 
The study was approved by the local ethics committee. We recorded 
demographic data, indications for intensive care admission, paediat-
ric index of mortality 2, duration of mechanical ventilation, length of 
stay, morphine and midazolam doses, clonidine indications and doses, 
side effects, efficacy and withdrawal symptoms. To asses level of seda-
tion in ventilated patients, we used the COMFORT behaviour scale. We 
hypothesized a potential opioid- and benzodiazepine-sparing effect 
of clonidine, and we analysed morphine and midazolam consumption 
during two time periods: 18 months before and 18 months after the 
introduction of clonidine in the unit. Data are expressed as numerical 
values and percentages for categorical variables, and as means and 
standard deviations for continuous variables.
Results During the study period, 57 patients received clonidine and 
48 were enrolled. Mean age at admission was 2.3 years, 36.9 % were 
male. Reasons for intensive care admission were mainly respiratory 
failure (46 %) followed by haemodynamic failure, postoperative care, 
and neurologic failure. Mean paediatric index of mortality 2 was 
10.2  %. Mean duration of mechanical ventilation was 10.2  days. The 
main reasons for clonidine administration were: increasing morphine 
and midazolam (>100  µg/kg/h) requirements (64  %), difficulties in 
achieving optimal level of sedation (38  %), difficult management of 
sedation and analgesia in the post-operative period (38  %), prevent-
ing withdrawal syndrome after prolonged administration of opioids 
and benzodiazepines (7.7 %), and treatment of withdrawal syndrome 
(5.13  %). The mean duration of clonidine infusion was 8  days. Mean 
COMFORT score value was 15.02 before clonidine was started and 
13.69 after beginning of clonidine infusion. The clonidine dose range 
used was 0.2–2 µg/kg/h. During clonidine infusion, 4 patients (10.2 %) 
experienced bradycardia, 3 (7.7 %) hypotension and 5 (12.8 %) both. 
Fifty-eight per cent of patients who showed haemodynamic instabil-
ity were less than 1 year old. These effects did not result in increased 
demand for intravenous fluid or catecholamines. We observed a sig-
nificant lower consumption of morphine and midazolam after cloni-
dine was introduced. Compared with the 18-month pre-study period, 
the consumption decreased by 9.3 % for morphine and by 47.1 % for 
midazolam (calculated as mg/months/hospitalized patients).
Discussion Adequate sedation is important in paediatric intensive 
care. By contrast, oversedation promotes drugs tolerance and with-
drawal leading to a delayed recovery. In the effort to reduce prolonged 
opioid and benzodiazepine exposure, we introduced clonidine in our 
sedation protocol. We found an acceptable side-effects profile and 
a clinical efficacy both in ventilated and in non-ventilated patients. 
Our data also confirm a benzodiazepine and opioid sparing effect 
of clonidine, with significant reduction in midazolam and morphine 
consumption.
Conclusion The use of clonidine in critically ill children is safe and 
effective. Clonidine can be beneficial to reduce the complications 
associated with prolonged use of opioids and benzodiazepines, and 
in the prevention and treatment of withdrawal syndrome. A prospec-
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Introduction Vancomycin is commonly administered for methicillin-
resistant staphylococcal infections. Resulting plasmatic vancomycin 
concentration is associated with clinical outcome. While continuous 
infusion for adult severe infection was previously described, very 
poor data related to paediatric population are available. The aim of 
the present study is to (i) describe and investigate continuous infu-
sion vancomycin therapy in critically ill children; (ii) to assess exposure 
and proper dosing taking into account estimated pharmacokinetic 
parameters.
Patients and methods This is a chart retrospective observational 
study conducted at Necker-Enfants Malades teaching hospital. Chil-
dren (aged less than 18  years) admitted in paediatric intensive and 
intermediate care unit (PICU) from January to June 2015, who received 
a continuous infusion vancomycin therapy for suspected or confirmed 
β-lactams-resistant cocci gram-positive infection with plasma vanco-
mycin level monitoring were included. General characteristic, clini-
cal and bacteriological data [isolated microorganism and minimum 
inhibitory concentration (MIC)], organ function, creatinine clearance, 
vancomycin dosing regimens and measured plasmatic level were 
described. Using the population pharmacokinetic model of vancomy-
cin published by Le et al. we derived the individual pharmacokinetics 
parameters of each patient (taking into account age, daily individual 
dose, body weight, creatinin level and vancomycin concentration). 
Using these parameters, we simulated the plasma time course of van-
comycin in every child. We could then describe the concentration after 
the loading dose and calculate the area under the curve (AUC24) from 
the first dose.
Results We analysed 29 patients aged from 1  month to 17  years 
and weighted from 3 to 53  kg (median 2.7  years and 12  kg). Fifteen 
patients (52  %) had one or more organ failure and 4 patients (14  %) 
received vasopressor or inotropic agents. Median creatinine clearance 
was 176 ml/min (range 75–343), and no patient required dialysis dur-
ing the time course of study.
Fourteen patients (48  %) received vancomycin for catheter-related 
infection mostly caused by coagulase-negative Staphylococcus [WU1] 
(n = 11), and empirically for 13 patients (45 %), MIC value (mg/L) was 
available for 3 documented infections (1; 1.5 and 1.5). Median vanco-
mycin loading dose was 14.8 mg/kg (range 12–16) over 1 h followed 
by a continuous infusion of 44 mg/kg/day (range 35–61). Median delay 
for first plasmatic level after loading dose was 20 h (range 10–51) with 
a level of 14.5 mg/L (range 9.8–46.9). Eleven patients (38 %) reached a 
level >15 mg/L. Sixteen patients (55 %) have had one or more dosing 
adjustment. Median of the 11 increases of vancomycin daily dose was 
+25  % (IQR +11 to +57), resulting in a median plasmatic drug level 
enhancement from 12.1 to 15.5 mg/L. Five patients (46 %) kept a van-
comycin level <15 mg/L.
During the first 24  h of treatment, assuming that MIC was equal to 
1 mg/L, AUC24/MIC was estimated to 349 (range [WU2] 201, 1001) and 
only 7 patients (24 %) reached an AUC24/MIC > 400. Median simulated 
concentrations of vancomycin at the end of the loading dose was 
20.4 mg/L (17.1–23.7), showing that the loading dose was appropriate 
to reach the target of 15–25 mg/L [WU3].
Clinical and bacteriological failure occurred for one of the 16 patients 
who had a confirmed infection. One patient exhibited a renal function 
deterioration 24 h after the start of the cure.
Discussion This is the first study to focus on the use of a loading dose 
of vancomycin followed by continuous infusion in critical ill children. 
Initial vancomycin loading and continuous doses were very similar 
among the patients. Loading dose seems adequate to achieve a suf-
ficient vancomycin level, but the following continuous dose was too 
low to maintain a level >15 mg/L and to achieve the target of AUC24/
MIC-1  >  400 for most of patients. In addition, the various practices 
in dosing adjustment failed to reach these objectives for half of the 
patients after several days of therapy initiation.
Conclusion Continuous infusion vancomycin therapy in critically ill 
children dosing as well as adjustments could not to be appropriate 
and lead to under exposure. Using pharmacokinetics models should 
be useful to achieve target concentration and AUC.
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Introduction The fight against nosocomial infections is a public 
health issue. Nosocomial infections increase patient’s morbidity and 
mortality and are expensive to treat. The risk of nosocomial infection 
is higher with patients in intensive care unit (ICU) than those hospi-
talised in conventional unit (respectively, 23 vs 5  % according to the 
national survey (adult and paediatric) executed in France in 2012 in 
1938 institutions). Identified risks factors are mainly due to invasive 
equipments, such as central venous catheter (CVC). In French paediat-
ric ICU, the incidence of CVC-associated bacteraemia is not described. 
The aim of this study was to define the incidence of CVC-associated 
bacteraemia per 1000 CVC-days in a French paediatric ICU (PICU).
Patients and methods This study was retrospective, descriptive, and 
monocentric in a PICU (14 beds) between the 01/01/2012 and the 
01/09/2014. Inclusion criteria were patients with 1) a short- or long-
term CVC and 2) a bacteraemia during hospitalisation, according to 
the National Healthcare Safety Network definition. Exclusion criteria 
were separated into (1) clinical aspect: patient with a bacteraemia 
related to an other infection site than the CVC (non-CVC-associated 
bacteraemia) (a) and (2) bacteriological analyses: epidemiological 
duplicates (b), non-nosocomial bacteraemia (c), bacteraemia induced 
by a common commensal not cultured from two or more blood cul-
tures, drawn on separate occasions (d), patient without a CVC at the 
time of the bacteraemia (e). Clinical and biological results were col-
lected by using ICCA® software (Philips Society) and bacteriological 
results by using MOLIS® software (Vision4health Society). Statistical 
analyses were performed using Fisher’s exact test and Mann–Whitney 
test. Differences were considered significant at p < 0.05. The CVC utili-
sation ratio was calculated by dividing the number of CVC-days by the 
number of patient-days.
Results During the time period (33  months), 1898 patients were eli-
gible and 99 patients with 221 bacteraemia were included. The fol-
lowing were excluded: 17 non-CVC-associated bacteraemia (a), 73 
epidemiological duplicates (b), 61 non-nosocomial bacteraemia (c), 52 
bacteraemia induced by a common commensal not cultured from two 
or more blood cultures, drawn on separate occasions (d) and 4 bacte-
raemia in patients without CVC at the time of the bacteraemia (e).
For the 1898 patients, the median age was 33 months (IQR 9–113), the 
median weight was 12 kg (IQR 7–25), the mean PICU length of stay was 
5.7 days (SD 18), the mean length of invasive ventilation was 6.4 days 
(SD 20), and the mortality rate was 4.6 % (87/1898).
There was 439 CVC and 14 CVC-associated bacteraemia corresponding 
to 11 patients. The incidence of CVC-associated bacteraemia was 3.9 
per 1000 CVC-days (95 % CI 2.1–6.5). The CVC utilisation ratio was 0.75. 
Between patients without CVC-infections (n = 366) and patients with 
CVC-associated bacteraemia (n = 11), the median PICU length of stay 
and the median length of invasive ventilation were statistically longer 
for patients with CVC-associated bacteraemia (respectively, p = 0.0001 
and p = 0.025). There was no statistical difference concerning the age 
and the mortality between the two groups.
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Discussion According to the National Healthcare Safety Net-
work report realised in 2011 in 300 medical and surgical PICU in 
the USA, the incidence of CVC-associated bacteraemia was 1.8 
per 1000  days with short- and long-term CVC [median (IQR) 1.3 
(0.0–2.6) and 90th percentile 4.1]. Our results are closer to the 90th 
percentile of this American study. However in our study, the CVC 
utilisation ratio was higher (0.75 vs 0.47 in the National Healthcare 
Safety Network study), showing a longer use of CVC and therefore 
an increased risk of presenting a CVC-associated bacteraemia dur-
ing hospitalisation.
Conclusion This study helped define the incidence of CVC-associated 
bacteraemia in a French paediatric intensive care unit and to find the 
measurement tools required for an automised extraction of the data. 
The prospect is to create an informatic tool allowing a continuous sur-
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Introduction Increasing proportion of hospitalized patients in the 
pediatric department of Strasbourg University Hospital benefits from 
a central venous catheter (CVC) placement. One of the main com-
plications of this device is the central-line-associated bloodstream 
infection. These hospital-acquired infections are responsible for an 
important morbidity and mortality. We tried to estimate the outcome 
at 2  months at the infectious level, of central venous catheter place-
ment in our department, comparing two periods separated by an 
update of the guidelines with the paramedical and medical teams.
Patients and methods This is a prospective study realized in the 
whole pediatric department of the Strasbourg University Hospi-
tal, comparing two periods: from September 1 to October 31, 2014 
(period 1), and from March 1 to April 30, 2015 (period 2). All the CVC 
placement in the department during those periods was collected. We 
have recorded all the central-line-associated bloodstream infection 
(positive blood culture and clinical and/or biological signs of infec-
tion). Between those two periods (from November 2014 to February 
2015), we have worked with the hygiene team to update, standardize 
and broadcast protocols of CVC placement and maintenance in the 
department.
Results Four hundred and one CVC were included: 198 during the 
period 1 and 203 during the period 2. The incidence rate of cen-
tral-line-associated bloodstream infection has decreased by 7.7–
5.0/1000 days of use (p = 0.122). The effect was particularly important 
in neonatology, in which the rate has fallen from 13.4 to 5.8/1000 days 
of use (p = 0.07).
Discussion This study is the first French pediatric study including 
the whole pediatric population. The insufficient number of included 
patients did not permit to highlight a statistically significant effect. 
However, the clinical efficiency was real and has confirmed the impor-
tance of protocols implementation and regular updates as well as the 
ongoing education of the healthcare teams.
Conclusion Although these results were not statistically significant, 
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Introduction The pediatric intensive care unit of the pediatric hospi-
tal of Professor BOKHROFA Abdelkader, Oran, Algeria, was inaugurated 
July 5, 2005, with 04 intensive care beds.
Materials and methods Evaluation of activity in 10 years (2005–2015) 
in an intensive care unit at a pediatric hospital in Oran, Algeria.
Results Business service of pediatric resuscitation:
A major change in 2008 when the number of beds has doubled 
to 08 beds and activity recent years has shown a marked increase 
in hospitalizations increased from 230 in 2008 to 520 in 2013. The 
number of children on average breakdown in our service pediat-
ric intensive care is on the increase (40  % in 2014) against (20  % 
in 2005) with a occupancy rate has increased from 71 % in 2011 to 
94 % in 2014.
The service always welcomes children from 1  month to 15  years for 
mainly respiratory distress, acute hemodynamic or neurological. The 
population welcomed comes from hospital medical pediatric services 
(infectious, hematology, gastroenterology, nephrology and pulmonol-
ogy) and postoperative.
The calls are on average 60 per month. The average residence time is 
7  days with prolonged periods, and this is up to 60  days due to the 
absence of a post-resuscitation service.
New techniques/units:
- Noninvasive ventilation introduced in 2008.
- Opening of two new units in 2013: A post-consultation resuscitation 
unit and a unit for sedation outside the block since 2012 (puncture 
marrow biopsy, bronchial endoscopy, CT and MRI)
Conclusion The decline in 10  years (2005 and 2015) and the service 
activity is increasing, requiring an increase in hospital capacity. There 
are one million newborns per year and thus there is the need to create 
new pediatric intensive care unities.
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Introduction Neonatal respiratory distress syndrome (RDS) is a fre-
quent medical condition encountered in preterm neonates. Outborn 
neonates with RDS may require mechanical ventilation (MV) and 
surfactant therapy before their transportation to the tertiary neona-
tal intensive care unit (NICU). High-frequency percussive ventilation 
(HFPV) has previously been used for management of RDS in neonates 
hospitalized in NICU. The aim of the present study was to assess the 
feasibility and safety of HFPV for the management of neonatal RDS 
during transportation.
Patients and methods We performed a retrospective observational 
monocentric study from September 2008 to August 2011. All outborn 
neonates requiring invasive mechanical ventilation for RDS before 
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their transportation were included. Neonates with severe malforma-
tions and those transported after 48 h of life were not included. When 
required, HFPV was provided by the Sinusoidal Bronchotron™ device 
(IMAPe®). For each infant, we recorded the mode of mechanical ven-
tilation (conventional vs. HFPV), the evolution of SpO2/FiO2 ratio, and 
maternal and neonatal characteristics. Our main outcome was SpO2/
FiO2 ratio, 1  h after initiation of either conventional mechanical ven-
tilation or HFPV (M60). The comparison was stratified by range of 
gestational age: <28, 28–31, 32–37, >37 weeks GA. In order to exam-
ine SpO2/FiO2 ratio in relation to mode of ventilation, we defined 
potential confounding variables: baseline SpO2/FiO2 ratio observed 
at the initiation of MV, obstetrical, maternal and neonatal characteris-
tics. Categorical variables were compared using Chi square or Fisher’s 
test as needed while continuous variables were compared using Stu-
dent’s t test. For main outcome, a multivariate analysis was performed 
using linear regression. p values <0.05 were considered statistically 
significant.
Results Out of the 169 neonates included in the study, 57 received 
HFPV while 112 were placed on conventional mechanical ventilation 
(CMV). Univariate analysis for obstetrical, demographic and neonatal 
data showed no statistical difference between HFPV and CMV group 
whatever the gestational age, except for Apgar score at 1′ and 5′ 
which was significantly lower in the neonates aged 37 weeks or more 
and receiving HFPV. In 28–31 and 32–37 weeks subgroups, baseline 
SpO2/FiO2 ratio was found significantly lower in infants receiving 
HFPV and this ratio remained lower after 1  h of ventilation. In the 
more mature infants, HFPV was associated with a higher increase in 
SpO2/FiO2 ratio when compared to CMV, but this difference failed 
to reach statistical significance. After multivariate analysis, the main 
determinant for SpO2/FiO2 ratio at M60 was the baseline value of 
this ratio. Noteworthy that complications usually associated with 
mechanical ventilation were not reported in this study.
Discussion This observational study emphasizes the feasibility and 
safety of HFPV in neonatal transportation. The use of both HFPV and 
CMV resulted in favorable respiratory outcome. The significant initial 
lower values of SpO2/FiO2 ratio in neonates between 28 and 37 weeks 
requiring HFPV may be explained by the retrospective design of the 
study. It is indeed reasonable to suspect that the more severe forms of 
RDS were immediately ventilated with HPFV.
Conclusion To our knowledge, this is the first study to assess the feasi-
bility and safety of HFPV during neonatal transportation. More studies 
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Introduction To describe the time course of lymphocytes in children 
with severe infectious shock and to search for an association between 
persistent lymphopenia, initial severity and risk for nosocomial 
infection.
Patients and methods This monocentric retrospective study enrolled 
all children aged less than 18, admitted to PICU for severe infectious 
shock between January 2011 and September 2014, excluding immu-
nosuppressed and died within the first day. Results are expressed in 
percentages, medians and interquartile ranges. Fisher’s exact test was 
used to compare groups.
Results One hundred and six patients were analysed: 27 (25.4 %) with 
severe sepsis (S), 42 (39.6  %) with septic shock (SS) and 37 (34.9  %) 
with toxic shock (TS). Eight cases were fatal (7.5  %) and 15 patients 
developed a nosocomial infection (14.2  %). Initial lymphopenia was 
found, respectively, in 17 (63 %), 35 (83.3 %) and 36 (97.3 %) children 
with S, SS and TS. Day3 lymphopenia was found in 6 (22.2  %), 19 
(45.2 %) and 13 (35.1 %) patients, respectively. Only 6 patients (5.6 %) 
presented neutropenia. An association was found between initial 
severity scores (PIM2, PELOD2, Goldstein) and initial lymphopenia. 
The most severe patients were more prone to develop day 3 lympho-
penia. The rate of nosocomial infections was 10 % in the group with-
out day 3 lymphopenia compared to 23 % in the day 3 lymphopenia 
group (p = 0.14).
Conclusion Initial lymphopenia in children with infectious shock was 
linked to initial severity of shock, and the most severe patients were 
more at risk of day 3 lymphopenia. The higher rate of nosocomial 
infections found in children with day 3 lymphopenia should be con-
firmed in a larger study.
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Introduction The scorpion envenomation is the first cause of acciden-
tal poisoning. One-third of the envenomed population corresponds 
to children under the age of 15 years which is constitute a vulnerable 
population group and consequently displayed greater frequency of 
serious complications. The cardiogenic shock that accompanies the 
motion of enzymes affects the prognostic of this pathology and grafts 
pediatric patients with a significant morbidity and mortality. The aim 
of the study was to analyze the correlation between admission tro-
ponin levels and patient outcomes.
Patients and methods This was a retrospective study, spread over a 
period of 2  years (2012–2013) and conducted in the pediatric inten-
sive care unit of a University Hospital Mohammed VI Marrakech. We 
included all patients admitted to pediatric intensive care unit for 
scorpion envenomation. The management of patients was codified 
according to a national protocol, and the troponin level was assessed 
in all the patients on admission. The cutoff level is 0.003 UI/L. The sta-
tistical program used was SPSS version 21.
Results Among the 252 of envenomed children, the troponin assay is 
performed for 172 cases (68.2  %). Males were predominant, and the 
mean age was 6 years. On admission, 24.5 % of patients had a pulmo-
nary edema, and 21.8  % of patients had signs of collapse. Neurologi-
cal manifestations were observed in 36.4 % of patients. Troponin levels 
were positive in 69.8 % on admission. All patient received dobutamine, 
15 % of them epinephrine with or without noradrenaline, while 18 % of 
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patients required mechanical ventilation. The average length of stay in 
hospitals was 50 h. Favorable evolution was noted in 901 %. The corre-
lation between the troponin levels and the severity of clinical situation, 
the need for mechanical ventilation, vasoactive drugs, the length of 
hospitalization and the unfavorable evolution is positive and statistically 
significant.
Conclusion As a myocardial enzyme marker, the troponin levels seem 
to be an interesting element in the immediate assessment of patients 
with severe envenomation and in the identification of people at risk.
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Introduction Hyperosmolar agents are commonly used agents for the 
first-tier management of intracranial hypertension in traumatic brain 
injury (TBI). Pediatric guidelines have highlighted the lack of pediatric 
literature on the effectiveness of hyperosmolar agents in TBI manage-
ment and stressed the need for further studies to support their use. The 
specific objective of this study was to describe the use of hyperosmolar 
therapy in pediatric TBI and examine its effect on intracranial pressure 
(ICP) and cerebral perfusion pressure (CPP). In addition, the study will 
aid in assessing feasibility and preparation of a future controlled trial.
Patients and methods A retrospective revue of all TBI patients admit-
ted to CHU Sainte-Justine between 2007 and 2014 was conducted. 
Eligible patients were age 1 month to 18 years old, had severe TBI as 
defined by GCS ≤  8 on admission, and were admitted to the critical 
care unit. Specific inclusion criteria were invasive intracranial pressure 
monitoring and administration of a hyperosmolar agent within 48  h 
of admission to pediatric intensive care unit. Hyperosmolar agents 
included boluses of 20 % mannitol or 3 % hypertonic saline received 
after ICP placement. For the first 2 boluses received for increased ICP 
(>20 mmHg), the impact on ICP and CPP was assessed during the fol-
lowing 4  h. Co-interventions to control ICP (additional hyperosmolar 
agent, propofol or barbiturate bolus), diuresis and serum sodium were 
also documented. Missing values at 4th hour (n = 3 values) for ICP and 
CCP were treated by imputation. Repeated measure ANOVA was used 
for analysis of trending mean ICP and CPP post bolus, with significance 
set at p = 0.05.
Results Sixty-four patients were eligible, of which 16 met inclusion 
criteria. Average age was 11  years (SD  ±  4), and median GCS was 
6 (range 4–7). Thirteen patients were stabilized in another center 
prior to transfer, and median time from Trauma to ICP monitor was 
8.5 h (range 7–12 h). Average number of hyperosmolar boluses per 
patient was 6.6 (SD ± 3.4) over 48 h; 70 % of these were 3 % hyper-
tonic saline and 30 % were 20 % mannitol. There was no difference 
in patient characteristics between the two groups. For the first two 
boluses received, both mannitol and hypertonic saline were followed 
by a decrease in ICP in the following 4-h period (mannitol n  =  8, 
p < 0.05 and hypertonic saline n = 14, p < 0.05), see Table 29. There 
was no significant change in CPP post-bolus (mannitol p =  0.8 and 
hypertonic saline p = 0.4). Eleven patients received a co-intervention 
to decrease ICP within the 4 h post-hyperosmolar agent. Diuresis was 
not significantly increased post-mannitol or hypertonic saline.
Conclusion In pediatric TBI patients with intracranial hypertension, 
mannitol and hypertonic saline are commonly used, and we did not 
identify clear determinants of the choice of the solute. The use of 
both agents was associated with a reduction in ICP. The sample size, 
retrospective design and non-randomized choice of the treatment 
limit further interpretation. This study provides an important basis 
for the development of a future controlled, prospective study, which 
is needed to determine the respective effects of mannitol and hyper-
tonic saline on intracranial hypertension in pediatric TBI. The high pro-
portion of non-eligible patients and frequent co-interventions will be 
potential barriers of crucial importance in such trial.
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Introduction Cerebral sinovenous thrombosis (CSVT) in children is 
a rare disorder. However, it is increasingly recognized and diagnosed 
in children with the advent of new technical means both the imaging 
plane as clinically, allowing an early and adapted medical care.
Patients and methods It is a retrospective and descriptive study based 
on cases of children hospitalized over 7  years from January 2008 to 
December 2014. All children having a CSVT in the imagery were included.
Results Seven cases were reported. The mean age was 5.3 years, with 
predominance in males (sex ratio = 1.3). 71.4 % of case with CSVT pre-
sented with an underlying disease: The infection was most frequently 
noted in all age groups (57.1  %), the dehydration is more common 
in infants (28.57  %), and the Behcet’s disease in 14.2  % of cases. The 
CVST were acute in 57  % of cases, subacute in 42.8  % of cases, with 
a polymorph clinical expression: intracranial hypertension syndrome 
(42.8 %), seizures (42.8 %), focal neurologic signs (85.7 %) and distur-
bances of consciousness (71.4 %).
The CVST diagnosis was made by a cerebral CT (computed tomogra-
phy) (direct or indirect signs) in 71.4 % of case and by a CT angiogra-
phy (when CT was non conclusive) in 51.4 % of cases.
The superficial venous systems was involved in 42.8  % of cases and 
extended in 28.5 % of cases.
The antithrombin therapy was prescribed in 28.5  % of children, cor-
ticosteroid therapy in 14.2  % of cases and an etiologic treatment 
(antibiotic treatment for cases involving infection + correction of rehy-
dration…) in 85.7  % of cases. The evolution was favorable in 28.5  % 
of cases. Death occurred in 14 % of cases, and 42.8 % of children kept 
neurological sequelae damage.
Conclusion Compared to the data of the literature, the CVST is char-
acterized by the large diversity of clinical presentations and etiologies. 
The small number of patients who received a treatment by antithrom-
botic does not provide a conclusion based on statistically solid results. 
However, the prognosis remains dreadful against the death risk and 
the sensorineural sequelae.
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Table 29 Mean intracranial pressure (± SD) before, and in the 4 h post‑hyperosmolar bolus
* Repeated-measures ANOVA
Agent Pre-bolus 1 h 2 h 3 h 4 h P*
Mannitol (20 %) 28.2 ± 6.6 21.2 ± 7.8 21.9 ± 6.3 22.9 ± 6.0 23.9 ± 5.0 0.016
Hypertonic saline (3 %) 25.3 ± 5.4 23.0 ± 6.0 19.1 ± 6.5 19.6 ± 5.7 20.9 ± 7.1 0.047
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Introduction pCRRT use has grown in recent years in paediatric inten-
sive care unit (PICU) and with the demands for adequate intensive 
care staffing levels. Because pCRRT number per year is low, the weight 
range of patients is very large (from <3 to >60 kg), and the turnover of 
nurses is high, the provision of a safe and sustainable pCRRT service, is 
a big challenge in PICUs. A pCRRT working group was created in August 
2014 to perform a training programme and to go with a switch in CRRT 
device. We evaluated this programme after the first operating year.
Materials and methods Staff (doctors and nurses) training pro-
gramme was organised twice a year (2 sessions each time). Each ses-
sion (7  h and 30  min) consisted of theoretical aspects of CRRT and 
practical simulation (low-fidelity) with peer feedback about assembly 
and troubleshooting of alarms and presentation of new visual tools. 
Fifty-two nurses (80  %) with more than 6-month experiences were 
trained during the first year.
Results A test (n  =  29 nurses) was realised in September to evalu-
ate theory and practical knowledge (6 months after the last session). 
Questions concerning theory of pCRRT were correct in 38  % and 
incomplete in 45.7  %. Questions about alarms management had the 
lowest ratio of correct answers with only 16.5 and 61.4  % of incom-
plete answer. However, a majority was more confident to manage 
children on pCRRT after theoretical teaching (72.1 %) and simulation 
(86.2 %).
Conclusion Post-programme assessment was positive, but anxiety 
about knowledge and practice persisted. Consolidation of skills and 
implementation of the training course with high-fidelity simulation, 
especially alarms management scenario, will be interesting to offer the 
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Introduction Informatics improvement and electronic device expan-
sion have led to massive data collection at bedside over the past dec-
ades. Thanks to the information systems and network architecture 
already available through fully electronic charting in our paediatric 
intensive care unit (PICU) at CHU Sainte Justine, we collected cardi-
orespiratory and clinical data within an electronic database (EDtb).
Patients and methods With the CHU Sainte Justine ethical commit-
tee approval, all patients under 18 years old admitted in the PICU were 
included. All data from admission to discharge were gathered in the 
EDtb. Cardiorespiratory data were collected from monitors every 5  s, 
thanks to the Mirth software, and every 30 s from mechanical ventila-
tors and infusion pumps. Data were then anonymized prior to organi-
zation in tables.
Results Between May 21 and September 10, 2015, 260 patients 
were included. The EDtb contained 3 categories of data: 24 841 592 
entries from the cardiac monitors for a storage volume of 21 GO, 
and 2 tables of 56,351,811 and 2,624,480 entries from the ventila-
tor and infusion pumps for a storage volume of 8GO and 340MO, 
respectively.
Discussion The EDtb will soon be linked with the electronic medical 
record of critical care patients. The EDtb will then be able to reproduce 
the patients`entire ICU course (perpetual patient) and be searchable 
for research purposes. The primary objective of this EDtb is to serve as 
virtual patient for the validation of computational models.
Conclusion Through an ongoing database, clinical and physiological 
data gathering in critical care and its reorganization in time can lead to 
the new concept of the perpetual patient.
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Introduction Extracorporeal membrane oxygenation (ECMO) is used 
as a rescue therapy in patients with severe and refractory respiratory 
and/or hemodynamic failure. Ideally, neonates or children candidates 
for ECMO support should be transferred to a referral ECMO center. 
However, sometimes patients are too ill to be safely moved with con-
ventional ventilator support. In these situations, ECMO cannulation at 
the referring facility and transfer by a transport ECMO team is a poten-
tially lifesaving intervention. With a 25-year experience on neonatal 
and pediatric ECMO, the pediatric intensive care unit and the pediatric 
surgery unit of the Armand-Trousseau Hospital in Paris developed in 
November 2014 a transport ECMO team. This mobile team has been 
developed in collaboration with the Robert Debré emergency trans-
port unit and the Civil Security of Paris. We report the first-year experi-
ence of this mobile team.
Patients and methods We retrospectively reviewed all neonatal and 
pediatric ECMO transports from November 2014 through September 
2015. Reviewed data included referring facility, mode and duration of 
transport, type of ECMO, clinical severity score (PaO2/FiO2, inotrope 
score) and laboratory tests (lactate, pH) before and after transport.
Results Twenty-two requests for intervention of the mobile team 
were received. In 8 cases, the team intervention was not deemed 
necessary or exceeded status. In 14 cases, the mobile team trav-
elled to the referring center. In one case the child was transported 
on conventional ventilation, and in 2 patients ECMO cannulation 
was not possible because of vascular problems. Eleven patients, 
including 4 neonates and 7 children, were transported on ECMO 
support. One patient was cannulated in our PICU and then trans-
ported to a pulmonary transplantation center. The median (range) 
run distance and round-trip duration were 117  km (4–392  km) 
and 8  h (2–13  h), respectively. Nine (81  %) transports were on 
venous-arterial ECMO and two (19  %) on venous–venous ECMO. 
Median (range) pre-ECMO cannulation pH, lactate, PaO2/FiO2 and 
inotrope score were, respectively, 7.03 (6.67–7.27), 5.5  mmol/L 
(0.6–13.8  mmol/L), 36 (24–127) and 568 (50–890). Corresponding 
post-ECMO cannulation values were 7.33 (7.17–7.43), 2.8  mmol/L 
(1–12.6 mmol/L) and 60 (0 à 310). No adverse events during ECMO 
transport were noticed.
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Discussion This first-year experience suggests that the development 
of the first neonatal and pediatric mobile ECMO team in the north 
of France. This rapidly increased activity meets a significant need for 
ECMO support in children too critically ill to be moved on conventional 
therapy. The ECMO rapidly improved respiratory and hemodynamic 
parameters allowing transportation in good conditions to our ECMO 
center. It allows children hospitalized in non-ECMO centers to benefit 
from this rescue treatment. It contributes to improve the access to the 
continuity of health care in France.
Conclusion Implantations and transportations of children on ECMO 
supports can be proposed to children with refractory respiratory or cir-
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Introduction Synthetic cathinones, beta-keto-amphetamine deri-
vates, are new psychoactive and stimulant substances with expo-
nentially increasing use since 10  years. Bath salts, often sold legally, 
contain mixtures of several cathinones like 3,4-methylenedioxypy-
rovalerone (MDPV) and mephedrone (4MMC). Toxicity of combina-
tion of two cathinones, mimicking their real use in humans, has never 
been studied. Our objective was to investigate possible synergy of 
MDPV/4MMC combination on their stimulant effects in the Sprague–
Dawley rat and analyze their mechanisms of interaction.
Materials and methods MDPV and 4MMC were synthesized in our 
laboratory. The effects of MDPV/3MMC mixture (administered by the 
intragastric route) were studied on rat locomotor activity in an open-
field using videotaping. Plasma concentrations of MDPV, 4MMC and 
their 3 major metabolites were measured using liquid chromatogra-
phy coupled to high-resolution mass spectrometry. Brain monoamine 
concentrations were determined using high-performance liquid chro-
matography coupled to fluorometry. For each animal and each time, 
we calculated the difference between the parameter value at that 
time and baseline and the area under the curve of its time course. 
Comparisons were made using two-way ANOVA followed by post-
tests using Bonferroni correction. Pharmacokinetics (PK) was mod-
eled and parameters calculated using WinNonlin® software.
Results MDPV (3 mg/kg)/4MMC (30 mg/kg) combination was respon-
sible for a significant increase in rat locomotor activity in comparison 
with saline, MDPV and 4MMC alone (p = 0.02), with a synergic inter-
action between the two drugs. 4MMC PK was not altered in the pres-
ence of MDPV, while MDPV absorption was reduced in the presence of 
3MMC without significant modifications in its half-life and clearance. 
The neurochemical study revealed significant increase in dopamine 
and serotonin but not in norepinephrine concentrations in the pre-
frontal cortex, when combining both drugs in comparison with each 
drug administered separately.
Conclusion MDPV/4MMC mixture as found in bath salts significantly 
increases locomotor activity in rats in comparison with each substance 
administered alone. Mechanisms of interaction include significant 
decrease in MDPV gastrointestinal absorption and significant increase 
in monoamine reuptake inhibition in the brain with reinforcement of 
both the dopaminergic and serotonergic profiles. However, further 
investigations at the level of the involved gastrointestinal transporters 
and monoamine transporters are required.
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Introduction Organophosphates insecticides (OPI) are commonly 
used as acetylcholinesterase inhibitor all over the word, especially in 
developing countries. OPI poisoning (OPIP) can be accidental or sui-
cidal. Its diagnosis is based on clinical presentation and decrease of 
acetylcholinesterase activity. Specific treatment is based on atropine 
for cholinergic crisis, and pralidoxime as acetylcholinesterase regener-
ator. Our study aimed to assess efficiency of pralidoxime in acute OPIP, 
concerning complications and outcomes.
Patients and methods We carried out a retrospective study of 
patients who had been admitted to our intensive care unit between 
January 1, 2010, and December 31, 2014, for occupationally related 
organophosphate intoxication. Seventy-five cases were 1.2 paired 
according to sex, age and Simplified Acute Physiology Score (SAPSII).
Results Eligible patients (39 females and 36 males) were aged of 
30 ±  17  years; their mean SAPSII was 26.5 ±  12. Dichlorvos was the 
main OPI responsible of poisoning. Muscarinic syndrome was present 
in 100  % of cases, followed by nicotinic syndrome (60  %) and then 
encephalic syndrome (20  %). The most frequent complications were 
acute pancreatitis (16  %), circulatory failure (13  %) and pulmonary 
edema (5 %). Mechanical ventilation was required for thirteen patients 
for neurological distress (n = 10) and respiratory distress (n = 3). The 
serum acetylcholinesterasic activity (AChE) rate was 571 ±  1399  UI/l 
(Nl 5000–12,000 UI/l), and the erythrocyte acetylcholinesterasic (AChE-
Er) rate was 3 ± 1 UI/ml (Nl 6–9 UI/ml of red blood cell). Pralidoxime 
was given to 25 patients (treated group) over 24 h as bolus of 5 mg/kg 
and continuous infused dose of 50 mg/kg.
The comparison between the treated group and the control showed 
no difference in complications occurrence, requiring atropine dose, 
mechanical ventilation necessity and prognosis.
Conclusion The regimens of pralidoxime use in the present study do 
not seem to be necessary in moderate dichlorvos poisoning.
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Introduction Calcium channel blockers (CCB) represent a heterogene-
ous class of drugs, which are commonly used to treat hypertension, 
arrhythmia and angina. Nifedipine is the most frequently prescribed 
CCB in our country. The aim of our study was to describe the clini-
cal presentation, the management and the outcome of nifedipine 
poisoning.
Patients and methods It was a retrospective study conducted over 
20  months, including all patients admitted to intensive care unit for 
nifedipine overdose between January 2013 and August 2015. Demo-
graphics data, details of ingestion, the clinical signs, complications and 
management were analyzed.
Results Sixty-three patients (12  M/51F) aged of 26 ±  6  years were 
eligible. Nifedipine was the only drug ingested in 30 cases (47.6 %). 
The mean ingested dose was 300 mg [100–1200]. The delay of con-
sultation period was 5 ±  4.5  h post-ingestion. Symptoms occurred 
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in 47.6  % of cases (n =  30) including digestive vomiting, dizziness, 
headache and cardiovascular disorders such as palpitation, chest 
pain and syncope. Tachycardia was the most frequent electric sign 
found in 68.3  % of patients (n =  43). Fifteen patients (28.3  %) had 
a shock which occurred on average of 6 h [2.75–9.5] after nifedipine 
ingestion and requiring vascular filling in all cases and norepineph-
rine in only 7 cases. By comparing shock and non-shock groups, only 
the ingested dose was significantly higher in shocked patients (400 
vs 200  mg, p  =  0.007). Shock was associated with prolonged ICU 
stay: 30 ± 10 h in shock group versus 20 ± 4 h in non-shock group, 
p  =  0.004. One patient with theophylline coingestion died from 
refractory shock.
Conclusion Our results confirmed that nifedipine poisoning could be 
considered as benign compared to other CCB because of their pre-
dominant vascular effect and scarcity of cardiac damage. Outcome of 
pure poisoning is generally favorable. Coingestion of other drugs with 
cardiovascular toxicity worsens the prognosis.
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Introduction 3,4-Methylenedioxypyrovalerone (MDPV), a synthetic 
cathinone with important reported toxicity and high abuse poten-
tial, has been increasingly used since the last 5 years. To date, scarce 
experimental studies have investigated MDPV-related behavio-
ral effects. We aimed at studying MDPV-related neurobehavioral 
effects according to various modalities of administration, mimicking 
human uses.
Materials and methods Sprague–Dawley rat investigation of MDPV-
induced effects on the locomotor activity, anxiety (openfield), res-
ignation (forced swimming), memory (Y-maze), hedonic status 
(sucrose consumption) and brain neurochemistry (monoamines 
content in the prefrontal cortex), using three different administration 
patterns including acute (3 mg/kg IP), binge-like (MDPV 3 mg/kg IP, 
3 times per day, 3 days) and prolonged treatment (MDPV 1 mg/kg IP, 
10 days). Plasma concentrations of MDPV and its two major metabo-
lites were measured using liquid chromatography coupled to high-
resolution mass spectrometry. Brain monoamine concentrations 
were measured using high-performance liquid chromatography 
(HPLC) coupled to fluorometry. For each animal and each time, we 
calculated the difference between the parameter value at that time 
and baseline and the area under the curve of its time course. Com-
parisons were made using two-way ANOVA followed by posttests 
using Bonferroni correction.
Results Acute MDPV administration was responsible for locomo-
tor hyperactivity with onset of stereotypies, significant decrease in 
anxiety, anhedonic status and memory impairment (p < 0.05 for each 
neurobehavioral measurement). Following binge-like MDPV admin-
istration, tolerance to immediate locomotor effects after drug with-
drawal and significant decrease in anxiety, hedonic status and food 
consumption were observed (p < 0.05 for each neurobehavioral meas-
urement). Increase in the prefrontal cortex serotonin levels occurred, 
in accordance with the observed behavioral effects. Prolonged MDPV 
treatment resulted in tolerance development after 1  week of drug 
withdrawal.
Conclusion Our results suggest MDPV-induced marked neurobehav-
ioral effects in the rat with the development of tolerance after binge-
like and prolonged repeated administration.
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Introduction Deliberate metformin poisoning was rarely reported 
in the literature. Lactic acidosis is the common complication of met-
formin intoxication, either in intentional or in incidental cases. Our 
study aims to report the experience of metformin poisoning in a spe-
cialized center of toxicology.
Patients and methods It was a retrospective study over a period 
of 7  years (2008–2015). From patient’s files, we reported the 
demographic characteristics, clinical and biological presenta-
tions and the outcomes of patients admitted to the intensive care 
department.
Results Seventy-eight patients were included. Sex ratio was 1  M/5F. 
The median age was 23 [19; 30] years (extremes 13 and 62). It was a 
deliberate poisoning in all cases. Multidrug poisoning was reported in 
67 % (n = 53) of cases. Among them, coingestion of sulfonylureas was 
the most frequent (n = 20). Median ingested dose was 10.2 [8; 17] g. 
Our patients were without history of cardiovascular disease, hepatic or 
renal failure in 93 % (n = 73). The average time of consultation was 3 
[1.6; 5] h.
Gastrointestinal disorders including nausea, vomiting and abdominal 
pain were the most reported symptoms in 57.7 % (n = 45) of patients. 
Polypnea occurred in 5.1 % of cases and hypotension in 3.8 %. Hyper-
lactatemia was noted in 51.3 % of cases (n = 40), with a mean value of 
5 ± 4 mmol/l and metabolic acidosis in 20.5 % of cases (n = 16). Clini-
cal symptoms worsen by coingestants, especially hypoglycemia with 
sulfonylureas in 9.2 % of cases (n = 7), hypotension and bradycardia 
with cardiotropics (n = 2).
Digestive decontamination was performed for 17.5  % of patients 
(n = 13): gastric lavage (n = 9) and activated charcoal in a single dose 
(n =  5). Conservative therapies were sufficient in 96  % of cases. The 
hemodialysis was performed only for three cases with severe acidosis.
The median of hospital stay was 24 [18; 38] h. There was no death in 
our cases.
Discussion The prevalence of metformin poisoning is 6.4 % of hospi-
talizations in our center.
Lactic acidosis, due to impairment of the mitochondrial respiratory 
function, is the most serious complication. But it was often sponta-
neously reversible with conservative therapies in our patients. These 
favorable outcomes may be explained by the absence of previous 
chronic conditions in our population.
Conclusion Metformin overdose is characterized by digestive symp-
toms and high plasma lactate levels. Although lactic acidosis is 
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Introduction Calcium channel blockers are increasingly used in the 
treatment of hypertension and arrhythmias. In the same way, calcium 
channel blockers poisoning is increasing in frequency, and it remains 
serious despite therapeutic progress. The aim of our work was to study 
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the epidemiology, clinical presentation, therapeutic management and 
prognosis of calcium channel blockers poisoning and to identify grav-
ity factors.
Patients and methods We conducted a retrospective study during 
6  years and 6  months, from January 2007 to June 2013 in a medical 
and toxicological intensive care unit, including cases of calcium chan-
nel blockers poisoning not associated with another cardiovascular 
drug.
Results We collected 74 cases. Sex ratio was 0.13 (9/65). Mean age 
was 22.7 ± 7.3 years (12–52 years). Fifty-five percent of patients were 
aged between 20 and 29 years. Most patients had no medical history 
(62  %). Hypertension was noted in 8  % of cases and coronaropathy 
in 1  %. In 9  % of cases, patients had history of suicide attempt. The 
agents responsible for poisoning were: nifedipine, nicardipine, amlodi-
pine, diltiazem and lercanidipine. Nifedipine was the most found 
(67 %). Poisoning was intentional in 42 % of cases and unintentional 
in 3 % of cases. The reason of ingestion was unknown in 55 % of cases. 
Patients have presented tachycardia in 92  % of cases, bradycardia in 
4  %, hypotension in 30  %, shock in 16  % and pulmonary edema in 
9 % of cases. Tachycardia was isolated in 51 % of cases. A patient has 
developed first-degree atrioventricular block, and two patients have 
manifested subepicardial ischemia. QT prolongation was noted in 
4 % of cases. Leucocytosis was found in 42 % of cases, hypokalemia in 
31 %, metabolic acidosis in 30 %, hyperlactatemia in 15 %, hypergly-
cemia in 11 %, hypocalcemia in 9 % and acute renal failure in 4 % of 
cases. Fluid replacement was conducted in 86 % of patients, vasopres-
sors in 16 % (norepinephrine in 16 %, associated with dobutamine in 
4 %, switched by epinephrine in 1 %), atropine in 3 % and mechani-
cal ventilation in 7 % of cases. Gastric lavage was performed in 11 % 
of cases. Charcoal was administrated in 34 % of cases. Gastric lavage 
and charcoal were associated in 4 % of cases. Calcium gluconate was 
used in 20  % of cases. Insulin euglycemia therapy was performed in 
4 % of cases. Most of our patients had good outcome. Only one case 
of death was recorded after 25 days of ICU stay. Hospital stay ranges 
from 1 day to 25 days (median = 1 day). Risk factors identified in the 
univariate analysis were the ingestion of nicardipine (p = 0.02; OR 5.7 
[1.4–23.2]), the ingestion of an amount superior to 150 mg of amlodi-
pine (p = 0.036; OR undefined), SAPS II score ≥16 (p < 0.0001; OR 61.6 
[10.5–358.9]), APACHE II score ≥7 (p =  0.002; OR 9 [2.3–34.5]), SOFA 
score ≥2 (p  <  0.0001; OR 135 [13.5–1347.2]), SAPS II expanded score 
≥1.9 (p < 0.0001; OR 110 [12.1–999.9]), hypotension (p < 0.0001; OR 1.6 
[1.2–2.1]), faintness (p = 0.01; OR 13.6 [1.9–94.6]), electrocardiographic 
abnormalities (p  =  0.044; OR 4.1 [1–15.8]), subepicardial ischemia 
(p =  0.033; OR 6 [3.5–10.4]), metabolic acidosis (p  <  0.0001; OR 61.2 
[7.1–525.2]), hyperlactatemia (p = 0.01; OR 21.3 [1.8–251.2]), hypocal-
cemia (p = 0.001; OR 18.4 [3–111.3]) and hyperglycemia (p < 0.0001; 
OR 13.2 [5.6–30.6]). Nifedipine ingestion was associated with less 
severe intoxications (p < 0.0001; OR 0.08 [0.02–0.3]). Multivariate anal-
ysis was inconclusive.
Conclusion Calcium channel blockers poisoning is severe and may be 
life-threatening. Its management is primarily symptomatic and must 
be early. The development of new antidotes may improve the progno-
sis of these intoxications.
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Introduction Community-acquired pneumonia (CAP) is a leading 
infectious cause of hospitalization and death among adults admit-
ted in intensive care unit (ICU). Despite advances in critical care man-
agement and antimicrobial therapy, its morbi-mortality still remains 
high. Our aims were to study characteristics and outcomes of patients 
admitted in ICU with severe community-acquired pneumonia over 
8 years.
Patients and methods It was a retrospective cohort study from Janu-
ary 1, 2008, to September 15, 2015. We described epidemiology, etiol-
ogy, treatment and outcomes of patients admitted to ICU during this 
period.
Results Three hundred and twenty-five patients were enrolled; 
the overall cumulative incidence was 85 episodes/1000 admis-
sions with progressive increase over the years. The median age 
was 59 ±  18  years and sex ratio =  3/1. Seventy-five percentage of 
patients were hospitalized from emergency room. One hundred and 
twenty-one patients had received antimicrobial treatment before 
ICU admission. Comorbidities were observed in 84  % of patients 
(253): Chronic lung disease in 59.3  %, chronic heart disease in 
40.3 %, diabetes mellitus in 21 % and immunosuppression in 9.85 %. 
Fine score was high (class IV et V) in 67.4  % of patients. The mean 
IGS II and SOFA scores at admission were, respectively, 37 and 6. 
Major criteria of ATS score were found in 72 % (more than half have 
at least 2 major criteria). All patients had an acute respiratory fail-
ure with mean P/F = 200 ± 87. Mechanical ventilation was needed 
in 64  % initially NIV for 75  % of them (n =  156). The median dura-
tion of mechanical ventilation was 3 days [1–135]. Septic shock was 
observed in 27  % (89). Radiographic finding are: alveolar infiltrate 
99 %, pleural effusion 27 %, multilobular and bilateral involvement 
in 66 and 49  %, respectively. Acute respiratory distress syndrome 
was present in 131 cases (27.6 %); it was classified as severe or mild 
(PaO2/FiO2 ≤ 150) in 75 patients. Pathogen was detected in 62 % of 
cases. It was complicated with bacteremia within 11 patients. The 
most frequent microorganisms isolated were Hemophilus influ-
enzae, Streptocoque pneumoniae, Pseudomonas aeruginosa and 
Legionella pneumophila; the respective averages were 11, 10. 7, 
4.6 and 3.4  %. More than one bacterium was identified in 14.8  % 
cases (48). All patients had empiric antibiotherapy at admission; it 
was given to 90 % of patients in the first 24 h and to 52.4 % in the 
first 6  h. Combination antibiotic therapy (betalactam  +  macrolide 
or fluoroquinolone) was prescribed in 33.8 % (n = 110). The median 
length of ICU stay was 13 ±  15  days. Mortality rate was 30  % (99). 
The common cause of death was multivisceral dysfunction 17  % 
(57). Univariate analysis showed that age ≥65 years, chronic respira-
tory disease, respiratory failure, septic shock at admission, bilateral 
involvement and bacteremia were predictive factors for mortal-
ity. Multivariate analysis showed that only multiorgan failure was 
an independent factor related to ICU mortality [OR 0.95; 95  % CI 
(0.214–1.11)].
Conclusion Our study confirms that CAP requiring hospitalization in 
the ICU is associated with high mortality. Presence of multiorgan fail-
ure at admission is the major factor for worse prognosis.
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Introduction
Background Community-acquired pneumonia (CAP) is a leading 
cause of mortality in intensive care units. It has not been determined 
whether CAP is associated with increased mortality among patients 
with specific pathogens as Streptococcus pneumoniae.
Purpose To compare demographic, clinical data, therapeutic and out-
comes of patients admitted to our ICU for pneumococcal community-
acquired pneumonia versus other microorganisms.
Patients and methods
Methods It was a retrospective study, which included 325 CAP over 
a period of 8 years from January 1, 2008, to September 15, 2015. We 
have defined 2 groups: GI (71 pneumococcal pneumonia) and GII (254 
other microorganisms).
Results
Results No significant difference was found in mean age (60 vs 
57 years), sex ratio (2.19 vs 3.09), IGSII (38 vs 37), and SOFA score (5 in 
two groups). Comorbidities such as diabetes and COPD were more 
frequent on group I. All patients had an acute respiratory failure. At 
admission, radiographic findings were similar in two groups. In group 
I, Streptococcus Pneumoniae was isolated in respiratory samples in all 
cases. Positive pneumococcal antigenuria was detected in 92.5  %, 
which allowed an early appropriate antibiotic therapy. CAP was associ-
ated with bacteremia in 50.7  % in pneumococcal group versus 31  % 
in second group. Initially, patients in group I were more severe: 18 % 
had an acute respiratory distress versus 12 %; 62 % needed mechani-
cal ventilation versus 64  %; 31  % had septic shock versus 26  % and 
acute kidney failure (50.7 vs 41 %). These differences were not signifi-
cant. Delay of starting antibiotic was shorter in group I with a median 
of 5.22  h versus 15.68 (p =  0.004). All strains of pneumococcal were 
susceptible to penicillin. Median duration of mechanical ventilation (8 
vs 10) and length of ICU stay (13 vs 17 days) were shorter in group I. 
Mortality rate was similar in two groups (30.6 vs 31.4 %).
Conclusion
Conclusion In comparison with other microorganism, pneumococ-
cal community-acquired pneumonia requiring hospitalization in ICU 
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Introduction L. pneumophila pneumonia is a rather frequent patho-
gen of community-acquired pneumonia (CAP) and can lead to severe 
complications such as septic shock, acute renal failure and ARDS, 
requiring admission to the ICU. Its rapid diagnosis has become easier 
using the urinary antigen detection.
Patients and methods We reviewed demographical, clinical, radiolog-
ical, biological and outcome data from all patients presenting to the 
emergency department with CAP, and who had a positive urinary anti-
gen for type 1 L. pneumophila and/or positive L. pneumophila cultures 
between 2009 and 2014. We compared data from patients admitted to 
the ICU and those admitted to the ward. Both univariate and multivari-
ate analysis were performed to identify risk factors for ICU admission.
Results Except for one patient, all received an initial antibiotic ther-
apy containing an anti-legionella antibiotic (macrolide or quinolone). 
Comorbidities frequently associated with L. pneumophila CAP were 
heavy smoking (43.7  %), cardiovascular disease (34.5  %), immune 
suppression (29.9  %), alcoholism (28.7  %), diabetes (23  %), and neo-
plastic disease (20.7 %). Of these 87 patients, 31 were admitted to the 
ICU, whereas 56 patients were sent to the ward. The CURB65 score was 
not found to be statistically different between the 2 groups. Patients 
admitted to the ICU had a significantly higher proportion of chronic 
pulmonary disease (mainly COPD), 29 versus 8.9  %, higher plasma 
urea, percentage of band forms, procalcitonin levels, a lower plasma 
albumin, blood lymphocyte count, PaO2/FiO2 ratio, arterial pH, and 
a multilobar pneumonia (4 quadrants, 45 vs. 3.6  %). Hospital mortal-
ity was higher in ICU-admitted patients (38.7 vs. 12.5  %, p =  0.005). 
Patients admitted to the ICU required mechanical ventilation (87.1 %) 
for a median duration of 6  days, 25.8  % received inhaled NO, 22.6  % 
CVVHD, 19.4 %, glucocorticoids for ARDS, and 12.9 % prone position-
ing. 67.7 % developed septic shock. Only 2 patients developed a pneu-
mothorax requiring drainage. A multivariate analysis identified plasma 
urea (adjusted odds ratio (aOR) per 1-unit increment 1.12 [95  % CI 
1.03–1.23], p = 0.01), percentage of band forms (aOR per 1-unit incre-
ment 1.09 [1.03–1.17], p  =  0.006), and a multilobar pneumonia (OR 
24.80 [4.10–149.88], p  <  0.0001) as independent predictors for ICU 
admission.
Discussion L. pneumophila CAP remains a serious condition frequently 
requiring admission to the ICU, with hemodynamic, ventilatory, and 
renal support, particularly those with preexisting lung disease. Some 
of these patients also required specific therapies such as inhaled NO, 
prone positioning, and glucocorticoids. Patients admitted to the ICU 
were also severely hypoxemic.
Conclusion High plasma urea, band forms, and a multilobar pneumo-
nia are independent risk factors for ICU admission in patients present-
ing with L. pneumophila CAP. In contrast, the CURB65 score did not 
identify high-risk patients. Mortality of patients admitted to the ICU 
was 3.1 times higher than that of patients admitted to the ward.
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Introduction The descending necrotizing mediastinitis is a very seri-
ous infectious disease life-threatening in 30–40  %. The prognosis 
depends on the speed and type of care, the patient’s condition at the 
time of diagnosis. The purpose of this study was to report the expe-
rience of our intensive care’s department in the management of this 
disease.
Materials and methods This is transversal study area between 2011 
and 2015 relating 60 patients treated for complicating the descending 
necrotizing mediastinitis facial cellulitis. We excluded from this study 
mediastinitis complicating postoperative mediastinitis and cases of 
cellulitis limited to the cervical region.
Results The mean age was 27 years. We identified 12 diabetics, 6 cases 
in pregnancy and 30 cases of anti-inflammatory prior decision. Fifty-
four patients had dental entrance door so that was a cervical metallic 
foreign body. The gaseous accounted for 60 %, while 40 % phlegmon-
ous. In 50 % of cases, the infection was polymicrobial. Involvement of 
the anterior mediastinum was observed in 70 % of cases, the average 
posterior mediastinum and in 20 %, one case of pericardial and pleural 
effusion and 5 cases of pleuresy. The postoperative course was marked 
by the death in 10 cases by septic shock or following an extensive 
infectious pneumonitis.
Discussion The descending necrotizing mediastinitis is very serious 
infections whose mortality remains high. The most of the deaths are 
in keeping with a cardiovascular collapse, a septic shock or a visceral 
multi-failure. The clinical diagnosis is easy when the clinical picture is 
complete but is often evoked with delay. The germs most frequently 
isolated is cocci Gram with which the antibiotic treatment has to 
cover Bacilli to negative Gram, the anaerobic germs, the hulls with 
positive Gram and must be of long term. The surgical care must be 
the most earliest to evacuate the abscesses. The supervision operating 
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comment is before all private hospital and is done in an middle of 
reanimation.
Conclusion Mediastinitis secondary to extension of head and neck 
cellulite remains a redoubtable complication burdened with a high 
mortality rate; the diagnosis is often mentioned with delay stage sep-
tic shock. The surgical management should be as early as possible.
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Introduction Leptospirosis is a major public health concern in Reun-
ion Island and in the other French overseas territories. The clinical 
manifestations are extremely varied (from flu-like condition to mul-
tiorgan failure), and significant mortality is described in some parts 
of the world. The pulmonary forms have a major impact on patients’ 
prognosis. The objective of this study is to describe characteristics of 
patients with leptospirosis presenting acute respiratory distress syn-
drome (ARDS) criteria, therapeutic approach and mortality risk factors 
in this specific population.
Patients and methods A retrospective study of 28 patients with lep-
tospirosis and ARDS at University Hospital of Reunion Island (Saint-
Denis) was performed from May 2004 to April 2015.
Results Demographic, clinical, biological and therapeutic data were 
collected. A mortality risk factors bivariate analysis was performed 
in 24 men and 4 women aged 42  ±  18, and IGS 2 to admission of 
58 ± 21. Hemorrhagic pulmonary forms are the most frequent (89 %) 
and mortality is 25 %. In situation of massive hemorrhagic syndromes, 
desmopressin was used in 11 patients: hemoptysis was under control 
and nine of them left the unit alive. Five patients underwent circula-
tory/respiratory support (ECMO). 80 % (ECMO) and 82 % (desmopres-
sin) survival rates are observed with these two therapeutics alone or 
associated. Last, seven biological parameters are independently asso-
ciated with mortality (survivors vs non-survivors for each parameter): 
total bilirubin [135 ± 147 vs 403 ± 359 μmol/L (p = 0.01)], transami-
nases: AST [159 ± 176 vs 256 ± 134 UI/L (p = 0.04)] and ALT [77 ± 60 
vs 216 ± 189 UI/L (p = 0.02)], prothrombin time [82 ± 12 vs 58 ± 29 % 
(p = 0.05)], base excess [−1 ± 5 vs −11 ± 8 mmol/L (p = 0.002)], potas-
sium [3.4 ± 0.4 vs 4.2 ± 1.1 mmol/L (p = 0.02)] and lactate [3.4 ± 3.6 vs 
12.8 ± 7.4 mmol/L (p = 0.002)].
Conclusion ARDS development is very important in severe lepto-
spirosis prognosis. Quick identification of clinical and laboratory 
parameters on admission can contribute to early establishment of pro-
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Introduction Leptospirosis is the most widespread zoonotic disease 
in the world. Its incidence is particularly important in the French over-
seas territories, including Guadeloupe. This study aims to characterize 
organ failures in patients with severe forms of leptospirosis.
Patients and methods This is a retrospective study conducted 
between November 2009 and November 2014 in the ICU of Pointe à 
Pitre University Hospital in Guadeloupe. All patients admitted to inten-
sive care during this period with a confirmed diagnosis of leptospirosis 
were included. We collected demographic, physiological, biological and 
radiographic data for each patients as well as sequential assessment 
of SOFA score of each organ on D1, D3, D6, D9, D12 and D15. Severe 
organ failure was defined by a SOFA score of 3 or 4. Univariate analysis 
was performed to identify organ failures associated with mortality.
Results Sixty-one patients were included, of whom 90.2 % were male, 
with a median age of 54  years [41–66]. A severe organ failure was 
met in renal, liver, hematological and hemodynamic failure in 66, 58, 
53 and 39 % of the patients, respectively. Mechanical ventilation was 
needed in 38 % patients, renal replacement therapy in 48 % and vaso-
active drugs in 52 %.
ICU and hospital mortality were 20 % and 23 M %, respectively. In uni-
variate analysis, factors associated with hospital mortality were SASP 
II, chronic hypertension, hyperlactatemia, mechanical ventilation and 
renal replacement therapy. Organ dysfunctions associated with mor-
tality are given in Table 30.
Conclusion Organ failure predominantly met in severe forms of lep-
tospirosis is kidney, liver and hematological failure as historically 
described in Weils triade. All but respiratory failure at day 1 is associ-
ated with mortality but none of them at day 3.
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Introduction Treatment of pre-eXtensively drug-resistant tuber-
culosis (pre-XDR-TB, i.e., resistant to isoniazid, rifampicin and 
fluoroquinolone or second-line injectables) and eXtensively drug-
resistant tuberculosis (XDR-TB, i.e., resistant to fluoroquinolones 
and second-line injectables) is a challenge because it needs a net-
working and a specific organization of care, to avoid the spread of 
mycobacteria, like it is specified in several reports, like that of the 
Haut Conseil de Santé Publique of December 2014. Pre-XDR and 
XDR-TB patients are managed in our university medical ICU, in neg-
ative pressure containment rooms with reverse air. We report our 
experience for the management of this population of pre-XDR and 
XDR-TB patients.
Patients and methods We collected data carried on pre- and XDR-TB 
patients hospitalized in our university medical ICU, between July 2012 
and July 2015: epidemiology, tuberculosis and treatment history, indi-
cation of surgery if required, events during post-surgery period, delay 
of sputum smear conversion and mortality.
Results Twenty-one tuberculosis patients were hospitalized in our 
ICU since 3 years: 11 XDR-TB (52 %) and 10 pre-XDR-TB (48 %). Two 
lived in France since more than 10  years, while others came from 
the Caucasus. The mean age was 34.8  ±  9  years. The body mass 
index was 19.75 ±  4.12. Fourteen percentage did not receive any 
treatment before the diagnosis in France; 86  % received at least 
five antibiotics molecules and on average 7.93; the mean period of 
antibiotic treatment before ICU admission was 112 ±  74  days. On 
admission, 6 patients (39  %) had converted their sputum smear. 
Among the 21 patients, 5 were admitted for vascular access com-
plications and 1 for acute respiratory distress. Fifteeen patients 
(71 %) were admitted for surgical reasons: The using of surgery was 
decided because the sputum cultures remained positive for 66  % 
of them and for irreversible pulmonary damages in the other cases. 
The surgery consisted of a lobectomy for 9 patients and pneumo-
nectomy for 6 patients. One patient had a life-threatening com-
plication during the surgery (bleeding by artery wound). Thirteen 
(87  %) were extubated in few hours, while 2 patients have been 
intubated for 6 and 20  days. During the immediate post-surgery 
period, 2 patients experienced an extra-pulmonary complication, 
while 4 had postoperative complication: 2 atelectasis, treated with 
medical care, 1 fistula and 1 pleural bleeding, needed a second sur-
gery. Among the 21 patients, 5 were admitted for vascular access 
complication and 1 for acute respiratory distress. Ninety-five per-
centage of patients were alive on leaving the ICU. For now, 1 medi-
cal patient died because of a septic shock; 2 surgical patients (13 %) 
died, 3 (20  %) are cured, 1 is lost sight and 8 (53  %) are always 
under treatment and are followed. Among 10 surgical patients 
whose sputum smear remained positive, 9 converted their sputum 
smear in a median time of 45 days. Among 5 medical patients, the 
median sputum smear conversion was observed in 143  days after 
the beginning of treatment. Among every patient, there was no 
complication attributable to the specific organization of care, in 
particular the conditions of containment.
Conclusion The management of pre- and XDR-tuberculosis patients 
is binding, time-consuming and resources consuming, needing a very 
specific organization of care. Experience shows that an ICU stay does 
not generate more complications for these tuberculosis patients and 
can improve their global outcome.
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Introduction The effectiveness of magnesium sulfate for tetanus 
treatment has already been proven in several studies [1–4]. However, 
despite the existing data regarding this treatment, the adverse reac-
tions remain the only fright, sometimes severe, suchlike respiratory 
depression, caused their stop being abandoned.
Objectives: To assess the relationship between the profit and the risk 
due to the treatment comparatively to diazepam during our daily teta-
nus management in adults.
Patients and methods The present study compares a series of 63 
patients with tetanus, who were treated by magnesium sulfate versus 
a historical serioes of 67 patients with tetanus, who were convention-
ally treated with diazepam. It took place within the reanimation multi-
service room of the provincial general referral hospital of Kinshasa in 
the Democratic Republic of the Congo (August 2013 through Septem-
ber 2015). All the consecutive patients, of over 15 years of age, admit-
ted for tetanus management during the study period were included, 
without any selection. Patients with kidney failure, shock or well 
known as allergic to magnesium sulfate were all excluded. Apart from 
the treatment of muscular spasm, all the patients in both groups were 
identically managed in accordance with their usual treatment as pro-
vided by the unit. The collected data were performed retrospectively 
from the medical forms of all the control patients and prospectively 
for the study group. The decisional main criterion was the total end of 
muscular spasm for effectiveness delay and the occurring frequency of 
adverse reactions for tolerance. The statistical data were obtained via 
SPSS software 21.0. This study was recorded at the Ethical Office of the 
School of Public Health of the University of Kinshasa, approval date: 
ESP/CE/043/2014.
Results Between the two groups, all the patients globally presented 
the same features. The average age was 31.54 y-o ± 16.56, and 72 % of 
those patients were males. The complete spasm stops were obtained 
in short course when treated by magnesium sulfate (5.8d  ±  1.5 vs 
9.8d ± 2.6; p = 0.000). The occurrence of respiratory depression was 
minimally observed in the category treated by magnesium sulfate (19 
vs 46.3 %, p = 0.001). This situation clearly showed the decrease use of 
mechanically based ventilation (12.7 vs 35.8 %, p = 0.002). Moreover, 
the duration of stay in resuscitation room decreased for this category 
(9.3d ± 1.8 vs 22.6d ± 10.1; p = 0.000), with the reduced risk of sepsis 
(14.3 vs 31.3 %; p = 0.023). Finally, the hospital mortality of any origin 
was also significantly weak for this group of patients treated by mag-
nesium sulfate (25.4 vs 50.7 %; p = 0.004).
Conclusion During our study, the balance profit risk was favorable to 
magnesium sulfate comparatively with diazepam. This molecule, even 
though slightly expensive, requires a good monitoring and frequent 
and rigorous control of tendinous reflexes, the respiratory beats, as 
well as the diuresis in order to primarily detect any overdosage.
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Introduction Over 20,000 people were infected during the 2014 Ebola 
fever outbreak in West Africa, with a mortality rate of approximately 
40 %.
The authors, who participated in two missions in various treatment 
units in Guinea and Liberia, systematically reviewed the literature and 
provide a historical perspective on the delivery of care in Ebola treat-
ment units.
Patients and methods We systematically reviewed published articles 
that described the clinical management of patients infected by Ebola 
virus since 1976. We compared with reports on the 2014 West African 
outbreak with previous publications and describe historical trends in 
monitoring, treatment and prognosis.
Results Since 1976, monitoring and treatment of patients treated 
within Ebola treatment units have not evolved. Monitoring of vital 
signs after the day of admission is never documented. Supportive care 
measures, such as fluid and electrolyte therapy, titrated to compensate 
losses, are also not mentioned. Survival has not significantly improved 
over time.
In contrast, in another filovirus infection, Marburg hemorrhagic fever, 
which is very like Ebola fever, mortality rate was approximately 25 % in 
Germany (1967), but approximately 80 % in sub-Saharan Africa.
Discussion As reported, monitoring and treatment of patients isolated 
in Ebola treatment units have not evolved since early reports. This 
potentially explains why mortality rates have remained high. Failure to 
ensure proper monitoring of vital signs and correction of fluid losses 
and electrolytes anomalies appears suboptimal and misaligned with 
clinical description of severe shock that are consistent across time.
Expert recommendations for monitoring and treatment remain 
unchanged since 1976. Our inability to comply with these recommen-
dations in Africa may explain why outcomes are poor, whereas survival 
was much higher, even during early outbreaks, in Europe.
Conclusion Improving the delivery of care for the next outbreak or a 
resurgence of the current Ebola fever outbreak will require that we col-
lectively address the issues of accountability.
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Introduction Ventilator-associated pneumonia (VAP) remains a 
significant complication of mechanically ventilated patients. VAP is 
associated with costs, increased duration of mechanical ventilation 
(MV), ICU stay and mortality. Our project aimed at decreasing the 
incidence of VAP using a multifaceted quality program, a bundle 
of care composed of 10 measures introduced stepwise, including 
selective oropharyngeal decontamination (SOD) with topical 
antibiotics.
Patients and methods The incidence density of VAP (number of 
VAP/1000 ventilation days in patients ventilated for ≥48  h) was 
measured monthly before the introduction of the VAP bundle (base-
line period, 8  months) and every month thereafter (implementa-
tion period, 11  months). VAP was diagnosed as “probable” if the 
patient had clinical, biological, and radiological signs of pneumonia 
(CPIS ≥ 6), and a potential pathogen in tracheal aspirates after 48 h of 
MV. VAP was “certain” if a pathogen was cultured ≥10E3 in BAL fluid 
obtained by a protected Combicath® catheter or ≥10E4 by bronchos-
copy. The bundle was introduced sequentially in blocks: first block: 
hand hygiene, bed head >30°, oral care using chlorhexidine mouth 
wash, daily evaluation of separation from the ventilator, daily awak-
enings, early mobilization, and use of the Combicath® to diagnose 
VAP; second block: implementation of endotracheal tubes with sub-
glottic aspiration and cuff pressure maintained ≥30 cmH2O using an 
automatic controller; third block: SOD administration TID containing 
colistin, tobramycine and nystatin. Small groups teaching allowed 
to train >90 % of the caregivers to the bundle within 3 months after 
the beginning of the implementation period. The compliance of the 
nurses to each measure of the VAP bundle was assessed 4  days per 
week during all study period in all intubated patients. A prevalence 
study of antibiotic resistance in stool bacteria was performed each 
month in all ICU patients.
Results Episodes of intubations ≥48 h were 318 (baseline period) and 
468 (implementation period). The compliance of nurses to the ele-
ments of bundles significantly increased during the implementation 
period for bed head >30°, oral care, cuff pressure ≥30 cmH2O, evalu-
ation of extubability, daily awakenings, use of subglottic endotra-
cheal tube, and use of SOD. The monthly incidence density of VAP 
(“probable” + “certain” VAPs) was 21.5 ± 7.8 before versus 10.8 ± 5.6 
VAP/1000  days of ventilation after the implementation of the bun-
dle (p  =  0.003). During the last 4  months, after the introduction of 
the SOD, the incidence density of VAP was 5.3 ± 1.4 VAP/1000 venti-
lation days. The number of first episode of VAP fell from 20.1 to 9  % 
(p < 0.0001). The median duration of mechanical ventilation in patients 
intubated ≥48 h fell from 7.14 (before) to 6.36 (after) days (p = 0.004). 
The use of Combicath® to diagnose VAP increased from 54 (before) to 
81  % (after, p =  0.003), with a concomitant increase in “certain” VAP 
diagnoses, from 56 to 88 % (p = 0.001). In monthly prevalence studies, 
the rate of fecal multiresistant bacteria was similar before and after the 
beginning of the SOD.
Discussion The implementation of VAP bundles based on measures 
recognized to prevent the development of VAP has invariably shown 
to decrease the incidence of VAP. Herein, we show that it is possible 
to significantly decrease the incidence density of VAP using a block 
of “classical” preventive measures, including the use of endotracheal 
tubes with subglottic aspiration and cuff pressure controller. The addi-
tion of SOD to the preventive measures was associated with further 
decrease of the VAP incidence density, constantly below 10 VAP/1000 
ventilation days since SOD introduction. This resulted in a significant 
decrease in the duration of mechanical ventilation in this patient pop-
ulation. The increase in the use of Combicath® in patients suspect of 
having VAP resulted in an increase of the diagnosis of “certain” VAP.
Conclusion A multifaceted program implementing sequentially meas-
ures known to prevent VAP was able to significantly decrease the 
incidence of VAP by more than half and to significantly decrease the 
duration of mechanical ventilation.
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Introduction Ventilator-associated pneumonia (VAP) is the most 
frequently encountered hospital acquired infection in the patients 
subjected to mechanical ventilation (MV). Significant mortality and 
prolonged length of stay (LOS) are generally related to VAP. Oral care 
including antiseptic agents application is part of bundles likely to 
prevent VAP. Tooth brushing efficacy is, however, controversial. We 
hypothesized that implementation of an enhanced oral care protocol 
including tooth brushing could reduce VAP incidence. Ventilator-asso-
ciated pneumonia (VAP) is the most frequently encountered hospital-
acquired infection in the patients subjected to mechanical ventilation 
(MV). Significant mortality and prolonged length of stay (LOS) are 
generally related to VAP. Oral care including antiseptic agents applica-
tion is part of bundles likely to prevent VAP. Tooth brushing efficacy is, 
however, controversial. We hypothesized that implementation of an 
enhanced oral care protocol including tooth brushing could reduce 
VAP incidence.
Patients and methods We conducted a before–after study includ-
ing all the patients admitted to our ICU and submitted to MV for at 
least 48  h during the “before” (April 1 to December 31, 2013) and 
the “intervention” period (April, 1 to December 31, 2014). Standard 
care in our ICU relied on basic oral care with chlorhexidine 0.5 % 6 
times a day. Intervention consisted on the implementation of a new 
oral care kit including tooth brushing and oral cleansing solution 
containing chlorhexidine 0.12 % (Q-Care®, Sage products, Cary, IL). 
Other infection control interventions were not modified between 
the 2 study periods. VAP occurrence was recorded prospectively 
during both periods as well as relevant clinical data. The primary 
outcome was VAP density of incidence expressed as the number 
of episodes/1000 MV days. The secondary outcomes were ICU LOS 
and mortality.
Results Three hundred and three patients (2714 MV days) and 304 
patients (3032 MV days) were analyzed during the “before” and the 
“intervention” periods, respectively. According to the study period, 
they were comparable regarding age, gender, main diagnosis and 
SAPS II value. Fifty-eight VAP episodes were recorded before the inter-
vention as compared to 41 after. As a result, VAP incidence was sig-
nificantly lower after intervention (13.5 vs. 21.4/1000 MV-days; odds 
ratio = 0.63 [0.42–0.94], 95 % CI; p = 0.029). However, neither LOS (9.9 
[13.0] vs. 8.7 [10.4]; p = 0.21) nor mortality (39.1 vs. 33.0 %; p = NS) was 
significantly reduced.
Conclusion Implementation of a new oral care kit including tooth 
brushing in our ICU was likely to significantly reduce VAP incidence, 
highlighting the need for a tight control of oral hygiene in the patients 
subjected to MV, as part of VAP prevention bundles.
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Introduction Ventilator-associated pneumonia (VAP) is the most 
frequent nosocomial infection in the ICU and has a clear impact on 
patient outcome (duration of mechanical ventilation, length of stay 
and mortality). The aim of this study is to evaluate the impact of a mul-
tifaceted VAP prevention program on VAP rates in a medical–surgical 
ICU in a secondary care hospital.
Patients and methods We conducted a retrospective observational 
monocentric study for two 6-month study period (from January to 
June, 2013 and 2014). All patients admitted in the ICU for more than 
48  h were included. The “Bundle” program involved all healthcare 
workers and included educational sessions, direct observations with 
performance feedback, and reminders. The bundle focused on a few 
number of targeted measures: Subglottic aspiration, tracheal cuff pres-
sure monitoring, gastric overdistension avoidance, backrest elevation, 
chlorhexidine oral hygiene, nonessential tracheal suction elimination, 
sedation protocols, hand hygiene and glove and gown use. VAP was 
diagnosed on the basis of clinical and radiological criteria and quan-
titative cultures of distal specimens. The primary outcome was the 
VAP rate. Secondary outcomes included compliance rates with bundle 
measures, patient outcome and risk factors for VAP in our population.
Results We included 189 patients in 2013 and 171 in 2014. Patient char-
acteristics and comorbidities were similar between the two study periods 
(average age 62 years, average IGS2 = 44.8, average SOFA max = 6.35). 
Our population was composed of 64 % of medical patients, with 40 % 
of them admitted for respiratory failure as main diagnosis. Our ICU also 
had trauma patients, with 6 % of them admitted for severe head injury. 
Compliance with preventive measures significantly increased between 
the study periods (overall compliance: 2.2  % versus 38.8  %; p  <  0.001). 
Among intubated patients (105 in 2013, 108 in 2014), mechanical ven-
tilation duration was higher during the intervention period (9.7 ± 6.9 vs 
7.4 ± 5.5 days; p < 0.05). Baseline and intervention VAP rates were 18.7 
and 24.4 per 1000 ventilator days, respectively (p = 0.71). However, dura-
tion of mechanical ventilation without VAP was longer in the interven-
tion group (8.7 ± 7.5 vs 6.9 ± 5.0 days; p < 0.05). VAP risk factors in our 
population were: ARDS, severe head injury, duration of mechanical venti-
lation. The only protective factor was antibiotic therapy at admission.
Conclusion A multifaceted bundle program for VAP prevention did 
not reduce VAP rates but increased duration of mechanical ventilation 
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Introduction Healthcare-associated infections (HAI) are important 
causes of morbidity and mortality in intensive care units (ICUs) and 
mostly caused by multidrug-resistant (MDR) bacteria. The aim of this 
study was to evaluate the potential effect of chlorhexidine (CHX) bath-
ing on HAI and MDR bacteria acquisition incidence rates.
Patients and methods This observational prospective study was con-
ducted in an ICU over a 10-month period, divided into two 5-month 
periods: a control period (CP: September 9, 2013, to January 30, 2014) 
during which patients were bathed in the traditional manner with 
soap and water, an intervention period (IP: September 9, 2014, to 
January 30, 2015) during which patients were bathed daily with 2 % 
CHX-impregnated wipes. Incidence rates of ICU-acquired bloodstream 
infection (BSI), ventilator-associated pneumonia (VAP), catheter colo-
nization, and MDR bacteria acquisition were collected and compared 
among the 2 study periods.
Results Two hundred and fifty-three patients were included in the 
study with 121 during the CP and 132 during the IP. Age, sex, SAPSII 
score, duration of mechanical ventilation and length of ICU stay did 
not differ significantly across the 2 periods. ICU-acquired BSI rates per 
100 patients were 7.6 in IP versus 12.4 in CP (p = 0.2). Infections rates 
stratified by type were as follows: catheter-associated BSI: 3 cases in CP 
and none in IP; VAP per 100 ventilated patients: 19.5 in IP and 16.3 in 
CP (p = 0.6). During the CP, BSIs (15) were caused in 41 % of cases by 
gram-positive, in 35 % by gram-negative species, and in 24 % by fungi. 
During the IP, BSIs (10) were caused in 50 % of cases by gram-positive, 
in 40  % by gram-negative, and in 10  % by fungi. Rates of colonized 
central lines per 100 catheters were 1.8 in IP versus 5.5 in CP (p = 0.07). 
MDR bacteria acquisition rates were 6.1 and 9.1 % in IP and CP, respec-
tively (p = 0.33). Methicillin-resistant Staphylococcus aureus, extended 
spectrum beta lactamase bacteria, MDR Pseudomonas aeruginosa and 
Acinetobacter baumannii accounted, respectively, for acquisition inci-
dence rates per 100 patients of 0.8, 4.9, 3.3, 2.5 and 2.3, 2.3, 1.5, 0 % in 
CP and IP; differences were not statistically significative. Overall mor-
tality rates of patients of CP and IP were 22 and 17 %, respectively.
Conclusion CHX daily cleansing did not induce a significant but only 
a slight reduction of ICU-acquired BSI, catheter colonization, and MDR 
bacteria acquisition incidence rates. Further and larger studies are 
required to confirm its effect as a component of an infection preven-
tion bundle in ICU settings.
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Introduction Multi-drug-resistant pathogens, and specifically third-
generation cephalosporin-resistant Enterobacteriaceae, represent a 
major issue in hospital. In intensive care unit (ICU), Gram-negative 
pathogens that are resistant to antibiotics by production of extended-
spectrum beta-lactamase (ESBL) are responsible for longer hospitali-
zations and poorer outcomes. The epidemiology of ESBL-producing 
enterobacteriaceae (PE) has been recently modified by the emergence 
of new ESBL. In the absence of new broad-spectrum molecules, it is 
crucial to control antibiotic consumption and prevent transmission 
between ICU patients. Our 12-bed ICU is made of three units of 2 twin 
bedrooms each so that recommendations on contact precautions 
cannot be thoroughly followed, since patients cannot be isolated in a 
single room. In our unit, contact precautions focus on hand washing 
with hydro-alcoholic solutions, on wearing a single-use gown before 
entering the room and on the use of gloves for soiled contacts. In this 
prospective study, we report the colonization and transmission rates 
of ESBL-PE in order to study whether this peculiar form of ICU with 
twin bedrooms could be responsible for increased transmission rates 
of ESBL-PE among ICU patients. Our secondary objectives were to 
describe the epidemiology of ESBLs in our ICU and to identify risk fac-
tors for their transmission.
Patients and methods This pure observational study based on our 
usual practices was prospectively conducted in the 12-bed ICU of a 
university hospital (Ambroise Paré, Boulogne-Billancourt, France), 
organized as a six twin bedrooms divided into three units. Inclusion 
criteria were: 1) adult patients and 2) a hospitalization for a period dur-
ing which the patient was nursed by at least two paramedical teams. 
Characteristics of patients at admission (age, sex, SAPSII) and clinical 
data during hospital stay (duration of mechanical ventilation, duration 
of ICU stay, outcome) were collected. Microbiological data concerning 
colonization and/or acquisition of ESBL-PE were monitored, as usu-
ally done in our unit, by rectal swabs collected at admission and once 
weekly for the whole duration of the ICU stay. Each strain of ESBL-PE 
was then identified and the enzyme type sequenced by PCR.
Results From June 2014 to April 2015, 580 patients were admitted in 
the ICU, among which 448 (77 %) were included in the study. On the 
132 patients excluded, 27 patients were admitted for a conventional 
hemodialysis, which is conducted in a special room and 105 patients 
(among which 29 died) were nursed only by one paramedical team.
Mean age was 65 ± 16 years, and mean IGS II was 47 ± 21. Sixty-one 
percent were male. The mean duration of ICU stay was 7.4 ± 8.8 days, 
and the mean duration of mechanical ventilation was 4.5 ± 8.1 days. 
Origin of patients was home/emergency for 49 % of them and another 
unit or hospital in 51 %.
The rate of ESBL colonization at admission was 13.2  %, mainly with 
Escherichia coli. The incidence of ESBL transmission among patients 
who were monitored by two or more rectal swabs was 4.3  % (11 
patients on 251), also mainly with Escherichia coli. Mortality did not 
differ for patients colonized or not with ESBL at admission, nor for 
patients for whom a transmission occurred during the ICU stay. In this 
cohort, neither the colonization with ESBL-PE, nor the transmission 
of ESBL-PE was associated with antibiotic exposure or hospitalization 
during the three months before admission.
Conclusion Prevalence of ESBL colonization in our ICU was 13.2  %, 
Escherichia coli being the most frequent bacteria identified. This rate 
of ESBL carriage on admission was comparable to other rates in French 
ICUs (15 %). Despite the unfavorable twin-bed architecture of our ICU, 
the incidence of ESBL acquisition was 4.3 %, which was actually lower 
than transmission rates previously published in other ICUs. Our results 
question whether the strict isolation in single bedrooms plays a major 
role for the prevention of ESBL transmission in ICU. They rather put for-
ward the crucial role of hand washing with hydroalcoholic solutions 
and of the gown for the prevention of ESBL-PE transmission. This study 
seems to corroborate many studies, suggesting that the routine con-
tact isolation could be challenged in a non-epidemic setting and that 
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Introduction Patients benefiting from a liver transplantation are sys-
tematically placed in a postoperative protective confinement during 
5  days (unit protocol, no institutional guideline). This confinement is 
realized for a variable period according to the teams on the grounds 
that immediate postoperative period is a time of major pharmacologic 
immunodepression and acquired because of the surgical stress.
Literature’s data do not allow to standardize these measures.
Patients and methods We have retrospectively analyzed data from 
liver transplant recipients from January 2012 to December 2013 in our 
intensive care unit. The type of hepatopathy and the severity at admis-
sion were collected. We have also gathered bacterial colonization data 
before and after the transplantation by distinguishing the multire-
sistant bacteria and the sensitive germs. Finally, we have recorded the 
time for these bacteria to appear after surgery.
Results During this period, 32 patients benefited from a liver trans-
plant. Among them, 9 (28 %) had fulminant hepatitis and 23 (72 %) an 
acute-on-chronic liver disease decompensation. The IGS II score upon 
admission was, respectively, 48 and 51. Bacterial colonization before 
and after surgery is shown in Table 31.
Twenty-one (66 %) patients acquired new germs during isolation time. 
The unit protocol of 5 days was followed in 7 (22 %) cases.
Discussion Patients having a chronical hepatopathy have a more 
frequent bacterial colonization due to preoperative sensitive germs. 
Indeed, infection is often the triggering factor of decompensation. 
This difference is not significative for resistive germs. The confinement 
period was often extended arbitrary (i.e.,: without reason justifying 
not to respect the protocol); nonetheless, we observe the acquisition 
of a lot of new bacteria during this time independently of the initial 
hepatopathy.
Conclusion An early postoperative protective confinement imme-
diately after liver transplant does not prevent the acquisition of new 
bacteria. The reason behind this practice is therefore questionable, 
and randomized trials are necessary to allow a conclusion on the inter-
est of such a practice.
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Introduction The cranberry fruit (Vaccinium macrocarpon) is par-
ticularly rich in polyphenols (tannins), and among these, the primary 
active compound is the A-type proanthocyanidin (cPAC), which exhibit 
potent antibacterial properties. In a previous study, we have made evi-
dence of the strong inhibitory effect of cPAC on growth, adhesion and 
virulence of oropharyngeal and lung isolates of E. coli [1].
The present study was undertaken to establish a baseline of knowl-
edge of the molecular responses of the highly virulent E. coli strain 
536 during growth in the presence of cPAC. We employed proteomic 
analysis and made complementary experiences to characterize the 
global response of exponential and stationary phases E. coli 536 grown 
in a nutrient-rich broth medium supplemented with 1 mg/mL, cPAC as 
compared with a reference culture grown without cPAC.
Materials and methods E. coli 536 exposed or not to 1 mg/ml of cPAC 
proteome was obtained in exponential and stationary growth phase 
by mass spectrometry proteomic analysis LC–MS/MS.
Evaluation of the intracellular ROS level by the dichlorofluorescein 
diacetate DCFH-DA method was evaluated using a spectrofluorimeter. 
Membrane potential, cell size and cell viability were evaluated using 
a flow cytometer (Guava EasyCyte Plus, Millipore). To examine the 
changes of membrane potential after cPAC exposure, the cells were 
stained with DiOC6(3) (3,3′-dihexyloxacarbocyanine iodide) and then 
immediately analyzed using a flow cytometer. The fluorescence-based 
LIVE/DEAD kit was used to examine the cell viability.
Results A total of 641 proteins were detected, and among these, 483 
were in both exponential and stationary growth phases, whereas 506 
and 618 proteins were detected only during the exponential and sta-
tionary growth phases, respectively. Proteins were manually grouped 
into 25 metabolic pathway categories. Among the 641 identified pro-
teins, 117 had a significant effect, and among these, 11 were in both 
exponential and stationary growth phases, whereas 68 and 60 proteins 
were detected only during the exponential and stationary growth 
phases, respectively. Considerable differences were also observed in 
protein abundances between the untreated and treated cells. During 
the exponential and stationary growth phases, many proteins were 
over-abundant (31 and 29, respectively) and under-abundant (37 and 
31, respectively).
The characterization of 117 proteins with a significant effect revealed 
that more proteins were over-abundant in different functional catego-
ries, especially those involved in glycolyse, fermentation, iron metabo-
lism and detoxification. In contrast, the under-abundant proteins were 
mainly implicated in transport, TCA cycle and respiration.
cPAC exposure mainly affected the pathways of iron metabolism with 
strong evidence of iron privation, cellular detoxification as response 
to the oxidative stress exerted by cPAC and a redirection of respira-
tory metabolism through the fermentative pathways. cPAC treatment 
also alters many membrane functions by the strong inhibition of 
membrane proteins transport and secretion, affecting the respiratory 
chains, fimbrial expression, cell division and proton-motrice force.
Supplementary experiments showed no effect of cPAC on bacterial 
viability, a size increase as result of cellular division inhibition and a 
drastic reduction of the proton-motrice force.
ROS dosage showed a significant decrease during stationary phase 
of growth in cPAC treated bacteria as response to the oxidative stress 
exerted by proanthocyanidins.
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Conclusion Proteomic analysis indicates the metabolic pathways 
affected by cPAC and E. coli adaptation. Treated bacteria are in a state 
of iron limitation, energy metabolism is redirected to fermentation 
and membrane proteins secretion and transport systems strongly 
inhibited. As a result, we observe a fimbriation inhibition affecting 
bacterial mobility, adhesion and virulence and alteration of the pro-
ton-motrice force and cellular division in E. coli. Our results highlight 
strategy adapted by E. coli 536 to resist the toxicity of tannins. During 
exposure to cranberry, E. coli is subjected to complex metabolic adap-
tations that aim to reduce the rate of intracellular ROS. The lack of pro-
duction of fimbriae caused by cranberry contributes to the permanent 
activation of the oxidative stress response.
Competing interests None.
Reference
1. Margetis, D., D. Roux, et al. (2015). “Effects of Proanthocyanidins on Adhe‑
sion, Growth, and Virulence of Highly Virulent Extraintestinal Pathogenic 
Escherichia coli Argue for Its Use to Treat Oropharyngeal Colonization 
and Prevent Ventilator‑Associated Pneumonia.” Crit Care Med 43(6): 
e170–8.
P168  
Is daily measurement of CRP useful to detect earlier 
ventilator‑associated pneumonia?
Justine Simonet1, Mathieu Boutonnet1, Jean‑Louis Daban1, Elisabeth 
Falzone1, Guillaume Dumas1, Philippe Vest2, Vincent Peigne1
1Réanimation, Hôpital d’Instruction des Armées Percy, Clamart, France; 
2Biochimie, Hôpital d’Instruction des Armées Percy, Clamart, France 
Correspondence: Vincent Peigne ‑ vincentpeigne@yahoo.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P168
Introduction C-reactive protein (CRP) is widely used as a biomarker 
of infection in ICU patients in spite of a lack of data supporting this 
practice. We evaluated whether the routine measurement of CRP 
could be a tool to detect ventilator-associated pneumonia (VAP) in a 
12-bed unit where VAP is diagnosed using bronchoscopy and where 
CRP was measured on a daily routine in all patients until January 
2015.
Patients and methods Before–after study led during two 6-month 
periods, with or without daily measurement of CRP. We compared 1) 
the delay between intubation and the diagnosis of VAP and 2) the 
number of bronchoscopy performed during the two periods.
Results In total, 152 and 153 patients were included during the peri-
ods with and without daily CRP measurement, respectively. Mor-
tality rate was 16 and 20  % (p 0.47). The number of patients who 
developed VAP during the two periods was 12 and 19 (p 0.19), and 
the mean time between intubation and VAP was 6.3 and 8.9 days (p 
0.52). The proportion of contributive bronchoscopy was 18 and 26 % 
(p 0.25).
Conclusion We could not identify any significant difference in the 
delay of diagnosis and the use of bronchoscopy during the periods 
with and without daily measurement of CRP. However, there is a trend 
toward an earlier diagnosis with an increased use of endoscopy when 
CRP is routinely measured. Further studies including more patients 
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Introduction Healthcare-associated meningitis is described as indo-
lent, with poor symptomatology and mildly inflammatory biology [1]. 
Bacteria responsible belong mostly to cutaneous commensal flora, 
especially coagulase-negative staphylococci (CNS); these germs have 
the ability to adhere to indwelling medical devices and to persist in 
biofilms, but lack classical virulence factors. Thus, they are considered 
as low or accidental pathogens and could be the reason behind those 
clinical and biological features. The main objective of this study was to 
compare clinical and biological characteristics of CNS meningitis with 
those of real pathogens healthcare-associated meningitis. The sec-
ondary objectives were to collate their bacteriological data and their 
outcome.
Patients and methods This retrospective study included consecu-
tive bacterial healthcare-associated meningitis admitted to University 
Medical Center Henri Mondor, in Créteil (France), between January 
2007 and December 2014. Patients were divided into two groups: CNS 
and real pathogens (control group). The diagnosis of meningitis was 
based on isolation of a bacterium in one cerebrospinal fluid culture, 
as reiterated by Mayhall et al. [2]. We decided to add an exception for 
CNS: Two positive samples with the same strain (same antibiotype) 
were necessary for the diagnosis. Infections due to other low patho-
gens (Corynebacterium spp and Propionibacterium spp) were 
excluded, as well as those complicated by an abscess or an empyema, 
or without appropriate antibiotic treatment. We compared demo-
graphic characteristics, clinical, biological and bacteriological profiles 
between two groups with Mann–Whitney and Fisher’s tests. Mortality 
was analyzed with Kaplan–Meier method.
Results Seventy-one meningitis were identified, 18 CNS and 53 con-
trols. Patients in both groups were not different in terms of age, sex, 
comorbidities, reason for admission, initial severity and presence of 
neurosurgical device. CNS meningitis occurred within a median of 
17 days after surgery, versus 12 days for the control group (p = 0.029). 
The Glasgow coma score at time of diagnosis was 14 among CNS infec-
tions versus 13 among controls (p  =  0.038). The cerebrospinal fluid 
analysis revealed less pleocytosis (18 versus 1330 white cells per mm3, 
p < 0.001), less polymorphonuclear neutrophils (55 vs. 90 %, p < 0.001), 
higher glucose level (4.1 vs 0.8 mmol/L, p < 0.001) and lower protein 
level (482 vs 1608 mg/L, p < 0.001) in the CNS group. In terms of bac-
teriology, CNS meningitis was more often bacteraemic than controls. 
Finally, the survival probabilities at 28 days and 1 year were more ele-
vated in the CNS infections.
Conclusion The indolent, paucisymptomatic and mildly inflammatory 
nature of healthcare-associated meningitis is related to one dominant 
low pathogen, the CNS. The lack of virulence of this bacterium could 
also explain a relatively low mortality.
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Introduction Acute pulmonary embolism (APE) is a rare life-threaten-
ing complication. Prognosis prediction often challenges the clinician, 
even assisted with different scores. Electrocardiographic (EKG) abnor-
malities, even polymorphous and with poor specificity have not been 
widely investigated in this issue.
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Objective: To assess the prognostic value of EKG abnormalities in 
patients with acute pulmonary embolism.
Patients and methods We performed a retrospective analysis includ-
ing all patients admitted to ICU between 2004 and 2014 with a con-
firmed diagnosis of APE. Patients’ characteristics were recorded, 
especially regarding catecholamine’s use, ventilator support and vital 
status at discharge. Pulmonary Embolism Severity Index (PESI), pro-
posed by the European Society of Cardiology, was calculated. Patients 
with PESI class ≥3 were considered with high early mortality risk. First 
available EKG records were used for analysis to identify signs of right 
ventricular strain, arrhythmias and repolarization disorders.
Results Twenty-eight patients with APE were collected. Mean age was 
54.6 ± 19.2 years. Fifteen patients (53.6 %) had high risk of early mor-
tality (PESI class ≥3). Fourteen (50 %) had received mechanical ventila-
tion and 15 (53.6 %) had received catecholamines. Mean ICU stay was 
5.39 ± 4.74 days. Thirteen patients (46.3 %) died in the ICU. There was 
no significant difference between deaths and survivals regarding EKG 
abnormalities. However, arrhythmia was more frequent in patients 
with high PESI (p = 0.007). Multivariate analysis failed to identify any 
independent electric predictor of ICU mortality probably because of 
the small sample size.
Conclusion In a selected population of APE critically ill patients, EKG 
abnormalities failed to demonstrate any prognostic predictive value. 
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Introduction Norepinephrine is a widespread used catecholamine in 
the hemodynamic management of septic shock. As under-dosage or 
overdosage can be harmful for the patients, it is necessary to maintain 
mean arterial pressure (MAP) in preset bounds. We hypothesized that 
setting a MAP alarm on the cardiovascular monitor could lead to a bet-
ter correlation between effective MAP and prescribed targets.
Patients and methods During two successive periods (P1 and P2), 
patients treated with norepinephrine for a septic shock for at least 
24 h were included (n = 50 per period). The protocol of norepineph-
rine’s administration was similar during the two periods including the 
prescription of MAP targets for all patients with a 10  mmHg range 
(e.g., 65–75 mmHg). Effective MAP and doses of norepinephrine were 
stored every hour. During P2, a MAP alarm was set on the cardiovas-
cular monitor with upper and lower bounds corresponding with pre-
scribed MAP targets.
Results During the study period, 460 patients were admitted in the 
ICU. Of them, 134 (29  %) had a septic shock. Baseline characteristics 
of the 100 (22 %) patients who met the inclusion criteria were similar 
among both periods (sex ratio: 1.4; age: 67 ± 15 years; IGSII: 59 ± 18). 
Time spent out of MAP preset ranges was significantly lower in P2 
when compared to P1: 27 ± 2 and 53 ± 2 %, respectively (p < 0.0001). 
MAP was higher than the upper limit of the target in 31 ± 3 % of time 
in P1 and 15 ± 1 % in P2 (p < 0.0001). MAP was under the target limit 
in 22 ± 2 % of time in P1 and 11 ± 18 % in P2 (p < 0.001). MAP alarm 
leads nurses to change more frequently the dose of norepinephrine 
to maintain MAP in the target during P2 (p < 0.01 vs P1). MAP alarm 
did not decrease norepinephrine dose during the first day of admin-
istration as compared to P1 (0.50  ±  0.07 vs 0.47  ±  0.06  μg/kg/min, 
p = 0.75). In the same way, MAP alarm did not accelerate withdrawal 
of norepinephrine and did not reduce length of stay and mortality 
(p = NS).
Conclusion Our study suggests that setting MAP alarm could enhance 
time within a MAP target range and therefore may prevent patients 
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Introduction Predicting fluid response is an important issue in ICU. 
Within the scope, the interest of monitoring continuously right atrial 
pressure (RAP) and periodically pulmonary wedge pressure (PWP) 
has been challenged. Dynamic change of pulse pressure during a res-
piratory cycle (ΔPP) has been proposed as an alternative in sedated, 
mechanically ventilated patients. However, in postoperative car-
diac surgery, the consequences of the extracorporeal circulation on 
lung compliance and the thoracic effusion/drainage may alter the 
relationships between intra-alveolar and heart extra-wall pressures. 
We designed this study to assess the predictability of monitorable 
preload indices to changes in cardiac performance during a fluid 
challenge.
Patients and methods This is a single-centre prospective cohort 
study. We included all consecutive patients who required a pulmonary 
artery catheter according to our standard protocol. We performed 
a complete hemodynamic analysis immediately after surgery, while 
patients were still under anaesthesia (baseline, H0). Three sequen-
tial fluid boluses of 5  ml/kg were eventually performed if RAP or 
PWP < 20 mmHg. After each fluid bolus, another hemodynamic stand-
point was collected (H1, H2 and H3). For each fluid challenge, initial 
preload indices were RAP, PWP and ΔPP. The fluid-induced cardiac per-
formance changes were: cardiac output (ΔCO), mean aortic pressure 
(APm), mean pulmonary artery pressure (PAPm), left ventricle power 
(ΔLVPW) and right ventricle power (ΔRVPW). LVPW was derived as CO 
x APm and RVPW by CO x PAPm. In order to identify the best possible 
predictor, a systematic analysis of all possible couples of thresholds 
was done using the S ratio [1].
Results Forty-two fluid challenges were realized in 17 patients. 
Twelve were men (66  %), and age was 68.9 ±  11.4 y. The number of 
grafts, valves, and combined surgery were 7, 6, and 4, respectively. Left 
ventricle ejection fraction was 37 ±  15. Right ventricle function was 
considered normal in 14 patients, 14 patients received inotropic sup-
port. Table 32 summarizes the R values of correlations between initial 
preload indices (columns) and fluid-induced change in cardiac perfor-
mance (lines), *p<0.05, ** p<0.01.
The best correlation was observed between RAP and ΔLVPW. Among 
all possible couples of thresholds, the S ratio selected RAP < 10 mmHg 
as predicting ΔLVSW > 42 g.m. with a selectivity of 0.63 and a specific-
ity of 0.61.
Discussion Although the small number of patients limits the analysis, 
possibly leading to a bias of selection, the number of correlated vari-
ables was suitable for showing a clinically relevant correlation, which 
was not observed. The systematic analysis of best couples of thresh-
olds did not allow identifying a good predictor of fluid responsiveness.
Table 32 See text for description
ΔCO ΔAPm ΔPAPm ΔLVPW ΔRVPW
DPP 0.08 0.03 0.19 0.10 0.05
RAP 0.33* 0.16 0.17 0.42** 0.38*
PWP 0.25 0.28 0.19 0.28 0.33*
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Conclusion Although low values of RAP and PWP were correlated with 
fluid responsiveness, and conversely, our study confirmed that RAP 
and PWP were poor predictors of preload reserve. ΔPP is not a valid 
alternative in postoperative cardiac surgery.
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Introduction Pulse pressure variation (PPV) is the most validated 
test among the different dynamic predictors of fluid responsiveness 
[1]. Nevertheless, testing its reliability depending on the hemody-
namic conditions of use remains poorly studied. Norepinephrine as a 
vasoactive drug interferes on both systemic arterial rigidity and pulse 
pressure (PP). These changes might subsequently alter PPV’s ability 
to predict fluid responsiveness. We therefore thought to study the 
prediction’s accuracy of this test among a very homogenous selected 
group of ICU patients with PPV’s validity criteria and mean arterial 
pressure (MAP) restored between 65 and 90 mmHg using norepineph-
rine. PPV was therefore modified into a new index called “optimized 
PPV” in which diastolic arterial pressure (DAP) was integrated, consid-
ering that it can account for the vasoconstrictor effect of norepineph-
rine. We then compared the respective performances of these two 
tests in this specific ICU population.
Patients and methods Patients monitored by transpulmonary ther-
modilution PiCCO2
® system and whose MAP was between 65 and 
90 mmHg using norepinephrine were prospectively included. Hemo-
dynamic parameters (as well as arterial pressure, cardiac index (CI) 
and PPV) were collected serially in six different conditions: at baseline, 
before and after an end-expiratory occlusion (EEO) test, before and 
after a passive leg raising (PLR) test, and lastly after volume expan-
sion (VE) (500 mL saline). We studied the diagnostic accuracy of PPV, 
stroke volume variation (SVV), EEO test and PLR test for predicting the 
response to volume expansion (i.e., VE-induced increase in CI ≥15 %). 
From PPV, we performed two additional tests:
- the product of PPV by DAP (PPVxDAP),
- a composite index obtained from a logistic regression model 
adjusted on PPV and DAP called “optimized PPV.”
For each test, we evaluated its diagnostic accuracy using its area under 
the ROC curve (AUC) and its 95 % confidence interval (95 % CI).
Results Thirty-four VE tests were collected, concerning 26 VE respond-
ers (76 %) and 8 VE non-responders in 25 patients (age 62 ± 13 years; 
SAPS 2 61 ± 21). At baseline, mean MAP, PPV and CI were, respectively, 
77 ± 7 mmHg, 11 % ± 5 and 2.94 ± 0.93 L min−1 m−2 for a mean nor-
epinephrine dose of 1.09 ± 3.06 µg kg−1 min−1.
During the 34 procedures, EEO test, PLR test and VE increased signifi-
cantly the CI by 8 ± 8 %, 12 ± 23 and 22 ± 15 %, respectively.
With a threshold of 13  %, PPV showed the lowest sensitivity of all 
tests (see Table 33). The sensitivity was increased when reducing the 
threshold to 8  %. Taking into account DAP as well as PPV increased 
both sensitivity and specificity: “Optimized PPV” (given by the formula: 
0.57xDAP +  0.56xPPV) reached the best performance with a AUC of 
94 % (95 % CI 87–100 %), while PPV got only 75 % (95 % CI 49–100 %), 
p < 0.05.
Conclusion In a selected group of ICU patients with PPV’s validity cri-
teria and whose MAP is restored between 65 and 90 mmHg using nor-
epinephrine, PPV is an inefficient test to predict fluid responsiveness. 
Optimizing the PPV through a composite index including DPA, seen as 
a reflection of the vasoconstrictor effect of norepinephrine, improves 
its performance under such conditions of use.
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Introduction Bedside monitoring of tissue perfusion is mandatory 
in septic shock. Macrovascular indices [mean arterial pressure (MAP), 
cardiac index (CI)] and microvascular parameters (base excess BE, lac-
tate, mixed (SvO2) or central venous oxygen saturations (ScvO2) have 
been utilized to evaluate the perfusion status and the effectiveness of 
resuscitation process. Recently, the central venous-to-arterial carbon 
dioxide Gap (P(v − a)CO2) and the P(v − a)CO2/arterial–venous oxygen 
content difference ratio (P(v − a)CO2/C(v − a)O2) have been proposed 
as additional resuscitation targets.
Aim
To analyze the correlations between hemodynamic, oxygenation and 
tissue perfusion values in septic shock.
Patients and methods Thirty patients with septic shock were pro-
spectively enrolled. All patients were resuscitated following the 
Table 33 Performances of each test to predict the fluid responsiveness. Results are given as percentage (95 % confidence 
interval)
Test used Threshold Sensitivity Specificity PPV NPV
PPV 13 % 19 (4–34) % 88 (65–100) % 83 (54–100) % 25 (9–41) %
PPV 8 % 73 (56–90) % 75 (45–100) % 90 (78–100) % 46 (19–73) %
SVV 13 % 23 (7–39) % 75 (45–100) % 75 (45–100) % 23 (7–39) %
EEO 6 % 69 (51–87) % 75 (45–100) % 90 (77–100) % 43 (17–69) %
PLR 10 % 66 (47–83) % 75 (45–100) % 86 (76–100) % 50 (23–77) %
PPVxDAP 432 92 (82–100) % 75 (45–100) % 92 (82–100) % 75 (45–100) %
Optimized PPV 36 92 (82–100) % 88 (65–100) % 96 (88–100) % 78 (51–100) %
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Surviving Sepsis Campaign guidelines. Transpulmonary thermodilu-
tion (TPTD) was used to monitor CI, oxygen delivery (DO2) and con-
sumption (VO2). Simultaneous blood samples were obtained from 
a central venous line and an arterial catheter. Correlations between 
macrohemodynamic and metabolic parameters were explored with 
the Pearson test. Two-tailed P  <  0.05 was taken to indicate statistical 
significance.
Results Between March 2015 and August 2015, 30 septic shock 
patients (sex ratio M/W 1.5) were studied. The average age of the 
patients was 57 ± 19 years. The sources of infection were as follows: 
the lungs (n = 13), the urinary tract (n = 10), the abdomen (n = 5) and 
the central nervous system (n =  2). The mean SOFA score at T0 was 
10 ± 4 points, and the mean IGS2 score was 54 ± 23.
We investigate the relationship between hemodynamic variables and 
metabolic parameters (Table 34).
There was a significant correlation between ScvO2 and P(v  −  a)
CO2 (r = −0.75, p =  0.033). Both parameters showed strong correla-
tions with oxygen extraction OER (Table 35). A significant correlation 
was found between P(v  −  a)CO2 and arterial BE values (r  =  −0.71, 
p  =  0.048). The preliminary results of our study demonstrated the 
significant impact of the cumulative inotrope index (CII) [1] on PH 
(r  =  −0.95, p  <  0.001), BE (r  =  −0.96, p  <  0.001), lactate (r  =  0.95, 
p < 0.001), P(v − a)CO2 (r = 0.74, 0.037) and OER (r = 0.71, p = 0.051). 
The CII was not related to the P(v − a)CO2/C(a − v)O2.
Conclusion All individual perfusion parameters have limitations. A 
multimodal monitoring integrating macrohemodynamic and micro-
circulatory perfusion parameters may overcome those limitations and 
rule out persistent tissue hypoxia.
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Introduction Volume status is difficult to predict in patients with 
chronic renal failure before hemodialysis. This parameter is very impor-
tant to know and to define the volume of fluid to be removed during 
dialysis.
We undertook this study to measure baseline N-terminal pro-brain 
natriuretic peptide (NT-pro-BNP) plasma concentration and weight 
gain derived for “dry weight” and to correlate their levels with changes 
in levels of NT-pro-BNP and weight before and after dialysis.
Patients and methods Over 8  months (February 2014–September 
2014), a prospective, observational study was performed in an 18-bed 
medical surgical intensive care unit at Tunis Military Hospital. Patients 
under hemodialysis (HD) treatment for end-stage renal disease (ESRD) 
were included in this study. All patients were on regular dialysis treat-
ment for at least 6 months, had no residual kidney function and under-
went a 4 h HD session 3 times a week. Patients with clinical evidence 
of congestive heart failure (CHF) (NYHA class III and higher) were 
excluded. Dry weight was determined by a clinical approach. Weight 
and levels of NT-pro-BNP were measured immediately before and after 
hemodialysis. The correlation between weight changes during the ses-
sion and variation of levels of NT-pro-BNP before and after hemodialy-
sis was studied.
Results A total of 22 patients were included. The mean age was 
50 years. There was a significant reduction in the values of weight after 
HD compared to the values before HD (p = 0.001). There was a signifi-
cant reduction in NT-pro-BNP levels after HD compared to the values 
before HD (p = 0.03). Using regression analysis, we found a weak cor-
relation between change in NT-pro-BNP and weight loss (r2  =  0.43, 
p =  0.04) before and after HD. There was also a correlation between 
levels of NT-pro-BNP and weight gain relative to the dry weight before 
dialysis (r2 = 0.63, p = 0.02).
Conclusion NT-pro-BNP can be used in patients with chronic renal 
failure undergoing dialysis for the assessment of volume status, 
especially if patient’s dry weight is unknown. But it must be inter-
preted according to clinical settings, particularly in case of heart 
disease.
Competing interests None.
Table 34 Relationship between hemodynamic variables and oxygenation parameters
Ratio: P(v − a)CO2/C(a − v)O2
PH BE Lactate ScvO2 P(v − a)CO2 Ratio OER
r p r p r p r p r p r p r p
MAP 0.61 0.11 0.77 0.026 −0.78 0.023 0.96 <0.001 −0.89 0.003 −0.28 0.5 −0.88 0.004
CI 0.70 0.051 0.60 0.12 −0.59 0.12 0.21 0.61 0.053 0.9 0.04 0.92 −0.37 0.365
Table 35 Relationship between metabolic parameters
PH BE DO2 VO2 OER
r p r p r p r p r p
Lactate −0.91 0.002 −0.88 0.004 −0.5 0.21 0.35 0.39 0.70 0.054
ScvO2 0.51 0.20 0.65 0.081 0.19 0.66 −0.70 0.052 −0.92 0.001
P(v − a)CO2 −0.55 0.16 −0.71 0.048 −0.14 0.75 0.55 0.16 0.68 0.066
P(v − a)CO2/C(a − v)O2 −0.29 0.47 −0.27 0.52 −0.35 0.40 −0.30 0.48 −0.1 0.86
Inotropic index −0.95 <0.001 −0.96 <0.001 −0.53 0.17 0.31 0.45 0.71 0.051
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Introduction While colonization with multidrug-resistant bacteria is 
a frequent issue in the ICU, its impact on patients’ outcome remains 
unclear. Particularly, patients with hematological malignancies may be 
at high risk of colonization, subsequent infection and mortality, but 
convincing evidence is lacking.
The aim of our study was to assess whether colonization with MDR 
bacteria was associated with increased length of stay and mortality in 
this specific population of immunocompromised patients.
Patients and methods We performed a multicenter database study. 
Hematological patients (i.e., patients with hematological malignan-
cies) were identified in the database using the International Classifica-
tion of Diseases coding or through the specific disease-related variable 
of the SAPS II score.
Only extended-spectrum beta-lactamase-producing Enterobac-
teriaceae (ESBL-PE) or methicillin-resistant Staphylococcus aureus 
(MRSA) colonization was considered. Intestinal carriage of ESBL-PE 
and nasal carriage of MRSA were routinely screened by rectal and 
nasal swabbing on ICU admission and weekly thereafter in all partici-
pating units.
Exclusion criteria were as follows: multiple ICU stays, ESBL-PE or MRSA 
colonization on ICU admission, and length of ICU stay of <7 days.
Patients with and without ICU-acquired colonization were first com-
pared by univariate analyses. Then, a multivariate logistic regression 
model was used to test the association of colonization with mortality, 
adjusting for confounding variables such as the SAPS II score.
Results A total of 343 patients were included. Mean age and SAPS II 
score were 55 ±  16.3  years and 52.2 ±  14.4 points, respectively. The 
global rate of ICU-acquired colonization was 9.6  %. Remarkably, the 
rate of MRSA colonization was lower than that of ESBL-PE colonization 
(1.7 vs 7.9 %).
ICU-acquired colonization significantly increased the lengths of ICU 
and hospital stays (medians in days [interquartile range]: 23 [15–39] vs 
9 [7–13], and 41 [26–67] vs 29 [18–48], respectively, p < 0.001).
Although having a similar SAPS II score, ICU and hospital mortality 
rates were higher among colonized patients (28.9 vs 20.8 %, and 43.3 
vs 31.6 %, respectively, p < 0.001).
In multivariate analysis, ICU-acquired colonization remained signifi-
cantly associated with ICU and hospital mortality (odds ratio, 95  % 
confidence interval 3.58, 1.60–8.03, p  <  0.001, and 2.65, 1.18–5.92, 
p = 0.02, respectively).
Conclusion Our results suggest that, although relatively infrequent, 
ICU-acquired colonization in hematological patients is associated with 
increased lengths of stays and mortality rates.
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Introduction Pseudomonas aeruginosa (PA), a ubiquitous environmen-
tal Gram-negative bacillus, is highly endemic in intensive care units 
(ICU) and is responsible for severe nosocomial infections. Transmis-
sion pathways and reservoirs of PA in ICUs are still a matter of debate. 
However, several studies underpinned the importance of environment 
colonization to explain patient colonization with PA. The increasing 
antibiotic resistance of PA isolated from ICUs is of particular concern; 
our ICU had, for instance, a high proportion of imipenem-resistant 
(imi-R) PA. In October 2014, our ICU moved to a new place inside our 
hospital. We took advantage of this unique opportunity to study the 
effect of a change of ICU location on the proportion of imipenem 
resistance across all PA isolated from clinical samples.
Materials and methods This observational before/after study is con-
ducted over 24 months separated in 2 periods: October 2013 to Octo-
ber 2014 (before the moving) and October 2014 to October 2015 (after 
the moving). All clinical samples growing with PA were identified. We 
excluded samples drawn within the first 2  days of patient admission 
and doublets. Imipenem resistance was determined with the disk 
method and confirmed with E-test. OprD phenotype was suspected 
when PA strains were sensitive to piperacillin and ceftazidime and 
resistant to carbapenem. We analyzed also routine environmental bac-
teriological samples in water, which were drawn every 3 months in a 
constant place of the ICU. We collected defined daily doses (DDD) of 
carbapenem (except ertapenem), monthly consumption of hydroalco-
holic solution (HAS), number of admissions ≥48 h, number of mechan-
ically ventilated patients, percentage of immunosuppressed patients, 
number of intravascular catheters, mean age, mean IGS II score and 
mean mortality. Finally, individual risk factors for colonization with 
imi-R PA were assessed: previous treatment with carbapenem, history 
of recent hospitalization in ICU and immunosuppression.
Results We provide below intermediate results of the study censured 
at the end of June 2015. In the first period, there were 77 bacteriologi-
cal clinical samples positive to PA in 65 patients, and 30 in 25 patients 
in the second period, distributed as follows: lower respiratory tract 
samples (56 and 15), catheters (9 and 4), abscesses (4 and 2), blood 
samples (3 and 6) and urine samples (5 and 3). The proportion of 
imi-R PA decreased dramatically in the second period: 36 versus 10 % 
(p = 0.008). Of note, imipenem resistance appeared to be mostly due 
to an OprD phenotype in both periods (75 vs 67 %). Interestingly, we 
found isolates of PA with an OprD phenotype in routine environmen-
tal bacteriological samples in both periods. During the study, DDD of 
carbapenem was similar during the 2 periods (103 vs 108 per 1000 
patient-days), and HAS consumption was stable around 180–200 L per 
1000 patient-days. Finally, the 2 periods were comparable in terms of 
number of admissions ≥48  h (566 vs 578), number of mechanically 
ventilated patients (338 vs 340), percentage of immunosuppressed 
patients (26.7 vs 21.3  %), number of intravascular catheters (407 vs 
397), mean age (64.3 vs 65.4), mean IGS II score (50.6 vs 49.2) and mor-
tality (19.4 vs 15.4 %). Finally, the drop in imipenem resistance was not 
explained by a difference in the proportion of patients that had a pre-
vious treatment with carbapenem (7.7 vs 6.7 %), immunosuppression 
(13.8 vs 23.3 %) or a recent history of hospitalization in ICU (0 vs 2 %).
Conclusion Our results showed that a change of the ICU location 
was associated with a dramatic decrease in imi-R PA clinical isolates, 
mainly OprD phenotype. We did not observe any differences in DDD of 
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carbapenem, HAS consumption, or any other changes between the 2 
periods that could explain this drop in imi-R PA. In parallel, we isolated 
OprD mutants in routine environmental samples. Altogether these 
findings in this quasi-experimental design suggest that environmental 
source is a critical factor in PA colonization. Final results with the data 
from June to October 2015 and genotype analysis of clinical and envi-
ronmental isolates of PA are ongoing.
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Introduction In intensive care units, life-threatening bacillus infec-
tions may occur. It is a very common situation. Probabilist extended-
spectrum antibiotic therapy has to be promptly instituted. The 
spectrum of this antibiotic should include extended-spectrum beta-
lactamases enterobacteria. Because of their broad spectrum of action, 
carbapenems are the standard treatment, especially in cases of noso-
comial infections. Lately, bacterial strains have acquired resistance 
mechanisms to carbapenems, including carbapenemase production. 
Because of few therapeutic options, the occurrence of bacterial resist-
ance to carbapenems is a real public health problem. The use of car-
bapenem is limited by expert’s recommendations to limit the risk of 
therapeutic impasse. The aim is to preserve their effectiveness. The 
objective of this work was to assess the incidence and risk factors for 
resistance acquisition in an intensive care unit, while rigorously good 
use of these antibiotics was applied.
Materials and methods We conducted a prospective observa-
tional cohort study in medical and surgical ICU of CHU Toulouse 
Rangueil between May and November 2014. The patients under-
going antibiotic therapy with carbapenem more than 48  h were 
included. Biological samples were performed according to the cur-
rent practices of the service. The primary endpoint was the occur-
rence of bacterial resistance to carbapenems diagnosed between 
the beginning of the treatment and the patient discharged from 
the intensive care unit. Univariate and multivariate analyses were 
performed.
Results Of 364 patients admitted to the service, 78 were included 
in our study, 16 (20.51 %) developed a carbapenem resistance. The 
two main risk factors found were: duration of hospitalization in 
the ICU over 29  days (HR =  3.61; p =  0.01) and presence of Pseu-
domonas aeruginosa in samples taken before the start of treatment 
(HR = 5.31; p = 0.002). No carbapenemase production was observed 
in our work.
Discussion Our prospective study evaluated risk factors of carbap-
enem resistance acquisition. It is an original study because of few 
dates on this topic. Other cohort included all patients, not just patients 
treated with carbapenems. Carbapenem antibiotic therapy is known 
to increase the risk of resistance. We specifically choose to study other 
risk factors in this population. In our service, we found Pseudomonas 
aeruginosa represents a higher risk of carbapenem resistance. Tough 
bacterial ecology is variable between two ICUs. Result should be inter-
preted with caution.
Conclusion The prescription of carbapenems in intensive care has 
to respect the recommendations of experts. Regarding our results, 
attention should be paid to patients whose ICU stay is extended and 
to patients in whom bacteriological samples were positive to Pseu-
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Introduction Intestinal carriage of extended-spectrum beta-lacta-
mase-producing enterobacteriaceae (ESBL-PE) is a common issue in 
ICU patients and may be associated with subsequent infection. Thus, 
carbapenems are often administered as first-line antibiotic therapy in 
patients with prior known colonization who develop severe sepsis or 
septic shock.
However, while ESBL-PE-related infections rarely occur in patients 
without prior colonization, infections occurring among colonized 
patients may be due to other less resistant pathogens.
In this view, it would be interesting to be able to predict, which 
patients will actually develop ESBL-PE-related infections, so as to con-
trol the increasing use of carbapenems that may jeopardize their effi-
cacy in a near future. The aim of this study was to identify simple risk 
factors for subsequent infection among ESBL-PE-colonized patients, 
likely to limit the use of carbapenems as first-line antibiotic therapy in 
case of severe sepsis or septic shock.
Patients and methods We performed a retrospective study in a 
16-bed ICU of a university hospital. All patients with ESBL-PE coloni-
zation were considered, irrespective of whether colonization was pre-
sent on ICU admission or acquired during the ICU stay. Rectal swabs 
were performed on admission and on a weekly basis thereafter. The 
following data were collected: age, sex, severity scores, admission cat-
egory (medical or surgical), underlying diseases, antibiotic exposure 
within 3  months before ICU admission, invasive procedures, type of 
ESBL-PE, and outcome. The number of infected patients without prior 
colonization was also recorded.
Results A total of 239 colonized patients were screened over a 3-year 
period, of which 37 were excluded because of missed rectal swabs 
on admission. Among the remaining 202 patients, 142 (70.3 %) were 
colonized on ICU admission. Escherichia coli (n = 101, 50 %), Klebsiella 
pneumoniae (n = 59, 29.2 %), and Enterobacter cloacae (n = 39, 19.3 %) 
accounted for 98.5 % of species recovered from rectal swabs.
During the study period, only five patients developed ESBL-PE infec-
tion without prior colonization. Among colonized patients, 24 (11.9 %) 
developed subsequent infections. There was a trend toward a higher 
rate of infection for Klebsiella pneumoniae and Enterobacter cloacae 
colonization than for Escherichia coli colonization (15.3 and 17.9 vs 
7.9 %, respectively). Overall, colonized patients with subsequent infec-
tion had received more carbapenems within 3  months before ICU 
admission, had a longer time to colonization, and were more likely 
to be admitted after planned or unplanned surgical procedures than 
colonized patients without subsequent infection.
Independent risk factors for subsequent infection were: prior exposure 
to carbapenems (OR 3.40; 95 % CI 1.03–11.20), median time to coloni-
zation greater than 14 days (OR 3.76; 95 % CI 1.21–11.67), and surgical 
admission category (OR 4.05; 95 % CI 1.38–11.88).
Conclusion We were able to identify three simple risk factors that 
may be considered in clinical practice to reduce carbapenems use as 
first-line antibiotic therapy in case of severe sepsis or septic shock in 
patients with known ESBL-PE colonization.
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Reducing carbapenems use in those patients is all the more important, 
as ESBL-PE infection following colonization seems to be a relatively 
rare issue.
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Introduction Empirical antimicrobial therapy is a major issue in pneu-
monia management in intensive care unit (ICU) [1]. It can be chal-
lenging due to the presence of multidrug-resistant (MDR) pathogens, 
especially extended-spectrum β-lactamase-producing enterobacte-
riaceae (ESBL-E), with a rising incidence. Indeed, rectal colonisation 
with ESBL-E concerns 15 % of patients admitted in ICU [2]. Many ICUs 
have organised MDR pathogen screening strategies; however, the 
impact of a MDR pathogen colonisation on empirical antimicrobial 
therapy for infection is unknown [3]. Regarding empirical antimicro-
bial therapy for pneumonia, the place of carbapenem in the strategy 
is not established.
The objective was to evaluate whether ESBL-E rectal colonisation was 
predictive of ESBL-E presence in the early (≤5 days) or late (>5 days) 
respiratory samples performed in the ICU.
Patients and methods Retrospective observational study performed 
between January 2012 and August 2014 in a 21-bed surgical ICU. 
Every early (≤5 days of ICU hospitalisation) and late (>5 days) positive 
respiratory sample was collected, along with rectal swab performed 
within 48  h before respiratory sample. Positive and negative predic-
tive values (PPV, NPV) of an ESBL-E positive rectal swab to predict the 
presence of ESBL-E in respiratory sample were analysed. Early and late 
samples were analysed separately.
Results During the study period, 425 (231 early and 194 late) positive 
respiratory samples were included, corresponding to 356 patients. 
Concerning early samples, 3/231 (1.3  %) respiratory samples and 
32/231 (13.9 %) rectal swabs were positive for ESBL-E. Among the 32 
ESBL-E positive rectal swabs, 2 respiratory samples were positive for 
ESBL-E. The PPV of ESBL-E positive rectal swab was 5.9 % (2.9–8.9) and 
the NPV was 99.5  % (98.0–100.0). Concerning late samples, 26/194 
(13.4  %) respiratory samples and 66/194 (34.0  %) rectal swabs were 
positive for ESBL-E. Among the 66 ESBL-E positive rectal swabs, 20 
respiratory samples were positive for ESBL-E. The PPV of ESBL-E 
positive rectal swab was 30.8 % (24.1–37.4) and the NPV was 96.1 % 
(93.4–98.9).
Conclusion ESBL-E rectal colonisation did not predict presence of 
ESBL-E in respiratory sample performed in the ICU, especially for 
early respiratory samples. Absence of ESBL-E rectal colonisation pre-
dicted the absence of ESBL-E in early and late respiratory samples 
with an excellent NPV. This strategy could be used to reduce carbap-
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Introduction Antibiotic therapy (AT) has to be reviewed within 
3  days and adapted with regard to confirmation of infection and 
appropriateness.
Aim of the study: To audit the present practice in AT in 5 ICUs totaliz-
ing 44 beds from a tertiary hospital, to compare it between severe and 
non-severe infections, to evaluate the level of inappropriate therapy 
and its impact on the outcome of patients.
Patients and methods This was a prospective study conducted from 
March 1 to August 31, 2015. All AT begun for infection were reappraised 
at day 4. Infectious episodes were defined as confirmed or absent or 
uncertain. Treatments were classified as appropriate, inappropriate or 
not evaluable. Severe infections included severe sepsis and septic shock.
Results In total, 424 AT given to 327 patients were analyzed. Fifty cases 
were not confirmed as infectious. Among the others, there were 219 
appropriate AT (51.6 %), 46 inappropriate (10.8 %) and 109 not docu-
mented (25.8 %).
Table 36 shows the medical decisions at day 4 according to the sever-
ity of infection and the 28-day ICU mortality of all the subgroups of 
patients.
Discussion (1) Half of the infections were severe (169/374  =  45  %) 
regardless of the appropriateness of AT. (2) Appropriate AT could be 
reduced in 36 %; this did not depend on the severity of infection. (3) 
Table 36 See text for description
Medical decision 
at day 4
Not severe 28-day ICU Severe 28-day ICU
Infections Mortality Infections Mortality
219 appropriate treatments
 Continued 69 (31.5 %) 15 (21.7 %) 40 (18.3 %) 9 (22.5 %)
 Reduced 37 (16.9 %) 2 (5.4 %) 42 (19.2 %) 9 (21.5 %)
 Patient dis‑
charged
1 (0.5 %) 0 (0 %) 4 (1.8 %) 0 (0 %)
 Early death 1 (0.5 %) 1 (100 %) 25 (114 %) 25 (100 %)
 Total 108 (49.3 %) 18 (16.7 %) 111 (50.7 %) 43 (38.7 %)
46 inappropriate 
treatments
 Continued 1 (2.2 %) 0 (0 %) 0 (0 %) 0 (0 %)
 Adapted 18 (39.1 %) 4 (22.2 %) 21 (45.6 %) 6 (28.6 %)
 Patient dis‑
charged
4 (8.7 %) 0 (0 %) 0 (0 %) 0 (0 %)
 Early death 1 (2.2 %) 1 (100 %) 1 (2.2 %) 1 (100 %)
 Total 24 (52.2 %) 5 (20.8 %) 22 (47.8 %) 7 (31.8 %)
109 non‑evaluable or uncertain treatment
 Continued 20 (18.2 %) 4 (20 %) 19 (17.3 %) 5 (26.3 %)
 Stopped 3 (2.7 %) 1 (33.3 %) 2 (1.8 %) 2 (100 %)
 Changed 14 (12.7 %) 4 (28.6 %) 8 (7.3 %) 2 (25 %)
 Patient dis‑
charged
10 (9.1 %) 0 (0 %) 0 (0 %) 0 (0 %)
 Early death 2 (1.8 %) 2 (100 %) 7 (6.4 %) 7 (100 %)
 Total 49 (44.5 %) 11 (22.4 %) 36 (32.7 %) 16 (44.4 %)
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Continuation of therapy was also the same in non-documented or 
uncertain infections regardless of the severity. (4) Inappropriate AT 
occurred in 10.8 % of the cases. (5) Inappropriate AT did not increase 
early (2/46 vs 26/219 p = 0.18) or late ICU mortality (10/46 vs 37/219 
p = 0.405). (6) Mortality of severe infection was in the range of other 
European series. 7) 50  % of mortality of severe infections occurred 
unexpectedly within 3 days (33/66).
Conclusion The severity of infection did not interfere with medical 
decision regarding the step-down therapy.
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Introduction Acquired infections are common in intensive care units. 
The aims of our study were to evaluate the epidemiology of intensive 
care unit (ICU)-acquired infections and to determine potential associ-
ated factors to such infections.
Patients and methods Patients with longer than a 48-h stay in an 
adult mixed medical–surgical ICU in a teaching hospital were included. 
The incidence (per cent) and incidence density (per 1000 patient days) 
of ICU-acquired infections were analysed prospectively in a 12-month 
study. Infections were diagnosed according to Centers for Disease 
Control and Prevention definitions. Risk factors for infection were 
determined by multivariable logistic regression.
Results One hundred and thirty-nine (28.8 %) of 482 patients, whose 
ICU stay was longer than 48 h, acquired a total of 174 infections (1.25 
per patient) during their ICU stay, with an infection rate of 66 per 1000 
patient days.
The most common infections were ventilator-associated pneumonia 
(35.6  %), central catheter-related or primary bloodstream infections 
(25.7 %) and urinary tract infections (16 %).
Infections were most commonly caused by K. pneumoniae (34.2  %), 
followed by P. aeruginosa (25.1  %), A. baumannii (11.6  %) and E. coli 
(2.6 %).
Multivariate analysis showed that clinical factors associated with new 
ICU-acquired infections were age ≥45 years (p = 0.029, 95 % CI [1082–
4316], OR 2.161), surgical admission (p = 0.002, 95 % CI [1.437–5.291], 
OR 2.757), ICU length of stay more than 7  days (p =  0.0001, 95  % CI 
[5.398–17.999], OR 9.857), duration of mechanical ventilation more 
than 5 days (p = 0.002, 95 % CI [1.485–5.941], OR 2.970) and a use of 
an urinary catheter more than 6 days (p = 0.004, 95 % CI [1.487–7.804], 
OR 3.406).
Mortality among infected patients was 38.1  %, and the risk of death 
was increased as patients were infected (p  <  0.001, 95  % CI [1.782–
4.021], OR 3.784).
Conclusion ICU-acquired infections were common in a cohort of 
mixed medical–surgical patients. Only age ≥45 years, surgical admis-
sion, ICU length of stay more than 7 days, duration of mechanical ven-
tilation more than 5 days and a use of an urinary catheter more than 
6  days were found to be independently associated with these infec-
tions; they were found to have a significant effect on ICU mortality.
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Introduction The impact of nosocomial infections (NI) in intensive 
care unit (ICU) on the whole hospital stay (from ICU admission to hos-
pital discharge) is seldom studied and is still a subject of controversy. 
Large raw data collections are available on this subject among various 
prospective cohort surveys like the REA-RAISIN, OUTCOMEREA and 
INICC programs. Nevertheless, statistical modelling of the mortality 
and excess in length of stay due to these NI may be challenging and 
should explain contradictory results.
The aim of our study was to compare, among ICU patients, the risk of 
death and the hospital length of stay between those with acquired NI 
in the ICU and those without acquired NI in the ICU.
Patients and methods Data were collected continuously from 
2004 to 2014 for each patient hospitalised more than 2  days in the 
30 beds medical ICU of Strasbourg University Hospital (France). The 
surveillance focused on ventilation-associated pneumonia, central 
venous catheter-related infection or bacteraemia and bloodstream 
infection according to the French’s Survey Network for ICU-acquired 
infection protocol (Réseau d’Alerte, d’Investigation et de Surveil-
lance des Infections Nosocomiales—REA-RAISIN). The analysis 
included patient’s characteristics, devices exposure and ICU-acquired 
infections.
We merged this database with the local diagnosis-related group 
database (PMSI—Programme de Médicalisation des Systèmes 
d’Information). In this way, we obtained the full hospital stay informa-
tion, including main diagnosis, SAPSII, length of stay and mortality.
We assessed the mortality risk and the length of stay with various mod-
els: linear and logistic regressions, Cox models and multistate models.
Results In the 7465 inpatient stays, 882 (12 %) presented at least one 
NI. Mean age was statistically the same for both groups (65 years), and 
the rate of antimicrobial therapy at admission in the ICU was the same 
(79 vs. 74 %). Patients with NI were more likely men (64 vs. 56 %), had 
a higher SAPSII score (54 vs. 49) and were more likely immunosup-
pressed (31 vs. 22 %).
Crude mortality during hospital stay was, respectively, 44 and 27  % 
for patients with and without NI. The mean length of stay was more 
important for patients with NI (51  days vs. 21). This last difference 
remained significant with multistate models.
Other models did not meet the necessary validity conditions. The 
proportion of patients with NI seemed to increase slightly during the 
10 years (11 % in 2004, 14 % in 2014).
Discussion Multistate models have to be used to study this asso-
ciation because the competitive risk between the events “Death” and 
“Discharge” cannot be handled with the others statistical models. 
These multistate models seem to be underused in the literature on 
this subject. A wider use of these models should be obtained by teach-
ing them in statistical classes and by using statistical software includ-
ing them like R or SAS®.
The increase of NI rates could be due to a change of practices in this 
ICU, change in data record definition along time or a better detection.
Our systematic review of the literature on MEDLINE did not find 
another French study on this subject with such a long follow-up 
period.
The main limitations of our study are the lack of adjustment of our 
models and the monocentric data. A multicentric study and more 
comprehensive statistical models are planned in later studies.
Conclusion Our results are in favour of a significant effect of the ICU-
acquired NI on length of stay but remain unclear about a possible 
effect on mortality. This field of search is open to larger, such as multi-
centric studies or to alternative statistical models.
Competing interests None.
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Introduction Catheter-associated urinary tract infections (UTIs) are 
one the most common hospital- and intensive care unit (ICU)-acquired 
infection and are often used as healthcare quality indicator. Because 
their diagnosis is not well defined, epidemiologic data vary between 
studies, and their impact on the prognosis of critically ill patients 
remain unclear. The objectives of this study were to describe the inci-
dence and the prognosis of catheter-associated UTI in a medical inten-
sive care unit.
Patients and methods A prospective observational study was con-
ducted in the medical intensive care unit of a French University Hospi-
tal, over a period of 1 year between February 1, 2014, and January 31, 
2015. All patients admitted to the ward for at least 48 h were included.
Results Four hundred and eighty-four patients were included. 
The incidence of catheter-associated UTI was 6.4 per 100 catheter-
ized patients and 5.9 per 1000  days of urinary catheter. Among 133 
patients who had at least one urine culture during their ICU stay, those 
with a diagnosis of infection (n =  31) were more likely to be admit-
ted for a neurologic issue. They had an ICU length of stay significantly 
longer than patients without infection (24 [16–45] vs 17 days [11–27] 
p =  0.0076), and a significantly longer length of urinary catheteriza-
tion (23 [16–38] vs 17 days [11–26] p = 0.013). In univariate and mul-
tivariate analyses, the occurrence of catheter-associated UTI was not 
found as an independent risk factor associated with mortality, unlike 
age and SAPS II score at ICU admission.
Conclusion Development of catheter-associated UTI is common in 
critically ill patients. Classic criteria for diagnosis have, however, a poor 
specificity. These infections are not associated with increased mortal-
ity, and related morbidity seems to be low. Because incorrect diag-
nosis of catheter-associated UTI treatment may have economic and 
ecologic impacts, in particular by the selection pressure induced by 
unnecessary prescription and improper use of antibiotics by patients, 
diagnostic criteria in the ICU setting need to be better defined, and 
catheter-associated UTI screening could be limited to a second step of 
evaluation of fever of unknown origin.
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Introduction Automatic tube compensation (ATC) is a feature avail-
able in some ICU ventilators to compensate for the resistive work 
of breathing (WOB) due to endotracheal tube. We performed a 
systematic review and meta-analysis on the effects of ATC on physi-
ologic respiratory variables and weaning outcome.
Materials and methods We searched for automatic tube compen-
sation in PubMed and Google scholar limiting to English language. 
Hand search in the retrieved studies was also performed. Studies were 
included if there were original, performed in ICU patients intubated, 
designed as randomized between an experimental group with ATC 
and at least one control group without ATC. Abstracted forms only 
and reviews were excluded. We separated the studies into two groups: 
group 1 on weaning outcome and group 2 on respiratory physiologic 
effects. For the first group, the main endpoint was weaning failure 
defined as reintubation or death within the 48  h after scheduled 
extubation. For the second group, we analyzed respiratory rate, tidal 
volume, minute ventilation, pressure–time product of the diaphragm 
and work of breathing. Two reviewers independently screened titles 
and abstracts and analyzed included studies using a dedicated form. 
Disagreements were solved by consensus. The quality of studies 
was assessed from ten items. Data were pooled using random-effect 
model. Statistical heterogeneity across the studies was assessed by 
using I2. Sensitivity analyses were performed for specific levels of pres-
sure support ventilation. Analysis was performed by using R software.
Results Search retrieved 65 studies of which 7 were included in group 
1 and 9 in group 2. For the group 2 studies, 3 of them investigated 2 
specific groups of patients (postoperative and medical patients in one 
study, high and low ventilation in one study and with and without 
dead space in one study). We used them as independent studies lead-
ing to 12 studies in group 2.
Regarding the quality criteria for group 1 studies, 2 studies met 6 crite-
ria, 4 met 5 criteria, and 1 met 4 criteria. Regarding group 2 studies, 3 
studies had 5 quality criteria, 4 had 4 criteria and 2 had 3 criteria.
For group 1 studies, 250 patients were included in the experimental 
group (ATC + PEEP 5 cmH2O in 6 studies and ATC + pressure support 
in 1 study) and 227 patients in the control group (pressure support in 
4, CPAP in 2 and T-tube in 1). The failure of extubation was not differ-
ent between experimental and control groups (relative risk 1.02 [0.97–
1.08]). I2 was not statistically significant [I2 = 0 % (P = 0.43)].
For group 2 studies, the experimental group consisted of ATC alone in 
9 studies, proportional assist ventilation + ATC in two and APRV + ATC 
in one. The corresponding control groups were pressure support, pro-
portional assist ventilation and APRV without ATC. Furthermore, in 
the control groups with pressure support ventilation, different levels 
of pressure support were used. Therefore, we performed two sensitiv-
ity analyses. The first analysis was done for 15  cmH2O pressure sup-
port level in 5 studies, 5 cmH2O in 3 and 7  cmH2O in 1. The second 
analysis was done for 5 cmH2O pressure support level in 8 studies and 
7 cmH2O in 1. In both sensitivity analyses, there were no statistical dif-
ferences between any respiratory variable between experimental and 
control groups.
Conclusion ATC was not associated with any significant improvement 
neither in respiratory physiologic variables nor in weaning outcome.
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Introduction
Hyperoxia-induced hypercapnia has been described more than 
60  years ago [1], and first recommendations to avoid hyperoxia in 
COPD patients were provided more than 50  years ago [2]. Despite 
abundant literature on this issue, it is still overlooked and alarm bell 
was recently raised [3] after the demonstration that high oxygen flows 
could increase mortality in patients with respiratory distress even 
within short exposure such as during pre-hospital transport [4]. We 
demonstrated that in this setting, high oxygen flows were also utilized 
in our country [5], in agreement with other reports [6, 7].
Materials and methods
Objectives We developed a device that continuously adjusts the FiO2 
with high flows of air/oxygen based on the FreeO2 system that titrates 
oxygen flow delivered to patients with the aim to maintain a constant 
oxygenation [8].
Results The FreeO2 system was modified to allow a mixture of oxygen 
and air administration with a constant gas flow. The proportion of oxy-
gen is based on an advanced closed loop to maintain a constant SpO2. 
We compared in healthy subjects this new prototype with Airvo2 set 
with minimal FiO2 of 30 % (3L/min of oxygen). Both devices were set 
at 30L/min, and we plan to recruit 10 healthy subjects. The experimen-
tal conditions were the following: healthy subjects will initially breath 
with high-flow therapy in normoxic conditions (5  min), followed by 
5 min of induced hypoxemia (nitrogen administration), and return to 
initial conditions for 5 min. We record SpO2, respiratory rate, heart rate 
and FiO2 delivered.
We conducted an evaluation of automated oxygen titration during a 
longer period of 30 min with induced hypoxemia.
Discussion Data concerning the first 5 healthy subjects are presented 
here healthy subjects. Initial data demonstrate the feasibility to deliver 
variable oxygen flows administered with air at high flows (from 20 to 
60 L/min). In this study, the flow was maintained constant at 30L/min. 
During nitrogen administration to the healthy subjects, with the new 
prototype controlling oxygen/air administration, the oxygen increases 
(leading to a FiO2 increase) to maintain constant the SpO2 level (set at 
96 % in this study), and the air flow decreases to maintain constant the 
total flow (30L/min). After cessation of nitrogen, the oxygen flow (and 
FiO2) is automatically reduced. The percentage of time in the SpO2 
target (96 ±  2  %) was significantly more important with automated 
titration during the induced hypoxemia (50 vs. 24 %, P < 0.05), and the 
percentage of time with hypoxemia was reduced with automated oxy-
gen titration (11 vs. 55 %, P < 0.05).
In 4 subjects, the mean time in the target during the 30-min evalua-
tion was 94.4 %.
Conclusion
Based on the results with this specific model, this new device may help 
to optimize oxygenation to maintain adequate oxygenation and avoid 
desaturation during high-flow oxygen therapy.
Competing interests Co-fondateur et actionnaire de Oxynov.
References
1. Davies CE, Mackinnon J. Neurological effects of oxygen in chronic cor 
pulmonale. Lancet. 1949;2(6585):883–5.
2. Campbell EJ. A method of controlled oxygen administration which 
reduces the risk of carbon‑dioxide retention. Lancet. 1960;2(7140):12–4.
3. Beasley R et al. High‑concentration oxygen therapy in COPD. Lancet. 
2011;378(9795):969–70.
4. Austin MA et al. Effect of high flow oxygen on mortality in chronic 
obstructive pulmonary disease patients in prehospital setting: ran‑
domised controlled trial. BMJ. 2010;341:c5462.
5. Lellouche F et al. Pre‑hospital oxygen administration in patients with 
respiratory distress. Why do we give too much oxygen? Am J Respir Crit 
Care Med 2012 Ab.
6. Hale KE et al. Audit of oxygen use in emergency ambulances and in a 
hospital emergency department. Emerg Med J. 2008;25(11):773–6.
7. Wijesinghe M et al. Pre‑hospital oxygen therapy in acute exacerbations of 
chronic obstructive pulmonary disease. Intern Med J. 2011;41(8):618–22.
8. Lellouche F, L’her E. Automated oxygen flow titration to maintain con‑
stant oxygenation. Respir Care. 2012 Aug;57(8):1254–62.
P187  
Accuracy of ventilators for intermediate care to deliver tidal 
volume. A bench study
Claude Guérin1, Loredana Baboi1, Sarah Guegan2, Fabien Subtil3
1Réanimation médicale, Hôpital de la Croix‑Rousse, Lyon, France; 2Stagi‑
aire 5ème année, ProG’HEI, Lille, France; 3Biostatistiques, Hospices Civils 
de Lyon, Lyon, France 
Correspondence: Claude Guérin ‑ claude.guerin@chu‑lyon.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P187
Introduction There is an ongoing development of home-care turbine-
powered ventilators able to support patients with mild acute respira-
tory failure in the intermediate care environment at the hospital. The 
capability for these ventilators to deliver accurate tidal volume (VT) is 
an important endpoint for patient’s safety. In present study, we aimed 
at comparing on the bench the performance of respirators for inter-
mediate care to deliver VT.
Materials and methods The following ventilators were used: Astral 
150, Elisée 150, Trilogy 200, Monnal T50 equipped with double-limb 
circuit and Evita XL. They were set in volume-controlled mode at con-
stant flow inflation shape and connected to ASL 5000 lung model. 
Four conditions were set at the ASL.
Three adult conditions pertaining to normal [compliance (C) 60  ml/
cmH2O, inspiratory (Ri) and expiratory (Re) resistance 5  cmH2O/LS], 
COPD (C 75, Ri 15, Re 25), and ARDS (C 33, Ri 15, Re 25) profiles. Fur-
thermore, a mechanical condition pertaining to children (C10, Ri 50, 
and Re 50) was used.
For each adult lung condition, two targeted VT (300 and 500 ml) and 
two PEEP levels (5 and 10 cmH2O) were tested. For the paediatric lung 
condition, targeted VT was 50 ml.
VT was measured with Citrex H4™ (imtmedical, Switzerland) over the 
last 10 breaths of the recording at the steady state defined as changes 
in VT less than 10 % from the previous sampling window. The sampling 
rate was 200 Hz. Citrex H4™ device was calibrated before each experi-
ment and set in ATP condition. Ventilators were set in BTPS conditions. 
Values of measured VT were expressed in BTPS conditions by using the 
following correction factor [PA/(PA-Pwater)] ×  (TB/TA), in which TA is 
273 K + ambient temperature, PA the ambient pressure continuously 
measured by Citrex H4™, Pwater 47 mmHg and TB 310 K. Measured VT 
was multiplied by this correction factor to obtain corrected VT. The val-
ues of VT error (measured corrected VT-target VT/target VT*100) were 
expressed as mean ± SD. A negative VT error value means that deliv-
ered VT was lower than targeted VT while a positive value has oppo-
site significance.
Given the nature of the investigation, i.e. a bench experiment, low 
within-ventilator variability for the values of VT was anticipated, 
and hence, we a priori decided not to perform statistical tests if this 
assumption was verified. Therefore, any observed differences in means 
for VT were considered as true.
We a priori defined a ±10 % VT error as a threshold for accuracy range 
limit.
Results The VT error is shown in the table below for the different lung 
conditions across the ventilators and PEEP levels, for set VT 300 ml in 
lung adult and 50 ml in paediatric lung. Same results were observed 
for 500  ml set VT. As anticipated, the variability was very low and 




Normal COPD ARDS Children
5 10 5 10 5 10 5 10
Astral 150 6.7 ± 0 3.3 ± 0 −0.5 ± 0 −3.6 ± 0 1.9 ± 0 2.8 ± 0 0.5 ± 0 0.6 ± 0
Elisée 150 1.6 ± 0 2.4 ± 0 6.4 ± 0 4.9 ± 0 −2.5 ± 0 1.0 ± 0 −38.0 ± 0 −38.0 ± 0
Trilogy 2002.1 ± 0 0.5 ± 0 16.2 ± 0 13.2 ± 0 4.7 ± 0 2.2 ± 0 −9.0 ± 0 −10 ± 0
Monnal 
T 50
15.3 ± 0 13.7 ± 0 19.6 ± 0 16.4 ± 0 11.3 ± 0 11.8 ± 0 −29.0 ± 0 −7.0 ± 0
Evita XL −2.5 ± 0 −1.9 ± 0 −3.7 ± 0 −3.6 ± 0 −10.9 ± 0 −10.5 ± 0 −36.0 ± 0 −37.0 ± 0
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Discussion Every turbine ventilator was within the 10  % accuracy 
range to deliver VT except for Monnal that over delivered the tar-
geted VT. VT delivered by ICU ventilator was systematically lower than 
expected within the 10 % range except for the ARDS condition. In the 
children lung configuration, Astral 150 was very accurate to deliver VT 
as low as 50 ml.
ConclusionThere were differences in VT delivery across ventilators. 
Some ventilators were particularly accurate in delivering low VT.
Competing interests None.
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Introduction There is an ongoing development of home-care turbine-
powered ventilators. These can be used in the intermediate care envi-
ronment at the hospital. The capability for these home-care ventilators 
to deliver adequate FIO2 is an important endpoint for patient’s safety. 
Therefore, our goal was to measure FIO2 delivered on the bench by 
such ventilators when non-vented (double-limb) circuit was used.
Materials and methods The following home-care turbine-pow-
ered ventilators, Astral 150, Elisée 150, Trilogy 200 and Monnal T50, 
equipped with non-vented double-limb circuit or equivalent, were 
set in volume-controlled mode (tidal volume 500  ml, breathing fre-
quency 15 cycles/min, inspiratory time 0.8  s, constant flow inflation 
shape, positive end expiratory pressure 5 cmH2O) and connected 
to ASL 5000 lung model set in a condition mimicking COPD patient 
(compliance 75 ml/cmH2O, inspiratory and expiratory airways resist-
ance 15 and 25 cmH2O/L/s, respectively). Oxygen was supplemented 
by plugging the low-pressure oxygen port at the rear of ventilator 
to the wall oxygen supply via a flowmeter. Three oxygen flow rates 
were delivered: 0, 3 and 15 L/min. FIO2 was measured with Citrex 
H4™ (imtmedical, Switzerland) and continuously monitored on the 
screen of the device. Once FIO2 reached a plateau, oxygen administra-
tion was maintained for an additional 1 min and FIO2 was measured 
over the last 10 breaths of the recording at the steady state defined 
as a change in FIO2 of less than 10  % from the previous sampling 
window. The sampling rate was 200  Hz. Citrex H4™ device was cali-
brated before each experiment. The values of FIO2 were expressed as 
mean ±  SD. As we anticipated very low variability across the meas-
urement at the steady state, we decided not to perform formal statis-
tical comparisons between the values.
Results The values of FIO2 are shown in the table below. The baseline 
values of FIO2 were similar across the ventilators. The FIO2 was greater 
with Astral and Elisé 150 at 15 L/min.
Mean values of FIO2 between ventilators at different oxygen sup‑
ply rates
0 L/min 3 L/min 15 L/min
Astral 150 22 ± 0.0 42 ± 0.0 99 ± 0.0
Elisée 150 21 ± 0.0 35 ± 0.0 94 ± 0.0
Monnal T 50 21 ± 0.0 40 ± 0.0 86 ± 0.0
Trilogy 200 22 ± 0.0 30 ± 0.0 62 ± 0.0
Conclusion FIO2 generated by home-care turbine-driven ventilators 
fed by low-pressure oxygen port was different across ventilators. At 
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Introduction A breath-synchronized nebulization option that could 
potentially improve drug delivery by limiting drug loss during exha-
lation is currently not available on bi-level ventilators. The aim of this 
in  vitro study was to compare aerosol delivery of amikacin with an 
experimental vibrating mesh nebulizer coupled to a single-limb circuit 
bi-level ventilator, using a conventional continuous (Conti-Neb) and 
an experimental inspiratory-synchronized (Inspi-Neb) nebulization 
modes.
Materials and methods Using an adult lung bench model of nonin-
vasive ventilation, we tested a vibrating mesh device coupled with a 
bi-level ventilator in both nebulization modes. Inspi-Neb delivered 
aerosol during only the whole inspiratory phase, whereas Conti-Neb 
delivered aerosol continuously. The nebulizer was charged with ami-
kacin solution (250  mg/3  mL) and placed at two different positions: 
before and after the exhalation port (starting from the lung model). 
Inhaled, expiratory wasted and circuit lost doses were assessed by 
residual gravimetric method.
Results Irrespective of the nebulizer position, Inspi-Neb produced 
higher inhaled dose (p < 0.01; +6.3 to +16.8 % of the nominal dose), 
lower expiratory wasted dose (p < 0.05; −2.7 to −42.6 % of the nom-
inal dose) and lower total lost dose (p  <  0.05; −6.3 to 20.6  % of the 
nominal dose) than Conti-Neb.
Conclusion During simulated noninvasive ventilation with a single-
limb circuit bi-level ventilator, the nebulization mode of the vibrating 
mesh device impacts significantly the aerosol delivery of amikacin. 
The use of an inspiratory synchronized nebulization mode improves 
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Introduction Nasal high flow (NHF) is increasingly used in the man-
agement of acute respiratory failure. Recent clinical data support its 
use as a first-line therapy in the treatment or prevention of hypoxemic 
respiratory failures. However, little is known about its impact on res-
piratory effort, which could explain some of the benefits in terms of 
comfort and efficiency.
Materials and methods We conducted a randomized controlled 
crossover study in patients with respiratory distress in order to evalu-
ate the short-term effects of NHF. Patients were included if they met 
the following criteria: respiratory rate >20 breaths/min, associated 
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with either hypercapnia (pH < 7.38 and PaCO2 > 45 mmHg) or hypox-
emia (SpO2 < 90 % with oxygen flow >3 L/min). Four sessions of 15 min 
were conducted under various conditions: a baseline period with con-
ventional oxygen therapy (nasal cannulas or face mask), followed by 
three periods of NHF set at 20, 40 and 60 L/min and delivered in a 
randomized order. During the whole protocol, FiO2 was continuously 
adjusted to achieve a target SpO2 of 94 % in hypoxemic and 90 % in 
hypercapnic patients. Work of breathing (WOB) was computed from 
esophageal pressure and tidal volume, which was estimated by respir-
atory inductive plethysmography. Calibration of the flow with a pneu-
motachograph was conducted at the end of each condition and used 
to optimize the plethysmography accuracy. We also measured and 
calculated the esophageal pressure–time product (PTPeso), minute 
ventilation, capillary blood gases at the end of each tested condition, 
airway resistance and compliance.
Results Recruitment is still in progress, and we report here the data of 
a preliminary analysis performed in 8 patients. Both WOB and PTPeso 
were significantly reduced with the use of NHF as compared to base-
line (5.68 ± 2.35 vs. 3.39 ± 1.72 vs. 4.22 ± 1.86 vs. 3.61 ± 2.77 J/min 
for WOB; p = 0.04; and 187.5 ± 69.1 vs. 129.9 ± 67.4 vs. 151.6 ± 78.6 
vs. 115.9 ± 87.0 cmH2O s/min for PTPeso; p = 0.004; respectively, for 
baseline, 20, 40 and 60 L/min). The maximal reduction in WOB was 
encountered for 20 L/min in hypercapnic patients (n = 4) (7.09 ± 2.12 
at baseline vs. 3.43  ±  1.74  J/min at 20 L/min; p  =  0.04) and for 60 
L/min in hypoxemic patients (n  =  4) (4.27  ±  1.76 at baseline vs. 
1.93 ±  1.13  J/min at 60 L/min; p =  0.04). Minute ventilation tended 
to decrease in hypercapnic patients between baseline and 20 L/min 
(5.24 ± 0.57 vs. 4.37 ± 0.33 L/min respectively; NS) and in hypoxemic 
patients between baseline and 60 L/min (5.83 ± 1.64 vs. 4.69 ± 1.0 L/
min; NS). However, PaCO2 was not significantly modified through-
out the study periods (50.2 ± 12.3 vs. 49.5 ± 12.1 vs. 47.3 ± 11.7 vs. 
47.4 ± 13.9 mmHg; NS). Mean inspiratory resistance was significantly 
reduced with the use of NHF from 50.6 ± 21.0 cmH2O/L/s at baseline 
to 39.3 ± 23.2; 43.9 ± 24.0 and 30.5 ± 25.7 cmH2O/L/s at 20, 40 and 60 
L/min, respectively (p = 0.02). Compliance was significantly increased 
with the use of NHF (0.036 ± 0.031 vs. 0.045 ± 0.021 vs. 0.048 ± 0.036 
vs. 0.084 ± 0.074 L/cmH2O; p = 0.01; respectively).
Discussion To our knowledge, this is the first study to evaluate the 
work of breathing during NHF in adult patients. This lack of data may 
be attributable to the technical complexity of evaluating respiratory 
flow during NHF. Here, we used respiratory inductive plethysmog-
raphy, which has been previously used by several authors, and has 
shown to provide an acceptable estimation of tidal volume.
Conclusion This preliminary analysis of the short-term physiological 
effects of NHF suggests that the use of NHF may significantly reduce res-
piratory effort in patients exhibiting respiratory distress symptoms. Opti-
mal flow may differ according to the population. These effects may be 
related to an improvement in respiratory compliance and resistance, but 
inclusions must be carried on to confirm these results in a larger cohort.
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Introduction Available lung models to test ventilators during spon-
taneous ventilation present several limitations due to their intrinsic 
functioning, especially during expiration. This artificial lung model was 
specifically designed to simulate complete spontaneous inspiratory 
and expiratory passive activity.
Materials and methods The lung model is composed of variable 
resistor orifice and adjustable compliance cylindrical lung (balloon). 
Respiratory effort is provided by the shifting of a piston. These efforts 
are simulated in real time by a programmed script on graphic interface 
based on NI LabView 2014 software (National Instruments, Texas). The 
system balloon/piston is located in a cylindrical vacuum box, which 
represents the thoracic cage. This vacuum allows the passive return of 
the balloon during the expiratory phase.
The acquisition and display device were tested at a frequency of 
20 cpm, an inspiratory pressure of 20 cmH2O and an inspiratory time 
of a second, using a ventilator (Vivo 40; Breas Medical) on a first ver-
sion of the prototype.
Results The figure below shows a screenshot of pressure curves, flow 
and volume recorded and displayed by the sensors and the measure-
ment system of our test lung.
Conclusion This original lung model prototype is the first to our 
knowledge to combine complete active inspiratory activity and pas-
sive expiratory activity. First recordings show the feasibility of the 
concept and validate the acquisition system. The next step is to vali-
date the intrapleural pressure effect, simulated by vacuum generated 
between the cylindrical walls of the system and lung. This validation 
will give the originality of this work by allowing a closer simulation of 
the natural functioning of the human respiratory system.
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Introduction In intensive care unit, many simulators are used to teach 
clinicians, nurses and respiratory therapists the principles of mechani-
cal ventilation. Modelling the mechanical properties of the respiratory 
system allows them to learn settings and monitoring of mechanical 
ventilators. In volume-controlled mode, the airway pressure (Paw) is 
an important parameter to monitor for an optimal management of 
ventilated patients. It can be calculated from the following equation of 
motion of the inspired gas (EMIG):
P0: start pressure, Ers: elastance of respiratory system, 
Vt: tidal volume, Rrs: resistance of respiratory system, Q: 
inspiratory flow.
Paw = P0+ (Ers× Vt)+ (Rrs× Q)
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The purpose of the study was to compare Paw calculated from the 
EMIG and Paw measured with 3 different teaching tools: a two-com-
partment adult lung model and 2 ventilator simulation softwares.
Materials and methods Using the EMIG formula, we measured Paw 
of 50 lung mechanics (range of elastance and resistance, respectively, 
11–77 cmH2O/L and 5–31 cmH2O/L s
−1). These values were compared, 
in the same conditions, with Paw measured with a Maquet Servo i® 
ventilator connected to a two-compartment lung model (Dual Test 
Lung® Michigan Instrument—TTL 1600) and 2 ventilator simulation 
softwares [Dräger Evita 4® simulator SW 3.99 (DS) and Hamilton sim-
ulator version 2.2. (HS)], all set in volume-controlled mode (Vt: 0.5 L; 
Rf: 20 cpm; inspiratory flow: 30 L min−1; I/E ratio:1/2; pressure trigger 
sensitivity: −20  cm H20; inspiratory plateau pressure: 25  %; inspira-
tory rise time: 0 %; peep: 0 cmH2O). Statistical method: Bland–Altman 
method and multiple linear regression.
Results 
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Conclusion Responses to several respiratory system characteris-
tics showed that the teaching tools react appropriately. The bias 
between EMIG and different tools was small with very narrow limits of 
agreement.
We conclude that pressure values obtain from EMIG are very close of 
values obtain from a two-compartment adult lung model connected 
to a volume ventilator, HS and DS. These methods are relevant and 
realistic for teaching principles of mechanical ventilation.
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Introduction Admission to the intensive care unit (ICU) carries a very 
high risk of mortality for neutropenic patients [1]. That is why early 
prognostic indicators should be identified to discriminate patients 
who are more or less likely to benefit from advanced ICU support. The 
aim of our study was to identify outcome and early prognostic factors 
in critically ill neutropenic patients.
Patients and methods It was a retrospective review of the medi-
cal records of 42 neutropenic patients admitted to a medical surgi-
cal intensive care unit (ICU) over an 8-year period. Neutropenia was 
defined as an absolute neutrophil count of less than 1.5 × 109/l.
Results Of the 42 patients included in the study, 22 (52 %) were men 
and 20 (48 %) women. The mean age was 51 ± 19 years.
Medical histories consisted of hematologic malignancy (n = 18), solid 
tumors (n  =  9), chronic disease under immunosuppressive therapy 
(n = 9) and toxic bone marrow aplasia (n = 6). Almost half of patients 
with hematologic malignancies were in remission.
Reasons for ICU admission were septic shock (n =  27), severe sepsis 
(n = 5), severe acute pancreatitis (n = 3), metabolic disorders (n = 2), 
hemorrhagic shock (n = 2), status epilepticus (n = 2) and high-risk pul-
monary embolism (n = 1).
APACHE II, SAPS II and SOFA scores at admission were 21 ± 6.4, 38 ± 16 
and 9 ± 4.6, respectively.
Mortality in our ICU was 67  % (28 deaths). At admission, only three 
variables were independently associated with outcome: pancytope-
nia (p =  0.03), high SOFA score (p =  0.04) and lactates ≥3  mmol  L−1 
(p = 0.01). These factors were associated with an increased risk of death.
Conclusion In our study, we identified three independent early pre-
dictors of outcome that may be of value in deciding in which neutro-
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Introduction Anemia is very common in critically ill patients. There are 
numerous possible causes for the anemia of critical illness, including 
chronic anemia, overt and occult blood loss. As a consequence of this 
anemia, critically ill patients receive a large number of RBC transfu-
sions. In this work, we study the contribution of phlebotomy to ane-
mia and need for RBC transfusion in critically ill patients.
Patients and methods A retrospective observational study was con-
ducted in a medical surgical intensive care unit at Tunis Military Hos-
pital during a period of 1  year extending from September 1, 2012, 
to December 31, 2012. Inclusion criterion was an ICU stay more than 
48  h. Exclusion criteria included: patients with obvious causes of 
hemorrhage on admission or during stay in the hospital and patients 
with history which can lead to hemoglobin rate below the transfu-
sion threshold (chemotherapy, Sickle cell disease, hemorrhage, etc.). 
Patients included were subdivided, according to baseline hemoglobin, 
into two groups: one for transfusion study (patients with admission 
hemoglobin ≥10  g/dl for cardiovascular history, and ≥7  g/dl for the 
others), second group for anemia study including patients with base-
line hemoglobin concentration ≥12 g/dl. Main data collected included 
the following: demographics, frequency of blood sample and asso-
ciated volume of blood drawn collected over 24  h, transfusion (rate, 
threshold pre-transfusion hemoglobin), hemoglobin variation and 
biological indicators: CRP, creatinine.
Results Over 382 consecutive patients admitted to ICU, 155 were 
included. The mean ICU length of stay was 8  days. Admission Acute 
Physiology and Chronic Health Evaluation II (APACHE II) score was 
17 ±  5. The mean baseline hemoglobin level was 11.6 ±  2.4  g/dl. In 
total, 25.2 % of patients had a martial treatment with 9 ± 1.1 g/dl as 
hemoglobin indication value. The mean blood loss via phlebotomy 
was 160 ± 150 ml overall hospital stay and 21 ± 9 ml daily per patient. 
Twenty-six percentage of blood draw were for biological analysis. 
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Overall, 24.5 % of patients received 6 ± 4 units. The mean pre-trans-
fusion hemoglobin was 7.8 ± 1.3 g/dl. The number of RBC transfusion 
was independently associated with: low baseline hemoglobin, length 
of stay more than 9 days, blood loss more than 110 ml, septic shock at 
admission and the need for dialysis. Anemia was independently asso-
ciated with low baseline hemoglobin, length of stay more than 9 days 
and blood loss more than 75 ml.
Conclusion Phlebotomy was a significant modifiable predictor of ane-
mia and RBC transfusion and therefore constitutes a target for action 
to improve the quality of care for patients in intensive care unit.
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Introduction The intensive care unit (ICU) is the place of choice for 
initial management of patients with thrombotic microangiopathies 
(TMAs). Thrombotic thrombocytopenic purpura, which is character-
ized by undetectable ADAMTS13 activity, is now well recognized by 
critical care specialists. However, atypical hemolytic and uremic syn-
drome (aHUS), another rare life-threatening TMA caused by uncon-
trolled activation of the complement system, remains a diagnostic 
challenge. The disease is mostly due to mutations in the complement 
regulatory proteins (factor H, factor I, or membrane cofactor protein 
[MCP]), or occasionally due to acquired neutralizing autoantibodies 
inhibitors of these complement system components (i.e., anti-factor H 
antibodies). As recent advances in aHUS therapy have been achieved, 
additional descriptive data are more than ever required to overcome 
diagnostic issues. As ICU data are scarce, we sought to describe a 
cohort of critically ill aHUS adult patients.
Patients and methods Single-center, retrospective study of aHUS 
patients managed between 2005 and 2015. Patients’ clinical and bio-
logical data, management and outcomes are reported.
Results Among the 34 patients with HUS managed in our ICU during 
the study period, 5 presented with typical HUS (Shiga toxin related) 
and 29 with aHUS. There were 14 men and 15 women, aged 47 (21–66) 
years. All met diagnostic criteria for TMA, including hemolytic anemia 
(median hemoglobin rate 9  g/dl, IQR [5.5–9.9]), presence of schisto-
cytes and negative Coombs test, increased LDH levels (median 1627U/l, 
IQR [750–4738]), undetectable haptoglobin (80 %), thrombocytopenia 
(median 44G/L, IQR [20–145]), and elevated free bilirubin (60 %). Arte-
rial blood pressure was 153 mmHg [125–205]/90 mmHg [80–122]. Five 
patients had fever. At ICU admission, 13 (45 %) patients presented with 
neurologic symptoms (9 confusion, 8 headaches, 6 seizures, 5 focal 
defects, 4 coma and 2 blurred vision). One patient had posterior revers-
ible encephalopathy syndrome, one had cerebellar syndrome and 
one had ischemic stroke. Ten patients (35 %) had digestive symptoms, 
including diarrhea in 8, and abdominal pain in 5. Five patients had 
aHUS-related cardiac involvement, all with negative T waves on ECG, 3 
with elevated troponin levels and one with chest pain.
All patients presented with acute kidney injury, with median urea at 
19 mmol/l (IQR [9–45]) and median creatinine at 273 µmol/l (IQR [143–
859]). Eleven (38 %) patients had significant proteinuria and 13 (45 %) 
hematuria. All patients had detectable ADAMTS13 activity. Comple-
ment data were available in 19 patients, including 7 patients with low 
C3 activity, and 4 with decreased CD46 rates. Four patients had docu-
mented complement factor H mutation (heterozygous) and 1 MCP 
mutation. No case of detectable E. coli-related Shiga toxin was found.
Treatment included dialysis for 13 patients (6 at admission), mechani-
cal ventilation for 9, and vasopressors for 2. Only 15 patients 
underwent plasma exchange therapy. All patients but two needed 2 
(1–4) antihypertensive drugs. Last, 6 recent patients received human-
ized monoclonal anti-C5 antibody (eculizumab). Ten (34  %) patients 
died before hospital discharge, and ten other patients were dialysis 
free. Half the patients who did not receive plasma exchange died.
Conclusion Patients with aHUS are far from presenting an isolated 
kidney disease. Multiple organ involvement, chiefly cardiac and neu-
rologic, occurs in up to half the patients. Plasma exchanges were not 
implemented in half of the cases. Large studies are needed to correlate 
severity at ICU admission and mortality. Also, as complement protein 
C5 blockade seems to greatly improve the prognosis of aHUS patients, 
the impact of ICU management on outcomes (mortality and chronic 
kidney disease) needs to be elucidated.
Competing interests None.
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Introduction The lack of donors for allogeneic hematopoietic stem 
cell transplantation (HSCT) has led to use unrelated umbilical cord 
blood (UCB) units as an alternative graft. Despite improvement in 
management of critically ill allogeneic HSCT recipients, survival rate 
remains low. Extended aplasia, poor and delayed immune reconsti-
tution and higher rates of severe infection after UCB transplantation 
compared to the evolution after allogeneic bone marrow (BM) or 
peripheral blood stem cells (PBSC) HSCT may lead to consider UCB 
transplantation recipients as poor candidates for intensive care unit 
admission. We compared the short- and long-term outcome of alloge-
neic recipients requiring admission to the intensive care unit accord-
ing to the source of hematopoietic stem cells.
Patients and methods Retrospective chart review of allogeneic HSCT 
patients admitted to intensive care unit from 2008 to 2013. The data 
were retrieved from the databases of the adult HSCT unit and the 
intensive care unit. The short-term outcome was assessed through 
the intensive care unit and in-hospital mortality rates. Overall survival 
was the retained long-term outcome criteria and was calculated from 
intensive care unit admission to death from any cause. Observations of 
patients still alive on January 1, 2015, were censored at this date.
Results Of the 103 patients, 23 received UCB transplantation. Intensive 
care unit admission rate was higher for UCB recipients (33 %) than for 
BM and PBSC recipients (22 %) (p = 0.048). The most common reasons 
for intensive care unit admission were acute respiratory failure regard-
less of the hematopoietic stem cells source. Intensive care unit mortal-
ity was 65 % (15/23) for UCB transplantation and 62.5 % (50/80) for BM 
and PBSC transplantation (p  =  0.812). In-hospital mortality was 74  % 
in UCB recipients and 82.5  % in BM and PBSC recipients (odds ratio: 
0.601, 95 % confidence interval 0.201–1.796, p = 0.371). In multivariate 
analysis, performance status >2 (p < 0.001) and mechanical ventilation 
(p = 0.039) were associated with worse in-hospital mortality. The 100-
day survival was 26.1 % for UCB transplantation and 25 % for BM and 
PBSC transplantation. The 1-year survival was 26.1 % in UCB recipients 
and 11.2 % in BM and PBSC recipients. While overall survival median was 
21 days in UCB recipients and 19 days in BM and PBSC recipients, sur-
vival distribution was not significantly different according to the source 
of hematopoietic stem cells (log-rank test p value = 0.232). Poor perfor-
mance status remained correlated with lower overall survival (p = 0.003) 
in multivariate analysis. After adjustment on variables independently 
associated with outcome, the in-hospital mortality remained simi-
lar between UCB and BM and PBSC recipients (odds ratio: 0.647, 95 % 
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confidence interval 0.175–2.394, p = 0.517) as well as the overall survival 
(hazard ratio: 0.828, 95 % confidence interval 0.491–1.396, p = 0.470).
Discussion The source of hematopoietic stem cell was not a predictor 
of short- or long-term outcome. Survival of allogeneic HSCT recipients 
after intensive care unit admission remained low, and we have not 
pointed out any significant transplant-related factors. Collaboration 
between intensive care specialists and hematologists is undoubtedly 
the key to select patients who may benefit from intensive manage-
ment, considering the underlying disease, its therapeutical strategy 
and prognosis.
Conclusion The identification of the important role of the perfor-
mance status on the evolution of critically ill allogeneic HSCT recipi-
ents may help to clarify the decision-making process of intensive care 
unit transfer after allogeneic HSCT and to implement intensive care 
unit admission policies. Therefore, substantial intensive care unit sur-
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Introduction Both hematological and solid malignancies may be 
directly responsible for life-threatening organ failures including obstruc-
tion of anatomical structures, tissue infiltration, tumor lysis syndrome, 
or coagulation disorders. Besides advanced life support and eventual 
instrumental interventions, the treatment of cancer-related organ fail-
ures relies on timely administration of chemotherapy. Published data 
about requirements of chemotherapy in the ICU are mostly related to 
patients with hematological malignancies, while reports of patients with 
solid tumors are scarce. In this study, we addressed the features and out-
comes of patients with organ failures directly related to solid tumors.
Patients and methods We performed a retrospective multicenter 
study within the GrrrOH research network. All adult patients who were 
admitted to the ICU with organ failures related to solid malignan-
cies and treated with chemotherapy between 2000 and 2015 were 
enrolled into the study. Patients were retrieved through the infor-
mation systems from hospital pharmacy units involved in the deliv-
ery of cytostatic drugs. Data were collected from individual files and 
included the overall severity through the SOFA score computed at the 
time of ICU admission, the type and mechanism of organ failures, and 
the modalities of chemotherapy administration. Endpoints were the 
in-ICU and in-hospital vital status.
Results We identified 48 patients [26 males/22 females; median age 
59 years (range 21–79)] from 5 centers. The median SOFA score at the 
time of admission was 4 (range 0–10). The causes of admission were 
acute respiratory failure (n  =  37, 77  %), thrombotic microangiopathy 
(n = 3, 6 %), septic shock (n = 2, 4 %), coma (n = 2, 4 %), hypercalcemia 
(n = 1, 2 %), cardiac arrest (n = 1, 2 %), acute kidney injury (n = 1, 2 %), 
and acute liver failure (n = 1, 2 %). Primary tumors were lung cancer in 
28 patients (58 %), including 21 (44 %) with small cell lung cancer, breast 
cancer in 3 (6 %), digestive tract cancer 5 (10 %), and others in 7 (14 %). 
The underlying disease was metastatic in 30 patients (62  %), and the 
primary site remained unknown in 5 (10 %) patients. The mechanisms 
of cancer-related organ failures were tissue infiltration in 25 patients 
(52 %), compression of anatomical structures in 21 patients (44 %) and 
paraneoplastic syndrome in 2 (4 %). Invasive mechanical ventilation was 
required in 32 patients (66 %), vasopressor therapy in 14 (29 %), renal 
replacement therapy in 4 (8  %) and venovenous extracorporeal mem-
brane oxygenation in 2 (4 %). Chemotherapy was complicated by tumor 
lysis syndrome in 7 patients (14 %). ICU-acquired infections occurred in 
18 patients (37 %), of whom 12 (25 %) developed septic shock. End-of-
life decisions were taken in 26 patients (54 %). The in-ICU and in-hospital 
survival rates were 50 and 13 %, respectively.
Discussion This abstract reports on a limited but preliminary cohort of 
patients. The collection of cases is ongoing in a number of additional 
centers. The results from the whole cohort will be presented at the 
congress.
Conclusion Acute respiratory failure related to lung cancer represents 
the main indication for prompt administration of chemotherapy in 
the ICU. Despite most patients presented with single organ failures 
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Introduction Despite an improvement in prognosis of patients with 
hematologic malignancy in recent years, the prognosis for patients 
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with hematological malignancies (HMs) admitted to the intensive care 
unit (ICU) remains poor. However, it is difficult to predict the outcome 
of these patients at their admission. The objective of this study was 
to evaluate the clinical characteristics and hospital outcomes of criti-
cally ill patients with HMs admitted to ICU to identify risk factors for 
mortality.
Patients and methods We conducted a retrospective, observational 
cohort study, over 2010–2014, in a medical ICU of the University Hos-
pital of Rouen. We analyzed 134 patients with HMs admitted to ICU. 
Data included: demographic characteristics, hematologic diagnosis, 
reasons for ICU admission, transplant status, the presence of neutrope-
nia, number of organ failures and level of organ support.
Results The mean age was 57 ± 14.5 years, and the sex ratio was 1.48. 
The hematologic disease represented was the LAM (37 %), non-Hodg-
kin lymphoma (31 %) and LAL (10 %). Ten percentage had undergone 
an autologous stem cell and an allograft 6 %. At the time of ICU admis-
sion, sixty-one patients (46 %) were at the stage of diagnosis and/or ini-
tial treatment of their disease, 32 (24 %) in complete remission, 11 (8 %) 
in partial remission and 30 (22 %) had relapsed. The main indication for 
admission was: acute respiratory failure in 65 cases (49 %), septic shock 
in 30 patients (22 %), severe sepsis in 15 patients (11 %) and acute renal 
failure for 13 patients (10 %). Sixty-seven patients (50 %) were neutro-
penic at admission, 87 (65 %) during the ICU stay. The average SAPS II 
score on admission was 60 ± 21, the SOFA score was 10 ± 4 at day 1 
and 9.5 ± 5 at day 3. Sixty-seven patients were intubated, and the aver-
age duration of ventilation was 9.5 ± 11.7 days, 51 (38 %) underwent 
non-invasive ventilation, as exclusive treatment of respiratory failure 
for 19 patients (14 %), 44 patients (33 %) required dialysis, 84 patients 
(63  %) received vasopressors. The average length of ICU stay was 
10.3 ± 13 days, the average length of stay in hospital 20.6 ± 17.2 days. 
Mortality in the ICU was 37 %, in-hospital mortality was 52 %, mortali-
ties at day 28, day 90, 6 months and 1 year were, respectively, 43, 56, 
64 and 71 %. Use of invasive mechanical ventilation, renal replacement 
therapy and vasopressors were associated with higher ICU mortal-
ity (69, 64 and 55 % respectively, p < 0.001). Patients with SOFA score 
increased at least 2 points over the third day had a mortality rate signifi-
cantly higher (68 %, p < 0.001) while those with SOFA score decreased 
at least 2 points had lower mortality (10 %, p < 0.001).
Conclusion The prognostic factors of in-hospital death were the need 
for invasive mechanical ventilation, the need for vasopressors and 
the need for renal replacement therapy in patients with hematologic 
malignancy admitted to ICU. The trend of organ failures in the first 
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Introduction Prognostic impact of neutropenia in critically ill cancer 
patients (CICP) remains controversial. Hence, although neutropenia is 
an independent risk factor for poor outcome in the general ICU popu-
lation with severe sepsis or septic shock, several studies in critically ill 
cancer patients failed to demonstrate impact of neutropenia on out-
come [1, 2]. This lack of statistical association might, however, reflect a 
lack of statistical power.
The aim of this study was to assess influence of neutropenia on mor-
tality of critically ill cancer patients. Secondary objectives were to 
assess influence of neutropenia on mortality of critically ill patients 
while taking into account underlying malignancy or changes related 
to period of admission.
Materials and methods This systematic review and meta-analysis was 
performed according to the PRISMA statements. Public domain data-
bases including PubMed and the Cochrane database were searched 
by using predefined keywords. The research was restricted to articles 
published in English and studies focusing on critically ill adult patients 
from May 2005 to May 2015.
Results were analyzed using Review Manager 5.1 software. Overall, 
mortality is reported as median (IQR). Publication bias was assessed 
by visually inspecting the funnel plot. Then, summary estimates of risk 
difference were then calculated using the random-effect model.
Results Our initial search yielded 1528 citations, of which 744 were 
excluded as irrelevant for the scope of this review or being duplicate. 
Among the 784 remaining records, abstracts and full-text articles were 
scrutinized for further evaluation. Finally, 38 studies with a total of 
6054 patients (including 2097 neutropenic patients) fulfilled our eligi-
bility criteria and were included.
Overall, mortality was of 54.1 % (3275/6054; 95 % CI 52.8–55.4). Mor-
tality of neutropenic and non-neutropenic patients was of, respec-
tively, 62.8 % (1316/2097; 95 % CI 60.7–64.8) and 49.5 % (1959/3957; 
95 % CI 47.9–51.0). Funnel plot failed to identify publication bias.
Neutropenia was associated with an increased risk of mortality of 11 % 
(9–14 %; P 0.0002; I2 = 50 %).
When analyzed separately, underlying malignancy did not modify 
the influence of neutropenia on outcome (respective risk difference 
of mortality in neutropenic patients of 11  % [95  % CI −4–27], 8  % 
[95 % CI 0–15] and 12 % [95 % CI 6–17] in patients with solid tumours 
(n = 428), hematological malignancy (n = 1354) or both (n = 4272), 
respectively).
Mortality in studies with inclusion period before 2005 was higher in 
the overall population and in non-neutropenic patients (Fig. 33).
The overall impact of neutropenia on outcome was, however, 
unchanged by the inclusion period (respective risk difference of mor-
tality in neutropenic patients of 10 % [95 % CI 4–15] before 2005 vs. 
10 % [95 % CI 3–17]).
Conclusion This systematic review suggests a meaningful survival in 
neutropenic critically ill cancer patients despite an 11 % (95 % CI 9–14) 
raw increase in mortality compared to non-neutropenic critically ill 
cancer patients.
Neither underlying malignancy nor period of admission was associ-
ated with the prognostic impact of neutropenia. The meaningful sur-
vival in neutropenic critically ill patients strongly suggests that ICU 
admission denial based upon neutropenia should be discouraged.
Competing interests None.
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Introduction Thrombotic microangiopathy syndromes are an uncom-
mon cause of ICU admission. They include several conditions charac-
terized by clinical and biological manifestations such as neurological 
disorders, renal failure, hemolytic anemia and peripheral thrombocy-
topenia. Thrombotic thrombocytopenic purpura (TTP) and hemolytic 
uremic syndrome (HUS) are the two classic forms of TMA.
Objective: To analyze the clinical and biological features and evaluate 
the prognosis of TMA in the ICU.
Patients and methods It is a retrospective study performed in an 
8-bed medical ICU during a period of 15 years from 2000 to 2014. Clini-
cal, biological, therapeutic and outcome characteristics of patients 
were analyzed.
Results Seven cases of TTP were collected during this period. Clinical, 
biological, therapeutic and outcome characteristics are displayed in 
Table 37.
In the present series, patients were rather young. Neurological symp-
toms were present in six patients and hemorrhagic signs only in three. 
Plasma exchange could be achieved in six patients with a favorable 
outcome only in three.
Conclusion Despite therapeutic progress and prognosis improvement 
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Introduction While n-3 poly-unsaturated fatty acids interfere with 
immune and inflammatory processes, the l-arginine deficit during 
sepsis impairs the arginine/NO pathway, setting off a multiple organ 
dysfunction syndrome leading to poor clinical outcomes in septic 
shock. However, there is no clear clinical benefit in supplementing 
septic patients with either n-3 PUFAs and/or l-arginine. The aim of our 
work was to assess the effects of different enteral nutrition formula-
tions containing n-3 poly-unsaturated fatty acids and/or l-arginine on 
septic shock-induced vascular dysfunction in rats.
Materials and methods Healthy rats were fed with different enteral 
products: Peptamen® HN (HN group), Peptamen® AF containing n-3 
poly-unsaturated fatty acids (AF group) or Peptamen® AF enriched 
with l-arginine (AFA group). After 72  h of nutritional pretreatment, 
peritonitis by cecal ligation and puncture was performed (CLP group) 
and compared to a SHAM group. Once septic shock was set, rats were 
actively resuscitated and monitored during 4  h. At the end of the 
experiment, vessels and organs were harvested to assess inflamma-
tion, oxidative and nitrosative stress, and ex  vivo vascular reactivity 
was studied.
Results Septic rats pretreated with an enteral nutrition enriched with 
l-arginine (AFA) had a significantly increased mortality compared to 
SHAM rats and to septic rats treated with a nutrition containing n-3 
poly-unsaturated fatty acids AF or a standard enteral nutrition HN. 
Norepinephrine infusion rates to reach the mean arterial pressure 
objective were significantly increased in septic rats treated with n-3 
poly-unsaturated fatty acid (AF and AFA groups), compared to SHAM 
and septic HN rats. Both AF and AFA significantly reduced mesenteric 
resistance arterial contractility, decreased vascular oxidative stress, 
but increased NF-κB and pIκB expression, nitric oxide and prostacyclin 
production in septic rats.
Discussion In this experimental septic shock model, an immunonutri-
tion diet enriched with l-arginine or n-3 poly-unsaturated fatty acids 
failed to improve septic shock-induced hemodynamic dysfunction. 
Moreover, l-arginine supplementation seems to increase septic rat 
mortality. The need to assess the relevance of these results in septic 
patients, calls for further studies, and the place for so-called immunon-
utrition shall be questioned.
Conclusion Although immunonutrition with n-3 poly-unsatu-
rated fatty acid or l-arginine supplementation exhibited an anti-
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Introduction Hyperglycemia is a feature of septic patient and has 
been associated with poor outcome and higher mortality. In contrast, 
insulin has been shown to decrease mortality and to prevent the inci-
dence of multi-organ failure but is often associated with deleterious 
hypoglycemia. Protein tyrosine phosphatase 1B (PTP1B) is a negative 
regulator of insulin signaling and NO production. We found that PTP1B 
inhibition or gene deletion improved mesenteric endothelial function 
and reduced cardiac and vascular inflammatory markers, leading to 
reduced cardiac dysfunction. The purpose of the present study was to 
assess the potential therapeutic effect of total PTP1B invalidation on 
glucose metabolism and cardiovascular insulin resistance using exper-
imental model of sepsis.
Materials and methods Thus, in order to address this question, we 
developed a cecal ligation and puncture (CLP) model of sepsis. CLP is 
followed by subcutaneous fluid resuscitation at 1, 5 and 9 h after CLP. 
Table 37 Thrombotic microangiopathy characteristics
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To evaluate the potential therapeutic effect of PTP1B invalidation, we 
used PTP1B-/- mice.
Metabolic phenotype study by indirect calorimetry was realized by 
tracking and recording food intake, physical effort and energy con-
sumption. To assess metabolism, glucose (GTT) and insulin tolerance 
tests (ITT) were performed 16  h after CLP. Organs and plasma are 
removed to evaluate inflammation and oxidative stress by q-RT-PCR, 
insulinemia by ELISA test and insulin pathway by Western blot. Vascu-
lar function was assessed on Halpern’s arteriograph.
Results Indirect calorimetry study showed that CLP induced a sig-
nificative diminution of VO2 inspired, VCO2 expired, physical activ-
ity with food and water consumption. This study characterizes a 
severity of our CLP model without difference between WT versus 
PTP1B−/−.
Although this is severe model, PTP1B−/− mice showed improved 
GTT and ITT. Moreover, the limited increase of insulinemia in CLP 
PTP1B−/− mice emphasizes the improvement of glucose metabolism.
Moreover, the heart expression of TNF-a, IL1-b, Gp91phox, VCAM-1, 
ICAM-1, and CD45 showed a significative increase of inflammation 
and oxidative stress in WT CLP mice compared with PTP1B-/- mice. 
Plasmatic dosage of insulin before and 15 min after glucose injection 
showed an elevation of insulin concentration in WT CLP mice showing 
a functional pancreas.
Insulin- and flow-mediated dilatation assessed in isolated perfused 
mesenteric arteries was abolished in WT CLP mice and was improved 
in PTP1B−/− mice.
Isolated perfused heart study showed that CLP induced a significative 
reduction of left ventricular developed pressure and cardiac efficiency 
in WT and PTP1B−/− mice. However, efficiency cardiac study showed 
a different utilization of substrate between WT CLP and PTP1B−/− 
CLP, WT sham and PTP1B−/− sham.
Moreover, we showed that PI3 k/Akt molecular pathway is functional 
in CLP mice suggesting a GLUT4 expression or translocation alteration. 
In fact, GLUT4 expression study showed that in plasma membrane 
fraction and endosome fraction, GLUT4 expression is abolished in WT 
CLP mice.
We also found that PTP1B−/− mice subjected to CLP had a higher sur-
vival rate compared to WT.
Conclusion CLP-induced sepsis changes the carbohydrate mecha-
nistic by abolishing GLUT4 expression, and PTP1B inhibition restores 
GLUT4 expression and improves metabolic function, cardiovascular 
function and survival. This suggests that PTP1B inhibition may be an 
attractive target for the treatment of sepsis.
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Introduction Spontaneous bacterial peritonitis (SBP) is a life-threaten-
ing complication of cirrhosis. Its diagnosis is based on ascitic fluid poly-
morphonuclear (PMN) count. However, manual quantification of PMN is 
operator-dependent and can delay the diagnosis and in fine antibiotic 
administration. We aimed to assess the interest of ascitic fluid TREM-1, a 
receptor expressed by activated PMN, for the diagnosis of SBP.
Patients and methods One hundred and thirty-two consecutive 
ascites samples from 112 patients with cirrhosis from 3 tertiary care 
medical centers were examined for PMN count. TREM-1 concentration 
in ascitic fluid was determined using ELISA. SBP was defined as a PMN 
count >250 cells/ml with or without a bacteria positive culture. Results 
were expressed as median [25th–75th percentiles].
Results Twenty-six (20 %) samples fulfilled diagnostic criteria for SBP. 
TREM-1 concentration in ascitic fluid was significantly higher in SBP 
samples (4456 [3351–5498] pg/ml) than in the non-SBP samples (642 
[417–899] pg/ml; P < 0.0001). By using a threshold of 1595 pg/ml, the 
sensitivity and specificity of the assay for SBP diagnosis were 96  % 
(95  % CI 80–100) and 99  % (95  % CI 95–100), respectively. The area 
under the receiver operating characteristic curve (AUROC) was 0.98 
(95 % CI 0.95–1.00). In an independent multicenter cohort of 205 sam-
ples including 28 SBP (14 %), the powerful performance of TREM-1 for 
SBP diagnosis was confirmed. The AUROC was 0.98 (95 % CI 0.96–1.00).
Conclusion Ascites TREM-1 level is a highly sensitive and specific test 
for the diagnosis of SBP. The development of assays for the meas-
urement of TREM-1 at bedside can be helpful for rapid and reliable 
screening in patients with cirrhosis.
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Introduction Although polymyxin-B hemoperfusion is supposed to 
improve outcomes in patients with sepsis by adsorbing endotoxin and 
decreasing systemic inflammation, the recent ABDOMIX study did not 
demonstrate any beneficial effect of polymyxin-B hemoperfusion in 
patients with septic shock due to peritonitis. In this context, cytokine 
clearance induced by polymyxin-B hemoperfusion is debated. The 
objectives of the study were to assess the influence of polymyxin-B 
hemoperfusion on plasma cytokine concentrations and to identify the 
cytokines associated with day 28 mortality.
Patients and methods This ancillary study of the ABDOMIX study 
investigated the impact of two polymyxin-B hemoperfusion sessions 
on day 28 mortality in peritonitis-induced septic shock. Blood sam-
ples were taken within 10  h post-surgery (P1), at the end of the first 
hemoperfusion session in the experimental group or 2  h after P1 in 
the control group (P2), 24  h after P1 (P3), and at the end of the sec-
ond hemoperfusion session in the experimental group or 2 h after P3 
in the control group (P4). Cytokines such as tumor necrosis factor α, 
interferon γ, interleukin-1β, interleukin-1α, interleukin-1RA, interleu-
kin-6, interleukin-4, interleukin-10, interleukin-17A and interleukin-22 
were assessed using magnetic bead-based immunology multiplex 
assay or enzyme-linked immunosorbent assay.
Results Among the 232 patients included in the ABDOMIX study, 19 
patients were excluded due to missing sampling and 213 patients (109 
in the hemoperfusion group and 104 in the control group) were con-
sequently included in the analysis. Postoperative P1 cytokine concen-
trations were not different between the 2 groups. Cytokine variation 
between P1 and P2 was not different between the 2 groups except for 
interleukin-1RA and interleukin-10, which decreased more pronounc-
edly in the control group than in the hemoperfusion group (p = 0.016 
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and 0.047, respectively). Cytokine variations between P3 and P4 were 
not different between the 2 groups except for IL-10 and IL-22, both of 
which decreased in the control group, whereas both of them increased 
in the hemoperfusion group (p = 0.002 and 0.04, respectively). Using 
a logistic stepwise regression model, the absence of decrease in inter-
leukin-10 and interleukin-22 between P1 and P3 was associated with 
day 28 mortality independently from Simplified Acute Physiology 
Score II (p = 0.002 and 0.04, respectively).
Conclusion Polymyxin-B hemoperfusion was not associated with a 
decrease in cytokine concentrations as compared to the control group. 
Higher levels of interleukin-10 and interleukin-22 in polymyxin-B 
hemoperfusion group may suggest unexpected deleterious interfer-
ence between these cytokines and PMX membrane. The absence of 
decrease in interleukin-10 or interleukin-22 blood concentrations 
within 24  h after peritonitis-related septic shock was independently 
associated with day 28 mortality.
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Introduction Acute hepatic dysfunction increases length of intensive 
care stay and mortality rate, but cholestasis cases during intensive care 
have not really been studied in medical literature. Hepatobiliary ultra-
sonography frequently repeated for the same patient in part of the 
cholestasis diagnosis process. This aim of the study is to describe the 
epidemiological data and the predictive factors for the patients under-
going abdominal echography aiming at a cholestasis diagnosis during 
surgical intensive care according to the positive or negative informa-
tive result of the examination.
Patients and methods This retrospective study being monocentric 
and observational includes all the patients having undergone diag-
nostic abdominal ultrasonography in the case of acquired cholestasis 
in a surgical intensive care unit in the city of Besancon, France. Choles-
tasis is defined by a bilirubin plasmatic rate over 30 micromol per liter, 
alkaline phosphatase over 195 international units per liter and gamma 
glutamyl transferase over 82.5 international units per liter. The demo-
graphic data, the patient’s ground and medical specificities have been 
notified as well as the various organ failures, biological results, drugs 
etiology through the Roussel Uclaf Causality Assessment Method 
score. Two groups have thus been defined: one group with “normal 
ultrasonography” or only sludge and the second with “pathologi-
cal ultrasonography” including the patients presenting the following 
ultrasonographic signs: enlarged gallbladder, thickened gallbladder 
wall, fluid pericholecystic area and acute cholecystitis.
Results One hundred and four patients have been included from July 
2011 to November 2014. Within the pathological ultrasonographic 
group, the median age is of 66 [52; 73] years old versus 53 [37; 64] 
years old in the other group p = 0.001. The Simplified Gravity Index is 
of 48 [38; 59] in the pathological ultrasonography group versus 44 [36; 
56] in the other group. In the pathological ultrasonography group, the 
patients present cardiovascular medical specificities and more acute 
kidney injuries. This group includes icteric patients suffering an aver-
age bilirubin rate of 34 ± 46 millimol per liter versus 19 ± 23 millimol 
per liter.
Three cholecystitis cases have been diagnosed, and the three of them 
being acalculous cholecystitis and all of them are dead.
Discussion The lack of balance between the two groups and the com-
paratively high death rate among the pathological group patients are 
the limits to the study. Even though ultrasonography is recommended 
in first intention, it is relevant and of high interest to use a drugs 
imputability score in an etiological approach.
Conclusion The patients with pathological ultrasonography within 
the framework of cholestasis diagnosis seem to be icteric patients with 
more pathological comorbidities, and they seem to have less drug eti-
ology on univariate analysis.
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Introduction In-hospital mortality of cirrhotic is variable in the lit-
erature. It depends on several factors. The aim of our work was to 
determine the in-hospital mortality rate of cirrhosis and to identify 
predictive factors among our cirrhotic patient.
Patients and methods A retrospective study was performed on clini-
cal records of cirrhotic patients admitted between 2013 and 2014. We 
identified demographic, clinical and laboratory parameters and stud-
ied their relationship with mortality.
Results Of the 78 patients admitted during the study period, there 
was a male dominance with a sex ratio equal to 0. 63 and an aver-
age age of 62.44. In total, 44.9 % of patients had cirrhosis secondary 
to hepatitis C and 15.5 had cirrhosis secondary to hepatitis B. Fifty-
six percentage of our patients were Child C and had a MELD score 
more than 30 in 92.3 % of cases. In-hospital mortality was 19.2 % (15 
deaths). Death was due to septic shock in 53.13 %, hepatic carcinoma 
in 13.3 and in the 30.7 % remaining cases to diverse reasons. The in-
hospital mortality among cirrhotic patients in our study increased with 
hyponatremia (p = 0.02), presence of renal failure (p = 0.01) and level 
of C-reactive protein exceeding 15 mg/l (p = 0.05).
Discussion In worldwide, cirrhosis is a major cause of mortality. The 
presence of hyponatremia, renal failure and an elevated C-reactive 
protein level are predictive factors of mortality. The prognosis of cir-
rhotic patient is affected by infection. Dysfunction of immune system 
could be among the potential reasons of fragility.
Conclusion Cirrhosis is a severe disease. An intensive resuscita-
tion should be promptly undertaken, especially when infection, 
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Introduction Constipation (or paralysis of lower gastrointestinal tract) 
in intensive care is multifactorial and is defined as the absence of stool 
for more than 3 consecutive days without mechanical obstruction. The 
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incidence of constipation in intensive care patients is more than 60 %. 
Constipation is associated with longer duration of mechanical ventila-
tion, longer stay in intensive care unit and increased mortality (1). The 
Working Group on Abdominal Problems (WGAP) of the European Soci-
ety of Intensive Care Medicine (ESICM) developed recommendations 
on the constipation management in intensive care, but their imple-
mentation varies among intensivists (2). The aim of this study was to 
assess knowledge, attitudes, and practices when it comes to constipa-
tion management in intensive care.
Materials and methods The questionnaire KAP (knowledge, atti-
tude, practices) for the national survey was sent by email to more 
than 1600 French intensivists. It was designed to investigate the 
characteristics of intensivists (10 issues), to assess knowledge with 
13 issues in accordance with the recommendations, each one scored 
0 or 1 allowing to calculate a knowledge score, to investigate behav-
iors (aka attitudes) regarding constipation management in their unit 
(9 issues) and practices with a case scored 4. The responses were 
collected anonymously. Descriptive statistics are expressed as a 
percentage.
Results In 2 months, 579 replies were recorded on Google Drive® for 
a response rate of 36 %. Forty-two percent of respondents are aged 
between 30 and 39  years, and the sex ratio is 2 males for 1 female, 
77 % are senior intensivists, 23 % are residents, 77 % work in teach-
ing hospital. The average knowledge score among all respondents 
is 7.5/13 (minimum 2/13, maximum 12/13). The average the case 
among all respondents is 2.3/5 (minimum 0/4, maximum 4/4). These 
two scores are statistically associated with the number of beds in the 
respondent’s unit, meaning that a better knowledge score is associ-
ated with a respondent working in an important intensive care unit 
(regarding the number of beds in the unit), but is not related to age, 
sex, teaching status, or seniority of medical practice. The intensiv-
ists do not know neither drugs, nor clinical and biological disorders 
which promote constipation in intensive care patients (1.4 and 2.8 %, 
respectively); 77.1 % (n = 444) underestimate the incidence of con-
stipation in intensive care unit and only 62.7 % believe that constipa-
tion affects mortality. Only 7 % (n = 41) of intensivists declare having 
a written protocol for constipation management in their unit, while 
93 % (n = 536) have a systematic monitoring of transit in their ser-
vice and 72  % (n =  415) initiate a treatment of constipation in the 
6  days following the admission in intensive care unit. Although 
60.6 % of intensivists (n = 349) consider that constipation is a daily 
concern in their unit, only 5.2  % (n =  30) of them plan to attend a 
session on gastrointestinal motility impairment during a national 
convention.
Conclusion This is the first national survey assessing the knowledge, 
attitudes and practices of French intensivists in the field of constipa-
tion management. Their knowledge is insufficient and is related to the 
lack of interest of intensivists in the subject. This is a matter of concern, 
and corrective actions are needed to improve constipation manage-
ment in intensive care units, such as implementation of written proto-
cols and evaluation of implementation programs. Finally, educational 
programs are necessary during initial training and more data are 
needed to enhance the scope of the WGAP recommendations.
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Introduction During the ingestion of caustic products, the realization 
of the upper gastrointestinal endoscopy is inevitable. In fact, the grav-
ity of gastrointestinal lesions does not correlate with neither the sever-
ity of oropharyngeal lesions nor clinical symptoms.
Patients and methods It is a retrospective study based on a case 
study. Sixty-three caustic ingestion observations were collected from 
2013 to 2015. We propose: (1) to analyze the epidemiological and 
clinical characteristics of patient’s victims of caustic ingestion, (2) to 
describe the different aspects of endoscopic lesions and (3) to seek 
predictive factors of severe lesions.
Results The average age of our patients is 29 years (range 2–73 years). 
Thirty-eight were female and 25 male or a sex ratio F/M =  1.52. The 
ingestion was voluntary in 50.8  % of cases and accidental in 49.2  %. 
Psychiatric history was found in 17  % of which six (9  %) suicide 
attempt. A strong alkali product was ingested by 25  % victims, an 
acidic agent by 8 % victims and 67 % of accidents were secondary to 
ingestion of oxidants. The most commonly involved agents are bleach 
(63.5 %) and caustic soda (23.8 %). The functional symptoms reported 
were mostly gastrointestinal. Physical examination was unremarkable 
and that interested the oropharyngeal sphere in 23.8  % of cases. It 
showed that the oxidants were associated with higher risk of occur-
rence of functional symptoms in 76  % of cases versus 23  % of cases 
with strong bases and to 1  % of the strong acids ingestion. Strong 
alkali were more responsible for hematemesis in 67 % cases and ulcer-
ation of the tongue in 57 versus 25 and 38 % within strong acids and 
8 and 5  % with oxidants (p =  0.002). In our series, the stomach was 
the most affected organ. The gastric lesions were isolated in 21 cases 
(33.3 %) or associated with esophageal lesions in 9 cases (14.3 %). The 
only caustic esophageal burns are identified in 12 patients (19 %) and 
in 11 cases (17 %); it was associated with other lesional levels. Other-
wise, caustic injury affected the duodenum in 6.4 %. The triple localiza-
tion (involving stomach, esophagus and duodenum) was objectified in 
2 patients (3.2 %). Endoscopic lesions are as follows: stage 0 (28.6 %), 
stage I (25.4  %), stage IIa lesions (20.6  %). More other serious were 
present: stage IIb (6.3 %), stage IIIa (7.9 %) and stage IIIb (3.2 %); the 
lesion was stenosing in 7.9 % of cases. Endoscopy was normal in 100 % 
of weak acids ingestion and in 35.7 % with oxidants. A significant sta-
tistically correlation between the caustic and the stage of endoscopic 
lesion (P = 0.006) was found. Caustic potash was at the origin of imme-
diate stenosing lesion in 100 % of cases. Endoscopy was pathological 
in 93 % of cases of soda-based and 35.7 % of endoscopies were normal 
Table 38 Univariate analysis between  OHCA patients 
admitted in ICU after ROSC who developed and non‑devel‑
oped a HH






Age (years) 60.7 [50.0, 72.6] 63.9 [48.1, 71.3] 0.74
Male gender 395 (70.5 %) 40 (55.6 %) 0.01
Preexisting hepatic 
disease
14 (2.5 %) 4 (5.6 %) 0.14
Public setting CA 212 (38.0 %) 16 (22.2 %) 0.01
Witnessed CA 486 (89.0 %) 59 (83.1 %) 0.14
Bystander CPR 322 (59.5 %) 39 (54.9 %) 0.46
Initial shockable 
rhythm
326 (58.4 %) 24 (33.3 %) <0.01
Time from collapse 
to ROSC (min)
20.0 [12.0, 30.0] 25.0 [17.0, 40.0] 0.01
Therapeutic hypo‑
thermia
527 (94.1 %) 68 (94.4 %) 0.91
Post‑CA shock 259 (46.2 %) 64 (88.9 %) <0.01
In‑ICU mortality 305 (54.5 %) 62 (86.1 %) <0.01
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in the case of bleach ingestion. The stomach was the most affected 
after caustic ingestion. The lesion in the stomach is often classified 
stage I (62 %). In the esophagus, stage IIa was the most present (41 %). 
The stage IIIb is objectified in the case where the lesion coexisted at 
the esophagus, stomach and duodenum. Stenosis was objectified 
in 80 % of cases in the esophagus. Endoscopy was normal in 55 % of 
patients who had an normal initial clinical examination. Clinical signs 
were more remarkable in cases of the stenosis and in stage IIIb lesions.
Conclusion Esophagoscopy is the key to diagnosis. The oropharynx 
injuries cannot predict the severity.
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Introduction Despite significant advances in post-cardiac arrest (CA) 
care, mortality of resuscitated out-of-hospital cardiac arrest (OHCA) 
remains high in intensive care unit (ICU) and is partially triggered by 
post-CA shock and associated organ damages. Few studies evalu-
ated the incidence and the prognosis impact of the organ failure after 
OHCA. Particularly, occurrence of hypoxic hepatitis (HH) in this setting 
is understudied. Aims of this study were to assess the prevalence of 
HH, to investigate the factors associated with HH and to investigate 
the association between HH and ICU mortality in a large population of 
OHCA.
Patients and methods We performed a retrospective study over a 
6-year period (2009–2014) in a French CA center. All non-traumatic 
OHCA patients admitted in ICU after return of spontaneous circulation 
(ROSC) who survived more than 24 h were included. In the specific set-
ting of CA, HH was defined as an elevation of alanine aminotransferase 
(ALT) over 20 times the upper limit of normal during the first 72 h after 
occurrence of CA (i.e. 900 IU/L). Liver function test (LFT) measurements 
were extracted from our local database and classified in 6 time points, 
every 24 h, from T0 (ICU admission) to T5 (H120). Utstein style catego-
ries concerning CA were considered. Univariate analysis and multivari-
ate regression analysis were performed.
Results Among the 632 OHCA patients included in the study, 72 
patients developed a HH (Table  38). Thus, the prevalence of HH 
was 11.4  % (95  % CI 9.0, 14.1). In multivariate analysis, the only pre-
hospital variable associated with the occurrence of HH was the time 
from collapse-to-ROSC [OR 1.02 per additional minute; 95 % CI (1.00, 
1.04); p  =  0.01]. After adjustment for confounding factors, HH was 
associated with a higher ICU mortality [OR 4.39; 95 % CI (1.71, 11.26); 
p < 0.01], and this association persisted even if occurrence of a post-CA 
shock was considered in the statistical model [OR 3.63; 95 % CI (1.39, 
9.48); p = 0.01].
Discussion Occurrence of HH may complicate the ICU course of 
patients admitted after OHCA and is associated with a higher ICU mor-
tality, independently of the occurrence of post-CA shock. However, a 
causal relationship between HH and mortality cannot be affirmed by 
this observational study, as HH may also reflect the severity of the 
post-CA syndrome and shock.
Conclusion HH is a common complication after CA, appears mainly 
triggered by the duration of resuscitation (no flow +  low flow) and is 
associated with early mortality in ICU.
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Introduction Patients in comatose state are at risk of aspiration pneu-
monia (AP) with increased burden in morbidity and mortality. Aspira-
tion may result in pulmonary injury due to chemical and/or bacterial 
aggression. No reliable clinical or biological criteria are available to 
ensure diagnosis of bacterial infection on patient admission. Antibiot-
ics in AP are thus widely prescribed, although theoretically effective 
only in bacterial AP. We defined a new protocol for management of 
comatose patients with the aim to reduce antibiotics use by treating 
only patients with suspected AP and by stopping antibiotics in case of 
negative bacteriological samples. The aim of our study was to assess 
effectiveness and safety of this protocol.
Patients and methods This prospective survey started in November 
2012 and ended in December 2014. All the patients admitted in ICU 
for coma (Glasgow coma score ≤8) requiring intubation and mechani-
cal ventilation were included. Respiratory specimen was obtained, and 
antibiotic treatment was began when an AP was suspected (two of the 
following criteria: temperature ≥38.5 ou ≤35.5 °C, leukocytosis or leu-
kopenia, purulent tracheal aspirates) and new infiltrates on the chest 
X-ray. Patients were divided into 3 groups: no AP, chemical AP (infil-
trates on chest X-ray but negative respiratory specimen) and bacterial 
AP (positive respiratory specimen).
Results Two hundred and fifty patients (56 years; SAPSII 55; duration of 
mechanical ventilation: 1.8 days; ICU length of stay: 3 days; ICU mortal-
ity 30 %) were included. An AP was suspected in 96 (38.4 %) patients. 
Of these patients, 45 (47 %) had a bacterial AP and 30 (53 %) a chemical 
AP. Bacterial or chemical AP were associated with increased duration 













56.9 (15.9) 57.5 (16.6) 51.2 (16) 0.09
Sex male [n 
(%)]
72 (46.7 %) 35 (68.3 %) 33 (73.3 %) 0.001
BMI [mean 
(SD)]
26.9 (5.1) 26.4 (5.9) 25.5 (4.5) 0.23
SAPS2 [mean 
(SD)]





1.1 [0.5–3] 2.8 [1.4–5] 3.4 [1.6–7] <0.001
ICU LOS, days, 
median  
[Q1–Q3]




2.5 [1–6] 6 [2–19] 8 [3–24] <0.001
Mortality  
[n (%)]
47 (30.5 %) 16 (31.4 %) 12 (26.7 %) 0.89
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of mechanical ventilation and length of stay. Only 2 patients of the 34 
with a chemical AP had a confirmed relapse of pneumonia after anti-
biotic treatment had been interrupted after initial negative respiratory 
specimen. They do not need invasive mechanical ventilation (Table 39).
Conclusion AP chemical or bacterial is associated with increase mor-
bidity without increase mortality. Systematic bacterial sampling and 
antibiotic withdrawing in case of negative culture lead to antibiotic 
interruption in 1/3 of AP cases without increased risk in AP relapse.
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Introduction Ventilator-associated pneumonia (VAP) is the most 
frequent intensive care unit (ICU)-acquired infection. Data regard-
ing onco-hematology patients are scarce and VAP might impact on 
prognosis.
Patients and methods Monocentric prospective and observational 
study, including cancer patients treated with mechanical ventila-
tion during more than 48  h over a 5-year period (from December 
2008 to February 2014). We evaluated risk factors for VAP among 
baseline characteristics of patients and ICU therapies. Using VAP as a 
time-dependent variable, Cox model was fitted to assess its impact 
on 1-year mortality, and multistate models were used to calculate its 
impact on morbidity.
Results Of the 208 patients included in the study, 66 patients (31.7 %) 
presented a VAP. ICU mortality rate was 55.8  % (118 patients). One-
year survival was 23  %. Most of VAP (87.8  %) had a microbiological 
documentation (Gram-negative bacilli predominantly). The use of 
hydrocortisone was the only independent risk factor for VAP, with a 
protective effect. Patients having a VAP had a longer ICU stay (mean 
extra length of stay: 4.2  days, for patients survivors from ICU) and 
a longer mechanical ventilation (mean extra duration: 1.7  days, for 
patients extubated). Regarding prognosis, when adjusting on SOFA 
score the day of intubation (HR 1.11; 95  % CI 1.07–1.16; p  <  0.0001) 
and disease stage (HR 1.83; 95 % CI 1.16–2.89; p: 0.01), the occurrence 
of VAP was independently associated with 1-year mortality (HR 1.50; 
95 % CI 1.05–2.15; p: 0.03).
Conclusion VAP is associated with 1-year mortality in this specific pop-
ulation. In association with standard preventive recommendations, the 
use of hydrocortisone might prevent occurrence of VAP. Randomized 
clinical trials are warranted.
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Introduction Pneumocystis jiroveci pneumonia (PCP) is a major 
cause of acute respiratory failure in immunocompromised patients. 
Although the pathogen is similar, clinical features carry significant dif-
ferences across different patient subgroups. The aim of this study was 
to describe and compare HRCT patterns in PCP patients with either 
AIDS, malignancies or steroid-induced-related immune suppression.
Patients and methods We performed a retrospective study among 
critically ill PCP patients between January 1, 2006, and July 31, 2015. 
All patients with a diagnostic of PCP and available HRCT within 
2 days of diagnosis were included. Only confirmed cases of PCP were 
included. Clinical and biological data were collected. CT scans were 
independently reviewed by two respiratory clinicians with a consult-
ant radiologist available to reach consensus. We compared HRCT 
patterns across three groups of PCP patients: AIDS, hematological 
malignancies and steroid-related immunosuppression.
Results Sixty-six patients (70  % men, age 56 [47–64]) were included 
in this study (23 AIDS, 21 Hemato, 22 Steroids). None of the AIDS 
patients had lymphoma or other malignancies. Underlying malignan-
cies included acute hematological malignancies in 9 patients, chronic 
hematological malignancy in 11 patients and other in 1 (1 %). Under-
lying disease in steroid group was mostly kidney transplant patients 
[16/22 (73 %)].
At ICU admission, respiratory rate was 29 [23–35]/min, oxygen flow 
was 6 [4–12] l/min, and 3 patients needed mechanical ventilation at 
admission (FiO2 100  %). During ICU stay, 36 (54  %) patients needed 
invasive mechanical ventilation during 9 [6–14] days, 24 (36  %) had 
shock and 13 (20  %) needed renal replacement therapy. All patients 
received trimethoprim-sulfamethoxazole for 21  days and 31 (47  %) 
received steroid. Twenty-five (38 %) had coinfection at ICU admission. 
ICU length of stay was 10 [5–16] days. Hospital mortality was 7.6  % 
(n = 5).
HRCT findings included the following: ground-glass opacities in 83 % 
(n = 55), ill-defined consolidations in 57 % (n = 38), interalveolar thick-
ening (septal lines) in 42 % (n = 28), bronchiectasis in 42 % (n = 28), 
crazy paving in 32 % (n = 21), nodular opacities in 21 % (n = 14), and 
cysts in 15 % (n = 10). Diffuse ground-glass opacities and crazy pav-
ing were present in 68 % of cases, and nodular opacities in 16 (24 %) 
Table 40 See text for description
ROC analysis revealed AUC > 0.9, positive predictive values between 0.67 and 
0.83, and negative predictive values between 0.94 and 0.95
Evaluation  
criterion
Mean Median p No. of patients
ARDS present/
absent (D0–D3)
7.02/13.95 5.45/9.33 <0.002 27/58
ARDS appeared/
absent (D1–D3)




3.11/13.01 3.15/9.23 <0.00001 10/72


















3.58 0.938 0.60 0.96 0.94 0.67 10/72
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patients. Lung opacities were bilateral (97 %), located in the superior 
parts of the lungs, and 45 % (n = 30) had no pleural effusion. Pneu-
mothoraces were rare [n = 5 (7.5 %)]. The lung opacities on HRCT were 
distributed similarly among the three immunocompromised groups 
as none of these patterns (topographic involvement and localization) 
were significantly different across the three groups. Consolidations 
and nodular opacities were significantly associated with the existence 
of coinfection (p 0.03).
Conclusion During PCP disease, the most frequent HRCT pattern is 
bilateral diffuse ground-glass opacities or crazy paving with no pleural 
space involvement. Alveolar or nodular opacities are less frequent but 
may be encountered. Therefore, despite striking differences in patho-
physiology and clinical presentation between AIDS and non AIDS 
patients, HRCT patterns are similar. Other HRCT findings such as con-
solidations and nodules might be ascribable to lung super infection.
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Introduction In severe sepsis and septic shock patients, respiratory 
failure usually occurs within 72  h following admission into intensive 
care unit. Endothelial dysfunction is thought to play a major role in its 
occurrence and prognosis.
Endocan is an anti-inflammatory molecule produced by the lung 
endothelium and released in the circulation in response to an infec-
tious or inflammatory insult. The main action of endocan relates to the 
inhibition of leukocyte diapedesis. By preventing leukocytes accumu-
lation in the lung, endocan reduces excessive pulmonary inflamma-
tion. Thus, a high circulating level endocan in septic patients would 
protect the lung from excessive inflammation and would be of better 
prognosis.
This hypothesis has been comforted by 2 pilot studies. In the context 
of severe polytrauma, high blood levels of endocan at ICU admission 
(>7 ng/mL) are observed in patients who do not develop respiratory 
failure (1). We found a similar profile in severe septic patients with a 
cutoff of 3.55 ng/mL best distinguishing patients with ARDS in the 3 
first day of ICU from patients who do not develop ARDS (2).
To extend these pilot studies, a prospective observational study in a 
population of severe sepsis and septic shock patients was designed in 
order to confirm the predictive value of blood endocan at admission 
for the occurrence of ARDS.
Patients and methods The objective was to compare endocan level 
at ICU admission in 3 different sets of 2 groups: presence or absence 
of ARDS between D0 and D3; appearance of ARDS or not between D1 
and D3; respiratory worsening or not between D0 and D3. The inclu-
sion criteria were severe sepsis or septic shock, as defined by the SSC 
2008. The exclusion criteria were age <18  years, dialysis, pregnancy, 
immunosuppression, systemic corticosteroid therapy. Patients were 
classified by 2 blinded independent intensivists. Endocan was meas-
ured in plasma EDTA in blind by 2 different laboratories: CHRU Lille, 
Inserm U1019E13. Nonparametric test was used for statistical analysis.
Results Eighty-five patients were definitively included. Fifty-eight 
did not develop ARDS. Among the 27 who developed ARDS, 19 had 
ARDS at admission. Among them, 2 worsened their ARDS at D3. Eight 
patients developed ARDS after admission. The mean/median levels of 
blood endocan in the ARDS groups (present, appeared, worsening) are 
significantly lower than in the control groups. The best significance is 
obtained when ARDS is appearing or worsening (p < 10−4, p < 10−5) 
(Tables 40, 41).
Discussion In patients with severe sepsis or septic shock, the level 
of blood endocan at ICU admission predicts the occurrence of ARDS: 
an endocan level <3.5  ng/mL indicates a patient at risk; an endocan 
level > 5.5 ng/mL indicates no risk of ARDS.
Conclusion Blood endocan may help to predict the occurrence or the 
worsening of ARDS in severe sepsis or septic shock patients and to 
early apply protective ventilation in those patients.
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Introduction Predicting fluid responsiveness is of paramount impor-
tance to avoid unnecessary fluid administration in ARDS patients, 
since a positive fluid balance is associated with ARDS mortality (1). 
Several tests with high reliability to predict fluid responsiveness are 
now available, but none of them have been validated in the prone 
position (PP) in ARDS patients, while this treatment is now a corner-
stone of the therapeutic armamentarium of severe ARDS (2). The aim 
of this study was to evaluate the diagnostic performance of three 
methods to predict fluid responsiveness in PP: cardiac index varia-
tion during the Trendelenburg position, cardiac index variation during 
end-expiratory occlusion, and pulse pressure variation after increasing 
tidal volume (VT) to 8 ml.kg predicted body weight (PBW).
Patients and methods This prospective single-center study enrolled 
ARDS patients with PaO2/FiO2  <  150  mm Hg in the supine position, 
under invasive mechanical ventilation in PP, monitored with the PiCCO 
device, and with acute circulatory failure. Patients were studied at 
baseline with bed angulation 13°, during a 1-min postural change in 
the Trendelenburg position with bed angulation −13°, during a 1-min 
increase of VT to 8 ml kg−1 PBW, during a 15-s end-expiratory occlu-
sion and after IV infusion of 500 ml crystalloids. Baseline settings were 
resumed for 1  min after each intervention. Cardiac index was meas-
ured with the thermodilution technique at baseline and after fluid 
administration. Pulse contour-derived cardiac index was continu-
ously monitored. Fluid responsiveness was deemed present if cardiac 
index assessed by thermodilution increased by at least 15 % after fluid 
administration. Numeric results are presented as median [1st–3rd 
quartile].
Results Twenty-three patients were included at the time of abstract 
submission. Patients characteristics at study inclusion were the fol-
lowing: SAPS II 56 [48–62], VT 6.0 [5.9–6.1] ml  kg−1 PBW, PaO2/FiO2 
ratio in PP 154  mm Hg [98–192], PEEP 8 [8–10] cmH2O, and plateau 
pressure 23 [20–28] cmH2O. Nine patients (41  %) were deemed fluid 
responsive after fluid administration. The area under ROC curve of the 
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pulse contour-derived cardiac index change during the Trendelen-
burg maneuver and the end-expiratory occlusion test was 0.86 [95 % 
CI 0.70–1] and 0.71 [95  % CI 0.46–0.96], respectively. An increase in 
cardiac index ≥7.5  % during the Trendelenburg maneuver enabled 
to diagnose fluid responsiveness with a sensitivity of 0.78 [95  % CI 
0.44–1], and a specificity of 0.86 [95 % CI 0.64–1]. Cardiac arrhythmia 
was present at baseline in 13 patients (57  %), which were therefore 
excluded from pulse pressure variation analysis. The area under ROC 
curve of pulse pressure variation during VT increase to 8 ml kg−1 PBW 
was 0.45 [95 % CI 0.05–0.85].
Conclusion Cardiac index variation during a Trendelenburg maneuver 
is a reliable method to assess fluid responsiveness in ARDS patients in 
the prone position, while pulse pressure variation may be of limited 
interest in this context.
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Introduction Management of severe acute respiratory distress syn-
drome (ARDS, PaO2/FiO2 =  P/F  <  100) is: controlled mechanical ven-
tilation (CMV), 24 (1)–48 (2) h of muscle relaxation, early prolonged 
proning (3), low driving pressure (4). This improves VA/Q ratio (Guerin 
2014), ventilator–patient synchrony (5), lowers VO2 (6) and controls 
H+. Mortality is halved (3). As ARDS is caused by a reduction of the 
surface offered for O2 diffusion, failure of the respiratory generator or 
the ventilatory muscles spontaneous ventilation (SV), with condition-
alities, may offer to the lung better circulatory and ventilatory condi-
tions to allow for healing.
Patients and methods A series of 6 patients in which the Berlin cri-
teria (7) were fulfilled, and sufficient details gathered were retrospec-
tively analyzed. P/F on PEEP ≥ 5 cmH2O was <100 with one exception 
(117). The patients were already present in the critical care unit (CCU) 
or admitted to the CCU following tracheal intubation for pulmo-
nary/extrapulmonary ARDS. Management was: imaging, fiberoptic 
bronchoscopy if needed, repeated transthoracic echocardiography 
(absence of right ventricular dilatation or reduction of tricuspid annu-
lar systolic excursion), venous and arterial lines insertion, circulatory 
optimization (8) to a SscvO2  > 70–75 %, arterio-venous CO2 gradient 
<6, lactates <2, volume loading (little or no ventilatory changes of the 
inferior vena cava), normothermia (35–7  °C), upright (9) (60° reverse 
Trendelenburg legs down) position, administration of an alpha-2 ago-
nist (clonidine 1–2 μg kg−1 h−1) combined if needed (−3 < RASS < −2) 
with loxapine 100  mg through nasogastric tube as required. PEEP 
(10–20 cm H20) aimed SaO2 ≥ 98–100 %; then, FiO2 lowered as early 
as possible to 0.4 over 24–72  h. As soon as metabolic acidosis was 
controlled (with extra-renal replacement therapy if needed), CMV was 
switched to pressure support (PS = 8 cm H20 lowered to 5: Vt ≤ 5 ml.
kg, PaCO  ≤  60  mm Hg, Pplat  ≤  30). Extubation (P/F  >  150–200, 
PEEP = 10) was followed by continuous noninvasive ventilation (NIV, 
FiO2 = 0.4, PEEP = 10 to 5, PS = 8 to 5) for 4 days (24/24 h, 18/24 etc.).
Results P/F increased > 200 over 12–72 h followed by improvement and 
then disappearance of bilateral diffuse opacities. Overall reduction in vaso-
pressor/inotropic requirements, markers of inflammation, etc. allowed 
one to extubate the trachea after 72–96 h following the beginning of said 
management. In some instances, the improvement of P/F was from ≈ 50 
to > 300 over ≤24 h. One patient was re-intubated because of re-infection 
in the presence of interrupted NIV and normothermia.
Discussion The limitations are: non-prospective non-randomized 
design; n = 6 although <50 patients were treated without full details 
(CCU mortality ≈ 5 %); H+ should be controlled before SV. The ration-
ale behind CMV +  proning (introduction) can be achieved with low-
ered temperature with alpha-2 agonists (10, 11), adequate SV (12) 
without ventilatory depression (13). SV improves circulatory stability 
and uses much higher PEEP + lower driving pressure. Fast-track extu-
bations were observed.
Conclusion Provided stringent physiological principles are met severe 
ARDS may be handled with CMV  +  muscle relaxation  +  proning 
(state-of-the-art) or SV. Evidence-based demonstration is required.
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Introduction Acute episodes of exacerbations triggered by respiratory 
pathogens mark the progression of chronic obstructive pulmonary dis-
ease (COPD), leading to substantial morbidity and mortality. Despite 
the life-threatening nature of these exacerbations, the underlying 
mechanisms remain unclear although a high number of neutrophils in 
the lungs of COPD patients are known to correlate with poor prognosis. 
We and others previously demonstrated that interleukin (IL)-22 pro-
tects and regenerates respiratory epithelial cells upon virus infections 
and also limits secondary bacterial infections. Indeed, IL-22, through its 
receptor (IL-22R), is a cytokine that plays a pivotal role in lung antimi-
crobial defence and tissue protection. Regarding the IL-22/IL22R anti-
microbial pathway, we hypothesized that any alteration of IL-22R in the 
lungs of COPD patients may compromise innate defence mechanisms 
and enhance susceptibility to infections. More specifically, we exam-
ined whether IL-22R expressed on lung epithelial cells is targeted by 
the neutrophil proteases present at the surface of lung mucosa.
Materials and methods We exposed human bronchial epithelial 
cells and BALB/c mice to viral, bacterial agents or cigarette smoke and 
assessed IL-22R expression by RT-qPCR and flow cytometry. IL-22R 
expression was also examined in the lung tissue of COPD and control 
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individuals. We also analysed the effect of neutrophil serine proteases 
on the expression, structure and function of IL-22R by flow cytometry 
and western blotting in mouse lungs, human epithelial cells and sputa 
from COPD patients with or without exacerbations.
Results Using in  vitro and in  vivo approaches as well as RT-qPCR, 
flow cytometry and/or western blotting techniques, we first 
showed that pathogens such as influenza virus promote IL-22R 
expression in human bronchial epithelial cells, whereas Pseu-
domonas aeruginosa, bacterial LPS, do not. We also investigated 
whether IL-22R lung expression was impaired by cigarette smoke 
in epithelial cells or in mice chronically exposed to cigarette smoke. 
Finally, we examined lung tissue from 129 patients (11  % non-
smokers, 41 % “healthy” smokers, 48 % COPD patients). IL-22R1 RNA 
expression was neither associated with the cigarette smoke expo-
sure nor the COPD status.
In view of the foregoing data and the evidence that neutrophilia is a 
pathological hallmark of COPD, we hypothesized that neutrophils 
induce posttranslational modifications of IL-22R expression and func-
tion. We first exposed human epithelial cells to supernatant from acti-
vated neutrophils and observed that IL-22R1 protein expression was 
strongly decreased under these conditions, whereas α-1 proteinase 
inhibitor prevented the disappearance of the receptor. Most impor-
tantly, neutrophil proteases impaired IL-22-dependent immune sig-
nalling and expression of antimicrobial effectors such as β-defensin-2. 
This proteolysis resulted in the release of a soluble fragment of IL-22R, 
which was detectable both in cellular and animal models as well as in 
sputa from COPD patients with acute exacerbations.
Conclusion Hence, our study reveals an unsuspected regulation by 
the proteolytic action of neutrophil enzymes of IL-22-dependent lung 
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Introduction ARDS is characterized by the accumulation of neutro-
phils (PMN) in the lung interstitium and alveolar space where they 
die in large numbers. The removal of apoptotic cells, a process known 
as efferocytosis, plays a crucial role in the maintenance of tissue 
homeostasis and resolution of inflammatory and immune responses. 
However, little is known about capacity of macrophages and PMN to 
phagocytes apoptotic PMN in ARDS patients.
Materials and methods In vitro experiments were carried out to 
investigate the efferocytosis ability of PMN and macrophages from 
ARDS and control patients. In a second set of experiments, we inves-
tigated the effects of bronchoalveolar lavage (BAL) fluids from ARDS 
and control patients on healthy donor PMN and macrophages effe-
rocytosis capacity. Lastly, we studied the effect of metformin, an AMP 
kinase activator, on the phagocytic activity of neutrophils and mac-
rophages in ARDS patients.
Results We demonstrated that PMN apoptosis was diminished in 
ARDS patients (Fig. 34. Fig 1). We also found that efferocytosis capac-
ity was diminished (Fig.  34. Fig  2). Lastly, we found that metformin 
enhanced efferocytosis (Fig. 34. Fig 3).
Conclusion Efferocytosis is markedly decreased in ARDS. Metformin 
could be an interesting therapeutic approach to increase efferocyto-
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Introduction Primary spontaneous pneumothorax is a common dis-
ease. Needle aspiration is recommended as first-line treatment by 
international guidelines and used as such in our intensive care unit. 
Nevertheless, little is known of factors associated with its success. Our 
main objective is to characterize these factors.
Patients and methods We conducted a prospective, observa-
tional, single-center study, including all patients admitted to our 
intensive care unit and step-down unit with a primary spontane-
ous pneumothorax from 01/2012 to 08/2015. Our primary end-
points were the number of patients with early success of needle 
aspiration (defined as the absence of chest-tube insertion within 
24 h following needle aspiration), and the factors associated with 
early success. Secondary endpoints were number of patients with 
consolidated success (defined as absence of chest-tube drainage 
within the first week following aspiration), length of intensive care 
unit and hospital stay.
Results Seventy patients were admitted for primary spontaneous 
pneumothorax; needle aspiration was performed in 62 (89 %), 50 men 
(81 %), aged 31 [24–38]).
Immediate success rate was 36 %, and consolidated success rate was 
29  %. Duration of evolution of pneumothorax (time from first symp-
toms to needle aspiration) was significantly longer when aspira-
tion was successful (18  h [6.5–63] vs 10  h [5–16]; p =  0.012). Factors 
associated with needle aspiration success were: performing needle 
aspiration after 24  h of onset of pneumothorax (success 65 vs 24  %; 
p = 0.006); a smaller pneumothorax size, estimated by the Light score 
(29 [15–45] vs. 80 [42–94]; p < 0.0001); and a lower body mass index 
(20 [19–22] vs 21 [20–23]; p = 0.045).
Patients with needle aspiration success had a significantly lower 
length of intensive care unit (1 [1–1.3] vs 3 days [3–5]; p < 0.0001) and 
hospital stay (1 [1–1.3] vs 6 days [3–10]; p < 0.0001). No adverse event 
of needle aspiration was reported.
Conclusion Needle aspiration was effective in a third of primary spon-
taneous pneumothorax treated in our institution. The immediate suc-
cess rate was significantly increased when aspiration was performed 
after 24  h of onset of the pneumothorax. Needle aspiration success 
enabled a significant reduction in length of intensive care unit and 
hospital stay and hence costs.
Competing interests None.
Fig. 34 See text for description
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Introduction Emergency thoracotomy is a salvage procedure for 
trauma patients. Successes have been reported, including in some 
cases of war casualties [1]. A process was implemented in our military 
trauma center to improve the practice of emergency thoracotomy. The 
aim of this study is to describe the feasibility and the results of our pro-
gram of emergency thoracotomy.
Patients and methods This retrospective study included all the patients 
for whom emergency thoracotomy was considered between Septem-
ber 2013 and July 2015 at Percy Military Teaching Hospital. During this 
period, the equipment required to perform a resuscitative thoracotomy 
was gathered in a box at the emergency room, and a procedure was set 
on to admit trauma patients directly at the operating room.
Results During the study period, 399 trauma patients who fulfilled at 
least one of the Vittel’s criteria of severity were admitted in our center. 
Resuscitative thoracotomy was considered for eight of them who were 
pulseless during the pre-hospital management or at admission. Two 
patients had cardiac arrest related to cervical spinal injury, and thora-
cotomy was not performed in these cases. The remaining six patients 
had emergency thoracotomy. The delay between admission and 
incision was inferior to 5  min for all patients. Results are reported in 
Table 42. Return of spontaneous circulation could not be obtained in 
any of the four patients with asystole. A sustained spontaneous circu-
lation was achieved in one patient: multiple organ failure occurred and 
the patient died in ICU 15 h after the procedure.
Discussion Although resuscitative thoracotomy has been performed 
very quickly after admission, all our patients died. This result can be 
explained, at least partially, by the prolonged time of cardiac arrest 
before admission and the frequency of blunt trauma among our 
patients. Some of the procedures we performed may even be consid-
ered as futile according to recommendations suggesting not to real-
ize thoracotomy in case of blunt chest trauma or cardiopulmonary 
resuscitation lasting more than 10 min without returning to circulatory 
activity [2]. However, other centers have reported such a large propor-
tion of inadequate procedure. Reducing the delays between trauma 
and admission and between cardiac arrest and admission could help 
to improve the outcome of the patients.
Conclusion We achieved the development of a process to perform 
resuscitative thoracotomy less than 5 min after admission of pulseless 
trauma patients. Unfortunately, such a management did not improve 
the outcome of the patients. The duration of the pre-hospital phase 
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Table 42 See text for description
Patient 1 Patient 2 Patient 3 Patient 
4
Patient 5 Patient 6
Age/gen‑
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4 5 4 8 10 6
Plasma 2 2 4 6 4 3
Platelets 0 0 0 0 1 0
Death Yes Yes Yes Yes Yes Yes
Page 149 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
Introduction Traumatic rupture of aortic isthmus is a major problem 
in the management of polytraumatized patient. Except the complete 
rupture of the aorta, treatment should be initiated after hemody-
namic and respiratory stabilization and after treating a lesion involving 
life-threatening.
Patients and methods This is a prospective analysis over a period of 
18 months between January 2014 and July 2015. Twelve polytrauma-
tized patients were admitted to our ICU with rupture of aortic isthmus. 
All patients underwent a whole body CT with angio-CT of mediastinal 
vessels.
Results During this period, among 300 polytraumatized patients were 
admitted to our ICU, 180 of them had chest trauma (60 %) of which 12 
patients had a traumatic rupture of aortic isthmus (4 %). The median 
age was 43 [27–64] years. All patients were male. The mechanism of 
injury was road traffic accident (motorcycle in 2 cases, motor vehicle 
in 5 cases). All patients required mechanical ventilation due to res-
piratory or neurological distress. Four patients (25 %) had a Glasgow 
Coma Scale Score less than 12/15. Eight patients (75 %) had a hypox-
emic report PaO2/FiO2 less than 200. One patient was initially in shock. 
The median SAPSII was 28 [22–48]. The median SOFA score was 3 [2–5]. 
The median Shock Index was 0.70 [0.61–0.97]. After hemodynamic and 
respiratory stabilization, all patients underwent a whole body CT with 
angio-CT of mediastinal vessels. We noted head trauma in 4 patients 
(25 %), abdominal trauma in 9 patients (75 %), fractures of pelvis in 6 
patients (50 %) and fractures of the long bones in 10 patients (83.3 %). 
The rupture of aortic isthmus was associated with odds fractures in 10 
patients (83.3 %), pneumothorax in 6 patients (50 %), hemothorax in 
5 patients (41 %) and pulmonary contusions in all patients. A trache-
otomy was performed in 8 patients (66.6  %). The ICU stay was com-
plicated by nosocomial pneumonia in all patients and pulmonary 
embolism in 6 patients (50 %), septicemia in 5 patients (41 %). Eleven 
of 12 patients underwent endovascular treatment. The median interval 
between admission in ICU and endovascular treatment was 18 [7–30] 
days. All patients received a single stent, mean length 25  ±  1  mm. 
There was no conversion to an open approach. The median ICU stay 
was 30 [14–48] days. Two patients died: the first before endovascular 
treatment because of cerebral herniation, the second after endovas-
cular treatment because of a septic shock. All surviving patients had a 
clinical and radiological follow-up every 3 months. No morbidity was 
noted until this day.
Conclusion Diagnosis of traumatic rupture of aortic isthmus should 
be considered in any serious polytrauma. Except the complete rupture 
of the aorta, treatment of these lesions can be done after stabilization 
of a lesion involving the immediate prognosis. Endovascular treatment 
became the treatment of choice, especially for patients with severe 
associated injuries and bleeding risk. Additional data on the long-term 
stents are necessary in these young patients.
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Introduction Both NT-proBNP and Doppler echocardiography have 
been approved in the diagnosis of heart failure. In our study, we com-
pared the contribution of the NT-proBNP levels with the Doppler echo-
cardiography findings in the diagnosis of decompensated congestive 
left heart failure (CHF) in patients with acute dyspnea.
Patients and methods It was a prospective, observational study at 
the teaching department of emergency and intensive care in the 
regional Hospital of Zaghouan, including patients with severe dyspnea 
over 6 months. All patients underwent physical examination, 12-lead 
ECG, RX Thorax, NT-proBNP essay and echocardiography by an attend-
ing cardiologist on admission. The accuracy of the two methods for 
etiologic diagnosis was compared on the basis of the final diagnoses 
established by the medical staff.
Results Sixty-five patients were enrolled, including 45 (69  %) with 
CHF. Diagnosis of CHF was due to coronary artery disease, hyperten-
sion, valve disease, arrhythmia and dilated cardiomyopathy. Non-CHF 
was due to decompensated chronic obstructive pulmonary disease, 
pneumonia and severe asthma. Fifteen patients (23  %) were misdi-
agnosed at admission. The mean NT-proBNP concentration was 8989 
[769 to 18945] pg/ml in the CHF subgroup and 462 [22 to 1589] pg/
ml in the other patients (p < 0.01). Systolic LV dysfunction (LVEF < 0.45) 
was found in 31 patients with CHF (60 %) and in 7 patients with other 
causes of dyspnea (15 %) (p < 0.01). The E/A ratio and the deceleration 
time of E-wave (DT) were, respectively, 1.85 ± 0.77 and 12o ± 23 in the 
group CHF; 0.81 ± 0.44 and 208 ± 47 in the group Non-CHF (p < 0.01). 
Impaired relaxation and restrictive mitral pattern were observed, 
respectively, in 28 and 30 % of the patients with CHF and in only two 
patients and three patients in the other group.
Conclusion Both NT-proBNP assay and echocardiography can be used 
for the diagnosis of CHF in acutely dyspneic patients. However, the 
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Introduction Heart diseases are not uncommon in pregnancy 
(0.5–2 %) (1). Physiological changes, including cardiovascular and res-
piratory ones observed during pregnancy, may exacerbate preexisting 
heart disease. The aim of our study was to describe the epidemiologi-
cal, clinical profile, paraclinical and therapeutic cardiac decompensa-
tion in peripartum and to analyze the factors influencing prognosis.
Patients and methods Transversal retrospective study spread over 
13  years, from January 1, 2000, to December 31, 2013, including all 
women in labor admitted in obstetrical ICU for heart failure, with or 
without known heart disease.
Results During the study period, 223 patients have been collected, 
with an incidence of 2.5  %. The average age was 32.77  ±  6.74, the 
medical story of rheumatic fever was frequently found (75  %), and 
79  % of women in labor were followed for rheumatic valve diseases. 
About 38.1  % were followed by a cardiologist, while 23.8  % of heart 
diseases have been discovered only during pregnancy. More than 
half of the pregnancies were not followed by an obstetrician (65.5 %). 
Cardiac decompensation the most common was acute heart failure in 
43.7 %, followed by arrhythmia in 32.2 % and cardiac shock in 21.9 %. 
Symptoms was dominated by dyspnea in 97  % and palpitations in 
84.3 %; majority of patients were stage III or IV of NYHA classification 
(92.3  %). About 62.8  % of patients were delivered by cesarean and 
under general anesthesia in 31  % of cases. The maternal and fetal 
mortality were, respectively, 10.8 and 26  %. Univariate analysis had 
identified the rural environment, discovering the cardiac disease dur-
ing pregnancy, the lack of following in pregnancy and in heart disease, 
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impaired ejection fraction, pulmonary hypertension and left obstruc-
tive heart disease as severe prognostic factors.
Conclusion Pregnancy and delivery are complicated situations with a 
high maternal and fetal risk, requiring early treatment and multidisci-
plinary care, which had to start before planning pregnancy and long-




1.  J.Grewal et al. pregnancy in women with heart disease: risk assessment 
and management of heart failure. Heart Failure Clinics 2014.
P223  
Peripheral intravenous catheter‑related complications in an 
emergency ward
Ines Sedghiani1, Hana Fredj1, Hamdi Doghri1, Youssef Zied El Hechmi1, 
Mohamed Ali Cherif1, Jerbi Zouheir1
1Emergency and Intensive Care Department, Hopital Habib Thameur, 
Tunis, Tunisia 
Correspondence: Ines Sedghiani ‑ sedghiani.ines@gmail.com 
Annals of Intensive Care 2016, 6(Suppl 1):P223
Introduction Peripheral intravenous catheter (PIVC) is the most com-
monly used vascular access on hospitalized patients. It remains sus-
ceptible to infectious and non-infectious complications, which are the 
cause of considerable morbidity. The aim of this study was to assess 
the pattern and complications of PIVC among patients admitted into 
emergency ward.
Patients and methods We conducted a prospective observational 
study in an emergency ward between February 1, 2015, and April 30, 
2015. All hospitalized patients who underwent PIVC insertions during 
the time of the study were included. PIVC-related characteristics and 
clinical outcomes were assessed every 8 h. When an individual patient 
had more than one PIVC inserted during the study period; each was 
regarded as a separate event.
Results Two hundred and thirty-nine PIVC in 153 patients were fol-
lowed up during a total of 2.7 catheter days. All patients were com-
plaining of medical problems. Mean age was 68 years (52–78).
The majority (99 %) of intravenous lines was inserted by the nursing 
staff in wrists (26 %), upper arms (38 %), forearms (22 %) and ante cubi-
tal fossa (14 %). Catheter sizes were 18 Gauge in 29 % of the cases, 20 
Gauge in 48 % of the cases and 22 Gauge in 23 % of the cases. Gauze 
dressings were applied for the majority of patients (97  %). One hun-
dred and eight (45 %) PIVCs were inserted in the resuscitation room, 
while 131 (55  %) PIVCs were inserted in the acute care unit. PIVC-
related complications occurred in 40  % of the cases after 36  h dwell 
time. Clinical outcomes were pain (5  %), erythema (5  %), palpable 
venous cord (4  %), infiltration (9  %), occlusion (9  %) and accidental 
removal (7 %).
Hydration was the most frequent infusate (55  %) followed by antibi-
otics (28 %) and blood products (5 %). PIVC-related complication was 
predicted with antibiotics administration (p = 0.001, OR 2.5) and was 
associated with prolonged hospital stay (6 vs 2  days for non-compli-
cated PIVC).
Conclusion Incidence of peripheral intravenous catheter-induced 
complications in the emergency ward was high. Antibiotic adminis-
tration was a risk factor for these complications. Better insertion tech-
niques may reduce hospital stay.
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Introduction Burnout has been defined as a syndrome of emotional 
exhaustion, depersonalization and reduced personal accomplishment. 
Emergency services are the busiest and the most stressful units of 
hospitals.
Aim: To assess the prevalence of burnout among Tunisian public hos-
pital doctors and nurses and to determine its causes and perceived 
repercussions.
Methods: in a first step, we assessed the work conditions, the per-
ceived burnout and its possible consequences in 100 healthcare pro-
viders from two departments of emergency of two hospitals from the 
North of Tunisia. In a second step, we used the Maslach Burn Inventory 
to assess the burnout symptoms in ours ample.
Results More than half (56  %) of our sample had a burnout. Forty-
seven percentage of the affected professionals had a high level of 
emotional distress, 36.6  % had a high level of depersonalization and 
33  % had a low level of professional fulfillment. Burnout had a high 
level in nurse which affects three dimensions relative to physicians. 
A high level of burnout had found in healthcare provider, which had 
sick leave with emotional distress (32 %) (p = 0.02), depersonalization 
(21 %) and a low level of professional fulfillment (11 %).
Discussion and conclusion Our results corroborate partially with 
those of the literature and illustrate some parameters that can be the 
cause of burnout, such as working conditions, role ambiguity, and lack 
of experience among the young nurse. Therefore, it is important to 
take into consideration this various factors and their impact on quality 
of life of caregivers.
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Introduction Geriatric patients remain largely unstudied in low–
middle income healthcare settings. The purpose of this study was to 
compare the characteristics and outcomes of older (age ≥65  years) 
versus younger adults hospitalized in a Medical Unit for the Acute Care 
(MUAC).
Patients and methods It was a cross-sectional survey, conducted 
between January and June 2015 in MUAC of Ibn Sina University Hos-
pital in Rabat, Morocco. Patient demographics, comorbidities, clinical, 
paraclinical characteristics, and outcomes of patient were included. 
Activity of daily living (ADL) 1 month before admission, on admission, 
and 1  month, and 3  month after discharge was assessed. Simplified 
Acute Physiology Score (SAPS II) and Charlson scale are also included. 
Outcomes measures included length of stay (in ED and hospital), and 
mortality (in ED and hospital, and 1 month, and three after discharge). 
Patients categorized as older (≥65  years) versus younger (<65  years) 
adults were compared for differences using descriptive statistics.
Results We included 534 patients; older patients constituted 43.1  % 
(n = 230) of the cohort. Among older adults compared with younger; 
older patients were mainly women [136 (61 %) vs 87 (39 %)] and affected 
by a high level of comorbidity [152 (74.1 %) vs 147 (52 %); p < 0.001], 
with a better therapy compliance [65 (36.3 %) vs 108 (51 %); p = 0.006].
Concerning clinical and paraclinical characteristics, older adults had 
more altered mental state [39 (19.1 %) vs 33 (11.8 %); p = 0.02], more 
extracellular dehydration signs [73 (36 %) vs 35 (12.6 %) p < 0.0001], 
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more bedsores [11 (5.4 %) vs 0; p < 0.0001], more radiological abnor-
malities in chest X-ray [141 (68.8 %) vs 124 (44.8 %); p < 0.0001, more 
elevated CRP [113.7 ±  105 vs 98 ±  90; p =  0.18], lower clearance of 
creatinine [42.6 ± 26.8 vs 66.7 ± 42.6; p < 0.001], and higher kalemia 
[4.5 ± 0.8 vs 4.2 ± 0.9; p = 0.01].
Relative to younger patients, older patients have higher Saps II and 
Charlson scale, respectively (18 ± 9 vs 30 ± 8), (1.4 ± 1.6 vs 4 ± 1.8), 
and lower ADL one month before admission (5.7 ± 0.8 vs 4.9 ± 1.7), on 
admission (3.4 ± 2.1 vs 2.1 ± 2), and one month (5.1 ± 1.7 vs 3.8 ± 2.3), 
and three month after discharge [(5.2 ± 1.6 vs 4.6 ± 1.9) p = 0.003]. 
Median [IQR] of length of stay in ED and in hospital was, respectively, 
6 [3–10] and 8 [4–14] with no difference in the 2 groups. Cumulative 
mortality three month after discharge was 105 (29.6  %) with higher 
mortality in older patients relative to younger: (a) in ED [30 (14.3 %) vs 
12 (4.1 %)], (b) in hospital [9 (4.2 %) vs 10 (3.4 %)], (c) 1 month after dis-
charge; [21 (16.8 %) vs 15 (7.5 %)], and d) three month after discharge 
[5 (9.8 %) vs 3 (3.6 %)].
Conclusion Nearly half of Inpatients are aged 65 years and over. Older 
patients are more seriously ill, less independent, and with a higher 
mortality rate. Understanding unique needs of geriatric patients is 
critical to enhancing the management and prioritization of appropri-
ate care in developing settings.
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Introduction Metabolomic analysis by untargeted nuclear magnetic 
resonance spectroscopy (1H-RMN) allows a global assessment of 
endogenous metabolites within a biological system. A metabolic pro-
file can be modified during various pathological states and can be con-
sidered as a “signature” of the disease. Here, we hypothesized that the 
metabolic profile of a respiratory fluid can be modified upon a lung 
infection and can be specific of an antimicrobial host response and/or 
a pathogen subtype. Consequently, metabolic analysis may help orient 
the diagnosis and management of severe pneumonia. As Influenza A 
virus (IAV) and Streptococcus pneumonia (SP) are the most commonly 
pathogens involved in the community-acquired pneumonia (CAP), the 
aim of our study was to characterize the metabolic profiles of respira-
tory fluids during acute lung infection by IAV or SP.
Materials and methods We developed C57BL/6 mouse models 
of CAP by intranasal instillation of a lethal dose of IAV or SP. Disease 
severity was evaluated based on clinical (i.e., lung plethysmography, 
animal weight), inflammatory (i.e. IL-6 release, neutrophil recruitment) 
and histopathological measurements. Metabolic profiles of bronchoal-
veolar lavage (BAL) fluids were further obtained by 1H-RMN. Data were 
classified according to the metabolic profile using a multivariate analy-
sis in principal component analysis. Then, discriminatory metabolites 
were identified and quantified according to their spectral region.
Results We first defined the time point at which severity of lung dam-
ages was similar in both IAV- and SP-infected animals. Metabolomic 
analysis of BAL fluids further identified 29 metabolites, which were 
modified during pulmonary infection. In non-supervised principal 
component analysis, spectral differences could explain 94  % of the 
variance. Moreover, metabolic profiles could differentiate IAV versus SP 
as the etiological agent. Metabolomic analysis correctly predicted the 
pathogen diagnosis in 86 % of cases.
Conclusion Development of innovative microbial technologies 
increases the detection sensitivity of microorganisms in the airways. 
Nevertheless, it is still challenging to distinguish between infectious 
microorganisms that contribute to the disease per se and those who 
are merely bystanders. Here, we demonstrated that CAP due to IAV 
or SP results in distinct metabolic host responses (similar to a specific 
“metabolic fingerprint”). We believe that this innovative approach may 
help to match the host metabolic signature with a microorganism at 
the origin of lung diseases onset and/or progression.
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Introduction In patients hospitalized in the ICU for pneumonia, the 
realization of a bronchoalveolar lavage (BAL) for microbiological docu-
mentation can be detrimental to the respiratory function. Per-bron-
choscopic bronchial aspiration (PBA) is less aggressive. We wanted to 
determine whether the documentation obtained by PBA is equivalent 
to that of BAL.
Patients and methods This is a prospective, observational study. All 
patients hospitalized in the ICU for community- or hospital-acquired 
pneumonia, who underwent fiberoptic bronchoscopy with realiza-
tion of the two types of respiratory samples, were enrolled. A PBA in 
the bronchial segment corresponding to the pulmonary infiltrate was 
performed, the operative channel of the endoscope was washed with 
20 ml of 0.9 % saline, and a BAL was realized with five aliquots of 20 ml 
of 0.9 % saline. The first was discarded as recommended. One was sent 
to the bacteriology laboratory together with the PBA. The samples 
were diluted with 0.9 %; homogenized and quantitative cultures were 
realized. Cultures were considered significant if they attained at least 
105 CFU/ml for PBA and at least 104 CFU/ml for BAL.
Results During a 15-month period, 104 cases were analyzed. Ten 
patients were included two times. Mean age was 66 ± 15 years, 70 % 
of patients were men. Fifty-eight percentage of the cases were com-
munity-acquired. In 45 cases (43  %), both samples provided identi-
cal significant (above threshold) microbiological documentation. In 
3 cases (3 %), both samples provided identical nonsignificant (below 
threshold) microbiological documentation. In 30 cases (29  %), both 
samples could not document the infection. Thus, microbiological 
data were fully concordant in 78 cases (75 %). In 13 cases (12.5 %), the 
microorganisms found were identical but significant (above threshold) 
in one of the 2 samples only (BAL: 6, PBA: 7). In the 13 remaining cases 
(12.5  %), a microbiological documentation was obtained in only one 
sample (BAL: 5, PBA: 8), above threshold in 6 cases (BAL: 3, PBA: 3), 
below threshold in 7 cases (BAL: 2, PBA: 5). In total, 96 bacteria were 
retrieved: Enterobacteria (25 including 11 strains of Escherichia coli), 
Streptococcus pneumonia (20), Pseudomonas aeruginosa (19), Staph-
ylococcus aureus (16), Haemophilus influenzae (6), various microor-
ganisms (10). The microbial documentation was monomicrobial in 51 
cases (69 %).
Conclusion Microbial documentation of pneumonia in ICU by PBA is 
very similar to that by BAL, suggesting that PBA could replace BAL in 
routine.
Competing interests None.
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Introduction Compliance with the Surviving Sepsis campaign (SSC 
2012) bundle improves outcome of severe sepsis and septic shock. 
Thus, prognosis of patients partly depends on their initial manage-
ment, including early diagnosis, symptomatic and etiological treat-
ment. In this study, we compared compliance with the SSC 3-h bundle 
according to the initial chain of care of patients admitted in the inten-
sive care unit for severe sepsis and septic shock.
Materials and methods We conducted a monocentric, prospective 
and retrospective study in a 500-bed general hospital.
For each patient, we noted initial patient severity (RISCC Score, IGS2, 
Sepsis score), compliance and timing of lactate dosing, blood culture 
sampling, empiric antibiotic therapy, fluid resuscitation and compli-
ance to the global H3 bundle according to the initial chain of care: 
patient admitted in the intensive care unit after admission in the Emer-
gency Department (ED), from the ward (W) or from another hospital or 
clinic (EXT). We also compared days 14 and 28 mortality according to 
the chain of care.
Statistical analysis was performed with Chi square and Kruskal–Wallis 
test and logistic regression.
Results We included 79 patients: 43 hospitalized after emergency 
care, 22 from the ward and 15 from another hospital or clinic.
Significantly, compliance to the bundle is significantly lower in 
patients previously hospitalized in a conventional hospital care (medi-
cal or surgical) compared to patients hospitalized after emergency 
care.
This difference is significant for different components of the H3 bun-
dle, with percentage of compliance reported as follows: H3 blood cul-
tures ED 75 %, W 30 %, EXT 25 % (p = 0.001), H3 lactate ED 83 %, W 
30 %, EXT 63 % (p = 0.00), H3 antibiotics ED 52 %, W 9 %, EXT 20 % 
(p = 0.001), with the exception of the fluid therapy timing (NS). The ED 
patients’ management fulfilled more frequently the global H3 bundle 
(48 %) than for those from the ward (10 %) or from exterior care (15 %) 
(p = 0.006).
In multivariate analysis, survival is associated with H1 antibiotics (OR 
7.7; p = 0.03) in the emergency group and blood cultures sampling in 
the conventional hospital group (OR 3.3; p = 0.01).
Conclusion It seems crucial to develop ways to improve the chain of 
care for patients at risk for poor management and poor outcome. Ward 
patients appear at high risk for delayed diagnosis and delayed empiric 
antibiotic treatment.
Improvement of sepsis chain of care involves better screening and 
early treatment, better “post-emergency” orientation and increase in 
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Introduction It is well accepted that outcome of infected ICU patients 
depends—among other factors—on age, severity of illness and ther-
apy appropriateness. However, the response to anti-infectious therapy 
could be another indicator of outcome.
Patients and methods The study was conducted from September 
1, 2014, to June 30, 2015, in 5 ICU units from a tertiary hospital. ICU 
patients ventilated for more than 2 days and treated for an infection 
were prospectively followed. For patients who developed an infec-
tion, only the first episode was taken into account. Age, sex, SAPS II on 
admission, severity of sepsis, SOFA and CRP levels were collected, as 
well as, for those who were actually infected, therapy appropriateness. 
The response to treatment was estimated by the CRP ratio between 
day 5 and day 1. Delta SOFA was also calculated between day 5 and 
day 1. Patients were classified into three groups according to their CRP 
ratio: fast responders if CRP ratio was ≤0.4; slow responders if CRP 
ratio was >0.4 and ≤0.8; and non-responders if CRP ratio was >0.8.
Results Two hundred and sixty-nine ventilated patients (95 women 
and 174 men) were treated for an infection, 170 on admission and 
99 during their ICU stay. Their mean age was 65  ±  15  years, and 
mean SAPS II was 48  ±  15. At day 1 of infection, mean CRP was 
211 ± 117 mg/l and the mean SOFA score 7.3 ± 3.7. Infection could 
not be confirmed in 11 (4  %) patients. According to bacteriological 
results, 157 (61  %) treatments were appropriate and 45 (17  %) were 
inappropriate. In 56 (22  %) treatment efficacy was not evaluable. At 
day 5, mean CRP level was 125 ± 93 mg/l and SOFA score 6.0 ± 4.2. 
Eighty-nine (35 %) patients were fast responders, 98 (38 %) were slow 
responders, and there were 71 (27  %) non-responders. ICU mortality 
was significantly higher among non-responders (15, 23.4 and 52  %, 
respectively, for fast, slow and non-responders; p  <  0.001). There 
was no statistically significant difference in mortality rate according 
to infection therapy appropriateness (36/157, 23  % vs 15/45, 33  %, 
respectively, for appropriate and inappropriate therapy—p =  0.166). 
However, the study lacked of statistical power to assess the observed 
mortality difference. After adjustment for SAPS II and deltaSOFA, CRP 
ratio remained significantly associated with ICU (1.08, 95  % CI 1.03–
1.14 for 10 % CRP ratio variation, p = 0.002) and hospital (1.07, 95 % 
CI 1.02–1.13 for 10 % CRP ratio variation, p = 0.009) mortality. In our 
cohort, CRP ratio had a good discrimination capacity (area under ROC 
curve = 0.72) and a good calibration (Hosmer–Lemeshow goodness-
of-fit test = 0.055) for ICU mortality.
Conclusion CRP ratio is an easy tool that may help to assess prognosis 
of infected ICU patients.
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Introduction Candidemia in patients admitted to the intensive care 
unit (ICU) is a serious problem and, of particular concern, associated 
with high mortality (1). The aim of our study was to determinate epi-
demiological characteristics and prognostic factors of candidemia in 
non-neutropenic critically ill patients.
Page 153 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
Patients and methods This retrospective study was carried out at the 
military hospital of Tunisia. From January 1, 2012, to December 31, 
2013, all patients with positive blood culture for Candida species were 
identified.
Results Over the 2-year study period, 36 episodes of candidemia 
in 760 patients were reported. The incidence was 1.57 per 1.000 
patient-days.
The mean age was 63 ± 13 years. SOFA score at admission and at day 
of diagnosis was 10 ± 4 and 15 ± 8, respectively.
The mean time from admission to the first positive blood specimen 
was 14 ± 10.5 days.
C. albicans was the most common pathogen (69.5 %, 25/36), followed 
by C. glabrata (11.1  %, 4/36) C. tropicalis (16.6  %, 6/36) and C. krusei 
(2.7 %, 1/36).
Candidemia was classified as catheter-related infection in 44.5  % of 
cases and as primary in 22.2 %. In other cases, it was associated either 
with peritonitis (22.2 %) or with pneumonia (11.1 %).
At the onset of candidemia, 10 patients (27.7 %) were not colonized by 
any Candida specimen and 26 (72.3 %) patients were positive for oral 
carriage of yeast.
Caspofungin was the most frequently used drug as primary treatment 
(66.6 %), followed by fluconazole (27.7 %) and amphotericin B (5.5 %).
For 27.7  % of cases, the initial antifungal drug was changed after a 
median of 5 days of treatment. The most frequent change was the sub-
stitution of fluconazole for caspofungin (6 cases) and caspofungin for 
fluconazole (4 cases). The median duration of treatment was 14 days 
(range 5–24).
Regarding bacterial strains associated with candidemia, a predomi-
nance of infection with Escherichia coli (33.3  %) followed by Acineto-
bacter baumannii (27.7  %) before the diagnosis of candidemia, was 
noted. While after the diagnosis of candidemia, Pseudomonas aerugi-
nosa (55.5 %) was the most frequently organism found.
Mortality in the ICU was 45  %. Tow factors were associated with an 
increased risk of death: high SOFA score at the onset of candidemia 
(p = 0.01) and the use of steroids (p = 0.03).
Conclusion This report shows that candidemia is a significant source 
of mortality in ICU. Determining factors associated with these high 
rates may lead to identifying measures that can help prevent disease.
Competing interests None.
Reference
1.  Curr Opin Crit Care 2008, 14:600–604.
P231  
Extracorporeal membrane oxygenation cannula‑associated 
infections: implication of virulent Escherichia coli phylogroups
Jonathan Messika1, Olivier Clermont2, Matthieu Schmidt3, Alexandra 
Aubry4, Romain Fernandes2, Erick Denamur2, Alain Combes3, 
Jean‑Damien Ricard1
1Service de réanimation médico‑chirurgicale, CHU Louis Mourier, 
Colombes, Colombes, France; 2Iame, umr 1137, INSERM, Univ Paris 
Diderot, Sorbonne Paris Cité, Paris, France; 3Service de réanimation 
médicale, Groupe Hospitalier Pitié Salpêtrière, Paris, France; 4Service de 
microbiologie, inserm u1135, immunity and infectious diseases center, 
Hôpital de la Pitié‑salpétrière, Sorbonne Universités, UPMC Univ Paris 06, 
Paris, France 
Correspondence: Jonathan Messika ‑ jonathan.messika@lmr.aphp.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P231
Introduction Infection is the most frequent extra-corporeal mem-
brane oxygenation adverse event. Among all sites, cannula-related 
infections are mainly due to Escherichia coli. E. coli population divides 
into commensals, poorly virulent (phylogroups A, B1, C, E) and extra-
intestinal virulent (phylogroups B2, D, F) strains. Owing to the fre-
quent femoral site of catheterization, one may wonder whether strains 
responsible for infection have particular traits or whether their pres-
ence simply reflects the proximity with the lower digestive tract. We 
therefore decided to investigate phylogenetic group belonging and 
antimicrobial susceptibility spectrum of E. coli strains from extracor-
poreal membrane oxygenation cannula-associated infections.
Patients and methods Retrospective study (November 2012–January 
2015) of phylogenetic group belonging (by polymerase chain reac-
tion determination) and antimicrobial susceptibility (calculation of 
a susceptibility score, according to the sensitivity to 17 antimicrobial 
agents) of E. coli strains of cannula-related infection or colonization, in 
Pitié-Salpétrière Medical Intensive Care Unit. Collection of clinical data 
and characteristics of infection or colonization episodes.
Results Thirty-five strains were collected (32 infections and 3 coloni-
sations), in 30 patients (18 men, aged 50.7  years, median Simplified 
Acute Physiology Score II 45). All but 2 extracorporeal membrane oxy-
genation was venoarterial, implanted for cardiogenic shock (75  %), 
cardiac arrest (20  %) or septic shock (5  %). Four patients had more 
than one strain collected: two patients had two separate infectious 
episodes each caused by different strains; 1 patient was colonized 
with one strain and subsequently infected with this strain and in the 
last patient, the same strain was retrieved at a 1 week interval despite 
antibiotics.
Median time to collection of strain was 14  days after extracorpor-
eal membrane oxygenation implantation. E. coli was associated with 
another pathogen in 14 episodes. E. coli cellulitis accounted for 27 epi-
sodes, of which two had concomitant bacteremia. Two other episodes 
of E. coli bacteremia were reported. Surgery was mandatory for 7 epi-
sodes, and extracorporeal membrane oxygenation was explanted in 4.
Of the 35 E. coli strains collected, 12 (34 %) had a wild-type phenotype 
towards beta-lactams, 15 (43  %) had penicillinase secretion pheno-
type, 6 (17 %) an extended spectrum beta-lactamase secretion pheno-
type, and 1 cephalosporinase phenotype.
Highly virulent extra-intestinal pathogenic strains were predominant, 
accounting for 23 isolates (66  %, 3 colonization; phylogroups: B2 
n = 13; D n = 9; F n = 1), whereas 11 (31 %) were grouped as com-
mensal isolates (A n = 3; B1 n = 3; C n = 4; E = 1), and 1 non-grouped. 
Interestingly, more virulent isolates evidenced more resistant pheno-
type, with a lower, albeit non-significant, susceptibility score (12 for B2, 
D or F vs 15.5 for A, B1, C, or E p = 0.06).
Discussion As the cannulas are placed in femoral vessels, contiguity 
with faecal flora may explain E. coli predominance in extracorporeal 
membrane oxygenation cannula-related infections, its polymicrobial 
feature, and the diversity of E. coli population. Nevertheless, among all 
isolates, highly virulent extra-intestinal pathogenic strains were pre-
dominantly collected. Their advantageous genetic background may 
explain their predominance in this context.
Conclusion As for other infectious sites, but to a lesser extent, our 
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Introduction Diabetes mellitus affects 10  % of the general popula-
tion worldwide, 10–25  % of critically ill patients, and is associated 
with high morbidity and mortality. Sepsis is among the main compli-
cations of diabetes. Patients with hematologic malignancies also are 
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immunocompromised because of underlying disease and treatments. 
Intensive care unit-acquired infections, especially bloodstream infec-
tions and ventilator-associated pneumonia, are challenging compli-
cations in critically ill patient. To our knowledge, no study reported 
the influence of diabetes mellitus on acquired sepsis in this setting. 
This study is a post hoc analysis of the prospective cohort TRIAL-OH 
to determine whether diabetes mellitus is associated with increased 
risk for intensive care unit-acquired infections in patients with hema-
tologic malignancies.
Patients and methods TRIAL-OH is a prospective multicenter cohort 
of patients admitted to 17 intensive care units in France and Belgium. 
We studied the subgroup of patients with intensive care length of 
stay superior to 3 days and who needed invasive mechanical ventila-
tion within the first 3  days of their admission. Patients with diabetes 
mellitus under treatment were compared to patients without diabetes 
or with only diabetic diet. A propensity score for diabetes was con-
structed using multivariable logistic regression and used to match 
patients with and without diabetes mellitus and to determine the 
influence of diabetes on hospital mortality and intensive care unit-
acquired infections (as defined by bacterial or fungal infections occur-
ring later than the second day of intensive care unit admission).
Results Among the 1011 patients of TRIAL-OH, 378 fulfilled the inclu-
sion criteria for this study. Forty-eight (12.7 %) had diabetes mellitus, 
38 with chronic complications and 10 uncomplicated. Diabetics were 
significantly older than controls (median 61.5 [interquartile ranges: 
58.7; 73] vs 60 [49; 71], p value = 0.019). Intensive care units and gen-
der were not different between patients with and without diabetes (73 
and 62  % male respectively, p value =  0.20). SOFA was close (8 [5.7; 
11.2] in diabetics vs 8 [5.2; 11.7] in others, p value = 0.94). There were 
significantly more frequently cardiovascular comorbidities in diabetics 
(71 vs 36 %, p value <0.0001). Other comorbidities were not different, 
as well as hematological features: The main hematologic malignancies 
were acute myeloid leukemia in 27 %, lymphoma in 32 %, myeloma in 
19.5 %, chronic lymphocytic leukemia in 19 %. Allogeneic and autolo-
gous bone marrow transplantation concerned 23 and 11 % of patients, 
respectively, with no difference between groups. Throughout their 
stay, 79 % of diabetic patients and 81 % of controls required vasopres-
sors, 25 and 21  % underwent sequential renal replacement therapy 
and 15 and 22 % continuous renal replacement therapy. Intensive care 
unit-acquired infections occurred in 10 (21 %) patients with diabetes 
mellitus and 91 (28  %) patients without diabetes mellitus. Intensive 
care unit mortality was 46 and 54 % in diabetic patients and controls, 
respectively. Hospital mortality was 54 and 62  % in diabetic patients 
and controls, respectively. After propensity score matching, there was 
no effect of diabetes mellitus on the occurrence of intensive care unit-
acquired infections (hazard ratio 0.57, 95 % confidence interval [0.26–
1.24], p value = 0.16) and on hospital mortality (hazard ratio 0.96, 95 % 
confidence interval [0.54–1.71], p value = 0.88).
Discussion Diabetes and hematological malignancies both are immu-
nosuppressive conditions. However, this study suggests that diabetes 
does not represent an additional risk factor in patients with hemato-
logic malignancies.
Conclusion Diabetes mellitus is not associated with increased rate 
of intensive care unit-acquired infections or mortality in critically ill 
patients with hematologic malignancies.
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Introduction Candidemia has a poor prognosis and is associated with 
a high mortality in part because of delayed diagnosis. There is no opti-
mal tool and, despite a rather low sensitivity, gold standard for candi-
demia diagnostic and follow-up still relies on blood cultures. The use 
of blood culture-specific media is not clearly addressed in guidelines. 
In vitro studies showed that the presence of an antifungal agent can 
significantly modify the rate and the time to positivity of blood cul-
ture not containing adsorbing agents. This can have a direct impact 
on diagnosis and on candidemia monitoring. Our objective was to 
study in clinical practice the impact of systemic antifungal therapy on 
the diagnostic performance of each medium and to highlight their 
added value in the management of candidemia in intensive care unit 
patients.
Patients and methods All intensive care unit patients experiencing 
a candidemia in a university hospital, with at least one blood sample 
collected, in a 4-year period (2010–2013) were included in a retrospec-
tive study. The Bactec Plus TM Aerobic/F (Aerobic) and Bactec Plus TM 
Anaerobic/F (Anaerobic) bottles, which both contain adsorbing resins, 
and the non-resin Bactec Mycosis TM IC/F (Mycosis) bottles were com-
pared. The clinical characteristics and the presence of systemic anti-
fungal therapy were recorded for each patient. We analyzed: (1) the 
positivity rate during candidemia; (2) the time to positivity; and (3) the 
agreement between bottles. Univariate analyses and multivariate hier-
archical model for repeated measures were performed.
Results A total of 64 patients with candidemia, median age of 61 years 
(interquartile range: 47–74) and a median IGSII score of 47.5 [42–57] 
were considered. Overall, positivity rate was greater in resin bottles 
(Aerobic and Anaerobic: 56.6  %) than in selective Mycosis bottles 
(43.4 %). In the presence of systemic antifungal therapy, the positivity 
rate decreased significantly (OR 0.19 (95  % confidence interval [0.07; 
0.52], p  <  0.01). This decline was observed with both resin and non-
resin Mycosis bottles. Overall, time to positivity was longer in resin bot-
tles (Aerobic and Anaerobic) (30 h; IQR 19; 60) than in Mycosis bottle 
(27 h, IQR 16–78). Systemic antifungal therapy prolonged time to posi-
tivity by a factor 1.92 ([1.29; 2.85]; p =  0.05). The impact of systemic 
antifungal therapy on the time to positivity was more pronounced in 
the Mycosis bottles than in those with resins (p < 0.01); however, TTP 
remained longer in resin bottles.
Fig. 35 Venn diagrams showing the number of agreement or disa‑
greement result between pairs composed of one Mycosis bottle (MY) 
and one resin bottle (aerobic and/or anaerobic)
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The agreement study showed that when the sampling was done the 
same day, on both resins and Mycosis blood cultures, in the absence 
of systemic antifungal therapy, 13 (19 %) and 15 (22 %) bottles were 
positive only on resin or only on Mycosis bottles, respectively, and in 
the presence of systemic antifungal therapy, 9 (41 %) and 5 (23 %) bot-
tles were positive only on resins or only on Mycosis bottle, respectively 
(Fig. 35). Thus, systemic antifungal therapy decreased the agreement 
rate between the bottles.
Discussion Systemic antifungal therapy modifies significantly the 
blood culture results independently of the presence of resin in the bot-
tles in intensive care units patients with candidemia. We also demon-
strated that there is a clear gain in sensitivity to collect concomitantly 
resin and Mycosis bottles, especially when systemic antifungal treat-
ment is present. However, a comparative multi-centric study would be 
necessary to confirm these results.
Conclusion These results encourage clinicians to use only pertinent 
empirical SAT prescription and to sample BC before any SAT initiation. 
In the presence of SAT, a systematic sampling of both Mycosis® and 
resins bottles may improve not only the primary diagnostic but also 
the time needed for the step-down or end of therapy.
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Introduction Invasive Candida infection is common in intensive care 
unit (ICU) patients and is associated with an increased mortality (up 
to 80 %) (1–2). The aim of the current study is to describe the clinical, 
microbiological and management patterns of invasive Candida infec-
tions in a Tunisian ICU.
Patients and methods A retrospective cohort study including consec-
utive patients admitted to our ICU between January 2012 and March 
2015 with invasive Candida infection, defined by a positive blood cul-
ture for Candida species and/or the presence of 50  % or more colo-
nized sites with Candida (Pittet index).
Results During the study period, invasive Candida infection was iden-
tified in 40 patients (median age 65  years, IQR 53.5–72, 55  % male, 
median SAPS III: 63, IQR 58–70.5). The most common underlying dis-
ease was diabetes present in 65 %. The main reason for ICU admission 
was acute respiratory failure in 30 patients (75  %); 80  % of patients 
were invasively ventilated at a moment of their ICU stay. Septic shock 
and ARDS were observed in 62.5 and 42.5  %, respectively. Candida 
species were isolated mainly in oropharyngeal (52 %), urinary (45 %) 
and rectal (32  %) sites, and blood cultures for Candida species were 
positive in 3 patients (7.5 %). Candida albicans was the most prevalent 
species, isolated in 23/40 patients (57.5  %) [a mixed infection with 
other Candida species was present in 5/40 (12.5 %)]; the other isolates 
were C. tropicalis in 12/40 (30 %) patients; C. glabrata in 7/40 (17.5 %) 
and other Candida species were identified in 10 %. Antifungal activity 
was tested in 21/40 patients (52.5 %), showing that 17/21 of species 
were susceptible to fluconazole (81 %) and to voriconazole in 19/21 
(90.5 %). Fluconazole was the first administered antifungal therapy in 
97.5  % of cases. Overall mortality was 55  % for a median predicted 
mortality by SAPSIII at 41.9 % (IQR: 31.5 to 58 %).
Conclusion Invasive Candida infection is mainly due to C. albicans and 
is associated with an increased mortality despite apparent susceptibil-




1.  Kett D, Azoulay E, Echeverria P et al. Candida bloodstream infections in 
intensive care units: analysis of the extended prevalence of infection in 
intensive care unit study. Crit Care Med 2011; 39: 665–70.
2.  Vincent JL, Rello J, Marshall J et al. International study of the prevalence 
and outcomes of infection in intensive care units. JAMA 2009; 302: 
2323–9.
P235  
Causes of admission in medical intensive care of patients 
suffering from severe psychiatric disorders
Hanane Ezzouine1, Constant Aniolo Edith1, Abdellatif Benslama1
1Anesthesiology and Intensive Care Department, University Teaching 
Hospital Ibn Rushd‑Casablanca, Casablanca, Morocco 
Correspondence: Hanane Ezzouine ‑ ezzouinehanane@yahoo.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P235
Introduction The involvement of ICUs in support of vital functions of 
failures among patients suffering from mental disorders has been rein-
forced by recent years. Few studies address the issue of the reconcilia-
tion between somatic medical disciplines and psychiatry.
Patients and methods This is a prospective study between January 
2012 and October 2014 including all patients admitted in medical inten-
sive care and have had severe psychiatric history. The various data were 
collected from the farm returns. Only the initial diagnosis was retained.
Results During the study period of 782 hospitalizations, 26 patients 
(3.32 %) were admitted with psychiatric history. The sex ratio was equal 
to 1 and age between 18 and 60  years. Psychiatric history was essen-
tially: schizophrenia (34.6  %), bipolar disorder (19.2  %), depression, 
psychosis, etc. The successful initial diagnosis: drug poisoning (34.6 %), 
impaired consciousness (30.7 %), shock, respiratory distress, metabolic 
disorders; suicide attempts; status epilepticus in 7.7  % of cases. Age 
advanced cardiovascular history and represents poor prognostic factors. 
Infection remains the most serious complication. Mortality was 19.2 % 
mainly by septic shock, with no correlation with psychiatric profile.
Conclusion The mentally ill are more exposed to various somatic 
pathologies that may require management in intensive care. On 
admission, there are more drug poisoning. Infectious complications 
are the cause of high mortality, not correlated with the severity score 
at admission or patient psychiatric history. The study was limited by its 
implementation on a single intensive care unit of the institution and 
having retained only the initial diagnosis.
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Introduction The precise impact of unplanned extubation (UE) on 
patients’ course in intensive care unit (ICU) remains elusive. While 
many studies have found an association between UE and increased 
time spent under mechanical ventilation (MV) or delayed ICU dis-
charge, UE has also been described to carry a beneficial effect on 
length of MV and ICU outcome in a subgroup of patients not requiring 
re-intubation. We aimed to describe the incidence, characteristics and 
outcomes of patients experiencing UE (UE patients) and to compare 
these issues with patients undergoing a planned extubation (non-UE 
patients).
Patients and methods This is a prospective single-center study in a 
15-bed university-affiliated mixed ICU, over an 18-month period. All adult 
patients undergoing tracheal intubation were included. A nurse driven 
sedation protocol based on RASS score was used in most mechanically 
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ventilated patients. Tracheal tubes were fixed with tape. The tape is 
fixed on the tracheal tube and wrapped around the neck. One strand 
of the tape sometimes passes on the bridge of the nose before reach-
ing the neck, according to the patient’s morphology. The use of physical 
restraints is prescribed by the attending physician but is widely used in 
our unit. Characteristics of UE were registered. Demographic characteris-
tics and ICU outcomes were compared between UE and non-UE patients.
Results During the study period, 882 patients were admitted 
and 580 patients required tracheal intubation (65.7  %). All the 
patients were orally intubated. Forty-six UE occurred in 42 patients 
(55.1 ± 20.6 years, SAPS II 46 ± 17). Mechanical restraints were present 
in 89 % of the episodes. The incidence density was 10.3 events every 
1000 days of MV. UE occurred equally during night and day and four 
times during nurse shift. Caregivers were aware of the UE risk in one-
third of cases. UE was not associated with MV settings. Among the UE 
episodes, 21 % occurred in agitated patients and 15 lead to re-intuba-
tion, within the following hour in most of the cases. Not re-intubated 
UE patients were younger (49.4 ± 20.1 vs. 65.3 ± 18.6 years, p < 0.05), 
had a shorter ICU LOS (2.8 ± 4.1 vs. 9.4 ± 11.1 days, p < 0.05) and a bet-
ter survival (100 vs. 79.2 %, p < 0.5) as compared to non-UE patients. 
Re-intubated UE patients were more likely to have a longer time under 
MV (21.9 ± 12.8 vs. 9.4 ± 11.1 days, p < 0.05) and ICU LOS (21.9 ± 12.8 
vs. 9.4 ± 11.1 days, p < 0.05) than non UE patients (Table 43).
Age, underlying systemic hypertension, time between admission and 
UE and between sedation withdrawal and UE were risk factors for re-
intubation. Voluntary intoxication as admission diagnosis was associ-
ated with UE good outcome.
Discussion Patients may self-extubate because they were not extu-
bated in an appropriate timing. Rapid modifications of conscious-
ness can lead them to waken in the unfriendly environment of ICU in 
between the nurse rounds, when deliberate UE might be unnoticed. 
Only one-fifth of UE patients was agitated. Nevertheless, RASS score 
was evaluated every 4 h, at nurse round. Agitation may occur within 
these rounds. The impact of physical restraints on UE remains unclear.
Conclusion UE might lead to a better outcome in the subset of not 
re-intubated patients. Altogether, UE underscores the need for a bet-
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Introduction The association between mortality and time of admis-
sion to ICUs has been extensively studied but remains a matter of 
debate. We aimed therefore to reassess the impact of time of admis-
sion on ICU mortality by retrospectively investigating a recent (2006–
2014) and large ICU cohort.
Patients and methods All adults (≥18  years) admitted between 
January 2006 and December 2014 to a French tertiary care medical 
ICU (staffed by onsite intensivist 24 h a day and 7 days a week) were 
included in the study. Patients’ characteristics, medical management, 
and mortality were extracted from our prospective ICU database. 
Patients were grouped according to their admission time: weekday, 
weeknight, and weekend. ICU mortality was the primary outcome, and 
adjusted hazard ratios (HR) of death were analyzed by multivariate Cox 
model.
Results A total of 2.428 patients were included: age 62  ±  18  years, 
male: 1515 (62 %), and median SAPSII score: 38 (IQ, 27–52). A total of 
1.449 (59.7  %) patients received invasive mechanical ventilation, 790 
(32.5  %) patients received vasopressors (epinephrine or norepineph-
rine) and 162 (6.7 %) patients required renal replacement therapy. The 
overall ICU mortality rate was 13.7 % (332/2428).
Admissions to ICU occurred during weekdays in 680 cases (28 %), dur-
ing nighttime in 1.461 cases (60  %), and during weekends (Saturday 
and Sunday) in 611 cases (25  %). Baseline characteristics patients 
were similar between groups except that patients admitted dur-
ing the second part of weeknight have a significantly higher SAPS II 
score than those admitted during weekdays (41, 28–56 vs 38, 26–51; 
p  =  0.034, respectively). Patients admitted during weekdays have a 
significantly longer duration of mechanical ventilation and length of 
ICU stay as compared to others (7, 3–15 days vs 5, 3–13 days, p < 0.001 
and 8, 3–20  days vs 7, 3–15  days, p  <  0.01 respectively). ICU mortal-
ity was comparable for patients admitted during weekdays (95/680, 
14 %), weeknights (142/1099, 12.9 %) and weekends (94/649, 14.5 %). 
Univariate analysis showed that admission during the second part of 
the night was associated with a higher ICU mortality (HR, 1.39; 95  % 
CI 1.06–1.81) as compared to other time admissions. However, multi-
variate Cox model controlling factors associated with mortality such 
as SAPS II score, ICU admission source, and intensity of treatment 
demonstrated that admission during weeknights and weekends was 
not associated with an increased risk for death. During the first part of 
the night, the adjusted HR was 0.95 (95 % CI 0.66–1.37) p = 0.80 and 
during the second part of the night the adjusted HR was 1.24 (95 % CI 
0.85–1.81) p = 0.25 in comparison with the weekdays admissions. Dur-
ing the weekend, the HR was 1.05 (95 % CI 0.82–1.33) in comparison 
with the rest of the week (p = 0.71).
Conclusion Time of admission, especially weeknight and weekend 
(off-hours admissions), did not influence the prognosis of ICU patients. 
The higher illness severity of patients admitted during the second part 
of the weeknight may explain the observed increased mortality in this 
part of population.
Competing interests None.
Table 43 See text for description
UE unplanned extubation, SAPS Simplified Acute Physiology Score, ICU intensive 
care unit, LOS length of stay, MV mechanical ventilation
* The comparison between non-UE patients and the whole cohort of UE patients
** p < 0.05 when comparing re-intubated UE patients and non-UE patients














Age (years) 65.3 ± 18.6 55.1 ± 20.6 49.4 ± 20.1… 67.4 ± 16.3 0.002
Gender (f/m) 280/300 16/26 13/24 3/12 0.9
SAPS II 49 ± 22 46 ± 17 45 ± 18 45 ± 18 0.13
Died in ICU 
[n (%)]
121 (20.8) 5 (11.9) 0 (0)… 5 (33) 0.31
ICU LOS 
(days)
9.8 ± 11.8 11.3 ± 10.9 5.4 ± 5.9… 19.8 ± 11.2** 0.1
Length of MV 
(days)
9.4 ± 11.1 7.5 ± 10.9 2.8 ± 4.1… 21.9 ± 12.8** 0.27
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Introduction Decisions on whether to admit a critically ill patient to 
ICU are complex, since they need to balance the potential risks and 
benefits for the individual patient with the limited bed availability and 
thus the implication for future patients. Although recommendations 
for ICU triage are available, compliance with them has been shown to 
be poor. Decisions regarding ICU admission are currently not based on 
scientific evidence, yet refusal is associated with increased mortality.
Aim To analyze determinants and outcomes associated with decisions 
to deny or to delay ICU admission in critically ill patients.
Patients and methods This is an observational prospective study over 
a 6-month period, between January 1, 2015, and June 30, 2015, in a 
7-bed medical intensive care unit. Patients’ characteristics, reasons for 
requesting ICU admission, severity of underlying disease, severity of 
acute illness and mortality were recorded. Multinomial logistic regres-
sion analysis was performed to identify factors associated with ICU 
admission refusal.
Results ICU admission was requested for 364 patients. One hundred 
and four (28.6 %) were admitted, 173 (47.5 %) were never admitted and 
87 (23.9 %) were admitted to the ICU at a later time. Reasons for refusal 
were: too sick to benefit, 62 (23.8 %); too well to benefit, 36 (13.8 %); unit 
full, 130 (50 %); therapeutic limitation, 28 (11 %); family order of non ICU 
admission, 5 (1.92 %) and other causes, 14 (5.38 %). Multivariate analysis 
revealed that the non ICU admission was associated with neurological 
disease (OR 3.08; 95  % CI [1.3–19.08]; p =  0.01), lack of available ICU 
beds (OR 6.26; 95 % CI [4.14–9.46]; p = 0.03), cardiac disease (OR 8; 95 % 
CI [2.91–591.06]; p < 0.001), and metabolic disease (OR 2; 95 % CI [1.02–
10.02]; p =  0.02). Hospital mortality was 36.5  % (38/104) for immedi-
ately admitted patients, 17.2 % (15/87) for patients admitted later and 
14.4 % (25/173) for never admitted patients.
Conclusion Refusal of ICU admission was correlated with the severity 
of acute illness and lack of ICU. Further efforts are needed to define 
which patients are most likely to benefit from ICU admission and to 
improve the accuracy of data on ICU refusal rates.
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Introduction ICU bed shortage and extremes in clinical status are 
among other reasons of refusals of patients proposed for ICU admis-
sion. The outcome of such patients relies heavily on local organization 
of healthcare facilities. The aim of this study is to describe characteris-
tics and outcomes of non-admitted patients in a Tunisian ICU.
Patients and methods Observational prospective cohort study con-
ducted from January 1, 2015, to August 30, 2015. All ICU admission 
proposals were analysed, and patients’ outcome was collected after 
48 h regardless of the type of decision: ICU admission or refusal.
Results During the study period, 320 patients were proposed for 
admission in our ICU (72.9  % of proposals occurred between 6:00 
AM and 06:00 PM); 54.1 % were referred from the emergency depart-
ment of our hospital. One hundred and five patients (32.5  %) were 
admitted to the ICU. The median age of non-admitted patients was 
62  years (49–75). The unavailability of free ICU beds was the most 
frequent reason for admission refusal (76.7  %), followed by patient’s 
severity considered as extreme (hopeless cases) in 12.1  %, or not 
enough severe in 10 %. Among the refused patients, 44 % were intu-
bated. The Table  44 compares characteristics of admitted and non-
admitted patients.
At day 2, 15.8 % of non-admitted patients died, 50.7 % were still in the 
ward, 25.1 % were transferred to another structure, and 7 % were sec-
ondarily transferred to our ICU.
Conclusion Two-third of referred patients is not admitted to our ICU, 
and the main cause for refusal was the unavailability of free ICU beds. 
Mortality in non-admitted patients is high.
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Introduction Up to 50 % of critically ill patients develop acute kidney 
injury (AKI) and up to 5 to 10  % require renal replacement therapy 
(RRT) in the intensive care unit (ICU). Studies that have investigated 
long-term outcome in this population suggest that these patients 






Age [median (IQR)] 62 (42.5–72.5) 62 (49–75) 0.551




5 (4–8) 5 (3–7) 0.051
Diabetes [n (%)] 77 (73.3) 92 (42.8) <0.0001
Hypertension [n 
(%)]
60 (57.1) 107 (49.8) 0.215
Malignancy [n (%)] 5 (4.8) 34 (15.8) 0.005




18 (17.1) 35 (16.3) 0.841
Dementia [n (%)] 5 (4.8) 7 (3.3) 0.538
Myocardial infarc‑
tion [n (%)]
14 (13.3) 33 (15.3) 0.632





93 (88.6) 164 (76.3) 0.009
Shock [n (%)] 30 (28.6) 51 (23.7) 0.349
Intubation [n (%)] 52 (49.5) 95 (44.2) 0.368
Mortality [n (%)] 24 (22.9) 107 (49.8) <0.0001
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have a poor prognosis and highlight the need for further investigation 
of factors associated with long-term outcome.
Patients and methods This is a retrospective single-centre study of 
patients admitted to the medical ICU of a tertiary hospital and who 
received RRT for AKI, between January 2008 and December 2011. AKI 
was defined and classified at ICU admission based on the Kidney Dis-
ease Improving Global Outcomes (KDIGO) classification using both 
creatinine and urine output. In order to identify predictors for death 
at 1 year of follow-up, a univariable analysis and a subsequent multi-
variable analysis were performed using a Cox proportional hazards 
regression model. Renal function recovery at 1  year was calculated 
using the following formula: [(estimated glomerular filtration Rate (e 
GFR) at 1 year minus baseline e GFR)/baseline e GFR], where e GFR was 
determined using the simplified modification of diet in renal disease 
equation using creatinine values within the 3  months prior to ICU 
admission to define baseline.
Results Of the 245 eligible patients, 214 were followed up for at least 
1 year after hospital discharge. Of the 147 (68.7 %) patients who had 
died at 1  year, 135 (92  %) died before hospital discharge. Using sur-
vival analysis, factors independently associated with mortality were 
illness’ severity at admission (using the Simplified Acute Physiology 
Score II, hazard ratio (HR) = 1.02, 95 % confidence interval [1.01–1.03], 
p =  0.004) and at RRT initiation (using the Sequential Organ Failure 
Assessment score, HR  =  1.07 [1.01–1.12], p  =  0.02), use of CVVH as 
compared to HDI (HR = 3.09, [1.74–5.50], p < 0.001), age (HR = 1.02, 
[1.01–1.04], p  =  0.001) and chronic liver diseases (HR  =  1.78 [1.06–
2.96], p = 0.03). At 1 year, renal function was known in 42 % (28/67) 
of the survivors; 21 % of them (6/28) had an e GFR stage 1 while 7 % 
(2/28) were dialysed. Renal recovery was analysed in 19 patients: 4 
patients (21 %) had a renal recovery between 50 and 89 %, 3 (16 %) 
had a renal recovery less than 50  %, and 12 (63  %) had a complete 
renal recovery (more than 90 % of recovery as compared to baseline 
e GFR).
Conclusion One-year mortality in ICU patients with AKI requiring RRT 
remains high with around two-thirds of patients dead at 1 year, mostly 
before hospital discharge. Although renal impairment persists in most 
survivors, only a few require long-term RRT. Prospective research is 




1.  Schiffl H, Fischer R. Five‑year outcomes of severe acute kidney injury 
requiring renal replacement therapy. Nephrol Dial Transplant. 2008 Jul 
1;23(7):2235–41.
2.  Lins RL, Elseviers MM, Daelemans R. Severity scoring and mortality 1 year 
after acute renal failure. Nephrol Dial Transplant Off Publ Eur Dial Transpl 
Assoc ‑ Eur Ren Assoc. 2006 Apr;21(4):1066–8.
P241  
Nowadays, SAPSII better predicts 1‑year mortality than hospital 
mortality
Jean‑Etienne Herbrecht1, Max Guillot1, Quentin Maestraggi1, Charlotte 
Kaeuffer1, Ralf Janssen‑Langenstein1, Sylvie L’hotellier1, Sophie Hatsch1, 
Benjamin Lebas1, Alexandra Boivin1, Maleka Schenck1, Marie‑Line Harlay1, 
Anne Meyer1, Vincent Castelain1, Francis Schneider1
1Réanimation médicale, Hôpitaux Universitaires de Strasbourg (Hôpital de 
Hautepierre), Strasbourg, France 
Correspondence: Jean‑Etienne Herbrecht ‑ jean‑etienne.herbrecht@
chru‑strasbourg.fr 
Annals of Intensive Care 2016, 6(Suppl 1):P241
Introduction The prognosis of patients admitted in an intensive care 
unit (ICU) has improved thanks to new therapies and technical pro-
gresses. Concomitantly, the average age of patients admitted in an 
intensive care unit has increased. We studied the functional and vital 
prognosis of current patient population admitted at our ICU.
Patients and methods We realized this retrospective, single-center 
study over a 5-month period in a 30-bed medical ICU. We collected the 
outcome up to 1 year after hospitalization of all consecutive patients.
Results Three hundred and eighty-eight patients were admitted with 
an average age of 62 years (±19 years). The population over 60 years 
represented 61  % of the admissions. The origin of the patients was 
equally distributed between medical hospital services, emergency ser-
vices and pre-hospital origin. The median SAPSII score was 48 (range 
6–119).
The main reasons for admission were respiratory distress (32 %), neu-
rological disorders (20 %), and infections (13 %). The observed mortal-
ity in the ICU (23 %) and during the whole hospital stay (30 %) differs 
from mortality predicted by the SAPSII score (42 %). The 1-year mortal-
ity in our cohort was 44 %.
Whatever the severity groups, the mortality rates during ICU and hos-
pital stay were lower than predicted. The mortality rate increased close 
to the rate predicted by the SAPSI only at 1-year follow-up.
Mortality is significantly influenced by an age over 60  years 
(p < 0.0001). There is no difference in mortality between patients over 
80 years and patients of 60–79 years (p = 0.47).
Twenty-one percent of patients alive at 1-year follow-up had a higher 
level of dependency as assessed by the Glasgow Outcome Scale. There 
is no link with age (Table 45).
Conclusion The SAPSII score enabled in 1993 to predict mortality dur-
ing hospital stay. Thanks to the improvement in care, the observed 
mortality rate at end of hospital stay is now substantially lower than 
the predicted rate. After discharge, the mortality rate increases signifi-
cantly during the first year but remains lower than predicted.
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Introduction Burn injuries are often associated with multisystemic 
complications essentially infectious, even in healthy patients. It is 
therefore recognized that for the diabetic patient, the underlying 
pathophysiologic alterations in vascular supply, peripheral neu-
ropathy, and immune function could have a poor prognosis. The 
aim of this study was to determine the incidence and the character-
istics of burn injuries in diabetic burn patients and to assess their 
prognosis.
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Patients and methods A retrospective study was conducted in a 
20-bed adult burn ICU in Tunis between 2009 and 2012. Diabetic 
burned patients were enrolled. Characteristics of diabetes and burn 
injuries and prognostic factors were collected. Statistical analysis was 
performed using the MedCalc software.
Results Of 1205 adult burn patients, 98 (8  %) diabetic burns were 
admitted and only 74 medical records were available and analysed. 
The mean age was 58  ±  12  years old. There were 44 males and 30 
females. The average TBSA was 21  % with an UBS of 53. The major 
mechanism of injury for the diabetic patients was scalding or flame 
burns (97 %). Diabetic patients had foot burns in 24, 3 %. The average 
healing time was 103.1 days. The healing failure rate was 30 %, and the 
death rate was 30 %.
A poorly balanced diabetes before hospitalization doubles healing 
time, lengthens five times risk of sepsis and was associated with mor-
tality in 50 % of cases.
Poor glycemic control during hospitalization is multiplied by 2.5 
healing period, risk of sepsis and risk of death. Increasing amounts of 
insulin in response to the continued high blood glucose levels was 
associated with lengthening healing time, a greater risk of sepsis and 
mortality. Severe hyperglycaemia at admission was difficult to control 
during hospitalization and was a marker of poor prognosis.
Conclusion Diabetics patients have a higher propensity for infection 
which worsens prognosis. The glycemic control during hospitalization 
is a first-order goal. Diabetic patient education must include caution 
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Introduction Decisions of withdrawal or withholding of life-sustain-
ing treatments (WWLST) almost always involve medical imaging. We 
worried about the risk of an excessive influence of the image on our 
representation of the patient, leading to a misevaluation of his prog-
nosis, and possible inadequate WWLST decisions.
Materials and methods To investigate this point, we submitted a 
quiz to all the doctors of the Pediatric Intensive Care Unit of Necker-
Enfants Malades Hospital (Paris). A first part consisted in questions 
about 6 images extracted from 6 clinical cases. For every image, they 
had to choose appropriate words characterizing it among a list of 18 
words. Then, having only the image as information on each patient, 
they had to answer 2 questions: “What is the prognosis of this patient?” 
and “Personally would you propose a WWLST?” The second part of 
the study was composed with general questions about the weight of 
imaging in WWLST decisions.
Results Fifteen of the 20 doctors of the team completed the quiz: 6 
senior doctors, 4 fellows and 5 residents. The words used to character-
ize the image were distributed in 2 groups: one with 8 neutral mean-
ing words and the other one with 10 emotional meaning words. A 
constant number of neutral words were used to characterize the 
images (14–20), while the number of emotional words varied from 6 to 
28 from an image to the other one. For 3 images, the prognostic evalu-
ation agreed with the real clinical evolution. For one image, which was 
characterized by 6 emotional words, the suspected prognosis was 
“good” or “doesn’t know” for 14/15 doctors. Only one doctor suspected 
a bad prognosis and proposed a WWLST. This patient drowned and 
died after a WWLST decision. For the last two images, who were char-
acterized by 24 and 28 emotional words, respectively, the suspected 
prognosis was “dead” for 8 and 9/15 doctors, respectively. Respectively 
5 and 10/15 proposed a WWLST. These two patients are alive after 
several years, respectively, without or with minor sequela. To the ques-
tion “Do you think that a visually impressive image but without pejo-
rative prognosis value for the radiologist risks to weigh wrongly in a 
decision of WWLST?”, the mean response from 1 (not at all) to 10 (com-
pletely) was 5.7. To the question “Do you think that a not very impres-
sive image which has a pejorative prognosis value for the radiologist 
has less impact on a WWLST decision than a visually impressive image 
with the same prognosis?”, the mean response was 5.6. Moreover, the 
doctors express the fact that for every situation clinical assessment is 
much more important than imaging and express the need to have a 
radiologist’s and an expert’s point of view for every situation.
Discussion On the basis of our quiz, we could suspect that a rather 
unimpressive image, characterized by few emotional words, risks to 
lead to an excess of optimism, while a very impressive image, char-
acterized by numerous emotional words, risks to lead to an excess of 
pessimism, which could lead to inadequate WWLST decisions. Our 
quiz overlines that the doctors are conscious of this risk and that to 
protect them against this risk, their WWLST decisions are based mostly 
on clinical examination, are helped by radiologists and experts and 
are always collective. In fact, real decisions for these patients weren’t 
influenced by the impressive character of the image, as the patients 
with the most impressive image are alive, and the patient with the less 
impressive one is dead after a WWLST decision.
Conclusion Our study underlines a real risk of an excessive influence 
of the image on the evaluation of the patient’s prognosis, which could 
lead to inadequate WWLST decisions. The consciousness of this risk 
can help the physicians to develop strategies to protect themselves 
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Introduction Recommendations to withhold or withdraw life-sus-
taining therapies (LST) in intensive care units (ICU) patients have been 
published in 2009 by the French Intensive Care Society. Since then, few 
ICUs have reported the use of these procedures in their unit. The aim 
of our study was to report modalities of decisions to forgo LST (DFLST) 
in dying patients and characteristics of these patients in our unit.
Patients and methods We performed a retrospective study assess-
ing all dying patients between November 2011 and December 2013 
in the Tourcoing Hospital ICU. Characteristics of these patients on 
ICU admission and during ICU stay and modalities for withholding or 
withdrawing LST were recorded. Two analyses were performed: the 
first concerned all patients who died; the second, patients dying in the 
72 h following ICU admission.
Results During the study period, 177 (79 %) of 224 patients dying in 
our unit had treatment withheld or withdrawn after a mean ICU stay 
of 12 ± 14.1 days, whereas 54 (24.1 %) patients had treatment(s) with-
held (i.e., not started or not increased if already engaged), 62 (27.7 %) 
had one or more treatment(s) withdrawn (i.e., invasive procedures 
engaged were stopped) and 61 (27.2  %) had a decision to with-
draw LST preceded by a withholding procedure. Mean ICU stay was, 
respectively, 10.3 ± 13.7 days and 11.1 ± 11.7 days for withheld and 
withdrawn patients. Withdrawal procedures occurred after a mean 
of 4 ±  3.2  days following the decision to withhold LST in concerned 
patients. Cardiopulmonary resuscitation (CPR) was the most frequent 
withheld procedure (91.3 %) followed, respectively, by “not started or 
not increased” vasopressor treatment (80  %) and renal replacement 
therapy (68.7  %). Terminal weaning from mechanical ventilation was 
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the most frequently withdrawn procedure (73.9  %) followed by dis-
continuation of vasopressor treatment (65.8  %). Therapeutic failure 
explained DFLST in 121 (68.3  %) patients, followed by an expected 
poor functional autonomy (47.4  %) and by the severity of underly-
ing diseases (40.6 %). Factors associated with a decision of withhold-
ing or withdrawing LST were: cirrhosis [OR 11.7, 95  % CI (1.1–106.4); 
p = 0.02], a Knaus score B, C, D [OR 5.4; 95 % CI (2.2–12.7); p = 0.0001], 
occurrence of medical complications during ICU stay [OR 3.4; 95 % CI 
(1.3–8.1); p = 0.0007].
Ninety-four patients (41.9 %) died in the 72 h following ICU admission. 
Among these, a procedure of withholding or withdrawing LST was 
recorded for 60 patients (63.8 %). Renal replacement therapy was the 
second most common withheld treatment (75 %) after CPR (94.4 %). 
A renal SOFA score 3.4 [OR 4.1; 95 % CI (1.2–13.2); p = 0.0002] and a 
Knaus score B, C, D [OR 6.9; 95 % CI (2.4–19); p = 0.01] were associated 
with a decision of withholding/withdrawal of LST.
Discussion Withholding and/or withdrawal of LST in European ICUs 
are common and variable. They are associated with age, diagnoses, 
ICU stay, geographic and religious factors. In our unit, we have not 
identified age, presence of cancer or severe co-morbidities as con-
ditions associated with LST procedures. This is probably due to the 
decision making of admission or non-admission in ICU appropriate 
to each hospital. Cirrhotic patients admitted to ICU have high mortal-
ity rates, but recent literature recommends to actively manage these 
patients in ICU during few days. This approach is applied in our unit 
and explains our result concerning patients with cirrhosis. Withhold-
ing RRT within 3 days following ICU admission suggests that RRT is a 
LST seeming excessive in some patients whose characteristics must 
be specified.
Conclusion Withholding/withdrawal of LST is common in ICU dying 
patients. Cirrhosis, poor previous functional status and occurrence of 
medical complications during ICU stay are associated with DFLST.
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Introduction The decision to admit a patient in the ICU may be com-
plex involving both objective criterions and subjective perceptions. 
The aim of the study was to analyse the subjective and emotional fac-
tors justifying the decision to admit or not an old patient with suicide 
attempt having written advanced directives.
Patients and methods In this qualitative exploratory study, a vignette 
describing the case of a 84-year-old patient admitted to the ER for a 
poisoning with several medications. He had written a letter explain-
ing clearly that he did not wanted any resuscitation. His clinical status 
was a coma (Glasgow scale 7), and he would require ICU admission 
and mechanical ventilation. Semi-directive interviews were conducted 
in five ICU-practitioner volunteers who were not prepared with the 
clinical case. Physicians were asked to comment and justify their deci-
sion to admit or not such a patient. Interviews were conducted by a 
psychologist (DA), recorded and analysed using semantic analysis con-
tent (Tropes VF8)
Results ‘Difficult’ was the mostly used word to qualify the current 
case and similar situations for which the interviewed physicians used 
to be faced in their clinical practice. Even though they actively set out 
their arguments about the case, some hesitations and contradictions 
were pointed out to justify the ‘good’ choice and the criteria proposed 
to evaluate this choice. Thus, pro and con factors used to present a 
rationalized final decision were associated with subjective factors.
The very old age of the patient was discussed a little. In contrast, the 
advanced directives were intensively debated. In the context of sui-
cide attempt, they were perceived as a ‘trap’ or a ‘alarm for help’ signal. 
Since the acute psychiatric disease could be potentially reversible, it 
could not justify a non-admission decision. The final proposal for the 
interviewed physicians would be to admit the patient in the ICU to see 
the evolution and to discuss the case in collegiality.
Discussion These interviews showed the subjective dimension sur-
rounding the decision of ICU admission or non-admission of some 
patients. The expressed doubts reflect the ethical dilemma related to 
the presented case. The suicide attempt context clearly overcomes the 
written advanced directives that were considered as a subjective ele-
ment complicating instead of simplifying the decision. The possibility 
of further collegial discussion after the admission was considered as 
an efficient safeguard to neutralize the doubts and the risks of an indi-
vidual wrong decision.
Conclusion This pilot study pointed out the ethical dilemmas associ-
ated with the complexity of medical decision in some specific context. 
Further studies may be of interest to analyse more deeply the emo-
tional and subjective parts in medical decision.
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Introduction The laws on advance directives arise from a transition 
of a paternalistic model to the deliberative model. However, the com-
plexity of the subject and easy answer by the avoidance made that this 
kind of law was rarely a priority at both the legislative level and medi-
cal level. The effect of patient’s rights and end-of-life laws has not had 
the desired result. Indeed, only 2.5 % of the patient at the end of life 
have written advance directives (1). The objective of this study was to 
explore whether an ICU stay is a good opportunity to discuss advance 
directives.
Materials and methods Since we expected subjective answers (hard 
to quantify), consequently we decided to conceive a qualitative study. 
To answer this question, over a period of 3  months: we selected all 
patients over 75 years old that got out alive of an intensive care unit 
stay. Then, we interviewed treating physicians of those patients over 
the phone. We used 5 open and 1 close questions to explore the 
knowledge about advance directives and to know whether those phy-
sicians have ever talked about advance directives with their patients.
Results We have collected 11 testimonies from physicians. In spite 
of media coverage of exceptional cases, advance directives remain 
unknown from patients and doctors. It’s hard for patients to write 
advance directives because it’s not easy to formalize thoughts in writ-
ings and also to predict all possible clinical situations. Another issue is 
that treating physicians aren’t used to talk about end of life and wait 
for their patients to ask about it.
Discussion A stay in an intensive care unit is a good opportunity to 
talk about advance directives because of the lack of opportunities 
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and all the more since those patients have a high risk to be hospi-
talized again in the next few months. In interviews, treating physi-
cians admit that the talk about advance directives is often too late 
in the evolution of diseases. One of the reasons for the unpopular-
ity about advance directives: physicians aren’t bind by them in the 
French law, but they are asked to take them into account for medi-
cal decisions.
Conclusion An ICU stay is a major event. Ideally, advance directives 
should have been made before that the ICU stay. That event is then 
an opportunity to revise them. The problem is complex and requires a 
solution at various levels: political, societal, economic, ethical, educa-
tional and relational. Various media coverage should allow to change 
mentalities. A bill is under discussion (2), and it should allow a partial 
response to some reluctance in the writing of advance directives.
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Introduction The incidence of withholding life support had increased 
during last years. While short-term outcome is frequently reported, 
there are no data about long-term outcome. Our objective was to 
report 6-month outcome of patients discharged from a general hospi-
tal ICU with treatment limitations.
Patients and methods We retrospectively collected data of patients 
discharged from a general hospital ICU with withheld life support from 
2009 to 2011. Age, sex, McCabe’s score, SAPS II score on admission 
and within 24 h, SOFA score, main indication for ICU, main comorbidi-
ties, modalities of treatments limitation, length of ICU and in-hospital 
length of stay were recorded.
Results One hundred and fourteen patients were included. Six-month 
survival rate was 58.8 %. Survival was associated with longer length of 
ICU and hospital stay, a respiratory indication for ICU (47.8 vs 19.1 %, 
p  =  0.006), a medical history of chronic respiratory disease (52.3 vs 
29.8 %, p = 0.017) and a lower SAPS II score on admission (44 vs 49, 
p  =  0.006). Only a respiratory indication for ICU was identified as a 
prognostic factor of survival in the multivariate analysis (OR 0.31, 95 % 
CI 0.1–0.7, p = 0.006).
Conclusion 58.8 % of patients discharged from ICU with withheld life-
sustaining therapies survived at least six months. Admission for a res-
piratory reason may be a prognostic factor of survival.
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Introduction Few process of refusals in intensive care unit (ICU) has 
currently been evaluated. This study aimed at investigating the epide-
miology of refusals, the factors influencing the decision and the out-
come of refused patients.
Patients and methods All referrals not followed by admission were 
prospectively collected over a 6-month period in a 12-bed ICU in 
a general hospital of 500 beds. In our ICU, the refusals are usually 
recorded with a specific form collecting the identities of the patient 
and the calling doctor, the reason for referral (ethical advisory or 
medical referral), a short medical history and the reason(s) of refusal. 
Outcome of the refused patients is retrospectively collected from the 
hospital charts.
Results One hundred twelve refusals were included in the present 
study. Over the same period, 269 patients were admitted to the ICU. 
The referrals were internal in 91 (81.3 %) cases and from other institu-
tions in 21 (18.7  %) cases. The reasons for the refusal were: support-
ive care deemed “futile” in 58 (51.5 %) cases, supportive care deemed 
unnecessary in 39 (35  %) cases, inadequate technical facilities in 10 
(9 %) cases and no ICU box available in 5 (4.5 %) cases. Among patients 
refused for “futility,” one or more criteria leaded to the decision: age 
(21.4 % of cases), acute pathology not curable (18.8 % of cases), multi-
ple comorbidities (17.9 %), patient bedridden or suffering from severe 
dementia (17.9  %) and “terminal” comorbidity with poor short-term 
prognosis (11.6 % of cases).
The outcome of the refused patients was evaluable in 79 of them hos-
pitalized in the hospital. Among them, 5 patients were secondarily 
admitted to the ICU: 3 for worsening clinical status and 2 after revision 
of the initial assessment of “futility.” Thirty-two patients were refused 
for unnecessary supportive care and 4 (12.5  %) died in the hospital. 
Forty-seven patients were not admitted to the ICU because supportive 
care was deemed “futile,” and 31 (66 %) of them died in hospital.
Among the 47 patients refused because supportive care was deemed 
“futile,” 25 (53.2 %) referrals were motivated by the need of a second 
doctor for ethical advisory. The intensivist called felt “alone to decide” 
in 9 (19 %) cases, and these 9 patients died (Fig. 36).
Discussion Refusals are common in our practice. Supportive care 
deemed “futile” represents the leading reason for these refusals. In 
these settings, the outcome of refused patients is dark, similar to that 
Fig. 36 See text for description  
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of critically ill patients with decisions of therapeutic limitations. The 
ICU physician was called for ethical advisory in only half of these cases 
and was therefore the only decider of the therapeutic limitation in a 
large proportion of these patients.
Conclusion Our experience highlights the need of rethinking the pro-
cess leading to ICU refusal in order to promote collegiality in these 
decisions of therapeutic limitation.
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Introduction Several sentences are often used in the Intensive Care 
Unit (ICU) and the Emergency Department (ED) and do not exactly 
mean what they sound. We asked intensivists to select the most often 
heard sentences, what their real meaning is and which consequences 
their misuses reveal.
Materials and methods All the intensivists (7 physicians), fellows (5), 
and ED physicians (5) working in an ICU and intermediate care unit 
were asked which sentences with confounding meaning they have 
already often heard in the ICU and the ED. Their real sense was then 
“traducted”, and their potential impact in daily practice was estab-
lished. The most cited sentences are presented with their “real-life” tra-
duction (Trad) and consequences (Csq).
Results 1st (14 votes): “it’s not for full code ICU but just to overcome 
a hurdle”. Trad: some patients with severe comorbid condition and 
acute organ dysfunctions are often referred to the ICU for limited care 
with scarce hope of recovery. Csq: inadequate intensity of care regard-
ing severity, overuse of ICU beds, lack of palliative care, harm for other 
potential patients.
2nd (11 votes): “we can still give another course of chemotherapy if 
he/she survives after ICU admission”. Trad: we have not decided about 
what is reasonable for this patient, so go on. Csq: patients with neo-
plasic disease and prolonged ICU stay are often unable to cope with 
subsequent toxic treatments, when they survive. There may be a lack 
of communication between ward physicians and intensivists, asso-
ciated with lack of knowledge of each other’s condition of patients’ 
management.
3rd (9 votes): “first give antibiotics a chance”. Trad: surgery is too risky 
right now, or for this patient. Csq: surgery is even more dangerous 
after surgery delay when the indication is clear.
4th (7 votes): “the patient does not sleep”. Trad: I am bored of surveying 
and speaking to this patient to reassure him. Csq: overuse of sedation, 
prolonged mechanical ventilation and ICU stay, sedation-related com-
plications (pneumonia, delirium).
5th (7 votes): “I’m saying this for the well-being of the patient”. Trad: 
I don’t want to do this. Csq: lack of beneficial care for the patient 
through bad (or no) communication between physicians and nurses’ 
teams, and overall, lack of motivation.
6th (6 votes): “this patient cannot go to the ward because of his/her 
severity” (even when no escalation of treatment is considered regard-
ing to age, comorbidities, or general condition). Trad: this patient can-
not die in a (my) speciality ward. Csq: overuse of ICU and intermediate 
care unit beds, that move towards “acute palliative units”.
7th (5 votes): “the patient goes alive from the ICU so for us it’s a suc-
cess”. Trad: this patient will die anyway, but later and somewhere 
else. Csq: inadequate communication with family and post-ICU units. 
We fail to look further than the ICU doors and to plan downstream 
management.
8th (5 votes): “we will see -the problem/the family- tomorrow”. Trad: we 
sometimes postpone difficulties and evade our responsibilities, wait-
ing for someone else to do it later. Csq: in the ICU and general acute 
care, the sooner is often better, and we fail to remind this. “The best 
way to take care of the patient is to care for the patient”—right now.
9th (4 votes): “we can’t allow him/her to die from sepsis/acute myo-
cardial infarction/pneumothorax/so on”. Trad: We just don’t not know 
how to stop when the engines are on, and sometimes we do not valu-
ate patients evolution with hindsight. Csq: everyone dies anyway at 
the end of his life, but we sometimes fail to remember it in the ICU and 
to learn it as well!
10th (3 votes): “the patient is fine”. Trad: this can mean almost every-
thing, from the patient is well educated or not dependent, or he’s able 
to seat or eat alone, to a complete lie when it’s more suited (ex: the 
patient is suffering dementia and needs total daily care, but looks well, 
and has to be transferred preferably in the ICU or in an intermediate 
care unit). Csq: you cannot trust anyone since you have not seen the 
patient by yourself first. Could telemedicine improve Critical Care as it 
was made by stroke teams?
Discussion What is said is not always what it means. These key sen-
tences could be recorded in daily practice to point out some ways of 
care improvement in the ICU, before the ICU, or after.
Conclusion Everyone should be careful of what is said around the ICU, 
and be aware of lies and falsehoods.
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Introduction The admission of a child in the pediatric intensive care 
unit (PICU) is a particular situation, with a high emotional stress for the 
parents, bound to a threat to life for the child. A lot of complex infor-
mation are given by the caregivers to the parents at the admission, 
during a family conference. The purpose of this study was to evaluate 
the comprehension of the parents in this context.
Patients and methods This prospective study took place in three uni-
versity-affiliated PICU in Paris, France. Forty-two parents of 30 children 
who were hospitalized in the PICU more than 48 h were included for an 
audio-recorded semi-structured interview, in the first 15 days following 
the admission. The physician and nurse who took care of the children 
at the admission filled a questionnaire. The information was assessed 
from parents and caregivers, based on 7 prospectively defined items: 
diagnosis, affected organ, purpose of admission, prognosis, treatments, 
further investigations and the organization of the unit. The parents’ 
comprehension was graded excellent, fair or poor, depending on the 
comparison between the answers of the parents during the interview 
and the answers of the physicians and nurses in their questionnaires.
Results The comprehension was excellent for the prognosis (96.2 %), 
the affected organ (84.6 %) and the organization of the unit (88.9 %), 
fair for the purpose of admission (68.4 %) and the diagnosis (61.9 %) 
and poor for the treatments (38.1  %) and the further investigations 
(34.5  %). Only 4 parents had a complete comprehension for all the 
items. The prognosis was not communicated to 16 parents (12 fam-
ily conferences), and 9 parents (6 family conferences) did not recall 
receiving any prognostic information. Twenty-five parents (59.5  %) 
thought that the given information by the physicians and the nurses 
were clear and sufficient. Sixty percentage of the parents expressed 
the need to have a good communication with the caregivers. But this 
parents’ need was not as important as the expectation for the caregiv-
ers’ professional skills (74 %).
Discussion The comprehension of the prognosis was excellent, 
despite a lack of communication about prognosis by the physicians in 
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the ICU and a high emotional stress for the parents. The anticipated 
information could be delivered before the ICU admission, by the emer-
gency department’s physician or the transport’s caregivers.
Conclusion At the admission of a child in the PICU, after a family con-
ference, the prognosis was the best understood information by the par-
ents, although it was not always communicated. Giving information to 
the parents is a challenge for the caregivers and must be improve.
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Introduction End of life has emerged as a major concern this year in 
France, with the adoption of the “Claeys-Leonetti” law, which is cur-
rently being examined by the Senate, together with the application of 
the “Maastricht III” (non-heart-beating donors) protocol in a few hospi-
tals. In this context, the Committee of young intensivists of the French 
Society for Intensive Care Medicine (FICS) has evaluated by question-
naire both the feeling of young intensivists on everyday practices 
and the knowledge of the current legislation regarding the end of life 
(“Leonetti” and “Maastricht III”).
Materials and methods A questionnaire was sent by email during the 
summer of 2015 to 1191 young members of the FICS (<35 years of age, 
representing approximately one third of the SRLF members).
Results Characteristics of the members who answered One hundred and 
twenty-three (10.3 %) replied to the questionnaire. The sex ratio W/M 
was 0.78, the mean age was 31 years old, and the geographical origin 
of the members who responded was not different from those who 
did not respond. Sixty-two percent of the members who answered 
declared working in a University hospital, 91  % in an adult intensive 
care unit, and 13 % in a pediatric intensive care unit. Thirty-three per-
cent were residents, and 67 % were senior intensivists.
Practice and feeling of answering members Excluding emergency situ-
ations, 90  % of decisions to forgo life-sustaining treatments were 
declared to be decided by ≥ 2 intensivists (including juniors and sen-
iors). In only 13  % of the decisions an external doctor was involved, 
whereas in 63 % of the cases nurses were involved. The decision was 
formalized on a specific form in 69 % of the cases. Young intensivists 
reported having been in disagreement with decisions to forgo life-sus-
taining treatments, because decisions were too early (65 %) or too late 
(94 %) according to them. Overall, 84 % of the young intensivists ques-
tioned felt qualified to announce and explain the decision to forgo 
life-sustaining treatments to the family members. Seventy-nine per-
cent stated they did not have a good knowledge of the different legal 
texts about end of life, and 93 % acknowledged that a formal update 
on the subject would be required.
Knowledge evaluation Overall, there were 81  % of correct answers to 
the multiple-choice questions evaluating the knowledge on current 
legislation concerning the end of life (“Leonetti” and “Maastricht III”), 
with a better knowledge of Leonetti vs. Maastricht III texts (83 vs. 71 %, 
respectively). Eleven percent of the answering members did not know 
what the Maastricht III text was about.
Discussion Only a small number of young intensivists, members of the 
FICS, have answered the questionnaire, which represents one of the 
main limitations of this survey. This low response rate may illustrate 
the discomfort of young intensivists with these issues. Positive points 
were, however, that the questionnaire was not only declarative, but 
that it also evaluated the actual knowledge of young intensivists. This 
survey therefore provides a picture of young intensivists’ knowledge, 
daily practices, and feelings regarding the end of life management.
Conclusion Our questionnaire sheds light on three major points: a 
discomfort about key decisions of active therapeutic limitations, a fair 
knowledge of legal documents, together with a strong demand for an 
update and teaching of these texts.
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Introduction Patients with hematologic malignancies (HM) requiring 
intensive care unit (ICU) admission are assumed to have a poor prog-
nosis. The aims of this study were to analyze long-term outcome and 
to develop a prognostic score evaluating mortality risk of patients with 
HM admitted to the ICU.
Patients and methods This was a retrospective single-center study of 
patients with HM admitted at least once to a university medical ICU, 
from 2003 to 2013. Hematologic history, circumstances and reason of 
ICU admission, life-supporting intervention were recorded. The study 
end points were ICU, 30 days, hospital, and 1-year survival.
Results Of 345 admissions, median age was 57.4 years (±0.9), 28.7 % 
had received allogeneic hematopoietic stem-cell transplantation, 
9.6 % had newly diagnosed malignancies, and 36.2 % were in remis-
sion. 39.4 % had a Performans Status (PS) between 3 and 4. The major 
causes of ICU admission were acute respiratory failure (38.6  %) and 
septic shock (27.2 %). Median SOFA score at admission was 8.8 (±0.2). 
Sixty-six percentage required invasive mechanical ventilation, 64  % 
vasopressor drugs, 35  % renal replacement therapy. Median time 
between hospital and ICU admission was 14.6 days (±1.6), and 15.4 % 
were emergency admissions. Two hundred and ninety-nine patients 
were admitted at least once. ICU, 30 days, hospital and 1-year survival 
rates were 58, 51, 31 and 26 %, respectively.
By logistic multiple regression analysis, PS ≥  3, age ≥  60  year, SOFA 
score  ≥  8, invasive mechanical ventilation and renal replacement 
therapy were independently associated with 30-day mortality (Fig. 37; 
Table 1). These factors were included in a prognostic score: the HICU 
Score (Hematologic ICU score) going from 0 to 5 points, for predict-
ing 30-day and 1-year mortality of patients with HM admitted in ICU 
(Fig. 37; Table 2). This score appears to be able to identify patients with 
a poor prognosis, independently of the type of HM. An HICU Score ≥ 4 
was associated with 30-day and 1-year mortality rates of 81 and 94 %, 
respectively (Fig. 37; Table 3).
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Conclusion The HICU Score is a new prognostic score, including Per-
formans Status, age, global severity, and two modalities of therapy, for 
predicting 30-day and 1-year mortality of patients with hematologic 
malignancies admitted to the ICU.
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Introduction Patients with multiple myeloma (MM) have experienced 
significant survival gains with the use of high-dose therapy regimen 
and newly released targeted therapies. Studies have shown continu-
ous survival improvement over time in critically ill myeloma patients. 
We sought to perform a follow-up study with patients with MM 
recently managed in the ICU.
Patients and methods This is a retrospective study including all 
myeloma patients admitted to a 12-bed medical ICU between 2007 
and 2014. Outcomes were compared with historical cohort of patients 
managed in the same ICU between 1999 and 2006 (control period). 
Determinants of hospital mortality were identified using a multivari-
able logistic regression model.
Results Two hundred and ninety-one patients were admitted to the 
ICU from 1999 to 2014: 182 in the study period and 109 in the con-
trol period. One hundred and thirty-seven (45  %) were male, aged 
62 [57–70] years old. Half the patients had at least one comorbidity, 
and SAPSII score at admission was 45 [37–58]. Underlying myeloma 
required 2 [1–3] lines of therapy (chemotherapy or targeted therapy 
were administered in 60 % of the patients), whereas 88 (30 %) patients 
had a newly diagnosed myeloma. Time from hospital admission to ICU 
admission was 1 [0–8] day. Reasons for ICU admission were acute res-
piratory failure (49 %), acute kidney injury (41.6 %) and shock (29.7 %). 
Throughout the ICU stay, patients needed mechanical ventilation 
(30 %), noninvasive ventilation (15 %), vasopressors (25 %) and renal 
replacement therapy (31 %). Hospital mortality was 32 % (93). Length 
of follow-up was 134 [10–462] days.
By univariable analysis, patients managed during the study period 
were older (63 [58–71] vs. 60 [54–65], p < 0.01) and had more comor-
bidities [93 (51 %) vs. 50 (41 %), p = 0.09]. In the recent period, MM was 
more frequently newly diagnosed [61 (34 %) vs. 27 (24 %), p < 0.001] 
and targeted therapies administered more frequently [142 (78 %) vs 40 
(33 %), p < 0.01]. In the study period, time from hospital to ICU admis-
sion was shorter (1 [0–6] vs 3 [0.25–9], p = 0.02). Interestingly, SAPS II 
was lower in the second period (43 [37–55] vs 49 [38–64], p = 0.006), 
but organ dysfunctions such as acute respiratory failure and acute 
kidney failure were more frequent [99 (54 %) vs 49 (40 %), p = 0.001 
and 107 (58 %) vs. 19 (16 %), p = <0.001, respectively]. Proportions of 
patients receiving supportive care were not different between the 2 
periods. Hospital mortality was lower in the recent period in compari-
son with the control period [47 (39 %) vs. 46 (25 %), p = 0.01]. Patients 
in whom life-sustaining therapies were withdrawn or withheld 
increased over time (5  % in the control period vs 18  % in the study 
period, p = 0.008), suggesting the increased use of ICU trials with time.
By multivariate analysis, factors associated with hospital mortal-
ity were the need for mechanical ventilation [OR 2.94 (1.58–5.49), 
p = 0.001], noninvasive ventilation [OR 2.55 (1.26–5.19), p = 0.01] and 
vasopressors [OR 2.65 (1.38–5.12), p = 0.003].
Strikingly, long-term survival was also higher in the second period. 
Long-term mortality was independently associated with age [OR 
1.0 (1.0–1.0), p  =  0.04], mechanical ventilation [OR 3.26 (1.78–5.96), 
p  <  0.001], Salmon–Durie stage III [2.0 (1.0–3.9) for class 3, p =  0.03] 
and end of life decisions [OR 3.4 (1.4–8.5), p  =  0.01]. Period of ICU 
admission was not associated with lower long-term mortality [OR 0.68 
(0.39–1.17), p = 0.17] by multivariate analysis.
Conclusion This study reports continuous survival gains over time in 
critically myeloma patients resulting from a changing use of ICU in 
this setting. For instance, older patients were managed, with earlier 
ICU admission, and increased use of ICU trial. Hospital and long-term 
mortality seem to plateau at rates that are among the lowest mortality 
rates reported in critically ill hematology patients.
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Introduction Bone marrow aspiration (BMA) is sometimes performed 
in intensive care unit (ICU) patients; however, its contribution in the 
management of ICU patients has not been extensively investigated 
yet.
Patients and methods This was a 5-year (2010–2014) retrospective 
cohort study in a 10-bed medical ICU on consecutive patients who 
underwent BMA during their ICU stay. BMA contributed in the man-
agement of patients when it yielded one of the following abnormali-
ties nonpreviously diagnosed (increased myeloid precursors with little 
maturation, hemophagocytic lymphohistiocytosis (HLH), infiltration 
of cancer cells (solid tumor or hematologic malignancy)) and/or when 
it resulted in the initiation or the interruption of a specific treatment, 
including the decision to forgo life-sustaining therapy (DFLST).
Results Adequate BMA specimens were obtained in 193 patients (sex 
ratio  =  1.5 and median Simplified Acute Physiology Score II  =  60). 
Samples were obtained by sternal aspirate in 155 patients and from 
the iliac crest in 38 (20  %). The median [interquartile range] time 
between ICU admission and BMA was 5  days [3–8]. The indications 
Fig. 37 See text for description 
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for BMA were thrombocytopenia (N  =  82), agranulocytosis (N  =  6), 
and suspicion of hematologic malignancy (N  =  71), of solid cancer 
(N = 6), of HLH (N = 18), of disseminated tuberculosis (N = 5) and of 
other causes (N = 5). BMA findings contributed in the management of 
41 patients (21  %) including increased myeloid precursors with little 
maturation (N = 10), HLH (N = 17), hematologic malignancy (N = 15), 
initiation of a specific treatment (N = 6), DFLST (N = 8). In multivariate 
analysis, the factors associated with a contributive BMA were persis-
tent sepsis from admission to BMA (OR 2.2, p = 0.049), ongoing hema-
tologic malignancy or solid cancer (OR 3.2, p  =  0.03), and a higher 
SOFA score (excluding platelet points) on the day of BMA (OR 1.1, 
p = 0.011). Similar results were observed in the 149 patients without 
ongoing hematologic malignancy and solid cancer on ICU admission.
Conclusion BMA has a significant impact on the management of 
severely ill patients with and without ongoing hematologic malig-
nancy and solid cancer on ICU admission.
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Introduction Red blood cells transfusions are common use in ICU 
to treat anemia. By enhancing oxygen delivery, fresh red cells may 
improve patient outcome.
Patients and methods ABLE study (multicenter, randomized, double-
blind trial) was designated to show a 90-day mortality reduction in 
patients who received fresh blood. Patients were eligible if a first red 
cells transfusion was prescribed within 7 days after admission in ICU. 
Enrolled patients were assigned to receive either red cells (stored less 
than 8 days) or standard issue red cells (oldest compatible units availa-
ble in the blood bank). ABLE was an international study, and 19 French 
ICU spread over 10 cities were associated with this project. We report 
the subset group of patients included in the French cohort compared 
to the global one.
Results Between April 2011 and May 2014, 287 patients (169 males, 
118 females) were enrolled in France while overall 2430 patients were 
included. The main reasons for ICU admission were respiratory or 
cardiovascular failure, trauma and sepsis. On the day of randomiza-
tion, mean age was 59.3 (±16.9), 96.5 % of patients were under inva-
sive mechanical ventilation, 67.6  % received vasoactive support, and 
33.8 % were receiving renal replacement therapy. The mean Apache II 
score was 24 ± 8.4. A total number of 1568 red cell units were trans-
fused in 285 patients (5.5 units per patient). The first transfusion 
occurred between 2 and 5  days after ICU admission. Pre-transfusion 
hemoglobin level was 7.6 ±  1.1  g/dL. Regarding 285 patients trans-
fused and treatment allocation, 139 patients were assigned to receive 
fresh red cells and 146 were assigned to receive standard red cells. Red 
cells were stored a mean (±SD) of 4.55 ± 1.7 days in the fresh-blood 
group as compared to 18.57 ± 6.9 days in the standard-blood group 
(P < 0.0001). Our data are different from the all cohort with lengths of 
storage of 6.1 ± 4.9 and 22.0 ± 8.4 days, respectively. At 90 days, 51 
patients (37.2 %) in the fresh-blood group and 48 patients (33.1 %) in 
the standard-blood group had died (absolute risk difference, 0.041 per-
centage points; 95 % confidence interval [CI], −0.07 to 0.15) compared, 
respectively, to 37.0 and 35.3 % (absolute risk difference, 1.7 percentage 
points; 95 % confidence interval [CI], −2.1 to 5.5) as reported in the inter-
national cohort. Consistent with ABLE results, no significant different 
90-day mortality has been demonstrated in the French cohort but the 
observed larger difference needs further analysis. Data were also ana-
lyzed regarding major illnesses; duration of respiratory, hemodynamic 
or renal support; length of stay in ICU, hospital; adverse events. There 
were no differences in these secondary outcomes.
Conclusion The French cohort did not demonstrate difference in pri-
mary and secondary outcome between fresh and standard red blood 
cells transfusion. The larger difference between mortality in the French 
cohort compared to the global one still needs further analysis.
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Introduction Studies on allogeneic stem cell recipients admitted to 
the intensive care unit constantly report poor outcomes, even though 
slight improvements have been recently reported. Factors such as 
mechanical ventilation or acute graft-versus-host disease are associ-
ated with increased hospital mortality. In studies on unselected hema-
tology patients, allogeneic stem cell recipients always exert highest 
mortality rates. However, these studies had difficulties defining graft-
versus-host disease, as they hardly describe graft-versus-host disease 
trajectory (as opposed to the binary absent/present graft-versus-host 
disease status).
Patients and methods This was a retrospective single-center study of 
allogeneic stem cell recipients patients admitted to the intensive care 
unit between 2005 and 2014.
Results Hundred and ninety-one patients were included. Median age 
was 42 [27–56], and 68.1  % of them were male. Hematologic malig-
nancy was in complete remission at intensive care unit admission in 
80.6  %, and acute graft-versus-host disease had occurred in 61.4  % 
before intensive care unit admission. Patients were mostly admitted 
for acute respiratory failure (42.9 %) or shock (38.8 %). Median SAPSII 
was 40 [29.5–52.5], and median SOFA at intensive care unit admission 
was 6 [3.3–9]. Mechanical ventilation was required in 34.6 %, vasopres-
sors in 41 %, and renal replacement therapy in 7 %. Hospital mortal-
ity was 42 %. By univariate analysis, remission of malignancy (70.3 vs 
51.2 %, p = 0.01), time from hospital to intensive care unit admission 
(1 [0–18.5] vs 12.5 [0–27.3] days, p = 0.01), SAPSII score (36 [28–43] vs 
48.5 [35.8–61.8], p < 0.001), SOFA at admission (5 [3–8] vs 8 [5.5–11], 
p < 0.001), the use of life sustaining therapies (mechanical ventilation 
24.3 vs 48.8 % (p = 0.001), vasopressors 32.4 vs 52.5 % (p = 0.01) and 
renal replacement therapy 2.7 vs 12.5  % (p =  0.02)) and acute graft-
versus-host disease prior to intensive care unit admission (53.7 vs 
71.6 %, p = 0.01) were significantly associated with hospital mortality.
Graft-versus-host disease trajectory was the main focus of interest in 
this study. Six groups of patients were identified: group 1 = no graft-
versus-host disease (29.8 %), group 2 = controlled acute graft-versus-
host disease at intensive care unit admission (38.2 %), group 3 = active 
and stable acute graft-versus-host disease at intensive care unit admis-
sion (11  %), group 4 =  newly diagnosed acute graft-versus-host dis-
ease during intensive care unit stay (10.5  %), group 5  =  improving 
acute graft-versus-host disease at intensive care unit admission (4.2 %) 
and group 6 = worsening acute graft-versus-host disease at intensive 
care unit admission (4.2 %). As expected, steroid doses and the num-
ber of immunosuppressive drugs required to control acute graft-ver-
sus-host disease differed significantly between the groups. Hospital 
mortality also differed significantly between the groups, ranging from 
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30 to 40 % (group 1: 28.1 %, group 2: 41.1 %, group 4: 30 %. group 5: 
37.5 %) to 62 % (group 3) and 100 % (group 6). By multivariate analy-
sis, graft-versus-host disease groups 3 and 6 (i.e., active or worsening 
graft-versus-host disease at admission) remained independently asso-
ciated with hospital mortality [OR 5.42 (1.87–15.70), p = 0.002]. Acute 
respiratory failure [OR 2.90 (1.26–6.68), p = 0.01], acute kidney injury 
[OR 3.23 (1.33–7.84), p =  0.01], hepatic failure [OR 9.74 (1.07–88.49), 
p = 0.04] and time from hospital to intensive care unit admission [HR 
1.01 (1.00–1.03), p = 0.03] were also independent risks factors for hos-
pital mortality.
Discussion This is the first study that includes a qualitative analy-
sis of graft-versus-host disease status at intensive care unit admis-
sion. As reported, reluctance to admit patients with graft-versus-host 
disease is appropriate for patients with active or worsening acute 
graft-versus-host disease at intensive care unit admission. Obviously, 
graft-versus-host disease cannot anymore be handled as a binary vari-
able. However, the study design exposes to admission bias as the most 
active graft-versus-host disease cases may have not been proposed 
for intensive care unit admission, or not admitted to the intensive care 
unit after a triage procedure. Hence, a control group of patients not 
admitted to the intensive care unit is required. Last, these data must 
be validated on an independent dataset for more reliability.
Conclusion In allogeneic stem cell recipients proposed for intensive 
care unit admission, a careful analysis of graft-versus-host disease 
trajectory is mandatory as to make appropriate decisions to admit 
the patients. Patients with acute graft-versus-host disease may actu-
ally benefit from intensive care unit management provided the graft-
versus-host disease is neither unresponsive nor worsening at the time 
where the decision of intensive care unit admission is made.
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Introduction Overall mortality of patients with solid cancer has 
improved over the last decade with lower cancer-related mortality as 
the result of diagnostic and therapeutic advances. Targeted therapies 
have been one of the major changes in cancer treatment between 
2000 and 2009. Use of these new molecules is associated with 
increased survival, especially in metastatic patients. However, whether 
these therapeutic novelties translate into better outcomes when 
patients become critically ill is still uncertain. We sought to determine 
trends in outcomes over time in critically ill patients with solid cancer.
Patients and methods Retrospective cohort of patients with solid 
tumors admitted to a single ICU over a 7-year period. Survival was 
compared between two time periods (before and after 2010). Factors 
independently associated with ICU mortality were identified through a 
multivariable logistic regression model.
Results Throughout the study period, 544 patients (age 62 years [45–
77], 308 [57 %] men) with solid cancer were admitted. Primary site of 
cancer was lung in 115 patients (22.3 %), digestive in 103 (20 %), uro-
logic in 98 (19 %), breast in 97 (18.8 %), and other sites in 103 patients 
(19 %). At ICU admission, 290 patients (54 %) were at metastatic stage, 
245 patients (45.4  %) were receiving chemotherapy, and 90 (16.7  %) 
were treated using targeted therapies (no difference between the 
2 periods). Time from hospital to ICU admission was 1  day (0–17). 
Patients were mainly admitted in the ICU for respiratory failure (48 %) 
or severe infection (27  %). Vasopressors were administered to 172 
patients (32.2 %), mechanical ventilation to 247 [58 (10.7 %) received 
noninvasive ventilation and 175 (31.6  %) were intubated], and renal 
replacement therapy to 72 (12.5  %). Goals of care at ICU admission 
varied substantially across the 2 study periods. For instance, full code 
concerned 69.1  % of the patients before 2010 and 50  % after 2010, 
whereas ICU trial was 30.1 % before 2010 and 47.8 % after 2010. Last, 
exceptional admission concerned 1 patient before 2010 and 9 patients 
after 2010 (P  <  0.01 for all comparisons). A decision to withhold/
withdraw life-sustaining therapies was implemented in 142 patients 
(26.1  %). ICU mortality decreased over time (28.5  % before 2010 vs 
16.1 % after 2010, P < 0.01). By univariable analysis, mortality was sig-
nificantly increased in patients with a metastatic stage (23.1 vs 14.2 %, 
P  <  0.01), those who were receiving chemotherapy at ICU admission 
(23.7 vs 15.3 %, P < 0.01) or those with greater time from hospital to 
ICU admission (2 days [0–10.5] vs 0 day [0–4], P = 0.01). Mortality was 
also associated with the need for vasopressors (44.7 vs 7.3 %, P < 0.01), 
intubation and mechanical ventilation (54.3 vs 2.4 %, P < 0.01), or renal 
replacement therapy (33.3 vs 17  %, P  <  0.01). Mortality was lower in 
patients with a full code status (13.4 vs 26  %, P  <  0.01) or when sur-
gery was part of the initial cancer treatment (14.8 vs 22.5 %, P = 0.02). 
By multivariable analysis, factors independently associated with ICU 
mortality were the need for vasopressors [OR 3.17, (95 % CI 1.61–6.14), 
P < 0.01] or mechanical ventilation [OR 32.9, (14.6–74.1), P < 0.01]; the 
period of ICU admission after 2010 [OR 0.30, (0.15–0.63), P < 0.01], and 
a full code management [OR 0.25, (0.12–0.54), P < 0.01].
Conclusion This study reports improved survival in oncology patients 
admitted to the ICU. Strikingly, this cannot be ascribable to the use of 
targeted therapies that did not differ across the two study periods. 
Beside patient’s severity and the need for life-sustaining therapies, the 
goals of care have an independent impact on mortality suggesting 
that oncologists and intensivists need to update their knowledge of 
outcomes to avoid making inappropriate end-of-life decisions.
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Introduction Despite robust prospective outcome data in patients 
with hematological malignancies admitted to the ICU, a little is known 
about the patients who were not admitted to the ICU. The aim of the 
study is to describe the circumstances of refusal, the decision-making 
process and the outcome of these patients.
Patients and methods Circumstances of ICU admissions/refusals 
were analyzed prospectively in 13 university centers in France and 
Belgium between January 1, 2010, and May 1, 2011. Of 1041 con-
secutive patients considered for ICU admission, and 202 were refused. 
Data including reason of refusal, reason of proposal, subjective eval-
uation of clinicians and outcome at hospital discharge and three 
months later were collected in the standardized case-report form. 
Results were compared with cancer patients who were admitted to 
the ICU.
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Statistical analysis: All tests were two-sided, and P values < 0.05 were 
considered as indicating significant association. Analyses were per-
formed using the R statistical software version 3.0.2.
Results The refusal rate in the study group was 202 (14 %), of which 96 
patients (47.5 %) were refused because they were considered too well 
to benefit, and 68 patients (33.7  %) too sick to benefit. Two patients 
(1 %) refused the admission themselves, and 34 patients (16.8 %) were 
not admitted due to lack of available ICU beds and were transferred to 
another hospital subsequently.
Reasons for proposition were acute respiratory failure (47.98 %), chock 
(33.84 %), acute renal injury (14.1 %), need for life-saving chemother-
apy (10.6 %), coma (8.6 %) and acute liver failure (2.5 %).
Reasons for refusal included poor performance status (44  %), poor 
prior quality of life (20  %), no specific anticancer treatment option 
(72  %), allogeneic stem cell transplantation with uncontrolled graft 
versus host disease (13.4 %) and expected burden of ICU (15 %).
Overall, clinicians were comfortable about the decision (at 9 on the 
scale from 0 to 10), a consensus was reached with the addressing clini-
cian in 86 % of cases.
The hospital survival in patients considered too well to benefit was 
48 (75  %) and 1 (2  %) in the group of patients too sick to benefit. 
The 3-month survival was 39 (69.64  %) and 0 (0  %) in both groups, 
respectively.
Conclusion Fourteen percent of patients considered for ICU admis-
sion are refused, and the ratio too well/too sick to benefit of 1.4 
suggests an early referral practice in these patients. The reasons for 
refusal, e.g., performance status and quality of life, remain unchanged 
during the last decade. The decision of non-admission of a patient 
with hematological malignancy in the ICU is made consensually by 
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Introduction The prognosis of malignant lymphomas has improved 
over the past years. However, some patients experience life-threat-
ening complications of treatments and need intensive care unit (ICU) 
admission. We conducted a retrospective study to assess factors asso-
ciated with survival for these patients.
Patients and methods The files of all patients with malignant lym-
phoma admitted to ICU in our University Hospital between January 
2008 and June 2014 were recorded. Demographic, biologic and dis-
ease characteristics as well as details of ICU admission were collected. 
Cox regression was performed to identify formal admission factors 
associated with hospital mortality. Respiratory failure was defined as 
previously reported (1). Hemodynamic, renal, hepatic and neurologic 
failures were defined as a MAP <70  mmHg, as a creatinine 2 times 
baseline (KDIGO score ≥2), as bilirubin >50 µmol/l and as a Glasgow 
coma score of less than 13, respectively.
Results One hundred and thirty-three patients with lymphomas 
were admitted to ICU during the studied period. Median age was 65 
(range 18–88). Hematologic malignancies were DLBCL (41 %), Hodgkin 
lymphoma (11  %), follicular lymphoma (8  %), mantle cell lymphoma 
(8 %), Burkitt lymphoma (5 %), other low-grade B cell NHL (14 %) and 
T cell lymphoma (13 %). Visceral involvement was present in 103 cases 
(77 %) with bone marrow involvement in 51 cases (49 % of them). At 
the time of admission, 22 patients were at the beginning of hemato-
logic treatment (17  %), 30 patients presented relapse or progressive 
disease (22 %), 28 (21 %) and 18 (14 %) patients were in complete or 
partial remission, respectively. Thirty-five patients (26 %) were admit-
ted before any treatment mostly for complications of lymphoma loca-
tions (54 %), infections (29 %) and spontaneous tumour lysis syndrome 
(14 %). Median time from diagnosis was 144 days (interquartile range, 
IQR: 26–874).
ICU admissions occurred after a median of 2  days of hospitalization 
(IQR 0–15). In the overall population, 84 patients presented signs of 
sepsis (63  %) complicated by shock for 27 patients (32  % of them). 
The main cause of admission was respiratory distress for 48 patients 
(36 %), shock for 31 patients (23 %), acute kidney injury for 19 patients 
(14 %), coma for 13 patients (10 %), cardiac arrest for 5 patients (4 %) 
and other cause for 17 patients (13 %). Median organ failures number 
was 2 (IQR 1–3). 69.2 % patients could be discharged from the ICU and 
61.7 % from hospital, whereas one-year overall survival was 37 %.
During the first 24 h after ICU admission, 50 patients (38 %) required 
vasopressive drugs, 57 patients (43 %) required mechanical ventilation 
and 18 patients (14 %) required renal replacement therapy. Number of 
organ replacement therapy during the first 24 h was greatly associated 
with overall survival. One-year OS rates were 51, 39.8 and 15.6 % for 0 
(51 patients, 38 %), 1 (45 patients, 34 %) and 2 to 3 (37 patients, 28 %) 
organ replacement therapy, respectively (log-rank p < 0.001).
In multivariate analysis, relapsing and progressive disease [HR 2.3 95 % 
confidence interval (CI) 1.2–4.3; p = 0.016] and neurologic or hepatic 
failures at admission (HR 2.2 95 % CI 1.2–4.2; p = 0.013 and HR 3.7 95 % 
CI 1.8–7.6; p < 0.001, respectively) were independently associated with 
higher risk of hospital mortality. Age  >  65  years, sepsis, neutropenia, 
respiratory, renal or hemodynamic failures were not independently 
associated with an increased risk of death. Median SOFA score (2) 
(Sequential Organ Failure Assessment) at ICU admission was 6 (range 
0–19) and appeared efficient to determine risk of mortality at hospital 
discharge (HR 1.3 95 % CI 1.2–1.4, p < 0.001). Since the SOFA score is 
calculated after 24 h in the ICU and thus cannot be assessed on admis-
sion, it was not included in the Cox model.
Conclusion To our knowledge, this is the first study describing the 
outcome of all malignant lymphomas in the ICU. Hepatic and neuro-
logic failures are dramatic complications for these patients. Simply and 
rapidly assessing organ failures in the hematology ward is required to 
predict prognosis before ICU admission for patients with lymphomas.
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Introduction Poor sleep is common in intensive care unit (ICU) 
patients, and environmental factors, such as noise and light, contrib-
ute to sleep deprivation and alterations of sleep architecture. The 
objective of the present study was to evaluate the impact of earplugs 
and eye masks on sleep architecture in ICU patients.
Patients and methods A single-center randomized controlled trial of 
64 ICU patients was conducted from April 2011 to June 2013. Patients 
were randomly assigned to sleep with or without earplugs and a face-
mask. A polysomnography was performed on the first day and night 
following inclusion. The primary end point was the proportion of sleep 
stage 3 + 4. Secondary end points were other descriptors of sleep and 
major outcome variables.
Results The proportion of sleep stage 3 +  4 was 11 [3–23]  % in the 
control group and 13 [6–23]  % in the protective group (p  =  0.72). 
Other descriptors of sleep were not different between the two groups 
with the exception of long awaking that were less frequent in the 
protective group than in the control group [21 (19–26) vs. 31 (21–47), 
p = 0.02]. In the protective group, 20 patients wore the earplugs and 
18 of wore their eye mask. There was no difference among the three 
groups in terms of sleep quality, occurrence of a delirium, ICU length 
of stay and mortality, anxiety and depression on ICU discharge and 
day 90 and the incidence of post-traumatic stress disorder.
Conclusion In ICU patients, earplugs and eye mask do not increase 
the proportion of sleep stage 3 + 4 but decreased the number of pro-
longed awakenings. They had no impact on the outcome.
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Introduction Phrenic nerve injury is a frequent complication of 
cardiac surgery, leading to prolonged hospitalization, especially in 
patients with chronic obstructive airway disease. Several mechanisms 
have been recognised including hypothermia, mechanical trauma 
and, possibly, ischaemia. A better understanding of these mechanisms 
is important in order to improve both surgical techniques and postop-
erative care. After stopping the pericardial ice slush and generalizing 
the warm blood cardioplegia, we designed this study to reassess the 
magnitude of early changes in the diaphragmatic function after car-
diac surgery and their predictive factors.
Patients and methods This was a single-centre prospective cohort 
study. We included all consecutive patients who were able to undergo 
a preoperative investigation. The diaphragmatic function was ana-
lysed by ultrasonography, performed at day 1 (reference), then days 1 
and 7, postoperatively. The collected information included bilaterally: 
(1) time motion in spontaneous ventilation, (2) time motion during a 
sniff test, (3) Doppler tissue imaging during a sniff test. The changes 
between pre- and postoperative values were derived and correlated 
with 20 pre- and peroperative data, seen as potential predicting fac-
tors, including demographic data, presence of chronic diseases, type 
of surgery, number of mammary arteries grafted, intraoperative dura-
tions, postoperative biomarkers.
Results One hundred and fourteen patients were included, 87 men 
(75 %), age 68.9 ± 11.4 years. The number of grafts, valves, and com-
bined surgery were 67, 39, and 8, respectively. One mammary artery 
was grafted in 8 patients and 2 in 66. The changes in the diaphrag-
matic function are summarized in Table 46.
We observed a global average decrease in all diaphragmatic function 
indices at D1, which mostly persisted at D7. The Doppler tissue imag-
ing correlated with time motion indices at D1 and D7 with p < 0.01 on 
both sides. According to the chosen criteria, 28 to 52 % of the patients 
did not exhibit more than 10 % decrease in their diaphragmatic func-
tion. However, this change was >50  % at day 1 in 14 to 20  % of the 
patients persisting at day 7 (7–19 %). Among the 20 data checked as 
potential predictive factors of diaphragmatic dysfunction, only 3 were 
slightly significant (height, weight, and BMI) for some of the informa-
tion tested. None was linked to all criteria.
Discussion This study has limitations. First of all, diaphragmatic ultra-
sonography is a highly operator-dependant technique leading to 
inter-observer variability. Second, the lack of power at day 7 may be 
partly due to missing values (patients discharged). Despite these limi-
tations, a strong pathophysiologic link between diaphragmatic dys-
function and the 20 studied factors is unlikely. In addition, due to the 
absence of ice slush and cold cardioplegia, the role of hypothermia is 
challenged.
Conclusion Cardiac surgery decreased the diaphragmatic function 
by 30 % as assessed using ultrasonographic indices. In the least quar-
tile, these changes reached 46–61  % according to the chosen index. 
All time motion indices were correlated, and Doppler tissue imaging, 
a new index, seems to bring comparable measurement sensitivity. We 
were unable to identify any strong predicting factor.
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Introduction Weaning from mechanical ventilation is a major issue 
in intensive care due to the excess mortality implies prolonged ven-
tilation time and reintubation. Diaphragmatic dysfunction in patients 
during the ICU stay is a factor involved in weaning failure. It is difficult 
to diagnose because of a poor nonspecific and noninvasive com-
plementary examinations carried out routinely. It therefore seems 
appropriate to focus on the diaphragmatic ultrasound as additional 
diagnostic tool, achievable by any practitioner.
Table 46 See text for description
Left time  
motion (cm)
Right time  
motion (cm)
Left sniff (cm) Right sniff (cm) Left tissue  
dop. (cm/s)
Right tissue  
dop. (cm/s)
D‑1 reference 1.62 ± 0.68 1.80 ± 0.72 2.72 ± 0.99 2.72 ± 0.97 10.4 ± 4.25 10.2 ± 4.39
D1 postop. 1.34 ± 0.57** 1.34 ± 0.48*** 1.97 ± 0.96*** 1.90 ± 0.71*** 7.40 ± 4.34*** 7.20 ± 3.51***
Least quartile −0.74 (−46 %) −0.96 (−53 %) −1.60 (−59 %) −1.50 (−55 %) −6.33 (−61 %) −5.81 (−57 %)
D7 postop. 1.40 ± 0.85* 1.61 ± 0.68 2.16 ± 1.71* 2.41 ± 1.21 8.24 ± 5.82 8.69 ± 4.70*
Least quartile −0.85 (−52 %) −0.91 (−51 %) −1.60 (−59 %) −0.96 (−35 %) −3.66 (−35 %) −5.38 (−53 %)
Page 169 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
Patients and methods The main objective was to assess the capac-
ity of the diaphragmatic excursion maximum expiration (EDEmax) to 
predict weaning failure (failure of extubation failure and withdrawal 
test). This was a prospective, observational, bi-centric study conducted 
in medical and surgical ICUs (CHU Bordeaux and CHR Libourne) after 
agreement of the CPP. It included all adult patients who received more 
than 48 h of mechanical ventilation and possessing the prerequisites 
for a withdrawal test. The diaphragmatic ultrasound was performed at 
the beginning of the weaning trial, disconnected from the ventilator 
patient. Three measures of EDEmax were made under diaphragmatic 
law, inspiration and forced expiration in TM mode. Collections of CV, 
PIM and MRC score were made just before the withdrawal test.
Results Sixty-seven patients were included. After the ICU stay, 33  % 
of patients had a weaning failure. A threshold of ≤2.7  cm EDEmax 
in women (If 63 %, Sp 63 %) and ≤3.5 cm in men (in 82 %, Sp 58 %) 
was selected to predict the test fails weaning. There was a correlation 
between EDEmax and MRC score [rho = 0.47 (0.25–0.68); p < 0.0001], 
CV [rho = 0.63 (0.37–0.89), p < 0.0001] and PIM [rho = 0.54 (0.22–0.87), 
p = 0.002]. A EDEmax ≤2.7 cm, a CVTh ≤30 % and PIM ≤25 cmH2O 
were significantly associated with weaning failure, respectively OR 
3.56 (95  % CI 1.25–10.10; p  =  0.002), OR 6.42 (95  % CI 1.34–30.60, 
p = 0.002) and OR 13.80 (95 % CI, 2.00 to 94.40; p = 0.009). However, 
an MRC score <48/60 was not associated with weaning failure.
Discussion The ability of the EDEmax predict weaning failure was 
not lower than the CV, MRC score, PIM, with a threshold ≤2.7  cm in 
women and ≤3.5  cm in man, similar thresholds being found as pre-
dictors of CVTh ≤30 %. These thresholds were sensitized in the anal-
ysis excluding patients with cardiogenic cause of failure. In addition, 
the MRC score in our study appeared to underestimate isolated dia-
phragmatic dysfunction without associated peripheral muscle deficit. 
The diagnosis of diaphragmatic dysfunction, associated with weaning 
failure, should result in a therapeutic approach to prevent this failure, 
such as the prophylactic administration NAV post-extubation.
Conclusion Our results confirm that the EDEmax is a useful measure 
to predict weaning failure, as well as the CV or PIM. In centers with-
out access to the measurement of CV or PIM in patients intubated for 
resuscitation, EDEmax is probably preferable, MRC score may prove 
defective in patients with isolated diaphragmatic dysfunction and so 
does not predictive of weaning failure.
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Introduction Breathing is a cyclic activity that is not monotonous and 
is therefore variable. The variability of tidal volume, inspiratory time 
and mean inspiratory flow is reduced during mechanical ventilation 
(MV). In MV patients, breathing variability has been mostly quantified 
with two indices: the coefficient of variation (CV) that is defined as the 
standard deviation to the mean ratio and the amplitude ratio of the 
first harmonic peak to that of zero frequency (H1/DC).
Previous reports have suggested that a low variability was associated 
with higher rate of weaning failure and mortality. However, these stud-
ies have quantified variability either on very specific time points or 
on the contrary on the whole intensive care unit stay. The aim of our 
study was to quantify breathing variability early in the intensive care 
unit stay according to two different indices: the CV and the H1/DC. We 
further evaluated the factors associated with a low variability and its 
prognosis impact.
Patients and methods Ancillary study of a multicentre, randomized 
controlled trial comparing neurally ventilator adjusted assist to pres-
sure support ventilation during the early phase of weaning. Airway 
flow and pressure were recorded during 4 sequences of 20  min. 
Respiratory rate, tidal volume and inspiratory were measured. Vari-
ability was assessed according to H1/DC and the CV. Impact of vari-
ability on clinical outcome was determined with a receiver operating 
characteristic.
Results The study included 108 subjects, 72 men (66 %), aged 68 (37–
86) years, SAPS II 44 (14–96). Sixty-two (58 %) subjects had hypoxemic 
respiratory failure. Length of mechanical ventilation prior to inclusion 
was 5 days long (1–35). Sensitivity and specificity were plotted as func-
tions of the ability of the coefficient of variation of the tidal volume, 
respiratory rate and mean inspiratory flow to predict day-28 mortal-
ity. The curves intersected at a coefficient of variation of 0.16 for tidal 
volume, 0.21 for respiratory rate and 0.14 for mean inspiratory flow 
(Fig. 38).
Mortality was significantly reduced in patients with a high coefficient 
of variation of tidal volume (12 vs 31 %, p = 0.024) and in patients with 
a low H1/DC ratio (16 vs 60 %, p = 0.04). No significant difference was 
observed in terms of hospital and intensive care unit length of stay, 
ventilator free days and duration of mechanical ventilation. Pulmo-
nary gas exchanges were better in patients with a high coefficient of 
variation of tidal volume (PaO2/FiO2 = 193 (88–390) vs 230 (87–395), 
p = 0.04).
Conclusion In MV patients reaching the early phase of weaning, low 
variability is associated with higher mortality. High variability is asso-
ciated with better oxygenation. Whether a low variability is a causa-
tive factor of mortality or a consequence of severity remains to be 
determined.
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Introduction Unplanned extubation (UE) is a common complication 
of mechanical ventilation (MV). High incidence of UE is increasingly 
used as a marker of poor quality of care. Risk factors for UE depend 
upon the care setting (case mix, nurse to patient ratio, presence of res-
piratory therapists, open/closed ICUs, …) 1 or the existence of defined 
care protocols aiming to reduce the duration of MV. Among those, the 
use of sedation and agitation scales to adjust infusion of sedatives, 
sedation vacation and weaning protocols may influence the incidence 
of UE1. We conducted this retrospective study to evaluate the inci-
dence and risk factors for UE before/after the introduction of RASS-tar-
geted sedation and weaning protocols, including daily sedation stops.
Patients and methods Monocentre, retrospective study was conducted 
in the 24-bed medical ICU of Cochin University hospital. Informed con-
sent was waived by our IRB for this observational study. Since 11/2006, 
all patients’ data are continuously recorded in a clinical information 
management system (Clinisoft®, GE Healthcare). Characteristics of each 
episode of UE (circumstances, staffing pattern, use of physical restraints, 
…) are prospectively documented and reviewed during morbidity and 
mortality rounds. In 2009, we introduced a sedation vacation and nurse-
driven, RASS-targeted sedation protocol. We retrospectively reviewed all 
cases of UE over a 6-year period to assess the incidence, characteristics 
and risk factors for UE before and after implementation of the protocol. 
Data are presented as medians and interquartile ranges. A P value <0.05 
was considered significant for all statistical tests performed.
Results Between 11/2006 and 11/2012, 4029 pts were mechanically 
ventilated for 3 [2;8] days. Among them, we identified 199 patients 
(age 51 [36,64], 132M/67F, SAPS2 52 [39,62], SOFA 6 [4,9]) with 199 
episodes of UE (incidence 7.5/1000 MV days). Reasons for intubation 
in the UE group were coma (97 pts), acute respiratory failure (61 pts), 
cardiac arrest (27 pts), shock (14 pts). There was a significant difference 
in the incidence of UE and characteristics of UE episodes before and 
after implementation of the RASS-targeted sedation protocols, wean-
ing protocols and sedation vacation (5.65/1000 vs 8.38/1000 MV days, 
P < 0.05). Of note, no UE occured during or within the 2 h following a 
sedation stop.
Conclusion Following implementation of a nurse-driven sedation pro-
tocol with sedation vacation, we observed an increase in the incidence 
of unplanned extubations although there was no temporal relation-
ship between sedation stops and UE. These data warrant a specific 
analysis of risk factors for UE during both periods.
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Introduction We tested whether performing lung ultrasound during a 
spontaneous breathing trial (SBT) could detect cardiogenic weaning-
induced pulmonary oedema (WIPO).
Patients and methods We included 35 patients who underwent 52 
consecutive SBT (1-hour T tube tests). Lung ultrasound was performed 
before the SBT and at the end of SBT. The reference diagnosis of WIPO 
was established on the evaluation by 4 experts who were blind for the 
lung ultrasound results. It was based on clinical, biological, chest X-ray 
and echocardiography data and on clinical evolution. Lung ultrasound 
was performed by two investigators (AF and MG) and analysed by four 
authors (AF, MG, DL, and GAM). Each lung was divided into 3 areas. 
WIPO was diagnosed if a B profile appeared during SBT. The B profile 
usually indicates hemodynamic interstitial syndrome. It was defined 
by 1) the presence of three or more B lines associated with lung-sliding 
between two ribs and 2) this pattern being disseminated at the ante-
rior chest wall.
Results The SBT failed in 34 cases. The WIPO diagnosis could not be 
established in one of these cases, which was excluded from analysis. 
WIPO occurred in 10 of the 33 remaining cases. Among these cases, 
lung ultrasound detected the occurrence of interstitial syndrome dur-
ing the SBT in 8 cases. Among the 41 cases without WIPO, the lung 
ultrasound did not find any occurrence of interstitial syndrome dur-
ing the SBT, except in two cases. For detecting WIPO, the sensitivity 
of lung ultrasound was 80  % (95  % CI 44–97  %), the specificity was 
95 % (95 % CI 84–99 %), the positive predictive value was 80 % (95 % 
CI 44–97  %) and the negative predictive value was 95  % (95  % CI 
84–99 %).
Conclusion Lung ultrasound performed during a SBT is reliable to 
establish the diagnosis of WIPO. In particular, it has a very good speci-
ficity and negative predictive value.
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Introduction Pleural effusions (PE) are common in intensive care 
unit (ICU) patients, especially in patients under mechanical ventila-
tion. Since PE can alter gas exchanges, one could hypothesize that PE 
could play a role in the outcome of weaning from mechanical venti-
lation. However, no study has yet reported the incidence and char-
acteristics of PE in the specific context of weaning failure. Therefore, 
the main goal of the present study was to describe the incidence of 
PE in patients who failed a first spontaneous breathing trial (SBT). We 
also compared the incidence of PE in patients who failed and who suc-
ceeded their first SBT.
Patients and methods We conducted a two-step prospective obser-
vational study in three medical ICU. During the first phase, all patients 
with a duration of mechanical ventilation >24 h who failed their first 
SBT had a pleural ultrasonography to determinate the absence or 
presence of small, moderate or large PE (visual evaluation). During the 
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second phase of the study, all patients ventilated more than 24 h per-
forming a SBT had a pleural ultrasonography and the presence of PE 
was determined so far.
Results During the first phase, 336 patients were screened and 
56 failed their first SBT. Among them, 28 patients (50  %) had no PE, 
18 patients (32 %) had small PE (left or right), 8 (14 %) patients had 
moderate PE, and 2 (4  %) patients had large PE. During the second 
phase, 295 patients were screened, 104 patients were included. PE 
was present in 27 (75 %) patients who failed the SBT and in 39 (57 %) 
patients who succeed the SBT (p > 0.05). There were no significant dif-
ferences between patients without or with small PE as compared to 
patients with moderate or large PE regarding the rate of failed SBT (34 
vs. 37 %, respectively). No significant difference was found regarding 
the length of stay in ICU, length of mechanical ventilation either the 
length of weaning between patients without or with small PE as com-
pared to patients with moderate or large PE. Two patients had a pleu-
ral drainage during the study period but without evidence of clinical 
effect.
Conclusion Pleural effusion is often found during the weaning from 
mechanical ventilation. Nevertheless, no significant impact was 
observed. The need of drainage of PE in this context is not supported 
by our data and deserves further studies.
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Introduction Sepsis induces a systolic and diastolic cardiac dysfunc-
tion. Echocardiography is widely used to assess left ventricular (LV) 
diastolic function at patients’ beside. The incidence of LV diastolic 
dysfunction in patients with sepsis ranges between 37 and 62 %. The 
prognostic impact of LV diastolic dysfunction in patients with septic 
shock remains controversial. This study aimed at evaluating a potential 
association between LV diastolic dysfunction identified during the ini-
tial phase of septic shock and intensive care unit (ICU) mortality.
Patients and methods This descriptive, retrospective, single-center 
study was conducted between 2009 and 2014. Patients were eligible 
if: (1) they were admitted in the ICU with a septic shock defined by: 
(i) persistent low blood pressure despite adequate fluid resuscitation 
and/or (ii) clinical signs of tissue hypoperfusion confirmed by biol-
ogy (lactate > 2 mmol/L; ScvO2 < 70 %) and (iii) a systemic inflamma-
tory response syndrome due to a clinically suspected or documented 
infection; and if (2) they underwent a transthoracic (TTE) and/or 
transesophageal echocardiography (TEE) during the first 24 h of hos-
pitalization with digitally recorded images. LV ejection fraction (EF) 
was calculated from the LV end-diastolic and end-systolic volumes 
measured in the four-chamber view using the monoplane modified 
Simpson’s rule. The maximal velocity of mitral Doppler E and A waves, 
E/A ratio, maximal velocity (Vmax) of E′ wave measured on the lateral 
mitral annulus using tissue Doppler imaging, E/E′ ratio, right ventricu-
lar (RV) and LV end-diastolic areas ratio, and the collapsibility index of 
the superior vena cava (∆SVC) were obtained. LV diastolic dysfunction 
was defined by a Vmax E′ at the lateral mitral annulus <10 cm/s. LV dil-
atation was defined by an indexed LV end-diastolic volume >75  mL/
m2. Patients’ characteristics were compared according to ICU outcome 
using bivariate analyses. The variables associated with ICU mortality 
with a P value <0.20 were incorporated into the multivariate analysis 
using forward and stepwise selection procedures. Odds ratios and 
their 95 % confidence intervals (CI) were estimated.
Results Among the 540 patients hospitalized in the ICU with septic 
shock during the study period, 223 were studied (140 men [63 %]; age: 
64 ± 13 years; IGS2: 55 ± 18; SOFA: 10 ± 3; Charlson: 3.5 ± 2.5) and 
204 of them (91  %) were mechanically ventilated. ICU mortality was 
35  %. The prevalence of LV diastolic dysfunction was 31  % and not 
significantly greater in nonsurvivors (28/78 [36  %] vs. 41/145 [28  %]: 
p  =  0.15). Intergroup bivariate comparisons of echocardiographic 
parameters are listed in the Table  47. Inappropriate initial antibiotic 
therapy [OR 4.17 (95 % CI 1.33–12.5); p = 0.03], maximal dose of vaso-
pressors [OR 1.38 (95 % CI 1.16–1.63) per mg/h; p = 0.01], SOFA score 
[OR 1.16 (95 % CI 1.02–1.32) per point; p = 0.02] and decrease in Vmax 
E′ [OR 1.12 (95 % CI 1.01–1.24) per cm/s; p = 0.02] were significantly 
associated with ICU mortality. After adjustment on IGS2, inappropriate 
initial antibiotic therapy and maximal dose of vasopressors remained 
independent prognostic factors, whereas Vmax E′ became quite not sig-
nificantly associated with ICU death (p = 0.07).
Conclusion These results suggest that LV diastolic dysfunction is mar-
ginally associated with ICU mortality of septic shock patients. A larger 
prospective multicenter study is required to confirm these results due 
to the selection bias of this single-center study.
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Introduction Norepinephrine (NE) is a potent vasopressor used in 
septic shock to reverse hypotension. An increase in cardiac output 
(CO) with NE has been reported in patients with septic shock, when 
administered early (1). This increase in CO was suggested to be mainly 








LVEF ( %) 48 ± 17 49 ± 17 46 ± 18 0.39
LVEDV (mL) 93 ± 36 95 ± 37 90 ± 34 0.37
E/A 1.03 ± 0.55 1.05 ± 0.58 0.99 ± 0.46 0.85
Vmax E′ lateral 
(cm/s)
11.4 ± 4.3 11.9 ± 4.5 10.5 ± 3.7 0.04
E/E’ lateral 8.0 ± 3.8 7.7 ± 3.7 8.5 ± 4.0 0.26
RVEDA/LVEDA 0.66 ± 0.51 0.59 ± 0.17 0.77 ± 0.83 0.01
Paradoxical 
septum (n)
14 (6) 7 (5) 7 (9) 0.23
ΔSVC ( %) 14 ± 13 15 ± 13 14 ± 12 0.97
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related to an increased cardiac preload via the α-agonist-mediated 
decrease in systemic venous capacitance. Whether NE exerts a positive 
effect on cardiac contractility through beta1-adrenergic stimulation is 
unclear. On the one hand, the sensitivity of beta1-adrenergic recep-
tors can be abnormally reduced in septic conditions. On the other 
hand, the down-regulation of beta1-adrenergic receptors may occur 
relatively late (2) and thus could be not seen when NE is administered 
early. Our study was designed to examine the inotropic effects of NE 
when administered in the early phase of septic shock.
Patients and methods We prospectively included patients suffering 
from septic shock and presenting with a mean arterial pressure (MAP) 
lower than 65  mmHg despite initial hemodynamic resuscitation and 
for whom the physician planned either to initiate Ne or to increase 
its dosage. Echocardiographic measurements were performed before 
(T0) and after either initiating NE or increasing its dosage in order to 
achieve a target MAP above 65  mmHg (T1). The following variables 
were collected: left ventricular ejection fraction (LVEF), velocity-time 
integral of the subaortic flow (VTI), tissue Doppler imaging of tricuspid 
annular motion (Sa), tricuspid annular plane systolic excursion (TAPSE), 
peak early transmitral flow velocity (E), and mean systolic velocity of 
the lateral mitral annulus (Sm).
Results Thirty-eight patients (68 ± 15 years) were included, their mean 
SAPS II was 55 ± 20, and the main sites of infection were the lung in 15 
patients, the abdomen in 8 patients, and the urinary tract in 6 patients. 
The mean interval time between the start of resuscitation and T0 was 
of 127 ± 58 min. At T0, patients have already received a mean volume 
of fluids of 1545 ± 688 mL and 16 patients had not yet received NE. 
In the other 22 patients, the mean dose of NE was 0.17  ±  0.45  µg/
kg/min at T0. At T1, the mean dose of NE was 0.58 ± 0.54 µg/kg/min 
for the whole population. From T0 to T1, MAP increased significantly 
from 56  ±  7 to 80  ±  9  mmHg, systolic and diastolic arterial pres-
sures increased from 85 ± 12 to 124 ± 15 mmHg and from 45 ± 6 to 
60 ± 10 mmHg, respectively, and lactate decreased from 3.2 ± 2.0 to 
2.5 ± 1.2 mmol/L (p < 0.05).
We observed significant increases (p  <  0.05) from T0 to T1 of: LVEF 
(from 49 ± 13 to 56 ± 13 %), Sm (from 10.8 ± 5.1 to 12.1 ± 5.0 cm/s), 
VTI (from 18 ±  5 to 20 ±  6  cm), E (from 81 ±  27 to 92 ±  28  cm/s), 
TAPSE (from 18.3 ± 5.1 to 20.4 ± 4.9 cm), and Sa (from 13.0 ± 5.6 to 
15.1 ±  6.4  cm/s). Even for the 15 patients with a LVEF ≤  45  % at T0, 
LVEF and VTI increased significantly from 36 ± 7 to 44 ± 9 % and from 
16 ± 6 to 18 ± 7 cm, respectively (p < 0.05).
Conclusion In spite of the increase in arterial blood pressure and thus 
in left ventricular afterload, NE administration at the early phase of 
septic shock increased the indices of left ventricular systolic function, 
even when the left ventricular systolic function is impaired. This sug-
gests that NE actually exerted a significant inotropic effect at the early 
phase of septic shock in addition to the effect on preload.
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Introduction There is a growing body of evidence that protective 
ventilatory strategies for ARDS with lower tidal volumes and higher 
PEEPs may benefit the lung. But high PEEP may induce right ven-
tricular (RV) dysfunction which may severely impair hemodynamic. 
We hypothesized that opening the lung with recruitment maneuver 
followed by maintaining high PEEP may be good for the lung and for 
the heart.
Patients and methods We decided to include ARDS patients under 
mechanical ventilation sedated and paralyzed with P/F  <  200. An 
open-lung protocol consisting of a 4-step recruitment maneuver 
(from 25 to 40 cm of PEEP) and a decremental PEEP titration (to find 
the best PEEP named open-lung PEEP) was performed after ruling 
out hypovolemia and severe acidosis. We recorded clinical param-
eters (mean arterial pressure (MAP), heart rate (HR)) as well as right-
to-left ventricle diameter ratio (RV/LV) using 2D echocardiography, 
tricuspid annular plane systolic excursion (TAPSE) with M-Mode 
echocardiography, aortic velocity time integral (using pulsed Dop-
pler) (VTI), systolic lateral RV annulus velocity using spectral tissue 
Doppler imaging (S) during the recruitment maneuver at 40  cm 
H2O and 1 and 24  h after this maneuver at the chosen best PEEP 
(open-lung PEEP). Cardiac output (CO) was measured using cardiac 
Doppler.
Results Ten patients with ARDS (age 55 ± 13 y/o) with SAPS 70 ± 15 
were included. Median open-lung PEEP of 21.0  cm H2O (16.0–23.0) 
was significantly higher than the baseline PEEP of 9 (6.0–13.5) 
cm H2O (p  <  0.01). PO2/FiO2 increased from 70.6 (40.6–89.6) to 
209  mmHg (141–229), p  <  0.01. This benefit was maintained 24  h 
later: 165.2 (107.3–199.8), p =  0.01 with no change of lung compli-
ance. RV/LV increased from 0.70 [0.58–0.75] to 0.80 [0.73–0.83], 
p =  0.02, during PEEP of 40  cm H2O and returned toward baseline 
values (0.75 [0.63–0.89], p = 0.10) at open-lung PEEP and remained 
at the same level at 24  h. The TAPSE showed a statistically signifi-
cant drop from baseline median value of 18 [17–21] mm to 16 [15–
17] mm (p = 0.02) at a peep of 40 cmH2O. At open-lung PEEP, TAPSE 
was the same as baseline 18 [17–19] mm (p = 1.00) and remained the 
same 24 h later. S was 16 [13–17] cm s−1 at baseline and significantly 
decreased during at PEEP 40 and returned to the baseline value at 
the end of the maneuver and remained stable at 24 h. MAP dropped 
from 89 [73–95]mmHg at baseline to a trough of 70 [60–81] mmHg 
(p = 0.01 vs baseline) during the last step of recruitment, was 70 [69–
77] mmHg at open-lung PEEP, and was 79 [67–84] mmHg 24 h later. 
CO decreased from 5.9  l min−1 (IQR 4.6–7.3) to 4.4  l min−1 (IQR 3.5–
6.4) during recruitment but returned to baseline value at open-lung 
PEEP (5.6 l min−1 (IQR 4.4–7.1)) and remained stable at 24 h. Ejection 
fraction was unchanged at open-lung PEEP and at 24  h, compared 
with baseline value.
Conclusion In our ARDS patients, recruitment maneuver permitted 
to open the lung with a dramatic increase in P/F and apply high PEEP 
of 21 cmH2O to maintain the lung open. Despite this high PEEP, right 
ventricular function was not impaired, confirming that what is good 
for the lung maybe not deleterious for the heart.
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Introduction The clinical significance and prognosis of septic myocar-
dial dysfunction is controversial. The paradoxical association between 
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septic myocardial dysfunction and improved survival in some stud-
ies may be explained by the influence of loading conditions. Our aim 
was to assess, in a large population of patients with septic shock, the 
prevalence and prognosis of left ventricle systolic dysfunction, while 
examining the potential role of loading conditions.
Patients and methods Patients were prospectively included at the 
medical intensive care unit of a tertiary hospital. Hemodynamic and 
echocardiographic data were recorded on the first 3  days of septic 
shock. Septic myocardial dysfunction (hypokinesia) was defined as 
a left ventricle ejection fraction <45  % or by the need of inotropes 
to achieve a left ventricle ejection fraction ≥45  %; hyperkinesia was 
defined by a left ventricle ejection fraction >60  %. Several indices of 
preload (estimates of left ventricle filling pressures and respiratory 
variations of vena cavae), contractility (ventricular-arterial coupling, 
left ventricle end-systolic maximal elastance, tissue Doppler imaging, 
speckle tracking imaging) and afterload (diastolic arterial pressure, 
systemic vascular resistance, end-systolic arterial elastance and left 
ventricle end-systolic wall stress) were assessed.
Results A total of 280 echocardiographies were performed in 133 
patients during the first three days of septic shock. Left ventricle 
ejection fraction was depressed in 42 (31.6 %) patients, normal in 57 
(42.9 %) patients and increased in 34 (25.6 %) patients. Patients with 
hypokinesia had an alteration in left ventricle contractility indices, 
whereas those with hyperkinesia exhibited the most severe altera-
tion in afterload indices. Most contractility indices were inversely 
correlated with afterload indices. Left ventricle longitudinal peak sys-
tolic strain was altered early in patients who secondarily deteriorated 
their left ventricle ejection fraction. Hyperkinetic patients exhibited 
the most severe alteration in afterload indices and a higher in-ICU 
and in-hospital mortality as compared to others. Altered afterload (as 
assessed by lower values of left ventricle end-systolic wall stress) was 
significantly associated with in-ICU mortality by multivariable analysis, 
along with fluid balance and SOFA score.
Conclusion The alteration of left ventricle ejection fraction dur-
ing septic shock was influenced by afterload, with an inverse cor-
relation between most contractility and afterload indices. Speckle 
tracking-derived strain was altered early in patients who secondarily 
deteriorated their left ventricle ejection fraction. Hyperkinetic patients 
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Introduction Bedside transthoracic echocardiography (TTE) has 
become an important tool in the management of critically ill patients. 
In fact, TTE enables the intensivist to categorize the shock state and to 
develop an effective management strategy.
In our noninvasive ICU, we still not have bedside TTE, and this exami-
nation is made by cardiologist, in the cardiology department.
Aim To evaluate, in our context, the use of TTE and its impact on the 
diagnosis and/or the management of the critically ill.
Patients and methods This was a retrospective study involving all 
patients admitted to ICU from January to December 2014, for respira-
tory or circulatory failure and who may have warranted a TTE. Patients’ 
characteristics and any change in diagnosis and/or management after 
TTE were recorded.
Results One hundred sixty-nine patients out of a total of 350 admis-
sions in 2014 were included. Forty-seven (28  %) have had a TTE. 
Compared patient characteristics between those who underwent 
TTE and not are displayed in Table 48. When performed, TTE revealed 
left ventricle dysfunction (27.5  %) and signs of chronic pulmonary 
hypertension (6  %). However, the TTE was normal in 20  % of exami-
nations. These findings led to a change of the diagnosis in 4 patients 
(10  %) and in the management of 8 (20.5 %) patients in which 15  % 
was considered important. Univariate analysis didn’t find any factors 
that predict a change in the diagnosis and/or the management of the 
patients (Table 49).
Conclusion In our noninvasive ICU, TTE is under-prescribed. When 
performed, its impact on the diagnosis or the management of the 
patients is uncertain. Bedside TTE would be a more valuable tool giv-
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Gender (M) [n (%)] 31 (66.0) 82 (67.8) 0.48
Underlying disease 
[n (%)]
43 (91.5) 93 (76.9) 0.02
Hemodynamic failure 
[n (%)]
13 (27.7) 58 (47.9) 0.013
Acute respiratory 
failure [n (%)]
47 (100) 110 (90.9) 0.024
EKG changes [n (%)] 27 (58.7) 30 (24.8) 0.38
Elevated cardiac 
troponin [n (%)]
13 (27.7) 11 (9.1) 0.40
Noninvasive ventilation 
[n (%)]
36 (76.6) 50 (41.3) <0.001
Invasive ventilation 
[n (%)]
22 (46.8) 86 (71.1) 0.003
Vasopressors [n (%)] 26 (55.3) 32 (26.4) 0.11
Table 49 Compared patients’ characteristics according 
to the presence or absence of change in diagnosis and/or 






Gender (M) [n (%)] 4 (50.0) 27 (69.2) 0.25
Underlying disease [n (%)] 7 (87.5) 36 (92.3) 0.53
Hemodynamic failure [n (%)] 4 (50.0) 9 (23.1) 0.13
Acute respiratory failure [n (%)] 8 (100) 39 (100) 0.56
Invasive ventilation [n (%)] 3 (37.5) 19 (48.7) 0.42
Noninvasive ventilation [n (%)] 6 (75.0) 30 (76.9) 0.61
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Introduction Echocardiography is increasingly used to assess patients 
with cardiopulmonary compromise. The identification of fluid respon-
siveness (FR) is key in the assessment of patients with acute circu-
latory failure. Several dynamic indices to predict FR obtained with 
transthoracic (TTE) and transesophageal echocardiography (TEE) 
have been previously validated in small populations of septic shock 
patients. Fluid resuscitation is the mainstay of acute management in 
most shocked patients, but a positive fluid balance is known to be 
detrimental on outcome. The present study aimed at determining the 
threshold value of echocardiographic indices to predict FR according 
to the clinical setting, to reduce false-negative or false-positive results.
Patients and methods This descriptive, prospective, multicenter 
study was conducted during a 24-month period in 5 French intensive 
care units (ICU). All ventilated patients >18  year old and requiring a 
hemodynamic assessment using echocardiography for an acute cir-
culatory failure (regardless of its etiology) were eligible to participate 
in the study. Acute circulatory failure was defined as the presence of: 
(1) hypotension (systolic blood pressure <90  mmHg or mean blood 
pressure <65  mmHg) and/or (2) signs of tissue hypoperfusion (e.g., 
mottled skin, oliguria, pH  <  7.35 and base deficit >−5  mmol/L, lac-
tate >2  mmol/L, ScvO2  <  70  %). Exclusion criteria were a contraindi-
cation for performing passive leg raising (PLR) or a TEE examination, 
or a shock secondary to a tamponade or an aortic dissection. Echocar-
diography was performed by an experienced operator in a patient in 
the semi-recumbent position (45°). The collapsibility index of superior 
vena cava (∆SVC), the distensibility index of inferior vena cava (∆IVC), 
the respiratory variations of aortic maximal doppler velocity (∆VmaxAo), 
the left ventricular ejection fraction (LVEF) and aortic Doppler velocity 
time integral (VTIAo) were measured. A 90°-PLR was then performed in 
all patients. VTIAo was measured after one minute of PLR. An increase 
in VTIAo > 10 % defined fluid responsiveness.
Results During the study period, 540 patients were studied (379 
men; age: 65  ±  13  years; SAPSII: 59  ±  18; SOFA: 10  ±  3), and FR 
was identified in 229 of them (42  %). Overall, 355 patients (66  %) 
had a tidal volume  <  8  mL/kg of predicted body weight, 174 
patients (32  %) had an IAP  ≥  12  mmHg and 78 patients (14  %) 
had a non-sinus rhythm. The origin of the acute circulatory fail-
ure was predominantly septic in 295 patients (55  %), cardio-
genic in 126 patients (23  %) and hypovolemic in 112 patients 
(21 %). ICU mortality was 39 %. Mean ΔSVC, mean ΔIVC and mean 
ΔVmaxAo were significantly greater in patients with FR (31 ± 24 vs. 
12 ± 15 %; 13 ± 14 vs. 8 ± 15 %; 15 ± 7 vs. 10 ± 7 %, respectively; 
all p  <  0.001). Patients with FR exhibited significantly lower AoVTI 
at baseline (14.8 ± 5.6 vs. 16.9 ± 7.2: p = 0.0002). During 90°-PLR, 
AoVTI variation reached 27 ± 18 % in patients with FR, whereas it 
remained as low as 0.5 ± 6 % in their counterparts. Threshold val-
ues to optimize the sensitivity or specificity of dynamic parameters 
are listed in Table 50.
Conclusion Threshold values of echocardiographic indices may 
greatly vary according to the clinical need of optimized sensitivity or 
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Introduction Right ventricular dysfunction is common in criti-
cally ill patients. Because of its disponibility, safety, and the valuable 
amount of information generated, transthoracic echocardiography 
has become the cornerstone of right ventricle exploration in the ICU. 
Norepinephrine could be useful in right ventricular dysfunction, by 
preventing right ventricular ischaemia. However, its role remains 
controversial, especially because of its effects on right ventricular 
afterload. The objective of this study was to evaluate the effects of 
norepinephrine on the right ventricle with use of echocardiography in 
critically ill patients.
Patients and methods We conducted a prospective, bicenter, physi-
ological study. Patients included were patients remaining hypotensive 
after fluid resuscitation. An echocardiography was performed before 
and after introduction of norepinephrine. Various parameters surro-
gates of right ventricular systolic function were collected: right ven-
tricular fractional area change (FAC), tricuspid annular plane systolic 
excursion (TAPSE), tricuspid annular motion (s’(t)) by Doppler tissue 
imaging, right ventricular dimensions, cardiac output, pulmonary 
pressures and right ventricular outflow tract velocity time integral (RV 
VTI).
Results Fifteen patients were included. Three had an altered fractional 
area change and 8 a longitudinal right ventricular dysfunction defined 
by a TAPSE lower or equal to 16  mm and/or a s(t) lower or equal to 
10 cm/s. In the whole population, only S(t) significantly increased from 
11 (8.3–14) to 14 (12–15.8) cm/s, p = 0.04 under norepinephrine. FAC, 
TAPSE, pulmonary pressures and cardiac output remained unchanged. 
In patients with a longitudinal right ventricular dysfunction, there was 
a significant increase in TAPSE from 14 (9.5–14.5) to 15 (11.5–17.0) mm, 
p = 0.016 and s’(t) from 8.5 (8.0–10.5) to 12.0 (8.0–13.0) cm/s, p = 0.027 
under norepinephrine. Cardiac output and pulmonary pressures 
remained unchanged.
Conclusion Norepinephrine appears to improve the right ventricular 
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Introduction In ARDS patients under mechanical ventilation, recruit-
ment maneuver may open the lung and improve blood oxygenation. 
During this maneuver, cardiac dysfunction may occur. We decide to 
analyze using speckle tracking, the effect of recruitment maneuver on 
the left ventricular longitudinal strain (LVLS).
Patients and methods We decided to include ARDS patients under 
mechanical ventilation sedated and paralyzed with P/F  <  200. An 





















90 % (39 %) 7 90 % (29 %) 18
ΔSVC 
(n = 460)
90 % (29 %) 5 90 % (42 %) 33
ΔIVC 
(n = 361)
76 % (37 %) 3 90 % (28 %) 19
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open-lung protocol consisting of a 4-step recruitment maneuver (from 
25 to 40 cm of PEEP) and a decremental PEEP titration (to find the best 
PEEP) was performed after ruling out hypovolemia and severe acido-
sis. We recorded clinical parameters (mean arterial pressure (MAP), 
heart rate (HR)) as well as ejection fraction (EF) using 2D echocardiog-
raphy, mitral annular plane systolic excursion (MAPSE) with M-Mode 
echocardiography, aortic velocity time integral (using pulsed Doppler)
(VTI), systolic lateral LV annulus velocity using spectral tissue Doppler 
imaging (S) and left ventricular longitudinal stress (LVLS) using speckle 
tracking at baseline, during the recruitment maneuver at 40 cm H2O 
and 2 min after this maneuver at the chosen best PEEP.
Results Nine patients with ARDS (age 55 ± 13 y/o) with SAPS 70 ± 15, 
P/F 130 ± 19, lung compliance 26 ± 8 ml/mmHg, PEEP 9 ± 3 cm H2O, 
respiratory rate 25 ± 5/mn, MAP 78 ± 12 mmHg, HR 85 ± 12/mn, EF 
60 ± 18 %, VTI 22 ± 6 cm, MAPSE 1.3 ± 0.5 cm, S 8.4 ± 4.5 cm/s were 
included. During recruitment at a PEEP of 40 cmH2O, HR 90 ± 14/mn 
and P/F176 ± 85 increased; MAP 62 ± 22 mmHg, MAPSE 1.3 ± 0.5 cm; 
S 8.4 ± 4.6 cm/s; EF 49 ± 22 %, VTI17 ± 8 cm all decreased. At the best 
PEEP of 12 ± 5cmH2O, P/F dramatically increase to 242 ± 80 and all 
hemodynamical and echocardiographic and Doppler parameters 
returned to the baseline values. LVLS was at −15.6 ± 5.6 % at baseline 
and dramatically increased to −8.1 ± 5.6 at a PEEP of 40cmH2O and 
returned to the baseline value of −13.8 ± 5 % immediately after the 
recruitment maneuver. This left longitudinal strain impairment during 
the maneuver was more severe at the apex (−19 ± 8 vs −7±8 %).
Conclusion Recruitment maneuver induces transient LV systolic dys-
function particularly at the apex of the LV. This dysfunction may be 
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Introduction In France, children diagnosed with type 1 diabetes pre-
sent often with diabetic ketoacidosis. In these circumstances multiple 
complications can occur as hydro-electrolytic disorders, hypoglycae-
mia and cerebral oedema, which is the most serious complication. 
Several potential risk factors for cerebral oedema have been identi-
fied; in particular, an early decrease in serum effective osmolality 
has been proposed as a possible mechanism. Thus, fast blood glu-
cose drop, which is linked to osmolality, is supposed to be cerebral 
oedema main risk factor, although no evidence has yet been proven. 
The International Society for Pediatric and Adolescent Diabetes 
(ISPAD) recommends capillary blood glucose not to fall more than 
5  mmol/l/h, and this threshold is found in several care protocols. 
Even though diabetic ketoacidosis complications are well known, 
treatment remains controversial and there is no national protocol to 
guide for the initial care of these patients. Thus, in two Parisians Pae-
diatric Intensive Care Units (PICU), different care protocols are used. 
The main difference concerns rehydration fluids. At Necker hospital, 
normal saline is used during at least 4 h and maintained until blood 
glucose falls of 5 mmol/l/h or under ≤15 mmol/l. Afterward, a 0.45 % 
sodium chloride infusion solution and dextrose 5 % is used. At Robert 
Debré hospital, normal saline is used during 2 h, regardless of blood 
glucose level, and then a 0.45 % sodium chloride solution with dex-
trose either 5 % or 10 % is used. The aim of this study is to compare 
safety and efficacy of those two protocols. The first objective was 
to compare number of patients with blood glucose levels dropping 
more than 5.5  mmol/l/h according to the protocol used. Secondary 
we looked for a difference between the two populations in osmotic 
variations, occurrence of hypoglycaemia, cerebral oedema, and delay 
for metabolic disorders normalization.
Patients and methods This 5-year retrospective cohort study (2010–
2015) included 93 children with inaugural and severe diabetic ketoaci-
dosis hospitalized in the two PICU. Severity was defined as venous 
pH < 7.10 or serum bicarbonate concentration <5 mmol/l or alteration 
in mental status or hemodynamic disorders or age <5 years. First, we 
recorded number of patients with at least one capillary blood glucose 
drop more than 5.5  mmol/l/h in the first 24  h of treatment. Second, 
we recorded patients characteristics, complications, maximal sodium 
level corrected for hyperglycaemia, osmolality decrease and maximal 
sodium concentration rise during the first 24 h of treatment.
Results No significant difference was found for demographic and 
clinical characteristics between the populations studied. No significant 
difference was noted in the number of patients with a capillary blood 
glucose fall more than 5.5 mmol/l/h, in the maximal glucose-corrected 
sodium and maximal effective osmolality decrease, and in sodium 
concentration rise during the first 24 h of care. Cerebral oedema and 
hypoglycaemia incidences were comparable in both populations. No 
cardiac arrhythmia was detected.  Although this results are nonsignifi-
cant, delay for pH normalization was longer in Necker (21.9 vs 14.9 h, 
p = 0.072) and delay for blood glucose normalization was shorter in 
Necker (8.7 vs 10.8 h, p = 0.171). Length of PICU stay was significantly 
longer in Necker (57.3 vs 37.7 h, p = 0.03).
Conclusion Although the care protocols for inaugural ketoacidosis in 
children are different, there were no significant differences in compli-
cations occurrence and in symptoms duration between both popu-
lations. Those two protocols are safe and should be combined for an 
easier and more efficient use in both hospitals.
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Introduction Children requiring intensive care are often chronically ill, 
and the intensive care stay may upset the balance between nutritional 
intakes and needs. As malnutrition is a key factor in morbidity/mortal-
ity in pediatric intensive care units (PICUs), screening for malnutrition 
and individualized adaptation of nutritional support are important 
elements of patient care. Yet, no study has previously evaluated the 
nutritional status of children admitted in French PICUs.
Patients and methods Principal objective: To determine the preva-
lence of malnutrition in the population of children admitted to inten-
sive care.
Secondary objectives: To describe nutritional status on the basis of 
simple anthropometric parameters and to characterize the profile of 
patients with and without malnutrition.
Type of study: Observational and multicentric.
Primary assessment parameter: Malnutrition, as defined by a body 
mass index (BMI) value <−2 SD, according to the WHO Child Growth 
Standards.
Inclusion criteria: All children (1  month–18  years) admitted in a unit 
participating to the study during three one-week periods in the course 
of the year 2014.
Results Four hundred and forty-four patients were enrolled by the 28 
participating PICUs.
The global prevalence of undernutrition was 18.5 %. It was particularly 
high among children under 5 years old: 19.6 %.
Young age, planned admission and chronic disease appeared as risk 
factors for undernutrition.
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The clinical impression of the physicians underestimated the patients’ 
malnutrition.
Conclusion This is the first study that describes the nutritional status 
of children admitted to intensive care in France.
Almost 1 in 5 children is malnourished on admission in a PICU.
These results should lead to the development of training initiatives 
and research protocols to optimize the screening of malnutrition and 
the early nutritional management for children in PICUs.
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Introduction Primary outcome was to evaluate the efficacy of apnea test 
provided by ventilator disconnection protocol and O2 administration for 
the clinical confirmation of brain death in children. Secondary objectives 
were to analyze cardiorespiratory complications occurring during the 
apnea test and the evolution of the number of eligible lung transplant.
Materials and methods Retrospective single-center study performed in 
all pediatric intensive care unit at Necker-Enfants Malades University Hos-
pital. From 2005 to 2014, all pediatric patients with a probable diagnosis 
of brain death and who required apnea test were included in the study.
Results One hundred and three patients were included from 2005 
to 2014. Apnea test was performed in 43/103 patients (42 %). Causes 
of brain death were trauma 14/43 (33 %), cerebral tumor 9/43 (21 %), 
neurovascular 8/43 (19  %), cerebral anoxia 7/43 (19  %), other 3/43 
(7  %) and meningitis 2/43 (5  %). Apnea test was successful in 40/43 
patients (93 %) and prematurely stopped in 3/43 patients (7 %). Causes 
of apnea test interruption were hemodynamic failure in 2 patients 
and hypoxemia in 1 patient. There were no significant differences 
between the number of successful apnea test in children ≤2 years old 
compared with children >2  years old (13/15 (87  %) vs. 27/28 (96  %), 
p = 0.3). PaO2/FiO2 ratio (276 ± 126 before apnea test vs. 179 ± 120 
after apnea test, p =  0.0002) and the number of eligible lung trans-
plant (18/41 (44 %) before apnea test vs. 6/38 (16 %) after apnea test, 
p = 0.007) significantly decrease during the apnea test course. No seri-
ous complications occurred during apnea test courses.
Discussion The efficacy of apnea test for brain death diagnosis in chil-
dren and infants is comparable with studies published in adult’s popu-
lation. However, gas exchange is impaired during apnea test course as 
showed by the drop in PaO2/FiO2 ratio. The decrease in PaO2/FiO2 ratio 
could be explained by atelectasis formation. Recruitment maneuvers 
and protective ventilation strategies could prevent PaO2/FiO2 ratio 
drop and limit the decrease in the number of available lung trans-
plant after apnea test. Systemic hypotension occurred in 9/41 patients 
(21 %) but without metabolic impairment as shown by the stability of 
base excess (−3.5 ± 4.6 vs. −4.8 ± 4.6 mEq/L, p = 0.3).
Conclusion Apnea test performed with a ventilator disconnection 
protocol is efficient for brain death diagnosis in children whatever age 
group without serious complication. However, prospective studies are 
necessary to evaluate methods such as alveolar recruitment maneu-
vers limiting the drop in PaO2/FiO2 ratio during apnea test course.
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Introduction The installation of central venous catheterization 
through (CVC) is a percutaneous procedure difficult in infants and chil-
dren. Venipuncture is usually done blindly; however, this procedure is 
associated with a high morbidity and a significant risk of failure. The 
purpose of this study is to evaluate the usefulness of the technique of 
ultrasound-guided installation in reducing the failure rate and morbid-
ity in pediatric intensive care unit.
Patients and methods Our study was conducted in the pediatric 
intensive care unit of University Hospital Farhat Hached of Sousse. 
We compared two groups. Group S: standard technique (N = 15) and 
Group E: technical guided echo (N = 15). We collected data related to 
the difficulty of installation and subsequent complications.
Results The average number of attempts and the duration of the pro-
cedure were significantly lower in group E, respectively, 4 and 2 versus 
7 min versus 17 min. The success rate at the first puncture was far more 
important in group E. The arterial punctures and bruises were avoided 
in group E 0/15 versus 5/15. The number of infections on catheters and 
thrombosis were significantly higher in group S.
Conclusion Our work has helped to highlight the superiority of the 
installation of central venous catheters guided by real-time ultrasound 
in children in intensive care unit.
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Introduction The feasibility and the reduction of complications 
related to the insertion of supra clavicular central venous catheters 
were already demonstrated in pediatric intensive care unit. The data 
concerning maintenance-related complications (thrombosis and cath-
eter-related bloodstream infections) with this insertion site are lacking.
We proposed to analyze the complications related to the maintenance 
of supraclavicular catheter versus the others sites of insertion.
Patients and methods A retrospective analysis was performed over a 
4-year period in a pediatric intensive care unit. All non-tunneled cen-
tral venous catheters inserted in the unit were enrolled. Dialysis cath-
eters, peripherally inserted catheters or umbilical cord catheter were 
excluded. The primary outcome was the comparison of rates of infec-
tion and/or thrombosis per 100 catheters and the incidence density 
of the catheter related blood stream infection per 1000 catheter-days. 
Secondarily were considered immediate complications and character-
istics of maintenance-related complications.
Results Two hundred and fifty-seven central venous catheters were 
included accounting for 2902 catheter-days. One hundred and forty-
seven catheters were inserted in supraclavicular position (57.2 %) with 
an increasing proportion during the study period (from 21 to 84  %; 
p  <  0.05). Patients were younger in the supraclavicular group (4.6 
(0.7–38.7) months vs 12.5 (2.4–41.6); p  =  0.014) and for the propor-
tion of neurologic or respiratory admissions. Ultrasound guidance was 
systematic for the supraclavicular approach compared to 56 % for the 
others sites (p < 0.001).
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Complications related to the maintenance were less frequent in the 
supraclavicular site (incidence rate 5.4 vs 16  % p =  0.006) especially 
regarding thrombosis (2.7 vs 10  % p  =  0.016) and approaching sig-
nificance for catheter-related blood stream infections (3.4 vs 9.1  %, 
p  =  0.063). The incidence density of catheter-related blood stream 
infections was also lower (2.8 episodes per 1000 catheter-days vs 8.9, 
p  <  0.001). Time of onset of maintenance-related complications was 
longer with the supraclavicular approach: Concerning thrombosis, it 
was 15.5 (9–25.5) vs 7 (6–21) days for the others sites (p = 0.157) and 
14 (6–16) vs 11 (9–15) days for the catheter-related blood stream infec-
tion (p = 0.771). The femoral site was found to be a significant risk fac-
tor for thrombosis in a logistic regression analysis (odds ratio 6.11 95 % 
CI 1.77–25.6; p =  0.0064). Coagulase negative staphylococci was the 
most frequent bacteria whatever the site.
Immediate complications were less frequent with the supraclavicular 
approach but only arterial puncture reached significance (Fig. 39).
Conclusion Supraclavicular approach of the innominate vein with 
ultrasound guidance is gaining interest since few years. This technique 
is feasible in pediatric intensive care unit even in the younger infant. 
We confirm that immediate complications are reduced. Furthermore, 
maintenance-related complications seem to be limited with this 
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Introduction The management of children with acute kidney injury 
(AKI) may require a renal replacement therapy (RRT). There are three 
RRT methods available for children including peritoneal dialysis (PD), 
intermittent hemodialysis (iHD) and continuous RRT (CRRT), but it 
is a challenge for pediatric units to maintain staff competency and 
expertise for all 3 methods due to the low RRT incidence (0.7–2.4  % 
of pediatric intensive care units (PICU) admissions (1)). The aim of our 
study was to assess the RRT methods currently used in French-speak-
ing pediatric centers.
Patients and methods We conduct a multicentric, prospective obser-
vational study in French-speaking pediatric centers (n  =  24), both 
PICUs (n  =  25) and pediatric nephrology units (PNUs, n  =  6) from 
France and Canada. EPURE study started in 2012 and is financially sup-
ported by a PHRC. PICUs and PNUs characteristics are collected, and 
children (0 to 17 years old) with AKI requiring RRT are included, after 
parent consent, and followed up for 1 year. The study is approved by 
French and Canadian Institutional Review Boards. The overall distribu-
tion of RRTs modalities among children already included in the study 
was analyzed.
Results Two hundred forty-three children with AKI and RRT are cur-
rently included in the EPURE study, (500 are planned) and data from 
181 are analyzed and reported in this abstract. The use of CCVH, PD 
and iHD among children with AKI was 43, 41 and 15 %, respectively. 
The RRT methods distribution differed according to the AKI diagno-
sis. In hemolytic uremic syndrome (HUS), the use of CCVH, PD and 
iHD among children was 29, 55 and 16 %, respectively. For the same 
age and AKI diagnosis, the RRT method used differed from a center to 
another probably because only 27 % of the analyzed centers reported 
that they were able to provide the three RRT methods to children.
Discussion The choice of technique does not seem to only depend on 
age and diagnosis but also on other factors such as center expertise.
Conclusion CCVH and peritoneal dialysis are more frequently used 
than hemodialysis in children with AKI. Further analysis of EPURE study 
that will include patients follow-up at 1  year will inform us on the 
impact of these RRT choices on AKI recovery.
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Introduction To determine the incidence of hyperglycemia and its 
impact prognosis in severe scorpion envenomed children requiring 
intensive care admission.
Patients and methods We retrospectively included 626 patients aged 
less than 16 years admitted for scorpion envenomation over a period 
of 15 years in the 22-bed intensive care unit (ICU) of our university hos-
pital. Were excluded all patients without biological glycemia on ICU 
admission. All included patients were stratified in two groups accord-
ing to their biological glycemia on ICU admission: hyperglycemia 
group (hyperglycemia >10 mmol/L) and hyperglycemia free group.
Results There were 361 males and 265 females. The mean age (±SD) was 
5.9 ± 3.9 years. The hyperglycemia group included 316 patients (50.4 %). 
The mean delay between scorpion envenomation and ICU admission 
was not significantly different between two groups. The comparison 
between two groups with and without hyperglycemia showed that res-
piratory failure, the use of mechanical ventilation, the presence of pulmo-
nary edema and the use of inotropes were significantly associated with 
the presence of hyperglycemia. PRISM score was significantly increased 
in hyperglycemia group. Finally, the mortality rate and the length of hos-
pital stay were significantly higher in hyperglycemic patients group in 
comparison with normoglycemic patient group (p = 0.01).
Discussion Hyperglycemia is often observed in severe scorpion 
envenomed children. The presence of hyperglycemia represents an 
indicator of severity in this specific condition.
Fig. 39 See text for description 
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Conclusion Our study confirms that hyperglycemia is often observed 
in severe scorpion envenomed children. The presence of hyperglyce-
mia represents an indicator of severity in this specific condition. More 
studies are needed on this subject.
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Introduction Prehospital care is crucial in the treatment of trauma 
patients. Nevertheless, there is a lack of data concerning the prehos-
pital care of severely injured pediatric patients with trauma in France. 
The main aim of our study was to describe the prehospital and initial 
hospital care in children with severe trauma, hospitalized in the inten-
sive care unit (ICU) at the Grenoble University Hospital, and were taken 
in charge by the trauma system “TRENAU” (trauma-system du réseau 
nord-alpin des urgences). The second objective was to describe the 
factors of the prehospital and initial care associated with the length of 
hospital stay and the outcome of the patients.
Patients and methods The data were retrospectively analyzed and 
collected from the register of the “TRENAU.” Data concerning the 
prehospital and initial hospital care of severely injured traumatized 
patients (according to the Vittel Criteria) were collected. All patients 
with those criteria, aged 0 to 15  years and hospitalized in the ICU 
at the Grenoble University Hospital between January 1, 2009, and 
December 31, 2011, were included in the study.
Results One hundred and one severely injured traumatized pediatric 
patients were hospitalized in the ICU. The three main causes of trauma 
were road accident (39 %), mountain accident (37 %) and fall from a 
great height (19  %). The most frequent injury was traumatic brain 
injury (74  %), associated or not with other injuries. Seven percent of 
the patients died, all with severe head trauma. The mean duration of 
the prehospital care was 100 (±40) min.
Among the patients with hypotension, only 50 % received fluid resus-
citation (mean volume 16 ml/kg). Concerning the neurological failure, 
16 % of the patients (n = 16) had a GCS less than 8 and 81 % of this 
patients (n = 13) were intubated during the prehospital or initial hos-
pital care. Concerning the intra-cranial pressure monitoring, 6 patients 
were monitored by an intra-cranial captor during the initial care, 
whereas 16 patients had an indication for it (GCS less than 8 and AIS 
less than 3 for the head).
In univariate analysis, many factors were associated with the outcome 
of the patients according to the Glasgow Outcome Scale (GOS). These 
factors were the age of the patient, osmotherapy, blood transfusion 
and the following scores: GCS, PTS, ISS, TRISS, RTS and PRISM.
In multivariate analysis, the age of the patient and blood transfusion 
were independently associated with the length of stay in the ICU.
Conclusion The prehospital care of pediatric patients with severe 
trauma, taken in charge by the TRENAU, enables guidelines compli-
ance in several points (fast orientation to adapted trauma center, dura-
tion of prehospital care). Nevertheless, it appears that some points 
could be improved (intubation, fluid resuscitation volume, monitoring 
of intra-cranial pressure). The results of our study provides some hints 
as to how to improve the prehospital management of pediatric trauma 
patients, especially at the level of our regional trauma system, by 
adaptation and diffusion of pediatric protocols and formation of the 
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Introduction Pseudomonas aeruginosa (Pa) is the leading cause of 
ventilator-associated pneumonia (VAP) and carries a high mortal-
ity. The exact impact of resistance of Pa strains on outcome is still on 
debate; some studies report association between Pa resistance and 
morbidity/mortality, other not. We therefore performed a study to ana-
lyze the risk factors, characteristics and outcomes of Pa-VAP according 
to the characteristic of the strains, i.e., susceptible or resistant.
Patients and methods This was a retrospective study on data pro-
spectively collected (1). Patients having developed bacteriologically 
confirmed Pa-VAP (diagnosed using bronchoalveolar lavage, tracheal 
aspirate or mini-bronchoalveolar lavage) were prospectively followed 
until ICU discharge or death. Pa strains were considered multidrug 
resistant (MDR) if resistant to ≥1 agent in ≥3 categories of antibiotics; 
extensively drug resistant (XDR) if resistant to ≥1 or more agent in all 
but ≤2 categories of antibiotics and pan-drug resistant (PDR) if resist-
ant to all antibiotics tested (2). Patients infected with susceptible (S) 
strains were compared to patients infected with MDR and XDR strains. 
In a second analysis, patients infected with a MDR or XDR strains 
(grouped together and therefore named R) were compared to patients 
infected with S strains. Results are expressed as mean ± SD or median 
(IQR).
Results One hundred and sixty-nine patients with at least one epi-
sode of Pa-VAP were included: 111 were males, and 58 females; they 
were 58 ± 19 year old, with a SAPS II score on admission of 51 ± 21 
and duration of MV before VAP episode of 11 [6–20] days. Of 169, 143 
(85 %) had received antibiotics in the preceding 15 days. One hundred 
and fifteen patients (68  %) were infected with S strain, 36 patients 
with MDR strain (21  %) and 18 patients (11  %) with XDR strain. No 
patient was infected with PDR strain. Patients infected with XDR and 
MDR strains had trend toward higher previous use of fluoroquinolo-
nes, ceftazidime, third-generation cephalosporins and piperacillin/
tazobactam than patients infected with S strains (33, 28 and 16 % for 
previous fluoroquinolones use, respectively; 22, 8 and 6 % for previous 
ceftazidime use respectively; 44, 39 and 26 % for previous third-gen-
eration cephalosporins use, respectively; 39, 40 and 25 % for previous 
piperacillin/tazobactam use, respectively. P = NS for all). No other dif-
ferences were observed between patients infected with S, MDR or XDR 
strains regarding initial characteristics of patients, VAP characteristics 
or outcomes (infection recurrence, ICU length of stay and mortality). 
Similar results were observed when comparing patients infected with 
S strains and those infected with R (MDR plus XDR grouped together): 
No difference at ICU admission or the day VAP was diagnosed except 
that patients infected with R strains received more frequently fluoro-
quinolone (30 vs. 16 %, respectively p = 0.03) and trend toward more 
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piperacillin/tazobactam (39 vs. 25 %, respectively, p = 0.07) and third-
generation cephalosporins (41 vs. 26 %, respectively, p = 0.054) than 
patients infected with S strains, but exhibited similar VAP recurrence 
(30 % and 39 %, respectively, p = NS), ICU length of stay (29 [20–50] 
and 38 [21–53] days, respectively, p = NS) and mortality rate (33 % and 
33 %, respectively).
Conclusion In this large cohort of Pa-VAP, resistance profile was not 
associated with infection recurrence, ICU length of stay or death. 
Except previous use of fluoroquinolones, we were not able to find any 
risk factor associated with resistance profile of Pa.
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Introduction Related to the absence of effective diagnostic tools for 
invasive candidiasis, empirical systemic antifungal therapies are rec-
ommended and largely prescribed to the intensive care unit patients 
with risk factors. However, secondary documented invasive candidi-
asis is not observed for all the patients who receive an empirical sys-
temic antifungal therapy. The objective of this study is to define the 
risk factors able to predict the probability for having a secondary 
documented invasive candidiasis after empirical systemic antifungal 
therapy by accounting for center and patient variables.
Patients and methods The patients with an empirical systemic 
antifungal therapy were prospectively included from a multicenter 
prospective observational study. Only patients without primary doc-
umented invasive candidiasis were included and were divided into 
two groups: patients without documented invasive candidiasis and 
patients with a secondary documented invasive candidiasis. A multi-
variate hierarchical model was performed to identify factors indepen-
dently associated with a secondary documented invasive candidiasis. 
Two sub-group analyses were performed by considering the type of 
intensive care unit admission (intra-abdominal surgery vs. other).
Results Five hundred and forty-four patients were included in the 
analysis, from whom 112 (21 %) had a secondary documented IC (can-
didemia 19 (17  %), intra-abdominal IC 64 (57  %) and deep-seated IC 
29 (26 %)). The proportion of secondary documented invasive candidi-
asis was higher for patients admitted for an intra-abdominal surgery 
(28  %) compared to the patients admitted for another reason (other 
surgery or medicine 14  %). The multivariate analysis confirmed that 
the patients admitted in intensive care unit for an intra-abdominal 
surgery had more than three times as likely to experience a secondary 
documented invasive candidiasis than the patients who were admit-
ted for a medicine reason (OR 3.02 [1.69; 5.40]: p < 0.01). The other fac-
tors significantly associated with a secondary documented invasive 
candidiasis were the presence of an infectious disease in the intensive 
care unit (OR 2.78 [1.07; 7.18], p = 0.03) and septic shock at the treat-
ment initiation (0.60 [0.368; 1.00]; p =  0.05). When we consider only 
patients who were admitted in intensive care unit for an intra-abdom-
inal surgery, the presence of an infectious disease in the intensive care 
unit and septic shock remained associated with secondary invasive 
candidiasis. Conversely, when we consider the sub-group of patients 
who were not admitted for an intra-abdominal surgery, there was no 
factor significantly associated with a secondary documented invasive 
candidiasis (Fig. 40).
Conclusion The patients admitted in intensive care unit for an intra-
abdominal surgery were more subjects to experience a secondary 
invasive candidiasis than other patients. Conventional risk factors 
for invasive candidiasis were unable to differentiate the two groups 
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Fig. 40 Risk factors for secondary documented invasive candidi‑
asis—multivariate analysis (OR > 1: in favor of a secondary docu‑
mented infection)
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Introduction Patients with hematological malignancies (HMs) are at 
high risk of severe bacterial infections. Septic shock still carries high 
mortality for these patients. The place of aminoglycosides (AMG) in 
this setting is still uncertain.
Patients and methods In a post hoc analysis of the Trial-OH study, 
we studied 444 patients with HMs admitted to 17 ICUs for septic 
shock as defined by the need for vasopressors and clinically or micro-
biologically documented infection, or neutropenia and fever. All 
patients were treated using broad-spectrum beta-lactams. AMG were 
prescribed according to clinician’s decision. The analysis was based 
on propensity matching (1:1 matching algorithm) and following vari-
ables such as neutropenia, acute kidney injury, myeloma, dialysis and 
ICU which might affect the administration of AMG in addition to age, 
Sepsis-related Organ Failure Assessment (SOFA), secondary acute leu-
kemia and remission status of the HMs. The primary endpoint was hos-
pital mortality.
Results A total of 313 patients (70.5 %) received AMG, whereas 131 did 
not. Hospital mortality was, respectively, 174 (55.6 %) and 73 (56.1 %); 
[OR] = 1.04 [0.68;1.54] P = 0.91. Age, SOFA, secondary acute leukemia 
and remission status were significant variables associated with mortal-
ity. Among the 131 patients who did not receive AMG, 123 could be 
matched to AMG-treated patients, resulting in a total of 246 paired 
observations in the propensity analysis. The proportion of hospital 
death was not significantly different between the two groups 56.1 % 
(no AMG) vs 55.3  %, P  =  0.89 [OR]  =  1.04 [95  % CI, 0.61- 1.76]. No 
center effect was reported. ICU length of stay was also not significantly 
different between AMG-treated patients and other patients.
Conclusion In HM patients with septic shock, up to 70 % receive AMG 
with no center effect. These data, in line with the literature in immuno-
compromised patients without septic shock, do not support the use of 
AMG in this setting. Randomized clinical trials are warranted.
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Introduction De-escalation of the antimicrobial therapy is recom-
mended in severe sepsis guidelines. This study investigated the preva-
lence of de-escalation and the factors associated with in hematology 
patients admitted to the intensive care unit (ICU).
Patients and methods This study is a retrospective evaluation of a 
prospective observational cohort of hematology patients admitted 
to the ICU. Patients without antibiotics prior to ICU admission and in 
whom antibiotics were initiated in the first 48 h were included in this 
ancillary study. De-escalation of antimicrobial therapy was defined 
either by the cessation of a β-lactam or a glycopeptide or by the switch 
from a β-lactam to another one with a narrower spectrum (carbapen-
ems > piperacillin/tazobactam > ceftazidime or cefepime > piperacil-
lin or ticarcillin > cefotaxime or ceftriaxone > other penicillins) before 
the day 5. Characteristics and outcomes of patients with (group D+) 
and without de-escalation (group D−) were compared.
Results Among the 1011 patients from the prospective cohort, 124 
patients were included in the present study, 82 men and 42 women 
with a median age of 60 (IQR 47–70) years. The underlying malignancy 
was acute leukemia in 46 (37 %) patients, lymphoma in 37 (30 %), mye-
loma in 14 (11 %), chronic lymphocytic leukemia in 12 (10 %) and mis-
cellaneous hematologic disorders in 15 (12 %). It was newly diagnosed 
in 59 (50 %) patients and in complete remission in 22 (19 %). Twenty-
eight (24 %) patients were neutropenic at ICU admission. Twenty-four 
(19  %) had received bone marrow transplantation, including alloge-
neic stem cell transplantation in 11 (9 %).
The median Charlson comorbidity index was 4 (IQR 3–6), and 18 (15 %) 
patients had poor performance status (WHO score 3–4). The cardiovas-
cular component of this score was present in 53 (43 %) patients, the 
pulmonary component in 33 (27 %), the liver component in 15 (12 %), 
the neurologic component in 11 (9  %), the renal component in 10 
(8 %), the HIV infection component in 7 (6 %) and the diabetes compo-
nent in 3 (2 %) patients.
The main reasons for ICU admission were acute respiratory failure in 85 
(69 %) patients, shock in 46 (37 %), acute kidney injury in 34 (27 %) and 
coma in 26 (21 %). Overall, 64 (52 %) patients had multiple organ fail-
ure. The median ICU and hospital lengths of stay were 12 and 32 days, 
respectively. In the whole cohort, 28 (23  %) patients died in the ICU 
and 43 (35 %) in hospital.
Empirical antimicrobial therapy consisted in a β-lactam in 122 (98 %) 
patients: 66 (53 %) received piperacillin/tazobactam, 30 (24 %) cefotax-
ime or ceftriaxone, 20 (16 %) a carbapenem, 13 (11 %) amoxicillin/cla-
vulanic acid, 6 (5 %) ceftazidime and 3 (2 %) piperacillin. Twenty-one 
(17 %) received a glycopeptide, combined to a β-lactam in 19 (90 %) 
of them. Thirty-five (27 %) patients received macrolides, 29 (23 %) an 
aminoglycoside and 28 (23 %) a fluoroquinolone.
The antimicrobial therapy was de-escalated in 46 (37  %) patients 
(group D+). Extensive comparison of patients with and without 
de-escalation showed no difference in patients’ characteristics, 
comorbidities or in the underlying malignancy status. The main rea-
sons for ICU admission were also similar in both groups. No differ-
ence was observed as regard to ICU admission severity according 
to SOFA score (6 [IQR: 4–8] in group D− vs. 7 [IQR: 3–10] in group 
D+, P =  0.55) or white blood cells count (9280 [IQR: 2000–24,625] 
vs. 7900 [IQR: 2822–17,990], P = 0.48). From the first to the third day 
spent in the ICU, the evolution of SOFA score (0 [IQR: −2 to 1] vs. 
0 [IQR: −4 to 3], P =  0.78) and the rate of neutropenia recovery (6 
[35 %] vs 6 [55 %], P = 0.44) were also similar. Finally, ICU (8 [17 %] in 
group D+ vs. 20 [26 %] in group D−, P = 0.38) and hospital mortality 
(12 [26 %] vs. 31 [40 %], P = 0.17) were not statistically different. No 
difference across group in terms of mortality was noted after adjust-
ment for confounders.
Discussion The rate of de-escalation was high in this cohort of criti-
cally ill hematological patients. De-escalation was not associated with 
a specific characteristic or the outcome of these high-risk patients. 
However, the lack of power and the design of the present study pre-
clude any firm conclusion.
Conclusion Further studies specifically designed to explore this topic 
are warranted to investigate the feasibility and safety of de-escalation 
of the antimicrobial therapy in critically ill hematological patients.
Competing interests None.
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Introduction The use of nasogastric tube (NG) is one means of admin-
istering antifungal therapy to critically ill patients unable to receive 
medication via the oral route. The aim of the study was to determine 
pharmacokinetics and absolute bioavailability of voriconazole in criti-
cally ill patients receiving continuous enteral feeding.
Patients and methods A prospective multicentric, crossover study 
was conducted. Stable critically ill patients on mechanical ventilation 
and receiving continuous enteral feeding with suspected or proven 
fungal invasive infection (IFI) treated with voriconazole were included. 
Voriconazole loading dose (6  mg/kg) every 12  h for 2 doses intrave-
nously was followed by maintenance dose of 4  mg/kg every 12  h 
during 3 days. From day 4, administration of 5 mg/kg every 12 h was 
performed through the NT. NG dose was 1  mg/kg greater than the 
recommended dose in order to avoid food reduction bioavailability. 
Blood samples were collected after the fifth intravenous (IV) infusion 
and after the fifth NG administration. Demographic, biologic data and 
concomitant drugs were collected. AUC/dose NG was compared to 
AUC/dose IV using a paired T test.
Results Eight patients (5 males, 3 females) were evaluable. Median 
(range) age and bodyweight were 67.5 (49–86) years and 76.5 (57.3–
117) kg. Only one patient did not receive esomeprazole. None had 
hepatic disease. Voriconazole concentrations were measured by using 
a validated high-performance liquid chromatographic assay (Table 51).
AUC/dose were not different between route (p = 0.6). Mean voricona-
zole absolute bioavailability was 106 % and range from 77 to 135 %. All 
subjects completed the study without any adverse effects.
Conclusion In tube-fed ventilated critically patients, a switch to NG 
voriconazole after initial IV therapy to simplify the treatment of IFI 
could be used. Furthermore, it suggests that concurrent enteral feed-
ing does not interfere with the absorption of voriconazole and, thus, 
does not have to be interrupted during voriconazole administration. 
All trough concentration patients were superior to the efficacy target 
(2  mg/L). However, after 6  days of treatment, 4 patients had trough 
concentration superior to upper therapeutic range target 5  mg/L. 
Therapeutic drug monitoring should be performed to avoid suprath-
erapeutic concentration and potential neurotoxicity.
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Introduction Linezolid was an antibiotic with time-dependent activ-
ity. It was assumed that adequate serum linezolid concentration will 
be achieved most of the time when using the recommended dose of 
600  mg every 12  h. Burns induce complex physiological changes as 
modification of distribution volume, increased clearance of drugs and 
decrease in protein binding. So, the pharmacokinetic of linezolid may 
then be modified. This requires dose adjustment particularly in burns.
The aim of our study was to assess the pharmacokinetic of linezolid 
in burn patients at a dose of 600 mg three times per day. Thresholds 
for therapeutic efficacy of linezolid were: plasma Cmin  >  2  mg/l and/
or AUC/MIC ratios of 80 (or AUC24  >  200  mg/h/l) or  %TMIC of  >  85 
(percentage of dosing interval during which linezolid concentration 
remains above the MIC of targeted bacteria) [1].
Patients and methods This study was conducted in burn center 
in Tunis. Patients with documented and/or suspected MDR Gram-
positive bacterium-related infections and whose burned area greater 
than 20 % (TBSA ≥ 20 %) were included. They were excluded pregnant 
women and patients <16 years old. Enrolled patients received linezolid 
at a dose of 600 mg in 1 h infusion three times per day. Blood samples 
for pharmacokinetic analysis were taken 5 min after the end of the first 
infusion, 5 min before the second and the third dose and 5 min before 
the dose of the day after. To assess linezolid serum level, 4 mL of blood 
was drawn from an arterial line, centrifuged and then stored at –80 °C. 
For all patients, linezolid minimum inhibitory concentration (MIC), the 
AUC 0–24 h (daily area under curve) and linezolid plasma concentra-
tions (trough (Cmin) and peak (Cmax) levels) were calculated.
Results During the period of study, 10 burned patients were included. 
The mean age was 39 ± 22 years old with a burned area of 30 ± 11 %. 
No case of renal failure (creatinine 73 ± 38 µmol/l) or of thrombocy-
topenia was noted in our patients (276  ±  176/μL). For all patients, 
linezolid administration at the dose of 600  mg three times a day 
allows to reach: an adequate daily linezolid exposure with a mean 
AUC 0–24  h/MIC (mg/h/l)* of 126 (recommended: 80–120), a Cmin of 
4.84 ± 2.33 mg/L and a %TMIC of 100. In our study, no case of poten-
tial overexposure was noted with this dosage of linezolid.
Conclusion Our study suggests that linezolid at the daily dosage of 
600  mg every 8  h in burned patients allows to reach optimal PK/PD 
targets for linezolid clinical efficacy: AUC/MIC of 126 and a %TMIC of 
100, and may reduce the emergence of linezolid resistance.
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Introduction Therapeutic success of amikacin associated with a B-lac-
tamin is proved to be related to an effective serum peak concentration 
(Cmax). In critically ill septic patients with increased volume of distribu-
tion, failure to obtain an effective Cmax (Cmax < 64 mg/l) was observed 
in thirty percent of patients. Similar changes in volume of distribution 
are observed after cardiopulmonary bypass for cardiovascular surgery; 
however, there are no published data concerning the prevalence and 
the predictive factor of insufficient Cmax.





Tmax (h) Cmax (mg/L)
IV route 0.16 ± 0.07 0.5–1.5 5.8 ± 2.0
NG route 0.17 ± 0.07 1–4 10.2 ± 4.2
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Patients and methods The aim of this monocentric retrospective 
study was to identify predictive factors for insufficient Cmax in a pop-
ulation of postoperative critically ill cardiovascular surgery patients 
between January 2012 and June 2015.
Results One hundred and thirty-six patients of 60 years were included. 
Administration of an average dose of 22 ± 5.1 mg/kg resulted in failure 
to achieve a Cmax > 64 mg/l in 39 % of patients and a Cmax > 60 mg/l in 
30.9 % of cases. More than 58 % had a Cmax > 80 mg/l.
In the univariate analysis, male gender, hypertension, diabetic and 
daily dose per body weight were significantly more important in the 
Cmax > 64 mg/l group compared to the Cmax < 64 mg/l group [respec-
tively (77.1 vs 75.5  %; p  <  0.01), (63.4 vs 44.2  %; p =  0.033), (38.3 vs 
22 %; p = 0.045), (23.7 ± 4.7 vs 19.3 ± 4.6; p < 0.01)]. In multivariate 
analysis, the amikacin dose per body weight (OR 0.79; p < 0.001) and 
the diabetes (OR 0.35; p = 0.03) are associated with a Cmax > 64 mg/l. 
There was no relation between insufficient Cmax and outcomes. Of 
interest, Cmax was significantly more important than 8 and 10 times the 
value of observed minimal inhibition concentration.
Conclusion In the population of postoperative cardiovascular surgery, 
the dose weight is the most important factor to have efficiency opti-
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Introduction Early and adequate antibiotic therapy increases the 
likelihood of survival in critically ill patients with sepsis. Optimal dos-
ing of antibiotics requires adjustment to large variability in distribu-
tion volume and renal elimination, which are characteristic of ICU 
septic patients. Beta-lactams (BL) are the most frequently prescribed 
antibiotics because of their broad-spectrum activity and low toxicity. 
They are time-dependent antibiotics, meaning that their trough level 
should be at least 5 times over the minimal inhibitory concentration of 
the targeted bacteria. Supra-therapeutic serum levels have been sug-
gested to be associated with clinical—mainly neurological—toxicity. 
Serum levels of BL are unpredictable during acute renal failure (ARF) 
and renal replacement therapy (RRT).
The objective of this study was to describe the prevalence of supra-
therapeutic BL serum levels in septic ICU patients requiring replace-
ment therapy for acute renal failure and their link with potential 
clinical toxicity.
Patients and methods Observational cohort study of patients admit-
ted to the medical surgical ICU of the Saint Joseph Hospital from 
1999 to 2013. This was a retrospective analysis of data prospectively 
collected into the French multicenter Outcomerea database and into 
the databases of the microbiological and pharmacological laboratory 
of the hospital. We included consecutive patients with sepsis and ARF, 
who had been sampled for a BL trough serum level assessment within 
7 days of sepsis and 3 days after intermittent dialysis. Sera were sam-
pled before the next administration in case of intermittent infusion 
and at 24  h in case of continuous infusion. Assays were performed 
with a microbiological method (measuring the active part of the anti-
biotic). Table  52 shows the BL assessed, the thresholds used and the 
distribution of the observed trough levels. We searched an associa-
tion between overdose and clinical toxicity (coma, seizures, length of 
mechanical ventilation, mortality) with univariate analyses.
Results One hundred and eight patients, developed 180 sepsis. 460 
serum BL assessments (BL inhibitor in combination with BL antibiotic 
is considered as 2 assays) were performed. Most assayed antibiot-
ics were piperacillin (25 %), tazobactam (20 %) and cloxacillin (18 %). 
They were delivered as follows: the mode of infusion and the interval 
time being decided by the attending physician according to patients 
characteristics: piperacillin/tazobactam: 4  g/0.5  g in 30  min, every 8, 
12 or 24 h; cloxacillin: 2–8 g per 24 h by continuous infusion, or 2 g in 
30 min, every 6, 8 or 12 h. The distribution of the serum levels was very 
scattered (see Table 52, 3rd column). A supra-therapeutic serum level 
for at least one BL was observed in 96/108 (89 %) patients and 156/180 
(86 %) septic events. A level in the highest quartile was observed for at 
least one BL in 54/108 (50 %) patients and 80/180 (45 %) septic events. 
Supra-therapeutic serum levels of piperacillin, tazobactam and cloxa-
cillin were observed in 66, 55 and 31 and were in the highest quartile 
in 33, 23 and 14 septic events, respectively. We did not observe a sta-
tistical link between serum overdose and clinical toxicity.
Conclusion Supra-therapeutic serum levels of beta-lactam antibiot-
ics are commonly observed in our ICU patients with ARF and RRT. We 
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Table 52 Antibiotics assessed, threshold used and trough 
serum levels (mg/l)
Upper therapeutic  
trough level
Observed trough  
level med [IQ]
Piperacillin 20 77 [44–109]
Tazobactam 5 13 [6–20]
Cloxacillin 20 60 [35–103]
Amoxicillin 20 31 [19–42]
Imipenem 3 2.9 [1.1–4.2]
Clavulanate 0.5 2.0 [1.3–3.6]
Ceftazidime 20 11 [49–87]
Cefepime 10 27 [16–47]
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Introduction Cardiac arrest (CA) management has improved survival 
and functional recovery during last decades. Recently, many studies 
focused on the post-cardiac arrest syndrome (PCAS) so as to amelio-
rate patients’ prognosis. PCAS is composed of four entities: persistent 
precipitating pathology, post-CA circulatory failure systemic, ischae-
mia-perfusion and post-anoxic brain injury. (1) We look forward to ana-
lyse our daily management of resuscitated patients admitted in our 
medical intensive care unit.
Patients and methods All patients admitted in our unit between 
January 2011 and June 2013 with the diagnosis of cardiac arrest were 
included retrospectively. We collected data about cardiac arrest itself 
but also those concerning PCAS. Exclusion criteria were: suspected or 
known acute intracranial haemorrhage or stroke, a body temperature 
on admission of less than 30  °C, unwitnessed cardiac arrest with ini-
tial rhythm asystole, known disease making 180 days survival unlikely, 
known pre-cardiac arrest Cerebral Performance Category score of 3 or 
4 (2), systolic blood pressure <80 mmHg in spite of fluid loading, vaso-
pressor and/or inotropic medication.
Results Eighty patients (pts) were included with average age of 
65  years (±14) (57 males and 23 females). Mean SAPS II was 72, and 
mean SOFA score was 11. Aetiology of cardiac arrest (CA) was car-
diac in 35 pts (43.8 %), non-cardiac in 32 pts (40 %) and unknown in 
13 pts (16 %). Coronarography has been realized for 31 pts (39 %), 21 
pts of whom had a percutaneous coronary intervention (PCI). Fifty-
seven pts (71 %) required catecholamine infusion during the first 48 h. 
Therapeutic hypothermia (32–34  °C) is prescribed for 46 pts (58  %). 
Twenty-four (52 %) had an initial shockable rhythm. ICU mortality was 
55 % (44 pts). Among survivors, Cerebral Performance Scale was good, 
moderate and severe for 33 (41.25 %), 1 (1.25 %) and 2 (2.5 %) patients, 
respectively.
Discussion PCAS is frequent after CA. Its management requires a rig-
orous control of many variables. Our retrospective study results were 
not far from the literature data. Only 39 % of our patients underwent 
coronarography. Indications and timing of coronarography are still 
not clear except for transmural myocardial infarction. Only half of our 
patients had therapeutic hypothermia. This point needs clearly to be 
improved.
Conclusion Functional and vital prognosis of CA could probably be 
improved by an aggressive management of PCAS. Close control of 
patients’ parameters is necessary to achieve such a goal. Application of 
guidelines must be emphasized in this setting.
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Introduction In-hospital cardiac arrest (IHCA) is still associated with 
poor outcomes. Early prediction of unfavourable outcomes is difficult 
but crucial to improve resource allocation. There is actually no predic-
tive score for IHCA outcome. Our objective was to determine whether 
the out-of-hospital cardiac arrest (OHCA) score based on clinical and 
easily accessible variables could correctly predict outcome in patients 
admitted in intensive care unit (ICU) after an IHCA.
Patients and methods This was a retrospective observational multi-
centric cohort study including all patients admitted in 7 French medi-
cal or mixed ICUs after an IHCA between January 2009 and December 
2014. Cardiac arrest (CA) occurrence in operating room or ICU was 
excluded. Outcome was assessed using the Cerebral Performance 
Categories score (CPC 1–2 for good outcome; CPC 3–4–5 for poor out-
come) at hospital discharge.
Results Of the 349 patients assessed for eligibility, 297 patients were 
finally included. Before CA, 267 patients (90  %) were hospitalized 
for a non-surgical disease, 18 (6  %) for programmed surgery and 12 
(4 %) for emergency surgery. IHCA occurred in a ward in 193 patients 
(65 %) and in the emergency room in 103 patients (35 %). IHCA was 
from cardiac origin in 75 patients (25 %). Median no flow duration was 
0.5 min (interquartile range 0.5–1.0), and low flow duration was 10 min 
(interquartile range 5–20). An initial shockable rhythm was found in 
62 patients (21  %), and hospital survival with favourable neurologi-
cal outcome occurs in 26  % of cases. OHCA score was significantly 
lower in patients with a favourable outcome compared to unfavour-
able outcome (14 [interquartile range 1–25] versus 29 [interquartile 
range 17–40], respectively; p  <  0.001). In multivariate analysis, OHCA 
score was independently associated with unfavourable outcome 
(odds ratio per OHCA score point: 0.97, 95  % confidence interval 
[0.95–0.99], p =  0.002) with a sensibility of 61  % and a specificity of 
85  % (area under the receiver operating curve =  0.77). For an OHCA 
score  >36, predictive mortality was 97  % (95  % confidence interval 
96–97) (Fig. 41).
Conclusion In this first retrospective multicentric study, OHCA score 
is independently associated with IHCA outcome at hospital discharge. 
Early prediction of IHCA outcome by OHCA score needs further studies 
to confirm this hypothesis.
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Introduction After cardiac arrest (CA) and therapeutic hypothermia 
(TH), a persisting coma despite discontinuation of sedatives is com-
monly considered as a trigger for initiation of neuro-prognostication. 
However, a persisting coma can also result from transient impairment 
of brain function. This study reports factors associated with delayed 
awakening in resuscitated patients treated with TH.
Patients and methods All consecutive patients admitted after CA and 
still alive after TH were studied. Using the Richmond Agitation Seda-
tion Scale (RASS) assessed every 3 h, awakening was defined as 3 con-
secutive measurements higher than –2 and was considered delayed 
when occurring later than 48 h after discontinuation of sedation. Fac-
tors associated with duration of coma and delayed awakening were 
identified using multivariate analysis.
Results Three hundred and twenty-six patients were included 
between 2008 and 2013. Patients were mostly male (71 %), with mean 
age of 59 years. Post-resuscitation shock occurred in 45 % of patients 
and 42  % had renal insufficiency (GFR  <  60  ml/min) at admission. 
During ICU stay, 194 patients awoke in a median time of 17  h (IQR 
7–60) after discontinuation of sedation (midazolam and fentany in all 
patients). Among awakeners, 29 % of patients had delayed awakening. 
In multivariate analysis, age over 59 (OR 2.2, 95 % CI 1.1–4.6; p = 0.03), 
initial shock (OR 2.8, 95 % CI 1.4–5.7; p = 0.005), renal insufficiency at 
admission (OR 3.2, 95 % IC 1.4–7.0; p = 0.004) and time before rewarm-
ing (OR 3.2, 95 % IC 1.4–7.0; p = 0.004) were associated with delayed 
awakening.
Conclusion Among patients admitted alive after CA, nearly one-third 
of them awoke more than 48 h after discontinuation of sedation. Renal 
impairment, older age and initial shock can delay awakening and 
should lead to delayed prognostication.
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Introduction Respective proportions of final etiologies are disparate 
in cohorts of cardiac arrest patients, depending on examined popula-
tion and diagnostic algorithms. In particular, incidence and character-
istics of sudden unexplained death (SUD) are debated. We aimed at 
describing etiologies in a large cohort of out-of-hospital cardiac arrest 
(OHCA) patients, in order to characterize victims without identified 
diagnosis.
Patients and methods We analyzed data from our prospective reg-
istry of OHCA patients admitted between January 2000 and Decem-
ber 2014. Initial diagnostic strategy included coronary angiography, 
brain and chest CT scan. This was completed by an extensive diag-
nostic strategy, encompassing biological and toxicological tests, 
repeated electrocardiograms and echocardiography, MRI, Holter mon-
itoring and endocavitary explorations. Two independent investigators 
reviewed each final diagnosis. Baseline characteristics were compared 
between subgroups of patients with Chi square test and Mann–Whit-
ney test, as appropriate. One-year mortality was compared between 
subgroups using univariate Kaplan–Meier curves.
Results Over the study period, 1857 patients were admitted in our 
unit after a resuscitated OHCA. The event was related to a non-cardiac 
and a cardiac cause in 526 (30.7 %) and 1057 (61.8 %) patients, respec-
tively. The main cause of cardiac-related OHCA was ischemic heart 
disease (78.4  %), while non-structural cardiomyopathies accounted 
for only 2.2  %. No diagnosis was evidenced in 127 (7.4  %) patients. 
In these SUD patients, baseline characteristics and 1-year survival 
of patients under 35 years were similar to those with identified non-
structural cardiomyopathy.
Conclusion We observed that ischemic heart disease was by far the 
most common cause of cardiac arrest, while non-structural cardio-
myopathies accounted for a very low part of diagnosis. Young patient 
victims of a sudden unexplained death shared similar baseline charac-
teristics and outcome with patients with non-structural cardiomyopa-
thies. Focusing on this subgroup of patients for further investigations 
and follow-up may help in managing themselves and their relatives.
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Introduction Retrospective observational data suggested potential 
harmful effects of hyperoxia in patients resuscitated from an out-
of-hospital cardiac arrest (OHCA). Experimental studies have shown 
that this deleterious effect of O2 could be due to the worsening of 
ischemia-reperfusion injuries and to an oxidative burst following 
resuscitation. Here we analyzed the relationship between arterial oxy-
gen tension and the pro- and antioxidant balance in a cohort of OHCA 
patients.
Patients and methods We analyzed a cohort of consecutive patients 
successfully resuscitated from an OHCA and admitted in the medical 
ICU of a tertiary universitary French hospital. We defined the expo-
sure using the PaO2 value on the first arterial blood gas (ABG) at 
admittance. Hyperoxia was defined as PaO2 of 300 mm Hg or greater, 
hypoxia as PaO2 of less than 60 mm Hg and normoxia as a PaO2 not 
classified as hyperoxia or hypoxia. The primary outcome measure was 
the relation between PaO2 and main blood markers of oxidative stress 
measured at admittance in ICU: thiols, advanced oxidation protein 
products (AOPP), protein carbonyls, superoxide dismutase (SOD), glu-
tathione reductase (GRx) and glutathione peroxidase activities (GPx).
Results Among 134 patients studied, 13 had hypoxia (10 %), 102 had 
normoxia (76 %) and 19 had hyperoxia (14 %). The overall intra-hos-
pital mortality was 59.7 % (n = 80). We found no differences between 
groups, with a 76.9  % (n =  10) mortality rate in the hypoxia group, 
56.9  % (n =  58) in the normoxia group and 63.2  % (n =  12) in the 
hyperoxia group. Median time from cardiac arrest to ABG analysis was 
similar between the hypoxia, the normoxia and the hyperoxia groups 
(respectively 278  min, interquartile range (IQR): 153–684; 180  min, 
IQR: 131–320 and 170  min, IQR: 103–626). There was no statistically 
significant correlation between any of the biological parameters 
and PaO2 values in the whole population, and we found no differ-
ence regarding blood markers of oxidative stress across the 3 groups 
(Table 53).
Conclusion In our study, PaO2 at hospital admission was not associ-
ated with differences in the ratio between oxidant and antioxidant 
parameters in patients resuscitated from cardiac arrest. We observed 
no evidence supporting a role of an impaired redox balance due to 
supranormal oxygen tension in this population.
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Introduction Acute coronary syndromes are one of the main causes of 
out-of-hospital cardiac arrest. These patients are at high risk of persis-
tent platelet reactivity under aspirin treatment. We herein evaluate the 
biological response to aspirin and ADP inhibitors in comatose patients 
resuscitated from out-of-hospital cardiac arrest treated by either oral 
or intravenous aspirin, with or without an ADP inhibitor.
Patients and methods Patients were randomized to receive long-
term antiplatelet treatment with either 100 mg oral or 100 mg intra-
venous aspirin and when necessary dual antiplatelet therapy after 
emergency coronary angiography. Patient’s blood samples were 
obtained at day 3 and day 7 after cardiac arrest. Biological response 
to aspirin was assessed 24 h after last aspirin intake using light trans-
mission aggregometry with arachidonic acid and the whole blood 
point-of-care assay PFA-100® system with collagen–epinephrin. Bio-
logical response to ADP inhibitors was assessed using flow cytometry 
(vasodilator-stimulated phosphoprotein platelet reactivity index), light 
transmission aggregometry with adenosine diphosphate and PFA-
100® system with collagen–adenosine diphosphate.
Results Twenty-two consecutive patients were prospectively included. 
Thirteen patients received aspirin in the intravenous route and 9 
patients in the oral route. Clinical, demographical, biological and 
angiographical characteristics were similar in both groups. Using 
light transmission aggregometry with arachidonic acid, 10 patients 
had persistent platelet reactivity, corresponding to 45  % of the total 
population. At day 3 after cardiac arrest, we found a significantly 
higher maximum intensity in the oral group when compared to the IV 
group (29 vs. 15 %, p = 0.04). The same way, closure time was signifi-
cantly faster in the oral group when compared to the IV group (155 vs. 
277 s, p = 0.04). We found no difference at day 7 after cardiac arrest. 
Irrespective of the biological test, clopidogrel was associated with a 
biological inefficacy at day 3. Under prasugrel, persistent platelet reac-
tivity was found in 20 % of samples with inadequate effect using flow 
cytometry, in 10 % using light transmission aggregometry with aden-
osine diphosphate and in 40  % using the PFA-100® system with col-
lagen–adenosine diphosphate. Stent thrombosis occurred in 1 patient 
treated with oral aspirin and efficiently by prasugrel. We found no dif-
ference in mortality in both groups.
Conclusion In this study, impaired response to aspirin both oral and 
intravenous is frequent in comatose patients resuscitated from out-of-
hospital cardiac arrest, with a higher rate using the oral route. The use 
of prasugrel as an ADP inhibitor seems to be associated with a highest 
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Introduction Early percutaneous coronary intervention (PCI) may 
improve survival in OHCA of ischemic cause, but selection of suitable 
patients remains challenging. Differences and results across gender 
remain unknown. We assessed the relationship between gender and 
coronary reperfusion after OHCA and the relationship between PCI 
and outcome according to gender.
Materials and methods All patients admitted in our center after 
OHCA were prospectively included in an electronic registry database, 
from 2000 to 2013. Characteristics were collected according to the 
Utstein style. We assessed the association between gender and coro-
nary reperfusion (using multivariate logistic regression and propensity 
score analysis) and between PCI and outcome (according to gender).
Results One thousand eight hundred and seventeen patients were 
included (520 women, 29  %). Women were older (62.8 vs 59.1  years, 
P < 0.0001), with less cardiomyopathy. They had less bystander cardio-
pulmonary resuscitation (84  % vs 88  %, P  <  0.05) and less shockable 
rhythm (42 % vs 61 %, P < 0.001). After multivariate logistic regression, 
male sex was associated with the performance of coronary angio-
gram (OR 1.73, 95 % CI 1.28–2.34, P < 0.001). Results after propensity 
score matching were consistent (P = 0.02). Among 1157 patients who 
underwent coronary angiogram, rate of PCI did not differ between 
men and women (OR 1.30, 95 % CI 0.90–1.88, P = 0.17). Results after 
matching (211 men, 211 women) were consistent (P = 0.13). PCI was 
associated with favorable outcome by multivariate logistic regression 
(OR 1.45, 95  % CI 1.07–1.96, P  =  0.02) with no interaction between 
gender and PCI (P for interaction = 0.40). Association between PCI and 
outcome was consistent across genders.
Conclusion After OHCA, women are less likely to undergo coronary 
angiogram. Rates of PCI after coronary angiogram do not differ across 
gender, and the association between PCI and favorable outcome is 
similar across gender.
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Thiols (µM) 9.7 (6.3–13.8) 11.3 (9.2–12.9) 11.3 (8.2–13.1)
AOPP (µM) 276 (162–599) 391 (248–615) 423 (210–510)
Carbonyls 
(nmol/mg)
70.8 (64.2–80.8) 69.6 (62.1–88.8) 70.7 (59.7–101.1)
SOD (U/mL) 495 (398–548) 440 (315–533) 463 (373–498)
GPx (nmol/min/
mL)
300 (169–455) 305 (170–429) 251 (180–398)
GRx (nmol/min/
mL)
45 (19–65) 48 (11–79) 62 (34–85)
Page 186 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
S47 
Prognostic factors of out‑of‑hospital cardiac arrests 
in Martinique: prospective study over a period of 29 months, 
about 385 cases
Dabor Resiere1, A. L. Dessoy1, Ruddy Valentino1, C. Chabartier1, Laurent 
Villain‑Coquet2, Jean‑Louis Ferge1, Y. Brouste2, Bruno Megarbane3, 
Hossein Mehdaoui1
1Service de réanimation médico‑chirurgicale, CHU de Fort de 
France, Fort‑de‑France, France; 2Samu 972, CHU de Fort de France, 
Fort‑de‑France, France; 3Service de Réanimation Médicale et Toxi‑
cologique, CHU Lariboisière, Paris, France 
Correspondence: Dabor Resiere ‑ dabor.resiere@chu‑fortdefrance.fr 
Annals of Intensive Care 2016, 6(Suppl 1):S47
Introduction Out-of-hospital cardiac arrest (OHCA) represents in 2015 a 
persistent public health problem, with always a bad prognosis and poor 
survival. Outcomes are improved by healthcare provider practices as 
recommended by the 2010 European Resuscitation Council Guidelines 
for Cardiopulmonary Resuscitation. In France, the National registry RéAC 
was set up in 2010 because of the lack of national and international out-
of-hospital cardiac arrest registry. Our study followed upon observation 
of the lack of data concerning the OHCA in Martinique. The aim of this 
study was to identify the prognostic factors of the OHCA in Martinique.
Patients and methods A prospective, observational, and monocen-
tric study was performed in Martinique over a 29-month period (from 
December 2012 to April 2015), including all out-of hospital cardiac 
arrests requiring the intervention of our emergency pre-hospital medi-
cal service (SAMU 972). We described the circumstances, demographic 
data, clinical and management of each link in the « chain of survival » and 
the different delays of care. Univariate analysis was performed to identify 
factors associated with mortality on hospital admission. Data from SAMU 
972 were compared to other French emergency medical centers.
Results Three hundred eighty-five patients with cardiac arrest were 
included. Fifty-nine percent were men with a median age of 63 years. 
Sixty-eight percentage of OHCA occurred at home and were witnessed 
in 74 % of cases, as compared to other French national centers. Cardio-
pulmonary resuscitation (CPR) was initiated by bystanders in 43 %. The 
absence of CPR and early defibrillation were associated with asystole 
(89 % of the cases), when advanced cardiac life support was initiated 
by firefighters and/or by emergency medical service. When the emer-
gency medical team arrived in the site, more than 80 % of the patients 
were found in asystole and only 6  % in VF/VT. Delay of departure of 
the emergency medical service vehicle and arrival at the scene were 
much more longer in comparison with other centers. The absence of 
CPR and delay for firefighters to reach the patients were associated 
with mortality on hospital admission (p = 0.03 and p = 0.04, respec-
tively). The rate of return of spontaneous circulation was 18 %, with a 
13 % survival rate on hospital admission and 3.4 % rate on day 30. The 
overall survival rate was lower than the other French centers (RéAC). 
Prognostic factors significantly associated with the survival rate were 
(p < 0.05): young age, immediate resuscitation by training bystanders, 
presence of emergency medical service personnel or firefighters at the 
time of OHCA, used of automated external defibrillator before the EMS 
providers arrived at the scene, delay and type of early rhythm, use of 
epinephrine and early therapeutic hypothermia in ICU.
Conclusion Out-of-hospital cardiac arrests in Martinique are similar 
to those from metropolis France with horrifying outcome. However, in 
Martinique, survival rate appears to be lower. Several proposals could 
be suggested to improve outcome, including (1) increasing population 
training to basic cardiac life support, (2) enhancing public access to 
early defibrillation, (3) reducing delays of out-of-hospital medical ser-
vices interventions, (4) standardizing advanced cardiac life support, and 
(5) strengthening ways to identify easily house’s number. However, the 
definitive benefit of such interventions should be further investigated.
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Introduction Glucose is the key energy substrate of monocytes 
(Monos), polymorphonuclears (PMNs) and lymphocytes (Ly), neces-
sary for their activation during pro-inflammatory phase. The impact of 
hyperglycemia (HG) of septic plasma (Spl) on phenotypic markers of 
immune cells is unknown. Objective: to assess the effect of incubation 
in septic plasma on glucose utilization and on phenotypic expression 
of immune cells.
Materials and methods Ten whole blood samples from healthy vol-
unteers (CCPSL UNT-No13/SL/015) were incubated 90  min in normo-
glycemia conditions (NG), hyperglycemia (HG, 12.5 mM glucose), in the 
presence of deoxyglucose (DOG 12.5 mM; inhibitor of glycolysis). For 
6 samples, a volume-to-volume septic plasmas pool testing the same 
conditions replaced healthy plasma (Hpl). We studied the expression 
of surface markers on immune cells as follows:
  • Monos (CD14+): HLA-DR, CD11b, CD62L (markers of cellular 
activation)
  • PMNs (CD16+): CD11b, CD62L
  • T Ly (CD3+): CTLA4 (marker of cellular inhibition)
 • B Ly (CD19+): HLA-DR
Results 1. In Hpl, HG did not increase the expression of markers of 
interest compared to NG. DOG decreased the expression of markers of 
interest for Monos (HLA-DR, CD11b and CD62L) and CD62L in PMNs. 
2. In Spl, there was no difference in the expression of surface mark-
ers between the 3-glycemic conditions.  3. The expression of surface 
markers in NG +  Spl collapsed compared to Hpl. The DOG +  Spl vs. 
Hpl induced increased expression of CD11b for both Monos and PMNs 
(p < 0.05); expression of CD62L was collapsed (10–15 times) for all con-
ditions in Spl vs. Hpl (p < 0.05 for each one). Expression of CTLA4 for 
T4 and T8 Ly collapsed (about 10 times) in all conditions in Hpl vs. Spl 
(p < 0.05). There was no difference for HLA-DR on Monos and B Ly.
Discussion Our results confirm that aerobic glycolysis is a central 
pathway of phenotypic changes of immune cells in healthy plasma. 
The incubation in plasma seemed to favor septic “activated” pheno-
types for both granular and T Ly independently of the use of glucose 
(no impact of HG on phenotypes of immune cells). No detectable 
effect of HG in septic plasma on studied surface makers, due to the 
huge changes caused by septic plasma.
Conclusion In acute phase, the impact of septic environment domi-
nates the effects of HG. These results ask about the interest of tight 
glycemic control in acute septic patient in ICU.
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Introduction Glucose is the main energy substrate (1) for immune 
cells (monocytes (monos) and polymorphonuclears (PMNs)). Glucose 
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has also a pro-inflammatory action through the production of reactive 
oxygen species (ROS).
Objectives: (1) to demonstrate an increase in ROS production during 
moderate hyperglycemia through the NADPH oxidase (NADPHox) 
pathway (NADPH comes from the pentose shunt pathway (PSP)); (2) 
to evaluate the phenotypic consequences on immune cells: monos, 
PMNs, and lymphocytes (lymphos).
Materials and methods Whole blood from healthy volunteers (CCPSL 
UNT-No13/SL/015) was incubated 90 min in: 1—normoglycemia (NG) 
or 2—hyperglycemia (HG, glucose 12.5 mM), or with deoxyglucose, a 
glycolysis blocker (DOG 12.5 mM), or with specific inhibitors of PSP: Epi 
Androsterone and 6 Aminonicotinamide (EPI 6AN).
Measurements: 1—overall ROS production with luminometry (2) tech-
nic (area under the curve (AUC) and slope of activation) at baseline 
and after stimulation with PMA-Ionomycin (Phorbol-12-Myristate-
13-Acetate, Ionomycin). 2—Phenotypic changes in immune cells:
  • Monos (CD14+): HLA-DR, CD11b, CD62L (markers of cellular 
activation)
  • PMNs (CD16+): CD11b, CD62L
  • T lymphos (CD3+): CTLA4 (marker of cellular inhibition)
 • B lymphos (CD19+): HLA-DR
Statistics: nonparametric tests.
Results ROS production: at baseline, AUC (n  =  19) in HG was higher 
than that in NG (p < 0.05) (increased production). After stimulation with 
PMA–ionomycin, this difference disappeared. Inhibitors reduced the 
AUC compared to the NG (p < 0.05). The slope of luminometry (reactiv-
ity) was higher in HG than in NG (p < 0.05). The slopes in NG and HG were 
higher than those observed with inhibitors in NG and HG (p < 0.05).
1. Phenotypic changes: no difference between monos, PMNs and lymphos 
in the 3‑glycemic conditions (there were only few decreases for some 
markers in DOG conditions).
Discussion Hyperglycemia increased ROS production of immune cells 
in basal condition. However, in stimulated conditions, hyperglycemia 
did not increase ROS production of the NADPH oxidase system but 
accelerated the reactivity of the system (slope of the luminometry 
curve). Nonspecific inhibitor (DOG) and specific inhibitors of PSP (EPI 
6AN) decreased ROS production and reactivity of NADPHox system.
Conclusion Our experiments confirm the implication of the PSP in 
ROS production. Functional changes induced by hyperglycemia were 
not associated with phenotypic alterations in immune cells.
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Introduction Polymorphonuclear neutrophils (PMNs) play a central 
role in acute inflammatory and innate immune responses through 
production of antibacterial peptides, cytokines, pro-inflammatory 
mediators such as reactive oxygen species (ROS), and extracellular 
traps. PMN activation and involvement in immune defense against 
pathogens during septic shock have been well described. However, 
despite evidences showing that PMN dysfunction could be found in 
patients with nosocomial infections, very few studies have focused on 
PMN function after septic shock. Herein, we examined the hypothesis 
that HMGB1 could induce a PMN dysfunction after septic shock which 
could be reversed using an anti-HMGB1 antibody.
Materials and methods In a first set of experiments, we explored 
PMN functions (ROS production, NETosis and bacteria killing ability) 
during late phase of sepsis in a murine model of CLP-induced sepsis. 
In a second set of experiments, we compared PMN function in patients 
admitted in ICU for sepsis to patients admitted for non-septic reason 
(control) and healthy donors.
Results We found a marked PMN dysfunction after sepsis, character-
ized by a decreased ability to produce ROS and NETs and to kill bac-
teria (Fig.  42). We also found that HMGB1 induced PMN dysfunction 
since plasma of septic patients induced PMN dysfunction in PMN iso-
lated from healthy donors (Fig. 43). Lastly, we found that anti-HMGB1 
specific antibody could restore ROS production (Fig. 43).
Conclusion PMN dysfunction is evident after septic shock, induced by 
HMGB1. Specific inhibition could restore ROS production of PMN after 
septic shock and could be an interesting therapeutic approach.
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Fig. 42 See text for description 
Fig. 43 See text for description 
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Introduction Myeloid-derived suppressor cells (MDSCs), an immature 
leukocyte subset composed of granulocytic (GrMDSC) and monocytic 
(MoMDSC), are well described in neoplastic diseases as an immuno-
suppressive actor. This population is also present in various clinical 
situations marked by activation of inflammation as trauma, burns or 
sepsis. During sepsis this leukocyte subset could play a key role in 
immunosuppressive states by killing T lymphocyte. To date, only few 
studies specifically focused on the potential role of this leukocyte sub-
set in sepsis. Mechanisms linked to MDSC mobilization in peripheral 
bloods and their origins need also to be explored to better understand 
their role in sepsis. The main objective of our study was to approach 
the kinetic of expression of MDSC in septic patients hospitalized in the 
intensive care unit (ICU). Secondary objectives were to assess the ori-
gin of production of MDSCs and their potential association with clini-
cal course.
Materials and methods Patients hospitalized in our medical-surgical 
ICU for less than 24 h at inclusion with a confirmed sepsis associated 
with a thrombocytopenia have been prospectively studied from Octo-
ber 2014 to August 2015. We followed the level of MoMDSC (CD45+, 
CD11b+, CD14+, CD33+, HLA-DR−) and GrMDSC (CD45+, Lin−, HLA-
DR−, CD33+, CD14−, CD11b+) by flow cytometry in the peripheral 
blood (leftover from complete blood count performed as part of rou-
tine care) at D0, D3, D7, D10 and D14. We analyzed the same popu-
lations in the leftover of bone marrow (BM) samples performed in 
thrombocytopenic septic patients at Day 0. We recorded the site of 
infection, the onset date and the microorganisms involved. Each infec-
tion was adjudicated and validated according to the diagnostic criteria 
of the international sepsis forum consensus conference. Clinical pro-
gression during ICU stay, occurrence of secondary infection and hospi-
tal discharge were also noted. Outpatients without any hematological 
or infectious disorders who were recruited at the time of anesthesia 
evaluation (peripheral blood analysis) or after a BM aspirate analysis 
considered as normal by hematologist were used as controls for com-
parison. MDSC results were expressed as percentages of CD45+ or as 
gram per liter (G/L).
Results A total of 16 patients (15 septic shocks, 1 severe sepsis) with 
sepsis-induced thrombocytopenia were studied, and for 7 of them 
kinetic of MDSCs in the peripheral blood was available. Of them, 9 
patients suffered from community infections. Main sites of infection 
were intra-abdominal (n = 8), urinary tract (n = 3) and lung infections 
(n  =  2). All infections were documented (10 gram-negative bacilli, 
6 gram-positive cocci). Median ICU stay was 8  days. ICU and hospi-
tal mortality were 31 and 44 %, respectively. At early phase of sepsis, 
levels of MoMDSC subset in the BM and in peripheral blood of sep-
tic patients were increased compared to controls (BM 1.31 vs 0.39 %, 
peripheral blood 0.36 vs 0.05 G/L). This increase was not correlated 
with the severity of initial sepsis. When compared to controls, septic 
patients had higher BM expression of GrMDCS (3.78 vs 0.18 %) but no 
significant increase in peripheral blood (0.06 vs 0.01 G/L, p  =  0.09). 
During sepsis course, most of patients exhibited an increase in MDSC 
mobilization in peripheral blood until D7 (mean level D0: 0.23 G/L, D3: 
0.72 G/L, D7: 1.1 G/L, D14: 0.34 G/L). MDSC level seems to be related 
to clinical course, patients with major organ failure exhibiting a higher 
overall MDSC level (Fig.  44). These leukocyte subset levels did not 
seem to be related to the site of infection, microbiological species or 
specific organ failure.
Conclusion During the early phase of sepsis associated with an exces-
sive systemic inflammation, MDSC level increased secondary to a BM 
excretion. This result suggests that pro-inflammatory and immunosup-
pressive mechanisms overlap during the early phase of sepsis. MDSC 
level which appears to be correlated with clinical severity could be a 
regulation factor of immune reaction during sepsis. These hypotheses 
need to be confirmed in a larger prospective study.
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Introduction The triggering receptor expressed on myeloid cells-1 
(TREM-1) amplifies the inflammatory response driven by TLR/NLR 
engagement. In various models of acute inflammation, septic or not, 
others and we have shown that the genetic deletion or pharmaco-
logic inhibition of TREM-1 protects animals from hyperresponsiveness 
and death. In this study, we demonstrate that a targeted deletion of 
TREM-1 on endothelial cells confers protection during septic shock in 
mice.
Materials and methods We generated constitutive Trem-1−/− as 
well as endothelium-conditional Trem-1 KO mice and submitted them 
to polymicrobial sepsis through CLP. Organs (BM, spleen, lungs, aorta 
and mesenteric artery) and blood were harvested at different time 
points and analysed for cellular content, gene expression, cytokine/
chemokine concentrations and vasoreactivity. Survival was monitored 
for 1w.
Results A targeting vector was designed for conditional deletion of 
exon 2 that encodes the extracellular domain of TREM-1. Breeding of 
Trem1+/flox chimeric offspring mice with ubiquitous or Cadherin 5 
Cre deleted mice yielded viable Trem1+/−  ×  (Cadh5) Cre+/− off-
spring. Interbreeding of Trem1+/− mice gave rise to Trem1−/− or 
endothelium-specific Trem1−/− (EndoTrem1−/−) mice at the 
expected Mendelian frequencies, and Trem1−/− mice were equal in 
size, weight and fertility to littermate controls. Moreover, the com-
position and abundance of immune cells in blood, BM, spleen and 
lungs did not differ between groups. Trem-1 deletion altered inflam-
matory cells mobilization and recruitment in lungs and spleen and 
favours the accumulation of reparative cells (Ly6Clow monocytes 
and M2 macrophages) in the lungs. This effect was even more pro-
nounced in EndoTrem1−/−. Consequently, the activation of many 
inflammatory genes was reduced in the lungs as well as the con-
centrations of various cyto/chemokines (MCP-1, VCAM-1, IL6, …). 
Fig. 44 See text for description 
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Sepsis induced a profound vascular hyporeactivity in WT mice. This 
phenomenon was absent in the absence of Trem1. Interestingly, in 
EndoTrem1−/− while vasoconstriction was still slightly impaired, 
endothelium-dependent vasodilation remained intact. Finally, sur-
vival was improved in the Trem1 KO animals and even more in the 
EndoTrem1−/− group.
Conclusion The targeted deletion of endothelial Trem1 confers pro-
tection during septic shock in modulating inflammatory cells mobili-
zation and activation and restoring vasoreactivity. The mechanism by 
which cellular recruitment is reduced is probably linked to a reduc-
tion of chemokines production by endothelial cells. The effect of 
Trem1 on vascular tone, while impressive, deserves further investiga-
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Introduction Severe sepsis remains a frequent and dreaded compli-
cation in cancer patients. Beyond the often fatal short-term outcome, 
the sepsis-induced immune dysfunctions may also directly impact on 
the prognosis of the underlying malignancy in survivors. We are cur-
rently developing a research project in order to investigate the recip-
rocal relationships between bacterial sepsis and malignant tumor 
growth. We already reported that sepsis promoted malignant tumor 
growth when tumor cells were inoculated in post-septic mice. How-
ever, whether a previously established tumor might alter the sep-
tic response or whether sepsis may impact the growth of previously 
established tumor remains unclear. To this aim, we set up a relevant 
double-hit animal model through tumor inoculation followed by pol-
ymicrobial sepsis.
Materials and methods We used 8- to 12-week old female C57BL/6J 
mice. Mice were first subjected to malignant tumor inoculation by 
either subcutaneous (model of local tumor) or intravenous (metastatic 
model) injections of the MCA205 fibrosarcoma cell line. Seven and 
14  days after tumor inoculation, respectively, corresponding to early 
and advanced stages of malignancy, mice were subjected to polymi-
crobial sepsis induced by cecal ligation and puncture (CLP), without 
any subsequent antibiotic treatment. Controls comprised both non-
cancer mice subjected to CLP and sham-operated counterparts cancer 
mice subjected to sham surgery. The main endpoints were survival to 
polymicrobial sepsis as well as local and metastatic tumor growth. The 
features of anti-tumoral immune response were compared between 
CLP- and sham-operated cancer mice and included immune cell infil-
tration within tumor tissues and draining lymph nodes through flow 
cytometry.
Results The mortality rate of polymicrobial sepsis was about 50  % 
in non-cancer mice and was similar in cancer mice, regardless of the 
inoculation route and the stage of the tumoral model. However, the 
24-h bacteremia was dramatically increased in cancer mice while 
blood cultures remained negative in non-cancer ones. As compared 
to their sham-operated counterparts, the local tumor growth was 
strongly inhibited in CLP-operated septic mice. In the same way, 
polymicrobial sepsis inhibited the pulmonary metastatic spread 
as assessed by macroscopic lung pathology and lung infiltration 
onto histological slides. With respect to the distribution of immune 
cells within tumor tissues, we observed no differences in the pro-
portion of tumor-infiltrating CD45+ hematopoietic cells between 
sham- and CLP-operated mice. However, tumors from septic mice 
comprised an increased proportion of monocytic-myeloid-derived 
suppressor cells (Mo-MDSC). Sepsis also altered the cell distribu-
tion in draining lymph nodes, with a decrease in the proportion of B 
cell lymphocytes while the proportion of monocytes and Mo-MDSC 
were increased.
Discussion The cellular and molecular mechanisms that account 
for sepsis-induced tumor inhibition are under investigation. We are 
currently addressing the respective contributions of host’s immune 
response and pathogens in the control of tumor growth.
Conclusion Sepsis applied to cancer mice inhibits both local and 
metastatic tumor development. The current results along with our pre-
vious experiments suggest a dual impact of sepsis on tumor growth 
depending on the sequence of the double-hit model.
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Introduction One of the major issues of the access to urgent health 
for patients with stroke in acute phase is the implementation of tel-
ehealth networks. Looking back on the numerous telestroke deploy-
ments already at work, there are grounds for identifying 4 critical 
issues as being the 4 key success factors for achieving such project as 
follows: training and skills maintenance of the actors, feedback about 
the care of stroke, ergonomic perception of telehealth tools, actual 
practice analysis and any updating and adjustments of protocols in 
different places. Telehealth platform ORTIF has been implemented 
since January 2015 in one of the biggest French regions and concerns 
12 M inhabitants. It involves 43 hospitals, with a final objective of 100 
expert and demanding hospitals, and covers the whole field of emer-
gency neurology (neurosurgery, stroke, exacerbation of chronicle neu-
rological disease). It enables through a digital interface on the web 
net, to share health and care contextual data, to transfer native radiol-
ogy image data and to organize medical consultations on vidéo-link 
between multiple actors from multiple remote locations. Considering 
the multiplicity of actors involved, the GCSDSISF*in charge of the man-
agement of the project had to design a whole industrialization process 
of the project, including definition of guidelines, implementation, 
assistance and mentoring.
Materials and methods A scientific committee has defined the ele-
ments of the telemedical record and the organizational and medico-
economic methods. A hotline user was put at disposal as of actors 
and of the protocols of formalized degraded procedures. A person 
receiving benefits specialized in ergonomics met the teams implied 
Page 190 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
on the pilot phase of the project to define specifications of the evolu-
tions desired on the product and the organizations. Meetings involv-
ing the doctors, the persons in charge, the actors of the information 
systems and the directions of establishment made possible to define 
the format of the initial and the following trainings. These formations 
were systematically evaluated by the listeners. A site of formation 
e-learning was deployed. It centralizes the whole of the documents of 
formation, the reference frames of operation and an access to videos 
of demonstration of use of the platform. An analysis of impact of the 
implementation of these actions is carried out over the first 7 months 
of operation between the months of January and July 2015 on the 43 
establishments deployed in completion date of analysis.
Results Five hundred and fifteen actors could profit from an individual 
initial training to the tool and the procedures for use. The note of aver-
age satisfaction was of 3.43/4.
After 7 months of use, 1271 sessions of telemedicine proceeded: 1043 
for neurosurgical expertise, 66 for neurovascular expertise and 162 
for expertise of neuroradiology which they are diagnostic or inter-
ventional. Increasing number of procedure was on average of 177 % 
between the months of April and May to the profit especially the neu-
rosurgical expertise which profited from a preliminary experiment 
of telemedicine. The uses fewer in the field of emergency neurology 
are explained by the low number of neurovascular expert centers 
deployed during the first 5  months of the project but show also the 
importance of an accompaniment of the professionals in these new 
methods of medical evaluation. The proportion of recourse to the 
hotline (many incidents/number functional establishments) was of 
2.4 at the end of the first month of the deployment and 0.78 in the 
last month of the analysis objectifying the functional quality of the 
platform.
Conclusion Telemedicine must be a tool support with the before-
hand definite medical organizations to allow an improvement of 
accessibility the care and thus of their quality. The professionals must 
perceive these tools like a help and not a constraint. The accompani-
ment of the structures and their actors is a strong challenge of the 
success of the deployment of such projects particularly when they 
imply very many establishments. The industrialization of these pro-
cesses is the key.
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Introduction Sickle cell disease (SCD) is one of the most frequent 
inherited haemoglobin disorders caused by a structurally abnormal 
variant of haemoglobin (HbS). Haemolysis and vaso-occlusive phe-
nomena account for acute, like vaso-occlusive crisis (VOC) and acute 
chest syndrome (ACS), and chronic complications associated with 
SCD. Oxidative stress has been shown to play a key role on red blood 
cell rigidity. Free haemoglobin (FHb) resulting from haemolysis is a 
powerful oxidizing agent. We aimed to analyse the usefulness of FHb 
concentration for stratifying SCD patients initially referred to the Emer-
gency Room (ER), according to their definite site of care.
Patients and methods We conducted a retrospective monocentric 
observational study in all consecutive SCD patients with VOC or ACS 
presenting at the ER of a French university teaching hospital in Paris, 
between January 2013 and December 2014. The considered geno-
types included HbSS and the compound heterozygous SC disease. 
Patients with no blood collection, or with unavailable or uncompleted 
medical records, were not included in the study. Plasma FHb concen-
tration was determined by a photometric method. The healthcare 
pathways from the ED were separated into home discharge, hospi-
talization in acute wards or in intensive care unit (ICU). Demograph-
ics and clinical data are described with median [interquartile range 
25–75] and number (percentage). Between groups comparisons used 
analysis of variance. A p value less than 0.05 was considered statisti-
cally significant.
Results Of 506 visits to the ED during the study period, 105 were 
excluded due to a lack of medical records. Altogether 277 patients 
presenting at the ED (401 visits) were analysed, and 215 patients 
(78  %) were hospitalized either in the wards (n =  184) or in the ICU 
(n = 31). Most of them (n = 125; 58 %) were treated with hydroxyurea. 
The main diagnosis at the ER guiding the decision to hospitalization 
was VOC (n = 204; 95 %) evolving for 1 [0–1] day. Differences in clinics 
and laboratory results are detailed in Table 54, according to the site of 
care of the patients. Increased FHb (≥30 mg/dL) was found in 40 % of 
the blood samples. Correlation between FHb result and baseline total 
haemoglobin value or changes in total haemoglobin value were non-
significant. Median values of FHb did not differ between discharged 
home patients (16  mg/dL [4–57]), patients hospitalized in the wards 








29 [27–36] 28 [25–30] 28 [25–31] 0.03
Genotype [n 
(%)]
SS 55 (89) 162(88) 31(100) 0.13
SC 7 (11) 22(12) 0(0)
Past medical 
history of 
ACS, n ( %)
43 (69) 139(76) 27(87) 0.17
Baseline biology, median [IQR 25–75]
Hb (g/dL) 8 [7.5–9] 8 [7.5–9] 8 [7.5–8.8] 0.5
Free Hb (mg/
dL)
5 [4–14] 4 [4–13] 6 [4–17] 0.2
BilirubinTot 
(μmol/L)
44 [29–71] 42 [29–64] 40 [32–64] 0.9
ASAT (IU/L) 41 [31–62] 41 [31–55] 46 [37–54] 0.6
ALAT (IU/L) 28 [17–39] 27 [18–41] 29 [19–40] 0.7
LDH (IU/L) 372 [287–511] 372 [277–463] 443 [333–515] 0.09
Biology at the ER, median [IQR 25–75]
Hb (g/dL) 8.7 [8–9.5] 8.9 [8.1–9.7] 8.5 [7.7–9.1] 0.15
Free Hb (mg/
dL)
16 [4–57] 19 [8–61] 20 [5–77] 0.09
BilirubinTot 
(μmol/L)
49 [19–69] 44 [29–66] 44 [34–73] 0.5
ASAT (IU/L) 30 [24–42] 29 [19–44] 36 [22–46] 0.9
ALAT (IU/L) 45 [36–63] 50 [38–68] 58 [46–69] 0.2
LDH (IU/L) 444 [340–562] 474 [359–610] 571 [463–688] 0.06
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(19 mg/dL [8–61]) or patients admitted to the ICU (20 mg/dL [5–77]). 
Splitting FHb results in three categories (<5; 5–150 and  >  150  mg/
dL) was significantly associated with hospitalization (OR 3.5; 95  % CI 
1.05–11.55).
Discussion A wide overlap in ER FHb results was observed. It might be 
due to the higher rate of in vitro haemolysis related to the sampling 
procedure and/or to the efficiency of haemoglobin clearance system. 
High levels of FHb should, however, be indicative for considering 
hospitalization.
Conclusion Although surrogate markers of haemolysis rise during 
VOC and ACS, FHb assay should be interpreted with caution at the ED 
to evaluate the severity of the acute event in patients with SCD.
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Introduction Since the 2000s, the development of bacterial resistance 
has become a major public health problem due to unreasonable use of 
antibiotics despite the introduction national and international action 
plans. The establishment of appropriate antibiotic therapy has positive 
economic impact and on the patient outcome. The aim of this study 
was to assess antibiotic prescription in an emergency department of 
a general hospital by Gyssens Method, the median time between pre-
scription and administration, and the factors that influence it.
Materials and methods This was a single-center, descriptive study. 
The one hundred adult consecutive patients for whom antibiotic treat-
ment was introduced as part of hospitalization were included between 
the September 22, 2014, and the October 5, 2014.
Results On 100 patients (56 % of men) with a median age of 62 years, 
34 % suffered from respiratory tract infection, 17 % of infections were 
digestive, 16 % of urinary origin, 14 % from skin, and more rarely stom-
atological or neurological origin. Penicillin were the most prescribed 
(approximately 40 %) with cephalosporin (only in 13 % of cases and in 
combination in 27 % of cases) and quinolones. 70.7 % of prescriptions 
were classified Gyssens I (i.e., in accordance with current recommenda-
tions). Non-compliance was essentially explained by the existence of 
a more effective alternative agent (16.1 % class IV), inappropriate dos-
age (3 % class IIa), improper route (3 % class IIc), and use of any anti-
microbial not indicated (3 % class V). Most errors in prescription dealt 
with penicillins. Twenty-nine percentage of the patients had clinical 
signs of severe sepsis and 4 % of septic shock (based on the surviving 
sepsis campaign), but nearly half of the patients with clinical signs of 
severity had an error antibiotic prescription due to underestimation of 
the severity. Median time of prescription and administration was 3.7 
and 3.9 h, respectively (significantly lengthened if the prescriber was a 
junior). They were not modified on period of guard, when specialized 
advice was requested or when the patient had clinical signs of sever-
ity (severe sepsis or septic shock). Before prescription, only 53  % of 
patients had bacteriological sample, and 35 % of patients had lactate 
assay.
Discussion The results of our study reported a relatively satisfac-
tory compliance rate compared to the literature data. But in order to 
reduce prescription errors and to preserve the existing molecules, it 
is important to improve practice by developing a local guide or pro-
tocols, through working groups in consultation with the emergency’s 
team and the infectiology specialist team of our general hospital. 
However, a specialized advice did not increase prescription delays of 
antibiotics.
Conclusion In order to reduce prescription errors and to preserve the 
existing molecules, efforts are to be undertaken to improve the pre-
scription of antibiotics. This requires better training of medical staff 
and developing a local guide or protocols.
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Introduction In trauma patients norepinephrine is the vasopressor 
recommended after fluid resuscitation to preserve hemodynamic 
stability. The aim of this study was to determine the dosage of norepi-
nephrine associated with an intensive care unit (ICU) death rate above 
90 % and whether high dosage of norepinephrine is associated with 
increased death rate.
Materials and methods We conducted a retrospective, noninterven-
tional, observational study in a single ICU in an academic hospital in 
Marseille. From July 2011 to December 2013, severe trauma patients 
requiring norepinephrine were included. Data were collected at the 
time of ICU admission, after 24 h, and when the maximal posology of 
norepinephrine was reached. Mortality was assessed at day 28.
Results Among the 179 trauma patients requiring norepinephrine, the 
death rate was 46 %. The death rate reached 50 % after 24 h and 80 % 
after 28 days for the quantile of patients receiving a dosage of norepi-
nephrine above 0.75 µg/kg/min. In our cohort, five independent factors 
of mortality were identified: age above 40 years (odds ratio 2.32 [95 % 
confidence interval, 1.20–7.19]; p = 0.02), Glasgow Coma Score below 
9 (odds ratio 4.48 [95  % confidence interval 3.56–24.17]; p  <  0.001), 
hemoglobin level at ICU admission below 9 g/dL (odds ratio 1.16 [95 % 
confidence interval 1.01–1.39]; p = 0.04), lactatemia at ICU admission 
above 3 mmol/L (odds ratio 1.95 [95 % confidence interval 1.10–5.70]; 
p < 0.001), and dosage of norepinephrine above 0.75 µg/kg/min (odds 
ratio 2.81 [95 % confidence interval 1.44–7.54]; p = 0.005) (Fig. 45).
Conclusion No dosage of norepinephrine was associated with an ICU 
mortality rate above 90  % in trauma patients requiring norepineph-
rine, but a dosage of norepinephrine higher than 0.75 µg/kg/min was 
an independent factor of mortality.
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Page 192 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
S60 
Bleeding risk of pleural procedures in patients taking antiplatelet 
therapy: a multicentric prospective study
Laurence Dangers1, Gilles Mangiapan2, Mikael Alves3, Naïke Bigé4, 
Jonathan Messika5, Elise Morawiec1, Mathilde Neuville6, Christophe 
Cracco7, Gaetan Beduneau8, Nicolas Terzi9, Isabelle Huet10, Xavier 
Dhalluin11, Nathalie Bautin12, Jean Jacques Quiot13, Corinne Appere De 
Vecchi14, Thomas Similowski1, Cécile Chenivesse1
1Service de pneumologie et réanimation médicale, Groupe Hospitalier 
Pitié Salpêtrière, Paris, France; 2Service de pneumologie et pathologies 
professionnelles, Centre Hospitalier Intercommunal de Créteil, Créteil, 
France; 3Service de réanimation, Centre Hospitalier Intercommunal de 
Poissy‑Saint‑Germain‑en‑laye, Poissy, France; 4Service de réanimation 
médicale, Hôpital Saint‑Antoine, Paris, France; 5Service de réanimation 
médico‑chirurgicale, CHU Louis Mourier, Colombes, Colombes, France; 
6Service de pneumologie, Hôpital Bichat‑Claude Bernard‑APHP, Paris, 
France; 7Service de reanimation, Service de Réanimation polyvalente, 
Angoulême, France; 8Réanimation médicale, Centre Hospitalier Univer‑
sitaire Rouen, Rouen, France; 9Service de réanimation médicale, C.H.U 
de Caen, Caen, France; 10Service de pneumologie, Centre hospitalier 
universitaire de Toulouse, Toulouse, France; 11Clinique des maladies res‑
piratoires, Centre Hospitalier Régional Universitaire de Lille, Lille, France; 
12Service de pneumologie et allergologie, Centre hospitalier de Roubaix, 
Roubaix, France; 13Département de médecine interne et de pneumolo‑
gie, Centre Hospitalier Régional Universitaire de Brest, Brest, France; 
14Service de pneumologie, Centre Hospitalier Victor Dupouy, Argenteuil, 
France 
Correspondence: Laurence Dangers ‑ laudangers@gmail.com 
Annals of Intensive Care 2016, 6(Suppl 1):S60
Introduction When pleural procedures are required in patients receiv-
ing antiplatelet therapy, the risk of bleeding with antiplatelet therapy 
continuation must be balanced again the risk of arterial thrombosis 
with antiplatelet therapy withdrawal. Currently, the bleeding risk of 
pleural procedures in patients with antiplatelet therapy is unknown.
The study aimed at assessing the incidence of bleeding events after 
pleural procedures in patients receiving antiplatelet therapy in com-
parison with controls.
Materials and methods A prospective multicentric study was con-
ducted in 18 respiratory care departments and 11 medical intensive 
care units. The occurrence of bleeding events was considered within 
the 24 h following pleural procedure performance.
Results One thousand one hundred and thirty-three pleural proce-
dures, half in respiratory care departments and half in intensive care 
units (p = 0.30), were recorded: 130 (12 %) blind pleural biopsies, 625 
(55  %) chest tube insertions, 378 (33  %) thoracocentesis in 185 sub-
jects with antiplatelet therapy and 948 controls. Subjects receiving 
antiplatelet therapy were more frequently males (89 vs 64 %; p = 0.02) 
and were older (73 ± 13 vs 58 ± 19 years; p = 0.02).
In the group with antiplatelet therapy, there was a higher prevalence 
of renal failure (42 vs 23  %; p  <  0.001) and ultrasound guidance (78 
vs 68  %; p =  0.007) and a lesser prevalence of thrombopenia with a 
platelet count below 100 G/L (7.5 vs 2  %; p =  0.006) in comparison 
with controls. There was no difference between groups concerning 
vitamin K antagonist and heparin therapies and operator’s experience 
and qualification.
Thirteeen bleeding events occurred: 9 hemothorax, 2 hemoptysis and 
2 hematomas. The incidence of bleeding events was higher in the 
group of patients receiving antiplatelet therapy compared to the con-
trol subjects [2.7 vs 0.8 %; p = 0.03; OR 3.3 95 % CI (1.05–10.09)].
Conclusion In this study, antiplatelet therapy provoked a 3 times 
increase in pleural procedures related bleeding risk.
Thus, their suspension should be considered when the arterial throm-
botic risk is minor such as in primary prevention.
However, the bleeding risk related to antiplatelet therapy remains low 
supporting their continuation during pleural procedures when the 
arterial thrombosis risk is high and associated with severe outcomes 
such as in coronary patients.
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Introduction The association of fibrinogen 3  g and tranexamic acid 
2 g was introduced into the management protocol for our maternity 
postpartum hemorrhage from 2012. Before that date, the use of one 
or both of these products was anecdotal. The objective of this study is 
to evaluate the effectiveness of the association (fibrinogen/exacyl) in 
the curative treatment of postpartum hemorrhage.
Patients and methods Our study is retrospective, descriptive and 
monocentric, on parturients presented with severe bleeding in the 
postpartum period from 2009 to 2014.
Inclusion criteria were as follows: any woman in labor who presented 
in the aftermath of a vaginal delivery or cesarean section, deemed 
severe genital bleeding (bleeding clinically abundant, significant 
hemodynamic changes, need for medical or surgical hemostasis). 
Exclusion criteria were parturients under anticoagulant treatment, 
parturients transferred from other health structures.
We have collected the records of all women in labor who experienced 
severe PPH, and we divided them into two groups: group including records 
of years 2009–2010–2011 and a second group including records of years 
2012–2013–2014. The collection has been using a pre-established grid. The 
main elements of judgment were: the incidence of hemostasis hysterec-
tomy, the average number of blood units transfused, the rate of non-trans-
fused patients, mortality and postoperative complications (particularly 
acute renal failure). We also establish the transfusion ratio PFC/CG.
Results One hundred and sixty-six cases were studied (58 of 2009–
2011: group 1 and 108 from 2012 to 2014: group 2). The two groups 
were comparable in terms of general and obstetric data. The associa-
tion was used in 18.9 % of patients in group 1 and in 71.3 % group 2. 
The rate of hemostasis hysterectomy decreased from 51.7 % (group 1) 
to 19.4 % (group 2). The rate of non-transfused patients increased from 
6.9 % (group 1) to 27.8 % (group 2). The average number of transfused 
packed red blood cells decreased from 5.3 (group 1) to 4.2 (group 2). 
Fig. 45 See text for description 
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There was no significant change with respect to transfusion ratio (fresh 
frozen plasma/red cell: PFC/CG), 1/0.79 (group 1) and 1/0.73 (group 2).
Conclusion Within the limits of this study, the association fibrinogen/
(AT) appears effective in reducing the incidence of hemostasis hyster-
ectomy and in the reduction of transfusion requirements in the man-
agement of severe PPH.
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Introduction HELLP syndrome (hemolysis, elevated liver enzyme, low 
platelets) is a gravidarum microangiopathy at the end of second and 
third trimester of pregnancy [1]. The aim of our work is to study the 
epidemiological, clinical and prognostic characteristics in obstetric 
patients admitted in ICU for HELLP syndrome.
Patients and methods Our study is retrospective and includes all 
cases of HELLP syndrome collected in the ICU of the university hospital 
of Sfax over a period of 15 years (1998–2012).
Results Among the 131,631 births occurred during the study period, 506 
patients had complications requiring ICU transfer of which 112 presented 
HELLP syndrome (22.1  %). Pregnancy has been followed in 77 women 
(68.7 %). The average age of patients was 31 ± 6.2 years. The average par-
ity was 2.1 ± 1.5 with a primiparity rates at 51.4 %. Gestational age of dis-
covery HELLP syndrome was 33 ± 3.9 weeks. Gravidarum hypertension 
was present in 107 patients (95.5  %). The average rate of hemoglobin 
was 10 ± 2.3 g/dl, that of SGOT 203 ± 259 IU/l, of SGPT 127 ± 137 IU/l, 
of platelets 72,942 ± 42,398 E/mm3, of bilirubin 54.2 ± 59.2 µmol/l and 
of LDH 746 ±  210  IU/l. The research of schisocytes was positive in 66 
patients (58.9 %). The HELLP syndrome has been associated with acute 
renal failure in 54 cases (48.2  %), to eclampsia in 24 cases (21.4  %), to 
disseminated intravascular coagulation in 23 cases (20.5 %), to retro pla-
cental hematoma in 16 cases (18.1 %), to acute pulmonary edema in 11 
cases (9.8 %) and to state of shock in 11 cases (9.8 %). Childbirth was via 
a vaginal approach in 19 cases (16.9 %) and cesarean section in 93 cases 
(83.1 %). Mechanical ventilation was required in 90 cases (80.3 %). Antihy-
pertensive therapy was initiated in 101 patients (90 %). Forty-six patients 
(41 %) received a transfusion. Hemodialysis was carried in 2 cases (1.8 %). 
The average length of stay in the ICU was 3.1 ± 4.4 days. The final out-
come of our patients was marked by the death of eight of them (7.1 %). 
Mortality was significantly higher (p < 0.05) in patients who developed 
systemic (acute renal failure, disseminated intravascular coagulation, 
state of shock, acute pulmonary edema) and/or obstetric complications 
(eclampsia, retro placental hematoma).
Conclusion HELLP syndrome is a rare complication of late pregnancy, 
but it is a cause of severe maternal morbidity. Correctly supported in 
ICU, the prognosis is better.
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Introduction Eclampsia is a major cause of maternal and fetal 
morbidity and mortality, particularly in the developing world (1). 
These maternal deaths are essentially caused by cerebral lesions, 
but their precipitating factors are unknown. The aim of the study 
was to determine the prevalence and incidence of neurological 
complications of eclampsia and determine their independent risk 
factors.
Patients and methods A retrospective study was conducted in the 
obstetrical and gynecological anesthesiology and reanimation unit 
of the Ibn Rochd University Hospital from January 2000 to December 
2013 and included all women with eclampsia. All patients with focal 
neurological deficit, persisting coma or convulsions after treatment 
underwent neuroimagery. Their epidemiological, clinical, biological, 
radiological, evolutive, therapeutic and obstetrical data were com-
pared with patients without cerebral lesions through a descriptive, 
univariate and multivariate analysis.
Results One thousand thirty patients were included, with a global 
prevalence of 0.81 %. Sixty-five pourcents were less than 30 years of 
age, and gestational age was above 32 weeks in 76.8 %. Systolic blood 
pressure (SBP) was above 160 mmHg in 74.5 %, diastolic blood pres-
sure (DBP) above 110 mmHg in 40.1 % and mean arterial pressure was 
above 150  mmHg in 7.9  %. One hundred ninety-one (14.9  %) had a 
neurological complication, a posterior reversible encephalopathy 
syndrome (PRES) in 88 %, and hemorrhagic stroke in 12 % of patients. 
They were no prepartum or postpartum predominance in the occur-
rence of cerebral lesions, except for hemorrhagic lesions which 
occurred significantly in prepartum (p = 0.041). Neurological compli-
cations were significantly associated with SBP  ≥  180  mmHg (unad-
justed OR 1.37; 95 % CI 1.00–1.88) or DBP ≥ 110 mmHg (unadjusted 
OR 1.49; 95 % CI 1.09–2.03), but these variables were not significant 
in the logistic regression model. HELLP syndrome in the complete 
(adjusted OR 3.37; 95  % CI 1.74–6.56) and partial form (AOR 2.26; 
95  % CI 1.21–4.23) was independently associated with neurological 
complications (p  <  0.001 and p  =  0.010, respectively). Intracerebral 
hemorrhage was significantly associated with pulmonary edema only 
(unadjusted OR 9.59; 95  % CI 2.60–35.36). Unused magnesium sul-
fate (AOR 2.46; 95  % CI 1.22–4.99) and mechanical ventilation (AOR 
5.16; 95 % CI 2.90–9.15) were independently associated with cerebral 
lesions (p = 0.012 and p < 0.001). Finally, these lesions were indepen-
dently associated with poor maternal (AOR 5.18; 95 % CI 1.77–15.10) 
and fetal (AOR 3.15; 95  % CI 1.16–8.57) outcome (p  =  0.003 and 
p = 0.025).
Conclusion Our study suggest that HELLP syndrome was the main risk 
factor for neurological complication of eclampsia, which are to link to 
endothelial dysfunction. These lesions were not independently associ-
ated with the elevation of BP, which contradicts recent works. Further 
studies are necessary to introduce new therapeutics to control the 
endothelial dysfunction process and improve the prognosis.
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Introduction Hepatic encephalopathy (HE) has been mainly attrib-
uted to elevated levels of ammonemia associated with inflammatory 
response due to modification of intestinal microbiota and increased 
bacterial translocation. Brain edema is frequently encountered in 
acute liver failure and has been shown, at a lower extent, in cirrhosis. 
Astrocytes display cytotoxic edema due to the presence of glutamine, 
an osmotic agent produced by the transformation of ammonia by glu-
tamine synthetase in the cytoplasm. This condition is not associated 
with increased brain volume since blood-brain barrier permeability 
is not modified. At the opposite, vasogenic edema is associated with 
an increased brain volume and a decreased specific gravity (SG) sec-
ondary to an increase in blood-brain barrier permeability. Brain vol-
ume, weight and SG, that can be measured by CT scan, can be used 
to estimate brain water contain and determine the type of edema. The 
physiopathological implication of hyperammonemia in the appari-
tion of vasogenic brain edema is nevertheless still debated in hyper-
ammoniemic encephalopathy. Objective: To determine the influence 
of ammonemia levels and their modification in the variation of brain 
water contain and the apparition of vasogenic edema.
Patients and methods We retrospectively included, from January 
2013 to June 2015, all the patients admitted for HE in ICU that dis-
played ammonemia levels higher than 150 μmol/L and that underwent 
a brain CT scan. Quantitative analysis of CT was performed using the 
Brainview software (Institut National des Télécommunications). This 
software enables analyses of DICOM images and the determination of 
the weight, the volume and the SG of the different brain regions (hemi-
spheres, brainstem, cerebellum, intraventricular cerebrospinal fluid).
Results Five patients were included, and 10 CT scan evaluated. Median 
ammonemia was 184  μmol/L [118–317]. Brain weights, volumes and 
SG were 1356  g [1163–1397], 1313  mL [1131–1355] and 1,0296  g/mL 
[1,0280–1,0327], respectively. The volume and the SG of both the brain 
and the hemispheres were correlated to ammonemia levels (p < 0.05). 
The increase in volume and the decrease in SG suggested the presence 
of vasogenic edema. Variation in ammonemia levels was associated 
with a modification in volumes and SG (p  <  0.05). The different brain 
regions were, however, not equally affected. Thus, brainstem and cer-
ebellum volumes were not correlated with ammonemia levels, and 
it variation was not associated with modification in volumes in these 
regions.
Conclusion Hyperammonemia is associated with vasogenic brain 
edema in hyperammoniemic encephalopathy. The vasogenic edema is 
mainly located in cerebral hemispheres.
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Introduction Hepatic encephalopathy (HE) is a major clinical problem 
in patients with cirrhosis, which influences short- and long-term prog-
nosis, impairs quality of life and increases costs. Clinical manifestations 
range from mild neurocognitive disturbances with normal clinical 
examination to coma. About one-third of patient with overt HE will 
display altered consciousness needing ICU admission and sometimes 
mechanical ventilation. Rapid correction of HE could avoid the need 
for mechanical ventilation in the most severe patients. Even if fluma-
zenil has been proposed to reverse HE, conflicting results exist and its 
use is not recommended. Recently, glycerol phenylbutyrate or sodium 
phenylbutyrate, that lowers ammonia by providing an alternate path-
way to urea for waste nitrogen excretion, has shown to be effective in 
preventing the occurrence of HE in RCT.
To determine whether sodium phenylbutyrate was effective in severe 
HE patients to decrease ammonia and avoid neurological worsening.
Patients and methods We prospectively included all the cirrhotic 
patients that presented with an ammonia >100 µmol/L, presented HE 
and that presented no conter-indication to the treatment. Glasgow 
coma scale, FOUR score, West-Haven, HESA, CHESS scales and criti-
cal flicker frequency were noted in each patient in order to assess HE 
before and after treatment.
Neurological improvement was defined as an improvement in either 
Glasgow coma scale, FOUR score, West-Haven score or critical flicker 
frequency. Side effects were noted. Data are given as median and 
interquartile range.
Results Between August 2014 and September 2015, 18 patients 
(median age: 59 [45–68] years, male 83 %; aetiology of cirrhosis: alco-
holic 56 %, viral 6 %, other 38 %; Child-Pugh 11 [8–12], MELD score 16 
[14–24]) were included. Nine patients (50  %) were admitted for HE, 
4 (22  %) for gastrointestinal bleeding, 3 (17  %) for acute liver failure 
and 3 for miscellaneous causes. At admission, ammonia level was 151 
[114–200] µmol/L, Glasgow coma scale 14 [13–15], FOUR score 16 [13–
16], West-Haven score 2 [2–3], CHESS 2 [0–6], HESA 2 [1–3] and critical 
flicker frequency at 33 Hz [30–38]. At day 1, ammonia decrease was 61 
[27–83], at day 2 51 [10–79] and at day 3 43 [26–83]. Eighty-three per-
centage patients presented a decrease in ammonia under treatment 
at day 1, 89 % at day 2 and 94 % at day 3. Neurological improvement 
occured in 10 patients (56 %) at day 1, in 77 % at day 2 and in 83 % at 
day 3. At 6 months, 6 patients (33 %) had died, 2 (12 %) were lost of 
follow-up and 10 (55 %) were still alive. No side effects were observed 
under treatment.
Conclusion Sodium phenylbutyrate seems effective in both reduc-
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Introduction Recent neuroimaging studies point to the critical 
involvement of hubs in neural networks localized in precuneus (PrCu) 
and posterior cingulate cortex (PCC) in self-conscious processing (1). 
We hypothesize that the major consciousness deficit observed in 
coma is due to the breakdown of long-range neuronal communication 
supported by PrCu and PCC and that prognosis depends on specific 
connectivity pattern in these networks.
Patients and methods We compared 31 prospectively recruited 
comatose patients suffering from severe brain injury (Glasgow Coma 
Scale <8; 16 traumatic and 15 anoxic cases) to 14 age-matched healthy 
participants. Standardized clinical assessment and fMRI were per-
formed on average 4 ± 2 days after withdrawal of sedation. Analysis of 
resting-state fMRI connectivity involved hypothesis-driven, ROI-based 
strategy. We assessed patient’s outcome after 3  months using the 
Coma Recovery Scale-Revised (CRS-R).
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Results Comatose patients showed a significant disruption of 
functional connectivity of brain areas spontaneously synchronized 
with PCC, globally notwithstanding etiology. The functional con-
nectivity strength between PCC and mPFC was significantly differ-
ent between comatose patients who went on to recover and those 
who eventually scored an unfavorable outcome 3 month after brain 
injury (Kruskal–Wallis test, p  <  0.001; linear regression between 
CRS-R and PCC-mPFC activity coupling at rest, Spearman’s ρ = 0.93, 
p < 0.003; see Fig. 46).
Discussion
Conclusion To summarize, the reorganization of PCC-centered, 
spontaneously synchronized large-scale networks, seems implicated 
in the loss of external and internal self-centered awareness observed 
during coma, largely independent of its etiology. The level of func-
tional connectivity between PCC and mPFC appears to be related to 
patient neurological outcome. Future work should further explore 
brain intrinsic network dysfunctions in larger patient’s cohort, aim-
ing to improve patient’s diagnosis, early prognostication, and ena-
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Introduction Veno-arterial extra-corporeal membrane oxygena-
tion (ECMO) is increasingly used to treat refractory shock or cardiac 
arrest. Use of ECMO support is associated with significant neuro-
logical complications, which may significantly impact on progno-
sis. Neurological status of adult patients on ECMO is hard to assess, 
as most of these patients are deeply sedated at the initial phase of 
resuscitation. Moreover, transportation for brain imaging is not eas-
ily feasible and brain MRI is contraindicated in those patients. The 
usefulness of electroencephalography (EEG) to predict neurologi-
cal complications or outcome is poorly studied in these patients. 
We aimed to assess the prognostic contribution of continuous 
EEG monitoring (cEEG) recordings over intermittent EEG (iEEG) on 
outcome.
Materials and methods We performed a monocentric, prospective, 
observational study on adult patients with cardiogenic shock requir-
ing veno-arterial ECMO. To be included in the study, patients had to 
meet the following criteria: (1) age >18  years; (2) initiation of veno-
arterial ECMO support for <24  h; (3) EEG recordings performed on 
the first day following ECMO cannulation. For each included patient, 
a systematic neurological assessment was conducted on the day of 
EEG recording, including measurements of RASS score, FOUR score, 
brainstem reflexes and motor responses assessments. EEG record-
ings consisted of iEEG, followed by cEEG monitoring overnight. An 
independent neurophysiologist interpreted results of iEEG and cEEG, 
including background abnormalities (presence of a discontinuous 
Table 55 See text for description







SAPS2 55 (41–78) 51 (37–75) 60 (43–82) 0.36
SOFA 10 (8–13) 9 (5–12) 11 (10–13) 0.18
Cardiac arrest 4 (18) 2 (18) 2 (18) >0.99
RASS score −5 (−5;−3) −3 (−5;−0.5) −5 (−5;−4) 0.08
FOUR score 4 (0–8) 6 (1–9) 1 (0–6) 0.51
iEEG recordings
Background: 14 (64) 4 (45) 10 (90) 0.03
 Discontinuous 
pattern
5 (23) 1 (9) 4 (36) 0.12
 Non‑reactive 
pattern
9 (41) 3 (27) 6 (55) 0.19
Focal abnor‑
malities
5 (23) 2 (18) 3 (27) 0.61
Paroxysmal 
alterations
2 (9) 1 (9) 1 (9) >0.99
Non convulsive 
seizures






1 (5) 1 (9) 0 (0) 0.23
New focal 
abnormalities




3 (14) 1 (9) 2 (18) 0.53
New periodic 
discharges




14 (64) 4 (45) 10 (90) 0.03
Fig. 46 The predictive role of PCC‑mPFC coupling measured dur‑
ing coma state and neurological outcome. Functional connectivity 
strength between PCC–mPFC assessed at the scan time (right panel) 
was significantly different between comatose patients who recovered 
consciousness (REC) and those who evolved toward a minimally con‑
scious state (MCS) or an vegetative state (VS) 3 month after the brain 
injury. PCC posterior cingulate cortex, mPFC medial prefrontal cortex 
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pattern and/or a non-reactive pattern), focal abnormalities, paroxys-
mal alterations, presence or absence of non-convulsive seizures, pres-
ence or absence of sleep elements (K-complexes, vertex sharp-waves 
and sleep spindles). The primary outcome was mortality 14  days fol-
lowing ECMO cannulation. Results are presented as number (percent-
ages) or median (interquartile range).
Results Twenty-two patients (age: 60 (54–67) years, SAPS2: 55 (41–78), 
SOFA score: 10 (8–13)) were included. Eleven (50  %) patients were 
post-cardiac surgery, and 11 (50 %) were medical patients (including 
4 (18 %) with refractory cardiac arrest). Five (23 %) patients had a his-
tory of stroke. Charlson score prior hospitalization was 1 (0–3). All the 
patients underwent mechanical ventilation, catecholamines levels 
were 0.4 (0–6.4) mg/h, and lactate levels was 2.3 (1.5–3) mmol/l. Day 
14 mortality was 50 % (n = 11). Characteristics of patients on the day 
of EEG recordings are presented in Table  55. Twenty (91  %) patients 
had ongoing sedation during EEG recordings. None of the clinical 
features were associated with outcome. On iEEG, only background 
abnormalities (discontinuous or unreactive background) were associ-
ated with outcome. Additional findings on continuous EEG recordings 
revealed that loss of EEG sleep elements was associated with outcome.
Conclusion In adult patients with cardiogenic shock requiring veno-
arterial ECMO, discontinuous or unreactive iEEG background is asso-
ciated with early mortality. Moreover, loss of EEG sleep elements on 
continuous EEG provides additional information on prognosis. These 
findings from this preliminary study need to be confirmed.
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Introduction Hyperglycemia during acute ischemic stroke is associ-
ated with a high risk of hemorrhagic transformation and a poor clinical 
outcome. High-density lipoprotein (HDL) levels are inversely associated 
with stroke incidence, suggesting a protective effect. Using a mouse 
model of ischemic stroke in hyperglycemic conditions, we tested the 
hypothesis that HDLs may limit hemorrhagic transformation and mor-
tality when administered intra-arterially at the reperfusion phase.
Materials and methods After a 3-h middle cerebral artery occlusion 
using a 7–0 silicon-coated monofilament, C57BL6 mice were randomly 
treated intra-arterially with human plasma purified HDLs versus saline 
immediately after reperfusion. Four groups were used with ten ani-
mals per group: Hyperglycemic mice with HDL treatment (HG-HDL), 
normoglycemic mice with HDL treatment (NG-HDL), hyperglycemic 
mice with saline treatment (HG-S) and normoglycemic mice with 
saline treatment (NG-S). We used d-glucose intraperitoneal injection 
(2.2  g/kg) to induce acute hyperglycemia. Blood glucose levels were 
followed up six times during experimental period. The effects of HDLs 
were assessed blindly 24 h later by evaluating the neurological deficit 
and mortality and by measuring both infarct volume and hemorrhagic 
transformation. Then brain blood content was estimated by hemo-
globin ELISA.
Results In both hyperglycemic groups, the blood glucose levels were 
significantly increased from 0.5 to 3  h after injection of d-glucose. 
Hyperglycemic mice with saline treatment had severe hemorrhagic 
transformation (parenchymal hematoma) relative to the hypergly-
cemic mice with HDL treatment (100 vs 70 % p = 0.01). Hemorrhagic 
transformation score were: 16.6 vs 11.5 p < 0.001 (0 = no hemorrhagic 
transformation to 20 = parenchymal hematoma >30 % in all five brain 
slices). These results were confirmed by ELISA quantification of hemo-
globin (HG-S: 1.911 ng/ml vs HG-HDL: 0.945 ng/ml p < 0.001). Ischemia 
volume was not statistically different between hyperglycemic mice 
with or without HDLs: 62.3 ± 11 vs 72.0 ± 11.0 mm3. HDL treatment 
failed to limit the mortality (HG-S: 52 % vs HG-HDL: 35 % p = 0.3).
Conclusion High-density lipoprotein injection limited hyperglycemia-
induced hemorrhagic transformation in an original hyperglycemic 
mouse model of middle cerebral artery occlusion. These results sup-
port the vasculoprotective action of HDLs and their potential use at 
the acute phase of ischemic stroke in hyperglycemic patients.
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Introduction Acute brain injury in neurological critical care is com-
monly associated with an early rise of intracranial pressure (ICP). In 
some patients, ICP rises sharply during a secondary stage of hyperten-
sion between 7 and 15  days. This delayed intracranial hypertension 
(ICHP) often evolves into a dramatic refractory edema, unresponsive 
to heavy therapeutic measures (deep sedation, hypertonic saline solu-
tions, hypothermia, and decompression surgery) eventually leading to 
death. Many studies have shown that glucocorticoids (GC) therapy at 
the early stage of acute brain injury is associated with a significant rise 
in death rate or disability (1). However, GC therapy has not yet been 
investigated for treating this delayed, refractory ICHP after acute brain 
injury. We hypothesized that GC therapy is associated with a reduction 
of ICP, better cerebral perfusion pressure and survival improvement.
Materials and methods Objective: To characterize effects of GC ther-
apy on ICP in patients with delayed refractory intracranial hyperten-
sion after acute brain injury.
Methods We retrospectively included in the Medical Surgical ICU of a 
French hospital from December 2011 to July 2015, all patients show-
ing refractory intracranial hypertension defined by a rebound of ICP 
(>20 mmHg) more than 8 days after acute brain injury and who had 
received GC. Patients were excluded if GC therapy was started prior 
to the admission in ICU for any other reason. ICP measurements were 
recorded every 4  h for each patient beginning 3  days before the GC 
therapy and ending 5 days after the GC therapy. Then, we studied the 
evolution of the median and the maximal value of ICP daily during 
those 8 days using pairwise comparisons (Friedman test).
Results Eighteen patients met inclusion criteria. Seven were excluded, 
due to GC being administered prior to the admission in order to treat 
preexistent neoplasic or parasitic diseases. Five were admitted in the 
ICU for intracerebral hemorrhage, four for severe traumatic brain 
injury, one for acute ischemic stroke, and one for subarachnoid hemor-
rhage. The median and maximal ICP at the worst stage of ICHT which 
prompted the rescue GC therapy were 26 [IQR =  28] mmHg and 37 
[IQR =  26] mmHg, respectively. The GC therapy was associated with 
significant reduction in ICP median values (p  <  0.05) and daily maxi-
mal values (p < 0.0001) (Fig. 47). Two days after GC therapy, ICHT was 
controlled (ICP under 20  mmHg) in most patients, median ICP =  15 
[IQR = 7]. One week later, the median ICP was under 5 [IQR = 10], and 
all but one patients were discharged from ICU. The rescue GC therapy 
consisted in methylprednisolone for all patients but with a significant 
variability of the initial posology (median =  2  mg/kg/day [IQR =  1]), 
the length of administration (median = 7 days [IQR = 4]). Bacterial pul-
monary infections occurred in five patients after starting GC therapy. 
Bacterial urinary tract infections occurred in four patients. Elevated 
serum glucose levels requiring intravenous insulin therapy were 
observed in four patients.
Conclusion GC therapy could be a suitable rescue option for delayed, 
refractory ICHT. However, there are currently insufficient data 
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concerning the functional outcome after the discharge of ICU. Because 
of their side effects, they should be used with caution and further 
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Introduction The aim of the early talks (ET) to the relatives is to intro-
duce organ donation (OD) before the occurence of brain death (BD) 
and to search intent of the potential donor not to be a donor. This 
paper aims at describing the results of ET method compared to the 
standard practice that introduces OD once BD has occured.
Patients and methods In 2012, ET procedures have been employed 
among intensive care unit (ICU), emergency room (ER) and stroke unit.
The ET method is used when patients are diagnosed with unrecover-
able brain damage, possibly leading to BD, with close relatives made 
aware of the situation and have agreed to withdraw invasive treat-
ments. The interview highlights several points among which are 
patients’ current state, the believed evolution of that state, OD in case 
of BD, its approval or disapproval from close relatives as well as a time 
frame of 72 h after which withdrawal of treatments will be done if BD 
doesn’t occur. All the collected information from potential donors is 
registered and helps to provide a comparison between the ET and the 
standard BD practice.
Time frames are expressed in median [interquartile range].
Results Between January 1, 2012, and September 15, 2015, 165 inter-
views regarding organ donation and the intent of the potential donor 
to be or not to be a donor have been conducted. Ninety-four (57 %) of 
them were ET, and the remaining 71 (43 %) were done after occurence 
of BD. At the time of the ET, 69 (73 %) patients were using invasive ven-
tilation, one being in the ER and 68 in the ICU. Among the 25 non-ven-
tilated patients, 17 were in the stroke unit, 5 in the ER and 3 in the ICU.
With the ET method, disapproval was met for 26 (38 %) invasive-venti-
lated patients and 10 (40 %) non-ventilated patients (p = 0.3).
Among the disapproval, 7 patients became brain dead before with-
drawal treatments, 3 of which occurred quite rapidly (less than 1  h 
after the interview) and 4 between a 16 to 24 h time frame in the deci-
sion period requested by the relatives.
In case of organ donation rejection, a median time of 2 h [1.2–9.3] was 
found between the ET and the actual withdrawal of treatments.
When organ donation has not been disapproved and patients became 
brain dead, the time span between ET and BD was 25 h [16–40]. In only 
one case, the patients have reached over the 72 h time frame (85 h).
With organ donation not rejected and brain death not happened, the 
time span between the ET and the actual withdrawal of treatments 
was 55 h [48–72]. In this case, the patients could become a potential 
donor after circulatory death (Maastricht III). Twenty-three patients 
were in this case, and 9 were less than 60 years old (between the ages 
of 40–56), 5 of which cardiac arrest happened within 3  h after with-
drawal of treatments (Table 56).
Discussion The ET method has become a common practice when the 
decision has been made to withdraw intensive treatments for patients 
who can potentially become brain dead. It helps providing clearer 
information to relatives and the disapproval rate has not risen with 
the ET methods. It allows an earlier withdrawal of treatments if OD was 
disapproved while pursuing care for a potential donor, thus increasing 
the chances to provide viable organ. The outcome of using ET seems 
overall positive for both the close relatives and medical staff. However, 
further study is needed to evaluate the relatives’ satisfaction.
Conclusion ET has become a common practice in our unit, and it is 
not a associated with increasing of OD denial and has helped increas-
ing the number of donors.
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Occurence of BD [n (%)] 42 (45 %) 71 (100 %)
Retrieval of organs [n (%)] 31 (33 %) 29 (41 %) 0.3
Disapproval [n (%)] 36 (38 %) 36 (51 %) 0.1
Sex = male [n (%)] 46 (49 %) 40 (56 %) 0.3
Age (years) 69 [54–82] 54 [44–64] <0.001
Organ retrieved/patient (n) 3 [2.5–4] 3 [3–4] 0.4
Length of stay in ICU réa, 
days
2.7 [1.3–4.2] 1.6 [1–2,4] 0.01
Time between admission 
and interview, days
0.9 [0.2–2.2] 0.7 [0.4–2] 0.7
Fig. 47 See text for description
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Introduction Remifentanil target-controlled infusion (TCI), widely 
used in the operating room owing to its reliability, is poorly assessed 
in the ICU, while several procedures may induce pain and discomfort. 
Only one series of 14 patients focused on Remifentanil-TCI use for per-
forming fiberoptic bronchoscopy (FOB) in the ICU (1).
We aimed to assess Remifentanil-TCI feasibility, safety and tolerance 
during several procedures performed at bedside in consecutive awake 
ICU patients and generating pain or discomfort.
Patients and methods This was an observational prospective study 
of Remifentanil-TCI use during ICU procedures generating pain or dis-
comfort, including fiberoptic bronchoscopy (FOB), digestive endos-
copy (DE), transoesophageal echocardiography (TOEC) and chest tube 
insertion (CT).
Primary end point was the complete achievement of the procedure, 
without any need for general anesthesia or additional analgesia. Sec-
ondary aims were objective (respiratory and hemodynamics parame-
ters) and subjective (pain, dyspnea and comfort assessment) tolerance 
and safety measurements during and after the procedure. Quantitative 
and qualitative variables are presented as mean (standard deviation), 
median [interquartile range] or number (percentage) as appropriate.
Results From November 2014 to September 2015, 79 patients (63 % 
men; age 61  ±  18  years; SAPS II score 34  ±  16) were included. The 
studied procedures were FOB (77  %), CT (9  %), DE (9  %) and TOEC 
(6 %). The procedures were performed in patients receiving nasal oxy-
gen (80  %), high-flow humidified oxygen (11  %), noninvasive venti-
lation (2  %) or invasive ventilation (5  %). Total infusion duration was 
22  min [15–29], maximal TCI concentration goal was 4  ng/mL [3–5], 
and total drug dose infused was 252 µg [184–362].
The procedures were performed completely without any additional 
drugs in 73 patients (92 %), whereas propofol was added in 6 (8 %). Six 
patients presented side effects including bradypnea (n = 5) and hypo-
tension (systolic arterial pressure of 70  mmHg, n  =  1) that occured 
during the procedure and were completely reversible with TCI goal 
decrease. Thus, the procedures were performed entirely without addi-
tional anesthesia or complication in 67 patients (87 %).
Confort was assessed in 52 patients (66  %): 43 patients (8  %) stated 
that they felt comfortable and experienced a bearable pain or no pain 
at all, 9 patients (17 %) had a moderate pain, and none felt severe pain. 
Among the 49 patients who were asked, 43 (88 %) answered that they 
would agree to have the same procedure in the same conditions.
Conclusion Our findings suggest that TCI of Remifentanil may be use-
ful and safe for performing procedures generating pain or discomfort 
in the ICU, with acceptable patient’s comfort and tolerance, even in 
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Introduction Hyperglycaemia and insulin resistance are commonly 
encountered in major surgery patients. Several multicenter randomized 
studies have failed to provide guidelines on intensive insulin therapy 
because of the high risk of provoking hypoglycaemia. Moreover, no 
study has so far assessed the impact of the insulin infusion device on 
hypoglycaemia occurrence. The objective here was to compare insulin 
infusion modalities so as to evaluate their impact on hypoglycaemia.
Patients and methods This was an open prospective randomized 
clinical trial conducted in a perioperative intensive care unit 
composed of 15 beds. It received the ethics committee approval. 
All patients hospitalized between September 2012 and December 
2013 were included. They received 1 IU/mL human insulin over 48 h 
infused via one of the two studied assembly lines. The glycaemic 
objective was between 140 and 180  mg/dL. The standard infusion 
line consisted in insulin administration through a six-stopcock mani-
fold connected to the distal line of a multilumen central venous 
catheter by 150  cm tubing. The optimized infusion line adminis-
tered insulin infusion through a multilumen device consisting of 
eight accesses connected to nine separate lumens united in a 150-
cm tube. Capillary glycaemia was measured by a glucometer every 
3  h and by an interstitial glucose sensor every 5  min. Moderate 
hypoglycaemia was defined as a capillary glucose level between 54 
and 70  mg/dL and severe hypoglycaemia by a level below 54  mg/
dL. Time spent in hypoglycaemia for 1000  h of insulin therapy 
was calculated from glucose sensor data. Results are presented as 
mean ±  standard deviation and were compared by a Mann–Whit-
ney U test (p < 0.05).
Results One hundred and seventy-two patients were included. One 
hundred and fifty-seven patient records were workable. Twenty-
eight patients presented hypoglycaemia events: 0.18  ±  0.52 ver-
sus 0.05  ±  0.22 severe events (p  =  0.087) and 0.02  ±  0.16 versus 
0.04 ± 0.19 moderate events (p = 0.655). Time spent in hypoglycae-
mia was significantly different from one insulin infusion system to the 
other (9.21 ± 24.44 min with the standard line versus 3.91 ± 13.95 min 
with the optimized system).
Discussion This study shows that the dead-volume measured from 
the point where drug and carrier streams meet to the patient’s blood 
affects hypoglycaemia occurrence in major surgery patients. Given 
the severity of undiagnosed hypoglycaemia, close monitoring of 
blood glucose and the use of low volume infusion sets need to be 
considered for patients most at risk of glycaemic dysregulation.
Conclusion The use of low dead-volume infusion devices means 
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Introduction Intensivists’ clinical decision-making should pursue two 
main goals: to decrease patient mortality and improve mean and long-
term outcomes in survivors (termed patient-important outcomes). 
We sought to investigate how published randomized controlled tri-
als (RCTs) explore these patient-important outcomes in critically ill 
patients.
Materials and methods We performed a systematic review of pub-
lished RCTs involving critically ill patients. Literature searches were 
conducted in MEDLINE (Pubmed®) over a one-year period (2013). Data 
extraction was conducted by 2 independent senior intensivists on 
standardized, pretested extract forms. We assessed patient and study 
characteristics. All outcomes (primary and secondary) were reviewed 
and classified as follows: 1/Patient-important outcomes (mortality and 
patient-centered outcomes after discharge from intensive care (ICU), 
such as quality of life and functional status); 2/clinical outcomes in ICU 
and hospital (such as organ failure, healthcare-associated outcomes 
or adverse outcomes); 3/biological/physiological/radiological out-
comes; 4/care provider decision-related outcomes (such as mechanical 
ventilation duration, length of stay or antibiotics exposure); 5/care-
performance outcomes (such as care procedure quality or noise/light 
exposure); 6/other outcomes.
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Results Of the 716 articles retrieved, we identified and assessed 150 
RCTs performed on ICU patients. These totaled 141,170 patients (age: 
61 [54–66] years, male sex: 62 %). Most common topics of these trials 
were mechanical ventilation (31 %), sepsis (20 %) and nutrition (14 %). 
Most frequent types of intervention were therapeutic strategy (40 %), 
drug (31 %) and device (15 %) evaluation.
One hundred and two (68 %) RCTs assessed the primary outcome after 
a fixed time-point of 7 [2–28] days (from randomization) and only 15 
(10 %) assessed the primary outcome beyond 30 days. The other RCTs 
assessed the primary outcome at ICU discharge (n = 33, 22 %) or hos-
pital discharge (n = 10, 7 %). Five did not specify the time from rand-
omization to primary outcome assessment.
Among the 150 primary outcomes (Fig.  48), 31 (21  %) were patient-
important outcomes (mortality = 25 (17 %); functional disability = 4 
(3  %); quality of life =  2 (1  %)); 36 (24  %) were clinical outcomes in 
ICU and hospital; 49 (33 %) were biological/physiological/radiological 
outcomes; 23 (15 %) were care provider decision-related outcomes; 3 
(2 %) were care-performance outcomes and 8 (5 %) others.
Among 794 secondary outcomes, 169 (21 %) were patient-important 
outcomes (mortality = 117 (15 %), quality of life = 22 (3 %), functional 
disability =  19 (2  %); neurological/cognitive performance =  7 (1  %); 
handicap = 2 (0.2 %); post-traumatic stress = 1 (0.1 %); patient satis-
faction = 1 (0.1 %)); 218 (27 %) were clinical outcomes in ICU and hos-
pital; 168 (21 %) were biological/physiological/radiological outcomes; 
196 (25  %) were care provider decision-related outcomes; 12 (2  %) 
were care-performance outcomes and 31 (4 %) others.
Conclusion Patient-important outcomes represented only 21  % of 
primary and secondary outcomes of RCTs performed in critically ill 
patients and published in 2013. The majority of them were mortal-
ity. Moreover, trial follow-up was short (only 10  % of trials assessed 
primary outcomes beyond 30  days from randomization), precluding 
mean or long-term assessment of patient-centered outcomes.
Future RCTs should include patient-important outcomes as major 
outcome criteria since they guide, as gold standard of quantitative 
research, intensivists’ clinical practice and patient care.
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S74 
Epidemiology of platelets transfusion in critically ill patients
Cécile Aubron1, Andrew Flint2, Michael Bailey2, Rinaldo Bellomo2, David 
Pilcher3, Allen Cheng4, Colin Hegarty5, Anthony Martinelli5, Benjamin 
Howden6, Michael Reade7, Zoe Mcquilten8
1Réanimation médicale, Chru De Brest, Brest, France; 2Depm, monash 
university, ANZIC‑RC, Melbourne, Australia; 3Intensive Care Unit, Alfred 
Hospital, Melbourne, Australia; 4Depm, Monash University, Melbourne, 
Australia; 5The Transfusion Service, Austin Hospital, Heidelberg, Australia; 
6Infectious Diseases Department, Austin Hospital, Heidelberg, Australia; 
7Australian Defense Force and Burns, Trauma and Critical Care Research 
Center, University of Queensland, 4029, Australia, Brisbane, Australia; 
8Depm, Monash University, Transfusion Research Unit, Melbourne, 
Australia 
Correspondence: Cécile Aubron ‑ cecile.aubron@monash.edu 
Annals of Intensive Care 2016, 6(Suppl 1):S74
Introduction Platelets (PLTs) transfusion is given to reduce the risk of 
bleeding or to be part of haemostatic treatment in bleeding patients. 
Nonetheless, some studies have reported an independent associa-
tion between PLTs transfusion and adverse events including mortality 
and infections. The aim of this study is to describe PLTs transfusion in 
a large cohort of critically ill patients and to determine whether PLTs 
administration is associated with patient outcomes.
Patients and methods This retrospective study using prospectively 
maintained databases was conducted in the intensive care unit (ICU) 
of two tertiary hospitals. Adults admitted to ICU between 2008 and 
2014 were included. Characteristics of patients who received PLTs were 
compared to those of patients who did not receive PLTs. The associa-
tion between PLTs administration and hospital mortality or infection 
including bacteraemia and/or bacteriuria was modelled using multi-
ple logistic regression. A Cox regression on outcomes using transfu-
sion variables as time-varying variables was also performed.
Results Of the 18 965 patients included, 2 250 (14.5 %) received PLTs 
in ICU. Patients who received PLTs were younger, more often male, 
were more severe at ICU admission (mean APACHE III score 65 ± 29 
versus 52 ± 25, p < 0.01) and had more often comorbidities (31 ver-
sus 19 %, p < 0.01) than patients without PLTs transfusion. They were 
more often hospitalised for cardiovascular (31 versus 27 %, p < 0.001), 
gastrointestinal (26 versus 18 %, p < 0.001), haematological diseases 
(4.3 versus 0.3 %, p < 0.001) and trauma (17 versus 14 %, p < 0.001). 
Invasive mechanical ventilation (87 versus 57 %, p < 0.001) and renal 
replacement therapy (20 versus 4 %, p < 0.001) were more frequently 
administered in patients receiving PLTs than in patients without PLTs. 
The median number of PLTs administered per patient was 1 unit (Inter 
quartile range [IQR] 1–3), and this figure rose up to 4 units (IQR 2–8) 
in haematological patients and to 2 (IQR 1–5) in trauma patients. 
Patients receiving PLTs had a higher rate of infection (12.7 versus 
4.7 %, p < 0.01) and a higher mortality (20.1 versus 10.2 %, p < 0.01) 
than patients who did not receive PLTs is ICU. After adjusting for con-
founders that included illness severity, administration of other blood 
components, admission diagnosis, centre and year, PLTs transfusion 
was independently associated with in-hospital mortality (adjusted 
odds ratio [OR] 1.35, 95  % confidence interval [CI] 1.15–1. 57) and 
infection (adjusted OR 1.62, 95 % CI 1.30–2.01).
Conclusion This large observational study shows that 12 % of patients 
receive PLTs while in ICU. After adjustment for confounders including 
illness severity and administration of blood components, PLT transfu-
sion was independently associated with mortality and infection occur-
rence in ICU. Prospective research is warranted to define ICU patient 
groups who benefit from PLT transfusion.
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Introduction The demands for intensive care unit admission for elderly 
patients are increasing throughout the world due to the increase in life 
expectancy and the progress of medicine. Outcome of elderly patients 
was most often reported for octogenarians. The mean age in studies 
was roughly 84 years old. The ICU and hospital mortality were 12 and 
25 %, respectively, for scheduled surgery (1). For the same endpoints, it 
was 38–64 and 45–55 % for medical and unscheduled surgery (2). The 
primary aim of this study was to precise outcome of youngest patients 
(80–89 years old) vs oldest (>90 years old). The secondary aim was to 
evaluate outcome according to supporting care in wards units com-
pared to geriatric units after ICU discharge for the nonagenarians.
Patients and methods A multicenter (14 ICUs) observational study 
(1997–2013) was performed in 14 ICUs belonging to the Outcom-
erea study group. We extracted from the prospective database Rhea 
patient’s characteristics, intensity of treatment, decisions of limitations 
of treatment (withholding, withdrawing and anticipated withholding), 
nurse workload (NEMS: Nine Equivalents of nursing Manpower Score), 
patient status at ICU and hospital discharge. Matching criteria were 
severity of illness (SAPS without age), center and year in the study.
Results The database included 2416 patients aged more than 80 years 
old hospitalized in 14 centers during the study period. Among them, 
176 (7.2  %) were more than 90  years old and represented the cases 
patients. We matched 176 patients aged 90  years old with patients 
between 80 and 89 years old hospitalized in the same center and the 
same severity of illness at admission (Table 57).
10/14 (71  %) of centers had a geriatric unit. Factors associated with 
transfer in a geriatric unit for nonagenarians vs other wards were 
severity of illness (SAPS-age, median [IQR] 35 [20.5–41] vs 23 [17–32], 
p = 0.03), use of dobutamine (6/16, 37.5 % vs 13/114, 11.4 %), length 
of stay before ICU admission (0 [0–0.5] vs 1 [1–0.5], p < 0.01). The hos-
pital mortality rate was not different (4, 25 vs 20, 17.5 %, p = 0.47). The 
main limitation of the study was the impossibility to research long-
term outcome due to higher rate of missing data.
Conclusion In a cohort of mainly selected medical patients, ICU and 
mortality rates were not different between nonagenarians and octo-
genarians in spite of a lower intensity of treatment. The discharge to a 
geriatric unit did not change the outcome.
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Introduction As the number of patients surviving critical illness is 
increasing, since these last years, many intensive care units (ICU) 
developed an ICU aftercare in order to improve patient well-being 
and recovery. Although there is no gold standard for ICU follow-up, 
some medical teams showed that a single consultation is beneficial 
to patient. So the aim of our monocentric retrospective study was to 
establish that doing a systematic follow-up consultation can help to 
maintain quality of care for an ICU.
Patients and methods Were included all adult patients, discharged 
alive from ICU after at least 72 h, coming in a follow-up consultation 
(FC), 3  months after their ICU stay, between February 2012 to June 
2014, in general hospital of Roubaix, France. Were excluded unsta-
ble psychiatric or socially isolated patients. Were collected baseline 
demographics and clinical characteristics. Were evaluated during this 
consultation in order to define qualitative aspects of care: ICU care 
results (e.g., length of stay, duration of mechanical ventilation or seda-
tion, muscle wasting and weakness, iatrogenic effects, SF 36, Barthel 
index); ICU healthcare conditions (e.g., questionnaire of sources of 
discomfort in ICU, using IPREA 2). We also performed during this con-
sultation a multidisciplinary coordinating action to promote patient 
well-being and recovery (e.g., patient clinical assessment, referrals to 
specialists or family physician if necessary and living wills).
Results A total of 160 patients were included, mostly males (54 %), with 
a median age of 64 years [14–95], a median Simplified Acute Physiology 
Score II at 45 [6–99]. Comorbidities were mainly chronic cardiac failure 
(64 %), chronic respiratory failure (38 %) and chronic renal failure (17 %). 
Table 57 Characteristics of  patients 80–89 and  >90  years 
old
Variables 80–89 years old 90 years old p value
SAPS, age
Median (IQR) 27 (19–39) 28 (19–41) 0.92
Age, years
Median (IQR) 83.4 (81.4–85.7) 92 (90.8–93.7) <0.0001
Type of patients
Scheduled 12 (6.9) 10 (5.7) 0.04
Unscheduled 42 (24) 54 (31)
Medical 121 (69.1) 110 (63.2)
NEMS day 1 and day 2
Median (IQR) 26 (17–37) 24 (14–32) 0.02
IMV day 1 or 2
N (%) 87 (49.4) 76 (43.2) 0.23
NIV day 1 or 2
N (%) 37 (21) 24 (13.6) 0.06
Vasopressive treatment 
day 1–2
N (%) 56 (31.8) 49 (27.8) 0.29
RRT day 1 or 2
N (%) 14 (8) 5 (2.8) 0.03
ICU mortality
N (%) 36 (20.5) 44 (25) 0.23
Hospital mortality
N (%) 64 (36.4) 70 (39.8) 0.46
Limitations of treatment
Withdrawing 4 (2.3) 3 (1.7) 0.70
Withholding 3 (1.7) 6 (3.4) 0.31
Anticipated withholding 18 (10.2) 16 (9.1) 0.70
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The indications of admission were varied: 70  % (112/160) of medical 
motifs, 39 % of sepsis and shock, 19 % of acute respiratory failure, 6 % 
of acute cardiac failure, 6 % of surgery aftermath, 6 % of drug overdose, 
22 % of multivisceral organ failure. Management consisted of 62 % of 
mechanical ventilation with a median duration of 8 days [0–158], 57 % 
of noninvasive ventilation, 77 % of technical gestures, 49 % of amines 
infusion. The median length of stay in ICU was 14 days [1–162], in hospi-
tal 29 days [3–191]. Events during ICU were mainly delirium (28 %), ven-
tilatory acquired pneumonia (18 %), dysphonia (14 %), bed sores (11 %) 
and unplanned extubation (8 %). Hospital readmission rate in the first 
year ICU stay was 12.50  % (20/160), whose 13 were admitted before 
their follow-up consultation for especially sepsis and shock (40 %), and 
9 readmitted post-FC. Median delay between ICU discharge and read-
mission was 81 days [2 - 298] and with consultation 3.5 months [0–5]. 
Death rate of this population was 9.38 % (15/160).
During consultation, some data were collected: presence of close 
relatives (44 %), complete memory of ICU stay (20 %), partial memory 
(43 %), negatives memories (27 %), feeling of non-information (41 %), 
nightmares (14  %), depression (11  %), posttraumatic stress disorder 
(11 %)), fear (9 %), dyspnea (40 %), chronic pain (30 %), muscle wasting 
(40 %), Barthel index (91 ± 14 %), SF36 physical (47 ± 5.71), SF 36 men-
tal (44 ± 5.67). Evaluation of sources of discomfort during patient ICU 
stay using IPREA 2 questionnaire brought to light pain, fear, isolation 
and intimacy with high average scores.
Referrals to specialists were 57  % (91/160), mainly cardiovascu-
lar (13  %), respiratory (11  %), psychiatric (11  %), pain (5  %). Twelve 
patients expressed their living wills (7.50  %). Patients appreciate fol-
low-up in 74 % of case because they have their issues.
In the subgroup of readmitted patients, 45 % (9/20) were for a surgi-
cal reason, representing 1/5 of surgical patients. When patients read-
mitted were compared to non-readmitted, it appeared that there 
was no causal link between readmission and surgical type of stay but 
a trend [18.75 (9/48) surgical readmitted vs 27.86 (39/140)] surgical 
non-readmitted, p  =  0.117). There was a link between readmission 
and renal comorbidity [35 % (7/20) vs 14.29 (20/140), p = 0.048], read-
mission and cirrhosis [25 % (5/20) vs 7.14 % (10/140), p = 0.024], and 
readmission and SAPS II [39.10 ± 12.46 vs 46.43 ± 18.59, p = 0.046]. 
Risk of death was higher in patients readmitted post-FC (3/9 vs 15/151, 
p = 0.040). Readmission post-FC raised more than Barthel index was 
low (82.50 ± 16.26 vs 91.22 ± 13.92, p = 0.071), and rehospitalization 
occurred before FC (0.89 ± 1.27 vs 0.11 ± 0.34, p < 0.001).
Discussion Our study showed that we should strengthen our active 
preventive measures against delirium, pneumonia, unplanned extu-
bation and its effects, ICU sources of discomfort, muscle wasting and 
pain management. In view of this significant readmission rate, it seems 
important to identify factors of readmission; these should help us to 
establish an easy score useable in ICU FC. Referrals to specialists con-
cern especially surgical patients.
Conclusion Doing a systematic ICU FC allows constantly evaluating 
and improving daily patient care. This clearly impacts and changes ICU 
behavior to focus on various aspects of long-term outcomes.
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Introduction Previous studies reported the impact of ICU admission 
on outcome and functional status in intensive care unit (ICU) survivors 
in various populations. The aim of our study is to describe functional 
autonomy change in patients admitted to a Tunisian ICU.
Patients and methods We analyzed a prospective collected database 
including patients consecutively admitted in our ICU between Janu-
ary 1, 2014 and June 30, 2015. Patients’ autonomy was assessed by 
Katz’s Activity of Daily Living (ADL) questionnaire recorded at admis-
sion, while current autonomy status was evaluated by phone call on 
August 2015. ADL scale was compared before and after ICU stay using 
Wilcoxon test.
Results Two hundred and ninety-five patients were admitted to our 
ICU, during the study period [median age: 62 years (42.5–72), median 
SAPS III: 50.5 (42–61), sex ratio (H/F):1.42, NIV as initial ventilatory 
mode in 53.3 %], median ADL scale at admission for the whole pop-
ulation: 12 (11–12). Fifty-seven patients died in the ICU (21 %), while 
167 were discharged alive and were actually eligible for the second 
evaluation. The phone evaluation contact was actually performed in 
131 patients (78.4 %), of whom only 111 were alive and 20 died; ADL 
questionnaire administration was hence made at a median follow-
up of 12 months (IQR 6–16). Figure 49 shows a statistically significant 
decrease in ADL scale for the 111 patients who were still alive [12 (11–
12) versus 11 (6–12), p < 0.001]. Autonomy impairment was significant 
for all items of ADL scale (bathing, dressing, toileting, transferring, con-
tinence, and feeding).
Conclusion ICU stay was associated with a significant impairment of 
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Introduction The recent improvement of the management of patients 
(pts) with cancer has led to a better quality of life and also a longer 
survival. With the aging of the population, admission in intensive care 
unit (ICU) of elderly cancer pts is more often asked.
The aim of our study was to assess the outcome of pts older than 
65 years with solid tumor admitted in ICU.
Fig. 49 See text for description 
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Patients and methods This was a retrospective study. All pts, older 
than 65  years, suffering from evolutive cancer and admitted in the 
medical ICU of the European Georges Pompidou Hospital between 
August 2009 and December 2014 were included. Non-inclusion crite-
ria were: hemopathy, cancer diagnosed during ICU stay, cancer remis-
sion superior than 5  years, limitation of active therapeutics and ICU 
stay inferior to 24 h.
The primary endpoint was in-ICU mortality. The secondary endpoints 
were in-hospital and 90-day mortality, and resumption of anti-tumoral 
treatment.
Data concerning cancer (type of cancer, number of metastasis, num-
ber of chemotherapy lines), reasons for admission (classified as related 
to cancer progression, related to complications of chemotherapy and 
other), patients (age, severity at admission, need of life-supporting 
therapies, decision of limitation of active therapeutics after 24 h) and 
outcome were collected.
Multivariate analysis was also performed to identify predictors of in-
ICU mortality.
Results Baseline characteristics 398 pts with cancer were screened, and 
262 pts were included. The 3 most represented cancer localizations 
were: gastrointestinal (n = 71, 27 %), lung (n = 68, 26 %) and genitou-
rinary (n = 60, 23 %). One hundred and fifty-eight pts (60 %) exhibited 
metastases.
The average IGS2 score was 62 (19–125). One hundred and thirty-five 
pts received mechanical ventilation (52 %), Thirty-five pts noninvasive 
ventilation (13  %), 126 pts inotrope drug (48  %) and 33 pts dialysis 
(13  %). The mean duration of ICU stay was 6.3  days (0–39), and the 
mean length of stay in hospital was 17 days (0–100).
Reasons for admission were distributed as follows: related to cancer 
progression n = 39 (15 %), related to anti-tumor drugs n = 49 (19 %) 
and other n = 174 (66 %).
Outcome In-ICU mortality was 34  % (n  =  88). Among in-ICU died 
patients, 46 pts had a limitation of active therapeutics after 24  h 
(17.5  %). In-hospital mortality was 44  % and 90-day mortality 49  %. 
Among the 174 in-ICU survivors, 77 (44 %) were able to resume their 
anti-tumoral chemotherapy, and 32 (18 %) had no treatment because 
they had localized tumor and no indication of a new chemotherapy.
In multivariate analysis, predictive factors of in-ICU death were IGS II, 
mechanical ventilation and administration of inotropes. Cancer type, 
presence of metastasis and number of chemotherapy lines were not 
associated with higher risk of death.
Conclusion The elderly patients admitted in ICU with evolutive solid 
cancer were severely ill. Though, 76  % of them survived to ICU dis-
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Introduction Despite major advances in blood purification technol-
ogy over the last decades, the mortality rate associated with acute kid-
ney injury (AKI) remains high and continues to exceed 50 %. Previous 
pediatric studies on renal replacement therapy (RRT) have suggested 
that the mortality rate is primarily related to the underlying diagno-
sis or the presence of a multiple organ dysfunction syndrome (MODS) 
rather than to a specific RRT modality or other risk factors. Several 
recent clinical studies have suggested that fluid overload before RRT 
could also influence mortality. The aim of this study was to identify the 
most important risk factors for 28-day mortality in patients with AKI at 
RRT initiation.
Patients and methods We conducted a retrospective cohort study in 
a tertiary care pediatric center. All critically ill children who underwent 
acute continuous RRT or intermittent hemodialysis for AKI between 
January 1998 and December 2008 were included, except those with 
chronic kidney disease. A case report form was developed, and spe-
cific risk factors were identified using an item generation—item selec-
tion modality with a panel of 10 pediatric intensivists and pediatric 
nephrologists. Risk factors analysis was made using logistic regression 
in SPSS version 21.
Results We enrolled 70 consecutive patients. The main PICU admission 
reasons were respiratory failure (34 %), septic shock (29 %), AKI (24 %) 
and postoperative (21 %). The most frequent underlying diseases were 
bone marrow transplant in 24 % and solid organ transplant in 17 % of 
patients. The majority of patients received continuous RRT only. The 
median pediatric intensive care unit (PICU) length of stay was 16 days 
[IQR 8–27]. Thirty-three patients (47 %) died within 28 days after PICU 
admission. The median age (8.9  years [IQR 1.9–14.2]), weight (28  kg 
[IQR 7.9–45]), PEdiatric Logistic Organ Dysfunction score (PELOD) 
(21 [IQR 20.3–31.8]), Pediatric Index of Mortality 2 (PIM 2) (7.7 [IQR 
7.2–28.8]), creatinine (102 [IQR 70.2–154.5]), vasoactive score (3 [IQR 
0–47.3]) and oxygenation index (7.3 [IQR 3.5–19.1]) at PICU admis-
sion were similar between survivors and non-survivors. We identified 
the following risk factors for mortality in univariate analyses: hemato-
logical underlying disease and factors at RRT initiation including: fluid 
overload ≥20 %, PELOD score ≥20 and higher creatinine. Of those risk 
factors, only PELOD score ≥20 was significant in the multivariate logis-
tic regression analysis (OR 4.5; 95 % CI 1.4–14.1; p = 0.01). After PICU 
discharge, 12 out of 35 survivors needed RRT. Among 31 survivors at 
hospital discharge, 3 patients required RRT.
Discussion Despite improvement in patient care, almost half of our 
patients with AKI requiring AKI died within 28 days. Our data suggest 
that a higher severity of illness is the most important risk factor for 
mortality in critical care patients with AKI requiring RRT.
Conclusion In our study, only the severity of illness, as measured by 
the PELOD score before initiation of RRT, was independently associ-
ated with an increased risk of mortality in critically ill children.
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Introduction Septic shock remains a major health issue even in our 
industrialized countries, with described mortality rates between 11.4 
and 24.3 % in the most recent European studies. Several international 
pediatric therapeutic guidelines have been published and widely 
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diffused. As for epinephrine, they recommend its use as a first-line 
drug in cold shocks resistant to a well-conducted fluid resuscitation or 
as a second-line drug in “cold” shocks resistant to dopamine or “warm” 
shocks resistant to norepinephrine. However, those recommenda-
tions are only based on adult or neonatal references that can hardly be 
applied to children as the physiopathology of children’s septic shock is 
different on several aspects. Thus, our study constitutes the first spe-
cifically pediatric work on epinephrine use in septic shock.
Patients and methods We conducted a retrospective, single-center, 
observational study of all children (newborn excluded) treated for sep-
tic shock, upon admission or during their hospitalization in our ward, 
between January 1, 2009, and December 31, 2013. The patients were 
divided in two groups: “with” and “without” epinephrine use. Medical 
and paramedical files were reviewed for a complete description of 
each group: sociodemographic, clinical and biological data, vasoac-
tive drugs (especially epinephrine) modality of prescription, patients’ 
outcome (mortality at 28 days) were collected. We then performed a 
comparison between the two groups in univariate and multivariate 
analysis.
Results One hundred and seventeen patients corresponded to the 
pediatric definition of septic shock and were included: 68 (51.8 %) in 
the group without epinephrine use, 49 (41.9 %) in the group with epi-
nephrine use. 78.6 % of the patients had an underlying comorbidity, 
immunodeficiency concerned almost half of them (46.2 %). More than 
half of the septic shocks were nosocomial (59.8  %), acquired in our 
PICU or in another ward of the hospital.
Epinephrine was prescribed for myocardic dysfunction (36.7  %), car-
diac arrest (30.6 %) and persistent hypotension (24.5 %). Compared to 
patients without epinephrine use, patients treated with epinephrine 
were more severe at the onset of the septic shock, both clinically (with 
4–6 organ dysfunction in 68.7 vs 45.2 % cases; p = 0.02) and biologi-
cally (lactate level of 4.15 vs 2.20 mmol/l; p = 0.0008). Our delay before 
initiating epinephrine was four times longer than the one prescribed 
in the international pediatric guidelines, and patients were then in a 
severe clinical and biological state. Above all, patients treated with 
epinephrine had a worse outcome than patients treated without. Not 
only did they need continuous renal replacement therapy more fre-
quently (32.7 vs 6 %; p = 0.0002), but they also had a higher mortality 
rate at 28 days (63.3 vs 16.2 %; p < 0.0001) in univariate and multivari-
ate analysis after adjustment on the initial gravity. Finally, we high-
lighted a potential association between the maximum epinephrine 
dose used and death with a 100 % death rate for an epinephrine maxi-
mum dose over 1.90 mg/kg/min.
Conclusion Acknowledging the fact that patients treated with epi-
nephrine have a higher mortality rate than patients treated with-
out three questions can be raised in order to improve the patients’ 
outcome.
Isn’t a better initial monitoring of our patients necessary to determine 
their hemodynamic profile at best and prescribe the most appropriate 
drug?
As patients were clinically and biologically severe when epinephrine 
was prescribed, would an earlier initiation of epinephrine have a ben-
eficial effect on the mortality rate of these patients?
As a potential relation exists between the maximum dose of epi-
nephrine used and the mortality rate, would alternative therapeutics 
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Introduction Acute complications of sickle cell disease can be life-
threatening and require intermediate care and/or pediatric intensive 
care. In this retrospective study, we describe the experience over 
5 years in a tertiary pediatric intensive care unit. Our secondary goal 
was to specifically study the population with respiratory failure.
Patients and methods This was a retrospective monocentric descrip-
tive study of all pediatric admissions for sickle cell disease from 2009 
to 2013 in our 16 bed pediatric intensive care unit. We collected 
demographic data, description of admission (reason, C-reactive pro-
tein and hemoglobin level), intensive care stay (organ failures, need 
for artificial support, blood transfusion or exchange, complications, 
mortality, length of stay, Pediatric Index of Mortality 2 and Pediatric 
Logistic Organ Dysfunction scores from 2010 on). Organ failure defini-
tions used were that of the 2005 International Conference on Pediatric 
Sepsis and of the 2015 Pediatric Acute Lung Injury Sepsis Investigator 
network.
Results (All patients not included yet): Primary goal: There were 74 
patients accounting for 88 admissions in our pediatric intensive care 
unit; 60.8 % were male; mean age was 9.6 ± 5.1 years; genotype was 
SS (93.2  %), SC (4.1  %), Sβ (2.7  %); reason for admission was respira-
tory in 64.7 % (acute chest syndrome 57.9 %), shock 1.1 %, osteomy-
elitis 2.2 %, cerebral stroke 11.4 %, acute anemia with hemolysis 2.2 %, 
surgery 6.8  %, pain management 11.3  %. Mean hemoglobin level at 
admission was 8.96  ±  1.59. Blood transfusion was administered in 
35  % before admission. Organs failure during stay were: respiratory 
71.5 % (52 % on mechanical ventilation), hemodynamic 2.2 % (septic 
shock with inotropes), neurological 11.4  %, hematological 9  %, renal 
2.2 %, hepatic 5.7 % and multi-organ failure 4.5 %. Blood was admin-
istered in 72.7  % (transfusion 29.5  %, exchange in 43.2  %). Median 
length of stay was 3  days (25–75  %: 2–4). Median Pediatric Index of 
Mortality 2 was 0.85 (25–75  %: 0.2–3), and median Pediatric Logistic 
Organ Dysfunction was 1 (25–75  %: 0–1). Two patients (2.2  %) died: 
one cerebral stroke with massive oedema and one septic shock and 
multi-organ failure.
Secondary goal: Fifty-two admissions for acute chest syndrome 
(59.1  %) occurred; 43 patients (82.7  %) received mechanical ventila-
tion (76.9 % exclusively noninvasive); 9 (17.3 %) none; 53 % received 
blood transfusion (21.7 % before, 31.3 % in our unit) and 47 % blood 
exchange; mean admission C-reactive protein level was 144 ± 76 mg/l. 
Mean initial hemoglobin level was 8.8 ± 1.5 g/dl. All received broad-
spectrum antibiotics without bacteriological proof of pneumonia. 
Almost all recovered quickly, with a median length of mechanical ven-
tilation of 3 days (25–75 %: 2–4) and an intensive care stay of 3 days 
(25–75  %: 2–4). Three of them (5.8  %) developed a more severe res-
piratory failure and needed invasive mechanical ventilation, and 
one required high-frequency ventilation and nitric oxide. Their mean 
initial hemoglobin level was 10.1  g/dl; all had received blood trans-
fusion before admission. All three survived with a median length of 
stay of 8 days (25–75 %: 6–8.5). Overall, we found a higher rate of ini-
tial C-reactive protein (144.32 vs. 102.6  mg/l, p =  0.028) and a more 
elevated white blood cell count (23.415 vs. 17,494 cell per millimeter, 
p  =  0.004) in acute chest population compared to non-acute chest 
syndrome patients.
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Discussion It is unclear why some patients develop life-threatening 
complications. In our series, acute chest syndrome is the main rea-
son for admission. It is a hypoxic pneumonia whose criteria strongly 
overlap with those of acute respiratory distress syndrome but which 
appears to be rapidly reversible most of the time with noninvasive 
ventilation and blood transfusion. Antibiotics are given systemati-
cally because of a high inflammatory state but without bacteriological 
evidence.
Conclusion In our hospital hosting a clinic devoted to sickle cell 
patients, usual reasons for pediatric intensive care unit admission are 
acute chest syndrome and cerebral stroke. A prospective study will 
give more insights into the management of this specific population.
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Introduction Management of analgesia and sedation is an integral 
component of the medical care of a critically ill child. Its role is to 
assure comfort and safety to a patient undergoing painful cares and 
technical procedures; it can also be a full-processing treatment, in 
particular situations like acute respiratory distress syndrome or acute 
brain injury.
Sedation involves, most of the time, the association of an opioid and 
a sedative. The use of these drugs is difficult in children, because of a 
specific metabolism, inducing tolerance and withdrawal in case of pro-
longed administration.
The COMFORT-BEHAVIOR (COMFORT-B) scale is a validated, simple, 
reliable and reproducible score evaluating sedation and analgesia. 
Sedation scoring systems must be used regularly to avoid inadequate 
sedation.
Excessive sedation is associated with poor outcomes like prolonged 
mechanical ventilation, longer hospitalisation and more frequent 
withdrawal symptoms. Adult and paediatric data suggest that goal-
directed sedation algorithms allow a more appropriate adaptation 
of the treatment to the patient’s need and permit a reduction in the 
duration of mechanical ventilation.
Our objective was to evaluate the impact of a nurse-driven sedation 
protocol in our paediatric intensive care unit (PICU) on duration of 
mechanical ventilation, total doses and duration of medications, PICU 
length of stay, incidence of ventilator-associated-pneumonia and 
occurrence of withdrawal.
Patients and methods After development of the sedation protocol 
in January 2014, we realised a before and after protocol implementa-
tion study in a 23-bed medical–surgical PICU at a university children’s 
hospital. We included all children aged from 0 to 18  years, requiring 
mechanical ventilation for at least 24  h. Prior to implementation of 
the protocol, analgesia and sedation were managed by the attending 
physician’s order. Afterwards, post-implementation, nurses managed 
analgesia and sedation following an algorithm, including COMFORT-
B scale. Data were collected from computerised medical chart, and 
descriptive and comparative analyses were done.
Results We included 200 patients, 107 who were consecutively admit-
ted before the implementation of the protocol between January and 
December 2013 and 93 who were admitted after the implementa-
tion, between May 2014 and March 2015. The characteristics of the 
two populations were similar, except that there was significantly more 
patients admitted for chirurgical pathology in the period “after” (38 vs 
24 %, p = 0.04).
Median duration of mechanical ventilation was significantly reduced 
in the group subjected to the nurse-driven protocol: 4.8 [1.3–25.3] 
days versus 6 [1.1–80.5] days (p = 0.05). Mean total dose of midazolam 
was also reduced (17 vs 28 mg/kg, p = 0.05), and duration of sufentanil 
administration (112 vs 157 h, p = 0.05). We observed fewer withdraw-
al’s symptoms (14 vs 24 %, p = 0.09) in the period “after,” but the differ-
ence did not reach statistical significance.
The use of the protocol improved sedation evaluation by increasing 
the number of total scores and of scores indicating adequate seda-
tion (COMFORT-B between 11 and 17); but was, on the contrary, not 
associated with more agitation episodes or unplanned endotracheal 
extubation.
Discussion These preliminary results are promising and allow us to 
think that implementation of a nurse-driven sedation protocol in a 
PICU is feasible and present a lot of advantages. To our knowledge, this 
is the first study, showing a reduction in duration of mechanical ven-
tilation. It would have to be confirmed on a larger cohort and after a 
longer use of the protocol. Adjusted analysis would have to be done 
on confounding factor like age or diagnosis at admission. In the future, 
it could be relevant to make a staff survey about the use of the algo-
rithm, corresponding to a deep change in practices.
Conclusion One of the actual challenges is to enhance the sedation 
management of the critically ill patients. Implementation of a nurse-
driven sedation protocol in a PICU seems to be associated with shorter 
duration of mechanical ventilation, lower total doses of benzodiaz-
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Introduction A previous history of epilepsy can influence the manage-
ment of children’s seizures. Assuming that there are significant differences, 
we described and compared the initial management of seizures between 
children with new-onset seizures and those with known epilepsy.
Patients and methods We conducted a single-center retrospec-
tive observational study. We included all children (1 month–18 years) 
who were admitted for seizures or status epilepticus from January to 
December 2014 in the emergency department and the intensive care 
unit at Necker-Enfants Malades Hospital.
Results One hundred and ninety patients with median age of 
38  months (1–214) and sex ratio male/female of 1.08 were included: 
72 with known epilepsy (38  %) and 118 with new-onset seizures 
(62  %) with a median age of 60  months (1–214) and 26.5  months 
(1–191), respectively (p  <  0.001). Life-threatening status epilepticus 
was reported in 83 children (38 with known epilepsy, 52  % and 45 
with new-onset seizures, 38 %; p = 0.05). Laboratory work and imag-
ing were frequent in both groups (n = 104, 88 % for those with new-
onset seizures and n  =  56, 78  % for children with known epilepsy). 
Children with new-onset seizures were more likely to have at least one 
diagnostic test performed (p  =  0.005). For children with known epi-
lepsy, conducting diagnostic evaluation was more likely performed 
in those with life-threatening status epilepticus (p < 0.02). Antiepilep-
tic drugs concentration measurement were performed in 20 children, 
i.e., 53 % of cases whenever it was possible and shown that 7 children 
(35 %) of them were under target concentration. The remaining inves-
tigations had no immediate therapeutic impact except for one child. In 
most cases (n = 52, 72 %), we did not find any provoking factor for the 
occurring seizures in children with known epilepsy. The first-line treat-
ment in both populations was usually diazepam, but was used more 
often in children with new-onset seizures (80 vs 46 %, p < 0.001), while 
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midazolam were more likely administered in children with known epi-
lepsy (25 vs 1  %, p  <  0.001). In second line, diazepam was continued 
for children with new-onset seizures, whereas clonazepam was used 
for those with known epilepsy (56 vs 34 %, p = 0.02 and 46 vs 24 %, 
p =  0.001, respectively). In a third line, phenytoin was administrated 
more frequently in children with new-onset seizures (54 vs 22  %, 
p < 0.001).
Discussion The management of seizures was different in children with 
new-onset seizures and those with known epilepsy: (1) laboratory 
works and imaging except antiepileptic drug concentration measure-
ment seem to be futile for children with known epilepsy; (2) mida-
zolam and clonazepam are usually used for those children, whereas 
diazepam and phenytoin are more often administrated in children 
with new-onset seizures.
Conclusion Initial diagnostic evaluation as well as treatment should 
be considered with caution and individualized for children with 
known epilepsy who exhibited seizures and status epilepticus.
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Introduction Available for more than 20 years, the imaging technique 
by magnetic resonance (MRI) revolutionized the diagnosis of numer-
ous diseases. However, the constraints are important and require the 
teams of anesthesia and intensive care for several reasons; the strict 
immobility is essential for the quality of the images. The environment 
is hostile because of noise and cold, the patient is alone in the tunnel 
of MRI, and an injection of contrast agent is often necessary. Children 
less than 6 years and with delay of development are concerned.
Our aim is to describe the characteristics of the sedation and the eval-
uation of its safety in the MRI suite.
Materials and methods Descriptive retrospective study over a period 
ranging from October 2013 to February 2015, in the radiology depart-
ment of pediatric EHS PrBoukhrofa AEK, Oran, Algeria, including chil-
dren aged 1 month to 15 years. All patients received a premedication 
with midazolam 0.3  mg/kg 30  min before and underwent induction 
with sevoflurane inhalation to 6  % with a mixed gas rates O2/N2O 
(60/40) and then maintains the anesthesia with sevoflurane 2 %.
Results We have anesthetized 212 patients, the mean age is 3  years 
(1  month–14  years), the sex ratio is 1.47, and the mean weight was 
14.5 kg (3–56 kg). 99.5 % of the children was classified as ASA I and ASA 
II and 0.5 % was ASA III. The MRI is realized in the case of emergency in 
27 %. A cerebral MRI in 83.4 % of the cases, medullary in 10.4 %, and 
in 6.2 % it concerns the shoulder, the hand and the abdomino-pelvic 
region. The mean time of the sedation is 56 min. Eight children com-
plicated with bronchospasm. The variations of the FC and the systolic 
pressure were transient and did not require intervention.
Conclusion The immobility of the patient and the control of move-
ment are the major problems of the MRI in pediatric practice as well as 
the risk of respiratory complication which requires a rigorous care and 
the most safety environment.
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Introduction Ventilator support is frequent after pediatric cardiac sur-
gery, but high airway pressures can be detrimental on right ventricu-
lar function and pulmonary blood flow. Neurally adjusted ventilatory 
assist (NAVA) is a mode that improves patient–ventilator interactions, 
thus helping to maintain spontaneous ventilation. The use of NAVA 
after pediatric cardiac surgery has been seldom studied.
Our hypothesis was that using NAVA in this population is feasible and 
allows for lower ventilation pressures.
Patients and methods We retrospectively studied all children that 
were ventilated with NAVA (invasively or noninvasively) after under-
going cardiac surgery between January 2013 and May 2015 in the 
pediatric intensive care unit of CHU Sainte-Justine, Montreal. Baseline 
patient characteristics and duration of the different ventilation periods 
in each mode were described. For the first period of invasive NAVA in 
each patient, ventilatory parameters, vital signs, and available blood 
gas data in the 4 h before and after the start of NAVA were extracted 
from electronic patient charts.
Results Thirty-three postoperative courses were included in 28 
patients with a median [25th–75th percentile] age of 3 [1–12] months. 
During invasive ventilation, NAVA was used in 27 postoperative 
courses over 49 episodes, for a total duration of 87 [15–334] hours 
per course. Seven (14 %) individual episodes lasted less than 2 h, and 
a single patient was treated with NAVA during less than 2 h in total. 
As illustrated in Fig. 50, peak inspiratory pressures and mean airway 
pressures decreased significantly after the start of NAVA (p < 0.0001 
for the mode; two-factor repeated-measures ANOVA). There was 
no significant difference in the vital signs or blood gas values. Dur-
ing noninvasive ventilation, NAVA was used in 14 patients, during 79 
[25–137] h.
Conclusion NAVA could be used in pediatric patients after cardiac 
surgery. The significant decrease in airway pressures observed after 
transition to NAVA could have a beneficial impact in this population. 
Prospective interventional trials are needed to assess the impact of 
NAVA on cardiac function and pulmonary vascular resistance in these 
patients.
Fig. 50 Evolution of peak inspiratory and mean airway pressures in 
the 4 h preceding and following the start of neurally adjusted ventila‑
tory assist (NAVA). Box plots illustrate the median values, interquartile 
range, and spread 
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Introduction Percutaneous central venous cannulation (CVC) in 
infants and children is a challenging procedure. It is usually achieved 
with a blinded, external landmark technique or by vein denudation. 
However, these procedures are associated with a high morbidity and 
a significant risk of failure.
The purpose of this study was to compare landmark-to-ultrasound-
guided central venous access in a pediatric intensive care unit.
Materials and methods A prospective observational study was con-
ducted in a pediatric intensive care unit. Forty-five critically ill patients 
requiring central venous access were divided into two groups. In 30 
patients, the cannulation of the vein was performed by ultrasound 
guidance (group S), and in 15 patients, the cannulation was performed 
with external landmark guided technique (group LM). We assessed the 
venous access site, the number of attempts, the access time (skin to 
vein), and the incidence of complications.
Results A cannulation of the central vein was achieved in 41/45 
patients. In group S, an access site to the internal jugular vein was 
preferred in 29/30 patients. In group LM, an attempt to access to 
the right femoral vein was performed in all cases. The procedure 
was successful in 96.6  % in the group S and 80  % in the group LM. 
The vein was entered at the first attempt in 96.6 % in group S versus 
40 % in group LM. The median number of attempts was 1.1 in group 
S and 3 in group LM. The median access time (skin to vein) was 3 and 
7 min in group S and group LM, respectively. No arterial punctures or 
hematomas occurred with the ultrasound technique. Three arterial 
punctures occurred with the seldinger technique.
Conclusion In a pediatric intensive care unit, the ultrasound-guided 
CVC is a more interesting technique compared to the Seldinger tech-
nique (1). In our study, ultrasound guidance seemed to reduce the 
number of attempts and the time of the procedure and improved the 
success rate and the occurrence of the complications.
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Introduction Recent studies showed that the remote ischemic pre-
conditioning may provide protection of renal function after cardiac 
surgery and contrast-medium-induced renal failure. The mechanism 
is linked to the production of vasodilatory substances leading to 
improve organ perfusion.
The aim of our study was to determine whether a noninvasive remote 
preconditioning could induce a vasodilation in intraparenchymal renal 
circulation measured by the renal resistive index.
Patients and methods Remote preconditioning procedure was 
applied in six volunteers as follows: cycles of 4-min inflation of a 
blood pressure cuff to a pressure 50 mmHg above the systolic arterial 
pressure to one upper arm, followed by 4-min reperfusion with the 
deflated cuff.
RRI was determined using renal Doppler-echography method per-
formed on the interlobar arteries using a 2.5-MHz transducer at 
1.8 MHz for Doppler analysis. The RRI was calculated as follows: (peak 
systolic velocity − end diastolic velocity)/peak systolic velocity. Three 
measurements were performed on right kidney and averaged to 
obtain the mean RI values.
Mean values were compared at baseline (T0), during each period with 
the deflated cuff (T1, T2, T3) and at the end of the protocol (T4) using 
paired Wilcoxon test.
Results The mean value of RRI significantly decreased from 0.57 ± 0.05 
before the remote conditioning to 0.49 ± 0.04 at the end of the experi-
ment p < 0.01. The progressive decrease in RRI was observed in the all 
six subjects. During the experiment, heart rate and arterial pressure 
were unchanged.
Conclusion In this pilot study, we demonstrated that the remote 
ischemic preconditioning induced a vasodilation of renal microcircu-
lation assessed by the decrease in RRI in each volunteer. The precise 
mechanism of such a vasodilation remains to be investigated.
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Introduction Acute kidney injury (AKI) frequently occurs in 
intensive care units (ICU) and is associated with poor outcomes, 
including persistent kidney injury evolving to chronic kidney dis-
ease. If sepsis is the main cause for AKI, diagnostic procedures 
and drugs, may also contribute to renal failure. Aminoglycosides, 
such as Amikacin (AMK), are potent, highly bactericidal antibi-
otics, increasingly used in ICU to broaden the spectrum against 
gram-negative bacilli during septic shock. They may have an 
acute tubular toxicity leading to AKI. Recently, French practice 
guidelines recommended using AMK with once-daily dosing reg-
imen of 25  mg/kg over 30  min in order to reach a peak plasma 
concentration ranging from 60 to 80 mg/l 30 min after the end of 
injection. No AMK dose adjustment is recommended for the first 
dose in patients with acute or chronic kidney failure. The once-
daily regimen is known to be protective for kidneys. Whether this 
high dose implies a greater risk of nephrotoxicity or not remains 
unknown. Thus, we performed a retrospective study to assess the 
association between the peak concentration of AMK and the class 
of AKI at day 90.
Patients and methods We included all patients hospitalized in a 
medical ICU, who had received AMK according to French guide-
lines, no matter their kidney function at the time of initiation of 
AMK. AKI was defined using Kidney Disease Improving Global Out-
comes (KDIGO) 2012 classification. AKI at day 90 was assessed 
comparing creatinine plasma level at day 90 to steady-state pre-
treatment one. Clinical and biological features, including severity 
scores and nephrotoxic use, were recorded. Creatinine plasma lev-
els were followed until 90 days after the first injection of AMK. We 
assessed the association between peak concentration of AMK and 
kidney function at day 90. A negative binomial model was used to 
compute the KDIGO class at day 90.
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Results From March 2013 to December 2014, 93 patients were 
included. Median SAPS II at time of admission was 48 IQR [37.5; 62]. 
The median peak concentration of AMK was 74.7  mg/l IQR [62.4; 
93.9], within the recommended range level according to national 
guidelines. Seventy-four percent of patients received only one 
injection of AMK. Thirty-one percent died before day 90. Seventy 
percent of patients had an AKI when starting treatment. Among 
survivors at day 90, 67  % of patients had recovered their kidney 
function. Four patients had end-stage renal disease, all undergoing 
hemodialysis. No association between peak concentration of AMK 
and kidney function at day 90 was found (RR = 1 (IC95 (0.99–1.01) 
p = 0.74). In multivariate analysis, KDIGO class at day 90 was asso-
ciated with the renal and non-renal components of SOFA score at 
admission, respectively, RR  =  1.44 (IC95 (1.19–1.74); p  =  0.0002) 
and RR = 1.08 (IC95 (1–1.17); p = 0.0469). Additional use of nephro-
toxic drugs was not associated with renal outcome (for iodide 
contrast media in the week preceeding treatment RR = 0.92 (IC95 
(0.42–2.02); p = 0.84), for iodide contrast media at day of treatment 
RR =  1.04 (IC 95 (0.40–2.73); p =  0.93), for vancomycin RR =  1.31 
(IC95 (0.41–4.29); p = 0.65), for calcineurin inhibitors RR = 0.90 (IC 
95 (0.32–2.53); p = 0.84).
Discussion In our study, following guidelines, 75 % of patients had a 
peak concentration of AMK above minimal concentration targets. AMK 
was used, regardless of kidney function at the time of the first dose. 
AKI class at day 90 was associated with initial intensity of extra-renal 
failures and kidney injury but not with the peak concentration of ami-
kacin. The small number of patients enrolled and the high number of 
early death limit the power of our study.
Conclusion High-dose short-course once-daily regimen for treatment 
with AMK reaches the peak concentration target and may not worsen 
renal recovery at day 90.
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Introduction In SEPSISPAM study, targeting a mean arterial pressure 
(MAP) of 80–85 mmHg in septic shock patients did not improve mor-
tality compared to a lower target of 65–70 mmHg. However, the MAP 
that should be targeted to prevent organ dysfunction during septic 
shock may depend on patient medical history. The aim of the present 
analysis was to determine the MAP target for a specific patient profile, 
during septic shock resuscitation.
Patients and methods Six hundred and seventy-four of the 776 
patients from SEPSISPAM prospective cohort were analyzed in per pro-
tocol, excluding patients with major protocol deviation (target pres-
sure not reached because the vasopressor treatment was not adjusted; 
no septic shock) and patients for whom a decision not to resuscitate 
was taken after the inclusion.
Results The per-protocol analysis confirmed the intention-to-treat analy-
sis, with no significant difference in mortality between the two groups at 
day 28 and day 90. Chronic hypertensive patients resuscitated with a low-
MAP target had a significantly increased risk of doubling of plasma cre-
atinine (HR 2.14, p = 0.01). Hypertensive patients without acute kidney 
injury at admission had a lower risk of doubling of creatinine (p = 0.01) 
when they were resuscitated with a high-target MAP compared to those 
in low-target group. Conversely, in patients with already installed acute 
kidney injury at inclusion, a high-target MAP was not associated with a 
better renal outcome as compared to the low-MAP target.
Discussion The MAP that should be targeted in patients with septic 
shock is still matter of debate. The main issue is probably that the opti-
mal MAP target differs among patients, according to his/her medical 
history, and this is the point we specifically examined in the present 
analysis. When acute kidney injury is already installed, increasing MAP 
target might be detrimental due to increased vasopressor load, which 
in turn may increase adverse events and especially cardiac side effects.
Conclusion Chronic hypertensive patients without acute kidney injury 
at admission benefit from resuscitation with high-MAP target during 
septic shock. Instead, when acute kidney injury is diagnosed, increas-
ing MAP target might be detrimental.
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Introduction Critically ill patients routinely require temporary dialy-
sis catheters (DCs) for renal replacement therapy (RRT). They carry a 
high risk of developing end-stage renal disease. Though, their vascu-
lar accesses must be preserved. Guidewire exchange (GWE) is often 
used to avoid venipuncture at new site. However, the impact of GWE 
on infection and dysfunction of DC in ICU has never been studied. 
The aim of this study was to compare the effect GWE and venipunc-
ture insertion (VPI) strategies on DC colonization and dysfunction in 
patients requiring DC placement.
Patients and methods Using data from the ELVIS RCT (1496 critically 
ill adults requiring DC for RRT or plasma exchange), we performed a 
matched-cohort analysis with replacement. Cases were DCs inserted 
by GWE (N = 178) (only the first DC inserted by GWE was taken into 
account in patients with multiple GWE-DC placements), were matched 
with DCs inserted by VPI. Matching criteria were participating center, 
SAPS II ± 10, insertion site (jugular or femoral), side for jugular site, and 
duration between ICU admission and DC placement. DC colonization 
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was defined by a quantitative DC-tip culture yielding ≥1000 CFU/mL 
with vortexing and ≥100 CFU/mL with sonication. DC dysfunction was 
defined as DC removal as a result of inadequate catheter flow despite 
attempts to restore DC patency.
A sensitivity analysis was performed on the specific subgroup of 
patients with a DC changed because of dysfunction of the previous one.
We used a marginal Cox model to estimate the effect of DC insertion 
(GWE vs VPI) on DC colonization and dysfunction.
Results GWE-DC were not different from their matched NSP-DC 
for SAPS II [66 (53–84)] and rate of internal jugular catheters (25  %). 
However, GWE patients had longer median ICU length of stay (19 
vs. 17  days; P  =  0.004) and median hospital length of stay (37.5 vs. 
31  days; P  <  0.01). DC colonization rate was not different between 
DC-GWX and DC NSP (10 (5.6 %) vs 10 (6.7 %); hazard ratio (HR) 4.11 
[0.14–122.32]; P = 0.41), but DC dysfunction was more frequent with 
DC-GWX (67 (37.6  %) vs 21 (14  %); HR, 3.56 [1.66–7.63]; P  <  0.001). 
Result was similar if analysis was restricted to DC changed for dysfunc-
tion. DC-associated bloodstream infection was observed in 2 GWE-DC 
and in 1 VPI-DC patients.
Conclusion In ICU patients, as compared to VPI, GWE of DCs did not 
contribute to DC colonization infection but was associated with a 
more than twofold increase in DC dysfunction.
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Introduction Restricting intravenous chloride administration in ICU 
patients decreased the incidence of acute kidney injury (AKI). Chloride 
may alter renal function by inducing vasoconstriction of renal afferent 
arterioles and cortical hypoperfusion. Also, tubular dysfunction may 
occur because of increased chloride delivery to the distal tube. There 
were no data on the effects of chloride balance on renal function on 
survivors from cardiac arrest (CA).
Aim: To investigate whether chloride serum and urinary levels as well 
as chloride load, balance and the anion urinary gap in the first day 
since admission are associated with the development of AKI among 
CA survivors.
Materials and methods Retrospective analysis of an institutional 
database including all adult comatose patients admitted to the 
Intensive Care Unit (ICU) after CA from January 2007 to December 
2014. Inclusion criteria were as follows: age ≥18; non-traumatic 
arrest; complete data available on serum and urinary samples for at 
least 3  days; survival ≥72  h after admission. Patients with previous 
AKI and with anuria on ICU admission and on chronic haemodialy-
sis were excluded. Demographics, CA-related findings and outcome 
information were included in the database. We collected chloride 
levels on daily blood (BCl) and urinary (UCl) analyses; chloride load 
(CL) was calculated by considering the amount of chloride present 
in the IV fluids administered daily to the patient, while chloride bal-
ance (CB) was calculated as: CL–CO, where CO is chloride output 
(UCl × daily urine output). Creatinine clearance (CrCl) was calculated 
on 24-h urinary collection. AKI was defined according to standard 
criteria.
Results Of the 404 eligible patients, 102 met the inclusion criteria 
and were eventually analysed. Median age was 58 [49–74] years, and 
3 S91 Postpartum acute renal failure: a multicenter study of risk factors in 
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75 (70  %) were male. Median time to ROSC was 15 [9–25] min, and 
46 (45 %) had a non-shockable initial rhythm. ICU mortality was 29 % 
(n = 30). Forty-three patients (42 %) developed AKI, after a median of 2 
[2–4] days since admission; 13 of them (13 %) also needed continuous 
renal replacement therapy. Patients with AKI had similar serum creati-
nine on admission and 24-h fluid balance than others; however, 24-h 
urine output (1111 [448–1870] vs. 2130 [1125–2775] mL, p =  0.004) 
and CrCl (21 [11–44] vs. 104 [71–143] mL/min; p < 0.001) were lower 
in AKI patients than those without AKI. Although the initial BCl (102 
[100–104] vs. 104 [101–107] mEq/L) and CL (341 [160–504] vs. 315 
[201–436]) were similar between groups, patients with AKI had a lower 
UCl (66 [33–95] vs. 106 [61–138] mEq/L; p =  0.001) and CO (62 [11–
125] vs. 177 [96–244] mEq; p < 0.001) than patients without AKI. This 
resulted in a higher CB (221 [68–462] vs. 125 [6–296] mEq; p = 0.02) 
and a trend towards higher AUG (45 [32–66] vs. 37 [24–54]; p = 0.16) in 
AKI patients when compared to others.
Conclusion After CA, AKI occurred in 40 % of patients and was associ-
ated with a significant alteration in renal chloride elimination, already 
during the first day. The pathological role of chloride and the impact 
of such findings on the management of fluid therapy in this setting 
remain to be further evaluated.
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Introduction Regional citrate anticoagulation (RCA) is one of the 
recommended procedures for extracorporeal circuit anticoagulation 
during renal replacement therapy (RRT) in intensive care unit (ICU), 
especially for high-bleeding risk patients. In liver failure, citrate metab-
olism is impaired with the risk of citrate accumulation. Total calcium/
ionized calcium ((Catot)/(Caion)) ratio is considered as a reliable sign 
of citrate overdose when greater than a 2.5 threshold. The aim of this 
study is to evaluate the security of RCA with a sustained low-efficiency 
dialysis (SLED) method on ICU patients with liver failure.
Materials and methods In this retrospective study, we collected data 
from all consecutive patients with acute liver failure or cirrhosis who 
required RRT on the hospitalization report from January 2014 to June 
2015. All patients characteristics, severity score, and model of end-stage 
liver disease score (MELD score) were recorded. In addition to blood gas 
analysis, we measured total calcium and ionized calcium in serum at base-
line and after each SLED run. The need of catecholamine and their doses 
are also recorded. For all SLED treatments, a blood flow (QB) of 150 mL/
min and a dialysate flow (QD) of 300 mL/min were applied. Sodium con-
ductance was set to 150  mmol/L and bicarbonate to 35  mmol/L. Each 
run lasted 6 to 12 h. Sodium citrate and calcium chloride infusion was set 
according to a homemade protocol. The SLED run efficacy was evaluated 
by the online KT/V data delivered by the dialysis system.
Results A total of 41 patients who benefited from 104 RRT sessions are 
extracted from the database. Sixty-seven runs are exploitable due to 
lack of information for other runs. Nine patients (22 %) had cirrhosis, 
and 32 patients (78 %) had an acute liver failure. The simplified acute 
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physiology score (SAPS II) is 71 [58–87]. Patients’ MELD score is 27 
[18.8–42]. None of the runs have thrombotic issue. There is no need of 
blood transfusion during RRT or 24 h after RRT. Noradrenaline infusion 
is not statistically different before and after the runs (0.8 mg/h [0–3] vs 
0.7 mg/h [0–4.3], p = 0.80). None of the (Catot)/(Caion) ratio is greater 
than the 2.5 threshold. pH level is significantly higher at the end of the 
runs 7.22 [7.10–7.32] vs 7.34 [7.24–7.40], p < 0.001. The mortality rate 
is 77.8 % and 81 %, respectively, for patients with cirrhosis and acute 
liver failure.
Discussion Despite retrospective limitations of our study and low 
number of patients, RRT using SLED method with RCA appears to be 
safe in patients with severely impaired liver function. The efficacy, eval-
uated KT/V value is 0.88 [0.7–1] instead of 1.2–1.4 according to consen-
sus, but it remains a secondary endpoint in these severely ill patients. 
Although there are no clinical complications and no indirect citrate 
overdose sign when using citrate on liver failure patients, there is no 
evaluation of the total amount of citrate infused to these patients with 
our SLED protocol.
Conclusion This study suggests that using RCA with SLED is safe for 
patients with acute liver failure or cirrhosis in ICU, who need RRT.
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Introduction Patients hospitalized in intensive care unit (ICU) for sep-
tic shock have an increased risk to develop acute renal failure (ARF). 
A quarter of the patients developing ARF during septic shock will 
require a renal replacement therapy (RRT). The best delay to start 
RRT is a matter of debate. Starting too early can expose the patient 
unnecessarily to adverse event, while a proportion of those patients 
will restore spontaneously their renal function. Conversely starting too 
late the RRT exposes the patient to potential metabolic life-threaten-
ing complications. The French guidelines consider that starting RRT 
48  h after the patient reached the KDIGO 3 level is late and starting 
RRT at the KDIGO 2 level is early. Therefore, if we could predict that 
a patient will not progress from a KDIGO level ≤2 toward the KDIGO 
3 level we would be able to discriminate the population that should 
not benefit of an early RRT. A new urine test, the Nephrocheck™ has 
been validated. It corresponds to the urine concentration product of 
2 tubular suffering markers (TIMP2 and IGFBP7) associated with a risk 
of developing an ARF within 12 h. The aim of our study was to analyze 
the capacity of the Nephrocheck™ to predict the absence of evolution 
toward the AKIN level 3 in a population of patients hospitalized for a 
septic shock who present an ARF AKIN 1 or 2.
Patients and methods This was a prospective study. Every patient 
admitted for a septic shock in our 16 beds medical ICU who pre-
sented an ARF AKIN 1 or 2 within the first 12  h following the start 
of catecholamines was included. Exclusions criteria were thera-
peutic limitations, preterminal chronic renal failure (GFR  <  15  ml/
min) or chronic dialysis, anuria, patients without ARF (AKIN 0) or 
with too severe ARF (AKIN 3). Nephrocheck™ urine assay was per-
formed at baseline (H0) and H12. Clinical and biological parameters 
(including AKIN staging) were collected at H0, H6, H12 and H24. The 
performance of the Nephrocheck™ to predict the absence of evolu-
tion toward the AKIN 3 level within the first 24 h was tested for the 
baseline measurement and for the evolution of the Nephrocheck™ 
between baseline and H12 (delta H0–H12).
Results Fifty patients were included between May 2014 and Sep-
tember 2015. The median (95 % CI) age was 63 (60–66) years old, 31 
(62 %) males and SAPSII 55 (50–61). The lung was the origin of sep-
sis in 70  % of cases. At baseline (H0), the median arterial pressure 
was 73 (67–78) mmHg, the median posology of noradrenaline 0.31 
(0.26–0.44) μg/kg/min, the median of fluid volume administered 15 
(9–20) ml/kg, median urine output 0.57 (0.4–0.8) ml/kg/h, median 
creatininemia 108 (89–144) μmol/l and lactate 2.6 (2.1–3.3) mmol/l. 
At baseline 36 (72  %) were classified AKIN 1 and 14 (28  %) AKIN 2. 
Between H0 and H12, 1 patient died and 7 patients developed 
anuria. At the end of the following (24  h after baseline), 14 (28  %) 
patients had developed an AKIN 3 level ARF (group AKIN =  3) and 
36 patients did not reached this level (AKIN < 3). At H0, the urine out-
put was significantly different between the two groups of patients 
AKIN  <  3 versus AKIN  =  3 (respectively 0.71 (0.4–1.5) versus 0.35 
(0.1–0.6) ml/kg/h; p =  0.016). There was no difference between the 
2 groups for the other variables at baseline. The Nephrocheck™ 
was significantly different between the two groups at H0 (AKIN < 3 
versus AKIN  =  3, respectively, 0.94 (0.3–2.1) versus 5.96 (2.5–11.6); 
p = 0.001) and at H12 (0.45 (0.2–1.5) versus 3.6 (1.1–9.7); p = 0.01). 
The median delta H0-H12 was not significantly different between 
the groups (−21 % (−66 to 150) versus −9 % (−61 to 57); p = 0.9). 
A Nephrocheck™ at H0  ≤  2.1 predict the absence of progression 
toward AKIN = 3 with a sensibility of 86 % and a specificity of 78 %. 
A urine output at baseline >0.37 ml/kg/h predict the absence of pro-
gression toward AKIN = 3 with a sensitivity of 57 % and a specificity 
of 75 %. The area under the ROC curve of Nephrocheck at H0 (0.833 
(0.701–0.924)) was not significantly higher than the baseline urine 
output (0.684 (0.537–0.808); p = 0.09).
Conclusion The Nephrocheck™ and the urine output at admission 
appear reliable to predict the absence of progression from AKIN 1 or 2 
toward the AKIN 3 level within 24 h of patients hospitalized in ICU for 
a septic shock. In contrast baseline creatinine and delta Nephrocheck™ 
between baseline and H12 are not discriminating. Whether or not the 
Nephrocheck™ can help to avoid futile RRT in this population remains 
to be determined.
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Introduction Thrombocytopenia is the most common hemostatic dis-
order in the intensive care unit (ICU). It has been shown to be globally 
associated with a poor prognosis in ICU patients. However, no study 
has specifically investigated the impact of early thrombocytopenia in 
patients with septic shock.
We aimed to investigate the impact of nadir platelet count within the 
first 24  h after initiation of noradrenaline on the risk of death within 
the 28 days following the onset of septic shock.
Patients and methods We conducted a prospective, multicenter, 
observational cohort study. Consecutive adult patients with septic 
shock admitted in fourteen ICUs from 10 French university teaching 
and non-academic hospitals between November 2009 and September 
2011 were eligible.
Thrombocytopenia was defined as a platelet count ≤150,000/mm3. 
We considered thrombocytopenic patients in 4 groups: platelet count 
<50,000/mm3 or [50,000–100,000]/mm3 or [100,000–150,000]/mm3 
or >150,000/mm3. Patients were compared according to their platelet 
count using appropriate bivariate tests. Variables associated with the 
platelet count with a p value <0.25 by bivariate analyses were included 
in a multivariate polytomic logistic regression to estimate their inde-
pendent effect on platelet count. The probability of death at 28 days 
was estimated using the Kaplan–Meier method and compared using 
the log-rank test. Multivariate analyses were performed using Cox’s 
proportional hazards model.
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Results Among 1495 eligible patients, 1486 (99.4  %) were included. 
SAPSII score ≥56, immunosuppression, age >65  years, cirrhosis, bac-
teraemia (p ≤ 0.001 for each) and urinary sepsis (p = 0.005) were glob-
ally associated with an increased risk of thrombocytopenia within the 
first 24 h following the onset of septic shock.
Survival at 28 days estimated by the Kaplan–Meier method was lower 
in patients with thrombocytopenia and decreased with thrombo-
cytopenia severity. By multivariate Cox regression, a platelet count 
≤100,000/mm3 was independently associated with a significant 
increase in the risk of death within the 28 days following septic shock 
onset. The risk of death increased with the severity of thrombocyto-
penia [hazard ratio 1.65 95 % CI 1.31–2.08 for a platelet count below 
50,000/mm3 vs >150,000/mm3 (p ˂ 0.0001)].
Discussion This is the first study to investigate thrombocytopenia 
within the first 24  h of septic shock onset as a prognostic marker of 
survival at day 28 in a large cohort of ICU patients. The increased mor-
tality in septic thrombocytopenic patients deserves closer investiga-
tion. Current data suggest that it could be explained by the role of 
platelets in endothelial dysfunction and microthrombotic events lead-
ing to multiple organ dysfunction, and by a more direct pathway, since 
platelets can be considered as immune cells. Measuring platelet count 
is inexpensive and easily feasible for the physician in routine practice 
and thus could represent an easy “alert system” among patients in sep-
tic shock.
Conclusion This study shows that a platelet count <100,000/mm3 dur-
ing the first day after onset of septic shock is associated with a signifi-
cantly increased risk of death at day 28.
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Introduction Critically ill patients present alterations of fibrinolysis, 
especially in the context of sepsis, and these alterations are associ-
ated with poor outcome. Euglobulin clot lysis time (ECLT) is the most 
commonly used test to estimate plasma fibrinolytic capacity and was 
correlated with organ dysfunction and C-reactive protein (CRP) levels 
in pilot studies. Our primary outcome was to study the correlation of 
ECLT with mortality in a large heterogeneous cohort of intensive care 
unit (ICU) patients. Our secondary objectives were to study the rela-
tionship of ECLT with organ dysfunction and inflammation.
Patients and methods After approval by the local ethical commit-
tee, we included patients with a predicted ICU length of stay of 48 h. 
Exclusion criteria were transfusion of any blood product in the 48  h 
before inclusion, any known hemato-oncologic disorder, extracorpor-
eal circulation, hemodia-filtration, burns, pregnancy and admission 
for thrombolysis. We assessed ECLT using a completely computerized, 
semi-automatic, 8-channel device (Lysis Timer, EREM, Belgium—refer-
ence values: 208 min for men and 117 min for women).
Fibrinolysis assessed by ECLT was correlated with ICU length of stay, 
ICU- and day-28 mortality. Organ dysfunction was assessed by the 
sequential organ failure assessment (SOFA) score, and inflammation 
was evaluated by measuring CRP concentrations. We used the Mann–
Whitney nonparametric test to compare groups and the Spearman 
test for correlations. P values above 0.05 were considered statistically 
significant. Results are expressed as median ± interquartile ranges.
Results We included 121 patients with (n  =  54) or without sepsis 
(n =  67) during the first 24  h of ICU stay. The admission SOFA score 
for all patients was 4 [2–7], and ICU- and day-28 mortality were 16 and 
20 %, respectively. CRP level was 6.7 [2.2–18.6] mg/dl. Admission ECLT 
was 796 [488–1276] minutes in the whole cohort. Admission fibrinoly-
sis was altered in septic as compared to non-septic patients: 1107 
[588–1504] versus 628 [474–1130] minutes (p = 0.007). ECLT not cor-
related with mortality or organ dysfunction but positively correlated 
with the ICU length of stay (R = 0.55, p < 0.0001). ECLT positively cor-
related with CRP in all patients (R = 0.39, p < 0.0001) and in the sep-
tic group (R = 0.34, p = 0.02) but not in non-septic patients (R = 0.17, 
p = 0.2).
Discussion We confirm that fibrinolysis assessed by ECLT is altered 
in critically ill patients, and this alteration is more pronounced in 
septic patients. ECLT does not correlate with mortality or organ dys-
function in our study, which could be due to low mortality rate and 
severity score of included patients. ECLT does, however, correlate with 
ICU length of stay. Interestingly, fibrinolysis impairment correlates 
with CRP levels. This relationship could be part of the link between 
inflammation and coagulation in critically ill patients, as suggested by 
murine and in vitro data. Indeed, specific effects of CRP on the fibrino-
lytic system were reported, including increased expression of the 
plasminogen activator inhibitor type 1 gene and decreased activity of 
tissue plasminogen activator.
Conclusion ECLT correlates with ICU length of stay but not with mor-
tality or organ dysfunction. Fibrinolysis impairment correlates with 
CRP, which is a basis for further pathophysiological investigations on 
the link between inflammation and coagulation.
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Introduction Inadequate stratification of septic shock patients may 
result in inappropriate treatment allocation in randomised clinical tri-
als (RCTs), especially regarding anticoagulants. We previously reported 
that endothelial-derived microparticles (MPs) are relevant biomarkers 
of sepsis-induced disseminated intravascular coagulation (DIC). In this 
validation cohort, we assessed MPs as surrogates of cell activation to 
improve early DIC diagnosis and patient stratification.
Patients and methods This is a prospective observational study in 
septic shock patients in four French medical intensive care units. Two 
hundred and eighty-five patients with septic shock were consecutively 
enrolled. DIC was diagnosed according to JAAM 2006 score. Endothe-
lial (CD105-MPs and CD31-MPs) and leucocyte-derived (CD11a-MPs) 
circulating procoagulant MPs were isolated and quantified by pro-
thrombinase assay on admission (D1), D3 and D7. Clinicaltrial.gov 
identifier NCT #02391792.
Results Two hundred and fifty-nine patients were analysed. Sixty-one 
had DIC on admission (DIC-D1), and 32 developed DIC during the first 
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24  h after admission (DIC-D2). These later patients were seriously ill 
with mortality as high as DIC-D1 patients. Multiple logistic regression 
model confirmed that endothelial cell-derived MPs were associated 
with DIC: CD105+-MPs (OR 2.13) and CD31+-MPs (OR 0.65) (p < 0.05). 
Furthermore, CD11a+-MPs to leucocyte ratio evidenced leucocyte 
activation (OR 1.59, p < 0.05). Prediction of DIC was also analysed after 
exclusion of DIC-D1 patients. A new multiple logistic regression analy-
sis demonstrated the association of CD105 + -MPs (>0.60 nM eq. Phtd-
Ser, OR 1.67, p < 0.01), platelets count (≤127 G/L, OR 0.99, p < 0.01) and 
prothrombin time (≤58  %, OR 0.98, p  <  0.05) with DIC. A combining 
score on admission is predictive of the absence of DIC. The predictive 
equation was:
with [CD105+-MPs] in nM eq. PhtdSer, [Plt] in G/L and [PT] in per-
centage ( %). The area under curve was 72.9 % with 95 % CI [66.2–78.9] 
(p < 0.001). Cut-off was –1.231 with a specificity of 71.2 % [63.7–77.9], 
a sensitivity of 71.0 % [52.0–85.8], a negative predictive value of 93.1 % 
[72.5–99.6] and a positive predictive value of 31.0 % [7.9–64.5].
Discussion DIC remains a challenge for many clinicians and biologists. 
Since coagulation constitutes a first line of defence in sepsis, accu-
rate DIC diagnosis is essential to distinguish an appropriate patient 
to treat with an appropriate treatment at the right moment. DIC can 
be efficiently diagnosed on admission with JAAM 2006 score. Among 
patients who had not developed patent DIC on admission (JAAM < 4), 
some would present a so-called preDIC state retrospectively diag-
nosed during the following hours (JAAM  ≥  4). Early recognition of 
patients who will not develop DIC with a new score would be a valua-
ble tool to avoid inappropriate antithrombin or thrombomodulin ther-
apy. In our study, they represented about one-third of all DIC patients. 
ISTH “non-overt” score is not useful for DIC prediction as assessed by 
our false-positive and false-negative results. Non-overt DIC (according 
to ISTH) and non-patent DIC on admission (DIC-D2) may represent two 
different states of coagulopathy.
Conclusion Procoagulant MPs from endothelial cells and leucocytes 
reflect a vascular injury during sepsis-induced DIC that precedes obvi-
ous activation of coagulation. A combination of prothrombin time, 
endothelium-derived CD105+-MPs and platelet count on admission 
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Introduction Septic shock is associated with activation/dysregula-
tion of blood coagulation, but assessment of this (unbalanced) adap-
tive response is still matter of debate and a clinical challenge. Despite 
experimental proof-of-concept, anticoagulant treatments failed to 
improve survival in large, randomised, placebo-control trials. Regard-
ing coagulation, the inadequate stratification of septic shock patients 
preDIC = 1.342+ (0.515× [CD105+-MPs])
− (0.012× [Plt])− (0.018× [PT])
could, at least in part, explain these negative results. This study was 
designed to evaluate haemostasis activation/dysregulation using rou-
tine and non-routine tests eventually combined according to DIC scor-
ing systems.
Patients and methods Two hundred and sixty-five patients with 
septic shock were included in 3 medical intensive care units. Platelet 
count, prothrombin time, activated partial prothrombin time, fibrino-
gen, D-dimers, fibrin monomers, antithrombin, protein C and pro-
thrombin fragments 1 + 2 were measured at admission.
Results DIC was present in 102/265 patients according to JAAM score. 
ISTH ‘overt’ and ‘non-overt’ scores allowed to diagnose 90 DIC and 88 
pre-DIC, respectively, with a relative accordance between scores (k 
values were 0.78 (JAAM/‘overt’) and 0.70 (JAAM/‘non-overt’). DIC diag-
nosis was associated with mortality when JAAM score was ≥5 points 
(HR 0.53 [0.30–0.75], p = 0.006). Patients were thereafter allocated to 3 
groups according to their JAAM score as follows: 1–2 points (minimal, 
n = 128), 3–4 (intermediate, n = 54) and 5–8 (patent, n = 83). Patients 
in the third group were more severely ill (SAPS2 and SOFA) with higher 
28-day mortality, impaired fibrin formation and decreased inhibitors.
Fibrinogen, FV, AT, PC and FM (not included in JAAM score) were not 
associated with DIC diagnosis in multiple logistic regression analy-
sis. Nevertheless, abnormal values were frequently observed in sep-
tic shock patients regardless of DIC diagnosis: 56.2  % for AT (47.2  % 
and 70.6 % for non-DIC and DIC patients, respectively), 73.6 % for PC 
(63.8 and 92.2 %) and 65.3 % for FM (63.8 and 67.6 %). Fibrinogen was 
elevated (above 4 g/L) in 73.6 % of patients (84.0 and 56.9 %, respec-
tively). A low fibrinogen (<1  g/L—ISTH ‘overt’ cut-off) was present in 
seven patients (2.6 %), all of whom were diagnosed with DIC according 
to JAAM, ISTH ‘overt’ and ‘non-overt’ scores. Generated thrombin (eval-
uated by prothrombin fragments 1 + 2) was elevated in two-thirds of 
the patients regardless the occurrence of DIC.
Discussion Physiology could explain why clinical trials, aiming at 
down-regulating thrombin generation, have been unsuccessful: 
thrombin is fundamental for survival during septic shock; it has mul-
tiple cellular and extracellular effects and may not be considered 
as a ‘murderer’ during septic shock. Excessive thrombin generation 
appears to play a different role in patients with or without DIC, and the 
lack of soluble fibrin monomers polymerization could be one. Fibrin 
polymerisation requires an activated transglutamase (FXIIIa) to bridge 
soluble FM. Delayed platelet activation may explain the impairment in 
fibrin formation reported in DIC.
Interestingly, moderate thrombophilia, characterised by recurrent 
thrombosis, may favour survival during septic shock. Indeed, patients 
with aPC resistance (FVR506Q) had a better outcome. On the other 
hand, genetic (FVIII or FIX deficiencies) or drug-induced (vitamin 
K-antagonists) haemorrhagic diathesis failed to protect against experi-
mental septic shock and death. Until now, anticoagulant treatment 
favoured survival in septic shock only when DIC was established. A 
better assessment of DIC may improve clinical trial design as well as 
patient survival.
Conclusion Low-grade activation of haemostasis assessed by JAAM 
score less than 5 could favour survival during septic shock. Only a 
rigorous scoring system may help clinicians to target the ‘good treat-
ments for the good patients’.
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Introduction During septic shock a life-threatening circulatory failure 
develops with inadequate tissue perfusion and vasoplegia. In this con-
text, early development of arterial high blood pressure after weaning 
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adrenergic vasopressors seems paradoxical. Regularly observed in our 
ICU, this phenomenon has not been described yet in the literature.
Patients and methods We conducted a descriptive, retrospective, 
single institution study to authenticate the existence of this empirical 
observation, specify its incidence, identify associated factors and pos-
sibly document a survival marker.
Results Two hundred and sixty-two septic shock patients were 
included. The median age was 66 years (56–76), and median SOFA and 
IGS II scores were 10 (8–12) and 53 (39–77), respectively. The mortality 
calculated after exclusion of patients that underwent early life support 
therapy limitation was 28.7 % at day 30 (n = 58) and 33.1 % at day 90 
(n = 62). Comparative analysis concerned 195 patients who survived 
to vasopressors weaning. Among them, 22  % (n  =  43) received an 
early antihypertensive therapy within the 24 h following vasopressors 
weaning. Patients who received an early antihypertensive treatment 
after vasopressors weaning did not differ significantly in terms of age, 
severity scores, past history of high blood pressure or antihyperten-
sive medication, chronic renal insufficiency, endocrinopathy, source of 
infection, volume resuscitation, weight gain during ICU stay, biological 
findings, or of norepinephrine treatment duration and maximum dose. 
In univariate analysis, patients with early antihypertensive therapy 
after vasopressors weaning presented more frequently gram-negative 
infection (33.6  %, n =  14 vs 23.2  %, n =  35; p  <  0.001) and received 
more frequently dobutamine (13.9 %, n = 6 vs 5.8 %, n = 9; p = 0.006), 
hydrocortisone opotherapy (55.8 %, n = 24 vs 45.9 %, n = 70; p = 0.02) 
and renal replacement therapy (25.6  %, n  =  11 vs 15.3  %, n  =  23; 
p  =  0.06). In multivariate analysis, predictive factors for developing 
early high blood pressure were past history of ischemic heart disorder 
(p = 0.001) and support by mechanical ventilation (p = 0.01). Neces-
sity of starting an early antihypertensive treatment after vasopres-
sors weaning was associated with a better survival at day 30: 94.5 % 
(n = 35/37) vs 82.5 % (n = 113/137), p < 0.001. In multivariate analysis, 
early high blood pressure development was predictive of survival at 
day 30 (OR 0.03, p = 0.03) whereas underlying rhythmic heart disorder 
seemed predictive of increased mortality (OR 24, p = 0.03).
Discussion Our results suggest that the development of an arterial 
high blood pressure within 24  h following norepinephrine weaning 
is a frequent phenomenon affecting nearly a quarter of patients who 
survived the phase of initial resuscitation. The studied population was 
comparable to that of the recent studies about septic shock. General 
characteristics did not appear to be related with the arising of this 
event. Initial management (doses and modalities of norepinephrine 
and fluid resuscitation) did not seem to be involved either. The role of 
an underlying rhythmic or ischemic heart disorders could influence 
different load adaptation. Association with a favorable survival out-
come at day 30 is limited but could reflect more advanced correction 
of tissue perfusion abnormalities at norepinephrine weaning time in 
patients requiring an early antihypertensive therapy.
Conclusion Development of an arterial high blood pressure within 
24  h following vasopressors weaning in septic shock is a frequent 
event. It could be a protective marker regarding mortality at day 30 
for patients who survived to vasopressors weaning. Physiopathologi-
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Introduction In large-scale trials, endotracheal intubation (EI) associ-
ated with mechanical ventilation is performed in 40–85 % of patients 
with septic shock possibly indicating an important variation in practice 
across physicians. No study has been dedicated until now to define the 
place of this procedure in shock patients, and recent guidelines does 
not put forward any recommendation. The objective of the study was 
to determine the characteristics associated with endotracheal intuba-
tion in septic shock patients.
Patients and methods This is a post hoc analysis of the database of 
the SEPSISPAM study, including patients with septic shock.
Results Among the 776 SEPSISPAM patients, 633 (82  %) were intu-
bated within 12  h of study inclusion (early intubation), 113 (15  %) 
were never intubated, and 30 (4  %) had delayed intubation. ICUs 
with at least 10 patients included were classified according to fre-
quency of early intubation: early intubation <80 % of patients (low-
est frequency: 7 ICUs, 254 patients), 80–90  % (middle frequency: 5 
ICUs, 170 patients), >90 % (highest frequency: 6 ICUs, 297 patients). 
Type of ICU, pulmonary infection, lactate >2 mmol/l, lower PaO2/FiO2 
ratio and absence of immunosuppression were independently asso-
ciated with early intubation. Patients never intubated had a lower 
initial severity, less frequent pulmonary source of infection, were 
more likely to have immunosuppression, lower ICU and hospital 
length of stay and a low mortality rate. In comparison with patients 
intubated early, patients with delayed intubation had fewer days 
alive without organ support by day 28. Early EI varied from 56 to 
100 % across ICUs. ICUs with the highest frequency of early intuba-
tion had a higher mortality rate in comparison with ICUs with middle 
frequency of early intubation. A nonsignificant increase in mortality 
was observed in ICU with lowest frequency of early intubation. No 
statistical difference was observed between the 3 types of ICU for 
university status, medical/surgical admission, number of beds per 
ICU and senior physician presence (Fig. 51).
Conclusion We observed a wide variation of early EI practice across 
centers independent from acute severity parameters and presence 
of immunosuppression. Our result suggests that practices regarding 
endotracheal intubation in septic shock may impact outcome, which 
opens the way for future studies.
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Introduction Fluid overload in septic intensive care unit patients is 
common, and recent studies have demonstrated that it is strongly 
associated with a poor outcome. In fact, we think that fluid overload 
is mainly the reflection of the intensity of capillary leak. Capillary leak 
is a determining factor of shock in sepsis, leading to hypovolemia 
and microcirculation alteration. Thus, hypovolemia and edema are 
the two faces of one pathophysiologic change in wall of microves-
sels, i.e., capillary permeability. Unfortunately, no treatment is capa-
ble of decreasing vascular permeability in sepsis at present. Fluid 
replacement appears to be a poor symptomatic treatment, com-
pensating only the leak flow and fueling formation of edema in the 
more elastic body tissues. Here, we propose an original therapeutic 
approach aiming to limit capillary leak in septic shock by means of 
total body contention. The principle of this method is to antagonize 
the distension of soft tissues of the trunk and limbs, which allows 
capillary fluid leak to continue. Subcutaneous tissue being by defini-
tion extensible (such as the cutaneous envelope), the volume they 
can “accept” can grow without a dramatic increase in pressure in the 
interstitial space. In this way, the pressure gradient stays favorable for 
the leak from vascular to interstitial compartments, despite the pres-
ence of edema. We hypothesize that capillary leak in septic shock 
can be quantitatively contained by limiting soft tissue extension at 
the onset of disease, using contention bandages on a large propor-
tion of the body surface. The objective of this study is to evaluate the 
efficiency, tolerance and feasibility of a new mechanistic treatment 
based on this hypothesis.
Patients and methods This is a phase II multicenter single-arm trial in 
critically ill, non-surgical septic patients receiving mechanical ventila-
tion. The study protocol was approved by an ethics committee (CPP). 
The therapeutic intervention is the application of contention band-
ages on more than 80 % of the body surface, initiated at the onset of 
septic shock. Contention is maintained until fluid balance is negative 
on two consecutive days. We chose inelastic, short-stretch bandages 
to apply limited interface pressure on an already poorly perfused skin. 
Primary outcome is neutral or negative net fluid balance on day 7 
(defined by a fluid balance ≤+500 cc). Secondary outcomes are cumu-
lative fluid balance, daily SOFA scores, death, duration of mechanical 
ventilation, occurrence of skin ulcers under bandages, reproducibil-
ity of interface pressure, monitoring of intra-abdominal pressure and 
monitoring of respiratory parameters correlated with chest wall com-
pliance such as plateau pressure and dynamic compliance. The design 
is a two-staged Simon’s plan, a methodology inspired by phase II 
cancer drug trials. Briefly, our primary outcome will be expressed as 
a response rate (  % of patients achieving a negative fluid balance at 
day 7) compared to existing data issued from a previous septic shock 
cohort recruited in our center. A sample size of 45 patients with avail-
able data at day 7 was calculated to demonstrate an increase in suc-
cess rate of 20 %, from 50 % (success rate of septic shock patients from 
our cohort) to 70 %.
Results The recruitment started on February 2015. We conducted a 
preliminary, intention-to-treat analysis with data issued from the first 
22 included patients. Median Simplified Acute Severity Score (SAPS 
II) and Sequential Organ Failure Assessment (SOFA) are 65 and 12, 
respectively. Eleven patients among the 16 (69 %) with available data 
at day 7 have a neutral or negative fluid balance. Cumulative fluid bal-
ance at day 4 is +5.9 L. Adverse events are limited for the time being 
to minor skin ulcers (stage I) in 4 patients (18 %), which did not require 
contention retrieval. Monitoring of abdominal pressure revealed a 
slight increase with contention (+2.5 mmHg), but no case of persistent 
abdominal hypertension is reported. Monitoring of airway pressure 
showed no significant increase in plateau pressure and dynamic com-
pliance difficulties with mechanical ventilation, and in our clinical 
experience there were no respiratory issues attributable to contention.
Conclusion The preliminary results of the COCOONs trial are encour-
aging, showing an increase in the percentage of patients with a neu-
tral or negative fluid balance at day 7 compared to a local cohort, 
despite higher severity scores in our patients. The cumulative fluid bal-
ance at day 4 is almost half of what was reported in a reference study 
(Boyd et al, 2011). The tolerance is excellent. If those results are con-
firmed, a randomized controlled study will be conducted.
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Introduction Mortality of patients resuscitated from cardiac arrest 
(CA) remains particularly high, mainly due to post-cardiac arrest syn-
drome and anoxic cerebral lesions. Veno-arterial extracorporeal mem-
brane oxygenation (VA-ECMO) is an effective technique to rescue 
patients with refractory cardiogenic shock (CS), which might benefit 
to some patients with refractory CS after CA. However, usefulness of 
VA-ECMO in refractory post-cardiac arrest syndrome is debated 
because most patients have profound vasoplegia, a condition in 
which VA-ECMO is ineffective. Furthermore, the unknown neurologi-
cal prognosis at the time of implantation strongly questions the use 
of such an invasive and expensive technique. We therefore conducted 
a retrospective study on patients who received VA-ECMO for refractory 
CS after CA to better describe the outcomes of such patients and to 
determine factors associated with poor outcome.
Patients and methods All patients who received VA-ECMO between 
March 2007 and January 2015 in our unit because of refractory CS after 
successfully resuscitated CA were included. Patients who received VA-
ECMO for refractory CA (E-CPR, ECMO under cardiopulmonary resus-
citation) were not included. Continuous variables were expressed as 
mean (SD) or median [IQR25–IQR75] and compared using the Student’s 
t test or Wilcoxon’s rank test. Categorical variables were compared with 
Chi square tests. Multivariable analysis using logistic regression analysis 
was used to determine independent predictors of mortality.
Results We included the 94 patients who received VA-ECMO for 
refractory CS after CA. Sex ratio (male/female) was 3/1, mean age 
was 50.8 (1.5) years, and median admission SAPS II score was 82 [78–
88]. CA was due to acute myocardial infarction in 66 patients (70 %), 
acute decompensation of chronic cardiomyopathy in 8 (8.5 %), pul-
monary embolism in 4 (4.3 %), drug intoxication in 3 (3.2 %), anaphy-
lactic shock in 3 (3.2 %), and miscellaneous causes in 10 (10.6 %). CA 
occurred out of hospital for 78 (83 %) patients, and ventricular fibril-
lation was the first rhythm in 56 (59.6 %). Median no-flow and low-
flow times were 0 [0–5] and 30 [15–42.75] min, respectively. Before 
VA-ECMO initiation, median left ventricle ejection fraction was 15 
[10–20] % and aortic velocity time integral (VTI) 7 [5–9] cm. Median 
time between cardiac arrest and VA-ECMO implantation was 7.4 
[3.3–14] hours, and median duration of ECMO support was 4 [2–6] 
days. Fifty-five (59  %) patients died, while on VA-ECMO, 33 (35.1  %) 
were successfully weaned, 4 (4.3 %) were bridged to a left ventricle 
assist device and 2 (2.1 %) to heart transplantation. 28-day, 6-month 
and 12-month survival rates were 29.8, 27.7 and 26.6 %, respectively. 
Causes of death were multiple organ failure (65.2  %), brain death 
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(16.7  %), postanoxic encephalopathy (13.6  %) and CA recurrence 
(4.5  %). The 25 survivors at 1-year had good neurological outcome 
(CPC 1). Univariable analysis retained serum lactate >11.5  mmol/L 
(OR 5.6, 95 % CI 2.1–15.2), prothrombin ratio <31 % (OR 7.1, 95 % CI 
2.4–20.9), admission SOFA score >14 (OR 9.1, 95 % CI 3.2–25.9), renal 
failure on admission (OR 8.6, 95 % CI 2.9–25.6), SAPS 2 score >82 (OR 
4.1, 95 % CI 1.5–10.9), ventricular fibrillation as first rhythm (OR 0.3, 
95 % CI 0.1–0.8) as factors associated with 28-day mortality. Accord-
ing to multivariable analysis, independent predictors of 28-day mor-
tality were serum lactate >11.5 (OR 3.3, 5 % CI 1.1–10.3), prothrombin 
ratio <31 % (OR 4.4, 95 % CI 1.3–14.5) and admission SOFA score >14 
(OR 4.2, 95 % CI 1.3–13.4).
Conclusion In this retrospective cohort of extremely severe patients 
who received VA-ECMO for refractory CS after resuscitated CA, sur-
vival with good neurological outcome was similar to that of CA 
patients who did not require ECMO support. Patients with multiple 
organ failures at the time of implantation had poorer outcomes, 
raising the question of futility in such patients. VA-ECMO should 
be considered as a rescue therapy in patients with refractory shock 
following resuscitated cardiac arrest. Further studies are, however, 
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Introduction High-risk pulmonary embolism (PE), requiring ICU 
admission, is associated with a high mortality rate. The potentiality for 
sudden and fatal hemodynamic deterioration needs early diagnostic 
and appropriate treatment. Veno-arterial extra-corporeal life sup-
port (ECLS) is useful for the management of obstructive shock. The 
aim of this study was to describe the outcome and management of 
patients treated with ECLS implantation for massive PE associated with 
obstructive shock or cardiac arrest in our university hospital.
Patients and methods This is a retrospective analysis of patients 
admitted to a medical ICU with massive PE and ECMO implantation.
Results From February 2009 to December 2014, 13 patients had 
implantation of ECLS for PE. The mean age was 41  year old, and 
there were mainly women (77  %). Six patients presented an extra 
hospital cardiac arrest, and 7 patients presented an obstructive 
shock. Three patients were still in cardiac arrest at ECLS implanta-
tion, and 2 patients presented a cardiac arrest during ECLS implan-
tation. Six patients had surgical thrombectomy only; 3 patients had 
thrombolysis only; 2 patients had thrombolysis followed by surgical 
thrombectomy; 2 patients had anticoagulation only. Mean dura-
tion of ECLS was 4  days. Global mortality was 54  % (7 patients) by 
cerebral anoxia (4 patients), hemorrhagic shock (2 patients) and 
stroke (1 patient). Only patients who had both ECLS and surgical 
thrombectomy survived.
Conclusion ECLS can be useful for the management of high gravity PE, 
but the mortality of these patients is still high. The appropriate timing 
of ECLS implantation for high gravity PE needs to be further evaluated. 
In clinical practice, the decision of ECLS implantation must be early 
discussed by a team including intensivist, surgeon and cardiologist.
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Introduction High-risk acute massive pulmonary embolism (PE), 
defined as pulmonary embolism with the presence of persistent hypo-
tension or shock, is a life-threatening condition, with very high mor-
tality. Reperfusion therapy with either systemic thrombolytic agents, 
surgical pulmonary embolectomy or percutaneous catheter-directed 
treatment is mandatory for these very severe patients. Because of con-
traindications or important clinical instability, a small group of these 
patients cannot have access to reperfusion therapies. In these cases, 
veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is 
one of the most reliable and quickest ways to decrease right ventricu-
lar overload, to improve hemodynamic status and to restore tissue 
oxygenation. We will describe herein our tertiary-care center experi-
ence in treating patients with acute massive high-risk PE who received 
VA-ECMO, and we will report their short- and long-term outcome.
Materials and methods We retrospectively collected demographic, 
admission severity scores, pre- and post-ECMO data, ECMO-related 
complications, and 90-day mortality of patients who received VA-
ECMO for high-risk acute PE in our 26-bed intensive care unit (ICU) 
from June 2006 to June 2015. Patients who survived were contacted in 
September 2015 and assessed for health-related quality of life, psycho-
logical and post-traumatic stress disorder status.
Results Seventeen patients [11 females, median age 51 (range 18–70), 
simplified acute physiology score II (SAPS II) 78 (45–95)] were placed 
on VA-ECMO for high-risk pulmonary embolism, with a median dura-
tion of ECMO support of 4 days (1–12). Fifteen patients (82 %) had pre-
ECMO cardiac arrest, with a low-flow time of 30 min (10–85), 7 of them 
(41  %) were cannulated during cardio-pulmonary resuscitation. Two 
other patients had been placed on ECMO for refractory cardiogenic 
shock. Eight patients (47 %) received thrombolysis before ECMO, and 4 
(24  %) were cannulated due to hemodynamic failure after percutane-
ous thromboaspiration or surgical pulmonary embolectomy. Pre-ECMO 
median values of mean blood pressure, pH, blood lactate were, respec-
tively, 42 mmHg (0–106), 6.99 (6.54–7.37) and 13 mmol/L (4–19). Major 
dilation of the right ventricle was noted in all patients; right ventricular/
left ventricular diameter ratio was 1.3 (0.7–1.6), and PE was diagnosed 
with chest CT scan in 12 (70 %) patients. 90-day mortality was 53 %. Fif-
teen patients (88 %) had severe hemorrhage during their ICU stay with 
no impact on survival. However, 90-day survivors exhibited a lower ino-
trope score 24 h after cannulation (p = 0.001), and a lower SOFA score at 
days 1 and 3. ICU and hospital length of stay of the survivors’ group were 
17 (7–91) and 45 (22–135) days, respectively. Lastly, compared with age- 
and sex-matched controls, our seven-responding high-risk PE survivors 
had significantly lower SF-36 physical domain scores and role emotional 
component (p < 0.001) 19 months (4–69) after ICU discharge.
Conclusion In this cohort of 17 high-risk PE patients, too unstable to 
tolerate at-risk thrombolytic interventions or who had failed first-line 
therapies, we observed that VA-ECMO can rapidly provide lifesaving 
hemodynamic support. Furthermore, we observed clot dissolution 
under conventional heparin therapy within a few days, questioning 
the benefit of additional therapies such as surgical thrombectomy or 
catheter-directed thromboaspiration in this setting.
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Page 215 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
S105 
Outcome of patient recused for extracorporeal membrane 
oxygenation for ARDS
Pierre‑Emmanuel Meynieu1, Benjamin Repusseau1, Virginie Perrier1, 
Arnaud Germain1, Antoine Dewitte1, Hadrien Roze1, Alexandre Ouattara1
1Réanimation polyvalente, service d’anesthésie réanimation 2, CHU de 
Bordeaux, Bordeaux, France 
Correspondence: Benjamin Repusseau ‑ benjamin.repusseau@gmail.
com 
Annals of Intensive Care 2016, 6(Suppl 1):S105
Introduction Extracorporeal membrane oxygenation (ECMO) is pro-
posed for patients suffering from severe acute respiratory distress 
syndrome (ARDS). ECMO allows maintaining oxygenation under pro-
tective ventilation until patient’s recovery, but complications are not 
rare and can lead to fatal outcome. Despite few studies, the decision to 
initiate ECMO is controversial and an European consensus conference 
recommends referral centres associated with a circulatory support 
mobile unit available 24/7 and ready to intervene in all healthcare cen-
tres in the region concerned. 1 The aim of this study is to describe and 
compare outcomes of patient accepted for ECMO to those refused.
Materials and methods This is a retrospective study between 2012 
and 2015 at the Universitary Hospital of Bordeaux. Indication of ECMO 
(veinoveinous) was decided using CESAR study criteria. 2 Recused 
patients stayed at the calling hospital and were categorized in ““con-
traindication” group (CI) and “to optimize” group (AO).
Results Seventy-two patients were analysed in the study, 19 (26  %) 
received ECMO, and 53 (74 %) were refused (34 CI and 19 AO). PaO2/
FiO2 ratio on demand was 52 (IQR 45–63) in ECMO, 75 (IQR 62–83) in 
AO and 69 (IQR 54–81) in CI (p = 0.001). 90-day mortality was equiv-
alent between ECMO and non-ECMO patients (53  %). Patients in 
AO group had the lower mortality (21  %), and their PaO2/FiO2 ratio 
increased significatively during the first 24 h (+71 %, p < 0.0001). There 
was no difference concerning the PRESERVE score between ECMO and 
non-ECMO patients (4 (IQR 3–5) vs. 5 (IQR 2–7), p =  0.144), but this 
score was higher in the CI group compared to the ECMO group (5.5 
(IQR 4–8) vs. 4 (IQR 3–5), p =  0.004). In the entire cohort, PRESERVE 
score was significantly higher in dead patients compared to those who 
survived (5 (IQR 4–7) vs. 3 (IQR 2–5), p = 0.04).
Discussion Mortality was high in both groups ECMO and non-ECMO, 
confirming severity of ARDS. Our study identifies a group of patients 
(AO) proposed to ECMO but, in our opinion, not enough severe to 
receive it immediately. These patients, with optimization of ventila-
tor settings or implementation of adjuvant therapy, rapidly increase 
their oxygenation within 24 h and have a low mortality. Interestingly 
in non-ECMO patients, the PRESERVE score was higher in the CI group.
Conclusion This suggests that the decision to initiate ECMO is diffi-
cult. A referral centre with a high number of calls and a follow-up of 
recused patients might help to improve this decision and probably 
avoid ECMO with its associated complications in some cases.
Competing interests None.
References
1.  Richard C, Argaud L, Blet A, et al. Extracorporeal life support for patients 
with acute respiratory distress syndrome: report of a Consensus Confer‑
ence. Ann Intensive Care 2014;4(1):15.
2.  Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assess‑
ment of conventional ventilatory support versus extracorporeal 
membrane oxygenation for severe adult respiratory failure (CESAR): a 
multicentre randomised controlled trial. Lancet 2009;374(9698):1351–63.
S106 
Refractory electrical storm rescued by venoarterial extracorporeal 
membrane oxygenation
Guillaume Baudry1, Guillaume Lebreton2, Guillaume Hekimian1, Nicolas 
Brechot1, Ania Nieszkowska1, Charles‑Edouard Luyt1, Jean Louis Trouillet1, 
Pascal Leprince2, Alain Combes1, Matthieu Schmidt1
1Service de réanimation médicale, Groupe Hospitalier Pitié Salpêtrière, 
Paris, France; 2Service de chirurgie thoracique et cardiovasculaire, Groupe 
Hospitalier Pitié Salpêtrière, Paris, France 
Correspondence: Guillaume Baudry ‑ guillaume.baudry@aphp.fr 
Annals of Intensive Care 2016, 6(Suppl 1):S106
Introduction Electrical storm refers to a state of cardiac electrical 
instability characterized by multiple episodes of ventricular tachycar-
dia or ventricular fibrillation within 24 h despite antiarrhythmic drugs 
or device-related therapies (defibrillation or anti-tachycardia pac-
ing) and for which overall mortality was 22–82  % in previous series. 
Triggering factors for this condition include worsening heart failure, 
early postoperative period, electrolyte abnormalities, and myocar-
dial ischemia. Since venoarterial extracorporeal membrane oxygena-
tion (VA-ECMO) can be used as a rescue therapy in this setting, we 
reviewed our experience and assessed the outcomes of patients who 
received VA-ECMO for refractory electrical storm in our center.
Materials and methods We retrospectively collected demographic, 
pre-ECMO, post-ECMO data and in-ICU mortality of patients who 
received VA-ECMO for refractory electrical storm in our 26-bed inten-
sive care unit from March 2007 to March 2015.
Results Of the 1286 VA-ECMO patients treated in our ICU during 
the study period, 38 had ECMO for refractory electrical storm after a 
median time of 24 (8–168) hours. Median age, SAPS II and SOFA scores 
at admission were 58 (49–62) years, 80 (55–87) and 13 (11–15), respec-
tively. Electrical storm was secondary to myocardial infarction in 26 
(68 %) patients. Cannulation was performed during and after cardiac 
arrest in 5 (13  %) and 17 (45  %) patients, respectively. Overall ICU 
survival was 47  % (one patient got a heart transplant and one a left 
ventricular assist device). Survivors spent 5 (4–10) days on ECMO, 14 
(9–25) days in ICU and 52 (34–59) days in hospital. Patients discharged 
alive from the ICU had lower body mass index, lower SOFA score 
before ECMO and at day 1 and received less inotropes in the 24 h fol-
lowing cannulation (p =  0.02). No difference was identified between 
alive and deceased patients regarding pre-ECMO anti-arrhythmic 
treatments and number of electrical shocks.
Conclusion Refractory electrical storm is a very severe condition 
that might be rescued by VA-ECMO support. The 47  % ICU survival 
rate we observed in this series parallels that of other cardiogenic 
shock populations rescued by VA-ECMO. Earlier ECMO support in 
the course of the disease might allow a rapid decrease in inotrope 
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Introduction Bleeding and need for blood product transfusion are 
common among patients requiring extra-corporeal membrane oxy-
genation (ECMO). Transfusion is associated with a poor outcome in 
critically ill patients. Risk factors of bleeding among patients under 
ECMO are unknown. The aims of this study were to describe bleeding 
and to determinate risk factors of bleeding under ECMO.
Patients and methods From 2013 to 2014, we retrospectively ana-
lyzed all the patients admitted to two ICU in a university hospital that 
required the use of ECMO. Bleeding was defined with ELSO criteria 
(ELSO anticoagulation guidelines). Patients were studied according 
to the presence or absence of severe bleeding while they were under 
ECMO.
Results One hundred thirteen patients were included. One hundred 
two patients received venoarterial (VA) ECMO and 11 venovenous (VV) 
ECMO. ECMO runs for a median of 5 days. One hundred six bleeding 
were identified in 83 patients. Severe bleedings occured in 56 (55 %) 
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patients with VA ECMO. Among them, 33 patients (59 %) had bleeding 
located on ECMO cannula. Other bleeding complications were intrac-
ranial bleeding in 4 patients, gastrointestinal bleeding, ear-nose bleed-
ing and hemoptysis.
Totally, 849 red blood cells, 534 fresh frozen plasma and 209 plate-
lets units were transfused. Predictive factors of severe bleeding were 
female sex (OR 2.8[1.4–10]), platelets <50G/L (OR 3.3 [1.3–8.7]) and 
antiagregant treatment (OR 3 [1.1–7.8]).
Conclusion Severe bleedings are highly more frequent during VA 
ECMO than VV ECMO: It occurs in more than an half of the patients 
with VA ECMO. Clinical management of these patients is difficult, and 
improving the management of severe bleeding under ECMO, in par-
ticular by defining the acceptable level of platelet count and hemosta-
sis tests, is required.
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Introduction Venovenous extracorporeal membrane oxygenation has 
become a widely accepted treatment option for life-threatening acute 
respiratory failure. To date, most of the studies described nosocomial 
infections or bloodstream infections occurring during extracorpor-
eal membrane oxygenation support but very few studied infections 
directly related to extracorporeal membrane oxygenation devices. The 
main objective of this study was to evaluate the incidence of infec-
tions and colonizations related to extracorporeal membrane oxygena-
tion device in venovenous extracorporeal membrane oxygenation 
adult patients.
Patients and methods We prospectively included all consecutive 
adult patients treated with venovenous extracorporeal membrane 
oxygenation for at least 48 h in our intensive care unit, from February 
2013 to June 2015. At the time of extracorporeal membrane oxygena-
tion removal, we systematically collected blood cultures, swabs on 
insertion cannula site (femoral and jugular) and intravascular cannula 
extremities. Then, we classified each extracorporeal membrane oxy-
genation support according to the infectious status in three groups: 
(1) uninfected/uncolonized extracorporeal membrane oxygenation 
device, (2) extracorporeal membrane oxygenation device coloniza-
tion, and (3) extracorporeal membrane oxygenation device infection. 
Impact on outcome was analyzed.
Results Eighty-one patients underwent 85 venovenous extracorpor-
eal membrane oxygenation support for a total of 1197 extracorporeal 
membrane oxygenation-days. The incidence of extracorporeal mem-
brane oxygenation device infection was 6.7 per 1000 extracorporeal 
membrane oxygenation-days (8 events, 9.4  %) including 5 extracor-
poreal membrane oxygenation device-related bloodstream infections 
(4.2 per 1000 extracorporeal membrane oxygenation-days). The inci-
dence of extracorporeal membrane oxygenation device colonization 
was 24.2 per 1000 extracorporeal membrane oxygenation-days (29 
events, 34.1  %). No difference was observed between the three 
groups, regarding days of mechanical ventilation, intensive care unit 
length of stay and mortality, and in-hospital mortality. We observed 
a longer extracorporeal membrane oxygenation duration (12 (9–20) 
days versus 7 (5–15) days respectively, p < 0.05) and a higher propor-
tion of male patients (72.4 % versus 54.2 %, p < 0.05) in extracorporeal 
membrane oxygenation device colonization group compared to unin-
fected/uncolonized extracorporeal membrane oxygenation device 
group, respectively.
Conclusion We performed a systematic analysis of extracorporeal 
membrane oxygenation device at the time of removal leading to the 
first description of incidence of extracorporeal membrane oxygena-
tion device-related infections (6.7 per 1000 extracorporeal membrane 
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Introduction Since 2007 in France, High Emergency Lung Transplant 
(HELT) combined with ECMO as a bridge to transplant represents an 
encouraging method to decrease mortality of patients on waiting list [1]. 
Acceptance for HELT is based on acute lung function worsening accord-
ing to the contraindications. In our institution, we developed a new strat-
egy for patients presenting temporary contraindications for HELT. These 
patients received ECMO as a bridge to evaluate before being considered 
eligible or not for HELT. We decided to evaluate this new strategy.
Patients and methods We reviewed the retrospective data from all 
patients with end-stage cystic fibrosis (CF) considered as potentially 
eligible for HELT and admitted in our institution since July 2007 to 
August 2015. The patients were classified into three groups: trans-
planted in HELT without ECMO (Group 1); transplanted in HELT with 
ECMO as a bridge to transplant (Group 2); potentially eligible for HELT 
but presenting one or more temporary contraindications for HELT and 
receiving ECMO as a bridge to wait for the recovery (Group 3). After 
this evaluation period, the patients were considered either eligible 
for HELT if the contraindication was corrected or definitively not if the 
contraindications persisted. Contraindications for HELT were based on 
the exclusion criteria defined by the French Organ Allocation Agency 
(l’Agence de la Biomédecine) associated with one local criteria: sys-
temic infection, extrathoracic organ failure or multiorgan failure, denu-
trition (defined by an BMI < 14 kg m−2). For the patients not directly 
eligible for HELT, contraindications were listed at the admission in ICU 
and transplant was decided after a collegiate meeting with intensiv-
ists, lung specialists and thoracic surgeons. This study compares the 
patients waiting for HELT with temporary contraindications (Group 
3) with the patient without contraindication (Group 2). The main out-
come was the 3-month mortality.
Results Forty-nine patients with end-stage CF were admitted before 
HELT. Twenty-one (43  %) patients were transplanted without ECMO 
with a 3-month mortality of 14  % (Group 1). Twenty-eight (57  %) 
patients needed ECMO as a bridge to transplant or to evaluate 
before transplant. Among them, 16 patients presented no contrain-
dications for HELT and were transplanted with a 3-month mortality 
of 0 % (Group 2). Twelve (43 %) patients presented one or more tem-
porary contraindications at the admission in ICU and received ECMO 
(Group 3). In this group, 3 patients were transplanted after correction 
of the contraindication. All of them were still alive within 3  months. 
Four patients were transplanted after incomplete correction of the 
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contraindications. One of them presented a subocclusive syndrome, 
one presented an unknown Cepacia Syndrome, and two presented a 
persistent renal failure. All of them died within 3 months. Four patients 
were definitively considered unfit for transplantation, and one did not 
survive during the evaluation period. The 3-month mortality in the 
Group 3 was higher than that in the Group 2 (75 vs 0 %, p < 0.0001).
Conclusion ECMO could be used as a bridge to evaluate temporary 
contraindicated patients for HELT and allowed to transplant them after 
complete correction of the contraindications. However, this strategy 




1.  M Lafarge MD, Pierre Mordant MD, Gabrien Tabut MD et al Experience of 
extracorporeal membrane oxygenation as a bridge to lung transplanta‑
tion in France J Heart Lung Transplant. 2013 Sep;32(9):905–13.
S110 
Malignant acute respiratory distress syndrome in diffuse lepidic 
adenocarcinoma (DLA): diagnosis and current issues
Maxens Decavèle1, Antoine Parrot1, Michael Duruisseaux2, Jocelyne 
Fleury3, Martine Antoine3, Marie‑France Carette4, Marie Wislez5, Muriel 
Fartoukh1
1Réanimation médico‑chirurgicale, Hôpital Tenon, Paris, France; 2Service 
de pneumologie, C.H.U de Grenoble C.H.U, La Tronche, France; 3Départe‑
ment d’anatomie et cytologie pathologiques, Hôpital Tenon, Paris, France; 
4Service de radiologie, Hôpital Tenon, Paris, France; 5Service de pneu‑
mologie, Hôpital Tenon, paris, France 
Correspondence: Maxens Decavèle ‑ maxencesar@hotmail.fr 
Annals of Intensive Care 2016, 6(Suppl 1):S110
Introduction Acute respiratory failure (ARF) is the leading cause for 
ICU admission of lung cancer patients. Despite its poor prognosis, 
recent series suggest a significant reduction in both ICU- and hospital-
mortality rates. The diffuse lepidic adenocarcinoma (DLA), formerly dif-
fuse bronchioloalveolar carcinoma, represents a rare specific pattern 
of worse prognostic lung neoplastic injury, with severity ranging from 
symptoms of limited expression to life-threatening ARDS. Mimicking 
non-resolving pneumonia or non-infectious inflammatory process, its 
diagnosis remains challenging and often delayed. Our purpose was 
(1) to provide a rigorous and reliable diagnosis reasoning process for 
guiding an early and targeted management susceptible to modify the 
prognosis and (2) to identify factors associated with ICU- and 90-day 
mortality.
Patients and methods This is a retrospective study including all con-
secutive patients with diffuse lepidic adenocarcinoma (DLA)-related 
ARDS, admitted to the intensive care unit (ICU) of Tenon hospital, 
Paris, France, from January 1994 to December 2014. Patients were 
classified according to the Berlin definition. DLA diagnosis was made 
on either histological or cytological samples. Specific clinical, biologi-
cal, radiological and cytological patterns conducting to the diagnosis 
were recorded. Performance of lung sampling procedures was com-
pared to other center when performed in other structures before 
ICU admission. Continuous variables were expressed as median and 
interquartile range and categorical variables as absolute value and 
relative frequencies. Univariable analysis was performed on ICU- and 
90-day mortality.
Results A total of 23 patients were included (17 men, age 71 
[61;76]). Diagnosis was made during the ICU stay in 83 % of cases. 
All patients presented with non-resolving pneumonia (median 
antibiotic lines 2 [2;3]), combining, smoking history (78  %), bron-
chorrhea (83 %), salty expectoration (64 %), significant weight loss 
(43 %), without fever (25 %). Radiological presentation was a bilat-
eral consolidation (95  %) with air bronchogram (90  %), base pre-
dominance (75  %), fissural bulging (55  %) and cavitations (40  %) 
associated with bronchiolar nodules (60 %). Bronchoalveolar lavage 
showed intense neutrophil alveolitis (total count 520,000 [240,000; 
900,000], with 64  % [48; 84] of neutrophils) and confirmed the 
diagnosis in 50 % of cases with a better yield than in the previous 
structures (50 vs 9  %, p  =  0.027). Sputum examination brought 
diagnosis in 5 patients. ICU- and 90-day mortality was 22 and 35 %, 
respectively. In univariable analysis, variables associated with ICU-
mortality were mediastinal lymphadenopathy, delay between first 
imaging and diagnosis, heart rate and respiratory rate on admis-
sion (Table 58).
Conclusion We reported the largest series of DLA-related ARDS. 
Simple rigorous physical examination and rapid on-site sputum or 
bronchoalveolar lavage examination may provide reliable diagnosis. 
Clinician should be aware of this atypic ARDS since an early recogni-
tion may impact prognosis. Prognosis is similar to the prognosis of 
other solid tumors in the ICU.
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Introduction Acute respiratory failure (ARF) in patient at the earli-
est phase of acute myeloid leukemia (AML) is related to either usual 
(infection, overload) or specific etiologies. The latter include three 
different groups, namely pulmonary leukemic infiltration (PLI), leuko-
stasis and acute lysis pneumopathy (ALP). Clinical and biological data 
are useful to precisely separate the three groups; however, they lack 
specificity. Yet, making the appropriate diagnosis is crucial as thera-
peutic strategy varies significantly across the three groups. In that 
setting, high-resolution computed tomography (HRCT) could be an 
interesting tool to better characterize patterns of pulmonary involve-
ment. We report HRCT findings in 29 patients with leukemic pulmo-
nary infiltrates.
Patients and methods Critically ill patients at the earliest phase of 
untreated AML were included. ARF was defined by presence of tachyp-
nea, labor breathing, respiratory distress and/or need for >5 l/min oxy-
gen or mechanical ventilation. Patients who underwent HRCT within 
2 days of respiratory symptoms onset were included, and their clinical 
and biological data were collected. ARF etiology was confirmed by 2 
senior intensivists with pulmonary background and extensive experi-
ence in managing AML. HRCT were independently analyzed by two 
clinicians and a radiologist. Disagreements were discussed until a con-
sensus was reached.
Results Twenty-nine patients, from 18 to 74 years old, were included. 
AML was mostly monocytic leukemia (Fab 4 or 5) with median leu-
kocyte count of 108 (IQR 1–3 (39.1; 224.9) G/L at ICU admission. 
Table 58 Univariable analysis on ICU mortality
Variable ICU death n: 5 ICU survival n: 21 P value
Mediastinal lymphad‑
enopathy
2 (40 %) 1 (5 %) 0.017
Heart rate 115 [103; 128] 102 [92, 113] 0.040
Respiratory rate 38 [32; 43] 26 [22; 31] 0.018
Delay first imaging/
diagnosis
144 [126; 157] 131 [122; 145] 0.027
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Hematological diagnosis was performed 1 day before admission [IQR 
1–3 (0;1)]. At admission, mean respiratory rate was 24 ±  7/min (SD) 
and mean oxygen flow was 4 ± 4 l/min. Patients had extra-pulmonary 
signs, including fever (70 %), gingival hypertrophy (34 %) or neurologi-
cal symptom (24 %). During ICU, 9 (31 %) patients needed vasopressors 
and 5 (17  %) were intubated for 13 (5–34) days. Twenty-six patients 
(90 %) received chemotherapy during ICU. All patients received antibi-
otics and 17 (59 %) patients received rescue steroids (dexamethasone 
10 mg × 4/j) until neutropenia. ICU mortality was 21 %, and median 
ICU length of stay was 6 [IQR 1–3 (4;9)] days. ARF etiology included leu-
kostasis for 7 patients, PLI for 13 patients and APL for 6 patients. For 
three patients, association of leukemic infiltrates with infection (one 
patient), atelectasis (one patient) or edema (one patient) precluded 
HRCT evaluation. HRCT findings included ill-defined consolidation 
(17, 59 %), mainly diffuse (10, 71 %), ground-glass opacities (14, 48 %), 
nodules (10, 34 %), peribronchovascular thickening (8, 28 %) or inter-
lobular septal thickening (8.28 %). Table 59 shows HRCT signs in the 3 
groups.
Kappa coefficient for interrater agreement was 0.863 [IC95 (0.681;1)] 
for consolidation, 0.862 [IC95 (0.677;1)] for ground-glass opacities, 
0.473 [IC95 (0.209;0.737)] for peribronchovascular thickening and 
0.627 [IC95 (0.333;0.922)] for nodules.
Conclusion HRCT may be helpful to assess precise ARF etiology at the 
earliest phase of AML in patients with leukemic pulmonary infiltrates. 
These preliminary data can be used as a framework for validation at a 
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Introduction Interstitial lung diseases (ILD) are a heterogeneous 
group of diseases, which can be life-threatening in case of acute res-
piratory failure. Until the last decade, few patients with ILD were 
admitted to the intensive care unit (ICU), due to the presumably poor 
prognosis and futility of mechanical ventilation. However, protective 
ventilation, spread of noninvasive ventilation, and increased consider-
ation for urgent lung transplantation have undoubtedly changed the 
admission criteria and management of these patients.
The aim of this study was to describe the epidemiology of ILD patients 
admitted to the ICU over the past 15 years and to assess whether char-
acteristics and outcome of these patients have changed over time.
Patients and methods We retrospectively analyzed all ILD patients 
admitted to the ICU of our university hospital from January 2000 to 
December 2014.
The following data were recorded: age, severity scores, etiology of the 
ILD, live-sustaining therapies, and ICU mortality.
We compared three periods:
  •  2000–2006: when protective ventilation was not systematic in 
acute lung injury,
  •  2007–2011: when protective ventilation was systematic but nei-
ther urgent lung transplantation nor ECMO were available, and
 •  2011–2014: when all conditions were available.
Results During the last 15  years, 196 ILD patients were admitted 
to our ICU. Mean age was 64.3  ±  12.6  years, and mean SAPS II was 
39.5 ± 19.3 points. Overall mortality was 47.9 %. Etiologies of ILD were 
as follows: idiopathic pulmonary fibrosis (n  =  51, 26  %), connective 
tissue disease (n  =  42, 21.4  %), miscellaneous (n  =  61, 31.2  %) and 
unclassified (n = 42, 21.4 %).
Regarding ventilatory support, 105 (53.7 %) patients required mechan-
ical ventilation (MV), among which 78 (74 %) died. MV was started in 
42/67 patients (62.6 %) after failure of noninvasive ventilation, with a 
subsequent mortality rate of 76.2 %. The remaining 17 patients were 
discharged alive. Of the 9 patients who initially received high-flow 
nasal oxygen, 6 further required MV, of whom 4 died.
Twelve patients were considered for urgent lung transplantation and 
transferred to referral centers for ECMO in the meantime (data on out-
come pending).
Among nonventilatory supports, catecholamines and renal replace-
ment therapy were provided to 80 (41  %) and 17 (8.7  %) patients, 
respectively, and were associated with mortality rates above 90 %.
Regarding changes over time, the number of ILD patients admitted to 
the ICU kept increasing but no significant modification in their man-
agement was observed.
Finally, mortality remained constant throughout the three periods. Yet, 
observed mortality was much superior to mortality as predicted by 
the SAPS II score.
Conclusion ICU mortality of ILD patients is high and remains stable 
despite global improvements in ventilatory support. Nevertheless, a 
significant proportion of ILD patients may survive.
Our data suggest that ILD per se should not be considered as a ground 
for ICU admission denial.
Further analyses are warranted to identify specific prognostic factors, 
and subgroups of ILD patients likely to benefit most from ICU care.
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11Réanimation médicale, Hôpital Saint‑Louis, Paris, France; 12Réani‑
mation médicale, CHU Dijon, Dijon, France; 13Réanimation, CHU de 
Strasbourg, Strasbourg, France; 14Réanimation polyvalente, Hôpital de 
Mercy, Ars Laquenexy, France; 15Service de réanimation médicale et 
infectieuse, Hôpital Bichat‑Claude Bernard‑APHP, Paris, France; 16Cardi‑
ologie ‑ centre d’investigation clinique pierre drouin, Centre Hospitalier 
Universitaire de Nancy, Vandœuvre‑lès‑Nancy, France 
Table 59 HRTC signs according to ARF etiology 
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Introduction The outcome of patients admitted in intensive care 
unit for acute manifestation of small vessel vasculitis has been poorly 
reported. The main goal was to determine the mortality rate and prog-
nostic factors of patients admitted in intensive care unit for acute 
manifestation of small vessel vasculitis.
Patients and methods We performed a retrospective, multicenter 
study of patients admitted from January 2001 to December 2014 in 20 
intensive care units in France specifically with acute manifestation of 
small vessels vasculitis. Primary end-point was assessment of mortality 
rate 90 days after admission.
Results Eighty-two patients were included in 20 centers, 93  % of 
whom with a recent diagnosis (<  6  months) of small vessel vascu-
litis. Main reasons for admission were respiratory failure (33  %) 
and pneumo-renal syndrome (32  %). Mechanical ventilation was 
required in 51  %, catecholamines in 31  % and renal replacement 
therapy in 71  %. Overall mortality at 90  days was 19  %. Mortality 
was related to infection in 69  % of cases. No difference was found 
at admission between survivors and non-survivors at 90  days in 
terms of reason for admission, comorbidities, type of vasculitis diag-
nosis and Birmingham Vasculitis Activity Score. Risk factors associ-
ated with 90-day mortality were higher SOFA score on the day of 
cyclophosphamide administration and delayed administration of 
cyclophosphamide.
Conclusion Even in cases of multiple organ failure, patients admitted 
in intensive care unit for the management of acute small vessel vascu-
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Introduction Pulmonary alveolar proteinosis (PAP) is a rare disease. 
The main symptomatic treatment is repetitive whole lung lavage 
(WLL). This technique is an invasive procedure that can worsen the 
clinical condition of the patients and lead to the intensive care unit 
(ICU). We hypothesized that factors related to the patient’s clinical con-
dition at the time of WLL or the procedure in itself could explain the 
occurrence of worsening and a prolonged ICU stay. Thus, the aim of 
our study was to characterize the modalities of the WLL and to high-
light predictive factors of complicated WLL defined by a prolonged 
hospitalization in ICU after the procedure.
Materials and methods We conducted a single-center retrospec-
tive cohort study examining WLL made between 2009 and 2015 at 
Necker-Enfants Malades. The primary endpoint was the hospitali-
zation in ICU greater than three days that characterized a compli-
cated WLL. For each procedure, we identified criteria related to the 
patient’s condition (nutritional status, respiratory status, the pres-
ence of fever) and related to the procedure (such as the experience 
of the endoscopist and the anesthetist, the amount of physiological 
saline instilled, the duration of the anesthesia). We performed univar-
iate and multivariate analysis to identify risk factors for complicated 
WLL.
Results Two hundred and twenty-five procedures corresponding to 
14 patients were analyzed. 27.1  % of procedures were the result of 
hospitalization in ICU. Univariate analysis showed that the risk of WLL 
complicated by a prolonged hospitalization in ICU is multiplied by 54.6 
for severe respiratory illness (p < 10−4), by 6.9 if oxygeno-dependence 
(p = 0.03) and 27.1 in cases of malnutrition (p < 10−4). The amount of 
saline instilled reduced the risk of hospitalization in the ICU up to 2 % 
per ml/kg (p = 0.009). In multivariate analysis, the risk of complicated 
WLL prolonged hospitalization in intensive care units is multiplied by 
59.7 for severe respiratory illness (p < 10−4) by 15 if oxygeno-depend-
ence (p = 0.02) and 7.3 in cases of malnutrition (p = 0.01). The expe-
rience of the endoscopist and anesthesiologist did not emerge as 
complicated WLL risk factors.
Conclusion Our study shows that the conditions attached to the WLL 
procedure are not predictive of prolonged ICU hospitalization. And 
that the clinical presentation of the patient (malnutrition and respira-
tory failure) seems to have an impact on complicated WLL. This result 
could allow us to better identify patients likely to be hospitalized in 
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Introduction Acute chest syndrome (ACS) is the main complication 
leading adult patients with sickle cell disease (SCD) to the intensive 
care unit (ICU). Fat embolism etiology is supposed to account for up 
to 40  % of ACS. In parallel with traumatic fat embolism syndrome, a 
medullary fat hydrolysis by phospholipase A2 could take place in ACS, 
increasing free fatty acids (FFA) responsible for acute lung injury. Ara-
chidonic acid may be one of the main FFA released, because its enzy-
matic conversion leads to pro-inflammatory mediators. The objective 
of this study was to determine whether the synthesis of arachidonic 
acid via secreted phospholipase A2 (sPLA2) was increased in SCD 
patients admitted to the ICU and leads to plasma FFA changes, as 
compared to steady state.
Patients and methods All SCD patients with ACS admitted to the ICU 
of a French University Teaching Hospital in Paris between April and 
June 2015 were included. Samples were collected serially at D2, D3 
and at hospital discharge. FFA were determined by enzymatic (total 
concentration) and gas chromatography/mass spectrometry (quan-
titative profile). Plasma activity of sPLA2 was measured by enzymatic 
method. Parameters changes between times are analyzed using non-
parametric Wilcoxon test. A p value less than 0.05 was considered sta-
tistically significant.
Results Twelve patients (homozygous hemoglobin SS, n =  11; com-
pound heterozygous SC disease, n = 1) were admitted to the ICU for 
the management of ACS. Five patients had a highly severe course 
during ICU stay. Twelve samples were collected at D2, 10 at D3 and 
3 at hospital discharge. Increased sPLA2 activity (202  µmol/min/mL 
[188–258]) and FFA concentration (0.44  mmol/L [0.39–0.46  mmol/L]) 
were found. FFA qualitative analysis demonstrated an inflamma-
tory profile, with increased levels of oleic, palmitic and linoleic acids, 
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when compared to healthy subjects. Conversely, the arachidonic acid 
concentrations were decreased. Within-group changes suggested 
a decrease in the repeated concentrations of oleic and linoleic acids 
(p = 0.1).
Discussion To our knowledge, this is the first study reporting the FFA 
sequential assays and the profiles in SCD patients with ACS. Our find-
ings are in accordance with Hassel et al. who reported high levels of 
palmitic and oleic acids in SCD patients developing ACS, as compared 
to vaso-occlusive crisis.
Conclusion Our findings may argue for the participation of sPLA2 
and free fatty acids, especially oleic, palmitic and linoleic acids, to 
the pathophysiological mechanisms of ACS. The steady-state profiles 
remain to be collected at this stage of the research.
Competing interests None.
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Introduction Primary graft dysfunction (PGD) is the result of pul-
monary edema following lung transplantation (LT). The definition of 
PGD is based on the ratio of the partial pressure of arterial oxygen to 
the fraction of inspired oxygen (PaO2/FiO2) and the presence of lung 
infiltrates on chest X-ray. Lung ultrasonography (LU) and extravascu-
lar lung water indexed to predicted body weight (EVLWi) are reliable 
methods for quantifying lung edema. We assessed whether LU and 
EVLWi were associated with grade 3 PGD.
Patients and methods Design and patients All patients scheduled to 
receive single or bilateral lung transplantation were screened for inclu-
sion between July 2013 and September 2014.
Data collection PGD was graded according to the ISHLT criteria. Chest 
X-rays were interpreted independently by two physicians blinded to the 
clinical variables, with adjudication of disagreements. The classification k 
for agreement on grade 3 PGD was 0.93. Grading ISHLT was performed 
at 4 time points: within the 6  h after ICU admission and over the fol-
lowing 3 days at 10 am. The worst grading of PGD was used to classify 
patients. The use of rescue therapies for severe hypoxemia was consid-
ered when the following criteria were fulfilled: prone positioning (PP) if 
PaO2/FiO2 was lower than 150 mmHg, continuous neuromuscular block-
ing agents infusion (NMBA) if PaO2/FiO2 was lower than 120 mmHg, iNO 
if PaO2/FiO2 was lower than 100 mmHg despite PP and NMBA infusion 
and veno-venous ECMO according to the French recommendations.
Transpulmonary thermodilution and lung ultrasound During the trans-
plantation, two thermodilution measurements were realized during 
chest-closed periods, one after induction of anesthesia and the second 
after the end of the surgical procedure. Thermodilution and LU scores 
were then performed during the three-day period following lung 
transplantation at the PGD assessment time points. Lung ultrasound 
examination was conducted using two specific methods: the echo 
comet score (ECS) and the 12-region technique (LUS). Due to barriers 
to US resulting from pneumothorax, subcutaneous emphysema, chest 
tubes or thoracic dressings, we weighted every score obtained by the 
number of interspaces (for the ECS) or areas (for the LUS) available.
Results Between August 2013 and September 2014, 36 patients were 
included prospectively. All except one underwent bilateral sequential 
single-lung transplantation. Thirteen patients (36  %) presented PGD 
grade 3 during the first 3 days following ICU admission. In the grade 3 
PGD group, crystalloids infusion was larger during the transplantation 
procedure than the one without grade 3 PGD. Overall ICU mortality 
was only 3 % (one death in the grade 3 PGD group). In the grade 3 PGD 
group, ICU length of stay and duration of mechanical ventilation were 
longer and the probability of rescue therapies need was higher.
No difference was observed in EVLWi during the intra-operative 
period. The EVLWi was higher in the grade 3 PGD group at ICU admis-
sion (p =  0.001), day one (p =  0.01) and day 2 (p =  0.002). The ROC 
curve analysis showed that a value of 14 mL/kg at ICU admission was 
the best cutoff for predicting PGD grade 3 after lung transplantation, 
with a sensitivity of 82 % and a specificity of 77 % at ICU admission. 
The area under the ROC curve was 0.85. Patients with delayed grade 
3 PGD had significantly higher EVLWi at ICU admission compared with 
patients without grade 3 PGD at any time point. Rescue therapies were 
needed in 64 % of patients with an EVLWi at ICU admission ≥14 mL/kg 
and in 10 % when EVLWi was <14 mL/kg (p < 0.001).
Less than half of the patients had all LU windows available. LU scores 
did not discriminate patients with grade 3 PGD.
Logistic regression analysis performed with crystalloids volume infu-
sion during surgery, mean arterial pressure, global end-diastolic vol-
ume indexed and EVLWi at ICU admission indicated that both EVLWi 
at ICU admission (odds ratio per 1 mL/kg increase, 2.78, 95 % CI [1.24–
6.21], p = 0.01) and crystalloids volume infusion during surgery (odds 
ratio per 1 L increase, 1.61, 95 % CI [1.04–2.50] p = 0.03) were associ-
ated with grade 3 PGD.
Conclusion Unlike lung ultrasound scores, a high EVLWi measured 
immediately after LT is associated with grade 3 PGD. Initial EVLWi 
offers a great added value for the early diagnosis of grade 3 PGD when 
it precedes the onset of grade 3 PGD.
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Introduction ICU patients prognosis is evaluated at admission by 
severity scores (APACHEII, SAPSII) that are time-consuming. 50  kHz 
phase angle (PhA) is measured easily and quickly by bioimpedance 
analysis (BIA). Lowered PhA is associated with worse prognosis of 
chronic diseases. The main aim was to determine whether PhA meas-
ured at ICU admission predicts 28-day survival.
Patients and methods Patients were recruited in 10 centers from 9 
countries. The inclusion criteria were: age >18 years, absence of implant-
able cardioverter defibrillator or pacemaker, expected ICU length of stay 
>48  h. PhA was measured at admission (day (d) 1) by the Nutriguard 
(Data-Input, Germany) BIA analyzer. APACHEII and SAPSII were calcu-
lated at d1. The following variables were collected: 28-day mortality, 
duration of mechanical ventilation, ICU length of stay, infections, and 
expressed as mean ±  standard deviations or median ±  interquartiles 
accordingly. Relations between PhA and 28-day mortality, duration of 
mechanical ventilation or ICU length of stay were analyzed by Kaplan–
Meier actuarial curves and Spearman test. Sensitivity, specificity and 
PhA cutoffs associated with 28-day mortality were analyzed by ROC 
curves and the Youden method. Variables associated with 28-day mor-
tality were determined by multivariate logistic regression.
Results Thirty-three percentage of screened patients were analyzed: 
n  =  918 (/1000 planned patients according to the power analysis 
sample calculation): Geneva, Switzerland (n  =  178), Pelotas, Brazil 
(n =  103), Brussels, Belgium (n =  100), Vilnius, Lithuania (n =  100), 
Clermont-Ferrand, France (n  =  99), Ljubljana, Slovenia (n  =  96), 
Palma de Majorque, Spain (n  =  94), Bydgoszcz, Poland (n  =  52), 
Zagreb, Croatia (n = 49), Rouen, France (n = 47). The characteristics 
of analyzed patients were: 549 males, 61 ± 16 years, body mass index 
26.4  ±  5.6, medical 63  %, shock all cause 29  %, APACHEII 19  ±  9, 
SAPSII 43 ± 19, PhA d1: 4.4 ± 1.7 degrees (°), 28-day mortality 21 %. 
Day 1 PhA was lower in non-survivors than in survivors (4.0  ±  2.0 
vs 4.5  ±  1.7, P  =  0.005). Sensitivity, specificity, positive predictive 
value (PPV) and negative predictive value (NPV) of d1 PhA  <  3.49 
for 28-day mortality were, respectively, 49, 74, 31 and 86  % (area 
under the curve (AUC) =  0.63 [0.58–0.68]). The Kaplan–Meier actu-
arial curve indicated a better 28-day survival in patients with d1 
PhA ≥ 3.49° (P < 0.001). Survival was worse in the quartile of patients 
with d1 PhA  <  3.23° vs. quartiles (3.23–4.24, 4.25–5.32,  >  5.32) 
(P < 0.001). Variables associated with d28 mortality were: SAPSII ≥ 46 
(hazard ratio (HR) 4.2 [2.1–8.3], P < 0.001), PhA < 3.49° (HR 2.2 [1.3–
3.8], P = 0.005) and age >64 years (HR 1.9 [1.0–3.5], P = 0.05). Sen-
sitivity, specificity, PPV and NPV of a multivariate model associating 
d1 PhA < 3.49° and SAPSII ≥ 46 for 28-day mortality were 77, 66, 32 
and 93 %, respectively (AUC = 0.78 [0.73–0.83]). There was a reverse 
correlation between d1 PhA and SAPSII (rho = −0.16), or APACHE II 
(rho = −0.19) (P < 0.001). The proportion of patients with mechani-
cal ventilation was higher in patients with PhA ≤ 4.2° vs. PhA > 4.2°: 
50 vs 31  %, P  <  0.001. There was no relation between PhA and ICU 
length of stay or infections.
Conclusion At ICU admission PhA is an indicator of 28-day mortality, 
even if SAPSII is the best predictor. A combined multivariate model 
associating PhA and SAPSII improves 28-day mortality predictability.
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Introduction Optimal nutrition in pediatric intensive care units 
(PICUs) is important to improve patient outcome. The aim of our study, 
conducted by NUTRISIP (Nutrition French-Speaking PICU Group), was 
to describe the present knowledge of healthcare professionals and the 
practices surrounding enteral and parenteral feeding in the French-
speaking PICUs, in order to adapt future interventions.
Materials and methods A cross-sectional survey with 69 questions 
concerning nutritional practices was sent to 42 French-speaking PICUs 
in June 2014. A member of the medical staff answered questions.
Results Overall response rate was 88  %. The main answers are sum-
marized in Table 60.
Conclusion Despite early enteral feeding in most PICUs, recommenda-
tions for nutrition in PICUs are not sufficiently known, particularly for 
assessment of energy requirements, or for duration of fasting before 
procedures. This survey highlights importance of future interventions 
to improve nutritional care.
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Table 60 See text for description
Nutrition considered 
priority
Yes (81.08 %) No (18.92 %)
Nutrition written 
protocols
Yes (54.05 %) No (45.95 %)
Level of knowledge of 








Yes (40.54 %) No (59.46 %)
Indirect calorimeter Yes (16.22 %) No (81.08 %)






Beginning of enteral 
nutrition (EN)
Within 24 h (54.05 %) Between 24 and 48 h 
(37.84 %)
Beginning of paren‑
teral nutrition if EN is 
insufficient
Day 1 (40.54 %) Between Day 1 and Day 
4 (48.65 %)
Duration of fasting 
before extubation
Many hours (67.57 %) Just before extubation 
(32.43 %)
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Introduction Malnutrition is frequent and deleterious in the inten-
sive care patient. Recent attention has been brought to the chal-
lenges raised by inadequate feeding choice of the adequate route, 
time of onset, and nutrients. Patients with Hematologic malignan-
cies are increasingly admitted to the intensive care and present 
specific hallmarks of their diseases, such as neutropenia, side effects 
from chemotherapy, specific gastrointestinal issues, and malnu-
trition preceding intensive care admission. We investigated the 
effects of the implementation of a computerized nutritional tool 
(the CHOCOBOX) on hematologic patients admitted to the intensive 
care.
Patients and methods Our study was a before-after study comparing 
two prospectively collected cohorts of hematologic cancer patients 
chronologically admitted to a single intensive care, before and after 
the implementation of an optimized nutritional protocol (the CHOC-
OBOX). This protocol included a computerized prescription tool; 
simulation of the best combination of products to reach target; team 
training before the implementation of the CHOCOBOX; dietician coun-
seling; and daily comprehensive computation of all caloric and protein 
intakes and of daily and total caloric and protein balances.
Our main objective was to show a 50 % increase in the compliance of 
caloric and protein delivery, using a Poisson regression model. Com-
pliances were defined as the numbers of days, respectively, within 
caloric ((25 kcal/kg/d ± 15 %) and protein (1.5G/KG/D ± 15 %) targets, 
adjusted on the length of ICU. Secondary objectives were to show a 
difference in morbidity (days of ventilation, CRRT, antibiotics, positive 
blood cultures, noradrenalin) and hospital mortality, in four subgroups 
of patients: neutropenic, bone marrow allografted, malnourished, and 
severe (SAPS II > 56), tested by a survival curve with a Gray test.
Results We included 275 patients: 147 patients from 2009 to 2011 and 
128 patients from 2012 to 2014, using the CHOCOBOX. On admission, 
the CHOCOBOX cohort showed significantly higher rates of neutro-
penic and malnourished patients, number of chemotherapy lines and 
bone marrow transplants (BMT). Caloric compliant days increased by 
50 % with 4.13 vs 2.1 days (adjusted RR on neutropenia, malnutrition 
status, chemotherapy lines and BMT, RR = 1.42, p = 0.03) in the after 
cohort, as well as protein compliant days with 4.1 vs 0.8 days (adjusted 
RR = 3.51 p < 0.001).
There was no statistically significant difference between the cohorts 
in the number of mechanical ventilation days, nor CRRT days, amine 
days, antibiotic days, number of days on more than 3 antibiotics, num-
ber of positive blood cultures per patient.
There was no statistically significant difference between the cohorts 
for the overall survival during the hospital stay, HR 0.70 [0.39–1.28] 
Fine & Gray test p = 0.26. Overall survival was higher in the after cohort 
in the neutropenic subgroup (n = 100, HR 0.53 [0.31–0.89] Fine & Gray 
test p = 0.018) and in the most severe patients (SAPS II > 56, n = 81, 
HR 0.52 [0.30–0.91] Fine & Gray test p = 0.023, but was not different 
for allograft patients (n = 70) nor for malnourished patients (n = 122).
Discussion Our study is the first to address nutritional issues in the 
intensive care in hematologic patients. A nutritional protocol was 
able to raise caloric and protein delivery to fairer levels and decreased 
global caloric and protein negative balance. Early-onset enteral feed-
ing has shown benefit in the ICU but was difficult for our patients 
who had specific enteral problems (esophagitis, mucitis, severe 
thrombopenia, intolerance, diarrhea, or neutropenic-related colitis). 
The standard of first choice exclusive enteral feeding may not be ade-
quate for all these patients, but trophic feeding was possible.
Survival was better with the CHOCOBOX in patients with failures (saps 
II > 56) and with neutropenia, perhaps because of higher quantities of 
protein, or because of a “package” of integrated nutritional manage-
ment, more than because of greater calories. Raised levels of compli-
ance remained mediocre, urging us to find more effective ways to feed 
this specific population.
Conclusion The implementation of a computerized prescription and 
follow-up nutritional tool is effective in increasing the number of com-
pliant days for protein and calorie delivery in the ICU setting. Such a 
protocol may lower mortality in some subgroups of patients.
Competing interests Some nutritional products were granted to 
the ICU by a laboratory for free.
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Introduction Noninvasive ventilation (NIV) is increasingly used in 
ICUs. Whereas there are specific guidelines related to feeding of criti-
cally ill patients receiving invasive ventilatory support, there are no 
guidelines related to feeding pts treated with NIV. We hypothesize 
that pts may be significantly underfed during the first 5 days of ven-
tilatory support with NIV. We conducted this study to evaluate caloric 
intakes of patients receiving NIV irrespective of the indication for NIV. 
Patients and methods Prospective, multidisciplinary, observational 
study in a 24-bed MICU. Inclusion criteria: all patients treated with NIV 
for more than 4H/day. Exclusion criteria: patients receiving parenteral 
or enteral nutrition in the management of underlying diseases or 
comorbidities. Data collected include demographics, patients’ medical 
characteristics, NIV indication and duration of NIV sessions, compli-
cations developed in the ICU, and nutritional data. We prospectively 
quantified and recorded all calories intakes through oral, enteral and 
parenteral routes during the whole duration of the ICU. We also meas-
ured BMI and albumin concentrations at the admission in ICU. Data are 
presented as median [IQR].
Results One hundred and thirteen pts (56  M/57F), 74  years old [65; 
82], SAPS2 40 [33; 52], SOFA 4 [2; 7], BMI 27 [23; 34] have been enrolled 
in the study. ICU length of stay was 6 [4;9] days. Patients were placed 
on NIV for 4 [2; 5] days. Mortality rates was 12.4 %, and 24 % of patients 













9 [5,7;12] 10,2 [6;14.9] 10 [5;13] 6,9 [4;10,5] 7 [3,8;10,7]
Oral intakes 
(Kcal)











89 [40;170] 70 [41;193] 84 
[25;214]
100 [40,208]
NIV pts with 
<1000 kcal/
day (%)
90 % 73 % 64 % 58 % 53 %
Page 223 of 236  Ann. Intensive Care 2016, 6(Suppl 1):S50
were intubated after NIV failure. Indication (classified according to 
the SRLF/SFAR consensus conference 1) were Group 1 (n = 85), Group 
2 + (n = 11) or Group 2- (n = 18). Main results are summarized below. 
Median energy an proteins intakes per day under NIV was 635 [406; 
925] KCal and 23 [10; 37] g of protein. Albumin blood concentration 
was 32 [28; 36] g/l on admission (Table 61).
Conclusion Patients treated with NIV for more than 4H/days have lim-
ited oral intakes and are significantly underfed. Long sessions of NIV, 
fear of aspiration and underestimation of the patient severity may 
explain the failure to provide adequate nutritional support in these 




1. SFAR et SRLF Ventilation non invasive au cours de l’insuffisance respira‑
toire aigue 2006.
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Introduction Stress-induced hyperglycemia is common in critically 
ill patients due to insulin resistance and increased hepatic output 
of glucose, and the relationship between stress hyperglycemia and 
poor outcome for patients hospitalized in the intensive care unit 
(ICU) was demonstrated. Although several randomized controlled 
studies, based on the use of whether paper protocols or computer-
ized protocols (1), have failed to replicate any mortality benefit, the 
interest for computerized decision-support system (CDSS) remains 
because meanwhile new therapeutic goals for blood glucose (BG) 
control in the ICU have emerged. Furthermore, harmful effects of 
severe hypoglycemia and multiple hypoglycemic episodes dur-
ing tight glucose control in critically ill patients have been recently 
demonstrated (2). The question arises whether a CDSS allowing 
the setting of a higher BG target and based on an enhanced algo-
rithm for the calculation of the insulin rate to be applied after each 
BG measure may reduce the incidence of severe and moderate 
hypoglycemia.
The objective of our study pilot is to assess the impact of the use in 
routine care of an improved CDSS on the incidence of hypoglycemia, 
whether severe or moderate, in comparison with a first-generation 
CDSS.
Patients and methods We used in routine care a CDDS for blood glu-
cose control in the ICU.
This CDSS is a second-generation software (CDSS-2) derived 
from that used during the CGAO-REA trial (NCT01002482), a non-
blinded parallel-group randomized controlled trial involving adult 
patients admitted to ICUs and comparing tight glucose control 
(TGC) with a first-generation CDSS (CDSS-1, BG range between 4.4 
and 6.1  mmol/l) and conventional glucose control (CGC) protocols 
(BG < 10 mmol/l).
The BG target has been set by default to 5–7.5 mmol/l in the CDSS-2. 
The embedded algorithm used for the calculation of the next insulin 
rate (to be applied after each BG measure) was of the type propor-
tional integral with variable coefficients to take into account variations 
of insulinosensitivity throughout the ICU stay.
The CDSS-2 was used on the admission whenever the patient required 
intravenous insulinotherapy and was our standard care protocol to be 
used (on medical prescription) by our nursing staff who had already 
gained experience during the CGAO-REA study.
We extracted the clinical data and that concerning BG control for all 
the patients treated with CDSS-2.
A Chi square test was used to compare the incidence of severe hypo-
glycemia and moderate hypoglycemia observed during the TGC arm 
of the CGAO-REA trial and the pilot study with CDSS-2.
Results The CGAO-REA study, carried out between October 2009 and 
June 2011, involved 2684 randomized patients, 1351 assigned to com-
puterized (CDSS-1) and 1333 to conventional blood glucose control, 
recruited in 34 ICUs (19 in academic tertiary care hospitals and 15 in 
community hospitals). Thirty-six patients were discarded from the 
analysis: 35 because they withdrew consent and one included twice. 
In the end, 1336 and 1312 patients were included in the TGC (with 
CDSS-1) and CGC arms, respectively. Among the 1336 patients treated 
with CDSS-1, 19 were discarded because important data concerning 
BG measurement were lacking. Thus, 1317 patients were analyzed for 
comparison.
The pilot study, carried out between September 2012 and May 2015, 
involved 685 stays (and 641 patients) in the ICU among a total of 973 
stays during the study period.
Severe hypoglycemia occured less frequently during the pilot study 
(CDSS-2) than during the TGC arm of the CGAO-REA trial (CDSS-
1), respectively, 58 stays of 685 (8.5  %, 95  % CI 6.4–10.6  %) and 174 
stays of 1317 (13.2  %, 95  % CI 11.4–15  %). Moderate hypoglycemia 
(<3.3  mmol/l) occured also less frequently during the pilot study 
(CDSS-2) than during the TGC arm of the CGAO-REA trial (CDSS-1), 
respectively, 236 stays of 685 (34.5  %, 95  % CI 30.9–38.1  %) and 743 
stays of 1317 (56.4 %, 95 % CI 53.7–59.1 %).
Discussion Further studies are needed to improve glycemic control 
in the ICU and reduce the incidence of hypoglycemia. The respective 
roles of the increase in the BG target, the refinement of the algorithm 
or the use of the software in routine care could not assessed by our 
historical comparison. Anyway our study paves the way toward the 
development of the most efficient CDSS for managing BG control in 
the ICU.
Conclusion In comparison with the use of CDDS-1, the use of CDSS-2 
was associated with a lower incidence of both severe and moderate 
hypoglycemia during blood glucose control in critically ill patients.
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Introduction Among the drugs reported in self-poisonings, benzo-
diazepines remain the leading class of psychotropic drugs. However, 
the pharmacology and the toxicology as well of these drugs remain 
complex due to a chain of active metabolites with a final pathway fre-
quently involving nordiazepam and oxazepam. In spite of the progres-
sive withdrawal of potent hypnotics, drug-induced coma remains a 
leading and even increasing cause of admission in intensive care units. 
This finding suggests potent drug–drug interactions. However, in the 
setting of human poisoning, basis of pharmacology failed to quantify 
interactions. To address this issue, we are currently developing a new 
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discipline entitled toxicodynetics aiming at defining the time course of 
events of drugs either alone or in combination. The major aim of the 
present study was to report data from the Paris Poison Control Centre 
(PPCC) aiming at defining toxicodynetic parameters dealing with pure 
oxazepam and nordiazepam.
Patients and methods We used data collected at the PPCC from 1999 
to 2015. Indeed, the method of collection of data was the same along 
this period of time. Cases of pure oxazepam and nordiazepam were 
selected on the basis of self-report by the patient or relatives with a 
particular attention paid to eliminate the concomitant alcohol inges-
tion. The classical toxicodynetics parameters were looked for using 
the individual medical record available at the PPCC. These parameters 
included (1) the supposed ingested dose which was expressed as a 
therapeutic index (TI) as defined by a percentage of the maximum rec-
ommended daily dose, (2) the time of ingestion (T0), the delay in onset 
(hours), (3) the rate of worsening (hours or on–off process), (4) the 
maximal observed effect (Emax), (5) the time of onset of the maximal 
effect (Tmax), (6) the shape of the duration of maximal effect as a peak 
or a plateau, (7) the rate of recovery, (8) the duration of hospitalization 
in uncomplicated poisonings.
Results During the study period the number of exposures to oxaze-
pam and nordiazepam as a mono- or combined intoxications reported 
to the PPCC centre was 840 and 157, respectively. The number of 
mono-intoxications with oxazepam and nordazepam included in the 
toxicodynetic study was 257 and 74 cases, respectively. The T0 was 
known in all cases (100 %). The Emax in both oxazepam and nordiaz-
epam was sleepiness or obtundation occurring in 108 and 36 cases 
of oxazepam and nordiazepam, respectively. Noteworthy, coma was 
never used to qualify alteration in consciousness of the poisoned 
patients. The median delay in onset was 1 h in both poisonings. Inter-
estingly in both poisonings, there was no reported delay in onset of 
the Emax which was reported on a “on–off” mode. The median TI 
resulting in the Emax effect was 3.3- and 19.6-fold, the maximum 
recommended daily dose in oxazepam and nordiazepam poison-
ings, respectively. Follow-up of the poisoned patients was performed 
in only 19 and 13  % of the oxazepam and nordiazepam poisonings, 
respectively, precluding any definitive conclusion about the duration 
of symptoms.
Discussion Toxicodynetics is a new discipline in clinical toxicology 
focusing on relevant clinical toxic effects induced by a substance. 
Toxicodynetics may be described for all toxic substances using clini-
cal and biological data routinely collected. Toxicodynetics does not 
require any toxicological analysis and may be performed in both 
mono- and poly-intoxication. In spite of major limitations of the 
study which was a monocentric, retrospective study, some informa-
tion is provided regarding the early toxicodynetic phases of oxaz-
epam and nordiazepam involving exposures to large doses of each 
toxicant. Both poisonings were quite similar in terms of delay in onset 
of about 1  h, an “on–off” mode of occurrence of the Emax. In spite 
of large supposed ingested doses, limited effects on consciousness 
were reported, never using the term of coma. Oxazepam is the termi-
nal common metabolite of a number of benzodiazepines, including 
nordiazepam. Oxazepam is both metabolized into inactive metabo-
lites and eliminated unchanged in the urine. During the course of 
nordiazepam, a part of nordiazepam is metabolized into oxazepam 
which actually always results in a mixed nordiazepam and oxazepam 
poisonings. In spite of the supposed ingestion of large doses, the 
Emax in nordiazepam poisoning was not greater than that induced 
by oxazepam.
Conclusion Toxicodynetics provides information allowing going 
further to understand which substances may dramatically alter con-
sciousness. These findings support the hypothesis of the role of a 
drug–drug intoxication. The toxicodynetic approach unveils limitation 
of data collected routinely in PCC, not allowing to describe the late 
phase of poisoning. Toxicodynetics provides quantitative information 
on the quality of report of data in acute poisonings.
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Introduction Over the past 5  years, events in the Middle East have 
increased the awareness about the possible use of chemical weapons 
and their surrogates, the so-called Toxic Industrialized Compounds. 
The major issue is to identify on a clinical basis the likelihood of expo-
sure to chemicals ranging from riot agents to lethal agents in order (1) 
to advice protection of rescuers and caregivers at the scene, (2) to pro-
vide adapted treatment to casualties, and (3) to address the need for 
antidote supply.
Patients and methods This study is a systematic review of the lit-
erature on acute chemical accidents resulting in casualties to identify 
easily collected clinical signs and symptoms resulting. This review 
provided a limited list of signs to be collected in a small subset of 
frankly symptomatic patients. The signs and symptoms were classified 
according to the corresponding organ(s) involved by chemical injury. 
All signs should be clinically collected using current physical examina-
tion. We hypothesized that (1) such a chemical disaster cannot injure a 
single patient, (2) the collection of data can be repeated due to either 
an immediate onset or a progressive onset of signs and symptoms on 
an hourly or longer basis at the request of the attending physician. 
We advised to examine at least three symptomatic casualties and no 
more than 10. There are presently three versions of the sheet: French, 
English, and Arabic. Owing to the political context and analytical diffi-
culties, we never attempted at precisely determining the agent having 
caused signs and symptoms.
Results The one-page questionnaire was used in 5 settings, includ-
ing (1) a chemical incident related to the opening of a chemical plan 
in Lumumbashi in 2011, (2) the repeated use of anticholinesterasic 
agents towards civilians in Syria from April 2013 up to that the attack 
launched the 21 August 2013, (3) repeated chlorine attack towards 
civilians in Syria since March 2014, (4) an attack using a vesicant agent 
towards civilians in August 2015 in Syria, and (5) the acute onset of 
paraplegia in Mali on Summer 2015. In each setting, the analysis of the 
quoted items on the sheet allowed to suggest the class of the toxicant 
within a few hours after exposure. In the case of exposure to chlorine 
and to the vesicant agent, two collections of signs over a period of a 
few hours were needed to draw definitive conclusion. The lowest num-
ber of casualties in an exposure was three after exposure to vesicant 
agents. The definitive diagnosis was in accord with the initial presump-
tion regarding the class of toxicant. Early identification allowed to 
advise adapted protection of caregivers at the site as well as define the 
need for antidote supply and the nature of the antidote. Conversely, in 
one setting (Mali 2015) a toxic origin was ruled out as not fitting any 
known toxicant while an infectious disease was identified as the likely 
cause of the outbreak.
Discussion In case of suspected chemical incident or supposed ter-
rorist attacks, a one-page sheet of the list of signs and symptoms 
dedicated to identity relevant signs and symptoms allowed to define 
a toxidrome specific of a class of toxicant, helped in protecting rescu-
ers and caregivers at the site and refined the needs for supportive and 
antidotal treatment. Repeated collection of signs may be required in 
agents acting progressively. A close collaboration with a skilled toxi-
cologist is needed when facing incident involving hazardous mate-
rials. At the scene only chemical incident was identified. However, 
repetition of bombing in the same area resulted in a more accurate 
and rapid response of pre-hospital and hospital at the scene.
Conclusion A one-page sheet easily filled out at the scene in the 
context of chemical incident allows defining the toxidrome and con-
sequently protection of rescuers, needs for supportive and antidotal 
supply. Owing to the rapidity of action a number of toxicant, a single 
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or repeated examination over a few hours is needed to define the toxi-
drome and therefore the class of toxicant.
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Introduction The diagnosis in clinical toxicology is based on the col-
lection of information on (1) the substance, the dose, and the route 
of administration, (2) signs and symptoms that have to fit the sup-
posed ingested drug (SID), and (3) toxicological analysis (TA) which 
is expected to provide the definitive diagnosis. However, in the past, 
the development of methods based on immunoenzymology provided 
information on the class rather the substance by itself with question-
able ability to quantify exposure. Consequently, routinely used TA was 
progressively discarded. TA was recommended in only a few number 
of toxicants and in conditions where SID does not explain major signs 
and symptoms. However, over the past decade, modern TA using vari-
ous modes of mass spectrometry was developed; meanwhile, analysts 
claimed they was able to address all toxicological concerns of attend-
ing physicians. From a theoretical viewpoint, this assumption was 
sounded. However, the translational to practice has not been assessed 
to our knowledge. The aim of this retrospective study performed in a 
medical polyvalent intensive care unit (MPICU) was to test the hypoth-
esis more especially as the MPICU has unlimited access to facilities pro-
vided by three University Toxicology Laboratory (Tox Lab).
Patients and methods Patients Included patients were adult patients 
admitted for suspicion of poisoning ranging from moderate to severe 
in our MPICU from the January 1, 2014, until April 2015. This period 
of time corresponded to the period of time at which the MPICU has 
unlimited access to the three Tox Lab. Toxicology analyses: According 
to our current practice, blood and urine specimens were collected at 
the time of admission and sent to the different Tox Lab owing to the 
facilities provided by each, including the local hospital for a limited of 
toxiciants, the Tox Lab on duty in our institution allowing screening 
and dosing, and the Tox Lab of the Forensic Department of our insti-
tution. The latter two have facilities of modern apparatus including 
mass spectrometry in various modes as well as separative process (gas 
and liquid). The Tox Lab was blinded regarding the aim of the study. 
Expression of results: In each patient results from the different labo-
ratory were gathered, one positive detection/quantification of a SID 
was considered SID+, TA+; lack of SID with positive TA: SID−, TA+, 
a SID+ with negative TA was considered SID+, TA−. Unfortunately, 
there was no SID6, TA− as there was no need to ask for the presence 
of a drug to Tox Lab knowing it is was absent in a study done in cur-
rent practice. Assessment of severity of exposure Severity of exposure 
is assessed only for drugs and alcohol using the maximum daily dose 
recommended for drugs (a therapeutic index >1 denotes an intoxica-
tion) and a blood alcohol level (BAL) of 0.4 g/l (a BAL > 0.4 g/l was con-
sidered toxic).
Results Over the study period, there were 224 occurrences concern-
ing 90 SID (a number of multiple occurrences of the same drug) in 70 
patients (a number of patients reported multiple drug ingestions). A 
SID+, TA+ was recorded in only 33 % of the 224 occurrences; however, 
the TI was >1 in 45  % of the dosed drugs. In addition, in the group 
of SSI−, TA+, the TA added 15  % of patients with SID−. However, in 
79 % of the SID−, TA+, the TI was less than 1. This finding suggests the 
detection was that of drugs prescribed or used by the patient thera-
peutically or recreatively in this class of patients SID6, TA+.
Discussion In the sixties, toxicological analysis was considered the 
gold standard to definitively assume the role of a substance in a poi-
soning. Surprisingly, while the methods used in analytical toxicology 
resulted in a manifold increase in sensitivity and specificity allowing 
to screen hundreds of substances in 10 microliter of whole blood, the 
added value of analytical toxicology is fairly low as shown by evidenc-
ing the SID in only 33 % of the occurrences. We can question about the 
accuracy of the SID. However, until the toxicological analysis does not 
currently assume the substance is not present, the analytical result is 
subject to caution. The question is open to know whether high-reso-
lution mass spectrometer can actually increase the added value of TA. 
Furthermore, closer collaboration regarding the actual needs of the 
clinician may help analysts in defining the lists of toxicant of interest, 
providing regular update of this list of toxicant.
Conclusion Gathering facilities provided by three University Tox Lab 
using modern technology resulted in a low added value of toxicologi-
cal analysis in acute poisonings daily presenting in ICU. Improving the 
gap might be helped by high-resolution mass spectrometry. However, 
a closer collaboration between toxicologists and analysts should result 
in filling the gap.
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Introduction Drug poisoning is a frequent cause of hospitalization in 
intensive care units. The history, physical examination, electrocardio-
gram and standard biology are usually sufficient to make the diagno-
sis. In the most difficult cases, recent advances in analytical toxicology 
(toxicological screening) can identify possible accidental or intentional 
overdose or poisoning with the most frequently used drugs. Recent 
French guidelines indicate when this drug screening should be used, 
but its clinical interest is not clearly demonstrated. The purpose of this 
study is to evaluate the diagnostic and therapeutic usefulness of toxi-
cological screening. We also checked whether toxicological screening 
requirements were consistent with indications from the 2012 French 
guidelines (clinical and complementary examinations incompatible 
with the expected toxidrome, unexplained hemodynamic failure or 
coma).
Patients and methods This is a retrospective single-center observa-
tional study conducted in a University Hospital. All patients hospital-
ized in the Medical Intensive Care Unit in 2013 and 2014 who received 
a toxicological screening were included. The result of toxicological 
screening was considered useful when it found a toxic etiology that 
was not initially suspected or if it concluded to a non-toxic cause in a 
patient suspected of drug overdose.
Results During the study period, 118 patients underwent a toxico-
logical screening in the medical intensive care unit. The most com-
mon reasons for admission were toxic coma (39 %) and coma of other 
cause (25 %). The main drugs responsible of overdose were toxic sub-
stances in the central nervous system (72  %), especially benzodiaz-
epines (28 %) and neuroleptics (11 %). Cardiotropic drugs were found 
in 8 % of cases, mainly beta-blockers (5 %). The toxicology screening 
was asked because of a suspicion of poisoning in 58 % of patients and 
because of clinical manifestations without obvious etiology in 42  % 
of cases. The toxicological screening was performed according to the 
2012 French guidelines in 48 % of cases. The main reason for prescrib-
ing a toxicological screening without following the guidelines was a 
toxic coma consistent with the suspected toxidrome (54 %). The result 
was considered useful in the diagnosis in 27 % of cases with the find-
ing of a toxic etiology or of a non-suspected toxic in 20 % of patients. 
However, the therapeutic management was never modified following 
the results.
Discussion The results of our study considering the diagnostic utility 
are consistent with existing data of the literature. The lack of change 
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in the therapeutic approach of patients is correlated with previously 
published studies but is probably underestimated in the context of 
our retrospective study. Our toxicology screening requirements were 
not in agreement with the guidelines in half of the cases. A change in 
the way we prescribe toxicological screening is ongoing (information 
sheet accompanying the prescription of a toxicology screening, better 
collaboration between clinicians and biologists) to improve the cost–
benefit ratio of this technique.
Conclusion Our study highlights the diagnostic utility of toxicological 
screenings. A prospective study would highlight their real impact in 
the therapeutic management of patients.
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Introduction Acute poisoning represents a frequent reason of admis-
sion in emergency rooms and intensive care units (ICU). Evaluation 
of intoxication severity should rely on a rigorous approach based on 
analysis of prognostic factors. Existing prognostic scores are not effi-
cient enough to predict ICU admission in daily practice. Our purpose is 
to identify ICU transfer risk factors for acute poisoning.
Patients and methods This was retrospective study from 2012 to 
2014. All patients admitted to emergency department (ED) with a 
diagnosis of accidental or voluntary intoxication were included. Clini-
cal and toxicological data were first analyzed with univariate tests.
Results During study period, 571 patients were included and 77  % 
were women. Mean age was 26 ±  13  years. Toxic ingestion was vol-
untary in 87 % of cases. The median delay of consultation was 2 h after 
ingestion. Thirty-five had psychiatric history (23 %). The offending toxic 
was a drug in 83 % of cases (dominated by psychotropic drug and car-
diotropic drug) and a pesticide in 25 % of cases. The initial examination 
had showed: consciousness disorders with coma, digestive disorders, 
hypotension (<90 mmHg) and fasciculation. The toxidrome were iden-
tified in 55  % of cases: anticholinergic, muscle relaxant, cholinergic, 
membrane stabilizer, opioid and adrenergic. Fifty-nine percentage of 
patients were admitted in ICU. The initial management in ED: digestive 
decontamination in 81  % of cases, antidotes, intubation and vasoac-
tive drugs. In multivariate analysis, history of previous ICU admission 
for poisoning (OR 3.56; IC 95  % 1.08–13.22; p  =  0.03) and Glasgow 
Coma Scale (GCS) less than 13 (OR 4.47; IC 95 % 2.6–7.25; p < 0.002) 
were identified as risk factor for intensive care admission.
Discussion and conclusion Anamnestic content (history of previous 
ICU admission for poisoning, type of toxic  =  chloralose) and clini-
cal criteria at admission (GCS an anticholinergic toxidrome) are easily 
identified prognostic factors for early and appropriate orientation 
patients admitted to the ED for acute poisoning.
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Introduction Acute poisoning (AP) outcome depends on an early and 
effective management. The aim of our study was to compare the initial 
management of AP in a specialised toxicology emergency to the other 
healthcare facilities referring to international recommendations.
Patients and methods We undertook a comparative prospective 
observational study over 3  months. We included ail patients aged 
over 14 years. The study population was divided into two groups: G1, 
patients directly consulting the specialised toxicology emergency; 
and G2, patients transferred from non-specialised emergency. The pri-
mary endpoint was the initiation of symptomatic treatment, appropri-
ate gut decontamination and antidote use. The secondary endpoints 
interested intensive care unit hospitalised patients and concerned the 
occurrence of aspiration pneumonia, nosocomial infection, length of 
stay, mechanical ventilation and mortality.
Results Our study included 420 patients, 123 men and 297 women, 
and the mean age was 26 [20, 35] years. Our two groups gathered 273 
patients for the G1 and 147 patients for G2, and they were comparable 
for demographic and anamnestic data.
The initiation of treatment of neurologic failure was significantly more 
frequent in G1 (p = 0.01). The treatment of circulatory shock and res-
piratory failure was comparable in both groups.
There was no significant difference between the two groups regarding 
the appropriate use of gastrointestinal decontamination. The antidote 
treatment was more appropriate for G1 (p = 0.0001).
For hospitalised patients, the occurrence of aspiration pneumonia, 
nosocomial infection, length of stay, mechanical ventilation and mor-
tality was similar in both groups.
Conclusion The initial management of AP was not always consistent 
with the recommendations especially in healthcare facilities other than 
CAMU. To overcome these shortcomings, training of primary care phy-
sicians and better collaboration with poison control centers is needed.
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Introduction Plant intoxication is more and more frequent in Tuni-
sia, especially in rural regions. It concerns nearly 2–3 % of calls to the 
national Tunisian poison center in the last 10 years. They occur mainly 
in Spring season. Plant poisoning still be rare and unrecognized by 
health caregivers working in emergency and intensive care depart-
ments. The aim of our work was to report an extremely rare accidental 
collective plant poisoning by “hyoscyanus Niger” which happened in 
Zaghouan in Tunisia in a traditional celebration.
Patients and methods It was a descriptive transversal and retrospec-
tive study reporting a family collective (twenty-one members (21)) 
poisoning. This accidental poisoning occurred in the region of Zagh-
ouan in the spring 2015 (May). All members of the family consumed 
in a traditional village marriage “couscous” prepared with an alkaloid 
plant identified as “jusquiame.” This plant was confounded with Swiss 
chard.
Results On May 2015, a family composed of twenty-one members 
(ten men and eleven women) was admitted to the teaching emer-
gency and intensive care department of the regional hospital of Zag-
houan (Tunisia). All of them attended emergency department with a 
non-medical transfer.
All members of the family presented nausea, vomiting, dizziness and 
hallucinations.
Ten patients presented generalized seizures. All patients presented a 
great agitation. They reported the ingestion 12 h before a traditional 
couscous prepared specially for a traditional marriage.
They reported that it was prepared by “Swiss chard” specific to the 
region.
The average of blood pressure was 160/100  mmHg. All members of 
the family experienced tachycardia with extremes ranging from 100 
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to 160 beats per minute. On physical examination, six members of the 
family had myalgia and abdominal pain without other clinical signs.
We performed for all patients standard chest X-ray which was normal 
and laboratory tests.
Five patients (5) had hyperglycemia. Six patients (6) presented hypoka-
lemia and hyperleukocytosis. All brain CT scans performed for the 
ten (10) patients presenting with seizures were normal. They received 
diazepam as anti-convulsive agent and were admitted in the inten-
sive care unit for a mean hospital stay of 3 days. All patients recovered 
totally and were discharged from hospital after a stay ranging from 3 
to 5 days.
Samples of the herbal decoction were obtained from the couscous 
and were sent to be analyzed in the laboratory of toxicology in the 
Center for Emergency Medical Assistance of Tunis in Tunisia.
Screening by GC–MS revealed the presence of scopolamine, hyoscya-
mine and hydroxyhyoscyamine.
Conclusion Plant poisoning still be rare in Tunisia. The plant con-
sumed in this case series report “jusquiame” belongs to the genus 
“hyoscyanus” and to the variety of “solanacés.” We conclude from our 
work that plant poisoning can be extremely severe with neurological 
complications like seizures. The management is mainly symptomatic. 
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Introduction The number of poisonings occurring during each year 
in Paris area is not known. The Paris Poison Control Centre (CAPTV) 
reports annually a number of exposures (asymptomatic) and poison-
ings (symptomatic exposure). However, a number of other medical 
activities deal with intoxications, including emergency department 
in hospitals, intensive care units, and forensic laboratories. This study 
aimed at addressing this issue by means of collaboration between dif-
ferent departments involved in the management of or dealing with 
acute poisonings in Ile-de-France.
Patients and methods The study, led by the local team of the French 
Institute for Public Health Surveillance (InVS) and the Regional Health 
Agency of Ile-de-France (ARS-IDF), is based on the descriptive analysis 
of patient data collected by the Paris Poison Control Center (CAPTV), 
an emergency department (SU) participating in the Oscour® network, 
a medical and toxicological intensive care unit (RMT) whose results 
were extended using the CUBRéa database, the regional coordination 
of pharmacovigilance (CRPV) in Ile-de-France, and two toxicological 
laboratories conducting judicial forensic expertise after extra-hospital 
deaths. Acute poisoning having occured in the Ile-de-France (IDF) 
region, in 2010 and 2011, whatever the circumstances and severity 
were included. Deaths were collected prospectively in 2014. Drug-
induced adverse effects were not included. A particular attention was 
paid to eliminate duplicate.
Results Besides 27 145 cases (annual average) of poisoning or toxic 
exposure/poisonings reported to CAPTV corresponding mainly to 
accidental poisonings of young children, it should be added 2 980 
annual cases for the SU, 270 in ICU, 279 for the CRPV corresponding 
to acute poisonings not reported to the CAPTV, and 207 toxic deaths. 
Based on these figures, about 63,000 cases of acute intoxications occur 
in IDF every year with a global death rate estimated at 0.8  %. The 
profile of the intoxicated subjects differ significantly, other partners 
dealing mainly voluntary poisoning in adults among them, drug poi-
soning predominate, associated or not with alcohol.
Conclusion This multisources cooperation confirms the hypoth-
esis of a significant underestimation of poisonings identified by the 
CAPTV (one in two cases beyond him) and the possibility to improve 
the knowledge of the epidemiology of acute poisoning, thanks to the 
multiplicity of ways of observation of each partner.
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Introduction Chlamydia pneumoniae and Mycoplasma pneumoniae 
are rare pathogens that may lead to life-threatening acute hypoxemic 
respiratory failure. We sought to describe critically ill patients with 
atypical pneumonia managed in 16 French ICUs.
Patients and methods This is a retrospective cohort study of adult 
patients admitted to the ICU with proven atypical pneumonia (posi-
tive serology or PCR) over a 15-year study period (2000–2015).
Results Eighty-nine patients were included (62 men, 27 women) with 
a median age of 56 [44–66] years. They were mainly admitted for acute 
respiratory distress (n = 82; 92 %). Main comorbidity was chronic res-
piratory failure (n  =  28; 31  %). Time from respiratory symptoms to 
hospital admission was 5 [3–8] days. At ICU admission all patients had 
tachypnea (respiratory rate was 31[27.5–36.5]/min) and half presented 
with respiratory distress. Physical examination reported fever in 71 % 
of the patients, crackles in 50  % (45 patients), ronchi in 14 (16  %), 
wheezing in 10 (11 %) and consolidation in 6 (7 %) patients. Extra-pul-
monary symptoms were present in 32 (36 %) patients (arthritis, n = 2; 
myocarditis, n  =  4; hemolytic anemia, n  =  4 and skin rash, n  =  6). 
Three patients (3  %) had confusion, and meningoencephalitis was 
diagnosed in one patient. Cold agglutinins were identified in 8 (9 %) 
patients, cytolysis was present in 9 (10 %) cases, and rhabdomyolysis 
in one patient. Ten (11 %) patients had shock and 27 had various neu-
rological disorders. SOFA score was 5 [2–7], and SAPSII was 33 [25–41]. 
Chest X-ray disclosed alveolar opacities (n =  49, 55  %) or interstitial 
opacities (n = 28, 28 %). Two [1–4] quadrants were involved on chest 
radiography. Pleural effusion (n = 5, 6 %) was a rare finding.
Pneumonia was related to Mycoplasma pneumoniae (n  =  66; 74  %) 
or Chlamydia pneumoniae (n =  23; 26  %). Microbiological diagnoses 
were confirmed by serology (positive IgM in favor of recent infection 
or elevated IgG, n = 57) or positive PCR in respiratory samples (n = 34). 
Coinfection was found in 18 cases (20 %), with viruses (n = 8), bacteria 
(n = 7) or fungi (n = 3). Throughout the ICU stay, mechanical ventila-
tion was required in 67 (75 %) patients and 31 (46 %) had criteria for 
ARDS. Four patients needed ECMO. Length of mechanical ventilation 
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was 13 [8–18] days. More than one-third of the patients (n  =  33) 
needed vasopressors. Ten patients required renal replacement therapy 
(11 %).
First-line antibiotics included active treatment on atypical bacteria 
in 54 cases (61 %), started 1 day [0–4] after ICU admission. Combina-
tion therapy was used in 52 patients (58 %): third-generation cephalo-
sporin (C3G) and macrolide in 19 (36 %) patients, C3G and quinolone 
in 12 (23  %) patients, other betalactam and macrolide in 15 (29  %) 
patients or other betalactam and quinolone in 6 (12 %) patients. Anti-
biotics were further adjusted with macrolides mostly (n = 60), quinolo-
nes (n = 22) or cyclines (n = 2). Nine (10 %) patients died in the ICU. 
ICU length of stay was 15 [8.5–27] days. Almost half of the patients had 
persistent hypoxemia at ICU discharge. By univariate analysis, factors 
associated with mortality were duration of mechanical ventilation (18 
[15.5–24.5] days vs 12 [8–17], p = 0.02) and renal replacement therapy 
(3 vs 7 patients, p = 0.02). Lack of respiratory distress was associated 
with a better outcome (p = 0.014).
Conclusion Atypical pneumonia is associated with 10 % case fatality. 
At admission, extra-pulmonary symptoms were frequent and could 
guide intensivists to avoid missing the diagnosis. Strikingly, time to 
effective antibiotic against intracellular pathogens was not associated 
with mortality. Studies are needed to validate an algorithm for estab-
lishing clinical probability of atypical pneumonia in the critically ill.
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Introduction Leptospirosis is a worldwide distributed zoonosis with a 
high mortality rate. It has been declared a major public health issue by 
the World Health Organization. Consensual definition of severe lepto-
spirosis is somehow lacking. Reunion Island is one of the few regions 
with a high endemicity rate where every kind of organ support is avail-
able, including extra-corporeal membrane oxygenation (ECMO). The 
aim of this study is to determine the mortality rate of leptospirosis in 
an intensive care unit (ICU) where all kinds of organ supports are avail-
able and to asses the organ failures. This would help to define what 
severe leptospirosis is, in order to decide what patients must to be 
admitted in ICU.
Patients and methods This is a retrospective study from January 2004 
to January 2015. All patients admitted with leptospirosis in two critical 
care units (Reunion Island, France) were included. We collected demo-
graphic, clinical and biological data and performed bivariate analysis 
to examine risk factors associated with mortality.
Results One hundred and thirty-four patients were included with 
biological diagnostic confirmed in 100  % of the cases. Mortality rate 
in ICU was 6  %. Mean Simplified Acute Physiology Score (SAPS)-2 
was 40 ± 19, and mean Sequential Organ Failure Assessment (SOFA) 
score was 10  ±  4. Mean age was 41  ±  15  years. Acute renal failure 
was identified in 95  % of cases, thrombopenia in 93  % of the cases 
and hyperbilirubinemia in 90 % of the cases. Pulmonary involvement 
was frequent, with 40 % alveolar hemorrhage. Twenty-one percent of 
the patients presented moderate-to-severe acute respiratory distress 
syndrome (ARDS), according to the Berlin definition. All patients have 
been treated by antibiotics. Fifty-six percent of the patients under-
went CRRT, 31 % underwent invasive mechanical ventilation and 4 % 
underwent ECMO. Mean time for CRRT setup was 1 [1–2] day. Mean 
time for tracheal intubation was 12 [4–22] h. Risk factors associated 
with mortality were SAPS-2, SOFA score, neurological and/or respira-
tory failure on admission, alveolar haemorrhage, time between onset 
of symptoms and antibiotherapy, need for invasive mechanical venti-
lation, need for vasoactive support, kaliemia, pH, lactate, base excess, 
bilirubinemia and blood products transfusion. Main cause for mor-
tality was refractory ARDS (62 % of cases). All deceased patients had 
required oxygen support or were already under invasive mechanical 
ventilation upon admission.
Discussion To our knowledge, this is the largest case series of patients 
admitted for leptospirosis in ICU. This study pinpoints two important 
findings in this young population, such as the association of a very 
low mortality rate despite high severity scores and a strong asso-
ciation between respiratory failure and death. Prompt organ support, 
including CRRT and mechanical ventilation, is most probably the main 
explanation for such low mortality rate. All patients requiring oxygen 
support, even if as little as 1  L/min, should promptly be admitted in 
ICU. CRRT should in no way be delayed in patients presenting with 
kaliemia >4  mmol/L and oligo-anuria. Hyperbilirubinemia is for the 
first time to be identified as a risk factor for mortality, but it has already 
been described as a risk factor for mortality in ARDS. Cause or effect, 
it may participate to the particular pattern of pulmonary failure in 
leptospirosis.
Conclusion Severe leptospirosis should be defined as leptospirosis 
with oxygen requirement, especially if acute renal failure is coexisting.
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Introduction Bacteria are usually recognized as the main causative 
group of pathogens in community acquired pneumonia (CAP), but the 
important role of respiratory viruses has recently emerged. In stud-
ies having used multiplex polymerase chain reaction (mPCR) in CAP, 
viruses were identified in 15 % to 49 % of the patients. The impact of 
such viral documentation in airways remains largely uncertain. We 
studied a cohort of adult patients with CAP requiring intensive care 
unit (ICU) admission and explored the impact of the viral presence in 
the respiratory tract.
Patients and methods This is a monocenter retrospective study. All 
consecutive adult patients admitted to the ICU (Hôpital Bichat Claude 
Bernard, AP-HP) from October 2011 to June 2015 with a final diagno-
sis of pneumonia were screened. Patients having undergone mPCR 
in the respiratory tract within the 72  h following the ICU admission 
were included. Demographics, past medical history, clinical, biologi-
cal, microbiological and radiological data, organ failures and supports 
and outcome were collected. Four groups of patients were constituted 
according to the microbiological diagnosis: bacterial, viral, mixed 
(viral–bacterial) and no etiology groups. The primary objective was to 
determine the impact of the viral–bacterial coinfection on the pres-
entation and prognosis. A composite criterion of “altered prognosis” 
included the hospital death or mechanical ventilation for more than 
7 days. The second objective was to describe the epidemiology of res-
piratory viruses in adult patients admitted to ICU for a CAP in Western 
Europe.
Results One hundred and seventy-four patients (132 men (76  %), 
age 63 [53–75] years, SAPS II 38 [27;55]) were studied. Fifty-eight 
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(33 %) patients were referred from medical wards or other ICU. The 
median PSI score at hospital admission was 106 [78;130]. Pneumo-
nia was considered healthcare-associated pneumonia in near half 
patients (86, 49  %). At least one factor of immunosuppression was 
presented in 57 (33 %) of patients. A microbiological documentation 
was obtained in 144 (83 %) patients. At least one virus was identified 
in 98 (56 %) patients. The numbers of patients in the bacterial, viral, 
mixed and no etiology groups were 46 (26 %), 53 (31 %), 45 (26 %) 
and 30 (17  %) patients, respectively. S. pneumoniae was the most 
commonly identified microorganism, found in 40 (23  %) patients. 
Influenza viruses and rhinovirus were the most commonly identified 
viruses, found in 38 (22  %) and 22 (13  %) patients, respectively. All 
the patients infected with bacteria, except one in the bacterial group 
(45/46, 98 %) and one in the mixed group (44/45, 98 %), received an 
appropriate antimicrobial regimen within the first 24 h of ICU admis-
sion. The incidence of shock was higher in patients with a docu-
mented bacterial infection (30  % and 24  % in bacterial and mixed 
group, respectively) in comparison with other patients (6 % and 13 % 
in, respectively, viral and no etiology groups, p  <  0.01). In terms of 
biological findings on ICU admission, virus-infected patients dis-
played a higher serum creatine kinase (viral: 231 [96;460], mixed: 381 
[143;829], bacterial: 127 [74;338] and no etiology: 155 [45;259] U/L, 
p < 0.01) and a lower platelet count (viral: 171 [116;223], mixed: 202 
[129;273], bacterial: 212.5 [180;266] and no etiology: 261 [203;315] 
ng/mL, p < 0.01) in comparison with other patients. In terms of radio-
logical patterns on ICU admission, a trend toward a higher frequency 
of alveolar-interstitial infiltrates was observed in virus-infected 
patients in comparison with other patients (viral: 32 (62  %), mixed: 
23 (55  %), bacterial: 15 (33  %) and no etiology: 14 (48  %) patients, 
p  =  0.06). Finally, an altered prognosis was highly frequent in the 
mixed group (31/45, 69  %), as compared to bacterial (18/46, 39  %), 
viral (15/53, 28  %) and no etiology (12/30, 40  %) groups (p  <  0.01). 
In multivariate analysis, the microbiological diagnosis was identified 
as an independent factor of altered prognosis (reference: bacterial 
pneumonia; OR, 3.58; 95 % CI, 1.16–11; p = 0.03). An additional mul-
tivariate analysis, limited to bacterial and mixed groups, identified 
the viral–bacterial coinfection as independently associated with the 
altered prognosis (reference: bacterial pneumonia; OR, 4.53; 95 % CI, 
1.29–15.9; p = 0.02).
Conclusion The viral–bacterial coinfection during severe CAP in adults 
is associated with an impaired presentation and an altered outcome. 
These findings highlight the key role of respiratory viruses as patho-
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Introduction HHV8-associated disorders (HAD), namely Kaposi sar-
coma (KS), multicentric Castleman’s disease (MCD) and HHV8-asso-
ciated lymphomas (HAL, including primary effusion lymphoma and 
plasmablastic lymphoma), are a group of rare pathologies associated 
with poor prognosis. We sought to describe intensive care unit (ICU) 
management and outcomes of patients with HAP.
Patients and methods This retrospective study included patients 
presenting with HAD between 2002 and 2014 at our center. Factors 
associated with ICU mortality were identified through a multivariable 
logistic regression model.
Results Throughout the study period, 77 patients presented with HAD 
at our ICU. Twenty-nine patients (37.7 %) had only KS, 21 (27.3 %) MCD, 
11 (14.3  %) HAL, 8 (10.4  %) had the 3 conditions and 8 other patients 
(10.4  %) had lymphoma not related to HHV8 but associated with KS. 
Sixty-one patients (79 %) were HIV-infected with a HIV viral load of 3.3 
log (1.6–5) and a CD4 count of 90/mm3 (39–192). Seven patients had 
received solid organ transplantation (5 kidney transplants, 1 liver and 
1 pulmonary transplant), and 9 other patients had Mediterranean KS 
or HIV-negative MCD. Median HHV8 viral load was 2.94 log (0–4.87). 
Reasons for ICU admission were acute respiratory failure in 33 patients 
(42.9 %), shock in 25 (32.5 %), acute kidney injury in 7 (9.1 %), hemato-
logic failure in 7 (9.1 %) and coma in 6 patients (7.8 %). Simplified Acute 
Physiology Score 2 (SAPS2) at ICU admission was 47 (37.7–57). Mechani-
cal ventilation was required in 38 patients (49  %), vasoactive agents in 
32 (42 %), renal replacement therapy in 21 (27 %) and blood transfusion 
in 40 patients (52 %). HAD were associated with hemophagocytic lym-
phohistiocytosis in 34 patients (40 %). Infection occurred in 64 patients 
(83  %), 59  % being microbiologically documented. Chemotherapy was 
administered in 29 patients (38  %). ICU mortality was 15/77 patients 
(19.5 %). Lengths of ICU and hospital stays were 4 days (2–8) and 21 days 
(9.3–37.8), respectively. Hospital mortality was 27/77 (35.1 %), and mor-
tality at a median follow-up of 245 days was 44/77 (57.1 %). By univari-
ate analysis, factors associated with increased hospital mortality were the 
presence of all-cause lymphoma HHV8-associated or not (59.2 vs 22 %, 
p = <0.01), the need for mechanical ventilation (51.3 vs 17.9 %, p < 0.01) 
or vasoactive agents (58.1 vs 19.6 % p < 0.01), higher SAPS2 (53 (43.2–62) 
vs 43.5 (33–54), p = 0.02), hypoprotidemia (58 (46.2–64.2) vs 63 (55–75), 
p = 0.02), high bilirubinemia (51 (15.3–97.6) vs 15.8 (12.5–34.5), p = 0.04), 
high alkaline phosphatase (136 (107.2–212.2) vs 98 (62–143.75), p = 0.01) 
and number of involved serosae (72.7 % for 2 serosae or more vs 30 % 
for 1 vs 28.6 % for none, p = 0.02). By multivariate analysis, independent 
risk factors were all-cause lymphoma (OR 8.31 [2.31–29.95] p = 0.04) and 
mechanical ventilation (OR 7.58 [2.17–26.46] p  =  0.02). When entered 
in the multivariable model, chemotherapy administration in the ICU 
(including etoposide monotherapy) was independently associated with 
decreased mortality (OR 0.24 [0.06–0.92] p = 0.04).
Conclusion HHV8 infection is responsible for a wide range of clini-
cal diseases that display highly variable prognosis. The presence 
of lymphoma, whether HHV8-related or not, is the major determi-
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Introduction Invasive fungal infections (IFIs) are associated with high 
morbidity and mortality in critically ill patients, especially those immu-
nocompromised. Aspergillus spp. remain an important cause of IFIs, but 
other moulds have emerged over recent years as significant opportun-
istic pathogens and are associated with even higher mortality rates. In 
this retrospective study, we aimed to describe epidemiological trends 
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and clinical features of IFIs caused by emerging moulds and to assess 
their outcome in intensive care unit (ICU) settings.
Patients and methods From our ICU database, we extracted all records 
of patients admitted to the ICU from 2006 to 2014, in which IFI due to 
emerging moulds was diagnosed. The following epidemiological and 
clinical data were collected: underlying disease, immunosuppressive 
status, severity scores, reasons for ICU admission, organ failures and 
therapeutic management including mechanical ventilation, vasopres-
sives agents and renal replacement therapy. We also collected risk fac-
tors for fungal infections, mould species, span between ICU admission 
and IFI diagnosis, anti-fungal treatment. ICU mortality was assessed.
Results Among 3600 patients admitted in medical ICU, 17 (4.7/1000 
patients) had a positive diagnosis of IFI due to emerging moulds: 3 
females and 14 males, with median age 58  years (53–68), underly-
ing disease: haematologic malignancy: 12 (70  %), diabetes: 2 (12  %), 
chronicle obstructive pneumonia disease: 2 (12  %) and solid organ 
transplantation: 1 (6  %). Most of the patients were immunocompro-
mised (16, 94 %), and 12 have been treated by corticotherapy (70 %). 
IFI was diagnosed early in the course of the disease, at ICU admission 
for 7 patients (41 %) and later after ICU admission for 10 patients (59 %). 
At IFI diagnosis, severity scores were: SOFA: 13 (10–16) and SAPS-II: 71 
(54–88). Diagnosis was made by blood cultures in 5 cases (29 %) and by 
bronchoalveolar lavage in 11 cases (65 %). Six patients had a retrospec-
tive diagnosis. Mould species were: Rhizopus: 7 (41  %), Trichosporon: 
6 (35 %), Fusarium: 2 (12 %) and Scedosporium: 2 (12 %). All patients 
were mechanically ventilated, 15 needed catecholamines, and 11 had 
renal replacement therapy. An antifungal treatment was administrated 
to 15 patients (88 %) but was appropriate only for 12 of them (70 %). 
Two patients benefited from surgery. All patients died in ICU.
Conclusion Incidence of IFIs due to emerging moulds is far from neg-
ligible. It occurs mostly in immunocompromised patients with high 
severity score and still carries high ICU mortality. Early diagnosis and 
appropriate treatment remain a challenge. Further studies are neces-
sary to improve our understanding of IFIs caused by emerging moulds 
and improve their outcome.
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Introduction The prognosis of cancer patients admitted to intensive 
care units improves since two decades. The rare publications available 
suggest high rates of healthcare-associated infections (HAIs) and poor 
prognosis of nosocomial pneumonia in such patients. There is a need 
for a better understanding of the HAIs epidemiology in critically ill 
hematology and oncology patients.
Our objectives are: (1) to describe the incidence, the pathogen distri-
bution and the risk factors for ventilator-associated pneumonia (VAP) 
and bloodstream infections (BSI) in critically ill cancer patients; (2) 
to assess the influence of ICU-acquired infections, characteristics of 
malignancy and patient’s severity on outcome.
Patients and methods This is a retrospective review of prospec-
tively recorded data (2000–2011) of patients treated for more than 
48 h in a 12-bed oncology medical-surgical ICU of a referral French 
cancer center. We described the development of VAP and BSI (pri-
mary, secondary and catheter-related) and evaluated the influence 
of clinical characteristics and device utilization on infection rates; 
and of infections on the ICU mortality. Logistic and Cox models 
were used for the study of risk factors for infection and mortality, 
respectively.
Results Three thousand three hundred and eighty-eight patients (first 
stay) acquired 198 VAP and 393 BSI (213 secondary, 103 primary and 
77 catheter-related bloodstream infections [CR-BSI]). The device utili-
zation rate was 26 % for mechanical ventilation and 106 % for central 
venous catheter (most of the patients had an indwelling intravascular 
device). The VAP rate was 25/1000 ventilator-days; the CR-BSI rate was 
2.3/1000 catheter-days. The estimated cumulative incidences in the 
first 25  days of exposure was 59  % for VAPs, 8.9  % for primary, 15  % 
for secondary and 5 % for catheter-related bloodstream infection. The 
distribution of pathogens differed according to the type of infection: 
more Gram-negative bacilli in VAP and secondary BSI, Gram-positive 
cocci in CR-BSI; more anaerobes and polymicrobial infections in sec-
ondary BSI. Mechanical ventilation duration, older age, scheduled sur-
gery and solid tumor were VAP-specific risk factors. ICU stay duration, 
high SAPS II, scheduled surgery, ECOG-PS > 2, absence of metastases 
and recent leukopenia were significant primary BSI risk factors. ICU 
stay duration, surgery and leukopenia were significant secondary BSI 
risk factors. No risk factors were found significantly associated with 
the risk of CR-BSI due to the rarity of these events. The occurrence of 
neither a ventilator-associated pneumonia nor a bloodstream infec-
tion was associated with a higher risk of ICU mortality. All risk factors 
identified were markers of the characteristics of malignancy and of 
patient’s severity.
Conclusion In our study, the occurrence of nosocomial infections was 
largely due to the characteristics of malignancy and patient’s severity 
and did not further influence the outcome of hematology and oncol-
ogy patients admitted in ICU. Our findings in a large population of 
critically ill cancer patients can help to identify subgroups with a par-
ticularly increased risk. These data might serve for comparative stud-
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Introduction Diabetes mellitus (DM) affects 10 % of the general popu-
lation worldwide, 10  % to 25  % of critically ill patients and is associ-
ated with high short- and long-term morbidity and mortality. Sepsis is 
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among the main acute complications of diabetes. Intensive care unit 
(ICU)-acquired infections, especially bloodstream infections (BSI) and 
ventilator-associated pneumonia (VAP), are challenging complications. 
To our knowledge, only few studies reported the influence of diabetes 
mellitus on ICU-acquired sepsis in this setting. This study is an analysis 
of the Outcomerea database. We sought to determine whether diabe-
tes mellitus is associated with increased risk of BSI and VAP.
Patients and methods Outcomerea is a prospective observational 
multicenter cohort of patients admitted to 12 French ICUs. We stud-
ied the subgroup of patients with ICU length of stay >3  days and 
who needed invasive mechanical ventilation within the first 3  days 
of their admission. Patients with complicated diabetes mellitus were 
compared to patients with uncomplicated diabetes mellitus and with 
patients without DM. Endpoint was occurrence of ICU-acquired sepsis 
(first bacterial or fungal BSI and VAP occurring later than the second 
day of ICU admission, and up to 2 days after extubation, exit or death, 
data censored at day 28). To estimate the influence of baseline covari-
ates on sepsis occurrence, we used the proportional hazards regres-
sion Fine and Gray model for competing risk.
Results Among the 15,876 patients of Outcomerea, 5865 patients 
were included with 4819 controls and 1046 (18  %) patients with 
diabetes mellitus (282 with and 764 (13  %) without chronic compli-
cations). Age was significantly higher in DM patients (69.8 [61–77.2] 
in complicated DM, 69.7 [60–77.6] in uncomplicated DM, and 63.2 
[50.6–75.3] in controls, p value  <  0.01). SAPS 2 score was greater in 
DM patients (54 [43–72] in complicated DM, 55 [43–67] in uncompli-
cated DM, and 51 [39;63] in controls, p value  <  0.01). Comorbidities 
were more frequent in patients with DM (155 (55 %) in complicated 
DM, 386 (50.5  %) in uncomplicated DM, and 1968 (40.8  %) in con-
trols). Main comorbidities were: respiratory (15.1 %), immunosuppres-
sion (14.8  %), cardiologic (13.3  %), hepatic (7.2  %), and renal (5  %). 
Main reasons for admission were: circulatory (21.6  %), neurologic 
(22.8 %), digestive (18.2 %), infectious (16.5 %), and metabolic (16 %). 
In patients with DM, reasons for admission were more often circula-
tory, metabolic, and infectious (p < 0.01). Throughout their ICU stay, 
183 (64.9 %) patients with complicated DM, 450 (58.9 %) patients with 
uncomplicated DM, and 2680 (55.6 %) patients without DM required 
vasopressors (p < 0.01). Two hundred and forty-five (86.9 %) patients 
with complicated DM, 595 (77.9 %) patients with uncomplicated DM, 
and 3610 (74.9  %) patients without DM underwent central venous 
catheterism (p < 0.01).
ICU-acquired sepsis occurred in 63 (22.3 %) patients with complicated 
DM (23 (8 %) BSI and 44 (16 %) VAP), 140 (18.3 %) patients with uncom-
plicated DM (48 (6.3  %) BSI and 109 (14.3  %) VAP), and 936 (19.4  %) 
patients without DM (317 (6.6 %) BSI and 749 (15.5 %) VAP). Main path-
ogens in bloodstream infections were: Staphylococcus aureus (14.25 %), 
Pseudomonas aeruginosa (9.66 %), Escherichia Coli (9.43 %), Enterococ-
cus faecalis and faecium (8.74  %), Staphylococcus epidermidis, (8.05  %) 
and Candida albicans (7.36 %). Main pathogens in ventilator-associated 
pneumonia were: Pseudomonas aeruginosa (24.40  %), Staphylococcus 
aureus (12.96 %), Escherichia Coli (6.88 %), and Haemophilus influenzae 
(5  %). ICU mortality rates were 27.3, 31.4, and 25.8  % in complicated 
DM, uncomplicated DM, and controls (p < 0.01). Corresponding hospi-
tal mortality rates were 39.7, 40.4, and 34.6 % (p < 0.01).
By multivariable analysis, independent risk factors for acquired sepsis 
(BSI/VAP) were: the ICU, male gender (hazard ratio 1.268, 95 % confi-
dence interval [1.120–1.436], p value = 0.0002), admission for a medi-
cal reason (1.230, [1.062–1.425], p value = 0.0058), higher SOFA score 
at day 1 and day 2 (1.048, [1.031–1.066], p value < 0.0001), respiratory 
comorbidity (1.259, [1.080–1.468], p value = 0.0033), need for central 
line (1.442, [1.220–1.706], p value <0.0001), existence of a bloodstream 
infection at admission (1.269, [1.055–1.527], p value  =  0.0115), and 
existence of a pneumonia at admission (1.443, [1.245–1.673], p value 
<0.0001). Diabetes mellitus with and without complications were not 
independent risk factors for acquired infections. There was a trend 
toward increased Staphylococcus aureus ventilator-associated pneu-
monia in patients with complicated diabetes mellitus (1.748, [0.990–
3.088], p value = 0.0544).
Conclusion Diabetes mellitus, whether complicated or not, does not 
seem to be a risk factor for intensive care unit-acquired bloodstream 
infection or ventilator-associated pneumonia. However, there is a trend 
toward an association between complicated diabetes mellitus and 
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Introduction Nasal high-flow (NHF) is increasingly used in the man-
agement of acute respiratory failure. Previous data suggest that the 
high-flow rates may result in an anatomical dead space washout. This 
mechanism is likely to reduce respiratory effort, but little is known 
about the physiological effects of NHF on the work of breathing in 
adults and the dose–response relationship.
Materials and methods We designed a prospective study in order to 
investigate the short-term effects of NHF on physiological respiratory 
parameters in healthy subjects. Five sessions of 10 min were evaluated: 
a baseline period with spontaneous breathing (SB), followed by a ran-
domised sequence of four conditions: 5 L/min with conventional nasal 
canulas, and 20, 40 and 60 L/min with high-flow nasal cannulas. Dur-
ing the whole protocol, FiO2 was set at 0.21. The primary outcome was 
the work of breathing (WOB), computed from esophageal pressure 
and tidal volume, which was estimated by respiratory inductive ple-
thysmography. We also measured and calculated the esophageal pres-
sure–time product (PTPeso), minute ventilation, capillary blood gases 
at the end of each tested condition, airway resistance and compliance.
Results Recruitment is still under progress. We report here the data of 
a preliminary analysis performed in 8 subjects. No significant differ-
ence in WOB was evidenced between the study periods (1.82 ± 0.92 
vs. 1.71 ±  0.80 vs. 2.56 ±  1.30 vs. 2.01 ±  0.17 vs. 2.38 ±  0.50  J/min; 
respectively, for SB, 5, 20, 40 and 60 L/min; p = 0.36). PTPeso was not 
significantly modified either (70.2 ± 27.3 vs. 70.6 ± 25.6 vs. 87.9 ± 34.4 
vs. 78.8 ±  25.6 vs. 93.4 ±  28.0  cmH2O  s/min respectively; p =  0.59). 
However, respiratory pattern was found to be different through-
out the study periods, with an increase in tidal volumes (345  ±  91 
vs. 377 ± 101 vs. 493 ± 138 vs. 445 ± 157 vs. 560 ± 102 mL, respec-
tively, for SB, 5, 20, 40 and 60 L/min; p = 0.002) and a flow-dependant 
decrease in respiratory rate (16.0 ±  1.9 vs. 13.2 ±  2.0 vs. 10.6 ±  2.6 
Fig. 52 PEEP (cmH2O) depending on the different phases. a Patients 
during weaning process, b non‑intubated spontaneously breath‑
ing patients. CSBT conventional spontaneous breathing trial, HFSBT 
spontaneous breathing trial with high‑flow therapy, MV mechanical 
ventilation, COT conventional oxygen therapy, HFT high‑flow therapy. 
*p < 0.05; **p < 0.01 
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vs. 9.5 ± 3.0 vs. 7.6 ± 2.4 breaths/min, respectively; p < 0.0001). This 
resulted in similar minute volumes between baseline, 5 and 20 L/
min (5.42 ±  1.02 vs. 5.01 ±  1.59 vs. 5.33 ±  2.09  L/min, respectively; 
p = 0.41), whereas a significant decrease was found with 40 and 60 L/
min (4.04  ±  1.36 and 4.18  ±  1.22  L/min respectively; p  =  0.009 vs. 
baseline). pH, PaCO2 and SpO2 were not significantly modified during 
the study periods. Respiratory compliance was not significantly dif-
ferent between the study periods either (p = 0.74), but mean airway 
inspiratory resistances did increase with increasing flows (14.6 ±  4.4 
vs. 15.6 ± 4.5 vs. 18.9 ± 6.2 vs. 22.5 ± 7.1 vs. 25.7 ± 9.6 cmH2O/L/s, 
respectively, for SB, 5, 20, 40 and 60 L/min; p = 0.01).
Discussion To our knowledge, this study is the first to evaluate the 
work of breathing during NHF in healthy adult subjects. This lack of 
data may be attributable to the technical complexity of measuring 
inspiratory flow during NHF. Here, we used respiratory inductive ple-
thysmography, which has been previously used by several authors, 
and has shown to provide an acceptable estimation of tidal volume.
Conclusion We found that the use of NHF above 40 L/min led to a sig-
nificant reduction of minute volume in healthy subjects, mainly driven 
by a dramatic decrease in respiratory rate, PaCO2 remaining constant. 
This finding strongly suggests a reduction in the physiological dead 
space and supports the necessity of such an evaluation in patients. 
No modification of WOB was evidenced, and this may be related to an 
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Introduction High-flow therapy (HFT) is commonly used in ICU. We 
hypothesize that in patient undergoing respiratory failure, beyond 
the positive end-expiratory pressure (PEEP) generated, HFT provides 
a moderate ventilatory support. This support could be able to reduce 
the electrical activity of accessories inspiratory muscles. The objective 
of this study was to evaluate the sternocleidomastoid’s (SCM) electro-
myographic activity during HFT versus conventional oxygen therapy 
(COT) in non-intubated patient and versus COT and mechanical ven-
tilation (MV) in intubated or tracheotomized patient during difficult 
weaning.
Materials and methods SCM electromyographic activity (EMG) 
was recorded as follows: Phase I included non-intubated hypoxemic 
patients who needed at least 8 L/min of COT. They received three 
times 20  min steps evaluation (COT–HFOT–COT). Phase II included 
intubated or tracheotomized patients in weaning failure. They have 
been randomly tested for conventional T-tube spontaneous breathing 
trial (CSBT) and high-flow SBT (HFSBT). These two 20-min steps were 
separated by a 20-min step of MV. FiO2, PEEP, arterial blood gazes and 
hemodynamic data were also collected.
Results Phase I included 11 patients. PEEP (Fig. 52b) was significantly 
higher with HFOT than with COT (5  ±  4.95 vs 1.44  ±  3.13  cmH2O, 
respectively, p  =  0.029), while EMG activity (Fig.  53b) was sig-
nificantly reduced with high flow (27.35  ±  15.77  mV with HFOT 
vs 31.31  ±  17.21  mV with COT, p  =  0.008). Phase II included 10 
patients. With HFSBT PEEP present an intermediary level compared 
with MV and with CSBT (2.2 cmH2O in HFSBT vs 6.2 cmH2O in MV vs 
0 cmH2O in CSBT, p < 0.001) (Fig. 52a). SCM EMG differs in CSBT and 
MV (32.92  ±  8.53  mV during CSBT vs 22.99  ±  4.39  mV during MV, 
p =  0.007), while during HFSBT, EMG presents an intermediary level 
(26.17 ± 6.56 mV) (Fig. 53a).
Conclusion We observed a decreased inspiratory muscle’s electromy-
ographic activity that reflects an improvement of the ventilation with 
HFT. This can be interesting for patient with respiratory failure, particu-
larly for patients in weaning phase.
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Introduction By preventing deleterious effects of bed rest, early mobi-
lization (EM) of critically ill patient improves various outcomes includ-
ing quality of life [1,2]. However, no data exist on patient’s perception 
of this EM. The aim of this study was to report on the feasibility and 
patient’s tolerance of EM.
Patients and methods Our local standardized EM protocol was pro-
spectively evaluated over a 2-month period in the 171 consecutive 
patients admitted in our mixed 14-bed ICU. Data on feasibility, adverse 
events, hemodynamic parameters and patient’s perception were 
collected.
Results Three percent (n =  22) of the 731 patient-days reached our 
standard exclusion criteria for EM (prior cardiac arrest, unstable spine 
fracture, active bleeding and uncontrolled intracranial pressure). From 
the remaining 709 patient-days, 86 % had at least one early mobiliza-
tion intervention (physiotherapy session or transfer out of bed); 74 % 
of patients were transferred out of bed to chair, and 59 % received at 
least one physiotherapy session. Fifty-one percent of patients were 
under mechanical ventilation (46 % patient-days), and 35 % had vaso-
pressor and 11  % continuous renal replacement therapy. In patients 
on mechanical ventilation, transfer out of bed was achieved in 68  % 
of patient-days and 80 % received at least one EM activity. Limitations 
to early mobilization included staff number, diagnostic or surgical 
Fig. 53 Sternocleidomastoid EMG (mV) depending on the diferent 
phases. a Patients during weaning process, b non‑intubated spon‑
taneously breathing patients. CSBT conventional spontaneous breath‑
ing trial, HFSBT spontaneous breathing trial with high‑low therapy 
MV mechanical ventilation, COT conventional oxygen therapy, HFT 
high‑low therapy. *p < 0.05; **p < 0.01
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procedures, patients’ refusal and hemodynamic instability. Very rare 
(0.8  %) and reversible adverse events were observed as reversible 
hypotension or arrhythmia. Hemodynamic parameters were not 
affected after active mobilization. Patient’s perception was reported 
close to good feeling after a physiotherapy session.
Conclusion EM shows to be a common and safe procedure and is 
achievable in the vast majority of critical ill patients even in the pres-
ence of multiple vital organ supports. Communicant patients report a 
positive feeling after application of this intervention.
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Introduction Early mobilization of critically ill patients is a major 
issue when it comes to ICU-stay shortening for multiple organ failure 
patients. It is well accepted that “bed-in-chair” sitting, first chair sitting 
exercise, passive verticalization and walking are crucial steps to better 
rehabilitation in the ICU and after patients have left the ICU. We aimed 
at assessing the real-life conditions performance of early rehabilitation 
practices in ICUs and to study why there are sometimes limitations to a 
large use of such training for patients.
Materials and methods A prospective telephone inquiry was per-
formed from February to March 2015 in 35 ICU (25 from university 
hospitals), representing 1046 beds; it recorded data on ICUs and on 
the real-life practice of rehabilitation in the setting of 5 clinical cases 
(1 coma patient undergoing mechanical ventilation weaning yet he 
was on low tapering NE infusion, 1 ARDS, 1 COPD under noninvasive 
ventilation, 1 acute/chronic liver failure patient infused tapering doses 
of norepinephrine, 1 postoperative patient) For each case, staff were 
questioned on the practice of transferring from flat bed to chair; bed 
in armchair positioning; transferring to edge of bed; standing position; 
and marching. In addition, we collected the reasons for not practicing 
early mobilization.
Results One hundred percentage of responses were made by physi-
otherapists, 64.5 % of which had less than 5-year working experience. 
The median number of patients taken in care by one physiotherapist 
was 14 (range 3.5–52), whereas simultaneously each nurse had 2.5 
patients in charge, and each nurse auxiliary 4.2. Shift-hours were on 
12 h a day in 58.8 % of the ICUs (Table 62).
The main reasons for not proposing early rehabilitation are low con-
sciousness level, NE infusion, curare infusion and the simultaneous 
presence of many surgical drains in the same patient.
Conclusion Despite low sedation, many critically ill patients are readily 
installed in a bed in armchair position because this position does not 
include danger and allows easy visual control. Postoperative patients 
with complicated surgical devices are not often proposed for early 
mobilization from bed: Nurses and physiotherapists bring up the prob-
lem of understaffing. Patients with low doses (or tapering low doses) 
of NE are infrequently proposed for early mobilization; although no 
reliable data concern the dose–effect relationship with negative side 
effects in such a population, a specific study is deserved to understand 
whether such patients would benefit from such rehabilitation in terms 
of shorter ICU stay and outcome.
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Introduction Motor imagery can be used in conjunction with fMRI 
(functional magnetic resonance imaging) to study brain plasticity 
during motor recovery for non-highly selected stroke patients. The 
presumed advantage of using motor imagery over overt movements 
is that they both share a number of behavioral (Jeannerod 1995) and 
Table 62 See text for description
a transferring from a flat bed to chair; b bed in armchair position; c transferring 
to edge of bed; d standing position; e marching; NE norepinephrine
Cases Rehabilitation % Limits
1. Resolving 
coma, taper‑
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physiological parameters (Kranczioch et  al. 2009), as well as certain 
functional neuroanatomical correlates (recruitment of motor net-
works) (Confalonieri et al. 2012). Motor imagery is in fact a broad con-
cept that includes both implicit and explicit mental imagery (Di Rienzo 
et al. 2014).
Clinical scores and questionnaires have been used to assess motor 
imagery abilities. The most frequent is the Kinesthetic and Visual 
Imagery Questionnaire (KVIQ), which can be somewhat subjective. In 
contrast, subject performance can additionally be objectively evalu-
ated using fMRI.
Patients and methods To determine the areas and brain networks 
engaged during motor imagery in healthy subjects and stroke 
patients, a literature review was conducted. The keywords used were 
“motor imagery,” “fMRI,” and “stroke.”
Results Functional imaging techniques have helped highlight the 
activation of a large network during motor imagery tasks, including 
fronto-parietal, subcortical, and cerebellar regions, as well as cortical 
areas involved in motor control. The activation of the primary motor 
cortex, however, has been controversial for many years (Lotze and 
Halsband 2006). Indeed, in a recent neuroimaging meta-analysis, Hétu 
et al. (2013) did not find the primary motor cortex to be consistently 
activated among subjects.
Finally, it is important to note that these activations depend on several 
parameters: the part of the body imagined, the mode (kinesthetic or 
visual), and the difficulty of the imagined motor task.
Discussion One of the limitations in assessing brain plasticity in stroke 
patients with motor imagery is their “chaotic” motor imagery perfor-
mance, revealed by a disruption of accuracy of imagined movements 
and temporal coupling between executed and imagined movements 
(Sharma, 2006). Moreover, certain stroke locations distinctly modify 
patient performance in motor imagery, such as parietal lobe damage 
or right-sided lesions.
Malouin et al. (2012) found a lower correlation between executed and 
imagined movements in right-sided lesions. They hypothesized that 
imagining movements was more demanding in right-sided strokes 
due to damage to the fronto-parietal network, known to be involved 
in the visuospatial domain. Patients with lesions involving the parietal 
cortex were also selectively impaired at predicting the time required 
to perform an explicit motor imagery task. This is consistent with pre-
vious findings of a decorrelation between executed and imagined 
movements in patients with lesions restricted to the parietal lobe 
(Sirigu et  al., 1996). The parietal lobe is indeed a complex structure 
responsible for several aspects involved in explicit motor imagery, 
such as correspondence between observed and executed move-
ments, representation of internal models, maintaining the postural 
representation of the upper limb, and movement intention and motor 
preparation.
Conclusion These findings suggest that fMRI is helpful in assessing 
patient motor imagery ability and could be used to determine which 
patients would benefit from motor imagery training.
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Introduction The use of diagnostic ultrasound by physiotherapists 
is not a new concept; it is frequently performed in musculoskeletal 
physiotherapy. Physiotherapists currently lack accurate, reliable, sen-
sitive and valid measurements for the assessment of the indications 
and effectiveness of chest physiotherapy. Thoracic ultrasound may be 
a promising tool for the physiotherapist and could be routinely per-
formed at patients’ bedsides to provide real-time and accurate infor-
mation on the status of pleura, lungs and diaphragm.
Materials and methods This is a narrative review. This review refers 
to lung and diaphragm ultrasound semiology and how thoracic ultra-
sound should be used in the physiotherapist’s clinical decision-making 
process.
Results Lung ultrasound provides real-time and accurate informa-
tion about the pleura, lung and diaphragm statuses of the patient: 
This allows the assessment of lung aeration, including interstitial 
syndrome to lung consolidation. Each ultrasound pattern is related 
to a level of aeration as follows: normal with A lines indicate a well-
aerated lung; B lines indicate alveolar-interstitial syndrome and 
increased extravascular lung water; and lung consolidation indicates 
total loss of aeration.
A physiotherapist must to accurately evaluate a patient in order to 
select the most suitable intervention. Thus, to reliably assess the lung 
status, lung ultrasound examinations should be comprehensive (i.e., 
both lungs and all of the chest areas should be investigated).
In cases of ICU bedridden patients, B lines are found primarily in the 
most dependent parts of the lungs and are frequently associated with 
basal lung consolidations; thus, body positioning and mobilization 
might be a suitable strategy to improve lung aeration.
In case of confluent B lines, alveoli are partially filled by fluid. Tech-
niques aimed at improving ventilation and preventing lung consoli-
dation should be considered and include positive expiratory pressure, 
body positioning and mobilization.
At the patient’s bedside, LUS performs much better than chest X-rays 
at diagnosing lung consolidation. LUS characteristics thus allow physi-
otherapists to quickly distinguish between atelectasis and pneumonia 
and to implement a suitable therapeutic strategy. For example, the 
dynamic air bronchogram rules out atelectasis.
In cases of lobar or hemilobar lung consolidation with fluid broncho-
grams in mechanically ventilated patients, the treatment should imply 
techniques that increase the expiratory flow rate (e.g., huffing, exsufla-
tor) with adjustments to the ventilator settings. With lung ultrasound, 
the physiotherapist monitors the consolidation and evaluates the 
effectiveness of treatments.
If the physiotherapist identifies a pleural effusion, it seems reasonable 
to address the patient and wait for medical or surgical treatment to be 
completed. Then, the physiotherapist may help to implement support-
ive respiratory management if a chest drain is not required.
Discussion In addition to clinical examinations, lung ultrasound may 
guide the choice of chest physiotherapy strategies (e.g., alveolar syn-
drome, lung consolidation) or help to determine whether the patient 
requires medical intervention and no chest physiotherapy (e.g., pneu-
mothorax, severe pleural effusion). An appropriate level of training is 
necessary to implement lung ultrasound in clinical practice. Thoracic 
ultrasound may be used in clinical research for chest physiotherapy 
because it is accurate, reliable and reproducible.
Conclusion Diagnostic ultrasound performs significantly better 
than chest X-rays or auscultation at diagnosing lung deficiencies 
that are relevant for the physiotherapist. Physiotherapists should 
use lung ultrasound semiology to guide, monitor and evaluate their 
chest physiotherapy treatments. This potential new tool for physi-
otherapists still requires significant development before being used 
commonly.
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Introduction During nebulization associated with noninvasive ven-
tilation using single-limb circuit bilevel ventilator, it has been shown 
that a part of drug nebulized during expiratory phase is held in the 
circuit and delivered during the next inspiratory phase. This “reservoir 
effect” could potentially improve drug delivery. Also, the use of an 
inspiratory synchronized nebulization has been shown to be effec-
tive in ventilated patient. The aim of this in vitro study was to compare 
aerosol delivery of amikacin using two different vibrating-mesh nebu-
lization modes coupled to a single-limb circuit bilevel ventilator: (1) an 
experimental expiratory (Expi-Neb) and (2) inspiratory (Inspi-Neb) syn-
chronized nebulization modes.
Materials and methods Using an adult lung bench model of non-
invasive ventilation, we coupled a vibrating-mesh nebulizer with a 
bilevel ventilator. The nebulizer was charged with amikacin solution 
(250  mg/3  mL) and positioned before and after the exhalation port 
(starting from the lung model). An experimental control system was 
used to perform an expiratory (aerosol generated during only the 
whole expiratory phase) and inspiratory (aerosol generated during 
only the whole inspiratory phase) synchronized nebulization modes. 
Inhaled doses were assessed by residual gravimetric method.
Results Irrespective of the nebulizer position, Inspi-Neb produced 
higher inhaled dose than Expi-Neb (position before exhalation port: 
75.8 ± 0.9 vs 55.9 ± 0.8 % of nominal dose; position after exhalation 
port: 34.0 ± 0.4 vs 15.6 ± 0.1 % of the nominal dose; p < 0.05 for both). 
At position after exhalation port, adding 289-mL corrugated piece of 
tubing between exhalation port and nebulizer was associated with an 
increase in aerosol delivery of Expi-Neb (+5.7 ± 0.2 % of the nominal 
dose; p < 0.05).
Conclusion During simulated noninvasive ventilation with a single-
limb circuit bilevel ventilator, aerosol delivery with a vibrating-mesh 
nebulizer was dependent on nebulization mode and position. Expira-
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Introduction O2 administration is essential for patient survival in clini-
cal situation as: reanimation or anesthesia of a polytrauma, CO poison-
ing, decompression sickness, etc.
When the oxygen stock is limited (critical situations as war zones, 
disasters, etc.), the delivery of high FiO2 for an extended period may 
become insufficient.
To limit the O2 volume required in spontaneously breathing patients, 
we can use the Wenoll system (rebreather with closed circuit to recap-
ture the exhaled O2).
This closed circuit provides a 100 % FiO2 for a low flow rate for patients 
at rest: O2 flow rate covers O2 consumption (VO2) and a soda lime car-
tridge absorbs the CO2 produced by the patient’s metabolism.
Since we know that an O2 flow rate of 1 to 2 l/min with an usual O2 cyl-
inder (O2C) is generally sufficient to ensure the VO2 of a patient venti-
lating at rest, our goal was to determine whether the use of a portable 
oxyconcentrator (POC) could effectively replace the use of a O2C and 
thus ensure proper FiO2.
Materials and methods The study was conducted on bench with the 
Wenoll system connected to an a two-compartment adult lung model 
(Dual Test Lung ®) controlled by a Maquet Servo I® ventilator (Vt: 0.5 
L; I/E: ½; Peep: 0 cm H2O: Rf 10 to 40 cpm). Different minute ventila-
tion (MV: 5 to 20 l/min) were investigated. An oxygen flow rate of 2 l/
min O2 was ensured using either a O2C (B2: Air Liquide 
™) or an POC 
(Sequal Saros ®). Two mode of O2 delivery systems were tested: Contin-
uous O2 (O2C and POC) and bolus O2: 74 ml at each breath (with POC). 
The FiO2 and MV measurements were made using a iWorx
® acquisition 
system (GA207 gas analyzer and analog/digital IX/228 s) and LabScribe 
II ® software. Statistical test used: ANOVA followed by a post hoc test 
(Tukey).
Results After a period of 5  min necessary for the denitrogena-
tion of the Wenoll system dead volume (O2 flow rate: 2  l/min), the 
FiO2 reached a value of 100  % with O2C and 92  % with POC at con-
tinuous flow (p < 0.05). With POC, there was no significant difference 
between continuous and bolus mode (pulsed volume of 74 ml at each 
respiration).
Conclusion We hypothesized that the oxygen extraction ratio (E) of air 
in the lung (E = FiO2 − FEO2) was stable and equal to 5 %. In this case, 
if VI is equal to VE, VO2 is:
VI volume of air inspired per minute (l min−1)/VE volume of air expired 
per minute (l  min−1), FiO2: Fraction inspired of O2/FeO2: fraction 
expired of O2.
Consequently, for MV from 5 to 20 l/min, with the use of an POC cou-
pled to Wenoll system, we can administer for a long period FiO2 near 
92 % with a very low O2 flow rate (2 l/min) to ensure the patient VO2. 
Note that the duration of effectiveness of the decarboxylation by soda 
lime cartridge of Wenoll system is estimated (by the manufactory) to 
be 5 h for a patient ventilating at rest.
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Introduction The O2 delivery in high altitude areas (HAA –  >  8000 
feet) is a major logistic problem. The oxyconcentrators (OCC) can be 
a solution to overcome this problem because they are an inexhaust-
ible source of oxygen so far as their power supply can be ensured. 
Very few studies have examined the OCC in HAA. The aim of our study 
was to evaluate the FiO2 and O2 flow rate issued by three OCC in high 
altitudes.
Materials and methods Three OCC (Simply go ®, Devilbiss®, Ever-
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hypobaric chamber (HC) (Aerospace Medicine Centre, Queen Astrid 
Military Hospital, Brussels). During the experimentation, the average 
temperature of the HC was maintained at 24  °C and relative humid-
ity at 58 %. Seven altitude levels (from 0 to 18,000 Feet) were succes-
sively achieved. FiO2 was measured in continuous by an analog iWorx 
station/digital IWx/214 coupled to an analyzer of CO2/O2 iWorx GA200. 
O2 flow rate was analyzed by a thermal mass flow meter Vogtlyn
™ Red 
Y. A oxygen cylinder was used as a reference gas to recalibrate O2 ana-
lyzer at each level of altitude.
Statistical test: ANOVA.
Results For the three OCC: Average FiO2 was 93 % (±1 %) at main sea 
level and 91 % (±2 %) by 18,000 feet (p > 0.05).
Average O2 flow rate was 1.8 l/min at main sea level and 1.2 l/min by 
18,000 feet (p > 0.05).
Conclusion At main sea level and 18,000 feet, the tested OCC were 
able to ensure a FiO2 which meets the manufacturer’s standards. How-
ever, we observed a decrease oxygen flow rate during the climbing, 
but was not statistically significant for an O2 flow rate of 2 l/min.
In our study, with an oxygen flow rate of 2  L/min, OCC are able to 
administer the correct oxygen concentration in high altitude.
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